data_2rv8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rv8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.35 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -128.63 123.59 33.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.7 146.76 23.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.624 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.2 m -142.35 155.44 45.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 155' ' ' ASP . 42.7 t80 -163.02 128.01 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.92 -96.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 43.2 p-10 -124.56 53.79 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 143.27 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.155 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -140.13 136.1 33.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.324 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.67 131.74 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -113.74 109.52 18.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.65 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 160' ' ' GLU . 1.5 mp0 -66.68 -12.21 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.838 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.8 -51.98 6.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.589 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 40.6 p -99.21 11.22 39.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 40.6 p-80 35.82 58.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.357 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.33 156.26 42.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.7 148.77 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.52 125.29 12.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 170' ' ' GLN . 31.8 tttm -128.83 117.24 20.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 62.74 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.1 26.26 70.21 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 167' ' ' LYS . 5.9 mt-30 -130.49 92.93 33.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 O-C-N 122.705 -0.291 . . . . 0.0 110.522 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.74 142.21 17.78 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.154 1.902 . . . . 0.0 111.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 131.01 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -88.46 88.35 7.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.92 154.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.42 165.2 32.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.3 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -42.12 -54.62 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.258 . . . . 0.0 112.362 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 53.7 m -57.68 -56.6 19.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.282 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -58.38 -34.69 70.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.933 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.82 -45.31 78.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.1 m -58.87 -39.92 82.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -54.27 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.72 -41.78 87.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -60.48 -46.67 89.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.081 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.684 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 19.5 t80 -62.3 -41.1 98.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.414 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.13 -43.67 82.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.93 -45.45 87.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.09 -37.24 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.84 25.6 11.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.07 124.33 16.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.44 -24.51 15.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.8 m -95.46 131.32 41.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.583 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 t -66.96 119.39 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.285 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 158.47 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.28 148.43 34.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mtpp -56.02 -55.01 46.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.486 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.0 Cg_endo -65.07 -39.96 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.851 1.701 . . . . 0.0 112.055 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.88 -51.55 68.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 37.5 mt -53.24 -42.96 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.179 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.68 -63.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.505 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.18 -29.59 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.259 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.684 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 6.1 t60 -71.2 -46.48 61.18 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.005 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.564 ' C ' ' H ' ' A' ' 204' ' ' ARG . 90.4 t -83.77 -60.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.46 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -50.55 -6.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.049 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.564 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.5 OUTLIER -59.33 -6.81 1.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.46 ' H ' ' C ' ' A' ' 203' ' ' TRP . 13.1 m-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.1 p -86.26 -10.36 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.92 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.71 -24.5 31.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.356 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.44 ' O ' ' OG ' ' A' ' 216' ' ' SER . 21.9 t -64.31 -34.76 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.04 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.93 -45.37 91.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.71 -45.72 77.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.311 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 33.0 p -60.1 -46.75 88.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.05 -38.81 92.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.54 -43.11 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.607 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.72 -45.56 93.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.55 -39.87 92.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.316 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -61.33 -45.81 92.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.269 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' ASP . 47.0 ttt180 -56.18 -43.12 78.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.345 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -67.47 -30.25 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.403 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -91.1 -11.26 39.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 225' ' ' ILE . 0.4 OUTLIER -120.16 -25.1 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.915 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -96.2 137.03 35.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.191 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -70.83 170.74 46.19 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.1 -12.51 59.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -93.32 111.03 22.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.8 ttp85 -92.39 103.81 16.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.02 -5.72 54.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.4 tp -114.3 106.79 14.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.418 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 130.85 39.63 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.46 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.9 m -100.91 112.78 25.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.202 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.4 mt -98.07 69.61 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.066 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' LEU . 71.3 mtt180 -38.26 131.79 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.07 -20.85 49.2 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.2 t -120.08 -58.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 110.422 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.17 -139.22 5.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.89 153.85 49.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.0 135.15 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.78 125.87 35.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.995 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -162.29 134.13 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.199 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -148.46 141.83 25.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.189 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 mt -90.47 151.15 21.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 158.59 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.056 0.455 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 154' ' ' ALA . 82.7 t80 -163.84 139.5 6.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.631 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.51 -104.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -124.63 53.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -138.4 154.26 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.18 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.41 144.84 32.21 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.59 131.73 34.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -114.82 98.95 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.83 -19.06 65.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.59 -31.51 70.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.909 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 33.8 p -129.29 -18.24 3.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.61 ' CE1' ' CD2' ' A' ' 179' ' ' PHE . 2.4 t60 83.81 54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.1 151.34 42.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.51 151.62 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.586 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.55 130.65 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.3 OUTLIER -127.78 111.36 13.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.68 71.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.83 43.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 167' ' ' LYS . 18.7 tp60 -132.19 93.45 26.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.18 139.1 21.01 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.968 1.779 . . . . 0.0 112.558 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.18 140.28 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.633 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 m -91.2 87.26 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.429 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.65 136.01 37.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.671 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 173.01 6.24 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.7 -52.25 9.43 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.26 1.973 . . . . 0.0 112.176 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -56.42 19.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.227 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -58.45 -38.68 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.61 ' CD2' ' CE1' ' A' ' 163' ' ' HIS . 13.1 t80 -61.75 -46.69 88.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.384 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -58.66 -41.57 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.42 -46.88 83.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.835 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.98 -39.79 87.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -58.24 -45.22 88.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.849 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.415 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 4.5 t80 -69.65 -39.29 77.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.2 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -40.97 83.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.627 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.17 -45.33 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.814 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.17 -34.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.415 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 63.1 m-20 -109.26 25.21 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.486 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.57 117.52 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.5 27.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.26 128.74 42.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.897 0.379 . . . . 0.0 110.792 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.69 114.25 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.529 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.62 156.78 16.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.747 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.24 147.91 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 3.7 mttp -58.94 -43.99 98.33 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.316 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 39.5 Cg_exo -54.64 -50.0 14.87 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.367 2.045 . . . . 0.0 111.875 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -62.22 -55.97 23.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -47.88 -43.98 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.934 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.93 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.89 -30.48 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.336 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -72.5 -48.15 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.542 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -83.39 -60.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.413 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -53.41 -4.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.1 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttt180 -62.13 -4.22 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.413 ' H ' ' C ' ' A' ' 203' ' ' TRP . 20.8 m-85 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.594 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.02 -4.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -98.73 -27.23 14.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.255 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.13 -41.33 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.77 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -53.24 -49.76 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.292 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.47 -47.07 87.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.242 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 73.7 m -61.07 -43.87 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.09 -40.62 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.656 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.41 -42.43 95.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.593 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -43.45 96.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -69.3 -30.43 68.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.35 -45.98 68.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.117 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 2.1 mtp180 -56.89 -44.93 82.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.59 -16.75 63.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -94.98 -29.45 14.63 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.683 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.28 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 110.713 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -110.19 137.49 47.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.593 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.52 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.01 -178.63 17.53 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.0 -15.42 63.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 110.649 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -91.58 111.78 23.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -86.01 136.07 33.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.393 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -88.21 -75.4 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.01 146.27 24.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -102.29 138.49 39.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.943 0.402 . . . . 0.0 110.856 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 45.1 m -95.4 110.54 22.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.979 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.61 70.81 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -40.57 120.68 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.39 -16.83 29.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.49 -53.14 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.281 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.09 -138.21 5.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.74 156.32 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.634 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.1 p -134.33 132.13 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.489 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.72 117.01 29.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 232' ' ' LEU . 4.9 ptm180 -162.8 132.04 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.994 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -125.41 124.25 41.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.92 154.81 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 153.65 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.512 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 154' ' ' ALA . 68.7 t80 -166.75 135.84 2.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.515 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.98 -105.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -124.47 53.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.52 145.86 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.221 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 19.7 tt0 -141.1 143.12 34.13 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.458 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.35 128.86 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.6 OUTLIER -113.91 105.3 13.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -65.86 -20.6 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.14 -39.04 84.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 110.665 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 70.3 p -115.9 -24.64 8.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.41 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.591 ' NE2' ' CE2' ' A' ' 179' ' ' PHE . 2.2 t-80 82.77 48.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.281 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -121.77 158.6 28.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 150.42 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.679 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.401 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.46 125.19 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.468 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 170' ' ' GLN . 8.7 tttt -125.61 117.39 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.33 64.13 0.2 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.272 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.25 30.67 67.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 167' ' ' LYS . 12.9 tt0 -133.99 92.92 21.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -76.96 136.41 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.927 1.751 . . . . 0.0 112.448 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.34 143.58 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.937 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.2 p -99.47 87.47 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.3 mt -95.45 154.18 17.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.364 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.0 168.31 23.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -48.8 -53.18 7.33 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.701 2.267 . . . . 0.0 112.572 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -47.59 85.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.91 -39.21 93.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.245 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.591 ' CE2' ' NE2' ' A' ' 163' ' ' HIS . 9.0 t80 -63.66 -48.61 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.682 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -55.49 -43.28 75.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -47.07 85.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.36 -42.37 99.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -59.96 -45.7 91.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.405 ' O ' ' ND2' ' A' ' 188' ' ' ASN . 19.4 t80 -66.04 -42.68 89.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.825 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -45.38 71.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.81 -49.29 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.53 -31.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 188' ' ' ASN . 0.5 OUTLIER -107.17 15.23 25.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -49.69 120.35 4.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.87 -28.89 8.94 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -93.9 131.62 39.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.13 122.24 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.39 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.501 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 149.23 31.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.584 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 13.3 mttp -55.68 -54.35 52.56 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.242 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.0 Cg_endo -66.99 -32.9 33.97 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.047 1.831 . . . . 0.0 111.768 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -47.49 71.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.772 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.02 -44.96 76.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.361 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.4 mt -61.77 -61.52 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.482 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.2 -38.91 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.995 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -72.01 -51.01 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.212 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 204' ' ' ARG . 37.7 t -83.6 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.234 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -51.29 -3.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.032 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.589 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp85 -62.46 -1.33 0.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.671 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 205' ' ' TYR . 42.7 t80 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.781 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.3 p30 . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.55 -6.5 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -88.47 -23.17 23.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.755 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.43 -39.29 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.027 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.86 -50.75 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.251 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -55.56 -48.5 74.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.39 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -43.25 97.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -43.97 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.625 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.1 -41.45 91.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.609 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.92 89.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.527 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.31 -27.15 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.0 -45.31 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.054 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.44 -46.19 80.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.664 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -66.9 -23.14 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.414 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -92.46 -24.33 18.85 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.565 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -112.67 -41.18 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.83 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.9 137.61 39.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.544 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 227' ' ' THR . 0.8 OUTLIER -174.37 37.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.89 179.91 18.86 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -73.45 -8.65 56.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.759 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -92.19 112.08 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.568 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.97 155.85 20.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.59 -38.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.523 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.34 120.15 40.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.68 128.87 47.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.417 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 109.04 20.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.36 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' ARG . 38.1 mt -94.35 69.11 3.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LEU . 40.8 mtm105 -41.07 110.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 124.01 -20.44 7.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.83 -46.66 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.62 -137.07 5.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 1.7 m-85 -125.21 157.12 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.643 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.0 128.94 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.51 142.47 27.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.9 136.29 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.4 mtm-85 -136.89 123.66 21.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.77 152.27 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.507 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -141.88 157.18 45.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.732 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.2 t80 -162.95 127.73 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.87 -98.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 10.2 p30 -125.07 54.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.35 147.23 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.201 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.75 137.23 31.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.534 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.05 137.37 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.551 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.78 108.48 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.455 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.586 ' OE2' ' NH1' ' A' ' 183' ' ' ARG . 25.4 mm-40 -66.52 -10.61 46.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.07 -42.86 8.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.067 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 163' ' ' HIS . 32.7 p -100.89 10.13 41.49 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 162' ' ' THR . 39.0 t-80 36.24 50.94 0.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -124.22 155.36 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.3 t -117.14 159.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.07 129.24 16.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.3 tptp -127.81 110.25 12.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.42 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.57 67.95 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.74 31.45 64.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 167' ' ' LYS . 34.2 tp60 -142.01 87.92 9.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.35 146.42 80.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.115 1.876 . . . . 0.0 112.008 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -128.94 136.8 58.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.734 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.8 m -92.89 86.95 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.37 152.19 18.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.44 169.23 18.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.95 -54.15 4.94 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 112.185 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.453 ' OG1' ' OE1' ' A' ' 178' ' ' GLU . 2.2 p -54.98 -57.35 12.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.021 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -57.48 -39.14 75.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.655 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -63.95 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.753 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 m -59.07 -39.66 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.19 -45.24 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.685 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 tp -63.85 -39.44 94.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.518 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.586 ' NH1' ' OE2' ' A' ' 160' ' ' GLU . 12.5 ttt180 -64.11 -44.8 91.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -62.84 -40.71 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.959 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.56 -45.15 99.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.777 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.8 mt -58.97 -37.05 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.9 28.59 8.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 118.91 5.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.504 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.56 -21.04 22.07 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -96.01 131.68 42.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.674 0.273 . . . . 0.0 110.724 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 192' ' ' VAL . 10.6 p -68.62 117.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.308 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.46 150.66 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.08 148.0 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.963 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 1.7 mttp -58.67 -46.43 99.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.1 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 45.5 Cg_exo -50.15 -51.65 10.51 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.024 1.816 . . . . 0.0 111.989 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.98 -55.23 27.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.321 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -49.17 -41.18 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.943 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.2 tp -61.43 -67.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.8 -16.78 7.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.133 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -71.11 -52.05 21.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.66 -44.3 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.449 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.4 m-90 -65.18 -5.72 7.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -2.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.82 0.343 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.4 p -79.71 -6.0 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.8 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.92 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.66 -48.62 87.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.415 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -52.63 -48.61 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.699 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.3 t -61.8 -48.32 81.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.38 -42.08 81.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.64 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 t -62.88 -46.32 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -43.92 92.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -33.31 74.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -46.19 75.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.081 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 18.2 mtp85 -56.17 -45.11 79.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -67.77 -24.82 65.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.542 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -93.19 -24.41 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.46 HD13 HG22 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.38 -36.4 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 5.4 t0 -98.59 138.49 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 -36.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.542 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.09 165.29 16.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -70.42 -8.33 50.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.855 0.36 . . . . 0.0 110.418 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.88 122.27 34.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -82.28 157.58 23.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.33 -41.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.073 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.1 112.92 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.451 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.561 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.2 m -96.27 108.55 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.194 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 237' ' ' ARG . 7.9 mt -95.41 69.75 3.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -35.57 127.0 0.64 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.104 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.57 39.97 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.16 -49.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.939 0.399 . . . . 0.0 110.204 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.85 -139.51 7.15 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.51 154.02 48.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.54 133.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.68 126.74 36.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.641 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -161.78 135.73 6.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.764 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.728 0.299 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -175.17 154.93 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.954 0.407 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 151' ' ' LEU . 10.9 mp -91.98 147.69 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.1 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -141.96 158.1 44.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.46 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 154' ' ' ALA . 74.8 t80 -168.65 142.9 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.05 -105.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -124.83 52.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.73 152.38 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.581 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -145.79 144.39 30.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.634 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.65 124.73 21.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.845 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.4 m-20 -104.39 105.24 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.775 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.4 -11.6 52.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -95.03 -39.58 10.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.633 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.9 p -103.84 8.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 74.9 m-70 37.52 47.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.21 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -121.82 157.05 31.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.749 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.05 152.04 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.81 125.65 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -126.18 115.41 19.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.48 56.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.5 75.5 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.0 mt-30 -131.07 96.27 22.78 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.27 137.79 15.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.087 1.858 . . . . 0.0 112.469 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.27 137.39 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.9 t -89.96 89.2 7.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.02 155.64 16.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.82 171.64 10.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -51.5 -52.16 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.302 2.002 . . . . 0.0 111.675 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.0 m -56.3 -52.08 65.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.956 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.92 -41.7 87.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.459 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 27.0 t80 -60.98 -44.58 97.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.101 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -58.0 -44.84 87.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.636 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -44.37 97.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -43.67 93.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -59.07 -45.16 91.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.55 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 14.1 t80 -65.34 -42.02 93.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.82 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.511 ' CD2' ' OH ' ' A' ' 241' ' ' TYR . 2.9 m-85 -54.6 -39.72 68.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.66 -49.31 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.099 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.3 -32.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.745 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.538 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 59.8 m-80 -107.91 18.17 21.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.56 114.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.709 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.07 -19.26 18.04 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.4 m -95.78 132.45 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.87 115.47 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.58 159.97 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.023 0.44 . . . . 0.0 110.532 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 147.72 28.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.58 -54.8 51.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.062 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.9 Cg_endo -66.84 -33.64 33.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.96 1.773 . . . . 0.0 111.693 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -64.28 -51.64 62.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.09 -41.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.87 -66.9 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -49.91 -28.24 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.101 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 69.9 t60 -72.19 -57.54 4.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 204' ' ' ARG . 57.3 t -83.42 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.378 . . . . 0.0 111.613 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.497 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.7 OUTLIER -49.12 -4.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.605 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.4 ttm180 -59.31 -0.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.072 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.6 m -79.05 -8.26 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.894 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -82.97 -14.82 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 80.9 t -68.75 -36.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.93 -49.81 79.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.204 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.83 -44.62 90.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.066 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 m -60.84 -46.97 88.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.71 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.42 -41.45 98.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.615 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.52 -43.33 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -45.53 91.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -28.96 68.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.05 -46.06 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 226' ' ' ASP . 32.9 ttm180 -56.03 -47.21 78.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.382 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -67.29 -15.56 63.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.504 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -93.45 -34.24 13.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.477 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.424 ' O ' ' CE ' ' A' ' 167' ' ' LYS . 2.1 pp -109.89 -36.14 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -98.42 141.79 30.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.337 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -161.4 25.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -117.93 169.03 13.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -65.89 -7.89 19.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.599 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 129.34 39.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.745 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.8 113.77 25.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.71 -4.82 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.102 0.477 . . . . 0.0 110.746 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.48 104.92 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.385 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 122.74 33.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.37 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.25 115.39 28.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 9.1 mt -96.1 69.17 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 31.5 mtp180 -35.84 128.19 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.738 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.68 -12.47 66.06 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.0 t -128.4 -60.26 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.88 -139.29 5.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -130.61 154.06 48.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.351 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 7.2 p -135.5 137.44 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.0 tp -91.92 116.9 29.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.225 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -162.27 144.47 11.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.837 0.351 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -123.43 121.51 35.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.87 159.5 16.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.36 153.94 47.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.981 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.9 t80 -160.26 125.16 3.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.472 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.62 -98.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' PHE . 13.5 m-20 -125.61 54.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.62 148.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.416 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -138.98 133.23 31.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.556 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.6 mp -128.6 140.17 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -113.07 102.39 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 0.0 110.376 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.0 -13.11 59.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -96.59 -50.08 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.824 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 50.3 p -94.08 11.86 28.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.504 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 96.5 m-70 36.27 53.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.87 157.37 29.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.428 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.18 156.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.39 128.2 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.456 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.5 ttpt -126.88 106.44 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.22 71.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.03 30.42 37.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.8 tt0 -140.95 85.9 12.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -63.42 154.07 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.411 2.074 . . . . 0.0 112.554 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.15 121.47 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.638 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 t -92.38 87.01 5.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.36 155.37 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -62.37 178.95 0.3 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.736 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 175' ' ' SER . 5.6 Cg_exo -67.6 -48.4 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.441 2.094 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.7 m -46.13 -54.18 9.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.298 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -43.68 84.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -55.8 -44.84 78.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -59.67 -46.99 87.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.575 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.77 -42.32 99.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.11 -46.12 90.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.743 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.55 -41.57 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.034 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.58 -43.78 88.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.72 -42.03 82.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.36 -53.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.92 -31.78 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.64 19.89 19.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.47 119.94 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.66 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.41 -25.83 10.14 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -94.16 126.38 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.56 120.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.349 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.29 157.62 15.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 148.62 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -56.41 -52.31 74.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.634 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.5 Cg_endo -63.83 -41.24 24.72 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.721 1.614 . . . . 0.0 112.155 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -60.91 -48.79 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.272 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.86 -40.47 71.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.917 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.431 ' CD2' ' C ' ' A' ' 199' ' ' LEU . 1.9 tt -56.68 -61.83 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.979 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -17.03 64.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.439 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.18 -45.6 63.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.581 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 204' ' ' ARG . 71.2 t -84.53 -53.7 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.793 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' A' ' 205' ' ' TYR . 4.8 m-90 -64.01 -3.07 2.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.528 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.6 ttp180 -40.97 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 203' ' ' TRP . 6.4 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.869 0.366 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.49 -10.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.665 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -91.53 -23.11 20.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.34 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.397 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.79 -48.0 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.181 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.35 -45.54 87.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.49 98.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -40.68 89.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.24 -41.29 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -44.3 88.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.0 -27.43 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.27 -48.76 32.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.105 0.479 . . . . 0.0 110.188 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 14.6 ttp180 -56.6 -51.32 69.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -67.05 -8.04 27.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -91.64 -37.46 13.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -117.54 -34.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.085 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -98.24 151.26 20.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.808 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.9 t -177.46 -30.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.209 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -65.38 174.02 18.66 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -67.08 -5.7 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.821 0.344 . . . . 0.0 110.795 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -92.96 104.77 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.477 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.6 107.31 18.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.56 -2.55 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.504 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.11 103.62 8.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.336 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 122.92 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 0.0 110.603 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.1 m -91.26 112.14 23.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.744 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.8 mt -96.29 70.12 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 236' ' ' LEU . 5.9 tpp180 -35.69 116.87 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.797 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.76 -9.97 40.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.9 -36.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.48 -137.39 8.89 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.8 150.75 51.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.24 141.08 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.08 116.57 28.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.135 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -162.2 127.5 3.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.646 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.5 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.99 0.424 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -135.85 128.94 31.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.19 149.12 21.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.7 m -141.6 155.83 45.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.5 t80 -158.15 124.48 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.989 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -94.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 153' ' ' PHE . 4.1 m-20 -124.41 53.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.3 151.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.37 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -147.76 140.7 24.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.576 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.89 138.92 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.424 ' CB ' ' OG1' ' A' ' 162' ' ' THR . 12.8 m-20 -111.36 106.37 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.382 . . . . 0.0 110.489 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -9.95 38.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.064 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.96 -47.37 4.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.015 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.0 p -94.73 8.48 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.768 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 162' ' ' THR . 12.7 m80 36.53 55.35 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -128.64 154.13 46.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.486 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.57 152.84 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.95 126.71 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.799 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 170' ' ' GLN . 10.0 tmtt? -130.13 115.69 17.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.341 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.04 67.88 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 56.7 29.47 58.19 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.1 tt0 -132.09 89.4 38.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.98 132.0 12.5 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.08 1.853 . . . . 0.0 112.475 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 135.56 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.741 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 96.51 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.7 148.19 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.562 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.31 169.85 18.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -54.18 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -49.44 77.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -60.71 -38.76 86.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.1 -46.39 87.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -63.13 -41.19 99.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.8 -48.87 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.555 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.1 -44.99 87.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.553 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -55.39 -42.69 74.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.53 -43.92 75.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.77 -41.39 73.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.5 -48.68 79.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.94 -32.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.791 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -106.45 23.12 14.7 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.093 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.51 116.6 3.2 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.31 10.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.9 m -91.76 129.4 37.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 110.291 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 68.8 t -67.57 121.28 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.1 162.69 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.96 147.96 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.1 mtmt -58.21 -54.75 52.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.252 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.6 Cg_endo -68.85 -30.64 26.49 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.923 1.749 . . . . 0.0 111.819 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -67.41 -50.73 58.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.933 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.9 mt -57.16 -39.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 210' ' ' ASP . 5.7 tt -59.47 -67.88 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.342 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -25.55 3.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -50.67 27.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.841 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' A' ' 204' ' ' ARG . 98.9 t -83.28 -59.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.657 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.551 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -52.73 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.5 tpp180 -53.54 -4.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.551 ' H ' ' C ' ' A' ' 203' ' ' TRP . 14.2 m-85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 m-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.2 p -84.15 -9.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.771 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -90.41 -23.94 20.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.771 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.18 -41.17 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.516 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.87 -50.58 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.327 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -56.64 -46.55 80.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -44.85 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.794 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.88 -38.84 89.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.62 -39.96 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.32 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -44.68 78.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.184 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -69.72 -14.15 62.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.4 -46.82 9.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.939 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.1 mtt-85 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -66.08 -14.5 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -93.13 -27.06 17.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 225' ' ' ILE . 0.1 OUTLIER -118.25 -45.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.592 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.3 t70 -93.67 137.1 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.005 0.431 . . . . 0.0 110.642 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.6 t -179.23 36.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.161 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -143.21 165.39 27.03 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.48 -3.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 228' ' ' GLY . 24.6 mttt -93.46 133.01 37.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.633 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -92.81 158.9 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.365 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.8 mt -147.21 -55.43 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.308 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.42 126.79 48.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.503 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 125.08 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.51 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 112.4 24.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 68.9 mt -96.22 67.82 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.67 115.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 -12.34 24.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.03 -55.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.512 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.83 5.69 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.5 152.45 49.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.718 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.9 p -136.03 131.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.184 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.88 128.7 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -162.89 138.2 6.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.296 179.813 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.713 0.292 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.54 HH12 ' CG ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -172.07 -178.32 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.532 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.49 154.07 41.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.6 m -139.29 156.7 46.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 156' ' ' ILE . 37.1 t80 -161.59 132.58 5.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.98 -102.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -121.38 52.48 1.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.85 141.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.213 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.54 ' CG ' HH12 ' A' ' 150' ' ' ARG . 15.8 tt0 -140.05 134.03 30.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 110.401 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -130.28 136.61 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 163' ' ' HIS . 83.3 m-20 -113.89 104.81 12.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.89 -27.76 68.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.789 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.64 -44.21 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 59.4 p -102.59 9.5 39.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.497 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CG ' ' C ' ' A' ' 162' ' ' THR . 12.6 p-80 37.13 55.2 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -126.85 158.92 35.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.4 t -121.75 155.01 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.648 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.33 125.19 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.5 tttm -124.81 109.06 12.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.26 57.34 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.121 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.76 29.15 71.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 167' ' ' LYS . 27.6 mt-30 -141.74 89.96 8.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.788 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -64.71 147.19 89.73 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 112.129 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.96 136.45 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -88.55 87.72 7.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.29 144.67 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.29 162.96 54.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.514 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.7 -53.83 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.51 2.14 . . . . 0.0 112.427 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 p -59.93 -50.04 75.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.78 -34.53 77.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.71 -46.32 79.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -58.12 -43.92 87.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 mt -58.19 -48.35 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.64 89.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -57.74 -44.79 86.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.558 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -66.23 -43.36 86.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.62 -46.55 77.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.604 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.76 -46.01 95.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.85 -38.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -104.3 23.92 12.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.98 123.58 11.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.4 -27.59 13.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.61 129.87 38.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 123.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.352 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.68 157.32 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 148.98 29.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.361 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.7 mtpt -56.57 -53.97 58.59 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 37.1 Cg_endo -71.4 -32.49 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.963 1.775 . . . . 0.0 111.828 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -64.2 -50.49 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.9 mt -56.91 -42.43 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.46 -63.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.21 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.34 -28.6 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -72.4 -52.01 17.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.303 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.0 t -82.94 -62.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.211 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.417 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.0 OUTLIER -51.17 -4.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.5 ttt180 -63.19 -3.89 2.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.892 0.377 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.4 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.448 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.971 0.415 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.5 -8.4 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -85.24 -15.83 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.888 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.55 -33.34 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.43 -50.31 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.216 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.11 -49.24 72.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -63.78 -39.97 95.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.46 -42.58 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' NH1' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -62.79 -43.65 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.39 -37.66 85.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.255 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.22 -46.78 85.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.069 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.42 -42.66 78.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.97 -10.12 50.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -39.14 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.69 -30.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.208 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 222' ' ' ARG . 19.9 t0 -91.57 -160.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.476 ' H ' ' CG ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER 72.14 6.11 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.73 -139.59 5.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -36.91 11.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -92.5 120.45 32.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.018 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 19.4 mtp85 -90.5 92.75 9.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.971 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -0.91 57.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.82 110.18 12.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.48 42.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.639 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 74.9 m -97.63 113.45 25.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 237' ' ' ARG . 4.9 mt -98.95 67.76 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.646 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.6 mtm180 -37.49 125.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.838 0.351 . . . . 0.0 110.79 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.72 -32.86 6.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.55 -56.77 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.457 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.24 -137.46 4.94 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.39 157.07 42.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.37 142.4 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 111.074 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.86 118.02 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.053 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -161.76 129.78 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.023 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.861 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -138.59 130.05 27.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.64 140.61 29.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 m -142.09 152.37 43.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.1 t80 -166.25 139.11 3.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.03 -104.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.37 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.13 147.17 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.991 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -144.62 141.67 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.712 0.292 . . . . 0.0 110.428 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -135.52 136.74 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.388 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.02 108.49 17.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.288 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -66.27 -9.95 37.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.661 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -100.2 -43.75 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.916 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' HIS . 25.6 p -95.74 9.04 41.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 162' ' ' THR . 10.9 m170 35.65 41.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.621 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -122.44 159.02 28.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.773 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.1 t -118.94 158.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.44 123.42 11.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.51 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.9 tmtm? -127.47 115.03 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.255 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.16 67.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.43 31.46 63.05 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -133.55 90.87 27.62 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.53 138.72 15.64 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.203 1.935 . . . . 0.0 112.36 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.18 138.74 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m -85.63 93.09 8.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.91 140.86 30.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.13 174.03 6.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.95 -53.49 7.07 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.382 2.055 . . . . 0.0 112.097 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.0 m -54.96 -56.65 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.773 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.98 -37.24 81.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.49 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.74 -46.36 88.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.63 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -58.65 -41.0 85.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -52.53 64.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.658 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.8 -41.86 87.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.503 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -62.41 -44.53 96.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.417 ' OH ' ' CE1' ' A' ' 201' ' ' HIS . 1.3 t80 -59.25 -39.73 83.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.77 -41.15 99.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.185 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.65 -43.24 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.962 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.8 -42.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.12 26.91 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.21 20.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.709 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.09 -23.5 30.5 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 126.8 41.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.821 0.343 . . . . 0.0 110.294 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.25 116.66 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 mp -96.56 153.12 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.15 149.23 24.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.313 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.69 -46.69 99.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.506 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 37.2 Cg_exo -55.11 -47.14 28.02 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.867 1.712 . . . . 0.0 111.897 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -61.91 -57.32 12.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.5 mt -50.63 -36.24 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.19 -58.33 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.146 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.43 -27.53 68.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.814 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' CE1' ' OH ' ' A' ' 184' ' ' TYR . 0.2 OUTLIER -73.2 -59.83 2.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.623 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.6 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -84.54 -58.22 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.704 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.464 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 t-105 -51.76 -4.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.055 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.6 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.8 ttt-85 -64.24 0.33 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.591 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 m-85 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.608 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.8 m -80.82 -1.0 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.7 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -95.14 -23.72 17.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 216' ' ' SER . 66.7 t -62.15 -38.47 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -44.6 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.85 -48.9 74.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 4.8 p -60.94 -44.18 97.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.337 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -40.44 97.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.54 -41.56 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.485 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -44.87 94.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 110.211 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -65.15 -37.85 88.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.56 -44.74 85.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.379 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 226' ' ' ASP . 21.7 mtp180 -55.28 -42.63 73.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -16.13 64.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -93.07 -26.63 17.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.509 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.87 -38.47 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.769 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.5 OUTLIER -98.3 136.67 38.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.503 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -173.27 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.872 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.25 179.87 0.73 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -79.39 -12.62 59.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.7 0.286 . . . . 0.0 110.716 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.66 122.19 35.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -82.67 158.35 23.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mp -146.78 -42.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.008 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.63 112.05 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.16 122.79 40.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.6 m -92.6 107.09 18.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.4 mt -93.21 71.8 4.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 57.5 mtp180 -36.78 133.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.644 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.23 74.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.12 -58.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.952 0.406 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 156.07 -139.61 6.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -129.17 154.6 46.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.551 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.0 p -136.67 132.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.91 126.28 35.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -162.22 130.43 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.5 mtm-85 -106.33 -177.17 3.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.0 mt -145.94 133.3 20.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.205 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -139.23 156.86 46.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 155' ' ' ASP . 8.8 t80 -164.92 130.85 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.89 -99.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 74.4 m-20 -124.45 53.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.43 144.39 30.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.349 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -140.29 131.0 25.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.946 0.403 . . . . 0.0 110.557 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.49 152.2 47.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.34 107.63 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.3 -12.23 55.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -96.11 -49.71 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.3 p -92.57 11.18 27.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.479 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 15.0 m80 35.27 48.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -117.58 159.92 22.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 t -125.43 150.09 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.428 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.3 127.09 14.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.512 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.8 tmtm? -129.45 114.13 15.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' CB ' ' HZ2' ' A' ' 167' ' ' LYS . . . 31.88 71.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.55 24.82 32.93 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.9 tt0 -129.02 94.73 33.26 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.488 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.94 137.28 12.34 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.158 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.63 135.83 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.068 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 m -92.63 88.96 6.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.5 153.94 17.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.67 171.48 10.52 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.455 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.8 -54.07 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.492 2.128 . . . . 0.0 112.319 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.3 m -54.76 -54.25 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.75 -38.01 83.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 110.756 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 22.5 t80 -63.57 -43.21 97.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.6 m -62.42 -43.46 98.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -59.35 -43.91 92.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 38.4 tp -71.36 -38.47 71.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.659 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -58.19 -41.24 83.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.691 ' CZ ' ' NE2' ' A' ' 201' ' ' HIS . 15.4 t80 -69.83 -39.85 76.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.804 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.61 -41.95 82.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.9 -48.16 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.64 -31.41 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.08 21.25 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.0 118.35 3.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.81 -19.62 35.38 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 m -98.27 126.97 43.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.5 p -68.53 122.08 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.59 159.82 14.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 147.85 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.796 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.4 mtmm -56.84 -56.69 30.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -63.64 -32.67 68.84 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.013 1.808 . . . . 0.0 111.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -68.61 -51.72 39.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.951 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 mt -53.0 -36.94 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.893 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.403 ' CD2' ' CG ' ' A' ' 203' ' ' TRP . 0.9 OUTLIER -61.21 -70.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.422 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -52.18 -17.33 1.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.155 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.691 ' NE2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.57 -53.38 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.099 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.2 t -83.26 -40.42 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.525 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -60.67 -3.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 202' ' ' VAL . 25.9 ttt180 -61.41 -0.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.6 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.085 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.901 0.381 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.2 m -83.4 -8.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -23.03 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.56 -35.5 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.16 -52.46 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.64 -45.5 91.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -44.84 96.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 110.735 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -61.52 -44.96 96.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -37.93 79.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.523 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -46.26 76.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.2 -17.41 63.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.389 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -49.19 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.069 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -55.75 -47.7 76.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.169 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -67.3 -13.04 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.553 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -95.05 -32.73 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.471 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.64 -34.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.222 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -100.08 140.04 34.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 110.69 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.23 -37.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -55.68 174.3 1.09 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.93 -9.4 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.799 0.333 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 104.64 16.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.655 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -83.69 112.59 20.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.486 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.83 1.05 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.09 107.11 12.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.25 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.63 123.37 35.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 67.9 m -90.96 111.2 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.037 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 237' ' ' ARG . 47.0 mt -95.85 68.27 2.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.467 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.4 tpp180 -38.52 124.26 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.25 -14.09 47.93 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.79 -56.79 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.632 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.19 -137.3 4.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 29.4 m-85 -128.37 156.96 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.55 133.55 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.6 tp -90.84 128.63 36.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -163.35 135.25 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.629 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.944 0.402 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.2 mtm105 -142.46 129.44 20.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.66 158.16 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.19 155.94 45.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.619 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 154' ' ' ALA . 28.0 t80 -165.47 129.81 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.912 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.5 -99.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.1 m-20 -124.67 54.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.43 152.16 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.604 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.78 145.65 35.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.408 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -143.67 116.95 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.63 108.22 18.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.57 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -66.71 -24.95 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -50.59 -40.35 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 69.7 p -119.53 -23.9 6.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.5 t-80 84.02 53.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.384 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -127.39 156.82 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.654 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 t -117.0 153.76 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.44 126.95 15.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 170' ' ' GLN . 16.0 ttpp -126.04 113.07 16.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.13 67.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.016 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.46 32.81 64.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -137.56 92.14 13.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.89 139.96 20.04 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.095 1.864 . . . . 0.0 112.326 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.82 140.8 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.911 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -96.29 90.19 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.386 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.68 150.18 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.672 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 169.43 17.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.77 -54.53 4.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.533 2.155 . . . . 0.0 112.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.327 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -57.07 -37.2 71.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -59.3 -46.08 89.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.4 m -63.82 -41.1 97.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.284 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -46.7 84.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -45.33 86.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.712 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -60.24 -42.98 96.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.658 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 11.6 t80 -65.25 -40.35 93.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -43.01 89.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.684 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.31 -45.35 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.8 -34.65 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.753 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -106.64 22.33 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.682 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.95 110.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.9 -27.52 7.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.3 132.39 33.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.27 113.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.49 ' HG ' ' H ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -107.85 148.02 30.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.64 -51.34 82.42 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.544 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 24.4 Cg_endo -64.13 -37.84 39.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.601 1.534 . . . . 0.0 111.682 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.49 ' H ' ' HG ' ' A' ' 194' ' ' SER . 31.6 tttt -65.76 -44.84 84.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.052 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.85 -41.99 68.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' TRP . 5.0 mt -61.93 -65.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -41.4 -34.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.658 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 53.7 t-80 -71.76 -53.78 12.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.9 t -83.54 -57.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -53.16 -2.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.217 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -60.76 -3.1 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.567 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.477 ' H ' ' C ' ' A' ' 203' ' ' TRP . 39.0 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.978 0.418 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.7 m -81.75 -6.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.562 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.22 -18.98 23.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.789 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.93 -33.5 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.278 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.28 -51.14 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.71 -46.01 70.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.982 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -48.55 81.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.47 -39.21 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.497 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.5 -42.23 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.256 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -25.48 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.24 -42.48 45.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 226' ' ' ASP . 44.5 ttt180 -55.79 -50.4 70.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.5 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -7.43 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.115 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -42.05 10.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.47 -25.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.398 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -101.99 146.35 28.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.935 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.7 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.62 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -49.23 162.86 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.0 -8.12 34.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.01 126.6 38.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -81.12 159.62 24.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.553 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.08 -41.17 0.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.969 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.9 114.67 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 124.32 42.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.534 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.56 114.61 27.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 238' ' ' GLY . 11.2 mt -95.88 68.72 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.161 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -41.87 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.162 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 236' ' ' LEU . . . 129.68 -13.28 5.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.55 -50.32 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.659 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.76 -137.71 5.46 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 151.65 50.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 127.65 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.4 tp -90.49 138.03 31.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.08 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 139.89 7.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.463 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.714 0.292 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -122.26 121.04 35.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mt -90.54 147.78 23.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.2 154.32 46.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.095 0.474 . . . . 0.0 111.094 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 155' ' ' ASP . 62.4 t80 -159.29 126.98 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.599 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.29 -96.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 1.2 p30 -124.34 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.56 145.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -144.21 138.68 28.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.787 0.327 . . . . 0.0 110.424 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.43 139.45 42.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.07 102.91 11.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 0.0 110.588 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.12 -8.94 26.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -99.0 -45.28 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.729 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.7 p -98.88 13.04 33.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.338 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 1.0 OUTLIER 35.12 54.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.635 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.26 152.49 48.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.25 157.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.35 125.85 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.479 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 19.2 tptt -122.9 110.53 15.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.397 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.58 59.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.483 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 23.65 77.72 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 24.5 mt-30 -131.86 95.99 21.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.402 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.49 134.92 14.3 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.082 1.855 . . . . 0.0 112.439 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.5 143.79 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.772 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.43 95.39 9.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.631 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.71 154.17 17.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.46 ' H ' ' HG ' ' A' ' 175' ' ' SER . 0.1 OUTLIER -88.48 172.46 7.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.262 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.37 -51.27 11.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.459 2.106 . . . . 0.0 112.149 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.2 m -58.1 -54.61 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.77 -43.96 77.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.483 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.92 -48.56 81.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.526 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 m -56.77 -46.32 81.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.586 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.46 -47.05 87.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.69 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.51 -41.53 98.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -59.57 -45.2 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.388 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -61.62 -43.98 97.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.615 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -55.51 -47.86 75.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -47.06 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.019 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mm -54.9 -34.32 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.786 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -112.53 20.4 16.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.0 119.59 4.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.28 -26.28 10.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.6 m -97.82 129.59 44.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.803 0.335 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.89 117.01 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.64 160.03 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.667 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.97 148.84 26.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.63 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 0.4 OUTLIER -58.06 -49.48 93.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 35.9 Cg_exo -54.08 -44.17 51.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.373 2.048 . . . . 0.0 111.778 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -59.93 3.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.4 mt -48.25 -42.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.49 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.502 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 17.0 t0 -53.7 -24.03 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.594 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 51.7 t-80 -71.84 -50.36 30.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.715 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.1 t -84.75 -62.17 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -49.35 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.337 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.7 ttp85 -60.9 -0.57 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.437 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 203' ' ' TRP . 12.2 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.916 0.389 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.66 -6.43 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.081 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -82.64 -18.21 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.392 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.99 -37.45 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.06 -49.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.868 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.35 -47.52 72.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.55 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.1 p -60.96 -47.52 86.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -38.56 91.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.0 -47.57 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.415 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -44.66 92.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.303 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.25 -23.3 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -76.73 -44.99 31.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.015 0.436 . . . . 0.0 110.151 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 226' ' ' ASP . 33.7 ttt-85 -55.44 -49.65 71.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.957 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -68.25 -7.52 31.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -94.38 -32.61 13.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.541 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.9 -7.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.124 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -116.09 138.25 51.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.006 0.431 . . . . 0.0 110.857 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 t -170.52 39.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.5 163.45 26.82 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.4 -5.61 11.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.733 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.98 104.48 16.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -86.81 101.26 13.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.44 1.87 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.588 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.92 96.46 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.57 125.83 34.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.718 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 44.3 m -95.83 112.32 24.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.65 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.6 mt -95.57 73.45 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.366 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 43.3 ttm-85 -35.92 128.03 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.55 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.46 61.21 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.2 -58.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 110.828 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.14 -138.1 5.6 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -127.11 156.28 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 0.0 110.711 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.7 136.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.462 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.22 112.41 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.355 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -162.2 131.49 4.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.474 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -126.53 121.06 31.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.37 148.78 22.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -143.71 156.68 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.8 t80 -163.85 130.27 3.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.56 -97.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 153' ' ' PHE . 5.1 m-20 -124.85 53.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.12 146.26 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -143.37 137.38 28.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 mt -132.53 134.59 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.124 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.1 m-20 -107.66 104.39 13.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.141 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.92 -11.6 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.722 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.47 -38.92 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.446 ' C ' ' ND1' ' A' ' 163' ' ' HIS . 2.7 p -99.81 6.59 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.227 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.446 ' ND1' ' C ' ' A' ' 162' ' ' THR . 52.0 p-80 36.77 51.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -122.06 158.28 29.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.5 t -128.4 147.69 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.39 127.51 15.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.5 tmtt? -130.78 112.46 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.268 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.47 68.98 0.11 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.055 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.15 57.34 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 167' ' ' LYS . 7.1 tt0 -130.64 90.83 39.35 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.25 142.58 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.92 1.747 . . . . 0.0 112.113 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.81 132.27 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.259 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.0 t -95.33 119.91 34.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.656 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -142.61 135.06 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.711 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.21 175.2 0.42 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.824 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.46 -41.83 73.39 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.481 2.12 . . . . 0.0 112.601 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.37 -65.83 0.49 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 111.104 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -60.09 -33.34 71.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.29 -50.39 73.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -41.33 85.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.81 -48.62 80.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.579 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -40.61 96.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.12 -45.13 91.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.498 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.585 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 26.5 t80 -65.65 -40.83 92.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -40.99 69.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.3 t -72.87 -42.99 60.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.43 -27.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.72 18.33 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.02 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.88 119.0 3.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.792 0.33 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.6 -26.6 10.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.9 m -94.72 130.15 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.43 114.77 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -95.12 153.63 17.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.89 148.42 26.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 16.2 mtpt -56.12 -54.92 47.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.991 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.0 Cg_endo -64.81 -32.15 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.782 1.655 . . . . 0.0 111.922 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -66.87 -48.81 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.288 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.5 mt -55.7 -39.82 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.771 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.38 -66.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -49.26 -29.34 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.585 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.7 t60 -72.01 -48.48 44.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.078 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 204' ' ' ARG . 42.4 t -84.04 -59.86 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.554 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.466 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.5 OUTLIER -49.55 -4.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.604 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.7 ttp180 -61.92 -2.55 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.637 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.466 ' H ' ' C ' ' A' ' 203' ' ' TRP . 58.5 m-85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.9 -9.74 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.072 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.04 -22.75 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.3 p -65.68 -40.04 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.305 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.458 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 12.7 t -60.4 -46.19 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.131 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.91 -48.04 79.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -45.18 95.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.62 -40.88 98.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.755 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.6 t -62.42 -39.73 85.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -45.38 81.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -68.49 -17.17 64.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.77 -47.98 11.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.676 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.9 OUTLIER -55.99 -38.55 70.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.471 179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -66.1 -29.15 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.504 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -28.56 15.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.659 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.17 -38.79 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.136 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 222' ' ' ARG . 9.2 t0 -100.27 -151.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 226' ' ' ASP . 68.6 p 54.07 10.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.499 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 226' ' ' ASP . . . -85.09 -136.07 3.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.18 -44.74 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.796 0.332 . . . . 0.0 110.269 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 107.26 19.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.581 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.413 ' CD ' ' H ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -82.87 91.15 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.9 -5.6 52.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.294 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.68 122.47 47.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.78 130.24 56.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.644 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.0 m -95.65 115.95 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.2 mt -95.92 77.16 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.29 119.97 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.78 -2.88 57.21 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.35 -58.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.77 -136.03 4.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 40.4 m-85 -127.59 153.96 45.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.749 0.309 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.8 133.1 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.49 121.38 33.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -161.46 133.81 5.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.174 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.088 179.536 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -125.68 121.17 32.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.182 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.64 150.77 21.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 m -141.15 158.34 44.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 1.4 t80 -165.46 131.51 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.519 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 38.23 -99.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 19.3 m-20 -124.96 53.36 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.94 150.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.278 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -142.41 140.88 32.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.74 131.59 33.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.437 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -113.65 108.17 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.5 -9.65 36.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.19 -52.58 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.651 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 51.3 p -98.14 9.76 42.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.266 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 47.3 m80 37.12 59.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.777 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -132.63 153.81 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.71 151.81 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.232 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.19 125.49 13.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.5 tttp -124.99 115.12 20.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.36 56.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.378 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.39 23.76 75.04 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.2 mt-30 -132.29 101.6 14.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -76.77 136.78 17.26 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.82 1.68 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.16 139.25 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.446 ' H ' ' HG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -97.91 121.68 40.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.416 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.06 140.68 34.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.765 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.87 173.46 4.77 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.98 -40.82 79.52 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.47 2.113 . . . . 0.0 112.576 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.7 m -51.11 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.62 -33.55 72.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.238 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -58.51 -52.79 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.9 m -57.6 -40.62 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 -47.16 85.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.58 -42.18 95.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.704 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -44.87 87.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.35 -42.13 88.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.44 -41.78 77.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.73 -49.12 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.67 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.9 mt -55.82 -36.15 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.012 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -109.96 23.76 13.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.3 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.77 118.78 4.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.81 10.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 m -90.01 129.6 36.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.05 120.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.552 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.94 163.93 12.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.09 148.39 29.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.962 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 4.1 mttt -56.67 -54.02 58.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.078 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 28.4 Cg_endo -70.57 -31.99 15.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.913 1.742 . . . . 0.0 112.043 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.61 -46.43 85.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.216 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.65 -39.81 86.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.62 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 203' ' ' TRP . 8.5 tp -64.25 -50.31 68.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.643 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 13.4 t70 -64.73 -30.2 71.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.444 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -72.0 -57.23 4.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.43 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.2 t -84.42 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.683 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -50.12 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.681 -179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -67.08 -3.21 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.441 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.656 -179.907 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 212' ' ' ASN . 1.3 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.867 0.365 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 211' ' ' VAL . 90.4 t -64.02 1.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 210' ' ' ASP . 57.9 m-20 -100.17 -30.69 11.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.08 -39.43 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.284 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.87 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.002 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -53.45 -49.56 67.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -46.19 90.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.23 -38.88 90.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.29 -43.15 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.734 0.302 . . . . 0.0 110.585 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -42.93 85.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -71.6 -13.24 61.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.15 -48.74 9.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.807 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 70.1 mtt180 -56.67 -44.04 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.367 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -19.36 65.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.982 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -93.96 -28.55 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.364 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 225' ' ' ILE . 0.4 OUTLIER -109.37 -39.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.228 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.29 145.38 25.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.9 t -176.79 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -145.34 167.29 27.47 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.26 -6.45 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.721 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -92.72 104.59 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.444 ' O ' ' CD2' ' A' ' 232' ' ' LEU . 45.6 mtt85 -78.93 160.16 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.444 ' CD2' ' O ' ' A' ' 231' ' ' ARG . 4.7 mt -146.16 -36.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.24 111.88 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.607 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.16 129.88 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.329 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 111.75 23.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' ARG . 3.8 mt -95.25 69.54 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.159 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' LEU . 3.7 ptt85 -35.09 128.28 0.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.95 -13.82 60.39 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.2 t -128.85 -58.17 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.416 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 159.42 -137.28 5.05 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.47 157.91 40.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.08 136.23 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 26.4 tp -93.05 118.91 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.505 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.67 131.01 3.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 0.0 111.04 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 179.701 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.757 0.313 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -140.78 132.93 27.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.77 151.56 21.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.82 156.84 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.0 t80 -166.06 125.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.86 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.3 p-10 -124.97 54.34 1.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.55 151.58 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.466 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -146.25 143.71 29.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.48 127.67 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.355 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.4 OUTLIER -113.33 103.15 11.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.839 0.352 . . . . 0.0 110.452 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.93 -12.48 55.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -71.63 -30.64 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 7.0 p -121.82 -25.39 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 162' ' ' THR . 4.9 t-80 83.13 47.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.871 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -124.26 160.09 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -146.23 125.42 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.7 tmtt? -130.05 117.65 20.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.374 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.98 70.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.04 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.02 34.69 52.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -136.68 91.31 15.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.554 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.81 137.82 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.316 2.011 . . . . 0.0 112.12 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.72 131.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 91.74 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.68 150.97 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.777 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 168.67 25.26 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.189 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.44 -53.9 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.408 2.072 . . . . 0.0 112.309 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -55.84 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -61.96 -38.48 88.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -48.34 82.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.2 m -58.97 -39.05 80.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.85 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.708 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.31 -42.58 91.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.69 -41.13 79.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.551 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -54.6 -43.81 72.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.8 -46.07 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.91 -38.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -107.87 26.57 10.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.86 117.64 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.664 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.37 -27.18 12.92 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.61 130.36 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.64 114.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.538 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -97.25 158.2 15.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.84 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.33 147.39 31.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.292 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -58.06 -52.99 70.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.208 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -62.84 -31.97 77.68 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.746 1.631 . . . . 0.0 112.2 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -68.9 -49.99 53.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.054 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.4 mt -55.91 -36.93 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.22 -70.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.787 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.534 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 0.0 OUTLIER -54.2 -23.87 16.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.512 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -73.9 -60.09 2.42 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.612 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 204' ' ' ARG . 99.4 t -85.82 -61.52 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.414 ' C ' ' H ' ' A' ' 205' ' ' TYR . 48.0 m95 -53.45 -3.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.833 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 200' ' ' ASP . 0.6 OUTLIER -63.16 -3.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 203' ' ' TRP . 4.3 t80 . . . . . 0 C--N 1.33 -0.279 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.74 0.305 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.28 -8.01 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.648 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -99.99 -29.22 12.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 2.5 p -66.28 -39.74 85.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.638 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.455 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 25.0 t -56.41 -50.5 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.106 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.03 -48.52 78.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.278 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -45.15 93.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -63.63 -41.83 98.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.28 -41.39 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.2 t -62.59 -47.93 81.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -33.45 75.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.369 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -67.32 -46.67 72.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.341 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.46 -44.18 76.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.316 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -66.53 -24.67 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -91.88 -28.41 17.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.677 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -108.99 -40.56 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.341 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -102.82 141.05 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.496 ' HG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -163.31 -40.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.783 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.11 173.21 6.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.32 -7.04 16.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -92.55 104.95 17.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -86.83 106.98 18.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.5 -0.36 57.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.546 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.93 113.22 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 123.17 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.488 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.0 m -88.28 114.33 24.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.774 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 237' ' ' ARG . 6.9 mt -96.75 72.99 2.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.23 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 236' ' ' LEU . 22.7 mtp180 -39.25 110.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.79 -16.24 13.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.71 -47.46 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.45 -137.28 6.17 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.18 152.39 48.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.383 . . . . 0.0 110.608 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.16 141.14 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.3 tp -91.43 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -162.02 134.03 5.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.868 0.366 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -104.81 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.434 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mt -146.09 134.85 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.571 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -137.51 155.78 48.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 111.069 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.462 ' O ' ' C ' ' A' ' 154' ' ' ALA . 87.3 t80 -165.39 139.0 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.519 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.46 -104.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.66 53.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.4 mm -137.52 146.56 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.921 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.43 131.28 29.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 147.27 48.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.433 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.8 m-20 -131.15 107.89 9.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.35 -38.32 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.772 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -51.45 59.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.533 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 4.6 p -106.58 13.15 28.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.119 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 162' ' ' THR . 9.3 p80 38.52 56.09 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.683 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -119.68 161.24 21.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.5 157.86 31.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.99 125.24 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -122.71 108.76 13.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.31 67.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.057 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.86 83.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 167' ' ' LYS . 14.2 tt0 -137.04 87.35 18.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.92 132.87 13.28 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.298 1.998 . . . . 0.0 112.669 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.7 147.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.27 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m -92.63 88.35 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.287 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.8 mt -96.0 155.81 16.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.32 170.69 8.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.26 -53.72 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 112.135 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -57.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.073 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.88 -39.71 95.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.053 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.16 -42.82 95.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.8 m -61.25 -45.61 93.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.49 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.2 -43.95 83.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.561 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.02 -46.18 78.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -58.13 -42.98 87.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.405 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.19 -44.97 94.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.516 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -62.83 -41.93 99.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 110.771 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.8 t -57.68 -52.66 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.394 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.42 -29.53 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.356 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.1 19.6 20.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.712 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -53.17 119.57 4.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.92 -23.76 20.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.1 m -92.18 125.29 36.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 11.3 p -69.1 118.08 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.95 149.14 22.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.7 p -99.88 149.44 23.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.53 -44.84 99.8 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.501 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 31.8 Cg_exo -52.94 -52.41 8.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.912 1.742 . . . . 0.0 111.996 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.67 -51.96 67.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.45 -42.98 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.179 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.41 -65.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.3 -16.04 30.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -49.87 31.7 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 204' ' ' ARG . 0.1 OUTLIER -84.11 -43.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.075 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.497 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -62.82 -3.97 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 202' ' ' VAL . 23.3 ttt-85 -57.66 -4.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.491 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.4 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.828 0.347 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.0 -14.68 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -85.39 -17.47 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.465 ' O ' ' OG ' ' A' ' 216' ' ' SER . 5.2 p -67.33 -38.1 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.43 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 85.6 t -59.7 -50.69 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -54.93 -47.06 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.536 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 9.7 p -60.21 -49.47 77.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.655 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -61.63 -41.01 96.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.46 -45.26 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.3 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -43.8 98.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.194 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -32.83 73.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.26 -47.47 73.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 109.999 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.0 OUTLIER -54.89 -46.21 74.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.147 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -15.22 63.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.417 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -95.07 -27.11 15.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.38 -13.53 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.32 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -111.92 138.21 48.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.372 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -175.37 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -48.74 168.94 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.59 -13.08 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.978 0.418 . . . . 0.0 109.962 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -93.21 151.86 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.897 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -93.08 158.96 15.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.6 mt -147.03 -50.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.98 119.86 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 130.29 45.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.64 108.82 20.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.2 mt -98.72 69.4 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.753 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -37.28 126.55 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.567 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.86 -7.58 62.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.41 -46.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.48 -137.33 7.48 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.89 152.81 47.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.31 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.62 135.95 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.964 0.411 . . . . 0.0 110.785 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.98 118.9 31.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.569 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -162.28 115.75 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.488 ' OE2' ' O ' ' A' ' 245' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.862 0.363 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.467 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -175.27 145.57 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.369 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.403 ' CD2' HH12 ' A' ' 183' ' ' ARG . 2.6 mm? -92.43 151.6 20.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -142.05 156.95 45.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 154' ' ' ALA . 70.7 t80 -167.03 140.14 3.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 34.41 -102.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 23.8 p-10 -124.3 52.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -138.08 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.467 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 13.9 tt0 -145.71 144.05 30.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 110.631 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.37 116.88 12.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.15 101.87 11.61 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.849 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -24.14 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.29 -32.3 56.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 34.1 p -127.5 -20.7 3.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.1 t60 82.14 52.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -122.51 156.45 34.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.12 151.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.143 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.73 125.24 13.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.419 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -127.13 113.11 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.259 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.77 70.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.234 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.67 26.72 47.19 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 3.1 tp60 -130.8 92.36 34.43 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.42 133.43 11.86 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.948 1.766 . . . . 0.0 112.195 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.93 138.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.576 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 75.2 m -89.58 88.32 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.9 mt -95.38 149.31 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.563 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.8 172.86 8.06 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -52.1 -55.3 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.394 2.063 . . . . 0.0 112.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.4 m -51.06 -52.5 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.55 -44.05 97.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.0 m -61.37 -45.51 94.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.86 -43.69 92.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.004 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.25 -39.13 93.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.389 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.403 HH12 ' CD2' ' A' ' 151' ' ' LEU . 3.3 ttt85 -65.09 -42.56 93.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.719 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.674 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 10.6 t80 -62.29 -44.57 96.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.6 -44.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.0 -47.68 87.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.88 -28.79 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -108.83 20.42 18.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.46 120.92 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.75 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.21 -23.28 23.38 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.3 m -98.17 124.64 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.42 122.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.8 165.86 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.602 ' HG ' ' CG ' ' A' ' 197' ' ' LYS . 1.1 p -109.77 151.11 27.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.03 -54.45 50.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.915 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 21.1 Cg_endo -66.4 -32.12 41.37 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.365 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.602 ' CG ' ' HG ' ' A' ' 194' ' ' SER . 18.9 mmtt -64.06 -58.44 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.2 -40.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.41 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.75 -64.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.67 -29.23 25.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.674 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 79.6 t60 -71.14 -48.59 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.159 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 204' ' ' ARG . 77.6 t -83.96 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.443 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.81 -2.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.294 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.7 ttp180 -61.17 -3.39 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.715 0.293 . . . . 0.0 110.68 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.4 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.544 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.83 -8.75 11.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.26 -16.42 40.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.2 p -68.9 -38.53 78.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.826 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 40.9 t -58.86 -47.85 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.527 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.14 -47.29 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.229 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 m -59.8 -43.72 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -43.39 98.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.1 -41.43 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.49 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.453 ' HG ' HH21 ' A' ' 223' ' ' ARG . 0.5 OUTLIER -62.85 -46.9 85.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.762 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.67 -21.9 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.642 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.82 -46.38 18.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.217 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.6 mtp180 -56.05 -47.09 78.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.974 0.416 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.453 HH21 ' HG ' ' A' ' 219' ' ' SER . 6.7 mtm180 -66.16 -11.27 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.537 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -92.09 -46.06 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.36 -27.42 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.31 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 4.6 t70 -94.78 143.31 26.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.742 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER 173.81 -27.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.513 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -50.43 162.63 0.97 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.51 -7.65 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 0.0 110.199 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -93.13 149.58 21.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -92.24 154.15 18.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.235 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 74.8 mt -147.35 -51.27 0.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.41 110.65 23.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.143 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 122.45 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.899 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.4 m -90.5 109.47 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.62 70.54 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -39.45 125.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 -13.75 40.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.5 -59.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.569 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.43 -138.06 5.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -127.79 160.98 30.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.424 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.88 128.8 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 57.4 tp -91.73 137.5 32.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 128.09 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.506 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.47 ' NH1' ' OD2' ' A' ' 159' ' ' ASP . 24.1 mtt-85 -147.08 139.35 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.2 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.46 157.35 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.68 157.7 45.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 110.86 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.5 t80 -164.18 127.16 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.476 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.47 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 13.7 p-10 -124.87 54.41 1.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.47 153.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.873 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -145.33 140.12 27.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.252 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.43 138.83 36.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.714 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 162' ' ' THR . 62.8 t0 -111.54 105.67 14.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -8.22 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.176 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.41 -46.09 5.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.956 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 69.2 p -98.66 13.65 31.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.812 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 162' ' ' THR . 44.4 m-70 35.76 53.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.541 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -121.9 150.9 41.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.8 152.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.317 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.77 121.4 9.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.4 tmmt? -124.97 112.83 17.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.365 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.39 71.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.517 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.44 25.58 34.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.5 tt0 -131.08 94.68 27.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.13 132.6 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 112.276 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.12 144.21 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.709 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 t -95.21 94.66 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.66 154.0 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.172 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.22 172.14 8.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -50.3 -54.24 5.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.37 2.047 . . . . 0.0 111.931 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -57.46 -46.41 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.694 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -45.0 96.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -61.68 -45.33 94.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.8 m -58.16 -47.03 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 -43.94 92.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.7 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.46 -43.5 90.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.504 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -55.89 -45.25 78.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.579 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -65.06 -43.64 91.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.58 -42.84 88.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.649 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.15 -47.68 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.625 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.72 -37.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -106.96 25.19 11.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.17 114.23 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.94 10.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.5 m -91.73 129.31 37.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 110.456 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.55 126.29 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.0 110.541 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -94.5 168.84 10.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.098 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.84 147.72 36.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 0.0 110.785 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 211' ' ' VAL . 6.7 mttm -56.85 -54.98 48.36 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.21 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.0 Cg_endo -65.7 -29.91 51.04 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.038 1.825 . . . . 0.0 112.426 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -70.18 -47.16 62.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.319 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.28 -38.01 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 109.978 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.96 -56.17 24.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.89 -16.6 63.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.071 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 46.4 t60 -71.76 -44.96 63.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.309 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 204' ' ' ARG . 24.5 t -84.24 -54.6 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.593 ' C ' ' H ' ' A' ' 205' ' ' TYR . 3.0 m-90 -61.92 -3.22 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.703 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 34.4 ttp85 -44.95 -11.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.593 ' H ' ' C ' ' A' ' 203' ' ' TRP . 17.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.35 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.595 ' O ' ' NZ ' ' A' ' 195' ' ' LYS . 2.9 m -86.42 1.5 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.841 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -96.49 -29.49 13.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.618 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.3 p -64.36 -38.89 83.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.303 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 17.6 t -60.56 -48.96 86.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.579 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.7 -44.58 85.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.166 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -60.46 -46.0 91.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.63 -38.76 87.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.899 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.03 -41.06 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.209 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.51 75.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.51 ' OH ' ' NZ ' ' A' ' 224' ' ' LYS . 32.0 t80 -71.19 -10.17 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.057 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.44 -56.02 4.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.087 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.4 ptm180 -57.41 -40.48 78.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.313 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -11.21 57.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . 0.51 ' NZ ' ' OH ' ' A' ' 220' ' ' TYR . 1.3 mmtp -93.2 -36.08 12.8 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.639 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.55 -24.04 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.834 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -97.93 153.01 18.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.647 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -174.32 -30.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.654 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -61.26 147.96 46.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.73 -5.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.404 . . . . 0.0 110.286 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.564 ' H ' ' C ' ' A' ' 228' ' ' GLY . 29.7 mttp -94.07 116.94 29.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.313 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.2 mtm-85 -81.02 131.15 35.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 244' ' ' ARG . 5.5 mp -89.08 -76.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.41 148.38 26.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.945 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -111.08 143.71 41.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 55.0 m -101.67 116.04 31.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.931 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 236' ' ' LEU . 0.8 OUTLIER -96.47 73.18 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -39.75 117.81 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.64 -25.48 9.04 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.45 -56.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.1 -136.79 4.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -129.35 160.67 32.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.889 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.84 134.64 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 53.0 tp -91.88 116.28 28.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 232' ' ' LEU . 10.1 ptm180 -163.37 117.19 1.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.343 179.623 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.802 0.334 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -120.18 123.87 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.83 156.11 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.59 163.04 33.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 156' ' ' ILE . 58.5 t80 -167.58 134.5 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.41 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 11.5 p-10 -125.18 53.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.1 mt -137.05 154.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -145.83 146.88 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.07 134.32 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.5 m-20 -112.77 109.24 18.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.8 OUTLIER -65.58 -16.28 63.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.97 -52.21 8.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.4 p -101.3 11.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.588 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 11.0 m-70 36.53 53.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.666 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.22 160.02 23.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.2 t -124.5 149.6 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.421 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.4 127.76 15.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 39.5 tttm -128.06 114.04 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.496 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.99 62.94 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.97 29.7 75.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 15.4 tt0 -132.9 93.28 23.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.74 140.23 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.282 1.988 . . . . 0.0 112.316 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.8 130.17 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.742 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 p -93.64 87.15 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.668 ' H ' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.14 154.87 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.606 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.04 168.86 23.62 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.325 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -45.93 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.54 2.16 . . . . 0.0 111.961 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -53.37 -63.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.131 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.18 -36.11 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.429 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -59.87 -48.15 82.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.5 m -60.09 -40.86 91.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.788 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.59 -47.55 85.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.84 -41.09 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -58.21 -46.88 85.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.821 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -68.17 -38.82 82.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -57.2 -44.0 83.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.483 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.35 -46.05 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 mm -53.93 -34.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -108.28 22.21 16.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.037 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.55 125.87 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.487 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.31 -33.2 6.77 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 m -87.07 132.81 33.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.04 124.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.22 161.27 13.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.24 147.88 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 5.5 mtmt -58.43 -56.36 36.2 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.35 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -63.31 -34.53 66.76 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.834 1.689 . . . . 0.0 111.967 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -64.82 -54.09 36.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.355 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 198' ' ' ILE . 18.2 mt -52.05 -39.36 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 0.0 110.12 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.7 tp -60.52 -68.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -50.49 -25.83 4.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.464 ' ND1' ' NH2' ' A' ' 204' ' ' ARG . 56.7 t60 -71.35 -55.12 8.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 204' ' ' ARG . 55.2 t -83.87 -58.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.337 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.1 -4.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.278 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.8 ttm180 -61.76 0.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.5 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.574 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.019 0.438 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.5 p -85.4 -12.2 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.846 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -91.08 -18.53 24.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 1.2 p -65.25 -37.99 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.995 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 0.3 OUTLIER -59.2 -45.79 92.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.605 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -61.45 -45.76 92.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.5 t -60.91 -41.69 96.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.433 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -39.03 76.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.854 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.27 -43.88 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -46.76 88.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.67 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -31.53 72.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.934 0.397 . . . . 0.0 110.172 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.87 -42.34 70.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.946 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 226' ' ' ASP . 35.5 ttp180 -55.11 -44.4 74.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -68.17 -26.36 65.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.468 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -93.41 -21.88 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.2 -31.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.305 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.7 t70 -107.23 135.71 48.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.462 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.64 21.35 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.31 167.84 17.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -12.49 61.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.371 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -92.42 106.2 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.815 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -89.46 110.15 21.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.28 -4.7 56.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.31 104.99 12.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.598 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 124.44 37.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.543 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -96.11 118.41 32.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.309 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.07 74.96 2.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.24 113.99 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.013 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.99 -20.64 23.82 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.63 -61.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.152 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.94 -139.17 5.66 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.77 153.05 47.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.703 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.1 132.13 32.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.84 143.36 26.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.397 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.01 139.85 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.498 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.849 0.357 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 10.2 mtm180 -124.56 121.0 33.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 61.8 mt -91.76 153.01 19.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.472 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 160.76 39.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 154' ' ' ALA . 77.0 t80 -165.93 140.23 4.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.78 -105.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -123.85 53.07 1.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.28 157.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.651 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 6.5 tt0 -143.38 142.95 31.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.655 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.77 134.66 35.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.0 m-20 -110.95 105.85 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.602 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.99 -13.72 60.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.307 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -48.09 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.9 p -94.88 6.38 49.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.594 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 159' ' ' ASP . 64.8 m80 38.39 51.27 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.15 157.04 29.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.01 151.5 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 110.334 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 124.72 12.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -124.27 117.11 23.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.289 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.83 60.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.574 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.95 24.4 71.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 mt-30 -129.89 96.0 27.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.1 135.97 15.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.928 1.752 . . . . 0.0 112.497 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.71 140.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.727 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.11 96.07 9.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.12 156.04 16.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.04 169.43 15.53 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.594 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.25 -53.87 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 112.263 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -54.44 45.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -56.58 -37.97 71.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.419 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -63.17 -49.92 72.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.9 m -58.13 -43.79 87.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.6 -50.44 73.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.56 -43.61 98.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.725 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -56.98 -45.84 82.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.5 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 21.1 t80 -62.9 -41.72 99.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.2 -41.33 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.39 -48.09 74.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.126 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.84 -37.55 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -104.67 25.08 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.96 120.93 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.94 51.51 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 131.88 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.88 118.18 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -96.55 154.48 17.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.191 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -106.92 148.82 28.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.346 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 3.3 mtpm? -56.02 -55.02 46.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.106 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -64.66 -32.63 57.33 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.919 1.746 . . . . 0.0 111.86 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.513 ' H ' ' HG ' ' A' ' 194' ' ' SER . 65.6 tttt -68.46 -54.02 19.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.2 mt -47.72 -41.81 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.937 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.15 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.629 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -46.41 -30.65 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.5 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 2.1 t60 -71.09 -51.19 26.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.026 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' A' ' 204' ' ' ARG . 58.4 t -84.34 -57.97 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.04 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.434 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -52.89 -2.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.478 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.0 ttt-85 -63.89 -1.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 203' ' ' TRP . 34.6 m-85 . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.396 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.851 0.358 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 m -82.56 -3.19 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.75 -20.84 25.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.017 0.437 . . . . 0.0 109.855 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.8 p -67.39 -40.45 84.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.478 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 95.6 t -56.21 -50.46 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.61 -48.02 80.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.544 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -46.36 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.461 ' CE1' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -62.86 -40.99 99.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.691 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 t -62.8 -42.13 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.82 94.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.301 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.69 -13.97 61.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.81 -47.28 9.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 226' ' ' ASP . 50.2 mtt180 -56.64 -46.31 81.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -10.68 50.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.187 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -94.65 -41.16 9.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.404 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.09 -27.86 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.143 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -97.79 143.66 28.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t -177.07 39.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.289 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -137.49 160.21 25.06 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.97 -7.26 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.355 . . . . 0.0 110.436 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -93.63 105.7 17.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -89.73 114.03 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.414 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.56 -3.37 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -121.2 110.17 15.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.316 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.98 136.12 33.24 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.7 m -101.29 112.55 25.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 237' ' ' ARG . 2.8 mt -95.27 68.19 3.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.053 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' LEU . 23.4 ttt180 -34.8 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.699 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 103.22 -17.24 52.1 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.37 -42.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.92 0.39 . . . . 0.0 110.364 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 141.86 -137.56 8.04 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 164.46 23.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.22 133.79 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.269 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.2 tp -91.22 122.93 34.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.355 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -161.65 130.8 4.52 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 111.047 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 -179.934 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.857 0.36 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -126.28 119.2 26.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -90.76 155.47 18.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.638 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -142.38 161.53 37.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.99 0.424 . . . . 0.0 111.148 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -165.23 132.48 2.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.645 179.749 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.57 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 36.65 -98.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.2 m-20 -125.55 53.69 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.13 153.52 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.492 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -146.03 140.82 27.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.766 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.27 134.39 37.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.136 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -110.3 107.97 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.932 0.396 . . . . 0.0 110.459 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.02 -9.26 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.057 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.98 -52.04 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.61 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.463 ' HG1' ' CD ' ' A' ' 164' ' ' GLU . 7.3 p -93.28 7.02 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 22.1 t60 36.92 62.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.463 ' CD ' ' HG1' ' A' ' 162' ' ' THR . 7.0 pt-20 -136.31 154.1 50.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.372 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.85 151.23 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.76 126.74 13.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.1 ttpm? -126.68 114.62 18.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.764 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.48 54.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.445 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.49 24.09 77.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 167' ' ' LYS . 54.2 mm-40 -129.39 95.68 29.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.34 136.4 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.109 1.873 . . . . 0.0 112.224 -179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.88 140.53 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.948 -179.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.7 t -93.86 94.11 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.546 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.9 mp -95.06 150.06 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.667 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.1 172.38 8.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.55 -57.02 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.544 2.163 . . . . 0.0 112.522 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -54.24 -50.14 67.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.4 -40.34 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.483 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.5 -47.4 85.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -57.41 -48.02 80.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.336 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.0 -51.22 70.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 tp -57.95 -47.18 83.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.055 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.407 ' CD2' ' ND2' ' A' ' 188' ' ' ASN . 18.5 t80 -61.33 -45.39 94.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.355 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.6 m-85 -57.45 -44.46 84.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.47 -50.11 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.35 -38.67 56.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.816 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 24.2 p30 -108.58 24.45 13.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -51.87 118.01 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.16 -23.68 13.71 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 m -89.43 133.66 34.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.21 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.26 120.88 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.612 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.25 156.27 16.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.413 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.08 148.6 28.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.0 OUTLIER -56.16 -56.09 34.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.982 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -66.32 -28.8 46.82 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.998 1.799 . . . . 0.0 111.927 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -49.33 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.948 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.31 -38.97 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.3 -68.51 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -49.89 -30.86 10.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.84 -49.57 44.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.282 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 204' ' ' ARG . 62.7 t -82.91 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.908 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.597 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -53.85 -2.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' A' ' 202' ' ' VAL . 30.4 ttt180 -50.91 -5.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.597 ' H ' ' C ' ' A' ' 203' ' ' TRP . 35.9 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.249 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.9 m -83.68 -10.04 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 215' ' ' GLU . 13.0 m120 -73.0 -70.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.227 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 212' ' ' ASN . 4.5 p -34.61 -36.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 212' ' ' ASN . 21.3 t -65.52 -44.87 93.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.56 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 212' ' ' ASN . 2.2 tp10 -57.58 -44.15 85.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -47.98 83.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.699 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.48 -39.95 92.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.0 -43.82 99.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.5 t -63.06 -44.73 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -36.87 85.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 110.189 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.1 mp -65.11 -45.6 84.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.671 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 52.1 mtm180 -56.2 -45.76 79.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.229 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.03 -22.44 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -92.94 -26.69 17.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.47 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -108.47 -40.37 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.823 -179.644 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.75 156.13 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.956 -179.677 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 226' ' ' ASP . 0.8 OUTLIER 167.78 -36.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.704 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.89 -175.22 10.52 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -78.81 -13.46 59.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.653 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -92.75 105.32 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.16 103.99 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.765 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.31 -3.03 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.645 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.88 113.51 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.666 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.24 118.35 36.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.128 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.1 m -93.01 114.06 26.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 237' ' ' ARG . 1.6 mp -96.23 68.68 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 236' ' ' LEU . 30.8 mtm-85 -33.94 129.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.836 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.93 65.99 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 69.9 t -133.01 -61.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 0.0 110.675 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.96 -140.27 6.32 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 153.4 51.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.597 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.13 138.9 49.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.583 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 tp -91.57 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.877 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -161.75 133.18 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 179.951 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.859 0.362 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 159' ' ' ASP . 15.3 mtt-85 -140.91 121.89 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.33 149.43 22.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -139.74 156.66 46.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.124 0.488 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' O ' ' C ' ' A' ' 154' ' ' ALA . 25.8 t80 -165.04 138.06 4.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.18 -104.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 52.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -137.85 148.18 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.305 -179.588 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -143.1 144.01 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.56 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.11 133.12 34.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.538 ' CG ' HH11 ' A' ' 150' ' ' ARG . 55.9 t0 -113.79 107.68 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -66.98 -14.77 63.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.49 -48.66 7.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 163' ' ' HIS . 76.9 p -97.64 8.59 44.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.522 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 162' ' ' THR . 20.8 m80 37.67 54.57 1.5 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -128.61 156.0 44.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.13 152.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 127.2 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.919 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 170' ' ' GLN . 6.2 tmtt? -130.38 117.58 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.281 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.61 64.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.28 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.56 28.54 65.28 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.4 tt0 -129.92 92.26 37.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.47 140.61 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.261 1.974 . . . . 0.0 112.392 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.3 135.75 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.1 OUTLIER -88.22 95.73 10.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.723 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.04 150.61 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.57 170.51 14.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.483 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -47.82 -54.22 5.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.658 2.238 . . . . 0.0 112.569 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -52.25 -61.0 2.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -56.76 -39.68 74.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.43 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -62.65 -46.37 88.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.31 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 m -59.4 -40.28 86.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -44.82 95.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.646 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.46 -46.7 87.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.29 -45.83 80.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.381 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.686 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.765 -179.826 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.77 -45.6 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.745 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.67 -46.81 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.34 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mt -65.71 -23.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.208 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -107.54 27.37 9.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.41 109.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.619 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.86 61.68 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -98.66 122.45 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.04 118.15 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.89 166.08 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.638 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.66 147.25 34.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.472 ' CB ' ' HZ3' ' A' ' 195' ' ' LYS . 2.6 mtpm? -58.01 -55.12 48.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.252 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.3 Cg_endo -67.89 -29.67 34.34 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.835 1.69 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -66.57 -50.75 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.843 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 mt -55.24 -42.18 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.66 -69.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.599 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -27.64 12.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.961 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.686 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -71.54 -51.49 23.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.129 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.622 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.3 t -84.28 -61.79 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.505 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -48.27 -3.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.723 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.622 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.7 OUTLIER -55.16 -7.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.321 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.13 -12.97 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -81.01 -17.84 48.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.364 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.2 p -66.68 -39.45 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.585 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 94.2 t -58.07 -50.02 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.44 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -56.12 -46.87 79.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.572 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 6.3 t -61.25 -45.94 92.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.53 -41.51 98.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.056 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.73 -40.82 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -66.11 -44.05 85.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.443 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -15.12 62.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.02 -45.64 13.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 226' ' ' ASP . 5.8 mtp-105 -59.22 -46.75 87.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.788 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -67.72 -10.46 52.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.525 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -93.04 -35.78 13.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.317 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.5 -26.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -95.2 137.3 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.793 -179.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.476 ' HG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -174.12 26.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.006 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.76 166.62 13.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.66 -9.86 58.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -92.86 130.5 38.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -83.47 156.02 23.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.711 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.6 mp -147.55 -41.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 109.93 22.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.0 123.83 37.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.334 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.1 m -92.01 109.41 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.939 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.6 69.26 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.313 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -39.25 120.49 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.008 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.97 -23.26 28.0 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.35 -41.66 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.697 0.284 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.24 -137.71 7.78 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 154.62 48.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.723 0.297 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.45 131.38 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 110.8 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.2 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.478 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.14 135.93 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.191 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.984 0.421 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -120.54 123.42 42.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.955 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -89.56 153.1 21.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.67 156.19 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.0 t80 -165.43 128.56 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.596 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.01 -99.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 56.7 m-20 -125.44 53.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.65 150.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.193 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -140.33 143.32 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.138 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.67 137.47 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 150' ' ' ARG . 2.1 m-20 -112.68 104.59 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 110.351 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.08 -10.65 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.72 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.6 -43.35 6.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.717 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 163' ' ' HIS . 82.3 p -98.58 9.47 43.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 162' ' ' THR . 16.8 m-70 37.18 47.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -124.1 161.39 25.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.832 0.348 . . . . 0.0 110.744 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.03 156.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.987 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.58 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.7 tmtt? -123.76 110.75 15.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.08 62.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.5 28.31 72.98 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 167' ' ' LYS . 25.4 tt0 -139.63 105.78 6.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 144.46 29.67 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.718 1.612 . . . . 0.0 112.466 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.88 138.91 50.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.9 t -86.14 138.86 31.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.281 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mt -142.85 99.6 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.656 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 171.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -46.88 -60.4 0.89 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.487 2.124 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.469 ' H ' ' HG1' ' A' ' 177' ' ' THR . 0.9 OUTLIER -53.33 -56.68 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.315 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 2.6 mm-40 -59.25 -36.76 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.761 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -60.92 -47.24 87.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.9 m -58.8 -41.54 86.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.417 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.659 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -61.33 -43.03 99.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -46.73 83.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.594 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.479 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 4.5 t80 -67.41 -39.14 85.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.676 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -43.84 79.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.03 -47.41 68.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.51 -36.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 20.5 m-80 -108.97 28.8 8.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.65 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.15 -22.49 22.89 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 m -95.29 135.26 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.055 0.455 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 84.9 t -69.19 123.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.4 mp -96.15 154.4 17.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.093 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.65 147.87 30.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.953 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.5 mtmt -57.83 -55.03 49.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.792 179.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.8 Cg_endo -67.63 -29.97 35.61 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.023 1.816 . . . . 0.0 111.949 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -68.33 -49.34 60.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 109.973 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 mt -55.98 -42.23 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.805 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 tp -59.2 -63.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.661 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -52.87 -28.83 24.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 19.3 t-80 -71.92 -48.34 46.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 204' ' ' ARG . 47.7 t -84.37 -61.52 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.529 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -53.23 -3.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.315 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp180 -61.59 0.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 110.636 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.529 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.3 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.501 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.64 -8.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.64 -17.64 50.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.345 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.28 -40.01 85.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.072 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.76 -50.51 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.12 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.52 -48.49 71.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.579 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.2 m -60.74 -47.77 84.82 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.6 -40.52 95.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.69 -43.27 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.438 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -43.92 97.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.14 -37.52 85.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -48.14 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 226' ' ' ASP . 4.6 mtp85 -56.19 -43.18 78.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.494 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -67.06 -17.22 64.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -96.19 -32.29 12.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.57 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.53 -33.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.268 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -104.49 137.83 41.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.73 27.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.404 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.59 -176.5 14.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.54 -8.7 57.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 110.481 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.67 104.81 17.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -96.15 104.46 16.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.7 -7.23 50.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.215 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.52 112.23 21.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 126.85 40.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.401 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.42 70.58 3.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -43.61 112.31 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.36 -13.24 16.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.94 -54.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 110.724 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.3 -139.25 6.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.43 155.35 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 4.1 p -137.05 135.57 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.62 126.32 36.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -162.53 135.7 5.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.178 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.489 179.832 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.651 0.263 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -174.63 153.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.713 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.37 153.86 18.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.317 -179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 152.37 41.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.6 t80 -163.7 128.08 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.812 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.75 -99.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.6 m-20 -124.82 53.82 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 0.0 109.836 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 142.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.49 140.16 42.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.887 0.375 . . . . 0.0 110.738 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.32 124.2 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.148 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -102.59 104.87 15.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.534 -179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.588 ' OE2' ' N ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -65.97 -12.72 57.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.588 ' N ' ' OE2' ' A' ' 160' ' ' GLU . 3.1 tt0 -81.63 -52.38 7.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 163' ' ' HIS . 80.5 p -97.32 14.88 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 162' ' ' THR . 24.4 m80 35.78 63.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.601 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -140.45 162.4 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.18 161.61 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.14 128.54 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.63 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -128.08 110.72 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.08 67.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.01 32.06 62.19 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -142.37 87.52 9.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.37 136.42 50.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.197 1.931 . . . . 0.0 112.133 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.4 152.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.129 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.3 m -90.11 126.62 35.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.145 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 mt -141.03 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.758 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.62 171.87 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.81 -53.81 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.556 2.171 . . . . 0.0 112.096 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -57.47 -52.73 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.29 -39.6 93.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.78 -46.61 88.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.362 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.7 m -59.21 -40.44 85.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -45.89 91.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.16 -43.16 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.928 0.394 . . . . 0.0 110.163 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -55.64 -45.18 77.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.334 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.685 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -64.8 -44.05 91.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.43 -44.81 65.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.7 t -68.69 -49.09 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.819 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 mm -54.13 -34.57 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER -109.53 27.53 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.561 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.38 116.55 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.36 -17.99 42.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.1 m -90.14 125.09 35.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.765 0.317 . . . . 0.0 110.93 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.76 115.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.962 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.91 160.44 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.677 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.658 ' HG ' ' H ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -107.45 148.43 29.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.697 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 12.9 mtpt -55.24 -53.37 62.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.8 Cg_endo -68.43 -29.77 30.71 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.658 ' H ' ' HG ' ' A' ' 194' ' ' SER . 1.0 OUTLIER -67.21 -46.22 74.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.16 -39.51 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.89 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.17 -51.4 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.724 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -72.49 -19.74 61.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.685 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 30.6 t-80 -71.39 -41.79 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.674 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.3 t -82.72 -53.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.587 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 205' ' ' TYR . 2.2 m-90 -67.29 -5.34 13.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.735 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.436 ' O ' ' NE ' ' A' ' 204' ' ' ARG . 0.4 OUTLIER -44.07 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.895 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.19 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 212' ' ' ASN . 2.3 m-20 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.3 m -58.59 1.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 210' ' ' ASP . 70.2 m-20 -96.2 -24.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.65 -31.41 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.33 -53.04 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -55.34 -43.83 75.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -60.59 -49.5 77.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.81 -38.44 91.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.434 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.81 -42.75 97.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.298 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -45.29 92.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.47 -31.33 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.33 -44.43 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.17 -41.79 72.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.3 mtm-85 -67.8 -22.0 65.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -25.11 19.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -116.31 -38.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.978 -179.526 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 222' ' ' ARG . 3.7 t70 -98.48 146.27 25.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.483 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t 175.45 -30.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.281 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -72.35 163.65 54.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -64.5 -4.24 3.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 110.713 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -92.71 131.26 37.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -86.99 158.12 19.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.16 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 82.4 mt -147.55 -48.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.291 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.54 119.31 38.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 124.49 41.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.264 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -91.68 109.93 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 30.0 mt -93.22 71.79 4.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 89.9 mtt180 -37.02 123.93 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 -39.82 2.74 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.1 -60.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.391 . . . . 0.0 110.659 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.08 -137.02 4.52 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -127.29 155.66 43.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 110.645 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.39 140.2 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 27.8 tp -93.39 111.39 23.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.262 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.26 131.97 5.21 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.255 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.049 179.553 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -174.74 153.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.225 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -91.15 148.07 22.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.089 0.471 . . . . 0.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -140.19 155.43 46.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.201 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 155' ' ' ASP . 70.3 t80 -156.86 124.93 5.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.005 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.77 -93.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.8 m-20 -124.86 52.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.75 138.43 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.984 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -134.99 133.02 39.03 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.715 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 mt -131.43 120.85 23.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -109.18 113.82 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.546 -179.521 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.95 -42.33 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.5 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.5 -47.18 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.1 p -103.62 8.99 37.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 162' ' ' THR . 0.7 OUTLIER 36.91 46.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.573 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.32 165.65 14.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.26 159.33 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.41 120.67 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.485 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -118.25 105.12 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.237 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.84 63.42 0.31 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.52 27.5 73.39 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 tt0 -134.05 94.63 18.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.612 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.59 134.12 10.87 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.291 1.994 . . . . 0.0 111.989 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.89 134.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.374 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.2 p -81.76 100.04 9.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.62 154.31 17.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.99 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.95 160.91 65.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.964 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.55 -43.07 52.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.537 2.158 . . . . 0.0 111.624 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -55.37 30.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.644 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -36.26 76.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.11 -52.78 64.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.37 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.1 m -57.47 -43.43 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.777 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -53.44 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.05 -41.5 95.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -55.54 -46.5 77.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.781 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 29.7 t80 -64.35 -42.53 96.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.18 -43.86 83.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.47 -43.68 94.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.988 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.02 -29.59 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 29.2 m-80 -113.99 23.25 13.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.109 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.23 121.36 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.776 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.59 -20.86 24.51 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -95.81 131.18 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 111.042 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 10.7 p -69.44 115.61 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -96.9 160.24 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.487 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.76 148.1 31.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.0 -50.14 89.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.751 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.4 Cg_endo -65.78 -34.59 39.68 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.56 1.507 . . . . 0.0 112.219 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.95 -47.6 65.28 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.108 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 mt -53.82 -40.91 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.991 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -64.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.475 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -27.65 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.294 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.14 -51.58 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.762 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.568 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.8 t -83.71 -61.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.239 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.491 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -50.6 -4.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -179.384 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttm180 -61.98 -1.44 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.53 -7.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.94 -49.31 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 8.1 p -54.75 -42.96 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.044 0.45 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.495 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 41.1 t -58.95 -44.85 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -61.13 -47.1 87.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.339 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -60.28 -41.03 92.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.984 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -64.09 -42.05 97.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.25 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.4 -40.32 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -45.15 74.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.313 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -13.07 62.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.432 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -57.09 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 24.2 ptt180 -57.54 -37.85 73.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.705 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 222' ' ' ARG . 1.4 mtt-85 -69.0 -20.76 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -94.87 -27.56 15.66 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.805 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.476 ' CG2' ' HZ1' ' A' ' 167' ' ' LYS . 1.8 pp -114.85 -27.62 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.839 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -102.84 139.04 38.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.997 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 -33.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -46.01 163.64 0.12 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -94.45 106.43 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -74.06 107.21 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.458 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.81 1.12 56.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.587 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.2 mt -126.58 96.23 4.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 122.06 31.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.7 m -93.26 113.68 25.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.1 mt -95.27 72.14 3.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -39.06 120.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.754 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.51 -17.58 30.79 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.584 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 63.6 t -128.33 -55.11 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.12 -137.25 4.76 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.8 OUTLIER -131.24 155.16 47.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 110.265 179.82 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.406 HG11 ' NE ' ' A' ' 244' ' ' ARG . 8.2 p -138.17 131.29 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.159 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.41 104.64 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.374 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.406 ' NE ' HG11 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -162.24 153.48 17.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.756 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -136.41 127.26 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.368 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.6 mt -90.57 152.72 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.95 148.97 39.5 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 156' ' ' ILE . 84.2 t80 -158.74 127.47 5.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.89 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.38 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.111 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 25.8 m-20 -123.94 53.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 145.06 29.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.256 -179.553 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.42 149.06 50.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.434 179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.35 121.87 8.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.137 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.79 27.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 -179.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.476 ' OE1' ' NH2' ' A' ' 183' ' ' ARG . 8.0 mt-10 -66.57 -22.42 66.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.625 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.0 -52.11 52.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.4 p -108.18 14.79 24.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 160' ' ' GLU . 9.6 m80 37.22 54.74 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -120.86 156.79 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.0 t -119.85 157.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.65 137.76 25.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -130.6 110.08 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 179.748 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.06 60.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.263 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.83 76.12 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.0 mt-30 -134.98 104.89 10.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.823 -0.222 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.39 144.72 26.14 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.889 1.726 . . . . 0.0 112.618 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.24 136.43 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.712 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.5 t -97.97 127.17 43.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -140.65 124.68 17.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.376 . . . . 0.0 110.539 179.707 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -45.67 174.57 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -179.617 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.7 -47.6 26.37 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.544 2.163 . . . . 0.0 111.853 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -52.34 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.07 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.52 -38.75 88.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.878 0.371 . . . . 0.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -48.39 81.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.711 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -59.38 -42.64 92.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.206 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -50.8 71.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.015 -179.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.95 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.746 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.476 ' NH2' ' OE1' ' A' ' 160' ' ' GLU . 2.3 ttt180 -60.21 -48.89 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.43 -39.41 93.79 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.555 -179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.14 91.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.19 -47.11 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.27 -27.65 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.062 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.54 18.54 20.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.462 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.53 120.23 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.44 -24.37 13.95 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 46.7 m -94.72 126.73 40.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.11 118.4 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -96.35 161.4 13.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.47 148.0 30.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.287 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.41 -55.75 36.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.034 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.3 Cg_endo -66.58 -33.6 35.72 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.962 1.774 . . . . 0.0 112.142 -179.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -46.33 85.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 36.8 mt -60.99 -39.09 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.94 -51.5 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.144 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.32 -28.87 69.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.019 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.85 -58.5 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.505 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.6 t -84.34 -60.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.013 -178.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -51.04 -5.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.834 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.606 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.9 ttp85 -61.4 -1.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.985 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 212' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.245 0.545 . . . . 0.0 110.434 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.3 0.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.32 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.59 ' H ' ' C ' ' A' ' 210' ' ' ASP . 37.3 m-20 -83.66 -12.41 55.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.57 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.11 -35.27 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.399 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.92 -55.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.052 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.29 -48.56 68.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.3 t -58.07 -50.53 73.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.026 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.51 -37.26 83.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.0 110.533 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.1 t -62.04 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.408 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -60.56 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.52 -39.89 94.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.73 -45.68 88.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.42 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.0 mmm-85 -56.68 -42.29 78.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.392 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -66.15 -22.5 66.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.634 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -93.22 -30.44 15.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.671 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -110.45 -37.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 0.0 110.766 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.5 t70 -95.02 145.18 25.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.458 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.91 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.461 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.53 -178.57 4.92 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -79.34 -11.21 59.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -94.4 104.89 16.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.026 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -92.08 109.37 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.265 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.81 -9.07 44.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.445 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.72 127.25 56.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.132 179.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.96 124.57 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.381 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.3 m -97.61 113.74 25.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.327 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 240' ' ' GLY . 7.2 mt -96.11 72.66 2.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.632 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -39.78 115.19 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.51 -20.42 20.71 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.795 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.3 -50.02 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.915 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 158.59 -145.64 11.94 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -131.48 152.71 50.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.538 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.13 137.45 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.21 127.09 36.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -163.61 131.1 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.736 -179.9 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -121.65 124.67 44.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.296 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.864 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -142.33 160.78 39.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.613 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 156' ' ' ILE . 69.6 t80 -165.53 128.72 2.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.53 -99.82 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.241 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 153' ' ' PHE . 22.8 p30 -122.76 53.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.55 155.04 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.707 -179.64 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -146.84 140.58 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -137.16 136.32 38.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.398 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -110.88 104.09 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.133 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.42 -11.08 39.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.902 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -96.92 -51.02 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.83 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.539 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 30.8 p -93.89 9.99 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.503 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 162' ' ' THR . 8.5 p-80 37.11 58.49 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -127.81 157.37 40.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.54 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.64 151.46 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.325 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.23 125.19 12.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 170' ' ' GLN . 23.8 tttp -124.49 115.24 20.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.611 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 59.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.66 75.26 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 167' ' ' LYS . 48.2 mt-30 -130.5 95.28 27.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.7 138.99 12.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.121 1.881 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.61 145.26 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.381 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -94.28 100.09 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.07 150.38 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.36 168.44 22.48 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.293 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.68 -52.17 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.367 2.045 . . . . 0.0 112.322 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -47.65 85.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.71 -37.5 84.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.615 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 1.8 t80 -64.71 -49.24 71.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.5 m -57.31 -46.04 83.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.55 -49.6 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.791 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.84 -44.77 96.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.75 -46.36 89.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 2.3 t80 -62.27 -42.25 99.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.819 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -43.99 93.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.337 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.19 -45.35 86.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.556 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 mm -57.35 -35.58 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -110.18 23.16 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.274 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.02 119.08 4.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.52 -26.83 9.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 127.62 35.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.326 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.88 114.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.96 157.5 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 149.83 28.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.497 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.8 mttt -57.12 -49.44 93.95 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -65.36 -35.43 40.02 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.56 1.507 . . . . 0.0 111.933 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -66.33 -55.48 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.029 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 mt -49.93 -38.1 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 48.7 tp -65.06 -68.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -46.05 -27.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.572 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 24.8 t-80 -71.53 -52.29 19.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.062 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.1 t -83.42 -56.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.462 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -51.68 -4.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.458 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.541 ' H ' ' C ' ' A' ' 202' ' ' VAL . 48.1 ttm-85 -58.69 -6.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -9.6 12.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.644 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.83 -17.97 34.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.18 -35.04 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.298 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.27 -49.51 81.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.322 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -58.4 -47.07 85.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.278 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 m -59.78 -45.35 92.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.38 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -45.34 94.79 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.2 -40.2 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -44.79 90.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.592 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.49 -28.5 66.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.572 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.61 -47.3 63.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 226' ' ' ASP . 3.1 mtp85 -57.02 -45.56 83.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.319 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -67.41 -10.14 48.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -90.58 -44.27 9.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.9 pp -110.14 -32.78 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -95.23 143.47 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.9 t -175.33 38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.06 -163.25 10.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -90.54 -20.54 22.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.552 ' CB ' ' HZ3' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -92.23 104.0 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.208 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -88.75 125.86 35.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.4 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 mt -91.25 -8.8 47.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.63 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.6 mp -121.6 116.32 24.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.183 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 127.57 37.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.46 105.88 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.6 mt -94.59 73.1 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.14 136.36 5.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.708 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.18 -12.74 65.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.15 -46.06 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 147.13 -141.77 9.68 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -131.12 153.59 49.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 0.0 110.476 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.48 136.61 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.41 119.92 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -163.03 127.12 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.148 179.589 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.824 0.345 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -141.38 134.6 29.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.76 161.09 16.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 157.79 44.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' OE2' ' A' ' 245' ' ' GLU . 91.9 t80 -162.55 122.96 2.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.668 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 32.8 m-20 -124.66 54.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 152.41 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.553 -179.329 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.1 tt0 -140.23 147.7 40.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.216 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.447 ' CD2' ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -146.33 117.46 7.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.257 -179.645 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -112.43 115.42 28.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.673 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.8 -45.07 79.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -49.49 -50.72 40.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.714 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 56.4 p -97.18 6.95 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.624 ' CE1' ' CE1' ' A' ' 179' ' ' PHE . 16.9 t60 36.1 57.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -134.18 159.18 41.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.54 154.45 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -146.42 129.14 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.123 -179.795 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 170' ' ' GLN . 25.5 tttp -127.51 114.55 17.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.414 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 65.06 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 60.4 29.57 69.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 167' ' ' LYS . 14.7 tp60 -132.95 92.18 26.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.29 136.81 16.32 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.134 1.89 . . . . 0.0 112.379 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.29 136.08 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.957 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 57.9 m -91.06 91.14 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.88 142.58 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.931 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 170.74 13.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.95 -53.96 6.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.408 2.072 . . . . 0.0 112.43 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -52.3 -63.44 1.14 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -58.33 -37.45 75.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.775 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.624 ' CE1' ' CE1' ' A' ' 163' ' ' HIS . 27.7 t80 -54.98 -51.71 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -62.77 -35.69 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.549 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.6 -51.17 69.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.152 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.18 -41.25 98.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.792 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -62.45 -41.79 99.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.23 -37.28 86.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.207 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.97 -46.05 92.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.43 -47.28 90.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.484 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -50.88 -42.08 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -108.98 25.36 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.75 117.34 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.62 -21.42 16.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.5 m -96.5 131.47 43.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.86 119.02 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.78 166.27 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 110.77 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.97 148.26 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.67 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.36 -51.08 84.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.574 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.6 Cg_endo -64.27 -44.6 11.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.675 1.583 . . . . 0.0 112.149 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.04 -51.54 68.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.244 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -55.52 -39.0 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 110.393 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 199' ' ' LEU . 2.6 tt -59.43 -67.39 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.071 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -58.13 -15.9 11.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -53.38 12.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.711 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.452 ' C ' ' H ' ' A' ' 204' ' ' ARG . 23.8 t -84.06 -30.66 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.269 -179.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -60.36 -3.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.92 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 202' ' ' VAL . 13.2 mmm-85 -61.01 -1.93 0.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.568 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.9 m-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.597 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.121 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -6.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.642 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -26.07 19.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.789 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.68 -32.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.7 t -57.85 -56.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.072 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.51 -46.92 76.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.229 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.0 t -60.6 -45.66 93.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.13 -39.03 89.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.15 -46.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.428 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -62.48 -43.32 99.09 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -72.69 -13.32 61.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -48.33 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 12.5 mtm-85 -56.07 -45.05 79.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.135 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -68.17 -11.14 58.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.766 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.4 tttp -92.7 -33.34 14.38 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.625 -179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -21.6 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.872 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.85 -39.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -53.25 168.98 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.16 -8.55 56.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.916 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 130.1 39.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -85.79 128.43 34.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -90.09 -74.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.543 ' H ' ' CD1' ' A' ' 233' ' ' LEU . 0.0 OUTLIER -91.95 145.45 24.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.646 -179.652 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -105.23 132.44 51.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.38 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -91.69 108.94 20.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.737 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 10.2 mt -94.87 72.96 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.469 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -36.84 142.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.19 179.641 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.1 36.04 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.59 -57.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.567 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 154.37 -138.95 6.44 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -130.51 160.74 33.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.697 179.996 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.8 p -142.64 126.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.74 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 36.8 tp -90.64 116.67 28.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.537 ' O ' ' NE ' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -161.9 147.18 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.437 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.545 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.4 mp0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.267 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.792 0.329 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -174.5 143.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.13 154.71 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -142.34 156.97 45.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.67 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 154' ' ' ALA . 26.2 t80 -169.66 133.84 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.833 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.95 -129.6 0.25 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.63 53.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.349 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.92 151.24 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -146.79 141.49 26.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.161 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.06 117.95 14.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.383 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -104.11 108.71 20.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.97 0.414 . . . . 0.0 110.354 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.95 -31.05 72.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.167 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 1.4 mp0 -58.77 -48.32 81.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.735 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.443 ' C ' ' HD1' ' A' ' 163' ' ' HIS . 65.9 p -109.17 13.93 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER 38.18 50.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.702 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -119.41 158.44 26.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.13 151.97 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.31 124.72 13.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.1 ttpt -128.64 121.13 27.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.57 58.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.6 27.76 70.28 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.6 mt-30 -132.18 97.83 17.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.56 138.52 17.37 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.977 1.784 . . . . 0.0 112.492 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.97 143.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.61 -179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -93.73 97.29 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -95.97 152.16 18.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.778 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.2 161.49 59.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.338 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.46 -45.05 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.628 2.219 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -42.75 88.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.773 0.32 . . . . 0.0 110.813 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -65.43 -34.46 78.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -62.41 -45.52 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.119 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -43.58 96.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.124 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -47.66 84.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.774 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.61 -44.04 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.499 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -56.11 -47.15 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.824 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.509 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 2.6 t80 -66.08 -38.6 88.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.603 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.594 ' CZ ' ' CE2' ' A' ' 241' ' ' TYR . 3.0 m-85 -55.88 -44.54 78.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.96 -47.62 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.94 -31.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -106.53 23.77 13.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.798 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.08 119.68 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.74 -23.0 27.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.1 m -94.86 127.8 41.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.535 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 14.7 p -68.62 112.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.157 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.32 151.18 19.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.0 p -100.33 148.38 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.371 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -58.39 -48.78 96.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 36.4 Cg_exo -55.03 -46.26 34.6 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.417 2.078 . . . . 0.0 111.666 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -61.97 -52.36 64.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.5 mt -49.95 -38.78 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.916 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.35 -67.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.419 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.93 -21.6 1.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.509 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 63.1 t60 -72.57 -59.19 2.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.576 ' C ' ' H ' ' A' ' 204' ' ' ARG . 64.6 t -83.69 -60.65 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -51.11 -4.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.1 OUTLIER -60.65 -0.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.678 0.275 . . . . 0.0 110.597 -179.927 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.2 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.37 . . . . 0.0 110.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 211' ' ' VAL . 7.1 p -78.48 -0.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.627 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.23 -22.16 19.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.689 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 t -64.18 -43.99 97.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.481 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.35 -43.05 95.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.239 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -58.88 -45.87 89.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.444 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.4 t -61.12 -40.74 94.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.106 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -64.04 -43.47 95.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.812 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.47 -41.02 90.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.284 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.83 -44.21 90.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -67.41 -31.29 71.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.5 mp -67.55 -45.71 74.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.87 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 226' ' ' ASP . 30.6 mtp85 -56.74 -46.16 81.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.35 -24.41 65.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -92.73 -23.37 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -111.12 -41.15 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.695 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 222' ' ' ARG . 24.3 t70 -100.81 141.1 34.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -37.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.422 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -59.37 165.89 9.34 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -69.26 -10.53 58.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.628 0.252 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -93.67 115.75 28.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.422 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -83.9 130.73 34.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 244' ' ' ARG . 27.9 mt -89.55 -74.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.64 145.72 26.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.577 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -105.17 140.26 38.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.662 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 m -95.85 114.75 26.51 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.036 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 240' ' ' GLY . 57.3 mt -96.14 72.12 2.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 236' ' ' LEU . 2.4 ptp180 -37.93 138.15 0.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.07 -18.64 43.39 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.15 -60.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.441 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 165.19 -142.07 7.47 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.594 ' CE2' ' CZ ' ' A' ' 185' ' ' PHE . 2.0 p90 -130.35 160.27 34.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.52 133.99 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.531 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 232' ' ' LEU . 7.8 ptm180 -162.73 127.9 3.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.541 179.839 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -149.2 138.09 21.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -90.72 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.575 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.0 158.03 44.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.0 111.218 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 3.8 t80 -164.79 139.76 5.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.347 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.544 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 37.28 -105.32 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.69 53.11 1.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -137.43 150.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.556 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -140.45 137.02 33.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.38 143.34 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.216 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.26 109.47 15.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.06 -17.38 64.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.41 -52.03 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 42.3 p -96.79 12.04 33.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 162' ' ' THR . 8.6 m80 37.36 41.15 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.1 169.36 9.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.868 -179.399 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.28 161.04 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.477 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.121 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.6 tmtm? -124.67 113.51 18.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.687 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 64.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.052 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.41 31.69 63.26 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.5 tt0 -142.3 89.39 8.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.82 150.07 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.23 1.953 . . . . 0.0 112.544 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.2 126.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.905 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 p -95.13 115.39 27.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -141.69 154.28 45.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.489 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.64 161.53 1.57 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.0 -33.99 95.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.889 2.393 . . . . 0.0 111.96 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -60.81 -53.61 55.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.13 -37.81 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.229 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.48 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 4.7 t80 -58.48 -48.08 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.9 m -58.8 -39.33 80.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.87 -46.87 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.348 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.18 -40.65 86.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -59.89 -43.62 94.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.64 -179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.45 -43.07 91.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.564 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.43 -43.11 83.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.91 -48.75 86.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.52 -35.67 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.136 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.4 23.25 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.48 117.23 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.914 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.66 -14.15 24.79 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.3 m -98.48 130.9 45.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.18 115.07 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.457 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.89 152.65 18.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.445 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.75 147.96 27.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.201 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -56.58 -51.34 81.94 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 22.0 Cg_endo -65.23 -36.35 36.72 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.65 1.567 . . . . 0.0 111.987 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -66.49 -46.83 75.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.92 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 32.7 mt -53.81 -42.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.139 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.1 mt -63.7 -64.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.524 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -32.39 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -53.59 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.9 t -83.5 -61.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.048 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -52.0 -3.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.189 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -61.14 -4.89 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.0 110.51 179.879 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.9 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.103 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.9 -4.79 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.67 -21.09 22.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.79 -33.83 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.951 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.94 -50.74 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.263 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -45.97 83.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 p -61.04 -44.04 97.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -40.48 94.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.45 -40.06 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.688 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -43.31 80.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -12.99 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.66 -50.18 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.984 179.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.3 ttp180 -56.28 -51.14 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.295 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -8.31 29.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.547 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -92.36 -37.09 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.57 -179.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.76 -25.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 0.0 110.72 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.3 OUTLIER -105.49 139.43 40.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.598 179.914 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 t -165.93 38.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.16 -173.52 13.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.2 -13.19 57.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.69 -0.255 . . . . 0.0 111.038 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -93.89 115.49 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.954 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -97.52 113.17 24.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -90.32 -1.68 57.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 107.48 15.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.93 125.01 41.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.7 m -91.8 111.48 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.539 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.7 mt -95.23 72.8 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 19.0 ttt-85 -36.75 127.04 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.98 -10.7 70.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.91 -39.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 135.96 -137.84 9.45 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.7 154.67 46.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 0.0 110.838 -179.846 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.09 138.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.75 113.61 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.416 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -161.7 130.95 4.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.586 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.16 -176.53 35.28 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -112.75 -15.16 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.9 t -51.63 -85.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.206 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 46.43 -108.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -40.53 102.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -59.85 146.73 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -87.55 9.02 22.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -119.71 78.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.609 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -109.89 55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.8 m -74.14 -3.72 31.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.45 117.67 29.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.98 -167.48 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 tp -176.07 50.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.741 0.305 . . . . 0.0 110.833 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.09 56.89 2.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.01 -6.55 19.46 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.538 2.159 . . . . 0.0 111.919 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -55.33 -18.57 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -147.05 -70.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t 53.77 -114.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.697 0.284 . . . . 0.0 110.467 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -161.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.41 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.33 -12.01 0.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.41 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -142.91 -57.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.45 135.49 2.57 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -141.58 23.87 2.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.666 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -54.27 -36.73 63.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.391 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.61 145.51 16.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.251 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.34 -65.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.294 1.996 . . . . 0.0 111.926 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.521 ' CG ' ' H ' ' A' ' 148' ' ' ASN . 38.5 ttm-85 -152.68 178.81 9.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.082 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -42.48 171.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.75 111.83 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.559 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -128.63 123.59 33.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.7 146.76 23.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.624 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.2 m -142.35 155.44 45.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 155' ' ' ASP . 42.7 t80 -163.02 128.01 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.92 -96.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 43.2 p-10 -124.56 53.79 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 143.27 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.155 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -140.13 136.1 33.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.324 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.67 131.74 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -113.74 109.52 18.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.65 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 160' ' ' GLU . 1.5 mp0 -66.68 -12.21 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.838 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.487 ' OE1' ' ND2' ' A' ' 148' ' ' ASN . 2.2 mt-10 -85.8 -51.98 6.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.589 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 40.6 p -99.21 11.22 39.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 40.6 p-80 35.82 58.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.357 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.33 156.26 42.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.7 148.77 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.52 125.29 12.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 170' ' ' GLN . 31.8 tttm -128.83 117.24 20.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 62.74 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.1 26.26 70.21 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 167' ' ' LYS . 5.9 mt-30 -130.49 92.93 33.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 O-C-N 122.705 -0.291 . . . . 0.0 110.522 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.74 142.21 17.78 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.154 1.902 . . . . 0.0 111.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 131.01 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -88.46 88.35 7.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.92 154.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.42 165.2 32.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.3 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -42.12 -54.62 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.258 . . . . 0.0 112.362 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 53.7 m -57.68 -56.6 19.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.282 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -58.38 -34.69 70.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.933 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.82 -45.31 78.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.1 m -58.87 -39.92 82.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -54.27 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.72 -41.78 87.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -60.48 -46.67 89.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.081 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.684 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 19.5 t80 -62.3 -41.1 98.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.414 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.13 -43.67 82.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.93 -45.45 87.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.09 -37.24 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.84 25.6 11.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.07 124.33 16.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.44 -24.51 15.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.8 m -95.46 131.32 41.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.583 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 t -66.96 119.39 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.285 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 158.47 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.28 148.43 34.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mtpp -56.02 -55.01 46.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.486 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.0 Cg_endo -65.07 -39.96 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.851 1.701 . . . . 0.0 112.055 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.88 -51.55 68.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 37.5 mt -53.24 -42.96 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.179 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.68 -63.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.505 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.18 -29.59 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.259 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.684 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 6.1 t60 -71.2 -46.48 61.18 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.005 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.564 ' C ' ' H ' ' A' ' 204' ' ' ARG . 90.4 t -83.77 -60.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.46 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -50.55 -6.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.049 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.564 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.5 OUTLIER -59.33 -6.81 1.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.46 ' H ' ' C ' ' A' ' 203' ' ' TRP . 13.1 m-85 -109.22 -1.03 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.511 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -175.29 92.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -69.18 149.34 48.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.203 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 121.6 59.13 0.22 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.61 103.57 0.23 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -51.63 -173.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.1 p -86.26 -10.36 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.92 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.71 -24.5 31.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.356 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.44 ' O ' ' OG ' ' A' ' 216' ' ' SER . 21.9 t -64.31 -34.76 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.04 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.93 -45.37 91.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.71 -45.72 77.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.311 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 33.0 p -60.1 -46.75 88.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.05 -38.81 92.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.54 -43.11 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.607 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.72 -45.56 93.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.55 -39.87 92.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.316 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -61.33 -45.81 92.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.269 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' ASP . 47.0 ttt180 -56.18 -43.12 78.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.345 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -67.47 -30.25 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.403 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -91.1 -11.26 39.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 225' ' ' ILE . 0.4 OUTLIER -120.16 -25.1 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.915 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -96.2 137.03 35.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.191 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -70.83 170.74 46.19 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.1 -12.51 59.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -93.32 111.03 22.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.8 ttp85 -92.39 103.81 16.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 mp -91.02 -5.72 54.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.4 tp -114.3 106.79 14.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.418 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 130.85 39.63 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.46 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.9 m -100.91 112.78 25.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.202 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.4 mt -98.07 69.61 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.066 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' LEU . 71.3 mtt180 -38.26 131.79 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.07 -20.85 49.2 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.2 t -120.08 -58.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 110.422 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.17 -139.22 5.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.89 153.85 49.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.0 135.15 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.78 125.87 35.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.995 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -162.29 134.13 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -69.68 154.08 95.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.199 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.84 130.31 20.24 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.535 2.157 . . . . 0.0 112.081 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.633 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.748 0.308 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.91 -45.2 0.02 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -46.17 156.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.919 0.39 . . . . 0.0 110.534 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.69 10.65 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.857 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -89.52 -32.83 16.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.466 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -134.81 88.6 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -163.62 -12.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.892 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -151.6 -32.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -56.07 160.85 2.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.72 93.68 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.856 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -69.02 -77.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.547 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.7 p 49.9 54.5 10.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . -169.4 -34.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 132' ' ' GLY . 1.4 tp 58.63 138.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 133' ' ' LEU . 2.8 t 41.14 60.1 8.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.103 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.29 -28.16 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.804 2.336 . . . . 0.0 113.109 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 138' ' ' SER . 4.6 tpp180 -166.79 88.34 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.63 33.9 1.39 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 136' ' ' ARG . 92.8 p -126.62 55.06 1.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 110.209 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -60.37 128.84 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.646 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.7 mtt -68.04 121.16 15.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.237 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -64.38 -65.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.43 2.59 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.4 m120 53.18 16.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -90.51 -33.51 15.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.395 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 147' ' ' ARG . 7.2 mt-10 51.2 72.75 1.13 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.98 -6.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.024 2.483 . . . . 0.0 112.55 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 145' ' ' GLU . 35.9 mtt85 63.94 76.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.841 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -86.36 122.98 31.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.36 139.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.862 0.363 . . . . 0.0 110.582 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -148.46 141.83 25.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.189 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 mt -90.47 151.15 21.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 158.59 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.056 0.455 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 154' ' ' ALA . 82.7 t80 -163.84 139.5 6.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.631 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.51 -104.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -124.63 53.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -138.4 154.26 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.18 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.41 144.84 32.21 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.59 131.73 34.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -114.82 98.95 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.83 -19.06 65.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.637 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.59 -31.51 70.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.909 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 33.8 p -129.29 -18.24 3.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.61 ' CE1' ' CD2' ' A' ' 179' ' ' PHE . 2.4 t60 83.81 54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.1 151.34 42.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.51 151.62 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.586 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.55 130.65 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.3 OUTLIER -127.78 111.36 13.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.68 71.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.83 43.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 167' ' ' LYS . 18.7 tp60 -132.19 93.45 26.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.18 139.1 21.01 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.968 1.779 . . . . 0.0 112.558 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.18 140.28 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.633 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 m -91.2 87.26 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.429 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.3 mt -96.65 136.01 37.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.671 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 173.01 6.24 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.7 -52.25 9.43 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.26 1.973 . . . . 0.0 112.176 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -56.42 19.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.227 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -58.45 -38.68 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.61 ' CD2' ' CE1' ' A' ' 163' ' ' HIS . 13.1 t80 -61.75 -46.69 88.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.384 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -58.66 -41.57 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.42 -46.88 83.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.835 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.98 -39.79 87.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -58.24 -45.22 88.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.849 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.415 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 4.5 t80 -69.65 -39.29 77.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.2 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -40.97 83.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.627 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.17 -45.33 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.814 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.17 -34.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.415 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 63.1 m-20 -109.26 25.21 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.486 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.57 117.52 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.5 27.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.26 128.74 42.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.897 0.379 . . . . 0.0 110.792 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.69 114.25 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.529 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.62 156.78 16.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.747 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.24 147.91 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 3.7 mttp -58.94 -43.99 98.33 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.316 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 39.5 Cg_exo -54.64 -50.0 14.87 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.367 2.045 . . . . 0.0 111.875 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -62.22 -55.97 23.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -47.88 -43.98 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.934 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.93 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.89 -30.48 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.336 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -72.5 -48.15 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.542 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -83.39 -60.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.413 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -53.41 -4.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.1 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttt180 -62.13 -4.22 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.413 ' H ' ' C ' ' A' ' 203' ' ' TRP . 20.8 m-85 -132.02 28.09 4.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 207' ' ' PHE . 6.0 t70 -160.91 -144.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.903 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.485 ' O ' ' O ' ' A' ' 206' ' ' ASP . 1.5 m-85 -42.01 170.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.617 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.67 -86.6 0.04 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -158.83 98.92 0.18 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -97.25 99.74 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.02 -4.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -98.73 -27.23 14.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.255 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.1 t -66.13 -41.33 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.77 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -53.24 -49.76 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.292 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.47 -47.07 87.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.242 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 73.7 m -61.07 -43.87 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.09 -40.62 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.656 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.41 -42.43 95.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.593 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -43.45 96.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -69.3 -30.43 68.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.35 -45.98 68.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.117 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 2.1 mtp180 -56.89 -44.93 82.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.59 -16.75 63.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -94.98 -29.45 14.63 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.683 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.28 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 110.713 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -110.19 137.49 47.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.593 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.52 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.01 -178.63 17.53 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.0 -15.42 63.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 110.649 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -91.58 111.78 23.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -86.01 136.07 33.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.393 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -88.21 -75.4 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.01 146.27 24.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -102.29 138.49 39.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.943 0.402 . . . . 0.0 110.856 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 45.1 m -95.4 110.54 22.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.979 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.61 70.81 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -40.57 120.68 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.39 -16.83 29.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.49 -53.14 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.281 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.09 -138.21 5.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.74 156.32 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.634 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.1 p -134.33 132.13 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.489 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.72 117.01 29.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 232' ' ' LEU . 4.9 ptm180 -162.8 132.04 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.74 152.65 86.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.994 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 111.46 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.369 2.046 . . . . 0.0 111.835 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.84 -179.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 143.13 120.51 1.52 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' HG ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -45.73 148.52 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.04 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.403 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 38.3 m80 -72.45 -109.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.789 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -46.14 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 124' ' ' HIS . 33.9 m-70 -68.1 165.42 18.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.183 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 42.61 -162.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -153.3 -30.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 58.03 86.64 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -79.41 92.91 5.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -107.62 107.73 18.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.05 151.96 8.41 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -26.11 15.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.995 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 4.5 t -133.42 54.56 13.33 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.776 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 37.0 Cg_endo -66.4 -67.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.671 2.247 . . . . 0.0 112.341 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.7 mmt-85 -47.48 -48.42 26.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.804 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.99 -64.78 0.54 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.5 p -173.68 171.87 3.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.94 0.4 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -126.62 -158.6 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -154.34 21.9 0.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.809 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.7 168.97 15.68 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.267 0.556 . . . . 0.0 111.874 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.84 82.09 0.14 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -83.63 -174.52 5.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.692 0.282 . . . . 0.0 110.609 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 145' ' ' GLU . 26.8 tttt -168.87 151.6 5.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.375 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 144' ' ' LYS . 57.0 mt-10 -39.64 105.57 0.37 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.018 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.39 28.39 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.281 1.987 . . . . 0.0 112.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -95.32 -108.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.523 HD21 HH21 ' A' ' 150' ' ' ARG . 0.1 OUTLIER -87.76 133.18 33.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.691 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.72 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.446 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.523 HH21 HD21 ' A' ' 148' ' ' ASN . 1.8 mtt180 -125.41 124.25 41.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.92 154.81 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 153.65 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.512 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 154' ' ' ALA . 68.7 t80 -166.75 135.84 2.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.515 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.98 -105.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -124.47 53.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.52 145.86 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.221 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 19.7 tt0 -141.1 143.12 34.13 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.458 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.35 128.86 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.6 OUTLIER -113.91 105.3 13.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -65.86 -20.6 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.14 -39.04 84.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 110.665 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 70.3 p -115.9 -24.64 8.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.41 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.591 ' NE2' ' CE2' ' A' ' 179' ' ' PHE . 2.2 t-80 82.77 48.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.281 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -121.77 158.6 28.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 150.42 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.679 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.401 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.46 125.19 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.468 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 170' ' ' GLN . 8.7 tttt -125.61 117.39 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.33 64.13 0.2 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.272 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.25 30.67 67.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 167' ' ' LYS . 12.9 tt0 -133.99 92.92 21.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -76.96 136.41 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.927 1.751 . . . . 0.0 112.448 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.34 143.58 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.937 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.2 p -99.47 87.47 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.3 mt -95.45 154.18 17.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.364 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.0 168.31 23.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -48.8 -53.18 7.33 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.701 2.267 . . . . 0.0 112.572 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -47.59 85.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.91 -39.21 93.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.245 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.591 ' CE2' ' NE2' ' A' ' 163' ' ' HIS . 9.0 t80 -63.66 -48.61 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.682 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -55.49 -43.28 75.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -47.07 85.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.36 -42.37 99.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -59.96 -45.7 91.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.405 ' O ' ' ND2' ' A' ' 188' ' ' ASN . 19.4 t80 -66.04 -42.68 89.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.825 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -45.38 71.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.81 -49.29 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.53 -31.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 188' ' ' ASN . 0.5 OUTLIER -107.17 15.23 25.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -49.69 120.35 4.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.87 -28.89 8.94 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -93.9 131.62 39.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.13 122.24 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.1 mp -95.39 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.501 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 149.23 31.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.584 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 13.3 mttp -55.68 -54.35 52.56 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.242 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.0 Cg_endo -66.99 -32.9 33.97 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.047 1.831 . . . . 0.0 111.768 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -47.49 71.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.772 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.02 -44.96 76.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.361 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.4 mt -61.77 -61.52 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.482 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.2 -38.91 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.995 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -72.01 -51.01 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.212 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 204' ' ' ARG . 37.7 t -83.6 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.234 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.58 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.6 OUTLIER -51.29 -3.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.032 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.589 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp85 -62.46 -1.33 0.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.671 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 205' ' ' TYR . 42.7 t80 -117.69 14.76 14.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.781 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER 167.1 105.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.59 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' A' ' 207' ' ' PHE . 25.7 p90 -80.78 123.74 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.619 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.491 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 156.45 55.11 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.58 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -160.28 100.72 0.19 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -53.33 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.603 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.55 -6.5 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -88.47 -23.17 23.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.755 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.43 -39.29 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.027 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.86 -50.75 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.251 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -55.56 -48.5 74.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.39 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -43.25 97.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -43.97 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.625 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.1 -41.45 91.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.609 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.92 89.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.527 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.31 -27.15 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.0 -45.31 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.054 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.44 -46.19 80.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.664 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -66.9 -23.14 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.414 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -92.46 -24.33 18.85 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.565 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -112.67 -41.18 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.83 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.9 137.61 39.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.544 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 227' ' ' THR . 0.8 OUTLIER -174.37 37.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.89 179.91 18.86 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -73.45 -8.65 56.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.759 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -92.19 112.08 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.568 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.97 155.85 20.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.59 -38.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.523 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.34 120.15 40.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.68 128.87 47.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.417 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 109.04 20.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.36 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' ARG . 38.1 mt -94.35 69.11 3.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LEU . 40.8 mtm105 -41.07 110.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 124.01 -20.44 7.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.83 -46.66 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.62 -137.07 5.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 1.7 m-85 -125.21 157.12 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.643 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.0 128.94 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.51 142.47 27.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.9 136.29 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.667 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.45 158.44 81.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 247' ' ' ARG . 87.4 Cg_exo -39.25 135.48 1.03 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.585 2.19 . . . . 0.0 111.731 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 246' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.753 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.42 -133.39 1.47 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.475 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -125.8 118.46 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.227 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.58 102.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.898 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -150.29 22.95 0.83 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -11.98 58.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.935 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -57.65 -34.95 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 110.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -101.2 61.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.571 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 15.1 t60 -154.56 17.56 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -88.58 -37.3 15.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 p -68.21 128.86 38.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -169.41 56.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 158.58 157.47 8.5 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 134' ' ' VAL . 0.7 OUTLIER 64.58 97.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.715 0.293 . . . . 0.0 110.981 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 133' ' ' LEU . 17.1 m -34.01 150.76 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.64 123.53 9.89 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.567 2.178 . . . . 0.0 112.67 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -91.42 90.53 7.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.39 62.12 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -80.51 -23.71 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.085 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.6 t60 62.84 153.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.974 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.3 mtp -142.25 156.15 45.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -96.8 -17.4 20.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.01 153.72 0.02 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -134.27 -35.27 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -113.16 -12.17 13.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.67 62.39 41.63 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.911 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.55 -91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.598 2.199 . . . . 0.0 112.292 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.51 109.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.849 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.588 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -76.93 147.51 36.91 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.288 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.84 112.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.4 mtm-85 -136.89 123.66 21.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.77 152.27 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.507 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -141.88 157.18 45.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.732 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.2 t80 -162.95 127.73 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.87 -98.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 10.2 p30 -125.07 54.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.35 147.23 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.201 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.75 137.23 31.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.534 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.05 137.37 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.551 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.78 108.48 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.455 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.586 ' OE2' ' NH1' ' A' ' 183' ' ' ARG . 25.4 mm-40 -66.52 -10.61 46.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.07 -42.86 8.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.067 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 163' ' ' HIS . 32.7 p -100.89 10.13 41.49 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 162' ' ' THR . 39.0 t-80 36.24 50.94 0.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -124.22 155.36 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.3 t -117.14 159.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.07 129.24 16.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.3 tptp -127.81 110.25 12.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.42 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.57 67.95 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.74 31.45 64.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 167' ' ' LYS . 34.2 tp60 -142.01 87.92 9.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.35 146.42 80.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.115 1.876 . . . . 0.0 112.008 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -128.94 136.8 58.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.734 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.8 m -92.89 86.95 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.37 152.19 18.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.44 169.23 18.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.95 -54.15 4.94 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 112.185 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.453 ' OG1' ' OE1' ' A' ' 178' ' ' GLU . 2.2 p -54.98 -57.35 12.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.021 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -57.48 -39.14 75.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.655 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -63.95 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.753 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 m -59.07 -39.66 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.19 -45.24 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.685 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 tp -63.85 -39.44 94.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.518 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.586 ' NH1' ' OE2' ' A' ' 160' ' ' GLU . 12.5 ttt180 -64.11 -44.8 91.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -62.84 -40.71 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.959 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.56 -45.15 99.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.777 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.8 mt -58.97 -37.05 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.9 28.59 8.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 118.91 5.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.504 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.56 -21.04 22.07 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -96.01 131.68 42.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.674 0.273 . . . . 0.0 110.724 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 10.6 p -68.62 117.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.308 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.46 150.66 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.08 148.0 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.963 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 1.7 mttp -58.67 -46.43 99.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.1 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 45.5 Cg_exo -50.15 -51.65 10.51 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.024 1.816 . . . . 0.0 111.989 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.98 -55.23 27.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.321 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -49.17 -41.18 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.943 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 30.2 tp -61.43 -67.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.8 -16.78 7.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.133 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -71.11 -52.05 21.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.66 -44.3 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.449 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.4 m-90 -65.18 -5.72 7.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -2.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 206' ' ' ASP . 0.4 OUTLIER -124.29 13.33 8.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 1.0 OUTLIER 177.35 94.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.334 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -72.88 133.49 44.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.52 61.28 0.02 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.59 106.3 0.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -59.99 178.44 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.193 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.4 p -79.71 -6.0 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.8 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.92 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.9 t -61.66 -48.62 87.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.415 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -52.63 -48.61 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.699 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.3 t -61.8 -48.32 81.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.38 -42.08 81.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.64 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 t -62.88 -46.32 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -43.92 92.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -33.31 74.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -46.19 75.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.081 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 18.2 mtp85 -56.17 -45.11 79.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -67.77 -24.82 65.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.542 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -93.19 -24.41 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.46 HD13 HG22 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.38 -36.4 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 5.4 t0 -98.59 138.49 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 -36.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.542 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.09 165.29 16.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -70.42 -8.33 50.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.855 0.36 . . . . 0.0 110.418 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.88 122.27 34.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -82.28 157.58 23.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.33 -41.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.073 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.1 112.92 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.451 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.561 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.2 m -96.27 108.55 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.194 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 237' ' ' ARG . 7.9 mt -95.41 69.75 3.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -35.57 127.0 0.64 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.104 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.57 39.97 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.16 -49.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.939 0.399 . . . . 0.0 110.204 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.85 -139.51 7.15 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.51 154.02 48.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.54 133.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.68 126.74 36.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.641 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -161.78 135.73 6.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.85 156.42 89.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.53 129.81 3.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.443 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -41.52 150.92 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.2 23.08 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.542 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.1 t -102.98 176.47 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.507 ' C ' ' H ' ' A' ' 126' ' ' HIS . 22.7 t60 58.44 74.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 109.91 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.471 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 24.3 t-80 -77.13 30.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.048 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 49.95 -165.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.011 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 47.69 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -169.82 153.86 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.716 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 59.58 114.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.979 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.9 p -165.06 137.44 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.27 147.79 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.83 121.91 5.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.44 -12.6 15.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.679 0.276 . . . . 0.0 110.593 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.5 t 41.76 61.69 7.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.505 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 20.1 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.713 2.275 . . . . 0.0 111.997 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.624 ' NH2' ' SD ' ' A' ' 140' ' ' MET . 0.6 OUTLIER 41.42 91.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.145 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.31 -13.95 0.06 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.2 p -136.64 150.95 48.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 140' ' ' MET . 29.7 m170 50.35 -162.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.624 ' SD ' ' NH2' ' A' ' 136' ' ' ARG . 3.9 mtt 36.91 94.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.774 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -123.47 -78.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.951 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 126.19 100.14 1.17 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.619 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.445 HD21 ' H ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -87.52 2.09 51.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 110.3 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -76.38 136.17 39.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 48.05 67.43 4.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 148' ' ' ASN . 94.7 Cg_endo -84.0 15.15 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.149 2.566 . . . . 0.0 113.005 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -41.88 95.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.403 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 147' ' ' ARG . 14.7 m120 43.88 101.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.637 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.69 134.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.581 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.475 HH21 ' CB ' ' A' ' 148' ' ' ASN . 4.7 ptt180 -175.17 154.93 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.954 0.407 . . . . 0.0 110.883 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 151' ' ' LEU . 10.9 mp -91.98 147.69 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.1 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -141.96 158.1 44.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.46 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 154' ' ' ALA . 74.8 t80 -168.65 142.9 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.05 -105.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -124.83 52.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.73 152.38 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.581 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -145.79 144.39 30.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.634 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.65 124.73 21.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.845 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.4 m-20 -104.39 105.24 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.775 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.4 -11.6 52.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -95.03 -39.58 10.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.633 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.9 p -103.84 8.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 74.9 m-70 37.52 47.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.21 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -121.82 157.05 31.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.749 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.05 152.04 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.81 125.65 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -126.18 115.41 19.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.48 56.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.5 75.5 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.0 mt-30 -131.07 96.27 22.78 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.27 137.79 15.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.087 1.858 . . . . 0.0 112.469 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.27 137.39 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.9 t -89.96 89.2 7.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.02 155.64 16.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.82 171.64 10.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -51.5 -52.16 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.302 2.002 . . . . 0.0 111.675 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.0 m -56.3 -52.08 65.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.956 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.92 -41.7 87.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.459 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 27.0 t80 -60.98 -44.58 97.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.101 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -58.0 -44.84 87.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.636 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -44.37 97.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -43.67 93.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -59.07 -45.16 91.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.55 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 14.1 t80 -65.34 -42.02 93.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.82 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.511 ' CD2' ' OH ' ' A' ' 241' ' ' TYR . 2.9 m-85 -54.6 -39.72 68.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.66 -49.31 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.099 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.3 -32.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.745 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.538 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 59.8 m-80 -107.91 18.17 21.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.56 114.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.709 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.07 -19.26 18.04 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.4 m -95.78 132.45 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.87 115.47 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.58 159.97 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.023 0.44 . . . . 0.0 110.532 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 147.72 28.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.58 -54.8 51.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.062 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.9 Cg_endo -66.84 -33.64 33.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.96 1.773 . . . . 0.0 111.693 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -64.28 -51.64 62.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.09 -41.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.87 -66.9 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -49.91 -28.24 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.101 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 69.9 t60 -72.19 -57.54 4.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.605 ' C ' ' H ' ' A' ' 204' ' ' ARG . 57.3 t -83.42 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.378 . . . . 0.0 111.613 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.497 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.7 OUTLIER -49.12 -4.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.605 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.4 ttm180 -59.31 -0.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.072 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 t80 -111.67 6.03 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.754 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -176.95 107.66 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.529 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 29.1 m-85 -87.77 110.12 20.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.59 52.26 0.02 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.39 103.37 0.22 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 209' ' ' GLY . 37.2 m-20 -45.16 177.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.6 m -79.05 -8.26 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.894 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -82.97 -14.82 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 80.9 t -68.75 -36.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.93 -49.81 79.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.204 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.83 -44.62 90.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.066 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 m -60.84 -46.97 88.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.71 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.42 -41.45 98.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.615 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.52 -43.33 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -45.53 91.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -28.96 68.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.05 -46.06 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 226' ' ' ASP . 32.9 ttm180 -56.03 -47.21 78.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.382 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -67.29 -15.56 63.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.504 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -93.45 -34.24 13.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.477 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.424 ' O ' ' CE ' ' A' ' 167' ' ' LYS . 2.1 pp -109.89 -36.14 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -98.42 141.79 30.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.337 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -161.4 25.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -117.93 169.03 13.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -65.89 -7.89 19.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.599 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 129.34 39.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.745 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.8 113.77 25.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.71 -4.82 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.102 0.477 . . . . 0.0 110.746 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.48 104.92 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.385 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 122.74 33.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.37 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.25 115.39 28.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 9.1 mt -96.1 69.17 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 31.5 mtp180 -35.84 128.19 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.738 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.68 -12.47 66.06 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.0 t -128.4 -60.26 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.88 -139.29 5.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -130.61 154.06 48.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.351 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 7.2 p -135.5 137.44 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.0 tp -91.92 116.9 29.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.225 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -162.27 144.47 11.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -77.02 153.77 82.73 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -36.75 128.03 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.679 2.253 . . . . 0.0 112.148 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.67 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 123' ' ' SER . . . -104.8 -170.7 24.41 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -46.03 90.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 121' ' ' GLY . 47.6 p -93.81 27.3 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -131.05 24.2 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.115 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.11 109.25 16.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.675 ' HD1' ' H ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER 42.66 -152.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -169.56 50.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -148.87 160.22 43.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 43.24 58.46 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.624 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -162.56 176.24 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.72 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.6 m 50.14 54.35 11.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.187 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.7 173.41 5.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.79 152.07 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 110.454 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 136' ' ' ARG . 13.6 p -160.31 56.63 0.83 Allowed Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.121 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.21 17.32 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.736 2.29 . . . . 0.0 111.952 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 134' ' ' VAL . 5.2 mtp85 56.34 164.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.13 -174.16 52.1 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.542 ' HG ' ' H ' ' A' ' 139' ' ' HIS . 15.4 p -138.17 -99.7 0.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.911 0.386 . . . . 0.0 110.414 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.542 ' H ' ' HG ' ' A' ' 138' ' ' SER . 0.2 OUTLIER -117.48 107.32 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.105 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.96 69.68 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -44.64 143.01 1.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.05 -160.23 9.64 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -140.83 -59.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.589 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -79.6 47.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.553 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 1.0 OUTLIER -64.23 -42.23 66.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 23.9 Cg_exo -61.42 -153.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.706 2.271 . . . . 0.0 112.064 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -151.18 38.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.75 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.17 139.72 22.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.36 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.89 114.35 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -123.43 121.51 35.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.87 159.5 16.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.36 153.94 47.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.981 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.9 t80 -160.26 125.16 3.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.472 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.62 -98.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' PHE . 13.5 m-20 -125.61 54.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.62 148.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.416 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -138.98 133.23 31.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.556 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.6 mp -128.6 140.17 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -113.07 102.39 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 0.0 110.376 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.0 -13.11 59.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -96.59 -50.08 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.824 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 50.3 p -94.08 11.86 28.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.504 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 96.5 m-70 36.27 53.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.87 157.37 29.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.428 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.18 156.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.39 128.2 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.456 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.5 ttpt -126.88 106.44 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.22 71.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.03 30.42 37.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.8 tt0 -140.95 85.9 12.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -63.42 154.07 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.411 2.074 . . . . 0.0 112.554 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.15 121.47 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.638 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 t -92.38 87.01 5.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.36 155.37 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -62.37 178.95 0.3 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.736 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 175' ' ' SER . 5.6 Cg_exo -67.6 -48.4 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.441 2.094 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.7 m -46.13 -54.18 9.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.298 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -43.68 84.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -55.8 -44.84 78.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -59.67 -46.99 87.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.575 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.77 -42.32 99.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.11 -46.12 90.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.743 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.55 -41.57 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.034 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.58 -43.78 88.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.72 -42.03 82.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.36 -53.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.92 -31.78 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.64 19.89 19.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.47 119.94 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.66 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.41 -25.83 10.14 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -94.16 126.38 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.56 120.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.349 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.29 157.62 15.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 148.62 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -56.41 -52.31 74.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.634 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.5 Cg_endo -63.83 -41.24 24.72 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.721 1.614 . . . . 0.0 112.155 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -60.91 -48.79 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.272 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.86 -40.47 71.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.917 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' A' ' 199' ' ' LEU . 1.9 tt -56.68 -61.83 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.979 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -17.03 64.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.439 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.18 -45.6 63.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.581 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 204' ' ' ARG . 71.2 t -84.53 -53.7 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.793 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 206' ' ' ASP . 4.8 m-90 -64.01 -3.07 2.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.528 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.6 ttp180 -40.97 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 203' ' ' TRP . 6.4 m-85 -100.12 27.42 5.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 166.05 103.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.948 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -43.38 149.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.499 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.45 178.67 27.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.66 64.36 0.29 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.26 94.53 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.869 0.366 . . . . 0.0 110.296 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.49 -10.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.665 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -91.53 -23.11 20.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.34 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.397 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.79 -48.0 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.181 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.35 -45.54 87.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.49 98.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -40.68 89.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.24 -41.29 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -44.3 88.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.0 -27.43 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.27 -48.76 32.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.105 0.479 . . . . 0.0 110.188 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 14.6 ttp180 -56.6 -51.32 69.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -67.05 -8.04 27.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -91.64 -37.46 13.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -117.54 -34.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.085 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -98.24 151.26 20.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.808 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.9 t -177.46 -30.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.209 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -65.38 174.02 18.66 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -67.08 -5.7 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.821 0.344 . . . . 0.0 110.795 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -92.96 104.77 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.477 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.6 107.31 18.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.56 -2.55 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.504 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.11 103.62 8.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.336 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 122.92 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 0.0 110.603 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.1 m -91.26 112.14 23.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.744 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.8 mt -96.29 70.12 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 236' ' ' LEU . 5.9 tpp180 -35.69 116.87 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.797 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.76 -9.97 40.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.9 -36.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.48 -137.39 8.89 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.8 150.75 51.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.24 141.08 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.08 116.57 28.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.135 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -162.2 127.5 3.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.646 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.5 mp0 -65.91 155.81 85.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.464 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.42 119.23 6.19 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.657 2.238 . . . . 0.0 112.186 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.619 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.93 20.5 2.33 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 123' ' ' SER . 0.2 OUTLIER -122.65 -59.42 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 122' ' ' SER . 0.6 OUTLIER -52.0 -32.15 32.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.769 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -154.27 139.17 17.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.389 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -104.09 -167.09 1.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.293 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 126' ' ' HIS . 2.9 p80 -122.33 122.7 39.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -117.11 -43.52 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.858 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -7.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.243 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER 57.46 179.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.572 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 131' ' ' SER . 44.4 m 48.43 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' SER . 14.7 m 53.0 107.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.4 -141.78 1.91 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 tp -124.61 76.66 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.778 0.323 . . . . 0.0 110.311 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.521 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 29.8 m -131.89 49.44 4.62 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 19.5 Cg_endo -63.69 179.02 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.921 2.414 . . . . 0.0 112.208 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -132.02 98.76 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.95 -44.77 94.05 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.6 t -82.48 147.95 28.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 140' ' ' MET . 14.2 t-160 -160.9 74.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.455 ' CB ' ' O ' ' A' ' 139' ' ' HIS . 4.9 ttm 77.98 -63.13 0.34 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.8 tttm 53.5 -151.77 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.392 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.95 -93.86 0.46 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -130.88 -57.95 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.08 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -61.35 144.1 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -95.03 152.16 39.34 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.376 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -38.66 121.99 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.618 2.212 . . . . 0.0 112.061 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -85.75 102.53 13.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -91.13 110.71 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.515 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.04 137.01 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.433 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -135.85 128.94 31.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.19 149.12 21.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.7 m -141.6 155.83 45.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.5 t80 -158.15 124.48 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.989 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -94.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 153' ' ' PHE . 4.1 m-20 -124.41 53.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.3 151.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.37 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -147.76 140.7 24.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.576 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.89 138.92 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.424 ' CB ' ' OG1' ' A' ' 162' ' ' THR . 12.8 m-20 -111.36 106.37 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.382 . . . . 0.0 110.489 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -9.95 38.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.064 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.96 -47.37 4.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.015 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.0 p -94.73 8.48 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.768 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 162' ' ' THR . 12.7 m80 36.53 55.35 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -128.64 154.13 46.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.486 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.57 152.84 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.95 126.71 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.799 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 170' ' ' GLN . 10.0 tmtt? -130.13 115.69 17.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.341 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.04 67.88 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 56.7 29.47 58.19 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.1 tt0 -132.09 89.4 38.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.98 132.0 12.5 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.08 1.853 . . . . 0.0 112.475 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 135.56 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.741 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 96.51 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.7 148.19 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.562 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.31 169.85 18.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -54.18 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -49.44 77.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -60.71 -38.76 86.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.1 -46.39 87.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -63.13 -41.19 99.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.8 -48.87 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.555 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.1 -44.99 87.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.553 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -55.39 -42.69 74.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.53 -43.92 75.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.77 -41.39 73.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.5 -48.68 79.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.94 -32.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.791 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -106.45 23.12 14.7 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.093 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.51 116.6 3.2 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.31 10.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.9 m -91.76 129.4 37.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 110.291 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 68.8 t -67.57 121.28 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.1 162.69 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.96 147.96 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.1 mtmt -58.21 -54.75 52.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.252 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.6 Cg_endo -68.85 -30.64 26.49 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.923 1.749 . . . . 0.0 111.819 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -67.41 -50.73 58.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.933 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.9 mt -57.16 -39.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 210' ' ' ASP . 5.7 tt -59.47 -67.88 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.342 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -25.55 3.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -50.67 27.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.841 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' A' ' 204' ' ' ARG . 98.9 t -83.28 -59.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.657 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.551 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -52.73 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.5 tpp180 -53.54 -4.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.551 ' H ' ' C ' ' A' ' 203' ' ' TRP . 14.2 m-85 -104.19 7.36 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -177.15 125.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.83 133.54 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -176.18 93.32 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.74 60.98 0.49 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 m-20 -108.64 95.86 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.2 p -84.15 -9.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.771 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -90.41 -23.94 20.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.771 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.18 -41.17 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.516 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.87 -50.58 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.327 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -56.64 -46.55 80.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -44.85 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.794 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.88 -38.84 89.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.62 -39.96 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.32 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -44.68 78.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.184 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -69.72 -14.15 62.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.4 -46.82 9.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.939 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.1 mtt-85 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -66.08 -14.5 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -93.13 -27.06 17.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 225' ' ' ILE . 0.1 OUTLIER -118.25 -45.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.592 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.3 t70 -93.67 137.1 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.005 0.431 . . . . 0.0 110.642 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.6 t -179.23 36.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.161 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -143.21 165.39 27.03 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.48 -3.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 228' ' ' GLY . 24.6 mttt -93.46 133.01 37.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.633 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -92.81 158.9 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.365 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.8 mt -147.21 -55.43 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.308 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.42 126.79 48.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.503 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 125.08 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.51 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 112.4 24.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 68.9 mt -96.22 67.82 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.67 115.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 -12.34 24.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.03 -55.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.512 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.83 5.69 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.5 152.45 49.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.718 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.9 p -136.03 131.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.184 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.88 128.7 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -162.89 138.2 6.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -79.71 156.08 75.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.296 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.0 107.47 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.291 179.72 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 34.1 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.01 -5.56 1.61 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 124' ' ' HIS . 2.1 p -168.16 14.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.356 . . . . 0.0 110.48 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' A' ' 124' ' ' HIS . 2.9 t 42.95 -88.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.552 ' N ' ' O ' ' A' ' 122' ' ' SER . 1.2 t60 69.88 168.73 0.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -92.93 -57.07 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -97.33 154.23 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.46 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -134.27 -70.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.501 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.614 ' CG ' ' N ' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -144.12 -149.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.333 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.614 ' N ' ' CG ' ' A' ' 128' ' ' HIS . 13.2 m170 -44.07 -96.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.7 m -158.99 -58.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.629 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 m -149.39 -92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.021 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.43 -25.17 24.0 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 134' ' ' VAL . 12.7 tp -112.6 115.14 28.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.835 0.35 . . . . 0.0 110.465 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 133' ' ' LEU . 1.6 m -30.59 97.31 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.547 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.4 -55.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.193 1.929 . . . . 0.0 112.391 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -107.78 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.722 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.77 155.16 38.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -86.62 59.75 5.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.862 0.363 . . . . 0.0 110.308 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 t60 -84.24 -14.38 50.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -149.29 172.04 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.997 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 tttm 53.3 77.62 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 110.213 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -135.32 28.87 2.97 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -80.72 -8.58 59.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 0.0 110.649 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -113.11 130.98 56.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -85.27 159.4 56.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.094 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 145' ' ' GLU . 80.6 Cg_exo -37.87 162.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.837 2.358 . . . . 0.0 112.222 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.47 5.85 9.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.067 0.461 . . . . 0.0 109.896 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.94 121.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.541 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.11 129.8 36.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.54 HH12 ' CG ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -172.07 -178.32 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.532 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.49 154.07 41.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.6 m -139.29 156.7 46.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 156' ' ' ILE . 37.1 t80 -161.59 132.58 5.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.98 -102.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -121.38 52.48 1.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.85 141.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.213 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.54 ' CG ' HH12 ' A' ' 150' ' ' ARG . 15.8 tt0 -140.05 134.03 30.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 110.401 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -130.28 136.61 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 163' ' ' HIS . 83.3 m-20 -113.89 104.81 12.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.89 -27.76 68.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.789 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.64 -44.21 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 59.4 p -102.59 9.5 39.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.497 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CG ' ' C ' ' A' ' 162' ' ' THR . 12.6 p-80 37.13 55.2 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -126.85 158.92 35.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.4 t -121.75 155.01 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.648 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.33 125.19 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.5 tttm -124.81 109.06 12.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.26 57.34 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.121 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.76 29.15 71.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 167' ' ' LYS . 27.6 mt-30 -141.74 89.96 8.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.788 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -64.71 147.19 89.73 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 112.129 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.96 136.45 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -88.55 87.72 7.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.29 144.67 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.29 162.96 54.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.514 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.7 -53.83 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.51 2.14 . . . . 0.0 112.427 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 p -59.93 -50.04 75.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.78 -34.53 77.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.71 -46.32 79.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -58.12 -43.92 87.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 mt -58.19 -48.35 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.64 89.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -57.74 -44.79 86.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.558 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -66.23 -43.36 86.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.62 -46.55 77.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.604 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.76 -46.01 95.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.85 -38.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -104.3 23.92 12.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.98 123.58 11.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.4 -27.59 13.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.61 129.87 38.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 123.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.352 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.68 157.32 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 148.98 29.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.361 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.7 mtpt -56.57 -53.97 58.59 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 37.1 Cg_endo -71.4 -32.49 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.963 1.775 . . . . 0.0 111.828 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -64.2 -50.49 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.9 mt -56.91 -42.43 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.46 -63.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.21 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.34 -28.6 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -72.4 -52.01 17.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.303 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.0 t -82.94 -62.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.211 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.417 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.0 OUTLIER -51.17 -4.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.5 ttt180 -63.19 -3.89 2.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.892 0.377 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.4 m-85 -118.82 6.79 11.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.448 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.89 101.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.646 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -84.07 120.2 25.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.54 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 160.14 48.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.29 106.87 0.3 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 209' ' ' GLY . 1.5 m-20 -49.22 -173.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.971 0.415 . . . . 0.0 110.55 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.5 -8.4 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -85.24 -15.83 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.888 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.55 -33.34 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.43 -50.31 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.216 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.11 -49.24 72.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -63.78 -39.97 95.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.46 -42.58 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.296 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' NH1' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -62.79 -43.65 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.39 -37.66 85.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.255 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.22 -46.78 85.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.069 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.42 -42.66 78.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.97 -10.12 50.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -39.14 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.69 -30.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.208 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 222' ' ' ARG . 19.9 t0 -91.57 -160.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.476 ' H ' ' CG ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER 72.14 6.11 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.73 -139.59 5.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -36.91 11.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -92.5 120.45 32.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.018 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 19.4 mtp85 -90.5 92.75 9.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.971 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -0.91 57.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.82 110.18 12.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.48 42.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.639 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 74.9 m -97.63 113.45 25.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 237' ' ' ARG . 4.9 mt -98.95 67.76 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.646 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.6 mtm180 -37.49 125.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.838 0.351 . . . . 0.0 110.79 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.72 -32.86 6.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.55 -56.77 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.457 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.24 -137.46 4.94 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.39 157.07 42.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.37 142.4 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 111.074 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.86 118.02 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.053 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -161.76 129.78 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.023 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.3 155.01 94.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -38.48 156.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.783 2.322 . . . . 0.0 112.435 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.612 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.3 ptm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.1 106.93 2.87 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.016 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.28 140.16 48.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 110.411 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 124' ' ' HIS . 1.6 m -159.55 36.43 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' A' ' 123' ' ' SER . 0.8 OUTLIER 66.86 33.26 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.515 ' CG ' ' H ' ' A' ' 126' ' ' HIS . 16.2 t-80 -52.94 174.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.515 ' H ' ' CG ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER 55.51 154.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.495 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -69.75 154.6 41.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.566 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -164.03 30.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -94.61 118.37 31.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -149.6 107.73 3.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 t -97.51 87.89 4.23 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.749 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.73 68.47 0.31 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.82 -23.43 13.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.601 0.239 . . . . 0.0 110.91 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' A' ' 134' ' ' VAL . 12.8 p -161.74 69.87 2.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.23 163.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.986 2.458 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.57 -173.18 2.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.527 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.08 84.49 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.95 -36.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.59 0.233 . . . . 0.0 110.434 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.18 136.3 34.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 59.1 mtt -45.99 154.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.347 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.76 8.71 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -39.48 129.57 2.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -146.53 63.64 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.313 . . . . 0.0 110.344 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -94.96 167.51 11.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.567 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 48.25 58.0 17.81 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.563 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.47 119.08 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.857 2.371 . . . . 0.0 112.205 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -90.38 -108.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 148' ' ' ASN . 0.3 OUTLIER 48.76 79.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.19 141.4 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.558 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -138.59 130.05 27.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.64 140.61 29.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 m -142.09 152.37 43.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.1 t80 -166.25 139.11 3.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.03 -104.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.37 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.13 147.17 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.991 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -144.62 141.67 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.712 0.292 . . . . 0.0 110.428 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -135.52 136.74 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.388 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.02 108.49 17.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.288 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -66.27 -9.95 37.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.661 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -100.2 -43.75 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.916 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' HIS . 25.6 p -95.74 9.04 41.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 162' ' ' THR . 10.9 m170 35.65 41.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.621 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -122.44 159.02 28.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.773 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.1 t -118.94 158.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -146.44 123.42 11.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.51 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.9 tmtm? -127.47 115.03 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.255 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.16 67.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.43 31.46 63.05 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -133.55 90.87 27.62 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.53 138.72 15.64 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.203 1.935 . . . . 0.0 112.36 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.18 138.74 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m -85.63 93.09 8.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.91 140.86 30.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.13 174.03 6.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.95 -53.49 7.07 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.382 2.055 . . . . 0.0 112.097 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.0 m -54.96 -56.65 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.773 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.98 -37.24 81.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.49 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.74 -46.36 88.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.63 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -58.65 -41.0 85.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.39 -52.53 64.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.658 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.8 -41.86 87.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.503 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -62.41 -44.53 96.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.417 ' OH ' ' CE1' ' A' ' 201' ' ' HIS . 1.3 t80 -59.25 -39.73 83.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.77 -41.15 99.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.185 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.65 -43.24 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.962 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.8 -42.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.12 26.91 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.21 20.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.709 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.09 -23.5 30.5 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 126.8 41.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.821 0.343 . . . . 0.0 110.294 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.25 116.66 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.728 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 mp -96.56 153.12 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.15 149.23 24.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.313 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.69 -46.69 99.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.506 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 37.2 Cg_exo -55.11 -47.14 28.02 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.867 1.712 . . . . 0.0 111.897 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -61.91 -57.32 12.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.5 mt -50.63 -36.24 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.19 -58.33 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.146 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.43 -27.53 68.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.814 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' CE1' ' OH ' ' A' ' 184' ' ' TYR . 0.2 OUTLIER -73.2 -59.83 2.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.623 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.6 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -84.54 -58.22 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.704 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' A' ' 206' ' ' ASP . 1.1 t-105 -51.76 -4.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.055 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.6 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.8 ttt-85 -64.24 0.33 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.591 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 m-85 -106.86 5.77 28.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.608 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -174.41 102.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.771 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.9 107.51 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.91 48.85 0.02 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -158.94 101.94 0.21 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.7 OUTLIER -48.78 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.151 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.8 m -80.82 -1.0 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.7 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -95.14 -23.72 17.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 216' ' ' SER . 66.7 t -62.15 -38.47 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -44.6 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.85 -48.9 74.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 4.8 p -60.94 -44.18 97.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.337 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -40.44 97.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.54 -41.56 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.485 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -44.87 94.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 110.211 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -65.15 -37.85 88.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.56 -44.74 85.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.379 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 226' ' ' ASP . 21.7 mtp180 -55.28 -42.63 73.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -16.13 64.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -93.07 -26.63 17.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.509 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.87 -38.47 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.769 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.5 OUTLIER -98.3 136.67 38.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.503 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -173.27 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.872 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.25 179.87 0.73 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -79.39 -12.62 59.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.7 0.286 . . . . 0.0 110.716 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.66 122.19 35.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.1 mmm-85 -82.67 158.35 23.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mp -146.78 -42.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.008 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.63 112.05 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.16 122.79 40.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.6 m -92.6 107.09 18.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.4 mt -93.21 71.8 4.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 57.5 mtp180 -36.78 133.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.644 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.23 74.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.12 -58.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.952 0.406 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 156.07 -139.61 6.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -129.17 154.6 46.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.551 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.0 p -136.67 132.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.197 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.91 126.28 35.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -162.22 130.43 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.44 157.0 87.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -37.23 113.87 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.738 2.292 . . . . 0.0 112.33 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.317 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.6 mmm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.52 -25.49 2.39 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -89.8 -86.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.809 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.5 p 47.6 -165.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -81.6 90.06 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.999 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -54.9 -56.49 18.97 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.465 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 127' ' ' HIS . 58.3 t60 -134.27 -128.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.765 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 126' ' ' HIS . 13.6 m-70 -121.52 117.12 26.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.248 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 12.1 m-70 -145.74 -72.48 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.191 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' SER . 12.4 m-70 -96.23 -45.54 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.528 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.1 OUTLIER 55.22 109.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.9 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 t -61.23 -28.16 68.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 110.076 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 130' ' ' SER . . . -121.51 148.86 17.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' C ' ' CD2' ' A' ' 133' ' ' LEU . 1.4 tt -115.1 -62.97 1.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' O ' ' CG1' ' A' ' 134' ' ' VAL . 9.4 p -154.38 59.66 2.54 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.546 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.84 177.14 8.5 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.271 2.647 . . . . 0.0 112.322 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -116.59 172.81 6.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.88 55.82 1.12 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -56.55 -95.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 141' ' ' LYS . 9.7 t-80 -82.53 -23.27 34.65 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.267 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.481 ' SD ' ' C ' ' A' ' 140' ' ' MET . 0.0 OUTLIER -60.13 78.15 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -75.93 -19.19 58.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.531 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.93 40.17 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -165.72 151.04 8.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -115.75 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.86 152.85 54.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.05 176.73 5.05 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.764 2.309 . . . . 0.0 112.593 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -146.37 111.18 5.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' A' ' 148' ' ' ASN . 0.9 OUTLIER 56.68 101.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.5 109.94 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.5 mtm-85 -106.33 -177.17 3.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.0 mt -145.94 133.3 20.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.205 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -139.23 156.86 46.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 155' ' ' ASP . 8.8 t80 -164.92 130.85 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.89 -99.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 74.4 m-20 -124.45 53.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.43 144.39 30.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.349 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -140.29 131.0 25.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.946 0.403 . . . . 0.0 110.557 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -127.49 152.2 47.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.34 107.63 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.3 -12.23 55.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -96.11 -49.71 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.3 p -92.57 11.18 27.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.479 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 15.0 m80 35.27 48.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -117.58 159.92 22.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.5 t -125.43 150.09 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.428 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.3 127.09 14.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.512 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.8 tmtm? -129.45 114.13 15.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' CB ' ' HZ2' ' A' ' 167' ' ' LYS . . . 31.88 71.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.55 24.82 32.93 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.9 tt0 -129.02 94.73 33.26 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.488 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.94 137.28 12.34 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.158 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.63 135.83 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.068 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 m -92.63 88.96 6.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.5 153.94 17.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.67 171.48 10.52 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.455 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.8 -54.07 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.492 2.128 . . . . 0.0 112.319 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.3 m -54.76 -54.25 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.75 -38.01 83.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 110.756 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 22.5 t80 -63.57 -43.21 97.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.6 m -62.42 -43.46 98.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -59.35 -43.91 92.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 38.4 tp -71.36 -38.47 71.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.659 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -58.19 -41.24 83.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.691 ' CZ ' ' NE2' ' A' ' 201' ' ' HIS . 15.4 t80 -69.83 -39.85 76.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.804 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.61 -41.95 82.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.9 -48.16 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.64 -31.41 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.08 21.25 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.0 118.35 3.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.81 -19.62 35.38 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 m -98.27 126.97 43.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.5 p -68.53 122.08 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.59 159.82 14.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 147.85 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.796 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.4 mtmm -56.84 -56.69 30.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -63.64 -32.67 68.84 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.013 1.808 . . . . 0.0 111.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -68.61 -51.72 39.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.951 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 mt -53.0 -36.94 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.893 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.403 ' CD2' ' CG ' ' A' ' 203' ' ' TRP . 0.9 OUTLIER -61.21 -70.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.422 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -52.18 -17.33 1.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.155 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.691 ' NE2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.57 -53.38 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.099 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.2 t -83.26 -40.42 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.525 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -60.67 -3.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 202' ' ' VAL . 25.9 ttt180 -61.41 -0.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.6 m-85 -118.24 -0.28 11.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.085 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -171.47 85.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.303 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -42.79 160.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.393 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.89 -158.1 20.7 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 210' ' ' ASP . . . -160.97 78.27 0.17 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 209' ' ' GLY . 15.3 m-20 -147.56 95.07 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 0.0 110.655 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.2 m -83.4 -8.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -23.03 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.56 -35.5 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.16 -52.46 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.64 -45.5 91.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -44.84 96.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 110.735 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -61.52 -44.96 96.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.24 -37.93 79.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.523 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -46.26 76.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.2 -17.41 63.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.389 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -49.19 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.069 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -55.75 -47.7 76.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.169 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -67.3 -13.04 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.553 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -95.05 -32.73 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.471 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.64 -34.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.222 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -100.08 140.04 34.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 110.69 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.23 -37.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -55.68 174.3 1.09 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.93 -9.4 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.799 0.333 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 104.64 16.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.655 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -83.69 112.59 20.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.486 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.83 1.05 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.09 107.11 12.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.25 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.63 123.37 35.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 67.9 m -90.96 111.2 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.037 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 237' ' ' ARG . 47.0 mt -95.85 68.27 2.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.467 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.4 tpp180 -38.52 124.26 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.25 -14.09 47.93 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.79 -56.79 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.632 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.19 -137.3 4.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 29.4 m-85 -128.37 156.96 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.55 133.55 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.6 tp -90.84 128.63 36.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -163.35 135.25 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.629 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 246' ' ' PRO . 7.4 mt-10 -76.09 155.86 84.28 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 245' ' ' GLU . 69.3 Cg_exo -39.89 169.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.675 2.25 . . . . 0.0 112.2 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.577 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' GLY . 17.5 mtp . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 122' ' ' SER . . . -35.3 -88.25 0.01 OUTLIER Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -34.98 111.32 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -148.56 124.14 10.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -151.39 120.29 6.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.862 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 126' ' ' HIS . 8.0 m-70 -161.74 -45.22 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 125' ' ' HIS . 93.8 m-70 36.82 -109.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.553 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -119.71 -78.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.35 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 50.49 66.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.148 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.42 165.88 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 m 58.11 58.72 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.79 120.38 29.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.814 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.5 54.23 0.49 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -62.63 1.31 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.683 0.277 . . . . 0.0 110.665 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.1 t -139.77 68.87 37.03 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.792 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.5 -10.87 17.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.742 2.295 . . . . 0.0 112.025 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -133.43 86.67 2.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.541 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.14 -109.64 3.37 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' MET . 47.4 m -155.02 -58.38 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.819 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -47.57 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.2 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -74.45 103.28 4.75 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.334 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.46 175.32 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.923 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.56 -171.3 37.67 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m120 42.6 74.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.432 . . . . 0.0 110.53 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 145' ' ' GLU . 1.7 pttt -91.83 16.41 10.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.927 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 144' ' ' LYS . 2.4 pt-20 33.77 76.52 0.4 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.53 -97.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.866 2.377 . . . . 0.0 112.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -165.61 18.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.32 113.93 25.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 117.21 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.2 mtm105 -142.46 129.44 20.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.66 158.16 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.19 155.94 45.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.619 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 154' ' ' ALA . 28.0 t80 -165.47 129.81 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.912 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.5 -99.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.1 m-20 -124.67 54.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.43 152.16 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.604 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.78 145.65 35.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.408 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -143.67 116.95 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.63 108.22 18.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.57 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -66.71 -24.95 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -50.59 -40.35 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 69.7 p -119.53 -23.9 6.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.5 t-80 84.02 53.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.384 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -127.39 156.82 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.654 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 t -117.0 153.76 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.44 126.95 15.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 170' ' ' GLN . 16.0 ttpp -126.04 113.07 16.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.13 67.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.016 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.46 32.81 64.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -137.56 92.14 13.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.89 139.96 20.04 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.095 1.864 . . . . 0.0 112.326 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.82 140.8 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.911 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -96.29 90.19 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.386 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.68 150.18 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.672 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 169.43 17.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.77 -54.53 4.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.533 2.155 . . . . 0.0 112.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.327 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -57.07 -37.2 71.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -59.3 -46.08 89.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.4 m -63.82 -41.1 97.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.284 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -46.7 84.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -45.33 86.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.712 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -60.24 -42.98 96.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.658 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 11.6 t80 -65.25 -40.35 93.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -43.01 89.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.684 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.31 -45.35 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.8 -34.65 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.753 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -106.64 22.33 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.682 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.95 110.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.9 -27.52 7.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.3 132.39 33.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.27 113.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.49 ' HG ' ' H ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -107.85 148.02 30.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.64 -51.34 82.42 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.544 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 24.4 Cg_endo -64.13 -37.84 39.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.601 1.534 . . . . 0.0 111.682 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.49 ' H ' ' HG ' ' A' ' 194' ' ' SER . 31.6 tttt -65.76 -44.84 84.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.052 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.85 -41.99 68.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' TRP . 5.0 mt -61.93 -65.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -41.4 -34.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.658 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 53.7 t-80 -71.76 -53.78 12.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.9 t -83.54 -57.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -53.16 -2.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.217 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -60.76 -3.1 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.567 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.477 ' H ' ' C ' ' A' ' 203' ' ' TRP . 39.0 t80 -117.41 10.0 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.64 97.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 132.89 41.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.274 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 149.47 55.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.12 103.04 0.22 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -52.81 -176.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.355 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.7 m -81.75 -6.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.562 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.22 -18.98 23.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.789 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.93 -33.5 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.278 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.28 -51.14 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.71 -46.01 70.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.982 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -48.55 81.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.47 -39.21 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.497 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.5 -42.23 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.256 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -25.48 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.24 -42.48 45.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 226' ' ' ASP . 44.5 ttt180 -55.79 -50.4 70.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.5 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -7.43 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.115 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -42.05 10.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.47 -25.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.398 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -101.99 146.35 28.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.935 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.7 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.62 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -49.23 162.86 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.0 -8.12 34.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.01 126.6 38.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -81.12 159.62 24.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.553 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.08 -41.17 0.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.969 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.9 114.67 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 124.32 42.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.534 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.56 114.61 27.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 238' ' ' GLY . 11.2 mt -95.88 68.72 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.161 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -41.87 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.162 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 236' ' ' LEU . . . 129.68 -13.28 5.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.55 -50.32 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.659 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.76 -137.71 5.46 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 151.65 50.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 127.65 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.4 tp -90.49 138.03 31.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.08 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 139.89 7.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -69.99 157.57 89.44 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.463 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.99 109.61 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.486 2.124 . . . . 0.0 112.091 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.631 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.445 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 5.3 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.8 35.86 4.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.2 128.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.92 27.99 4.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.59 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER -53.0 -78.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.034 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -60.74 -174.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.427 ' HD1' ' H ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -117.71 -166.45 1.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.048 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.474 ' HD1' ' N ' ' A' ' 128' ' ' HIS . 1.4 t-80 -150.22 115.82 5.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.915 0.388 . . . . 0.0 110.063 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.474 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 63.5 t60 -97.92 142.58 29.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.937 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.83 118.66 2.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.933 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.27 -36.68 22.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.6 p -54.17 120.91 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.465 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.72 79.11 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 mt -104.19 141.07 36.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.411 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 3.0 m -145.42 56.52 3.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.309 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 39.6 Cg_endo -68.84 50.07 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.827 2.351 . . . . 0.0 111.886 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.8 54.29 0.88 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.303 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -50.76 -62.25 5.41 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.5 m -167.92 -53.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.279 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -150.16 99.74 2.84 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.378 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.13 -57.76 1.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.808 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -86.65 -54.25 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.275 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -45.64 103.56 0.06 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -168.72 -65.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.116 0.484 . . . . 0.0 110.224 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 51.0 mttm -40.66 124.5 2.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.357 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.648 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 2.2 tt0 -81.18 -39.66 1.03 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.971 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 23.6 Cg_exo -61.09 156.94 41.89 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.547 2.165 . . . . 0.0 111.815 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -113.97 -29.48 7.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.754 0.311 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.59 123.05 28.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.777 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.96 114.35 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.461 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -122.26 121.04 35.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mt -90.54 147.78 23.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.2 154.32 46.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.095 0.474 . . . . 0.0 111.094 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 155' ' ' ASP . 62.4 t80 -159.29 126.98 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.599 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.29 -96.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 1.2 p30 -124.34 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.56 145.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -144.21 138.68 28.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.787 0.327 . . . . 0.0 110.424 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.43 139.45 42.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.07 102.91 11.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 0.0 110.588 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.12 -8.94 26.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -99.0 -45.28 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.729 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.7 p -98.88 13.04 33.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.338 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 1.0 OUTLIER 35.12 54.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.635 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.26 152.49 48.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.25 157.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.35 125.85 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.479 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 19.2 tptt -122.9 110.53 15.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.397 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.58 59.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.483 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 23.65 77.72 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 24.5 mt-30 -131.86 95.99 21.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.402 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.49 134.92 14.3 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.082 1.855 . . . . 0.0 112.439 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.5 143.79 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.772 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.43 95.39 9.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.631 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.71 154.17 17.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.46 ' H ' ' HG ' ' A' ' 175' ' ' SER . 0.1 OUTLIER -88.48 172.46 7.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.262 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.37 -51.27 11.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.459 2.106 . . . . 0.0 112.149 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.2 m -58.1 -54.61 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.77 -43.96 77.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.483 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.92 -48.56 81.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.526 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 m -56.77 -46.32 81.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.586 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.46 -47.05 87.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.69 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.51 -41.53 98.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -59.57 -45.2 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.388 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -61.62 -43.98 97.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.615 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -55.51 -47.86 75.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -47.06 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.019 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mm -54.9 -34.32 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.786 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -112.53 20.4 16.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.0 119.59 4.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.28 -26.28 10.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.6 m -97.82 129.59 44.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.803 0.335 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 43.7 t -67.89 117.01 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.64 160.03 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.667 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.97 148.84 26.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.63 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 0.4 OUTLIER -58.06 -49.48 93.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 35.9 Cg_exo -54.08 -44.17 51.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.373 2.048 . . . . 0.0 111.778 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -59.93 3.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.4 mt -48.25 -42.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.49 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.502 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 17.0 t0 -53.7 -24.03 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.594 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 51.7 t-80 -71.84 -50.36 30.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.715 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.1 t -84.75 -62.17 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -49.35 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.337 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.7 ttp85 -60.9 -0.57 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.437 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 203' ' ' TRP . 12.2 m-85 -117.47 10.91 13.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.294 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.78 105.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 7.0 p90 -86.94 114.62 23.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.69 47.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.27 103.22 0.22 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 209' ' ' GLY . 16.2 m-20 -48.98 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.811 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.66 -6.43 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.081 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -82.64 -18.21 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.392 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.99 -37.45 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.06 -49.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.868 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.35 -47.52 72.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.55 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.1 p -60.96 -47.52 86.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -38.56 91.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.0 -47.57 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.415 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -44.66 92.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.303 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.25 -23.3 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -76.73 -44.99 31.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.015 0.436 . . . . 0.0 110.151 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 226' ' ' ASP . 33.7 ttt-85 -55.44 -49.65 71.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.957 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -68.25 -7.52 31.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -94.38 -32.61 13.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.541 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.9 -7.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.124 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -116.09 138.25 51.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.006 0.431 . . . . 0.0 110.857 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 t -170.52 39.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.5 163.45 26.82 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.4 -5.61 11.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.733 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.98 104.48 16.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -86.81 101.26 13.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.44 1.87 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.588 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.92 96.46 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.57 125.83 34.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.718 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 44.3 m -95.83 112.32 24.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.65 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.6 mt -95.57 73.45 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.366 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 43.3 ttm-85 -35.92 128.03 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.55 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.46 61.21 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.2 -58.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 110.828 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.14 -138.1 5.6 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -127.11 156.28 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 0.0 110.711 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.7 136.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.462 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.22 112.41 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.355 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -162.2 131.49 4.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.13 152.52 82.08 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.33 112.61 3.38 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.397 2.065 . . . . 0.0 111.993 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.521 179.857 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.8 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 121.0 142.26 6.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER 54.95 39.16 31.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.45 149.13 49.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.634 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -157.98 130.57 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.252 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.13 136.96 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -88.61 149.16 23.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.092 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.54 -67.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.054 0.454 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.86 -15.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.339 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.488 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 1.4 m170 -88.2 133.07 34.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.103 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 143.19 50.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 131' ' ' SER . 5.0 p 41.35 51.64 3.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.03 -158.01 34.13 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.7 mp 58.66 98.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 136' ' ' ARG . 71.3 t -132.16 78.44 68.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.068 0.461 . . . . 0.0 110.798 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.24 3.27 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.151 2.567 . . . . 0.0 111.874 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -95.95 64.14 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -172.93 -178.51 43.0 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -131.38 -177.14 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -112.89 -24.48 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.845 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.94 -78.18 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.336 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 142' ' ' GLY . 9.9 tttm 55.18 -168.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.809 0.338 . . . . 0.0 111.042 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 141' ' ' LYS . . . -166.53 -147.32 5.17 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -119.83 154.38 34.37 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 122.706 -0.29 . . . . 0.0 110.477 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -147.8 -17.72 0.36 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.732 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.46 65.88 27.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -41.99 136.74 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.833 2.355 . . . . 0.0 112.243 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -102.12 78.27 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.967 0.413 . . . . 0.0 111.374 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.13 133.92 33.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.69 110.71 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -126.53 121.06 31.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.37 148.78 22.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -143.71 156.68 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.8 t80 -163.85 130.27 3.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.56 -97.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 153' ' ' PHE . 5.1 m-20 -124.85 53.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.12 146.26 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -143.37 137.38 28.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 mt -132.53 134.59 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.124 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.1 m-20 -107.66 104.39 13.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.141 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.92 -11.6 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.722 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.47 -38.92 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.446 ' C ' ' ND1' ' A' ' 163' ' ' HIS . 2.7 p -99.81 6.59 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.227 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.446 ' ND1' ' C ' ' A' ' 162' ' ' THR . 52.0 p-80 36.77 51.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -122.06 158.28 29.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.5 t -128.4 147.69 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.39 127.51 15.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.5 tmtt? -130.78 112.46 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.268 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.47 68.98 0.11 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.055 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.15 57.34 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 167' ' ' LYS . 7.1 tt0 -130.64 90.83 39.35 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.25 142.58 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.92 1.747 . . . . 0.0 112.113 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.81 132.27 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.259 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.0 t -95.33 119.91 34.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.656 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 0.4 OUTLIER -142.61 135.06 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.711 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.21 175.2 0.42 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.824 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.46 -41.83 73.39 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.481 2.12 . . . . 0.0 112.601 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.37 -65.83 0.49 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 111.104 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -60.09 -33.34 71.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.29 -50.39 73.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -41.33 85.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.81 -48.62 80.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.579 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -40.61 96.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.12 -45.13 91.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.498 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.585 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 26.5 t80 -65.65 -40.83 92.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -40.99 69.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.3 t -72.87 -42.99 60.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.43 -27.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.72 18.33 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.02 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.88 119.0 3.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.792 0.33 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.6 -26.6 10.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.9 m -94.72 130.15 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.43 114.77 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -95.12 153.63 17.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.89 148.42 26.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 16.2 mtpt -56.12 -54.92 47.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.991 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.0 Cg_endo -64.81 -32.15 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.782 1.655 . . . . 0.0 111.922 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -66.87 -48.81 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.288 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.5 mt -55.7 -39.82 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.771 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.38 -66.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -49.26 -29.34 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.585 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.7 t60 -72.01 -48.48 44.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.078 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 204' ' ' ARG . 42.4 t -84.04 -59.86 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.554 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.678 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -49.55 -4.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.604 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.7 ttp180 -61.92 -2.55 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.637 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.466 ' H ' ' C ' ' A' ' 203' ' ' TRP . 58.5 m-85 -118.19 11.95 13.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER 172.33 104.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.417 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -83.73 108.13 16.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.434 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.523 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 174.09 55.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.678 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -159.0 102.52 0.21 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -50.46 -173.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.945 0.402 . . . . 0.0 110.56 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.9 -9.74 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.072 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.04 -22.75 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.3 p -65.68 -40.04 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.305 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.458 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 12.7 t -60.4 -46.19 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.131 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.91 -48.04 79.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -45.18 95.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.62 -40.88 98.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.755 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.6 t -62.42 -39.73 85.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -45.38 81.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -68.49 -17.17 64.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.77 -47.98 11.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.676 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.9 OUTLIER -55.99 -38.55 70.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.471 179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -66.1 -29.15 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.504 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -28.56 15.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.659 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.17 -38.79 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.136 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 222' ' ' ARG . 9.2 t0 -100.27 -151.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 226' ' ' ASP . 68.6 p 54.07 10.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.499 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 226' ' ' ASP . . . -85.09 -136.07 3.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.18 -44.74 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.796 0.332 . . . . 0.0 110.269 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 107.26 19.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.581 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.413 ' CD ' ' H ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -82.87 91.15 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.9 -5.6 52.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.294 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.68 122.47 47.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.78 130.24 56.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.644 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.0 m -95.65 115.95 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.2 mt -95.92 77.16 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.29 119.97 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.78 -2.88 57.21 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.35 -58.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.77 -136.03 4.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 40.4 m-85 -127.59 153.96 45.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.749 0.309 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.8 133.1 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.49 121.38 33.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.928 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -161.46 133.81 5.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.174 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.34 153.3 85.99 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.22 124.66 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.406 2.071 . . . . 0.0 112.276 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 24.4 ptt-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.65 179.732 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.3 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.2 58.84 0.5 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.4 m -76.29 -109.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -98.54 -170.88 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.545 ' N ' ' OG ' ' A' ' 123' ' ' SER . 8.3 m80 -157.62 157.18 33.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -67.28 85.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.661 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -146.59 91.76 2.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.553 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -140.71 151.44 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.436 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -95.66 -59.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.83 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -71.89 127.06 31.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 p -171.46 91.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.768 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.86 39.86 1.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.47 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.22 -52.57 1.34 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.99 150.03 49.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.707 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.78 63.02 45.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.138 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -39.15 122.04 0.73 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.965 2.444 . . . . 0.0 112.791 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.57 -36.5 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.18 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.56 -145.28 2.79 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.1 m -83.61 175.56 9.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.987 0.423 . . . . 0.0 110.908 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 139' ' ' HIS . 6.7 p80 -132.73 111.95 11.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.192 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 39.3 ttp -124.37 102.49 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.659 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -116.93 90.94 3.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.896 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.14 170.67 39.78 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.6 39.5 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -118.92 121.14 39.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.35 73.52 4.37 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -52.27 114.99 1.9 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.659 2.24 . . . . 0.0 112.01 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -70.5 -92.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -63.12 145.18 56.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.421 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.88 109.92 23.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.795 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -125.68 121.17 32.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.182 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.64 150.77 21.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 m -141.15 158.34 44.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 1.4 t80 -165.46 131.51 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.519 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 38.23 -99.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 19.3 m-20 -124.96 53.36 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.94 150.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.278 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -142.41 140.88 32.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.74 131.59 33.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.437 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -113.65 108.17 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.5 -9.65 36.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.19 -52.58 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.651 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 51.3 p -98.14 9.76 42.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.266 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 47.3 m80 37.12 59.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.777 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -132.63 153.81 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.71 151.81 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.232 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.19 125.49 13.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.5 tttp -124.99 115.12 20.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.36 56.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.378 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.39 23.76 75.04 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.2 mt-30 -132.29 101.6 14.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -76.77 136.78 17.26 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.82 1.68 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.16 139.25 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.446 ' H ' ' HG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -97.91 121.68 40.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.416 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.06 140.68 34.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.765 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.87 173.46 4.77 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.98 -40.82 79.52 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.47 2.113 . . . . 0.0 112.576 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.7 m -51.11 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.62 -33.55 72.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.238 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -58.51 -52.79 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.9 m -57.6 -40.62 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 -47.16 85.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.58 -42.18 95.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.704 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -44.87 87.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.35 -42.13 88.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.44 -41.78 77.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.73 -49.12 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.67 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.9 mt -55.82 -36.15 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.012 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -109.96 23.76 13.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.3 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.77 118.78 4.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.81 10.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 m -90.01 129.6 36.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.05 120.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.552 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.94 163.93 12.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.09 148.39 29.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.962 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 4.1 mttt -56.67 -54.02 58.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.078 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 28.4 Cg_endo -70.57 -31.99 15.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.913 1.742 . . . . 0.0 112.043 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.61 -46.43 85.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.216 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.65 -39.81 86.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.62 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 203' ' ' TRP . 8.5 tp -64.25 -50.31 68.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.643 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 13.4 t70 -64.73 -30.2 71.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.444 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -72.0 -57.23 4.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.43 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.2 t -84.42 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.683 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -50.12 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.681 -179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -67.08 -3.21 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.441 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.28 14.52 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 207' ' ' PHE . 29.0 m-20 -137.77 -151.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.619 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 206' ' ' ASP . 0.2 OUTLIER -43.44 171.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -45.08 -93.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.67 89.6 0.11 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 212' ' ' ASN . 1.3 m-20 -97.65 94.64 7.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.867 0.365 . . . . 0.0 110.174 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 211' ' ' VAL . 90.4 t -64.02 1.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 210' ' ' ASP . 57.9 m-20 -100.17 -30.69 11.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 20.2 t -62.08 -39.43 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.284 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.87 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.002 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -53.45 -49.56 67.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -46.19 90.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.23 -38.88 90.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.29 -43.15 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.734 0.302 . . . . 0.0 110.585 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -42.93 85.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -71.6 -13.24 61.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.15 -48.74 9.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.807 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 70.1 mtt180 -56.67 -44.04 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.367 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -19.36 65.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.982 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -93.96 -28.55 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.364 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 225' ' ' ILE . 0.4 OUTLIER -109.37 -39.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.228 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.29 145.38 25.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.9 t -176.79 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -145.34 167.29 27.47 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.26 -6.45 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.721 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -92.72 104.59 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.444 ' O ' ' CD2' ' A' ' 232' ' ' LEU . 45.6 mtt85 -78.93 160.16 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.444 ' CD2' ' O ' ' A' ' 231' ' ' ARG . 4.7 mt -146.16 -36.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.24 111.88 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.607 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.16 129.88 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.329 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.42 111.75 23.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' ARG . 3.8 mt -95.25 69.54 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.159 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' LEU . 3.7 ptt85 -35.09 128.28 0.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.95 -13.82 60.39 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.2 t -128.85 -58.17 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.416 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 159.42 -137.28 5.05 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.47 157.91 40.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.08 136.23 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 26.4 tp -93.05 118.91 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.505 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.67 131.01 3.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 0.0 111.04 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -80.35 156.42 73.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -67.26 141.35 56.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.51 2.14 . . . . 0.0 112.174 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.495 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -172.49 7.55 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.288 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.471 ' C ' ' HG ' ' A' ' 123' ' ' SER . 1.4 m -74.56 179.92 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.113 0.456 . . . . 0.0 111.033 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 122' ' ' SER . 2.4 m -147.54 142.8 27.27 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.41 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.41 -6.41 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.678 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.8 m80 49.1 -159.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.857 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.46 168.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.23 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.35 -166.97 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -152.05 2.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 109.98 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.57 153.68 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.626 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -106.8 60.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.556 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.5 p -108.49 161.14 15.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.134 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.35 -2.21 0.03 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.344 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.19 27.48 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.337 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 136' ' ' ARG . 14.9 m -131.35 63.53 70.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.4 28.37 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -106.19 1.81 26.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.04 170.13 39.19 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 t -101.1 140.52 35.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.67 0.271 . . . . 0.0 110.82 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 140' ' ' MET . 10.5 p-80 -162.84 -177.67 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 0.0 110.998 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' HIS . 8.7 mmt -34.22 131.29 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -88.37 5.53 41.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 56.53 -85.28 0.01 OUTLIER Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' LYS . 44.3 p30 -157.98 0.96 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.975 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.4 tttt 65.29 94.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -166.59 68.15 1.02 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.466 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -47.21 151.06 2.81 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.636 2.224 . . . . 0.0 111.73 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -127.37 141.46 51.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.38 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 149.24 45.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.383 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -140.78 132.93 27.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.77 151.56 21.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.82 156.84 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.0 t80 -166.06 125.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.86 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.3 p-10 -124.97 54.34 1.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.55 151.58 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.466 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -146.25 143.71 29.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.48 127.67 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.355 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.4 OUTLIER -113.33 103.15 11.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.839 0.352 . . . . 0.0 110.452 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.93 -12.48 55.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -71.63 -30.64 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 7.0 p -121.82 -25.39 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 162' ' ' THR . 4.9 t-80 83.13 47.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.871 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -124.26 160.09 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.8 t -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -146.23 125.42 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.7 tmtt? -130.05 117.65 20.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.374 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.98 70.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.04 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.02 34.69 52.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -136.68 91.31 15.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.554 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.81 137.82 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.316 2.011 . . . . 0.0 112.12 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.72 131.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 91.74 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.68 150.97 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.777 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 168.67 25.26 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.189 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.44 -53.9 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.408 2.072 . . . . 0.0 112.309 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -55.84 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -61.96 -38.48 88.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -48.34 82.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.2 m -58.97 -39.05 80.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.85 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.708 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.31 -42.58 91.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.69 -41.13 79.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.551 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -54.6 -43.81 72.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.8 -46.07 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.91 -38.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -107.87 26.57 10.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.86 117.64 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.664 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.37 -27.18 12.92 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.61 130.36 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.64 114.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.538 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -97.25 158.2 15.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.84 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.33 147.39 31.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.292 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -58.06 -52.99 70.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.208 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -62.84 -31.97 77.68 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.746 1.631 . . . . 0.0 112.2 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -68.9 -49.99 53.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.054 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.4 mt -55.91 -36.93 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.22 -70.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.787 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.534 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 0.0 OUTLIER -54.2 -23.87 16.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.512 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -73.9 -60.09 2.42 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.612 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 204' ' ' ARG . 99.4 t -85.82 -61.52 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.414 ' C ' ' H ' ' A' ' 205' ' ' TYR . 48.0 m95 -53.45 -3.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.833 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 200' ' ' ASP . 0.6 OUTLIER -63.16 -3.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 203' ' ' TRP . 4.3 t80 -131.92 21.71 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.703 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -143.02 -144.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 110.817 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.494 ' O ' ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -42.72 164.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.549 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 207' ' ' PHE . . . -47.47 -105.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.23 89.7 0.11 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.2 124.15 46.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.287 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.28 -8.01 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.648 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -99.99 -29.22 12.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 2.5 p -66.28 -39.74 85.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.638 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.455 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 25.0 t -56.41 -50.5 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.106 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.03 -48.52 78.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.278 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -45.15 93.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -63.63 -41.83 98.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.28 -41.39 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.2 t -62.59 -47.93 81.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -33.45 75.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.369 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -67.32 -46.67 72.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.341 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.46 -44.18 76.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.316 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -66.53 -24.67 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -91.88 -28.41 17.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.677 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -108.99 -40.56 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.341 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -102.82 141.05 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.496 ' HG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -163.31 -40.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.783 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.11 173.21 6.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.32 -7.04 16.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -92.55 104.95 17.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -86.83 106.98 18.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.5 -0.36 57.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.546 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.93 113.22 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 123.17 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.488 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.0 m -88.28 114.33 24.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.774 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 237' ' ' ARG . 6.9 mt -96.75 72.99 2.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.23 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 236' ' ' LEU . 22.7 mtp180 -39.25 110.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.79 -16.24 13.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.71 -47.46 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.45 -137.28 6.17 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.18 152.39 48.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.383 . . . . 0.0 110.608 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.16 141.14 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.3 tp -91.43 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -162.02 134.03 5.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -76.64 149.4 80.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -36.61 101.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.529 2.153 . . . . 0.0 112.006 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.62 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' SER . . . -96.7 59.9 1.23 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 p -72.92 14.54 0.27 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' GLY . 75.2 m -87.43 28.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.586 ' N ' ' HD1' ' A' ' 124' ' ' HIS . 0.7 OUTLIER 63.69 178.26 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.28 -22.06 25.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -56.85 154.95 8.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.26 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.43 126.49 0.19 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.781 0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' N ' ' HD1' ' A' ' 128' ' ' HIS . 7.0 p-80 -169.34 -14.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.402 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -152.51 92.28 1.66 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.485 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 32.2 t -126.31 89.15 2.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 131' ' ' SER . 38.8 p 44.2 75.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.932 0.396 . . . . 0.0 110.202 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.68 160.29 10.51 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mp -94.6 21.86 6.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.057 0.456 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.1 t 44.08 68.65 2.93 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.314 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 137' ' ' GLY . 52.3 Cg_exo -46.83 -41.75 25.04 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 123.131 2.554 . . . . 0.0 112.519 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 66.97 -61.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 135' ' ' PRO . . . 163.33 177.36 36.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 140' ' ' MET . 22.2 t -129.87 127.31 39.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 140' ' ' MET . 2.8 t60 -74.96 36.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.487 ' H ' ' C ' ' A' ' 138' ' ' SER . 0.0 OUTLIER 34.35 -121.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -96.81 92.04 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.377 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . . . -142.69 23.57 2.32 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 142' ' ' GLY . 7.2 m120 -154.0 143.78 21.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.673 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -149.76 20.9 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 51.81 61.32 12.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.96 161.09 33.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.868 2.378 . . . . 0.0 111.73 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -168.22 -37.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.821 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -86.76 102.4 14.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.36 113.78 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.381 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -104.81 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.434 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mt -146.09 134.85 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.571 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -137.51 155.78 48.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 111.069 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.462 ' O ' ' C ' ' A' ' 154' ' ' ALA . 87.3 t80 -165.39 139.0 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.519 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.46 -104.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.66 53.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.4 mm -137.52 146.56 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.921 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.43 131.28 29.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 147.27 48.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.433 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.8 m-20 -131.15 107.89 9.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.35 -38.32 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.772 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -51.45 59.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.533 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 4.6 p -106.58 13.15 28.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.119 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 162' ' ' THR . 9.3 p80 38.52 56.09 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.683 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -119.68 161.24 21.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.5 157.86 31.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.99 125.24 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -122.71 108.76 13.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.31 67.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.057 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.86 83.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 167' ' ' LYS . 14.2 tt0 -137.04 87.35 18.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.92 132.87 13.28 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.298 1.998 . . . . 0.0 112.669 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.7 147.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.27 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m -92.63 88.35 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.287 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.8 mt -96.0 155.81 16.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.32 170.69 8.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.26 -53.72 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 112.135 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -57.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.073 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.88 -39.71 95.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.053 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.16 -42.82 95.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.8 m -61.25 -45.61 93.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.49 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.2 -43.95 83.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.561 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.02 -46.18 78.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -58.13 -42.98 87.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.405 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.19 -44.97 94.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.516 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -62.83 -41.93 99.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 110.771 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.8 t -57.68 -52.66 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.394 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.42 -29.53 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.356 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.1 19.6 20.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.712 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -53.17 119.57 4.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.92 -23.76 20.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.1 m -92.18 125.29 36.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 11.3 p -69.1 118.08 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.95 149.14 22.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.7 p -99.88 149.44 23.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.53 -44.84 99.8 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.501 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 31.8 Cg_exo -52.94 -52.41 8.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.912 1.742 . . . . 0.0 111.996 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.67 -51.96 67.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.45 -42.98 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.179 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.41 -65.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.3 -16.04 30.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -49.87 31.7 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 204' ' ' ARG . 0.1 OUTLIER -84.11 -43.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.075 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.548 ' HE1' ' C ' ' A' ' 208' ' ' GLY . 1.2 m-90 -62.82 -3.97 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 202' ' ' VAL . 23.3 ttt-85 -57.66 -4.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.491 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.4 m-85 -121.29 15.77 11.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.523 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 0.4 OUTLIER 171.84 116.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.484 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -84.32 129.81 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.548 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 144.58 66.4 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.64 102.69 0.22 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.38 -173.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 110.103 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.0 -14.68 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -85.39 -17.47 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.465 ' O ' ' OG ' ' A' ' 216' ' ' SER . 5.2 p -67.33 -38.1 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.43 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 85.6 t -59.7 -50.69 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -54.93 -47.06 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.536 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 9.7 p -60.21 -49.47 77.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.655 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -61.63 -41.01 96.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.46 -45.26 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.3 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -43.8 98.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.194 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -32.83 73.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.26 -47.47 73.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 109.999 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.0 OUTLIER -54.89 -46.21 74.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.147 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -15.22 63.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.417 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -95.07 -27.11 15.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.38 -13.53 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.32 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -111.92 138.21 48.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.372 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -175.37 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -48.74 168.94 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.59 -13.08 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.978 0.418 . . . . 0.0 109.962 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -93.21 151.86 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.897 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -93.08 158.96 15.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 90.6 mt -147.03 -50.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -94.98 119.86 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 130.29 45.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.64 108.82 20.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.2 mt -98.72 69.4 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.753 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -37.28 126.55 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.567 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.86 -7.58 62.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.41 -46.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.48 -137.33 7.48 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.89 152.81 47.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.31 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.62 135.95 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.964 0.411 . . . . 0.0 110.785 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.98 118.9 31.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.569 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -162.28 115.75 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.488 ' OE2' ' O ' ' A' ' 245' ' ' GLU . 0.4 OUTLIER -87.92 149.53 45.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.44 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 124.79 10.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.301 2.0 . . . . 0.0 112.131 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.475 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.79 -118.92 3.17 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.438 ' C ' ' OG ' ' A' ' 123' ' ' SER . 0.4 OUTLIER -163.87 110.46 1.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 122' ' ' SER . 0.0 OUTLIER 61.21 110.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.949 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -55.15 175.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -72.4 -63.74 1.09 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -90.32 -107.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.91 -56.51 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.237 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.461 ' N ' ' HD1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER 44.08 28.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.426 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 130' ' ' SER . 11.5 t-160 -71.15 -107.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.404 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -72.0 -52.09 18.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 73.78 -11.65 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.239 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 130' ' ' SER . . . -97.19 -169.13 33.24 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 mt -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.85 65.99 4.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.064 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.31 154.51 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.275 1.983 . . . . 0.0 111.849 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -85.7 39.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.773 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 138' ' ' SER . . . 85.5 -5.56 83.03 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 137' ' ' GLY . 19.3 p 25.74 52.86 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.964 0.411 . . . . 0.0 111.088 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -67.01 -82.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.833 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.2 ttt -75.58 107.8 7.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -120.29 -49.11 2.29 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.23 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.29 -150.52 25.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -165.43 -25.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' O ' ' CD ' ' A' ' 145' ' ' GLU . 1.3 pttm -101.4 71.13 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.627 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.457 ' CD ' ' O ' ' A' ' 144' ' ' LYS . 1.4 mp0 -133.98 77.67 61.67 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.28 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.37 120.86 8.91 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.217 2.611 . . . . 0.0 112.422 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -100.21 102.43 13.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.462 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -83.64 124.45 30.83 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.76 111.3 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -175.27 145.57 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.369 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.403 ' CD2' HH12 ' A' ' 183' ' ' ARG . 2.6 mm? -92.43 151.6 20.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -142.05 156.95 45.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 154' ' ' ALA . 70.7 t80 -167.03 140.14 3.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 34.41 -102.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 23.8 p-10 -124.3 52.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -138.08 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.467 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 13.9 tt0 -145.71 144.05 30.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 110.631 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.37 116.88 12.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.955 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.15 101.87 11.61 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.849 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -24.14 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.29 -32.3 56.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 34.1 p -127.5 -20.7 3.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.1 t60 82.14 52.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -122.51 156.45 34.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.12 151.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.143 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.73 125.24 13.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.419 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -127.13 113.11 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.259 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.77 70.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.234 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.67 26.72 47.19 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 3.1 tp60 -130.8 92.36 34.43 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.42 133.43 11.86 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.948 1.766 . . . . 0.0 112.195 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.93 138.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.576 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 75.2 m -89.58 88.32 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.9 mt -95.38 149.31 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.563 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.8 172.86 8.06 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -52.1 -55.3 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.394 2.063 . . . . 0.0 112.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.4 m -51.06 -52.5 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.55 -44.05 97.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.0 m -61.37 -45.51 94.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.86 -43.69 92.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.004 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.25 -39.13 93.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.389 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.403 HH12 ' CD2' ' A' ' 151' ' ' LEU . 3.3 ttt85 -65.09 -42.56 93.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.719 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.674 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 10.6 t80 -62.29 -44.57 96.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.6 -44.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.0 -47.68 87.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.88 -28.79 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -108.83 20.42 18.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.46 120.92 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.75 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.21 -23.28 23.38 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 32.3 m -98.17 124.64 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.42 122.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.8 165.86 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.602 ' HG ' ' CG ' ' A' ' 197' ' ' LYS . 1.1 p -109.77 151.11 27.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.03 -54.45 50.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.915 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 21.1 Cg_endo -66.4 -32.12 41.37 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.365 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.602 ' CG ' ' HG ' ' A' ' 194' ' ' SER . 18.9 mmtt -64.06 -58.44 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.2 -40.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.41 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.75 -64.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.67 -29.23 25.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.674 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 79.6 t60 -71.14 -48.59 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.159 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 204' ' ' ARG . 77.6 t -83.96 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.443 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.81 -2.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.294 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.7 ttp180 -61.17 -3.39 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.715 0.293 . . . . 0.0 110.68 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.4 m-85 -117.73 16.35 14.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 0.5 OUTLIER 171.11 103.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -82.17 125.56 31.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.474 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 153.35 50.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -158.89 103.79 0.24 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.4 OUTLIER -50.46 -174.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.084 0.469 . . . . 0.0 110.671 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.83 -8.75 11.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.26 -16.42 40.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.2 p -68.9 -38.53 78.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.826 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 40.9 t -58.86 -47.85 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.527 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.14 -47.29 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.229 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 m -59.8 -43.72 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -43.39 98.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.1 -41.43 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.49 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.453 ' HG ' HH21 ' A' ' 223' ' ' ARG . 0.5 OUTLIER -62.85 -46.9 85.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.762 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.67 -21.9 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.642 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.82 -46.38 18.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.217 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.6 mtp180 -56.05 -47.09 78.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.974 0.416 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.453 HH21 ' HG ' ' A' ' 219' ' ' SER . 6.7 mtm180 -66.16 -11.27 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.537 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -92.09 -46.06 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.36 -27.42 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.31 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 4.6 t70 -94.78 143.31 26.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.742 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER 173.81 -27.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.513 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -50.43 162.63 0.97 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.51 -7.65 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 0.0 110.199 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -93.13 149.58 21.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -92.24 154.15 18.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.235 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 74.8 mt -147.35 -51.27 0.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.41 110.65 23.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.143 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 122.45 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.899 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.4 m -90.5 109.47 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.62 70.54 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -39.45 125.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 -13.75 40.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.5 -59.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.569 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.43 -138.06 5.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -127.79 160.98 30.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.424 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.88 128.8 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 57.4 tp -91.73 137.5 32.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 128.09 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 246' ' ' PRO . 9.0 mt-10 -71.25 156.35 91.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.506 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 245' ' ' GLU . 71.2 Cg_exo -39.15 163.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.708 2.272 . . . . 0.0 112.024 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.9 ptt-85 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.716 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.49 178.18 21.83 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -146.22 0.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.29 -176.69 6.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -103.38 13.47 33.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.877 0.37 . . . . 0.0 110.688 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 144.58 46.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.172 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.66 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.558 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -78.0 -78.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -163.49 164.25 24.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 110.824 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -131.09 107.73 9.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.313 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.49 -39.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -152.82 161.15 42.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.18 -27.31 3.46 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -105.72 116.82 32.58 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 7.3 p -176.77 60.02 0.17 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.73 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.49 126.99 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.765 2.31 . . . . 0.0 112.586 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.26 146.34 45.47 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.33 31.64 0.18 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.9 m -47.72 -33.48 7.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -93.1 164.87 13.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.691 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.2 mtt 42.09 80.8 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.855 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -106.82 110.57 22.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.435 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.46 46.48 0.17 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -113.0 -155.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -59.86 179.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.9 153.32 88.99 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -38.86 150.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.258 1.972 . . . . 0.0 111.62 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -101.28 -166.03 1.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.55 ' OD1' ' NH1' ' A' ' 150' ' ' ARG . 11.1 t-20 56.71 96.79 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.469 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -83.08 146.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.481 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.55 ' NH1' ' OD1' ' A' ' 148' ' ' ASN . 24.1 mtt-85 -147.08 139.35 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.2 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.46 157.35 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.68 157.7 45.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 110.86 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.5 t80 -164.18 127.16 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.476 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.47 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 13.7 p-10 -124.87 54.41 1.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.47 153.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.873 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -145.33 140.12 27.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.252 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.43 138.83 36.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.714 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 162' ' ' THR . 62.8 t0 -111.54 105.67 14.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -8.22 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.176 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.41 -46.09 5.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.956 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.503 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 69.2 p -98.66 13.65 31.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.812 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 162' ' ' THR . 44.4 m-70 35.76 53.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.541 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -121.9 150.9 41.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.8 152.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.317 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.77 121.4 9.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.4 tmmt? -124.97 112.83 17.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.365 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.39 71.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.517 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.44 25.58 34.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.5 tt0 -131.08 94.68 27.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.13 132.6 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 112.276 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.12 144.21 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.709 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 t -95.21 94.66 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.66 154.0 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.172 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.22 172.14 8.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -50.3 -54.24 5.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.37 2.047 . . . . 0.0 111.931 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -57.46 -46.41 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.694 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -45.0 96.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -61.68 -45.33 94.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.8 m -58.16 -47.03 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 -43.94 92.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.7 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.46 -43.5 90.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.504 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -55.89 -45.25 78.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.579 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -65.06 -43.64 91.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.58 -42.84 88.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.649 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.15 -47.68 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.625 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.72 -37.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -106.96 25.19 11.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.17 114.23 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.94 10.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.5 m -91.73 129.31 37.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 110.456 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.55 126.29 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.0 110.541 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -94.5 168.84 10.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.098 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.84 147.72 36.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 0.0 110.785 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 211' ' ' VAL . 6.7 mttm -56.85 -54.98 48.36 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.21 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.0 Cg_endo -65.7 -29.91 51.04 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.038 1.825 . . . . 0.0 112.426 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -70.18 -47.16 62.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.319 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.28 -38.01 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 109.978 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.96 -56.17 24.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.89 -16.6 63.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.071 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 46.4 t60 -71.76 -44.96 63.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.309 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 204' ' ' ARG . 24.5 t -84.24 -54.6 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.593 ' C ' ' H ' ' A' ' 205' ' ' TYR . 3.0 m-90 -61.92 -3.22 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.703 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 34.4 ttp85 -44.95 -11.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.593 ' H ' ' C ' ' A' ' 203' ' ' TRP . 17.4 t80 -105.88 26.94 9.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.35 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.8 OUTLIER 165.86 -174.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -92.71 125.46 37.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.63 103.43 0.54 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.15 59.96 0.35 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.81 101.11 3.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.595 ' O ' ' NZ ' ' A' ' 195' ' ' LYS . 2.9 m -86.42 1.5 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.841 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -96.49 -29.49 13.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.618 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.3 p -64.36 -38.89 83.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.303 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 17.6 t -60.56 -48.96 86.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.579 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.7 -44.58 85.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.166 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -60.46 -46.0 91.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.63 -38.76 87.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.899 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.03 -41.06 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.209 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.51 75.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.51 ' OH ' ' NZ ' ' A' ' 224' ' ' LYS . 32.0 t80 -71.19 -10.17 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.057 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.44 -56.02 4.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.087 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.4 ptm180 -57.41 -40.48 78.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.313 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -11.21 57.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.51 ' NZ ' ' OH ' ' A' ' 220' ' ' TYR . 1.3 mmtp -93.2 -36.08 12.8 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.639 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.55 -24.04 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.834 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -97.93 153.01 18.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.647 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -174.32 -30.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.654 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -61.26 147.96 46.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.73 -5.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.404 . . . . 0.0 110.286 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.564 ' H ' ' C ' ' A' ' 228' ' ' GLY . 29.7 mttp -94.07 116.94 29.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.313 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.2 mtm-85 -81.02 131.15 35.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 244' ' ' ARG . 5.5 mp -89.08 -76.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.41 148.38 26.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.945 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -111.08 143.71 41.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 55.0 m -101.67 116.04 31.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.931 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 236' ' ' LEU . 0.8 OUTLIER -96.47 73.18 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -39.75 117.81 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.64 -25.48 9.04 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.45 -56.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.1 -136.79 4.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -129.35 160.67 32.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.889 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.84 134.64 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 53.0 tp -91.88 116.28 28.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 232' ' ' LEU . 10.1 ptm180 -163.37 117.19 1.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.64 154.87 6.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.343 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -38.73 132.55 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.72 2.28 . . . . 0.0 112.101 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.47 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.445 ' H1 ' ' H ' ' A' ' 121' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.445 ' H ' ' H1 ' ' A' ' 120' ' ' MET . . . -48.63 -58.13 7.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' SER . 3.0 t 58.21 44.78 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.84 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' SER . 14.8 p -36.3 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 110.552 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -113.0 139.88 48.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.679 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.668 ' HD1' ' H ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -114.92 -170.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.476 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.08 157.47 15.8 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.41 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.7 170.68 8.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.64 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -105.57 -172.42 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.029 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 128' ' ' HIS . 0.2 OUTLIER 55.19 155.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.844 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 131' ' ' SER . 0.6 OUTLIER -173.28 -17.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.704 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 130' ' ' SER . 0.7 OUTLIER 36.11 37.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.687 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.15 141.99 6.68 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.76 67.74 1.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.544 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.07 149.57 68.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -41.61 156.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.268 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 54.5 97.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.29 116.2 5.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -88.25 166.44 14.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.292 . . . . 0.0 110.645 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.558 ' C ' ' H ' ' A' ' 141' ' ' LYS . 6.9 t60 -170.42 74.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.498 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.59 19.02 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 139' ' ' HIS . 5.2 tttt 69.29 138.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.84 106.93 0.22 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 17.8 7.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER 49.0 -153.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -142.53 72.36 20.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.945 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.07 28.83 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.784 2.322 . . . . 0.0 111.954 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -110.72 86.11 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.78 81.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.0 117.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -120.18 123.87 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.83 156.11 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.59 163.04 33.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 156' ' ' ILE . 58.5 t80 -167.58 134.5 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.41 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 11.5 p-10 -125.18 53.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.1 mt -137.05 154.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -145.83 146.88 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.07 134.32 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.5 m-20 -112.77 109.24 18.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.8 OUTLIER -65.58 -16.28 63.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.97 -52.21 8.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.4 p -101.3 11.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.588 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 11.0 m-70 36.53 53.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.666 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.22 160.02 23.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.2 t -124.5 149.6 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.421 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.4 127.76 15.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 39.5 tttm -128.06 114.04 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.496 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.99 62.94 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.97 29.7 75.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 15.4 tt0 -132.9 93.28 23.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.74 140.23 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.282 1.988 . . . . 0.0 112.316 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.8 130.17 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.742 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 p -93.64 87.15 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.668 ' H ' ' CD1' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.14 154.87 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.606 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.04 168.86 23.62 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.325 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -45.93 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.54 2.16 . . . . 0.0 111.961 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -53.37 -63.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.131 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.18 -36.11 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.429 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -59.87 -48.15 82.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.5 m -60.09 -40.86 91.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.788 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.59 -47.55 85.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.84 -41.09 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -58.21 -46.88 85.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.821 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -68.17 -38.82 82.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -57.2 -44.0 83.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.483 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.35 -46.05 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 mm -53.93 -34.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -108.28 22.21 16.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.037 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.55 125.87 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.487 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.31 -33.2 6.77 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 m -87.07 132.81 33.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.04 124.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.22 161.27 13.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.24 147.88 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 5.5 mtmt -58.43 -56.36 36.2 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.35 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -63.31 -34.53 66.76 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.834 1.689 . . . . 0.0 111.967 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -64.82 -54.09 36.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.355 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 198' ' ' ILE . 18.2 mt -52.05 -39.36 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 0.0 110.12 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.7 tp -60.52 -68.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -50.49 -25.83 4.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.464 ' ND1' ' NH2' ' A' ' 204' ' ' ARG . 56.7 t60 -71.35 -55.12 8.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 204' ' ' ARG . 55.2 t -83.87 -58.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.337 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.1 -4.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.278 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.8 ttm180 -61.76 0.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.5 m-85 -119.44 10.27 11.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.574 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.444 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.4 OUTLIER 178.04 111.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.467 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -86.93 110.71 20.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 167.44 51.72 0.03 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -154.79 100.55 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 209' ' ' GLY . 6.5 t70 -51.88 -173.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.019 0.438 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.5 p -85.4 -12.2 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.846 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -91.08 -18.53 24.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 1.2 p -65.25 -37.99 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.995 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 0.3 OUTLIER -59.2 -45.79 92.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.605 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -61.45 -45.76 92.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.5 t -60.91 -41.69 96.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.433 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -39.03 76.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.854 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.27 -43.88 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -46.76 88.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.67 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -31.53 72.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.934 0.397 . . . . 0.0 110.172 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.87 -42.34 70.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.946 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 226' ' ' ASP . 35.5 ttp180 -55.11 -44.4 74.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -68.17 -26.36 65.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.468 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -93.41 -21.88 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.2 -31.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.305 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.7 t70 -107.23 135.71 48.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.462 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.64 21.35 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.31 167.84 17.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -12.49 61.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.371 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -92.42 106.2 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.815 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -89.46 110.15 21.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.28 -4.7 56.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.31 104.99 12.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.598 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 124.44 37.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.543 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -96.11 118.41 32.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.309 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.07 74.96 2.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.24 113.99 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.013 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.99 -20.64 23.82 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.63 -61.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.152 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.94 -139.17 5.66 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.77 153.05 47.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.703 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.1 132.13 32.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.84 143.36 26.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.397 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.01 139.85 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.53 151.59 44.31 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.498 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 247' ' ' ARG . 50.1 Cg_exo -41.32 126.65 2.89 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.599 2.2 . . . . 0.0 112.059 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 246' ' ' PRO . 26.3 mtm180 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.662 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.49 174.94 19.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.6 p -163.55 166.61 22.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.458 0.647 . . . . 0.0 111.44 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -108.01 127.62 53.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.708 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' A' ' 124' ' ' HIS . 12.5 p80 -51.56 79.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.808 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 123' ' ' SER . 75.4 m80 -56.31 144.67 29.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.172 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -113.53 160.52 18.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.257 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -105.36 -55.98 2.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.672 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -54.58 -28.93 49.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.926 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.67 -177.72 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 t 54.82 -175.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.572 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.17 170.61 0.52 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 134' ' ' VAL . 3.2 mt -80.88 98.79 8.01 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.837 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . 13.4 t -32.73 97.46 0.11 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.611 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 133' ' ' LEU . 90.9 Cg_endo -84.01 -37.98 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.715 2.277 . . . . 0.0 111.801 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -99.16 104.81 16.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.99 101.65 0.15 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.92 98.58 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 43.2 89.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.419 . . . . 0.0 110.025 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.3 ttt -59.83 144.16 49.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -43.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.59 105.39 0.42 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -21.89 65.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 0.0 110.78 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -167.76 54.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 110.185 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 146' ' ' PRO . 76.2 tt0 -153.67 65.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.743 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 145' ' ' GLU . 54.1 Cg_exo -45.89 -176.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.982 2.454 . . . . 0.0 112.417 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 148' ' ' ASN . 24.5 ptt-85 -165.6 119.16 1.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 147' ' ' ARG . 4.8 t-20 37.37 95.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 119.87 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.317 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 10.2 mtm180 -124.56 121.0 33.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 61.8 mt -91.76 153.01 19.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.472 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 160.76 39.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 154' ' ' ALA . 77.0 t80 -165.93 140.23 4.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.78 -105.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -123.85 53.07 1.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.28 157.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.651 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 6.5 tt0 -143.38 142.95 31.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.655 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.77 134.66 35.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.0 m-20 -110.95 105.85 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.602 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.99 -13.72 60.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.307 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -48.09 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.9 p -94.88 6.38 49.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.594 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 159' ' ' ASP . 64.8 m80 38.39 51.27 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.15 157.04 29.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.01 151.5 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 110.334 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 124.72 12.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -124.27 117.11 23.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.289 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.83 60.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.574 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.95 24.4 71.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 mt-30 -129.89 96.0 27.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.1 135.97 15.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.928 1.752 . . . . 0.0 112.497 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.71 140.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.727 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.11 96.07 9.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.12 156.04 16.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.04 169.43 15.53 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.594 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.25 -53.87 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 112.263 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -54.44 45.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -56.58 -37.97 71.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.419 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -63.17 -49.92 72.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.9 m -58.13 -43.79 87.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.6 -50.44 73.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.56 -43.61 98.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.725 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -56.98 -45.84 82.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.5 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 21.1 t80 -62.9 -41.72 99.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.2 -41.33 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.39 -48.09 74.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.126 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.84 -37.55 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -104.67 25.08 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.96 120.93 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.94 51.51 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 131.88 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.88 118.18 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -96.55 154.48 17.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.191 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -106.92 148.82 28.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.346 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 3.3 mtpm? -56.02 -55.02 46.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.106 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -64.66 -32.63 57.33 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.919 1.746 . . . . 0.0 111.86 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.513 ' H ' ' HG ' ' A' ' 194' ' ' SER . 65.6 tttt -68.46 -54.02 19.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.2 mt -47.72 -41.81 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.937 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.15 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.629 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -46.41 -30.65 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.5 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 2.1 t60 -71.09 -51.19 26.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.026 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' A' ' 204' ' ' ARG . 58.4 t -84.34 -57.97 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.04 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.434 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -52.89 -2.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.478 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.0 ttt-85 -63.89 -1.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 203' ' ' TRP . 34.6 m-85 -116.72 8.8 13.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 172.87 105.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.449 ' O ' ' CG ' ' A' ' 207' ' ' PHE . 17.2 p90 -80.6 130.39 35.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.181 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.46 60.45 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.63 101.45 0.2 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 0.0 110.432 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 m -82.56 -3.19 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.75 -20.84 25.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.017 0.437 . . . . 0.0 109.855 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.8 p -67.39 -40.45 84.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.478 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 95.6 t -56.21 -50.46 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.61 -48.02 80.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.544 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -46.36 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.461 ' CE1' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -62.86 -40.99 99.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.691 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 t -62.8 -42.13 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.82 94.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.301 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.69 -13.97 61.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.81 -47.28 9.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 226' ' ' ASP . 50.2 mtt180 -56.64 -46.31 81.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -10.68 50.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.187 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -94.65 -41.16 9.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.404 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.09 -27.86 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.143 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -97.79 143.66 28.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t -177.07 39.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.289 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -137.49 160.21 25.06 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.97 -7.26 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.355 . . . . 0.0 110.436 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -93.63 105.7 17.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -89.73 114.03 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.414 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.56 -3.37 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -121.2 110.17 15.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.316 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.98 136.12 33.24 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.7 m -101.29 112.55 25.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 237' ' ' ARG . 2.8 mt -95.27 68.19 3.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.053 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' LEU . 23.4 ttt180 -34.8 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.699 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 103.22 -17.24 52.1 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.37 -42.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.92 0.39 . . . . 0.0 110.364 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 141.86 -137.56 8.04 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 164.46 23.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.22 133.79 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.269 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.2 tp -91.22 122.93 34.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.355 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -161.65 130.8 4.52 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 111.047 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -63.29 157.64 62.3 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -38.41 114.99 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.794 2.33 . . . . 0.0 111.907 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.91 -179.289 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 122' ' ' SER . 12.0 mmt . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -47.12 92.12 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 120' ' ' MET . 82.7 p -89.65 150.06 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -162.39 152.0 15.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.44 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 126' ' ' HIS . 1.3 t-80 -110.71 29.37 7.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 0.0 110.542 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m170 40.26 -90.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.816 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -56.65 142.09 41.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.264 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' A' ' 126' ' ' HIS . 2.1 p80 -133.22 147.99 52.0 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.247 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.43 135.77 45.86 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.4 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -94.75 91.02 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.959 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.49 162.12 39.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.657 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.1 p 51.13 -172.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.208 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.84 155.75 28.06 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.43 150.05 48.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.0 p -167.19 70.5 0.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.906 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -66.0 106.16 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.237 2.625 . . . . 0.0 112.239 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 68.72 92.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 0.64 2.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.411 -178.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 50.57 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.406 0.603 . . . . 0.0 110.58 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 141' ' ' LYS . 23.2 t-80 -145.63 85.36 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 61.76 2.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.986 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 139' ' ' HIS . 18.4 mmtt -98.95 -83.64 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.889 0.376 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.88 112.77 5.29 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -106.79 -175.54 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.308 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -134.45 -22.51 1.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 54.67 61.02 9.75 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.924 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.54 -166.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.615 2.21 . . . . 0.0 112.127 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -174.17 -33.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -89.03 113.7 24.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.09 120.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.845 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -126.28 119.2 26.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -90.76 155.47 18.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.638 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -142.38 161.53 37.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.99 0.424 . . . . 0.0 111.148 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -165.23 132.48 2.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.645 179.749 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.57 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 36.65 -98.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.2 m-20 -125.55 53.69 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.13 153.52 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.492 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -146.03 140.82 27.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.766 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.27 134.39 37.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.136 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -110.3 107.97 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.932 0.396 . . . . 0.0 110.459 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.02 -9.26 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.057 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.98 -52.04 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.61 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.463 ' HG1' ' CD ' ' A' ' 164' ' ' GLU . 7.3 p -93.28 7.02 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 22.1 t60 36.92 62.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.463 ' CD ' ' HG1' ' A' ' 162' ' ' THR . 7.0 pt-20 -136.31 154.1 50.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.372 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.85 151.23 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.76 126.74 13.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.1 ttpm? -126.68 114.62 18.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.764 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.48 54.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.445 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.49 24.09 77.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 167' ' ' LYS . 54.2 mm-40 -129.39 95.68 29.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.34 136.4 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.109 1.873 . . . . 0.0 112.224 -179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.88 140.53 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.948 -179.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.7 t -93.86 94.11 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.546 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.9 mp -95.06 150.06 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.667 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.1 172.38 8.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.55 -57.02 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.544 2.163 . . . . 0.0 112.522 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -54.24 -50.14 67.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.4 -40.34 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.483 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.5 -47.4 85.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -57.41 -48.02 80.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.336 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.0 -51.22 70.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 tp -57.95 -47.18 83.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.055 -179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.407 ' CD2' ' ND2' ' A' ' 188' ' ' ASN . 18.5 t80 -61.33 -45.39 94.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.355 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.6 m-85 -57.45 -44.46 84.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.47 -50.11 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.35 -38.67 56.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.816 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 24.2 p30 -108.58 24.45 13.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -51.87 118.01 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.16 -23.68 13.71 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 m -89.43 133.66 34.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.21 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.26 120.88 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.612 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.25 156.27 16.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.413 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.08 148.6 28.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.0 OUTLIER -56.16 -56.09 34.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.982 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -66.32 -28.8 46.82 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.998 1.799 . . . . 0.0 111.927 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -49.33 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.948 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.31 -38.97 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.3 -68.51 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -49.89 -30.86 10.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.84 -49.57 44.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.282 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 204' ' ' ARG . 62.7 t -82.91 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.908 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.597 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -53.85 -2.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' A' ' 202' ' ' VAL . 30.4 ttt180 -50.91 -5.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.597 ' H ' ' C ' ' A' ' 203' ' ' TRP . 35.9 m-85 -103.4 19.91 18.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.249 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 205' ' ' TYR . 1.3 m-20 166.53 126.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -68.49 140.96 55.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 -179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.21 104.89 0.18 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.64 59.71 2.5 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.81 96.6 6.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.776 0.322 . . . . 0.0 110.666 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.9 m -83.68 -10.04 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 215' ' ' GLU . 13.0 m120 -73.0 -70.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.227 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 212' ' ' ASN . 4.5 p -34.61 -36.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 212' ' ' ASN . 21.3 t -65.52 -44.87 93.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.56 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 212' ' ' ASN . 2.2 tp10 -57.58 -44.15 85.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -47.98 83.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.699 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.48 -39.95 92.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.6 t -63.0 -43.82 99.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.5 t -63.06 -44.73 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -36.87 85.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 110.189 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.1 mp -65.11 -45.6 84.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.671 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 52.1 mtm180 -56.2 -45.76 79.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.229 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.03 -22.44 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -92.94 -26.69 17.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.47 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -108.47 -40.37 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.823 -179.644 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.75 156.13 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.956 -179.677 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 226' ' ' ASP . 0.8 OUTLIER 167.78 -36.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.704 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.89 -175.22 10.52 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -78.81 -13.46 59.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.653 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -92.75 105.32 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.16 103.99 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.765 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.31 -3.03 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.645 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.88 113.51 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.666 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.24 118.35 36.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.128 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.1 m -93.01 114.06 26.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 237' ' ' ARG . 1.6 mp -96.23 68.68 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 236' ' ' LEU . 30.8 mtm-85 -33.94 129.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.836 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.93 65.99 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 69.9 t -133.01 -61.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 0.0 110.675 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.96 -140.27 6.32 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 153.4 51.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.597 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.13 138.9 49.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.583 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 5.3 tp -91.57 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.877 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -161.75 133.18 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -60.95 158.13 36.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.68 109.25 2.05 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.513 2.142 . . . . 0.0 111.975 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.671 -179.932 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.53 -29.06 5.02 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.033 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.26 135.89 55.05 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.6 t 47.54 73.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.3 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -176.14 59.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.292 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -122.33 12.46 10.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.301 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -56.17 -45.49 79.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.149 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -142.25 157.08 45.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -144.15 -23.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -166.58 26.64 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.0 p -69.11 -84.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 p -52.89 124.11 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.831 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 133' ' ' LEU . . . -138.89 -177.34 15.3 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 132' ' ' GLY . 5.1 mt -39.03 124.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.932 0.396 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -68.93 151.34 97.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.563 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.5 134.69 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.549 2.166 . . . . 0.0 112.222 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -66.53 -30.74 71.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.41 45.11 0.52 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.0 p 42.97 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.745 0.307 . . . . 0.0 110.256 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -114.73 -90.75 0.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.054 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.0 ttm -156.78 47.02 0.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.828 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -75.8 -50.94 13.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.452 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -42.99 142.42 1.76 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.66 -25.64 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 110.485 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.76 167.27 27.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.59 152.85 43.04 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.71 101.13 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 112.163 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -120.03 67.82 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.566 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.66 152.68 45.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.615 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.86 112.89 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.55 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 159' ' ' ASP . 15.3 mtt-85 -140.91 121.89 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.33 149.43 22.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -139.74 156.66 46.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.124 0.488 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' O ' ' C ' ' A' ' 154' ' ' ALA . 25.8 t80 -165.04 138.06 4.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.18 -104.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 52.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -137.85 148.18 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.305 -179.588 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -143.1 144.01 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.56 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.11 133.12 34.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.538 ' CG ' HH11 ' A' ' 150' ' ' ARG . 55.9 t0 -113.79 107.68 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -66.98 -14.77 63.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.49 -48.66 7.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 163' ' ' HIS . 76.9 p -97.64 8.59 44.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.522 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 162' ' ' THR . 20.8 m80 37.67 54.57 1.5 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -128.61 156.0 44.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.13 152.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 127.2 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.919 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 170' ' ' GLN . 6.2 tmtt? -130.38 117.58 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.281 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.61 64.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.28 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.56 28.54 65.28 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.4 tt0 -129.92 92.26 37.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.47 140.61 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.261 1.974 . . . . 0.0 112.392 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.3 135.75 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.1 OUTLIER -88.22 95.73 10.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.723 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.04 150.61 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.57 170.51 14.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.483 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -47.82 -54.22 5.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.658 2.238 . . . . 0.0 112.569 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -52.25 -61.0 2.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -56.76 -39.68 74.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.43 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -62.65 -46.37 88.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.31 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 m -59.4 -40.28 86.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -44.82 95.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.646 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.46 -46.7 87.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.29 -45.83 80.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.381 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.686 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.765 -179.826 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.77 -45.6 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.745 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.67 -46.81 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.34 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mt -65.71 -23.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.208 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -107.54 27.37 9.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.41 109.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.619 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.86 61.68 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -98.66 122.45 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.04 118.15 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.89 166.08 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.638 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.66 147.25 34.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.472 ' CB ' ' HZ3' ' A' ' 195' ' ' LYS . 2.6 mtpm? -58.01 -55.12 48.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.252 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.3 Cg_endo -67.89 -29.67 34.34 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.835 1.69 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -66.57 -50.75 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.843 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 mt -55.24 -42.18 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.66 -69.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.599 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -27.64 12.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.961 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.686 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -71.54 -51.49 23.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.129 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.622 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.3 t -84.28 -61.79 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.505 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -48.27 -3.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.723 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.622 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.7 OUTLIER -55.16 -7.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.321 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER -112.27 26.23 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER 164.83 100.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.557 -179.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -81.23 104.89 12.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.42 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.09 54.97 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -155.51 100.42 0.19 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 209' ' ' GLY . 23.0 m-20 -51.89 -173.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.811 0.339 . . . . 0.0 110.249 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.13 -12.97 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -81.01 -17.84 48.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.364 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.2 p -66.68 -39.45 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.585 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 94.2 t -58.07 -50.02 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.44 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -56.12 -46.87 79.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.572 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 6.3 t -61.25 -45.94 92.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.53 -41.51 98.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.056 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.73 -40.82 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -66.11 -44.05 85.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.443 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -15.12 62.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.02 -45.64 13.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 226' ' ' ASP . 5.8 mtp-105 -59.22 -46.75 87.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.788 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -67.72 -10.46 52.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.525 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -93.04 -35.78 13.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.317 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.5 -26.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -95.2 137.3 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.793 -179.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.476 ' HG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -174.12 26.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.006 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.76 166.62 13.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.66 -9.86 58.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -92.86 130.5 38.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -83.47 156.02 23.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.711 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.6 mp -147.55 -41.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 109.93 22.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.0 123.83 37.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.334 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.1 m -92.01 109.41 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.939 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.6 69.26 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.313 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -39.25 120.49 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.008 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.97 -23.26 28.0 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.35 -41.66 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.697 0.284 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.24 -137.71 7.78 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 154.62 48.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.723 0.297 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.45 131.38 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 110.8 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.2 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.478 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.14 135.93 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -78.15 151.3 78.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.191 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.67 144.73 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.406 2.071 . . . . 0.0 112.216 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.687 -179.963 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.46 159.05 8.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.19 126.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.561 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.31 -72.04 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -50.75 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.454 ' O ' ' CB ' ' A' ' 126' ' ' HIS . 1.6 p80 -137.76 21.43 2.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.454 ' CB ' ' O ' ' A' ' 125' ' ' HIS . 1.1 t-80 78.01 148.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -100.16 172.11 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.437 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -107.14 147.87 29.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -25.79 14.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -16.66 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.239 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 44.78 90.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -106.63 65.51 0.26 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 mp -121.44 -22.12 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.851 0.358 . . . . 0.0 110.636 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t 53.99 67.37 3.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -47.49 -25.4 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.724 2.283 . . . . 0.0 111.642 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 57.43 -94.29 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.093 179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 158.83 140.3 2.88 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.06 -9.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.031 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 139' ' ' HIS . 9.9 m80 -90.92 -45.38 8.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.1 mtp -99.43 75.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.355 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.589 ' C ' ' H ' ' A' ' 143' ' ' ASN . 0.7 OUTLIER -152.22 -37.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.376 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 144' ' ' LYS . . . 69.3 -20.86 0.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.589 ' H ' ' C ' ' A' ' 141' ' ' LYS . 7.4 m120 -49.72 84.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -112.35 -71.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.387 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.15 156.04 71.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.539 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.93 140.49 55.16 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.699 2.266 . . . . 0.0 112.239 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 148' ' ' ASN . 72.5 mtt-85 -116.54 17.23 15.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.461 HD21 ' CD ' ' A' ' 161' ' ' GLU . 1.2 m120 58.59 141.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.734 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.48 112.62 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -120.54 123.42 42.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.955 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -89.56 153.1 21.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.67 156.19 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.0 t80 -165.43 128.56 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.596 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.01 -99.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 56.7 m-20 -125.44 53.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.65 150.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.193 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -140.33 143.32 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.138 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.67 137.47 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 150' ' ' ARG . 2.1 m-20 -112.68 104.59 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 110.351 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.08 -10.65 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.72 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.461 ' CD ' HD21 ' A' ' 148' ' ' ASN . 2.8 mt-10 -98.6 -43.35 6.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 163' ' ' HIS . 82.3 p -98.58 9.47 43.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 162' ' ' THR . 16.8 m-70 37.18 47.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -124.1 161.39 25.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.832 0.348 . . . . 0.0 110.744 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.03 156.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.987 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.58 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.7 tmtt? -123.76 110.75 15.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.08 62.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.5 28.31 72.98 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 167' ' ' LYS . 25.4 tt0 -139.63 105.78 6.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 144.46 29.67 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.718 1.612 . . . . 0.0 112.466 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.88 138.91 50.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.9 t -86.14 138.86 31.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.281 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mt -142.85 99.6 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.656 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 171.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -46.88 -60.4 0.89 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.487 2.124 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.469 ' H ' ' HG1' ' A' ' 177' ' ' THR . 0.9 OUTLIER -53.33 -56.68 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.315 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 2.6 mm-40 -59.25 -36.76 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.761 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -60.92 -47.24 87.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.9 m -58.8 -41.54 86.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.417 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.659 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -61.33 -43.03 99.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -46.73 83.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.594 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.479 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 4.5 t80 -67.41 -39.14 85.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.676 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -43.84 79.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.03 -47.41 68.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.51 -36.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 20.5 m-80 -108.97 28.8 8.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.65 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.15 -22.49 22.89 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 m -95.29 135.26 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.055 0.455 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 84.9 t -69.19 123.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.4 mp -96.15 154.4 17.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.093 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.65 147.87 30.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.953 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.5 mtmt -57.83 -55.03 49.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.792 179.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.8 Cg_endo -67.63 -29.97 35.61 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.023 1.816 . . . . 0.0 111.949 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -68.33 -49.34 60.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 109.973 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 mt -55.98 -42.23 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.805 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 tp -59.2 -63.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.661 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -52.87 -28.83 24.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 19.3 t-80 -71.92 -48.34 46.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 204' ' ' ARG . 47.7 t -84.37 -61.52 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.529 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -53.23 -3.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.315 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp180 -61.59 0.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 110.636 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.529 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.3 m-85 -121.52 13.18 10.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.423 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.2 OUTLIER 175.07 100.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.633 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.11 110.16 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.39 48.86 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.06 104.23 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 209' ' ' GLY . 10.7 m-20 -49.21 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.877 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.64 -8.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.64 -17.64 50.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.345 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.28 -40.01 85.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.072 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.76 -50.51 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.12 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.52 -48.49 71.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.579 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.2 m -60.74 -47.77 84.82 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.6 -40.52 95.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.69 -43.27 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.438 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -43.92 97.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.14 -37.52 85.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -48.14 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 226' ' ' ASP . 4.6 mtp85 -56.19 -43.18 78.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.494 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -67.06 -17.22 64.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -96.19 -32.29 12.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.57 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.53 -33.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.268 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -104.49 137.83 41.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.73 27.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.404 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.59 -176.5 14.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.54 -8.7 57.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 110.481 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.67 104.81 17.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -96.15 104.46 16.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.7 -7.23 50.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.215 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.52 112.23 21.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 126.85 40.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.401 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.42 70.58 3.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -43.61 112.31 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.36 -13.24 16.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.94 -54.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 110.724 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.3 -139.25 6.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.43 155.35 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 0.0 110.467 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 4.1 p -137.05 135.57 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.62 126.32 36.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -162.53 135.7 5.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.178 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.97 154.94 94.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.489 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 161.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.804 2.336 . . . . 0.0 112.169 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.525 179.973 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.1 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -47.19 95.4 0.01 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.2 p -59.51 -30.46 68.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.374 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t -88.0 147.48 24.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.779 ' HD1' ' H ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -110.58 -74.05 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.416 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.779 ' H ' ' HD1' ' A' ' 124' ' ' HIS . 0.6 OUTLIER -169.1 -162.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.554 179.662 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -101.68 -168.99 1.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -105.41 -13.75 15.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -80.53 108.14 13.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 130' ' ' SER . 21.4 t-80 -50.48 -103.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.439 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.56 ' N ' ' CG ' ' A' ' 129' ' ' HIS . 2.6 p 54.32 -164.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.219 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.8 t -112.01 154.02 25.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.372 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.2 50.08 0.45 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.6 168.84 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.636 0.255 . . . . 0.0 110.626 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.07 78.71 11.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.211 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.5 91.59 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.454 2.103 . . . . 0.0 111.563 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -47.92 148.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.321 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -105.22 101.25 1.85 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 t -52.68 -61.19 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.57 137.34 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.766 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.6 mmt -122.99 123.17 40.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -90.24 107.57 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.074 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.06 61.48 1.34 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -83.55 92.88 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.34 . . . . 0.0 110.622 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -118.6 114.94 23.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.06 158.34 75.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.302 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.11 177.34 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.5 2.134 . . . . 0.0 112.012 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 148' ' ' ASN . 38.2 mtm180 -61.16 161.34 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.519 ' CG ' HH21 ' A' ' 150' ' ' ARG . 71.2 m-80 -38.88 142.28 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.664 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.65 118.98 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.519 HH21 ' CG ' ' A' ' 148' ' ' ASN . 4.5 ptt180 -174.63 153.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.37 153.86 18.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.317 -179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 152.37 41.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.6 t80 -163.7 128.08 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.812 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.75 -99.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.6 m-20 -124.82 53.82 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 0.0 109.836 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 142.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.49 140.16 42.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.887 0.375 . . . . 0.0 110.738 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.32 124.2 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.148 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -102.59 104.87 15.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.534 -179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.588 ' OE2' ' N ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -65.97 -12.72 57.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.588 ' N ' ' OE2' ' A' ' 160' ' ' GLU . 3.1 tt0 -81.63 -52.38 7.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 163' ' ' HIS . 80.5 p -97.32 14.88 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 162' ' ' THR . 24.4 m80 35.78 63.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.601 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -140.45 162.4 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.18 161.61 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.14 128.54 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.63 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -128.08 110.72 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.08 67.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.01 32.06 62.19 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -142.37 87.52 9.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.37 136.42 50.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.197 1.931 . . . . 0.0 112.133 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.4 152.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.129 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.3 m -90.11 126.62 35.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.145 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 mt -141.03 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.758 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.62 171.87 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.81 -53.81 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.556 2.171 . . . . 0.0 112.096 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -57.47 -52.73 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.29 -39.6 93.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.78 -46.61 88.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.362 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.7 m -59.21 -40.44 85.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -45.89 91.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.16 -43.16 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.928 0.394 . . . . 0.0 110.163 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -55.64 -45.18 77.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.334 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.685 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -64.8 -44.05 91.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.43 -44.81 65.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 10.7 t -68.69 -49.09 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.819 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 mm -54.13 -34.57 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER -109.53 27.53 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.561 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.38 116.55 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.36 -17.99 42.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.1 m -90.14 125.09 35.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.765 0.317 . . . . 0.0 110.93 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.76 115.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.962 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.91 160.44 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.677 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.658 ' HG ' ' H ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -107.45 148.43 29.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.697 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 12.9 mtpt -55.24 -53.37 62.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.8 Cg_endo -68.43 -29.77 30.71 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.658 ' H ' ' HG ' ' A' ' 194' ' ' SER . 1.0 OUTLIER -67.21 -46.22 74.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.343 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.16 -39.51 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.89 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.17 -51.4 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.724 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -72.49 -19.74 61.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.685 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 30.6 t-80 -71.39 -41.79 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.674 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.3 t -82.72 -53.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.587 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 205' ' ' TYR . 2.2 m-90 -67.29 -5.34 13.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.735 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.436 ' O ' ' NE ' ' A' ' 204' ' ' ARG . 0.4 OUTLIER -44.07 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.895 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -98.5 25.61 6.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.19 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER 174.19 -167.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.22 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -68.91 159.99 31.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -71.82 -176.96 27.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -141.82 -157.01 7.0 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 212' ' ' ASN . 2.3 m-20 -86.17 128.01 34.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.098 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.3 m -58.59 1.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 210' ' ' ASP . 70.2 m-20 -96.2 -24.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.65 -31.41 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.33 -53.04 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -55.34 -43.83 75.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -60.59 -49.5 77.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.81 -38.44 91.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.434 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.81 -42.75 97.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.298 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -45.29 92.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.47 -31.33 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.33 -44.43 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.17 -41.79 72.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.3 mtm-85 -67.8 -22.0 65.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -25.11 19.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 225' ' ' ILE . 0.3 OUTLIER -116.31 -38.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.978 -179.526 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 222' ' ' ARG . 3.7 t70 -98.48 146.27 25.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.483 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t 175.45 -30.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.281 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -72.35 163.65 54.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -64.5 -4.24 3.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 110.713 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -92.71 131.26 37.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -86.99 158.12 19.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.16 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 82.4 mt -147.55 -48.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.291 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.54 119.31 38.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 124.49 41.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.264 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -91.68 109.93 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 30.0 mt -93.22 71.79 4.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 89.9 mtt180 -37.02 123.93 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 -39.82 2.74 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.1 -60.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.391 . . . . 0.0 110.659 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.08 -137.02 4.52 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -127.29 155.66 43.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 110.645 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.39 140.2 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 27.8 tp -93.39 111.39 23.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.262 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.26 131.97 5.21 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.255 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -69.95 155.33 93.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.049 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.51 108.23 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.477 2.118 . . . . 0.0 112.034 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.64 -179.913 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 148.58 121.09 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.74 -50.03 27.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.263 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.4 t 57.88 44.83 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.664 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -68.79 -61.73 1.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.431 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.03 177.14 7.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.046 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -110.27 167.74 9.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -120.63 86.53 2.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.426 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -179.45 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.409 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 130' ' ' SER . 8.1 t60 -82.33 -148.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.18 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.676 ' H ' ' CG ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -107.97 161.69 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.815 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.8 t -156.74 56.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.61 -79.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.89 -166.13 1.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 110.427 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.91 71.86 77.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.701 179.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' ARG . 50.8 Cg_exo -45.49 116.79 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.887 2.392 . . . . 0.0 112.186 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' PRO . 2.6 mtt-85 38.07 62.75 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.245 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.39 90.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.42 114.27 8.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -58.2 -106.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.6 mtt -54.89 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -131.9 81.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.94 -14.76 73.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -81.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 tttt 55.08 94.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -158.06 148.5 15.86 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.94 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.48 167.71 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.237 1.958 . . . . 0.0 111.846 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 99.05 8.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.444 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -88.51 103.22 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.454 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.27 139.56 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.419 HH21 ' CG ' ' A' ' 148' ' ' ASN . 2.4 ptt180 -174.74 153.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.225 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -91.15 148.07 22.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.089 0.471 . . . . 0.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -140.19 155.43 46.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.201 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 155' ' ' ASP . 70.3 t80 -156.86 124.93 5.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.005 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.77 -93.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.8 m-20 -124.86 52.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.75 138.43 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.984 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -134.99 133.02 39.03 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.715 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 mt -131.43 120.85 23.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -109.18 113.82 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.546 -179.521 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.95 -42.33 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.5 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.5 -47.18 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.1 p -103.62 8.99 37.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 162' ' ' THR . 0.7 OUTLIER 36.91 46.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.573 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.32 165.65 14.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.26 159.33 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -146.41 120.67 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.485 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -118.25 105.12 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.237 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.84 63.42 0.31 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.52 27.5 73.39 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 tt0 -134.05 94.63 18.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.612 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.59 134.12 10.87 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.291 1.994 . . . . 0.0 111.989 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.89 134.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.374 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.2 p -81.76 100.04 9.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.62 154.31 17.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.99 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.95 160.91 65.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.964 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.55 -43.07 52.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.537 2.158 . . . . 0.0 111.624 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -55.37 30.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.644 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -36.26 76.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.11 -52.78 64.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.37 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.1 m -57.47 -43.43 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.777 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -53.44 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.05 -41.5 95.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -55.54 -46.5 77.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.781 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 29.7 t80 -64.35 -42.53 96.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.18 -43.86 83.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.47 -43.68 94.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.988 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.02 -29.59 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 29.2 m-80 -113.99 23.25 13.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.109 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.23 121.36 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.776 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.59 -20.86 24.51 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -95.81 131.18 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 111.042 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 10.7 p -69.44 115.61 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.7 mp -96.9 160.24 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.487 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.76 148.1 31.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.0 -50.14 89.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.751 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.4 Cg_endo -65.78 -34.59 39.68 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.56 1.507 . . . . 0.0 112.219 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.95 -47.6 65.28 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.108 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 mt -53.82 -40.91 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.991 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.29 -64.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.475 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -27.65 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.294 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.14 -51.58 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.762 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.568 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.8 t -83.71 -61.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.239 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.491 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -50.6 -4.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -179.384 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttm180 -61.98 -1.44 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER -117.13 11.43 14.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.782 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.65 108.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.632 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -85.3 120.24 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.448 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.67 52.19 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.457 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -156.35 102.1 0.21 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -174.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.53 -7.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.94 -49.31 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 8.1 p -54.75 -42.96 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.044 0.45 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.495 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 41.1 t -58.95 -44.85 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -61.13 -47.1 87.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.339 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -60.28 -41.03 92.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.984 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -64.09 -42.05 97.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.25 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.4 t -62.4 -40.32 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -45.15 74.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.313 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -13.07 62.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.432 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -57.09 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 24.2 ptt180 -57.54 -37.85 73.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.705 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.414 ' N ' ' CG ' ' A' ' 222' ' ' ARG . 1.4 mtt-85 -69.0 -20.76 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -94.87 -27.56 15.66 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.805 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.476 ' CG2' ' HZ1' ' A' ' 167' ' ' LYS . 1.8 pp -114.85 -27.62 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.839 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -102.84 139.04 38.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.997 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 -33.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -46.01 163.64 0.12 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -94.45 106.43 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -74.06 107.21 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.458 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.81 1.12 56.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.587 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.2 mt -126.58 96.23 4.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.93 122.06 31.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.7 m -93.26 113.68 25.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.1 mt -95.27 72.14 3.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -39.06 120.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.754 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.51 -17.58 30.79 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.584 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 63.6 t -128.33 -55.11 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.12 -137.25 4.76 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.8 OUTLIER -131.24 155.16 47.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 110.265 179.82 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.406 HG11 ' NE ' ' A' ' 244' ' ' ARG . 8.2 p -138.17 131.29 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.159 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.41 104.64 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.374 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.406 ' NE ' HG11 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -162.24 153.48 17.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.03 155.62 79.94 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.53 117.66 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.407 2.071 . . . . 0.0 112.129 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.551 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 142.34 -65.03 0.49 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -69.93 150.83 46.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.79 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.013 0.435 . . . . 0.0 111.186 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.62 -25.04 0.37 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.011 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -79.48 -25.5 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -61.99 -25.51 67.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.801 -179.723 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -53.66 86.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.332 179.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.633 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.2 OUTLIER 57.26 -149.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.682 179.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -139.35 -85.55 0.24 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.944 0.402 . . . . 0.0 110.551 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.575 ' HG ' ' H ' ' A' ' 131' ' ' SER . 10.4 t -115.97 -141.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.865 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.575 ' H ' ' HG ' ' A' ' 130' ' ' SER . 0.9 OUTLIER 69.59 -13.57 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.653 179.834 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 130' ' ' SER . . . 46.05 -108.22 0.23 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.699 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.09 69.16 28.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 137' ' ' GLY . 46.6 Cg_exo -49.32 159.05 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.724 2.283 . . . . 0.0 112.041 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -63.04 -1.53 0.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.272 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 135' ' ' PRO . . . 85.36 -55.77 4.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 t -145.08 144.65 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 110.509 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -131.11 -7.77 3.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.465 -179.943 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.6 mtm -66.33 -12.65 57.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -74.07 112.26 10.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.665 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -146.87 -92.63 0.11 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.14 -68.6 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.362 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 mttt 61.47 41.76 12.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.467 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 50.09 69.48 2.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.749 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 147' ' ' ARG . 40.9 Cg_exo -53.41 92.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.806 2.337 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 146' ' ' PRO . 57.1 mtm180 59.35 122.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -170.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 116.19 37.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -136.41 127.26 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.368 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.6 mt -90.57 152.72 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.95 148.97 39.5 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 156' ' ' ILE . 84.2 t80 -158.74 127.47 5.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.89 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.38 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.111 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 25.8 m-20 -123.94 53.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 145.06 29.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.256 -179.553 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.42 149.06 50.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.434 179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.35 121.87 8.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.137 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.79 27.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 -179.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.476 ' OE1' ' NH2' ' A' ' 183' ' ' ARG . 8.0 mt-10 -66.57 -22.42 66.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.625 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.0 -52.11 52.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.4 p -108.18 14.79 24.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 160' ' ' GLU . 9.6 m80 37.22 54.74 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -120.86 156.79 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.0 t -119.85 157.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.65 137.76 25.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -130.6 110.08 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 179.748 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.06 60.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.263 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.83 76.12 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.0 mt-30 -134.98 104.89 10.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.823 -0.222 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.39 144.72 26.14 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.889 1.726 . . . . 0.0 112.618 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.24 136.43 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.712 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.5 t -97.97 127.17 43.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -140.65 124.68 17.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.376 . . . . 0.0 110.539 179.707 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -45.67 174.57 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -179.617 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.7 -47.6 26.37 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.544 2.163 . . . . 0.0 111.853 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -52.34 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.07 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.52 -38.75 88.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.878 0.371 . . . . 0.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -48.39 81.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.711 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -59.38 -42.64 92.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.206 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.85 -50.8 71.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.015 -179.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.95 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.746 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.476 ' NH2' ' OE1' ' A' ' 160' ' ' GLU . 2.3 ttt180 -60.21 -48.89 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.43 -39.41 93.79 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.555 -179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -43.14 91.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.19 -47.11 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.27 -27.65 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.062 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.54 18.54 20.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.462 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.53 120.23 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.44 -24.37 13.95 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 46.7 m -94.72 126.73 40.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.11 118.4 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 mp -96.35 161.4 13.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.47 148.0 30.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.287 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.41 -55.75 36.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.034 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.3 Cg_endo -66.58 -33.6 35.72 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.962 1.774 . . . . 0.0 112.142 -179.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -46.33 85.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 36.8 mt -60.99 -39.09 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.94 -51.5 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.144 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.32 -28.87 69.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.019 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.85 -58.5 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.505 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.6 t -84.34 -60.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.013 -178.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -51.04 -5.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.834 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.606 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.9 ttp85 -61.4 -1.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -111.96 9.86 20.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.985 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -171.04 67.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 0.0 110.629 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.86 171.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.404 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.17 61.18 1.76 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.11 102.44 0.21 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -43.09 139.09 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.245 0.545 . . . . 0.0 110.434 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 24.5 t -55.3 0.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.32 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.59 ' H ' ' C ' ' A' ' 210' ' ' ASP . 37.3 m-20 -83.66 -12.41 55.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.57 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.11 -35.27 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.399 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.92 -55.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.052 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.29 -48.56 68.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.3 t -58.07 -50.53 73.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.026 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.51 -37.26 83.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.0 110.533 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.1 t -62.04 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.408 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -60.56 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.52 -39.89 94.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.73 -45.68 88.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.42 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.0 mmm-85 -56.68 -42.29 78.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.392 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -66.15 -22.5 66.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.634 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -93.22 -30.44 15.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.671 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -110.45 -37.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 0.0 110.766 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.5 t70 -95.02 145.18 25.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.458 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.91 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.461 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.53 -178.57 4.92 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -79.34 -11.21 59.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -94.4 104.89 16.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.026 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -92.08 109.37 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.265 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.5 mp -91.81 -9.07 44.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.445 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.72 127.25 56.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.132 179.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.96 124.57 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.381 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.3 m -97.61 113.74 25.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.327 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 240' ' ' GLY . 7.2 mt -96.11 72.66 2.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.632 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -39.78 115.19 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.51 -20.42 20.71 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.795 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.3 -50.02 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.915 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 158.59 -145.64 11.94 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -131.48 152.71 50.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.538 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.13 137.45 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.21 127.09 36.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.652 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -163.61 131.1 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.76 158.27 86.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.736 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.14 113.4 3.26 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.671 2.247 . . . . 0.0 112.152 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.945 -179.671 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.96 -131.56 3.08 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.79 130.05 45.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.924 0.393 . . . . 0.0 110.832 179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 125' ' ' HIS . 5.3 p -102.58 25.51 9.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.572 ' N ' ' HD1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -47.4 94.41 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.493 0.663 . . . . 0.0 110.274 -179.585 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 123' ' ' SER . 2.2 t-80 -78.36 123.74 27.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.286 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -135.56 -71.01 0.47 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 67.92 170.75 0.27 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.426 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 15.9 m80 -74.26 -76.17 0.14 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.745 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 128' ' ' HIS . 7.2 t60 74.69 139.63 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.159 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' HIS . 1.5 m 37.6 64.29 0.67 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.416 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 t -81.97 -42.84 18.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.889 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.99 -54.97 0.02 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mt -100.83 144.07 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.713 0.292 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.542 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -111.88 156.8 41.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.807 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.07 2.39 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.265 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 134' ' ' VAL . 3.7 tpp180 71.71 29.67 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.64 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ARG . . . 33.39 -106.84 0.03 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' HIS . 20.5 m 49.91 -117.96 1.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' SER . 2.0 m-70 -45.18 169.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.481 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.6 mtt 55.44 -158.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.135 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.2 158.11 16.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.36 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.93 152.32 22.94 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 112.79 2.47 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.659 -0.318 . . . . 0.0 110.767 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -106.25 123.26 47.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' ARG . 20.5 mt-10 -93.07 150.61 39.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.569 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -41.64 89.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.083 1.855 . . . . 0.0 111.804 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' GLU . 32.8 mtt180 -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.205 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 147' ' ' ARG . 99.1 m-20 57.4 135.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.05 111.58 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.726 179.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -121.65 124.67 44.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.296 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.864 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -142.33 160.78 39.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.613 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 156' ' ' ILE . 69.6 t80 -165.53 128.72 2.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.53 -99.82 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.241 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 153' ' ' PHE . 22.8 p30 -122.76 53.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.55 155.04 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.707 -179.64 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -146.84 140.58 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -137.16 136.32 38.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.398 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -110.88 104.09 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.133 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.42 -11.08 39.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.902 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -96.92 -51.02 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.83 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.539 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 30.8 p -93.89 9.99 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.503 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 162' ' ' THR . 8.5 p-80 37.11 58.49 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -127.81 157.37 40.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.54 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.64 151.46 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.325 179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.23 125.19 12.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 170' ' ' GLN . 23.8 tttp -124.49 115.24 20.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.611 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 59.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.66 75.26 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 167' ' ' LYS . 48.2 mt-30 -130.5 95.28 27.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.7 138.99 12.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.121 1.881 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.61 145.26 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.381 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -94.28 100.09 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.07 150.38 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.578 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.36 168.44 22.48 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.293 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.68 -52.17 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.367 2.045 . . . . 0.0 112.322 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -47.65 85.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.71 -37.5 84.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.615 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 1.8 t80 -64.71 -49.24 71.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.5 m -57.31 -46.04 83.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.55 -49.6 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.791 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.84 -44.77 96.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.75 -46.36 89.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 2.3 t80 -62.27 -42.25 99.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.819 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -43.99 93.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.337 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.19 -45.35 86.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.556 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 mm -57.35 -35.58 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -110.18 23.16 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.274 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.02 119.08 4.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.52 -26.83 9.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 127.62 35.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.326 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.88 114.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.96 157.5 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 149.83 28.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.497 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.8 mttt -57.12 -49.44 93.95 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -65.36 -35.43 40.02 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.56 1.507 . . . . 0.0 111.933 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -66.33 -55.48 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.029 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 mt -49.93 -38.1 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 48.7 tp -65.06 -68.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -46.05 -27.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.572 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 24.8 t-80 -71.53 -52.29 19.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.062 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.1 t -83.42 -56.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.462 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -51.68 -4.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.458 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.541 ' H ' ' C ' ' A' ' 202' ' ' VAL . 48.1 ttm-85 -58.69 -6.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.3 OUTLIER -114.87 14.25 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.66 116.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.074 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -91.16 119.28 31.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.429 179.561 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 160.82 53.42 0.02 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.74 98.21 0.17 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 209' ' ' GLY . 44.1 m-20 -47.87 -177.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -9.6 12.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.644 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.83 -17.97 34.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.18 -35.04 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.298 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.27 -49.51 81.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.322 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -58.4 -47.07 85.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.278 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 m -59.78 -45.35 92.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.38 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -45.34 94.79 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.2 -40.2 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.358 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -44.79 90.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.592 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.49 -28.5 66.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.572 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.61 -47.3 63.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 226' ' ' ASP . 3.1 mtp85 -57.02 -45.56 83.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.319 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -67.41 -10.14 48.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -90.58 -44.27 9.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.9 pp -110.14 -32.78 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -95.23 143.47 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.9 t -175.33 38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.06 -163.25 10.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -90.54 -20.54 22.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.552 ' CB ' ' HZ3' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -92.23 104.0 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.208 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -88.75 125.86 35.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.4 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 mt -91.25 -8.8 47.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.63 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.6 mp -121.6 116.32 24.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.183 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 127.57 37.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.46 105.88 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.6 mt -94.59 73.1 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.14 136.36 5.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.708 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.18 -12.74 65.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.15 -46.06 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 147.13 -141.77 9.68 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -131.12 153.59 49.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 0.0 110.476 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.48 136.61 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.41 119.92 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -163.03 127.12 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -56.97 154.97 16.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.148 179.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -36.57 140.13 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.852 2.368 . . . . 0.0 112.075 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.48 -179.886 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.0 tmm? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.62 170.65 12.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.4 t -124.77 -38.34 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.364 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 93.0 p -149.42 169.44 20.86 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.833 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.86 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -42.77 136.7 2.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.483 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.86 156.55 44.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 129' ' ' HIS . 10.5 m170 55.48 62.12 2.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.697 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -73.07 11.54 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 127' ' ' HIS . 33.2 t-80 46.29 88.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.09 115.61 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.832 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.476 ' H ' ' HG ' ' A' ' 131' ' ' SER . 6.1 p -77.83 64.83 3.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.58 93.8 1.49 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.14 123.78 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.84 154.07 37.44 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.463 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.79 -164.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.967 2.445 . . . . 0.0 112.618 -179.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -153.56 15.1 0.5 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.525 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.54 -165.77 26.01 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 139' ' ' HIS . 9.5 t -90.82 -3.81 57.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.171 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' SER . 1.7 t-80 60.84 127.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.254 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 36.5 mtt -119.26 -108.51 0.36 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.02 -8.46 3.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.312 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.32 142.57 3.49 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.45 -15.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.939 0.399 . . . . 0.0 110.419 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -65.31 167.93 7.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.555 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER 177.88 -49.62 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.4 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 49.6 Cg_exo -51.0 161.03 1.62 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.362 2.041 . . . . 0.0 111.957 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.01 -84.8 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -66.15 174.66 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.152 -179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.93 115.04 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.299 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -141.38 134.6 29.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.76 161.09 16.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 157.79 44.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' OE2' ' A' ' 245' ' ' GLU . 91.9 t80 -162.55 122.96 2.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.668 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 32.8 m-20 -124.66 54.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 152.41 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.553 -179.329 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.1 tt0 -140.23 147.7 40.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.216 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.447 ' CD2' ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -146.33 117.46 7.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.257 -179.645 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -112.43 115.42 28.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.673 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.8 -45.07 79.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -49.49 -50.72 40.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.714 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 56.4 p -97.18 6.95 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.624 ' CE1' ' CE1' ' A' ' 179' ' ' PHE . 16.9 t60 36.1 57.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -134.18 159.18 41.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.54 154.45 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -146.42 129.14 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.123 -179.795 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 170' ' ' GLN . 25.5 tttp -127.51 114.55 17.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.414 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 65.06 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 60.4 29.57 69.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 167' ' ' LYS . 14.7 tp60 -132.95 92.18 26.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.29 136.81 16.32 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.134 1.89 . . . . 0.0 112.379 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.29 136.08 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.957 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 57.9 m -91.06 91.14 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.88 142.58 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.931 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 170.74 13.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.95 -53.96 6.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.408 2.072 . . . . 0.0 112.43 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -52.3 -63.44 1.14 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -58.33 -37.45 75.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.775 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.624 ' CE1' ' CE1' ' A' ' 163' ' ' HIS . 27.7 t80 -54.98 -51.71 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -62.77 -35.69 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.549 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.6 -51.17 69.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.152 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.18 -41.25 98.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.792 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -62.45 -41.79 99.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.23 -37.28 86.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.207 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.97 -46.05 92.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.43 -47.28 90.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.484 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -50.88 -42.08 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -108.98 25.36 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.75 117.34 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.62 -21.42 16.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.5 m -96.5 131.47 43.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.86 119.02 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.78 166.27 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 110.77 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.97 148.26 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.67 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.36 -51.08 84.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.574 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.6 Cg_endo -64.27 -44.6 11.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.675 1.583 . . . . 0.0 112.149 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.04 -51.54 68.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.244 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -55.52 -39.0 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 110.393 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 199' ' ' LEU . 2.6 tt -59.43 -67.39 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.071 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -58.13 -15.9 11.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -53.38 12.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.711 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.452 ' C ' ' H ' ' A' ' 204' ' ' ARG . 23.8 t -84.06 -30.66 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.269 -179.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.575 ' NE1' ' O ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER -60.36 -3.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.92 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 202' ' ' VAL . 13.2 mmm-85 -61.01 -1.93 0.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.568 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.9 m-85 -121.83 4.47 9.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.597 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.68 110.06 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.84 172.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.575 ' O ' ' NE1' ' A' ' 203' ' ' TRP . . . 139.65 80.89 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.88 59.04 0.99 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.54 98.2 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -6.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.642 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -26.07 19.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.789 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.68 -32.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.7 t -57.85 -56.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.072 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.51 -46.92 76.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.229 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.0 t -60.6 -45.66 93.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.13 -39.03 89.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.15 -46.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.428 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -62.48 -43.32 99.09 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -72.69 -13.32 61.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -48.33 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 12.5 mtm-85 -56.07 -45.05 79.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.135 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -68.17 -11.14 58.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.766 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.4 tttp -92.7 -33.34 14.38 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.625 -179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -21.6 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.872 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.85 -39.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -53.25 168.98 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.16 -8.55 56.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.916 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 130.1 39.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -85.79 128.43 34.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -90.09 -74.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.543 ' H ' ' CD1' ' A' ' 233' ' ' LEU . 0.0 OUTLIER -91.95 145.45 24.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.646 -179.652 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -105.23 132.44 51.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.38 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -91.69 108.94 20.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.737 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 10.2 mt -94.87 72.96 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.469 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -36.84 142.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.19 179.641 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.1 36.04 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.59 -57.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.567 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 154.37 -138.95 6.44 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -130.51 160.74 33.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.697 179.996 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.8 p -142.64 126.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.74 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 36.8 tp -90.64 116.67 28.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.537 ' O ' ' NE ' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -161.9 147.18 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.437 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.545 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.4 mp0 -74.52 154.63 87.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.92 150.45 73.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.505 2.137 . . . . 0.0 111.967 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.645 -179.754 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.456 ' H1 ' ' H ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.456 ' H ' ' H1 ' ' A' ' 120' ' ' MET . . . -157.85 -112.86 0.36 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 123' ' ' SER . 12.7 t -80.38 81.31 6.67 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.055 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 122' ' ' SER . 59.4 p 39.25 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.277 0.561 . . . . 0.0 111.491 178.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -77.06 -73.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.738 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.518 ' ND1' ' H ' ' A' ' 126' ' ' HIS . 3.8 t-80 -173.3 -176.65 1.37 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 -179.135 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.518 ' H ' ' ND1' ' A' ' 125' ' ' HIS . 1.0 OUTLIER -127.4 34.47 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 179.884 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 135.68 33.54 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -93.85 44.89 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.653 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -116.67 -0.01 12.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.281 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -29.69 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 122.19 32.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 0.0 110.8 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.32 -121.08 1.11 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mt -102.28 -165.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.69 0.281 . . . . 0.0 110.344 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.74 71.96 74.04 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.996 0.427 . . . . 0.0 110.959 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.84 170.68 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.855 2.37 . . . . 0.0 111.966 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 59.26 60.53 2.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.57 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.09 165.78 31.32 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.7 m -103.95 -5.01 22.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -151.34 149.6 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.8 ttt -60.43 -90.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.431 179.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 143' ' ' ASN . 4.3 mtpt -147.53 20.6 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.531 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.06 -24.11 1.69 Allowed Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.494 ' CG ' ' N ' ' A' ' 144' ' ' LYS . 10.7 t30 -141.99 170.12 16.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.494 ' N ' ' CG ' ' A' ' 143' ' ' ASN . 27.8 mttm -100.45 170.55 8.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.006 0.432 . . . . 0.0 111.331 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -128.38 151.1 75.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.79 126.7 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.907 2.405 . . . . 0.0 112.4 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.44 -8.95 8.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.75 115.06 19.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.29 129.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -174.5 143.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.13 154.71 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -142.34 156.97 45.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.67 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 154' ' ' ALA . 26.2 t80 -169.66 133.84 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.833 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.95 -129.6 0.25 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.63 53.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.349 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.92 151.24 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -146.79 141.49 26.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.161 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.06 117.95 14.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.383 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -104.11 108.71 20.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.97 0.414 . . . . 0.0 110.354 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.95 -31.05 72.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.167 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 1.4 mp0 -58.77 -48.32 81.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.735 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.443 ' C ' ' HD1' ' A' ' 163' ' ' HIS . 65.9 p -109.17 13.93 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER 38.18 50.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.702 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -119.41 158.44 26.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.13 151.97 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.31 124.72 13.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.1 ttpt -128.64 121.13 27.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.57 58.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.6 27.76 70.28 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.6 mt-30 -132.18 97.83 17.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.56 138.52 17.37 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.977 1.784 . . . . 0.0 112.492 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.97 143.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.61 -179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -93.73 97.29 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -95.97 152.16 18.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.778 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.2 161.49 59.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.338 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.46 -45.05 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.628 2.219 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -42.75 88.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.773 0.32 . . . . 0.0 110.813 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -65.43 -34.46 78.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -62.41 -45.52 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.119 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -43.58 96.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.124 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -47.66 84.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.774 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.61 -44.04 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.499 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -56.11 -47.15 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.824 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.509 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 2.6 t80 -66.08 -38.6 88.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.603 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.594 ' CZ ' ' CE2' ' A' ' 241' ' ' TYR . 3.0 m-85 -55.88 -44.54 78.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.96 -47.62 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.94 -31.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -106.53 23.77 13.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.798 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.08 119.68 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.74 -23.0 27.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.1 m -94.86 127.8 41.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.535 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 192' ' ' VAL . 14.7 p -68.62 112.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.157 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.32 151.18 19.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.0 p -100.33 148.38 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.371 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -58.39 -48.78 96.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 36.4 Cg_exo -55.03 -46.26 34.6 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.417 2.078 . . . . 0.0 111.666 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -61.97 -52.36 64.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.5 mt -49.95 -38.78 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.916 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.35 -67.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.419 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.93 -21.6 1.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.509 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 63.1 t60 -72.57 -59.19 2.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.576 ' C ' ' H ' ' A' ' 204' ' ' ARG . 64.6 t -83.69 -60.65 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -51.11 -4.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.1 OUTLIER -60.65 -0.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.678 0.275 . . . . 0.0 110.597 -179.927 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.2 m-85 -120.2 14.39 12.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.37 . . . . 0.0 110.452 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.28 98.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.7 111.2 16.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.738 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.61 52.19 0.04 OUTLIER Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.24 101.36 0.2 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 209' ' ' GLY . 7.4 t70 -47.57 -177.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 211' ' ' VAL . 7.1 p -78.48 -0.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.627 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.23 -22.16 19.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.689 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 t -64.18 -43.99 97.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.481 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.35 -43.05 95.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.239 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -58.88 -45.87 89.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.444 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.4 t -61.12 -40.74 94.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.106 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -64.04 -43.47 95.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.812 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.47 -41.02 90.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.284 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.83 -44.21 90.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -67.41 -31.29 71.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.5 mp -67.55 -45.71 74.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.87 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 226' ' ' ASP . 30.6 mtp85 -56.74 -46.16 81.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.35 -24.41 65.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -92.73 -23.37 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 226' ' ' ASP . 0.3 OUTLIER -111.12 -41.15 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.695 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 222' ' ' ARG . 24.3 t70 -100.81 141.1 34.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -37.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.422 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -59.37 165.89 9.34 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -69.26 -10.53 58.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.628 0.252 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -93.67 115.75 28.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.422 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -83.9 130.73 34.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 244' ' ' ARG . 27.9 mt -89.55 -74.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.64 145.72 26.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.577 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -105.17 140.26 38.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.662 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 m -95.85 114.75 26.51 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.036 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 240' ' ' GLY . 57.3 mt -96.14 72.12 2.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 236' ' ' LEU . 2.4 ptp180 -37.93 138.15 0.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.07 -18.64 43.39 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.15 -60.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.441 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 165.19 -142.07 7.47 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.594 ' CE2' ' CZ ' ' A' ' 185' ' ' PHE . 2.0 p90 -130.35 160.27 34.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.52 133.99 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.531 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 232' ' ' LEU . 7.8 ptm180 -162.73 127.9 3.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.9 154.18 84.95 Favored Pre-proline 0 C--O 1.232 0.165 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.77 110.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.043 2.495 . . . . 0.0 112.846 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.408 179.327 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.68 ' N ' ' NE2' ' A' ' 124' ' ' HIS . 5.4 ptm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.84 22.13 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -135.12 147.74 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 110.489 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.94 20.68 6.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.859 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.68 ' NE2' ' N ' ' A' ' 120' ' ' MET . 1.6 m-70 -109.24 125.03 51.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.178 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.678 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 6.1 p80 -152.66 -135.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.908 0.385 . . . . 0.0 111.127 -179.402 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.678 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 1.3 m-70 -73.64 -21.41 60.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.661 ' H ' ' CE1' ' A' ' 125' ' ' HIS . 4.6 m170 67.26 125.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 176.81 142.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.351 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -149.65 -89.2 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.699 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.61 137.11 41.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.573 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.9 -75.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 114.47 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp 69.71 111.74 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 134' ' ' VAL . 9.1 p -163.85 54.62 0.42 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 33.0 Cg_endo -66.12 156.59 63.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.872 2.382 . . . . 0.0 111.83 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -92.47 145.31 24.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.659 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.15 125.83 0.81 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 140' ' ' MET . 0.0 OUTLIER -103.76 -13.16 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.633 0.254 . . . . 0.0 110.52 -179.801 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.4 m80 63.72 -30.85 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.621 ' H ' ' C ' ' A' ' 138' ' ' SER . 4.7 ttm -172.47 117.97 0.36 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.108 0.48 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -70.23 -23.61 62.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.435 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.52 -110.77 0.45 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.608 HD21 ' H ' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -56.09 133.68 52.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.687 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' N ' HD21 ' A' ' 143' ' ' ASN . 10.4 mtpt -109.13 10.22 26.0 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.608 ' H ' HD21 ' A' ' 143' ' ' ASN . 0.6 OUTLIER -162.25 77.11 2.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.667 179.567 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.48 -15.14 46.89 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.623 2.215 . . . . 0.0 111.112 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -107.54 167.29 10.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.737 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.07 129.0 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.11 140.46 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -149.2 138.09 21.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -90.72 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.575 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.0 158.03 44.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.0 111.218 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 3.8 t80 -164.79 139.76 5.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.347 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.544 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 37.28 -105.32 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.69 53.11 1.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -137.43 150.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.556 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -140.45 137.02 33.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.38 143.34 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.216 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.26 109.47 15.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.06 -17.38 64.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.41 -52.03 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 42.3 p -96.79 12.04 33.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 162' ' ' THR . 8.6 m80 37.36 41.15 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.1 169.36 9.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.868 -179.399 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.28 161.04 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.477 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.121 179.647 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.6 tmtm? -124.67 113.51 18.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.687 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 64.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.052 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.41 31.69 63.26 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.5 tt0 -142.3 89.39 8.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.82 150.07 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.23 1.953 . . . . 0.0 112.544 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.2 126.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.905 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 p -95.13 115.39 27.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 0.6 OUTLIER -141.69 154.28 45.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.489 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.64 161.53 1.57 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.0 -33.99 95.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.889 2.393 . . . . 0.0 111.96 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -60.81 -53.61 55.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.13 -37.81 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.229 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.48 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 4.7 t80 -58.48 -48.08 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.9 m -58.8 -39.33 80.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.7 tp -60.87 -46.87 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.348 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.18 -40.65 86.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -59.89 -43.62 94.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.64 -179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.45 -43.07 91.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.564 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.43 -43.11 83.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.91 -48.75 86.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.52 -35.67 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.136 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.4 23.25 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.48 117.23 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.914 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.66 -14.15 24.79 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.3 m -98.48 130.9 45.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.18 115.07 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.457 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.89 152.65 18.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.445 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.75 147.96 27.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.201 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -56.58 -51.34 81.94 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 22.0 Cg_endo -65.23 -36.35 36.72 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.65 1.567 . . . . 0.0 111.987 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -66.49 -46.83 75.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.92 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 32.7 mt -53.81 -42.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.139 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.1 mt -63.7 -64.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.524 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -32.39 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -53.59 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.9 t -83.5 -61.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.048 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -52.0 -3.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.189 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -61.14 -4.89 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.0 110.51 179.879 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.9 t80 -113.95 -0.22 14.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.103 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -175.22 91.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.57 110.56 15.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 176.14 48.86 0.06 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -155.19 101.56 0.21 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 209' ' ' GLY . 1.3 m-20 -49.55 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.776 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.9 -4.79 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.67 -21.09 22.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.79 -33.83 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.951 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.94 -50.74 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.263 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -45.97 83.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 p -61.04 -44.04 97.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -40.48 94.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 49.5 t -62.45 -40.06 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.688 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -43.31 80.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -12.99 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.66 -50.18 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.984 179.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.3 ttp180 -56.28 -51.14 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.295 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -8.31 29.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.547 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -92.36 -37.09 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.57 -179.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.76 -25.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 0.0 110.72 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.3 OUTLIER -105.49 139.43 40.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.598 179.914 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 t -165.93 38.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.16 -173.52 13.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.2 -13.19 57.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.69 -0.255 . . . . 0.0 111.038 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -93.89 115.49 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.954 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -97.52 113.17 24.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -90.32 -1.68 57.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 107.48 15.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.93 125.01 41.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.7 m -91.8 111.48 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.539 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.7 mt -95.23 72.8 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 19.0 ttt-85 -36.75 127.04 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.98 -10.7 70.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.91 -39.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 135.96 -137.84 9.45 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.7 154.67 46.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 0.0 110.838 -179.846 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.09 138.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.75 113.61 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.416 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -161.7 130.95 4.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.25 154.08 82.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.57 126.24 12.57 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.74 2.293 . . . . 0.0 112.086 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.552 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.35 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -128.63 123.59 33.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.7 146.76 23.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.624 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.2 m -142.35 155.44 45.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 155' ' ' ASP . 42.7 t80 -163.02 128.01 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.92 -96.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 43.2 p-10 -124.56 53.79 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 143.27 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.155 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -140.13 136.1 33.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.324 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.448 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.67 131.74 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -113.74 109.52 18.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.65 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 160' ' ' GLU . 1.5 mp0 -66.68 -12.21 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.838 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.8 -51.98 6.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.589 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 40.6 p -99.21 11.22 39.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 40.6 p-80 35.82 58.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.357 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.33 156.26 42.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 174' ' ' LEU . 21.9 t -122.7 148.77 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.52 125.29 12.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 170' ' ' GLN . 31.8 tttm -128.83 117.24 20.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 62.74 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.1 26.26 70.21 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 167' ' ' LYS . 5.9 mt-30 -130.49 92.93 33.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 O-C-N 122.705 -0.291 . . . . 0.0 110.522 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.74 142.21 17.78 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.154 1.902 . . . . 0.0 111.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 131.01 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -88.46 88.35 7.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 165' ' ' VAL . 1.2 mt -93.92 154.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.42 165.2 32.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.3 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -42.12 -54.62 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.258 . . . . 0.0 112.362 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 53.7 m -57.68 -56.6 19.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.282 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -58.38 -34.69 70.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.933 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.82 -45.31 78.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.1 m -58.87 -39.92 82.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -54.27 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.72 -41.78 87.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -60.48 -46.67 89.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.081 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.684 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 19.5 t80 -62.3 -41.1 98.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.414 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.13 -43.67 82.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.93 -45.45 87.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' TYR . 55.5 mt -57.09 -37.24 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.84 25.6 11.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.07 124.33 16.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.44 -24.51 15.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.8 m -95.46 131.32 41.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.583 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 t -66.96 119.39 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.285 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 158.47 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.28 148.43 34.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mtpp -56.02 -55.01 46.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.486 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.0 Cg_endo -65.07 -39.96 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.851 1.701 . . . . 0.0 112.055 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.88 -51.55 68.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 37.5 mt -53.24 -42.96 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.179 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.68 -63.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.505 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.18 -29.59 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.259 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.684 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 6.1 t60 -71.2 -46.48 61.18 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.005 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 90.4 t -83.77 -60.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -50.55 -6.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.049 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.5 OUTLIER -59.33 -6.81 1.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 13.1 m-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 211' ' ' VAL . 10.1 p -86.26 -10.36 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.92 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.71 -24.5 31.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.356 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 216' ' ' SER . 21.9 t -64.31 -34.76 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.04 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 218' ' ' VAL . 39.5 t -65.93 -45.37 91.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.333 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.71 -45.72 77.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.311 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 33.0 p -60.1 -46.75 88.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.05 -38.81 92.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 214' ' ' VAL . 79.7 t -63.54 -43.11 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.607 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.72 -45.56 93.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.55 -39.87 92.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.316 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -61.33 -45.81 92.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.269 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' ASP . 47.0 ttt180 -56.18 -43.12 78.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.345 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -67.47 -30.25 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.403 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -91.1 -11.26 39.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -120.16 -25.1 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.915 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -96.2 137.03 35.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.191 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -70.83 170.74 46.19 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.1 -12.51 59.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -93.32 111.03 22.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.8 ttp85 -92.39 103.81 16.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mp -91.02 -5.72 54.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.43 HD12 ' HG ' ' A' ' 243' ' ' LEU . 1.4 tp -114.3 106.79 14.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 130.85 39.63 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.46 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.9 m -100.91 112.78 25.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.202 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.4 mt -98.07 69.61 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.066 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' LEU . 71.3 mtt180 -38.26 131.79 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.07 -20.85 49.2 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.2 t -120.08 -58.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 110.422 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.17 -139.22 5.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.89 153.85 49.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.8 p -137.0 135.15 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -90.78 125.87 35.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.995 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -162.29 134.13 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.199 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -148.46 141.83 25.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.189 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 151' ' ' LEU . 5.2 mt -90.47 151.15 21.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 158.59 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.056 0.455 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 154' ' ' ALA . 82.7 t80 -163.84 139.5 6.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.631 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.51 -104.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -124.63 53.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -138.4 154.26 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.18 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.41 144.84 32.21 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.59 131.73 34.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -114.82 98.95 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.5 mp0 -66.83 -19.06 65.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.637 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.59 -31.51 70.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.909 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 33.8 p -129.29 -18.24 3.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.61 ' CE1' ' CD2' ' A' ' 179' ' ' PHE . 2.4 t60 83.81 54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.1 151.34 42.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 174' ' ' LEU . 2.6 t -122.51 151.62 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.586 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.55 130.65 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.3 OUTLIER -127.78 111.36 13.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.68 71.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.83 43.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 167' ' ' LYS . 18.7 tp60 -132.19 93.45 26.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.18 139.1 21.01 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.968 1.779 . . . . 0.0 112.558 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.18 140.28 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.633 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 m -91.2 87.26 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.429 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -96.65 136.01 37.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.671 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 173.01 6.24 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.7 -52.25 9.43 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.26 1.973 . . . . 0.0 112.176 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -56.42 19.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.227 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -58.45 -38.68 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.61 ' CD2' ' CE1' ' A' ' 163' ' ' HIS . 13.1 t80 -61.75 -46.69 88.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.384 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -58.66 -41.57 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.42 -46.88 83.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.835 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.98 -39.79 87.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.486 ' NH1' HD11 ' A' ' 187' ' ' ILE . 59.1 ttt-85 -58.24 -45.22 88.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.849 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.415 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 4.5 t80 -69.65 -39.29 77.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.2 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -40.97 83.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.627 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.17 -45.33 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.814 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.486 HD11 ' NH1' ' A' ' 183' ' ' ARG . 70.5 mt -58.17 -34.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.415 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 63.1 m-20 -109.26 25.21 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.486 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.57 117.52 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.5 27.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.26 128.74 42.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.897 0.379 . . . . 0.0 110.792 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.69 114.25 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.529 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.62 156.78 16.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.747 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.24 147.91 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 3.7 mttp -58.94 -43.99 98.33 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.316 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 39.5 Cg_exo -54.64 -50.0 14.87 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.367 2.045 . . . . 0.0 111.875 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -62.22 -55.97 23.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 202' ' ' VAL . 2.9 mt -47.88 -43.98 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.934 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.93 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.89 -30.48 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.336 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -72.5 -48.15 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -83.39 -60.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.454 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -53.41 -4.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.1 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttt180 -62.13 -4.22 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.594 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.02 -4.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -98.73 -27.23 14.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.255 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.454 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 13.1 t -66.13 -41.33 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.77 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -53.24 -49.76 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.47 -47.07 87.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.242 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 73.7 m -61.07 -43.87 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.09 -40.62 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.656 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 214' ' ' VAL . 71.1 t -62.41 -42.43 95.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.593 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -43.45 96.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -69.3 -30.43 68.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.35 -45.98 68.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.117 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 2.1 mtp180 -56.89 -44.93 82.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.59 -16.75 63.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -94.98 -29.45 14.63 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.683 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.28 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 110.713 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -110.19 137.49 47.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.593 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.52 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.01 -178.63 17.53 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.0 -15.42 63.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 110.649 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -91.58 111.78 23.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -86.01 136.07 33.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.393 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -88.21 -75.4 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.01 146.27 24.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -102.29 138.49 39.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.943 0.402 . . . . 0.0 110.856 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 45.1 m -95.4 110.54 22.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.979 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.61 70.81 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -40.57 120.68 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.39 -16.83 29.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.49 -53.14 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.281 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.09 -138.21 5.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.74 156.32 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.634 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.1 p -134.33 132.13 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.72 117.01 29.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 232' ' ' LEU . 4.9 ptm180 -162.8 132.04 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.994 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -125.41 124.25 41.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.92 154.81 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 153.65 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.512 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 154' ' ' ALA . 68.7 t80 -166.75 135.84 2.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.515 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.98 -105.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -124.47 53.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.52 145.86 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.221 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 19.7 tt0 -141.1 143.12 34.13 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.458 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 165' ' ' VAL . 4.2 mp -140.35 128.86 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.91 105.3 13.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.108 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -65.86 -20.6 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.14 -39.04 84.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 110.665 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 70.3 p -115.9 -24.64 8.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.41 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.591 ' NE2' ' CE2' ' A' ' 179' ' ' PHE . 2.2 t-80 82.77 48.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.281 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -121.77 158.6 28.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.475 HG21 HD12 ' A' ' 174' ' ' LEU . 2.9 t -120.61 150.42 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.679 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.401 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.46 125.19 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.468 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 170' ' ' GLN . 8.7 tttt -125.61 117.39 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.33 64.13 0.2 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.272 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.25 30.67 67.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 167' ' ' LYS . 12.9 tt0 -133.99 92.92 21.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -76.96 136.41 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.927 1.751 . . . . 0.0 112.448 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.34 143.58 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.937 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.2 p -99.47 87.47 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -95.45 154.18 17.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.364 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.0 168.31 23.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -48.8 -53.18 7.33 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.701 2.267 . . . . 0.0 112.572 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -47.59 85.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.91 -39.21 93.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.245 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.591 ' CE2' ' NE2' ' A' ' 163' ' ' HIS . 9.0 t80 -63.66 -48.61 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.682 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -55.49 -43.28 75.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -47.07 85.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.36 -42.37 99.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.639 ' HE ' HD11 ' A' ' 187' ' ' ILE . 7.4 ttp180 -59.96 -45.7 91.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.04 -42.68 89.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.825 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -45.38 71.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.81 -49.29 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.639 HD11 ' HE ' ' A' ' 183' ' ' ARG . 56.6 mt -56.53 -31.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -107.17 15.23 25.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -49.69 120.35 4.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.87 -28.89 8.94 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -93.9 131.62 39.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 192' ' ' VAL . 9.0 p -69.13 122.24 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 193' ' ' LEU . 11.1 mp -95.39 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.501 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 149.23 31.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.584 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 13.3 mttp -55.68 -54.35 52.56 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.242 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.0 Cg_endo -66.99 -32.9 33.97 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.047 1.831 . . . . 0.0 111.768 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -47.49 71.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.772 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.02 -44.96 76.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.361 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.4 mt -61.77 -61.52 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.482 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.2 -38.91 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.995 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -72.01 -51.01 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.212 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 204' ' ' ARG . 37.7 t -83.6 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.234 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -51.29 -3.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.032 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp85 -62.46 -1.33 0.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.671 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 205' ' ' TYR . 42.7 t80 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.781 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.667 ' OD1' HG23 ' A' ' 213' ' ' VAL . 23.3 p30 . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.55 -6.5 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -88.47 -23.17 23.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.755 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.667 HG23 ' OD1' ' A' ' 210' ' ' ASP . 48.0 t -65.43 -39.29 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.027 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 218' ' ' VAL . 74.9 t -56.86 -50.75 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.251 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -55.56 -48.5 74.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.39 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -43.25 97.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -43.97 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.625 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.2 t -62.1 -41.45 91.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.609 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.92 89.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.527 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.31 -27.15 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 218' ' ' VAL . 16.3 mt -76.0 -45.31 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.054 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.44 -46.19 80.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.664 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -66.9 -23.14 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.414 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -92.46 -24.33 18.85 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.565 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.67 -41.18 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.83 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.9 137.61 39.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.544 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 227' ' ' THR . 0.8 OUTLIER -174.37 37.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.89 179.91 18.86 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -73.45 -8.65 56.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.759 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -92.19 112.08 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.568 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.97 155.85 20.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.59 -38.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.523 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.34 120.15 40.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -101.68 128.87 47.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.417 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 109.04 20.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.36 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' ARG . 38.1 mt -94.35 69.11 3.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LEU . 40.8 mtm105 -41.07 110.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 124.01 -20.44 7.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.83 -46.66 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.62 -137.07 5.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 1.7 m-85 -125.21 157.12 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.643 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.5 p -143.0 128.94 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 244' ' ' ARG . 0.7 OUTLIER -90.51 142.47 27.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.406 ' H ' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.9 136.29 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.667 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.835 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.4 mtm-85 -136.89 123.66 21.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.77 152.27 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.507 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -141.88 157.18 45.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.732 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.2 t80 -162.95 127.73 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.87 -98.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 10.2 p30 -125.07 54.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.35 147.23 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.201 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.75 137.23 31.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.534 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.05 137.37 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.551 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.78 108.48 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.455 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.586 ' OE2' ' NH1' ' A' ' 183' ' ' ARG . 25.4 mm-40 -66.52 -10.61 46.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.07 -42.86 8.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.067 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 163' ' ' HIS . 32.7 p -100.89 10.13 41.49 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 162' ' ' THR . 39.0 t-80 36.24 50.94 0.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -124.22 155.36 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 166' ' ' TRP . 13.3 t -117.14 159.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.449 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -146.07 129.24 16.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.3 tptp -127.81 110.25 12.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.42 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.57 67.95 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.74 31.45 64.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 167' ' ' LYS . 34.2 tp60 -142.01 87.92 9.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.35 146.42 80.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.115 1.876 . . . . 0.0 112.008 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -128.94 136.8 58.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.734 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.8 m -92.89 86.95 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.37 152.19 18.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.44 169.23 18.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.95 -54.15 4.94 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 112.185 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 p -54.98 -57.35 12.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.021 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -57.48 -39.14 75.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.655 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -63.95 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.753 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 m -59.07 -39.66 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.19 -45.24 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.685 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 tp -63.85 -39.44 94.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.518 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.586 ' NH1' ' OE2' ' A' ' 160' ' ' GLU . 12.5 ttt180 -64.11 -44.8 91.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -62.84 -40.71 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.959 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.56 -45.15 99.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.777 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.8 mt -58.97 -37.05 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -108.9 28.59 8.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 118.91 5.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.504 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.56 -21.04 22.07 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -96.01 131.68 42.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.674 0.273 . . . . 0.0 110.724 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.6 p -68.62 117.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.308 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.46 150.66 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.08 148.0 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.963 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 1.7 mttp -58.67 -46.43 99.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.1 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 45.5 Cg_exo -50.15 -51.65 10.51 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.024 1.816 . . . . 0.0 111.989 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.98 -55.23 27.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.321 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -49.17 -41.18 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.943 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' A' ' 214' ' ' VAL . 30.2 tp -61.43 -67.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.8 -16.78 7.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.133 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -71.11 -52.05 21.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.66 -44.3 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.4 m-90 -65.18 -5.72 7.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -2.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.82 0.343 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.4 p -79.71 -6.0 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.8 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.92 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 199' ' ' LEU . 17.9 t -61.66 -48.62 87.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.415 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -52.63 -48.61 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.699 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.3 t -61.8 -48.32 81.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.38 -42.08 81.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.64 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 t -62.88 -46.32 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -43.92 92.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -33.31 74.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -46.19 75.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.081 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 18.2 mtp85 -56.17 -45.11 79.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -67.77 -24.82 65.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.542 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -93.19 -24.41 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.38 -36.4 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 5.4 t0 -98.59 138.49 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 -36.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.542 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.09 165.29 16.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -70.42 -8.33 50.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.855 0.36 . . . . 0.0 110.418 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.88 122.27 34.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -82.28 157.58 23.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.33 -41.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.073 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.1 112.92 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.451 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.561 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.2 m -96.27 108.55 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.194 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 237' ' ' ARG . 7.9 mt -95.41 69.75 3.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -35.57 127.0 0.64 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.104 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.57 39.97 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.16 -49.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.939 0.399 . . . . 0.0 110.204 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.85 -139.51 7.15 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.51 154.02 48.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.54 133.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.68 126.74 36.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.641 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -161.78 135.73 6.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.764 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.728 0.299 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -175.17 154.93 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.954 0.407 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -91.98 147.69 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.1 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -141.96 158.1 44.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.46 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CE2' HD21 ' A' ' 243' ' ' LEU . 74.8 t80 -168.65 142.9 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.05 -105.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -124.83 52.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.73 152.38 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.581 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -145.79 144.39 30.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.634 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.65 124.73 21.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.845 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.4 m-20 -104.39 105.24 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.775 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.4 -11.6 52.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -95.03 -39.58 10.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.633 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.9 p -103.84 8.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 74.9 m-70 37.52 47.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.21 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -121.82 157.05 31.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.749 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.05 152.04 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.81 125.65 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -126.18 115.41 19.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.547 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.48 56.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.5 75.5 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 167' ' ' LYS . 44.1 mt-30 -131.07 96.27 22.78 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.27 137.79 15.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.087 1.858 . . . . 0.0 112.469 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.27 137.39 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.9 t -89.96 89.2 7.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.02 155.64 16.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.82 171.64 10.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -51.5 -52.16 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.302 2.002 . . . . 0.0 111.675 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.0 m -56.3 -52.08 65.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.956 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.92 -41.7 87.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.459 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 27.0 t80 -60.98 -44.58 97.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.101 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -58.0 -44.84 87.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.636 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.63 HD12 HG21 ' A' ' 202' ' ' VAL . 0.7 OUTLIER -61.45 -44.37 97.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.804 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -43.67 93.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -59.07 -45.16 91.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.55 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 14.1 t80 -65.34 -42.02 93.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.82 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.6 -39.72 68.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.66 -49.31 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.099 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 187' ' ' ILE . 43.6 mm -57.3 -32.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.745 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.91 18.17 21.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.56 114.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.709 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.07 -19.26 18.04 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 193' ' ' LEU . 94.4 m -95.78 132.45 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.87 115.47 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 191' ' ' THR . 4.6 mp -96.58 159.97 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.023 0.44 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 147.72 28.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.58 -54.8 51.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.062 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.9 Cg_endo -66.84 -33.64 33.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.96 1.773 . . . . 0.0 111.693 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -64.28 -51.64 62.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.09 -41.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.87 -66.9 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -49.91 -28.24 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.101 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 69.9 t60 -72.19 -57.54 4.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.63 HG21 HD12 ' A' ' 181' ' ' LEU . 57.3 t -83.42 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.378 . . . . 0.0 111.613 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.7 OUTLIER -49.12 -4.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.4 ttm180 -59.31 -0.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.072 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.6 m -79.05 -8.26 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.894 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -82.97 -14.82 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 80.9 t -68.75 -36.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.2 t -57.93 -49.81 79.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.83 -44.62 90.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.066 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 m -60.84 -46.97 88.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.71 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.42 -41.45 98.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.615 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 214' ' ' VAL . 99.1 t -62.52 -43.33 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -45.53 91.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -28.96 68.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.05 -46.06 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 226' ' ' ASP . 32.9 ttm180 -56.03 -47.21 78.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.382 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -67.29 -15.56 63.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.504 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -93.45 -34.24 13.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.477 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.424 ' O ' ' CE ' ' A' ' 167' ' ' LYS . 2.1 pp -109.89 -36.14 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -98.42 141.79 30.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.337 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -161.4 25.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -117.93 169.03 13.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -65.89 -7.89 19.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.599 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 129.34 39.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.745 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.8 113.77 25.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.71 -4.82 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.102 0.477 . . . . 0.0 110.746 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.48 104.92 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.385 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 122.74 33.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.37 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.25 115.39 28.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 9.1 mt -96.1 69.17 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 31.5 mtp180 -35.84 128.19 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.738 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.68 -12.47 66.06 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.0 t -128.4 -60.26 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.88 -139.29 5.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -130.61 154.06 48.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.351 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 7.2 p -135.5 137.44 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.484 HD21 ' CE2' ' A' ' 153' ' ' PHE . 3.0 tp -91.92 116.9 29.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -162.27 144.47 11.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.837 0.351 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -123.43 121.51 35.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.87 159.5 16.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.36 153.94 47.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.981 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.9 t80 -160.26 125.16 3.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.472 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.62 -98.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' PHE . 13.5 m-20 -125.61 54.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.62 148.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.416 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.729 ' C ' HD12 ' A' ' 158' ' ' LEU . 1.8 mt-10 -138.98 133.23 31.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.556 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 157' ' ' GLU . 10.6 mp -128.6 140.17 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -113.07 102.39 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 0.0 110.376 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.0 -13.11 59.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -96.59 -50.08 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.824 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 50.3 p -94.08 11.86 28.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.504 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 96.5 m-70 36.27 53.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.87 157.37 29.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.428 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.18 156.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.39 128.2 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.456 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.5 ttpt -126.88 106.44 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.22 71.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.03 30.42 37.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.8 tt0 -140.95 85.9 12.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -63.42 154.07 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.411 2.074 . . . . 0.0 112.554 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.15 121.47 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.638 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 t -92.38 87.01 5.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.36 155.37 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -62.37 178.95 0.3 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.736 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 175' ' ' SER . 5.6 Cg_exo -67.6 -48.4 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.441 2.094 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.7 m -46.13 -54.18 9.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.298 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -43.68 84.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -55.8 -44.84 78.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -59.67 -46.99 87.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.575 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.77 -42.32 99.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.11 -46.12 90.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.743 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.55 -41.57 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.034 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.58 -43.78 88.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.72 -42.03 82.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.36 -53.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.92 -31.78 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.64 19.89 19.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.47 119.94 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.66 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.41 -25.83 10.14 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -94.16 126.38 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.7 p -68.56 120.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.29 157.62 15.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 148.62 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -56.41 -52.31 74.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.634 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.5 Cg_endo -63.83 -41.24 24.72 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.721 1.614 . . . . 0.0 112.155 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -60.91 -48.79 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.272 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.86 -40.47 71.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.917 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.531 ' O ' HD23 ' A' ' 199' ' ' LEU . 1.9 tt -56.68 -61.83 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.979 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -17.03 64.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.439 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.18 -45.6 63.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.581 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -84.53 -53.7 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.793 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' A' ' 205' ' ' TYR . 4.8 m-90 -64.01 -3.07 2.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.528 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -40.97 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 203' ' ' TRP . 6.4 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.869 0.366 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.49 -10.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.665 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -91.53 -23.11 20.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.34 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.397 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 218' ' ' VAL . 97.3 t -53.79 -48.0 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.35 -45.54 87.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.49 98.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -40.68 89.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.24 -41.29 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -44.3 88.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.0 -27.43 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.27 -48.76 32.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.105 0.479 . . . . 0.0 110.188 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 14.6 ttp180 -56.6 -51.32 69.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -67.05 -8.04 27.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -91.64 -37.46 13.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -117.54 -34.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.085 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -98.24 151.26 20.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.808 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.9 t -177.46 -30.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.209 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -65.38 174.02 18.66 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -67.08 -5.7 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.821 0.344 . . . . 0.0 110.795 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -92.96 104.77 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.477 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.6 107.31 18.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.56 -2.55 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.504 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.11 103.62 8.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.336 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 122.92 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 0.0 110.603 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.1 m -91.26 112.14 23.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.744 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.8 mt -96.29 70.12 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 236' ' ' LEU . 5.9 tpp180 -35.69 116.87 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.797 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.76 -9.97 40.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.9 -36.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.48 -137.39 8.89 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.8 150.75 51.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.24 141.08 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.08 116.57 28.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.135 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -162.2 127.5 3.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.646 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.5 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.99 0.424 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -135.85 128.94 31.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.19 149.12 21.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 156' ' ' ILE . 1.7 m -141.6 155.83 45.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.5 t80 -158.15 124.48 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.989 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -94.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 153' ' ' PHE . 4.1 m-20 -124.41 53.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.3 151.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.37 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -147.76 140.7 24.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.576 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.89 138.92 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.424 ' CB ' ' OG1' ' A' ' 162' ' ' THR . 12.8 m-20 -111.36 106.37 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.382 . . . . 0.0 110.489 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -9.95 38.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.064 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.96 -47.37 4.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.015 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.0 p -94.73 8.48 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.768 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 162' ' ' THR . 12.7 m80 36.53 55.35 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -128.64 154.13 46.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.486 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.57 152.84 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.95 126.71 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.799 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 170' ' ' GLN . 10.0 tmtt? -130.13 115.69 17.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.341 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.04 67.88 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 56.7 29.47 58.19 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.1 tt0 -132.09 89.4 38.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.98 132.0 12.5 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.08 1.853 . . . . 0.0 112.475 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 135.56 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.741 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 96.51 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.7 148.19 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.562 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.31 169.85 18.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -54.18 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -49.44 77.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -60.71 -38.76 86.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.1 -46.39 87.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -63.13 -41.19 99.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 202' ' ' VAL . 1.1 tp -57.8 -48.87 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.1 -44.99 87.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.553 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -55.39 -42.69 74.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.49 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 8.1 t80 -68.53 -43.92 75.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.488 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.77 -41.39 73.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.5 -48.68 79.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.94 -32.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.791 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.49 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 51.8 m-20 -106.45 23.12 14.7 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.093 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.51 116.6 3.2 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.31 10.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.9 m -91.76 129.4 37.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 110.291 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 242' ' ' VAL . 68.8 t -67.57 121.28 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.1 162.69 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.96 147.96 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.1 mtmt -58.21 -54.75 52.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.252 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.6 Cg_endo -68.85 -30.64 26.49 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.923 1.749 . . . . 0.0 111.819 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -67.41 -50.73 58.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.933 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.9 mt -57.16 -39.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 210' ' ' ASP . 5.7 tt -59.47 -67.88 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.342 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -25.55 3.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -50.67 27.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.841 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 204' ' ' ARG . 98.9 t -83.28 -59.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.657 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.534 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -52.73 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.5 tpp180 -53.54 -4.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 203' ' ' TRP . 14.2 m-85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 m-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.2 p -84.15 -9.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.771 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -90.41 -23.94 20.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.771 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.18 -41.17 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.516 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.87 -50.58 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.327 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -56.64 -46.55 80.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -44.85 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.794 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.88 -38.84 89.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.62 -39.96 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.32 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -44.68 78.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.184 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -69.72 -14.15 62.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.4 -46.82 9.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.939 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.1 mtt-85 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -66.08 -14.5 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -93.13 -27.06 17.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.897 ' O ' HD12 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -118.25 -45.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.592 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.3 t70 -93.67 137.1 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.005 0.431 . . . . 0.0 110.642 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.6 t -179.23 36.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.161 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -143.21 165.39 27.03 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.48 -3.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 228' ' ' GLY . 24.6 mttt -93.46 133.01 37.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.633 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -92.81 158.9 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.365 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.8 mt -147.21 -55.43 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.308 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.42 126.79 48.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.503 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.494 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.81 125.08 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.51 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 112.4 24.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.447 HD12 HG13 ' A' ' 192' ' ' VAL . 68.9 mt -96.22 67.82 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.67 115.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 -12.34 24.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.03 -55.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.512 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.83 5.69 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.5 152.45 49.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.718 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 192' ' ' VAL . 5.9 p -136.03 131.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.184 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -91.88 128.7 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -162.89 138.2 6.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.296 179.813 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.713 0.292 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.558 HH12 ' CG ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -172.07 -178.32 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.532 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.49 154.07 41.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.6 m -139.29 156.7 46.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 156' ' ' ILE . 37.1 t80 -161.59 132.58 5.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.98 -102.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -121.38 52.48 1.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.85 141.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.213 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.558 ' CG ' HH12 ' A' ' 150' ' ' ARG . 15.8 tt0 -140.05 134.03 30.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 110.401 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.663 HD23 HG22 ' A' ' 165' ' ' VAL . 1.3 mt -130.28 136.61 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 163' ' ' HIS . 83.3 m-20 -113.89 104.81 12.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.89 -27.76 68.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.789 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.64 -44.21 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 59.4 p -102.59 9.5 39.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.497 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CG ' ' C ' ' A' ' 162' ' ' THR . 12.6 p-80 37.13 55.2 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -126.85 158.92 35.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.794 HG21 HD12 ' A' ' 174' ' ' LEU . 18.4 t -121.75 155.01 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.648 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.41 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.33 125.19 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.5 tttm -124.81 109.06 12.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.26 57.34 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.121 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.76 29.15 71.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 167' ' ' LYS . 27.6 mt-30 -141.74 89.96 8.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.788 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -64.71 147.19 89.73 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 112.129 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.96 136.45 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -88.55 87.72 7.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 165' ' ' VAL . 5.9 mt -94.29 144.67 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.29 162.96 54.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.514 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.7 -53.83 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.51 2.14 . . . . 0.0 112.427 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 p -59.93 -50.04 75.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.78 -34.53 77.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.71 -46.32 79.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -58.12 -43.92 87.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 mt -58.19 -48.35 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.64 89.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -57.74 -44.79 86.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.558 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -66.23 -43.36 86.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.62 -46.55 77.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.604 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.76 -46.01 95.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.85 -38.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -104.3 23.92 12.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.98 123.58 11.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.4 -27.59 13.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.61 129.87 38.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 123.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.352 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 198' ' ' ILE . 9.3 mp -94.68 157.32 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 148.98 29.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.361 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.7 mtpt -56.57 -53.97 58.59 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 37.1 Cg_endo -71.4 -32.49 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.963 1.775 . . . . 0.0 111.828 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -64.2 -50.49 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 193' ' ' LEU . 54.9 mt -56.91 -42.43 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.46 -63.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.21 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.34 -28.6 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -72.4 -52.01 17.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.303 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.0 t -82.94 -62.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.211 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -4.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.5 ttt180 -63.19 -3.89 2.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.892 0.377 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.448 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.971 0.415 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.5 -8.4 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -85.24 -15.83 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.888 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.55 -33.34 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.43 -50.31 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.216 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.11 -49.24 72.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -63.78 -39.97 95.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 241' ' ' TYR . 18.2 t -62.46 -42.58 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' NH1' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -62.79 -43.65 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.39 -37.66 85.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.255 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.22 -46.78 85.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.069 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.42 -42.66 78.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.97 -10.12 50.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -39.14 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.69 -30.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.208 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 222' ' ' ARG . 19.9 t0 -91.57 -160.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER 72.14 6.11 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.73 -139.59 5.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -36.91 11.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -92.5 120.45 32.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.018 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 19.4 mtp85 -90.5 92.75 9.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.971 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.9 OUTLIER -90.73 -0.91 57.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.82 110.18 12.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.48 42.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.639 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 74.9 m -97.63 113.45 25.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 237' ' ' ARG . 4.9 mt -98.95 67.76 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.646 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.6 mtm180 -37.49 125.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.838 0.351 . . . . 0.0 110.79 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.72 -32.86 6.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.55 -56.77 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.457 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.24 -137.46 4.94 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -128.39 157.07 42.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.37 142.4 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 111.074 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.86 118.02 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.053 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -161.76 129.78 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.023 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.861 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -138.59 130.05 27.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.64 140.61 29.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 m -142.09 152.37 43.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.1 t80 -166.25 139.11 3.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.03 -104.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.37 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.13 147.17 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.991 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -144.62 141.67 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.712 0.292 . . . . 0.0 110.428 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -135.52 136.74 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.388 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -112.02 108.49 17.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.288 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -66.27 -9.95 37.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.661 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -100.2 -43.75 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.916 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 25.6 p -95.74 9.04 41.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 162' ' ' THR . 10.9 m170 35.65 41.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.621 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -122.44 159.02 28.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.773 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.944 HG21 HD12 ' A' ' 174' ' ' LEU . 25.1 t -118.94 158.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.465 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -146.44 123.42 11.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.51 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.9 tmtm? -127.47 115.03 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.255 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.16 67.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.43 31.46 63.05 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -133.55 90.87 27.62 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.53 138.72 15.64 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.203 1.935 . . . . 0.0 112.36 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.18 138.74 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m -85.63 93.09 8.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.944 HD12 HG21 ' A' ' 165' ' ' VAL . 89.3 mt -95.91 140.86 30.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.454 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.13 174.03 6.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.95 -53.49 7.07 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.382 2.055 . . . . 0.0 112.097 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.0 m -54.96 -56.65 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.773 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.506 ' CD ' HD11 ' A' ' 221' ' ' LEU . 2.5 mt-10 -60.98 -37.24 81.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.49 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.74 -46.36 88.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.63 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -58.65 -41.0 85.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.795 HD12 HG21 ' A' ' 202' ' ' VAL . 1.0 OUTLIER -61.39 -52.53 64.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.658 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.8 -41.86 87.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.503 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -62.41 -44.53 96.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.417 ' OH ' ' CE1' ' A' ' 201' ' ' HIS . 1.3 t80 -59.25 -39.73 83.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.77 -41.15 99.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.185 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.65 -43.24 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.962 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.8 -42.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.12 26.91 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . . . -56.13 125.21 20.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.709 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.09 -23.5 30.5 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 126.8 41.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.821 0.343 . . . . 0.0 110.294 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 192' ' ' VAL . 13.6 p -68.25 116.66 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 mp -96.56 153.12 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.15 149.23 24.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.313 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.69 -46.69 99.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.506 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 37.2 Cg_exo -55.11 -47.14 28.02 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.867 1.712 . . . . 0.0 111.897 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -61.91 -57.32 12.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.5 mt -50.63 -36.24 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.19 -58.33 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.146 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.43 -27.53 68.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.814 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' CE1' ' OH ' ' A' ' 184' ' ' TYR . 0.2 OUTLIER -73.2 -59.83 2.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.623 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.795 HG21 HD12 ' A' ' 181' ' ' LEU . 13.9 t -84.54 -58.22 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.704 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.436 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 t-105 -51.76 -4.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.055 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.8 ttt-85 -64.24 0.33 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.591 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 m-85 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.608 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.8 m -80.82 -1.0 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.7 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -95.14 -23.72 17.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.15 -38.47 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -60.81 -44.6 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.85 -48.9 74.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -60.94 -44.18 97.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -40.44 97.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' VAL . 53.5 t -62.54 -41.56 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.485 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -44.87 94.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 110.211 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -65.15 -37.85 88.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' A' ' 178' ' ' GLU . 1.8 mp -65.56 -44.74 85.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.379 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 226' ' ' ASP . 21.7 mtp180 -55.28 -42.63 73.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -16.13 64.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -93.07 -26.63 17.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.509 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -117.87 -38.47 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.769 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.5 OUTLIER -98.3 136.67 38.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.503 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -173.27 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.872 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.25 179.87 0.73 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -79.39 -12.62 59.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.7 0.286 . . . . 0.0 110.716 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -93.66 122.19 35.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.563 ' C ' HD12 ' A' ' 232' ' ' LEU . 18.1 mmm-85 -82.67 158.35 23.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -146.78 -42.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.008 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.63 112.05 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.16 122.79 40.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.6 m -92.6 107.09 18.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.4 mt -93.21 71.8 4.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 57.5 mtp180 -36.78 133.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.644 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.23 74.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.12 -58.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.952 0.406 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 156.07 -139.61 6.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -129.17 154.6 46.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.551 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 242' ' ' VAL . 15.0 p -136.67 132.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.197 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.91 126.28 35.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -162.22 130.43 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.5 mtm-85 -106.33 -177.17 3.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.59 HD22 HG11 ' A' ' 186' ' ' VAL . 3.0 mt -145.94 133.3 20.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.205 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -139.23 156.86 46.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 8.8 t80 -164.92 130.85 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.89 -99.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 74.4 m-20 -124.45 53.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.43 144.39 30.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.349 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -140.29 131.0 25.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.946 0.403 . . . . 0.0 110.557 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.506 HD23 HG22 ' A' ' 165' ' ' VAL . 1.4 mp -127.49 152.2 47.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.34 107.63 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.3 -12.23 55.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -96.11 -49.71 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.3 p -92.57 11.18 27.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.479 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 15.0 m80 35.27 48.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -117.58 159.92 22.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 158' ' ' LEU . 14.5 t -125.43 150.09 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.428 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.3 127.09 14.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.512 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.8 tmtm? -129.45 114.13 15.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.88 71.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.55 24.82 32.93 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.9 tt0 -129.02 94.73 33.26 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.488 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.94 137.28 12.34 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.158 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.63 135.83 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.068 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 m -92.63 88.96 6.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.5 153.94 17.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.67 171.48 10.52 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.455 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.8 -54.07 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.492 2.128 . . . . 0.0 112.319 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.3 m -54.76 -54.25 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.75 -38.01 83.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 110.756 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 22.5 t80 -63.57 -43.21 97.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.6 m -62.42 -43.46 98.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -59.35 -43.91 92.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 182' ' ' LEU . 38.4 tp -71.36 -38.47 71.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.659 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.474 ' HE ' HD11 ' A' ' 187' ' ' ILE . 8.7 ttp180 -58.19 -41.24 83.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.691 ' CZ ' ' NE2' ' A' ' 201' ' ' HIS . 15.4 t80 -69.83 -39.85 76.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.804 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.61 -41.95 82.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 151' ' ' LEU . 56.4 t -67.9 -48.16 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.474 HD11 ' HE ' ' A' ' 183' ' ' ARG . 88.3 mt -58.64 -31.41 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -106.08 21.25 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.0 118.35 3.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.81 -19.62 35.38 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 m -98.27 126.97 43.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 192' ' ' VAL . 3.5 p -68.53 122.08 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 198' ' ' ILE . 5.2 mp -96.59 159.82 14.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 147.85 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.796 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.4 mtmm -56.84 -56.69 30.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -63.64 -32.67 68.84 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.013 1.808 . . . . 0.0 111.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -68.61 -51.72 39.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.951 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 193' ' ' LEU . 18.2 mt -53.0 -36.94 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.893 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 199' ' ' LEU . 0.9 OUTLIER -61.21 -70.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.422 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -52.18 -17.33 1.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.155 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.691 ' NE2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.57 -53.38 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.099 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.2 t -83.26 -40.42 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -60.67 -3.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 202' ' ' VAL . 25.9 ttt180 -61.41 -0.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.6 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.085 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.436 ' O ' HG12 ' A' ' 213' ' ' VAL . 15.3 m-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.901 0.381 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.2 m -83.4 -8.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -23.03 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 210' ' ' ASP . 2.4 p -63.56 -35.5 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 218' ' ' VAL . 98.8 t -57.16 -52.46 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.494 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.64 -45.5 91.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -44.84 96.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 110.735 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -61.52 -44.96 96.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 214' ' ' VAL . 87.4 t -62.24 -37.93 79.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.523 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -46.26 76.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.2 -17.41 63.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.389 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -49.19 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.069 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -55.75 -47.7 76.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.169 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -67.3 -13.04 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.553 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -95.05 -32.73 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.471 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.64 -34.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.222 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -100.08 140.04 34.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 110.69 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.23 -37.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -55.68 174.3 1.09 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.93 -9.4 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.799 0.333 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 104.64 16.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.655 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -83.69 112.59 20.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.486 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.83 1.05 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.09 107.11 12.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.25 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.548 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -92.63 123.37 35.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.618 HG23 ' CE2' ' A' ' 241' ' ' TYR . 67.9 m -90.96 111.2 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 237' ' ' ARG . 47.0 mt -95.85 68.27 2.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.467 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.4 tpp180 -38.52 124.26 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.25 -14.09 47.93 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.79 -56.79 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.632 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.19 -137.3 4.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG23 ' A' ' 235' ' ' THR . 29.4 m-85 -128.37 156.96 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 234' ' ' HIS . 5.2 p -140.55 133.55 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 2.6 tp -90.84 128.63 36.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -163.35 135.25 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.629 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.769 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.944 0.402 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.2 mtm105 -142.46 129.44 20.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.66 158.16 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.19 155.94 45.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.619 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 28.0 t80 -165.47 129.81 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.912 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.5 -99.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.1 m-20 -124.67 54.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.43 152.16 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.604 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.78 145.65 35.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.408 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -143.67 116.95 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.63 108.22 18.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.57 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -66.71 -24.95 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -50.59 -40.35 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 69.7 p -119.53 -23.9 6.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.5 t-80 84.02 53.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.384 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -127.39 156.82 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.654 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 t -117.0 153.76 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.44 126.95 15.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 170' ' ' GLN . 16.0 ttpp -126.04 113.07 16.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.13 67.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.016 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.46 32.81 64.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -137.56 92.14 13.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.89 139.96 20.04 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.095 1.864 . . . . 0.0 112.326 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.82 140.8 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.911 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -96.29 90.19 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.386 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.68 150.18 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.672 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 169.43 17.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.77 -54.53 4.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.533 2.155 . . . . 0.0 112.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.327 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -57.07 -37.2 71.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -59.3 -46.08 89.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.4 m -63.82 -41.1 97.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.284 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -46.7 84.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -45.33 86.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.712 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -60.24 -42.98 96.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.658 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 11.6 t80 -65.25 -40.35 93.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -43.01 89.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.684 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.31 -45.35 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.8 -34.65 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.753 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -106.64 22.33 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.682 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.95 110.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.9 -27.52 7.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.3 132.39 33.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.27 113.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.85 148.02 30.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.64 -51.34 82.42 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.544 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 24.4 Cg_endo -64.13 -37.84 39.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.601 1.534 . . . . 0.0 111.682 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -65.76 -44.84 84.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.052 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.85 -41.99 68.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' TRP . 5.0 mt -61.93 -65.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -41.4 -34.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.658 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 53.7 t-80 -71.76 -53.78 12.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.9 t -83.54 -57.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -53.16 -2.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.217 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -60.76 -3.1 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.567 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 39.0 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.605 ' O ' HG12 ' A' ' 213' ' ' VAL . 89.6 m-20 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.978 0.418 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.7 m -81.75 -6.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.562 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.22 -18.98 23.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.789 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 210' ' ' ASP . 7.0 p -65.93 -33.5 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 218' ' ' VAL . 58.7 t -65.28 -51.14 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.072 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.71 -46.01 70.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.982 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -48.55 81.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.47 -39.21 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.497 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.6 t -62.5 -42.23 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -25.48 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.24 -42.48 45.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 226' ' ' ASP . 44.5 ttt180 -55.79 -50.4 70.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.5 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -7.43 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.115 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -42.05 10.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.47 -25.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.398 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.555 ' C ' HG22 ' A' ' 227' ' ' THR . 0.2 OUTLIER -101.99 146.35 28.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.935 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 226' ' ' ASP . 0.1 OUTLIER -176.7 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.62 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -49.23 162.86 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.0 -8.12 34.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.01 126.6 38.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.56 ' C ' HD12 ' A' ' 232' ' ' LEU . 10.9 mtp180 -81.12 159.62 24.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -147.08 -41.17 0.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.969 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.9 114.67 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.476 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -97.9 124.32 42.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.534 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.56 114.61 27.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 238' ' ' GLY . 11.2 mt -95.88 68.72 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.161 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -41.87 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.162 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 236' ' ' LEU . . . 129.68 -13.28 5.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.55 -50.32 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.659 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.76 -137.71 5.46 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 151.65 50.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.2 p -140.04 127.65 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 16.4 tp -90.49 138.03 31.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.08 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 139.89 7.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.463 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.714 0.292 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -122.26 121.04 35.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mt -90.54 147.78 23.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.2 154.32 46.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.095 0.474 . . . . 0.0 111.094 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 155' ' ' ASP . 62.4 t80 -159.29 126.98 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.599 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.29 -96.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 1.2 p30 -124.34 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.56 145.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -144.21 138.68 28.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.787 0.327 . . . . 0.0 110.424 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.43 139.45 42.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.07 102.91 11.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 0.0 110.588 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.12 -8.94 26.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -99.0 -45.28 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.729 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.7 p -98.88 13.04 33.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.338 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 1.0 OUTLIER 35.12 54.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.635 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.26 152.49 48.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.25 157.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.35 125.85 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.479 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 19.2 tptt -122.9 110.53 15.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.397 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.58 59.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.483 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 23.65 77.72 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 24.5 mt-30 -131.86 95.99 21.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.402 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.49 134.92 14.3 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.082 1.855 . . . . 0.0 112.439 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.5 143.79 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.772 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.43 95.39 9.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.631 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 182' ' ' LEU . 10.9 mp -94.71 154.17 17.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.48 172.46 7.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.262 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.37 -51.27 11.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.459 2.106 . . . . 0.0 112.149 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.2 m -58.1 -54.61 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' A' ' 221' ' ' LEU . 24.8 mt-10 -55.77 -43.96 77.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.483 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.92 -48.56 81.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.526 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 m -56.77 -46.32 81.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.586 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.46 -47.05 87.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.69 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 174' ' ' LEU . 0.9 OUTLIER -63.51 -41.53 98.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -59.57 -45.2 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.388 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -61.62 -43.98 97.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.615 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -55.51 -47.86 75.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -47.06 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.019 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mm -54.9 -34.32 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.786 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -112.53 20.4 16.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.0 119.59 4.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.28 -26.28 10.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.6 m -97.82 129.59 44.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.803 0.335 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.672 HG22 ' HB ' ' A' ' 242' ' ' VAL . 43.7 t -67.89 117.01 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.651 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.64 160.03 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.667 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.97 148.84 26.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.63 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.503 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.06 -49.48 93.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 35.9 Cg_exo -54.08 -44.17 51.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.373 2.048 . . . . 0.0 111.778 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -59.93 3.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.4 mt -48.25 -42.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.49 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.502 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 17.0 t0 -53.7 -24.03 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.594 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 51.7 t-80 -71.84 -50.36 30.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.715 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.1 t -84.75 -62.17 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.489 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -49.35 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.337 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.7 ttp85 -60.9 -0.57 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.437 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 203' ' ' TRP . 12.2 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.916 0.389 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.66 -6.43 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.081 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -82.64 -18.21 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.392 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.99 -37.45 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.06 -49.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.868 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.35 -47.52 72.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.55 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.1 p -60.96 -47.52 86.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -38.56 91.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.0 -47.57 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.415 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -44.66 92.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.303 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.25 -23.3 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 178' ' ' GLU . 1.2 mp -76.73 -44.99 31.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.015 0.436 . . . . 0.0 110.151 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 226' ' ' ASP . 33.7 ttt-85 -55.44 -49.65 71.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.957 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -68.25 -7.52 31.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -94.38 -32.61 13.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.541 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.9 -7.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.124 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -116.09 138.25 51.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.006 0.431 . . . . 0.0 110.857 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 t -170.52 39.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.5 163.45 26.82 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.4 -5.61 11.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.733 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.98 104.48 16.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -86.81 101.26 13.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -89.44 1.87 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.588 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.92 96.46 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.57 125.83 34.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.718 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 44.3 m -95.83 112.32 24.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.65 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.6 mt -95.57 73.45 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.366 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 43.3 ttm-85 -35.92 128.03 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.55 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.46 61.21 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.2 -58.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 110.828 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.14 -138.1 5.6 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.485 ' OH ' ' NZ ' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -127.11 156.28 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 0.0 110.711 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.672 ' HB ' HG22 ' A' ' 192' ' ' VAL . 2.3 p -139.7 136.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.22 112.41 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.355 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -162.2 131.49 4.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.474 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -126.53 121.06 31.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.37 148.78 22.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -143.71 156.68 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.8 t80 -163.85 130.27 3.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.56 -97.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 153' ' ' PHE . 5.1 m-20 -124.85 53.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.12 146.26 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -143.37 137.38 28.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 165' ' ' VAL . 22.1 mt -132.53 134.59 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 162' ' ' THR . 1.1 m-20 -107.66 104.39 13.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.141 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.92 -11.6 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.722 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.47 -38.92 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 2.7 p -99.81 6.59 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.227 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.446 ' ND1' ' C ' ' A' ' 162' ' ' THR . 52.0 p-80 36.77 51.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -122.06 158.28 29.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 174' ' ' LEU . 32.5 t -128.4 147.69 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.39 127.51 15.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.5 tmtt? -130.78 112.46 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.268 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.47 68.98 0.11 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.055 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.15 57.34 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 167' ' ' LYS . 7.1 tt0 -130.64 90.83 39.35 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.25 142.58 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.92 1.747 . . . . 0.0 112.113 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.81 132.27 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.259 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 174' ' ' LEU . 28.0 t -95.33 119.91 34.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -142.61 135.06 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.711 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.21 175.2 0.42 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.824 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.46 -41.83 73.39 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.481 2.12 . . . . 0.0 112.601 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.37 -65.83 0.49 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 111.104 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 221' ' ' LEU . 8.6 mt-10 -60.09 -33.34 71.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.29 -50.39 73.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -41.33 85.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 202' ' ' VAL . 1.9 tp -58.81 -48.62 80.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.579 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -40.61 96.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.12 -45.13 91.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.498 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.585 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 26.5 t80 -65.65 -40.83 92.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -40.99 69.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.3 t -72.87 -42.99 60.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.43 -27.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.72 18.33 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.02 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.88 119.0 3.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.792 0.33 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.6 -26.6 10.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.9 m -94.72 130.15 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 242' ' ' VAL . 48.6 t -68.43 114.77 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 184' ' ' TYR . 2.6 mp -95.12 153.63 17.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.89 148.42 26.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 16.2 mtpt -56.12 -54.92 47.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.991 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.0 Cg_endo -64.81 -32.15 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.782 1.655 . . . . 0.0 111.922 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -66.87 -48.81 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.288 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.5 mt -55.7 -39.82 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.771 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.38 -66.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -49.26 -29.34 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.585 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.7 t60 -72.01 -48.48 44.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.078 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 204' ' ' ARG . 42.4 t -84.04 -59.86 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.554 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.5 OUTLIER -49.55 -4.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.604 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.7 ttp180 -61.92 -2.55 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.637 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 58.5 m-85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.56 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -87.9 -9.74 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.072 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -91.04 -22.75 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.3 p -65.68 -40.04 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.305 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.458 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 12.7 t -60.4 -46.19 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.131 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.91 -48.04 79.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -45.18 95.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.62 -40.88 98.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.755 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.6 t -62.42 -39.73 85.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -45.38 81.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -68.49 -17.17 64.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.489 HD11 ' HG2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -82.77 -47.98 11.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.676 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.9 OUTLIER -55.99 -38.55 70.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.471 179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -66.1 -29.15 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.504 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -28.56 15.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.659 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.17 -38.79 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.136 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 222' ' ' ARG . 9.2 t0 -100.27 -151.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 226' ' ' ASP . 68.6 p 54.07 10.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.499 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 226' ' ' ASP . . . -85.09 -136.07 3.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.18 -44.74 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.796 0.332 . . . . 0.0 110.269 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.537 ' HB3' HD21 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -96.14 107.26 19.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.581 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.481 ' CD ' ' H ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -82.87 91.15 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.72 ' O ' HD23 ' A' ' 243' ' ' LEU . 0.8 OUTLIER -91.9 -5.6 52.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.294 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.68 122.47 47.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.78 130.24 56.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.644 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.0 m -95.65 115.95 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.2 mt -95.92 77.16 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.29 119.97 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.78 -2.88 57.21 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.35 -58.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.77 -136.03 4.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 40.4 m-85 -127.59 153.96 45.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.749 0.309 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 192' ' ' VAL . 12.8 p -140.8 133.1 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.49 121.38 33.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.928 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -161.46 133.81 5.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.174 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.088 179.536 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -125.68 121.17 32.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.182 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.64 150.77 21.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 m -141.15 158.34 44.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 1.4 t80 -165.46 131.51 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.519 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 38.23 -99.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 19.3 m-20 -124.96 53.36 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.94 150.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.278 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -142.41 140.88 32.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.74 131.59 33.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.437 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -113.65 108.17 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.5 -9.65 36.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.19 -52.58 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.651 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 51.3 p -98.14 9.76 42.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.266 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 47.3 m80 37.12 59.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.777 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -132.63 153.81 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.56 HG21 HD11 ' A' ' 174' ' ' LEU . 46.8 t -115.71 151.81 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.232 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.19 125.49 13.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.5 tttp -124.99 115.12 20.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.36 56.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.378 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.39 23.76 75.04 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.2 mt-30 -132.29 101.6 14.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -76.77 136.78 17.26 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.82 1.68 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.16 139.25 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.91 121.68 40.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.416 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -141.06 140.68 34.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.765 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.87 173.46 4.77 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.98 -40.82 79.52 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.47 2.113 . . . . 0.0 112.576 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.7 m -51.11 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.62 -33.55 72.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.238 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -58.51 -52.79 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.9 m -57.6 -40.62 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 -47.16 85.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.58 -42.18 95.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.704 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -44.87 87.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 201' ' ' HIS . 2.5 t80 -66.35 -42.13 88.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.587 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.44 -41.78 77.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.73 -49.12 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.67 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.9 mt -55.82 -36.15 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.012 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -109.96 23.76 13.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.3 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.77 118.78 4.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.81 10.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.587 ' O ' HD12 ' A' ' 193' ' ' LEU . 11.5 m -90.01 129.6 36.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.05 120.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.552 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 191' ' ' THR . 4.9 mp -96.94 163.93 12.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.09 148.39 29.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.962 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 4.1 mttt -56.67 -54.02 58.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.078 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 28.4 Cg_endo -70.57 -31.99 15.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.913 1.742 . . . . 0.0 112.043 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.61 -46.43 85.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.216 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.65 -39.81 86.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.62 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 203' ' ' TRP . 8.5 tp -64.25 -50.31 68.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.643 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 13.4 t70 -64.73 -30.2 71.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.444 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.542 ' CE1' ' CE1' ' A' ' 184' ' ' TYR . 18.4 t-80 -72.0 -57.23 4.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.43 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.2 t -84.42 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.683 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.494 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.8 OUTLIER -50.12 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.681 -179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -67.08 -3.21 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.441 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.656 -179.907 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 212' ' ' ASN . 1.3 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.867 0.365 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 211' ' ' VAL . 90.4 t -64.02 1.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 210' ' ' ASP . 57.9 m-20 -100.17 -30.69 11.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.494 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 20.2 t -62.08 -39.43 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.87 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.002 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -53.45 -49.56 67.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -46.19 90.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.23 -38.88 90.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.29 -43.15 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.734 0.302 . . . . 0.0 110.585 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -42.93 85.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -71.6 -13.24 61.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.15 -48.74 9.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.807 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 70.1 mtt180 -56.67 -44.04 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.367 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -19.36 65.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.982 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -93.96 -28.55 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.364 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -109.37 -39.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.228 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.29 145.38 25.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.9 t -176.79 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -145.34 167.29 27.47 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.26 -6.45 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.721 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -92.72 104.59 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.858 ' O ' HD23 ' A' ' 232' ' ' LEU . 45.6 mtt85 -78.93 160.16 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 231' ' ' ARG . 4.7 mt -146.16 -36.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.24 111.88 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.607 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.16 129.88 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.329 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.497 HG23 HH22 ' A' ' 222' ' ' ARG . 0.2 OUTLIER -94.42 111.75 23.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' ARG . 3.8 mt -95.25 69.54 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.159 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' LEU . 3.7 ptt85 -35.09 128.28 0.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.95 -13.82 60.39 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.2 t -128.85 -58.17 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.416 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 159.42 -137.28 5.05 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.47 157.91 40.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.08 136.23 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.404 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 26.4 tp -93.05 118.91 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.505 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.67 131.01 3.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 0.0 111.04 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 179.701 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.757 0.313 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -140.78 132.93 27.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.77 151.56 21.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.82 156.84 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.0 t80 -166.06 125.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.86 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.3 p-10 -124.97 54.34 1.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.55 151.58 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.466 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.7 mt-10 -146.25 143.71 29.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.48 127.67 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.355 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.4 OUTLIER -113.33 103.15 11.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.839 0.352 . . . . 0.0 110.452 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.93 -12.48 55.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -71.63 -30.64 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 7.0 p -121.82 -25.39 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 162' ' ' THR . 4.9 t-80 83.13 47.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.871 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -124.26 160.09 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 166' ' ' TRP . 31.8 t -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.405 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -146.23 125.42 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.854 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.7 tmtt? -130.05 117.65 20.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.374 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.98 70.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.04 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.02 34.69 52.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -136.68 91.31 15.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.554 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.81 137.82 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.316 2.011 . . . . 0.0 112.12 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.72 131.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 91.74 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.68 150.97 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.777 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 168.67 25.26 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.189 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.44 -53.9 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.408 2.072 . . . . 0.0 112.309 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -55.84 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -61.96 -38.48 88.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -48.34 82.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.2 m -58.97 -39.05 80.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.85 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.708 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.31 -42.58 91.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CE2' HD21 ' A' ' 193' ' ' LEU . 24.8 t80 -68.69 -41.13 79.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.43 ' CD1' HD13 ' A' ' 243' ' ' LEU . 1.2 m-85 -54.6 -43.81 72.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.8 -46.07 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.91 -38.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -107.87 26.57 10.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.86 117.64 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.664 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.37 -27.18 12.92 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.61 130.36 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.64 114.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.538 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 184' ' ' TYR . 3.9 mp -97.25 158.2 15.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.33 147.39 31.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.292 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -58.06 -52.99 70.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.208 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -62.84 -31.97 77.68 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.746 1.631 . . . . 0.0 112.2 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -68.9 -49.99 53.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.054 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 193' ' ' LEU . 7.4 mt -55.91 -36.93 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.196 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.22 -70.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.787 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.534 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 0.0 OUTLIER -54.2 -23.87 16.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.512 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.596 ' ND1' HG23 ' A' ' 202' ' ' VAL . 10.0 t-80 -73.9 -60.09 2.42 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.612 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.596 HG23 ' ND1' ' A' ' 201' ' ' HIS . 99.4 t -85.82 -61.52 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -53.45 -3.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 200' ' ' ASP . 0.6 OUTLIER -63.16 -3.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 C--N 1.33 -0.279 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.703 -179.822 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.74 0.305 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 211' ' ' VAL . 9.0 p -82.28 -8.01 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -99.99 -29.22 12.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 2.5 p -66.28 -39.74 85.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.638 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.455 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 25.0 t -56.41 -50.5 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.106 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.03 -48.52 78.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.278 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -45.15 93.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.434 ' O ' HD13 ' A' ' 221' ' ' LEU . 2.4 m-85 -63.63 -41.83 98.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.28 -41.39 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.2 t -62.59 -47.93 81.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -33.45 75.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.369 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 217' ' ' TYR . 2.9 mp -67.32 -46.67 72.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.341 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.46 -44.18 76.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.316 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -66.53 -24.67 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -91.88 -28.41 17.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.677 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.99 -40.56 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.341 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -102.82 141.05 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -40.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.783 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.11 173.21 6.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.32 -7.04 16.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -92.55 104.95 17.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -86.83 106.98 18.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.1 mt -88.5 -0.36 57.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.546 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.93 113.22 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 123.17 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.488 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.0 m -88.28 114.33 24.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.774 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 237' ' ' ARG . 6.9 mt -96.75 72.99 2.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.23 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 236' ' ' LEU . 22.7 mtp180 -39.25 110.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.79 -16.24 13.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.71 -47.46 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.45 -137.28 6.17 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.18 152.39 48.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.383 . . . . 0.0 110.608 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.16 141.14 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' A' ' 185' ' ' PHE . 1.3 tp -91.43 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -162.02 134.03 5.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.868 0.366 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -104.81 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.434 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mt -146.09 134.85 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.571 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -137.51 155.78 48.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 111.069 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.552 ' HB2' HG13 ' A' ' 186' ' ' VAL . 87.3 t80 -165.39 139.0 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.519 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.46 -104.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.924 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.5 OUTLIER -124.66 53.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 155' ' ' ASP . 2.4 mm -137.52 146.56 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.921 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.43 131.28 29.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 147.27 48.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.433 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.8 m-20 -131.15 107.89 9.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.35 -38.32 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.772 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -51.45 59.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.533 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 4.6 p -106.58 13.15 28.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.119 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 162' ' ' THR . 9.3 p80 38.52 56.09 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.683 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -119.68 161.24 21.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.536 HG21 HD12 ' A' ' 174' ' ' LEU . 4.3 t -124.5 157.86 31.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.99 125.24 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -122.71 108.76 13.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.31 67.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.057 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.86 83.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 167' ' ' LYS . 14.2 tt0 -137.04 87.35 18.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.92 132.87 13.28 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.298 1.998 . . . . 0.0 112.669 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.7 147.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.27 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m -92.63 88.35 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.287 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.536 HD12 HG21 ' A' ' 165' ' ' VAL . 35.8 mt -96.0 155.81 16.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.32 170.69 8.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.26 -53.72 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 112.135 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -57.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.073 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.678 ' OE2' HD11 ' A' ' 221' ' ' LEU . 1.4 mm-40 -62.88 -39.71 95.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.16 -42.82 95.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.8 m -61.25 -45.61 93.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.49 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.635 ' O ' HD23 ' A' ' 181' ' ' LEU . 1.5 tt -57.2 -43.95 83.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 186' ' ' VAL . 2.1 mp -66.02 -46.18 78.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.267 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -58.13 -42.98 87.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.405 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.19 -44.97 94.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.516 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -62.83 -41.93 99.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 110.771 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 182' ' ' LEU . 65.8 t -57.68 -52.66 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.394 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.42 -29.53 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.356 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -106.1 19.6 20.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.712 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -53.17 119.57 4.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.92 -23.76 20.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.1 m -92.18 125.29 36.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.3 p -69.1 118.08 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.95 149.14 22.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.7 p -99.88 149.44 23.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.53 -44.84 99.8 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.501 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 31.8 Cg_exo -52.94 -52.41 8.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.912 1.742 . . . . 0.0 111.996 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.67 -51.96 67.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.45 -42.98 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.179 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.41 -65.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.3 -16.04 30.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -49.87 31.7 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.11 -43.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.075 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.461 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -62.82 -3.97 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -57.66 -4.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.491 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.4 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 213' ' ' VAL . 43.9 m-20 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.828 0.347 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.0 -14.68 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -85.39 -17.47 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 210' ' ' ASP . 5.2 p -67.33 -38.1 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 218' ' ' VAL . 85.6 t -59.7 -50.69 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -54.93 -47.06 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.536 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 9.7 p -60.21 -49.47 77.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.655 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -61.63 -41.01 96.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 214' ' ' VAL . 66.3 t -62.46 -45.26 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.3 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -43.8 98.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.194 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -32.83 73.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.678 HD11 ' OE2' ' A' ' 178' ' ' GLU . 2.1 mp -66.26 -47.47 73.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 109.999 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.0 OUTLIER -54.89 -46.21 74.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.147 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -15.22 63.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.417 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.422 ' CE ' HD21 ' A' ' 174' ' ' LEU . 33.9 mtpt -95.07 -27.11 15.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.38 -13.53 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.32 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -111.92 138.21 48.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.372 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -175.37 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -48.74 168.94 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.59 -13.08 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.978 0.418 . . . . 0.0 109.962 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -93.21 151.86 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.897 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -93.08 158.96 15.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 245' ' ' GLU . 90.6 mt -147.03 -50.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 242' ' ' VAL . 1.1 mt -94.98 119.86 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 130.29 45.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.64 108.82 20.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.2 mt -98.72 69.4 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.753 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -37.28 126.55 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.567 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.86 -7.58 62.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.41 -46.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.48 -137.33 7.48 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -127.89 152.81 47.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.31 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.459 ' O ' HD23 ' A' ' 233' ' ' LEU . 11.1 p -136.62 135.95 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.964 0.411 . . . . 0.0 110.785 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.98 118.9 31.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.569 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -162.28 115.75 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 232' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.862 0.363 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.467 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -175.27 145.57 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.369 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.909 HD23 HH12 ' A' ' 183' ' ' ARG . 2.6 mm? -92.43 151.6 20.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -142.05 156.95 45.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 243' ' ' LEU . 70.7 t80 -167.03 140.14 3.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 34.41 -102.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 23.8 p-10 -124.3 52.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -138.08 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.467 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 13.9 tt0 -145.71 144.05 30.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 110.631 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.527 HD21 HD23 ' A' ' 182' ' ' LEU . 1.0 OUTLIER -137.37 116.88 12.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.955 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.15 101.87 11.61 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.849 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -24.14 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.29 -32.3 56.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 34.1 p -127.5 -20.7 3.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.1 t60 82.14 52.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -122.51 156.45 34.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 174' ' ' LEU . 2.7 t -121.12 151.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.143 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.73 125.24 13.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.419 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -127.13 113.11 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.259 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.77 70.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.234 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.67 26.72 47.19 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 167' ' ' LYS . 3.1 tp60 -130.8 92.36 34.43 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.42 133.43 11.86 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.948 1.766 . . . . 0.0 112.195 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.93 138.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.576 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 75.2 m -89.58 88.32 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 165' ' ' VAL . 71.9 mt -95.38 149.31 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.563 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.8 172.86 8.06 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -52.1 -55.3 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.394 2.063 . . . . 0.0 112.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.4 m -51.06 -52.5 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.55 -44.05 97.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.0 m -61.37 -45.51 94.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.86 -43.69 92.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.004 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.527 HD23 HD21 ' A' ' 158' ' ' LEU . 29.6 tp -63.25 -39.13 93.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.909 HH12 HD23 ' A' ' 151' ' ' LEU . 3.3 ttt85 -65.09 -42.56 93.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.719 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.674 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 10.6 t80 -62.29 -44.57 96.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.6 -44.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.0 -47.68 87.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.88 -28.79 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -108.83 20.42 18.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.46 120.92 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.75 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.21 -23.28 23.38 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.544 ' O ' HD12 ' A' ' 193' ' ' LEU . 32.3 m -98.17 124.64 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.3 p -69.42 122.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 191' ' ' THR . 5.5 mp -96.8 165.86 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' SER . . . . . 0.422 ' OG ' ' CG ' ' A' ' 197' ' ' LYS . 1.1 p -109.77 151.11 27.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.03 -54.45 50.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.915 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 21.1 Cg_endo -66.4 -32.12 41.37 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.365 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.422 ' CG ' ' OG ' ' A' ' 194' ' ' SER . 18.9 mmtt -64.06 -58.44 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.2 -40.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.41 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.75 -64.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.67 -29.23 25.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.674 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 79.6 t60 -71.14 -48.59 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.159 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 204' ' ' ARG . 77.6 t -83.96 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.41 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.81 -2.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.294 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.7 ttp180 -61.17 -3.39 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.715 0.293 . . . . 0.0 110.68 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.4 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.544 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.83 -8.75 11.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.26 -16.42 40.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.2 p -68.9 -38.53 78.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.826 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 40.9 t -58.86 -47.85 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.527 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.14 -47.29 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.229 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 m -59.8 -43.72 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -43.39 98.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.1 -41.43 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.49 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -46.9 85.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.762 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.67 -21.9 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.642 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.82 -46.38 18.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.217 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.6 mtp180 -56.05 -47.09 78.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.974 0.416 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -66.16 -11.27 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.537 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -92.09 -46.06 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.36 -27.42 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.31 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 4.6 t70 -94.78 143.31 26.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.742 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER 173.81 -27.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.513 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -50.43 162.63 0.97 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.51 -7.65 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 0.0 110.199 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -93.13 149.58 21.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -92.24 154.15 18.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.235 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 243' ' ' LEU . 74.8 mt -147.35 -51.27 0.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.41 110.65 23.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.143 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.441 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -93.21 122.45 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.899 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.4 m -90.5 109.47 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.481 HD12 ' CG2' ' A' ' 192' ' ' VAL . 16.1 mt -95.62 70.54 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -39.45 125.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 -13.75 40.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.5 -59.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.569 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.43 -138.06 5.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -127.79 160.98 30.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.424 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.7 p -143.88 128.8 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.4 tp -91.73 137.5 32.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 128.09 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.506 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.47 ' NH1' ' OD2' ' A' ' 159' ' ' ASP . 24.1 mtt-85 -147.08 139.35 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.2 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 158' ' ' LEU . 1.6 mm? -89.46 157.35 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.68 157.7 45.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 110.86 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' A' ' 243' ' ' LEU . 3.5 t80 -164.18 127.16 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.476 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.47 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 13.7 p-10 -124.87 54.41 1.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.47 153.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.873 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -145.33 140.12 27.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.252 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.879 ' N ' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.43 138.83 36.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.714 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 162' ' ' THR . 62.8 t0 -111.54 105.67 14.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -8.22 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.176 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.41 -46.09 5.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.956 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.545 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 69.2 p -98.66 13.65 31.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.812 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 162' ' ' THR . 44.4 m-70 35.76 53.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.541 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -121.9 150.9 41.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.8 152.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.317 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.77 121.4 9.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.4 tmmt? -124.97 112.83 17.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.365 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.39 71.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.517 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.44 25.58 34.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.5 tt0 -131.08 94.68 27.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.13 132.6 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 112.276 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.12 144.21 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.709 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 t -95.21 94.66 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.66 154.0 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.172 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.22 172.14 8.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -50.3 -54.24 5.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.37 2.047 . . . . 0.0 111.931 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -57.46 -46.41 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.694 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -45.0 96.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -61.68 -45.33 94.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.8 m -58.16 -47.03 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 -43.94 92.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.7 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.46 -43.5 90.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.504 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -55.89 -45.25 78.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.579 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -65.06 -43.64 91.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.58 -42.84 88.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.649 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 151' ' ' LEU . 54.1 t -63.15 -47.68 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.625 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.72 -37.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -106.96 25.19 11.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.17 114.23 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.94 10.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.5 m -91.73 129.31 37.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 110.456 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.55 126.29 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.0 110.541 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -94.5 168.84 10.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.098 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.84 147.72 36.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 0.0 110.785 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 211' ' ' VAL . 6.7 mttm -56.85 -54.98 48.36 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.21 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.0 Cg_endo -65.7 -29.91 51.04 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.038 1.825 . . . . 0.0 112.426 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -70.18 -47.16 62.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.319 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.28 -38.01 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 109.978 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 199' ' ' LEU . 2.7 tt -60.96 -56.17 24.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.89 -16.6 63.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.071 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 46.4 t60 -71.76 -44.96 63.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.309 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 204' ' ' ARG . 24.5 t -84.24 -54.6 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 205' ' ' TYR . 3.0 m-90 -61.92 -3.22 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.703 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 34.4 ttp85 -44.95 -11.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 203' ' ' TRP . 17.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.35 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.595 ' O ' ' NZ ' ' A' ' 195' ' ' LYS . 2.9 m -86.42 1.5 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.841 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -96.49 -29.49 13.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.618 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.3 p -64.36 -38.89 83.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.303 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 17.6 t -60.56 -48.96 86.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.579 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.7 -44.58 85.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.166 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -60.46 -46.0 91.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.63 -38.76 87.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.899 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 214' ' ' VAL . 42.0 t -61.03 -41.06 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.51 75.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.51 ' OH ' ' NZ ' ' A' ' 224' ' ' LYS . 32.0 t80 -71.19 -10.17 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.057 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.44 -56.02 4.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.087 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.4 ptm180 -57.41 -40.48 78.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.313 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -11.21 57.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.51 ' NZ ' ' OH ' ' A' ' 220' ' ' TYR . 1.3 mmtp -93.2 -36.08 12.8 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.639 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.55 -24.04 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.834 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -97.93 153.01 18.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.647 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -174.32 -30.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.654 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -61.26 147.96 46.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.73 -5.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.404 . . . . 0.0 110.286 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 228' ' ' GLY . 29.7 mttp -94.07 116.94 29.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.313 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.2 mtm-85 -81.02 131.15 35.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 244' ' ' ARG . 5.5 mp -89.08 -76.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 233' ' ' LEU . 0.3 OUTLIER -85.41 148.38 26.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.945 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -111.08 143.71 41.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 55.0 m -101.67 116.04 31.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.931 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.8 OUTLIER -96.47 73.18 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -39.75 117.81 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.64 -25.48 9.04 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.45 -56.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.1 -136.79 4.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -129.35 160.67 32.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.889 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.568 HG12 HD21 ' A' ' 236' ' ' LEU . 14.4 p -138.84 134.64 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.522 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 53.0 tp -91.88 116.28 28.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 232' ' ' LEU . 10.1 ptm180 -163.37 117.19 1.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.343 179.623 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.802 0.334 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -120.18 123.87 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.83 156.11 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.59 163.04 33.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 156' ' ' ILE . 58.5 t80 -167.58 134.5 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.41 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 11.5 p-10 -125.18 53.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.1 mt -137.05 154.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -145.83 146.88 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.07 134.32 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.5 m-20 -112.77 109.24 18.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.8 OUTLIER -65.58 -16.28 63.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.97 -52.21 8.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.4 p -101.3 11.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.588 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 11.0 m-70 36.53 53.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.666 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.22 160.02 23.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD11 ' A' ' 174' ' ' LEU . 95.2 t -124.5 149.6 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.4 127.76 15.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 39.5 tttm -128.06 114.04 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.496 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.99 62.94 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.97 29.7 75.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 15.4 tt0 -132.9 93.28 23.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.74 140.23 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.282 1.988 . . . . 0.0 112.316 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.8 130.17 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.742 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 p -93.64 87.15 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.942 ' H ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.14 154.87 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.606 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.04 168.86 23.62 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.325 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -45.93 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.54 2.16 . . . . 0.0 111.961 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -53.37 -63.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.131 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.18 -36.11 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.429 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -59.87 -48.15 82.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.5 m -60.09 -40.86 91.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.788 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 202' ' ' VAL . 1.3 tp -59.59 -47.55 85.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.84 -41.09 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -58.21 -46.88 85.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.821 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -68.17 -38.82 82.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -57.2 -44.0 83.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.483 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.35 -46.05 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 mm -53.93 -34.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -108.28 22.21 16.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.037 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.55 125.87 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.487 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.31 -33.2 6.77 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 m -87.07 132.81 33.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.04 124.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.22 161.27 13.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.24 147.88 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 5.5 mtmt -58.43 -56.36 36.2 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.35 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -63.31 -34.53 66.76 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.834 1.689 . . . . 0.0 111.967 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -64.82 -54.09 36.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.355 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 mt -52.05 -39.36 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 0.0 110.12 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.7 tp -60.52 -68.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -50.49 -25.83 4.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.464 ' ND1' ' NH2' ' A' ' 204' ' ' ARG . 56.7 t60 -71.35 -55.12 8.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 204' ' ' ARG . 55.2 t -83.87 -58.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.337 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.481 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.1 -4.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.278 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.8 ttm180 -61.76 0.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.5 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.574 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.019 0.438 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.455 ' O ' HG22 ' A' ' 211' ' ' VAL . 11.5 p -85.4 -12.2 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.846 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -91.08 -18.53 24.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 1.2 p -65.25 -37.99 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.995 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -59.2 -45.79 92.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.605 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -61.45 -45.76 92.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.5 t -60.91 -41.69 96.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.433 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -39.03 76.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.854 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 214' ' ' VAL . 60.9 t -62.27 -43.88 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -46.76 88.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.67 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -31.53 72.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.934 0.397 . . . . 0.0 110.172 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.87 -42.34 70.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.946 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 226' ' ' ASP . 35.5 ttp180 -55.11 -44.4 74.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -68.17 -26.36 65.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.468 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -93.41 -21.88 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.2 -31.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.305 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.7 t70 -107.23 135.71 48.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.462 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.64 21.35 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.31 167.84 17.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -12.49 61.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.371 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -92.42 106.2 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.815 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -89.46 110.15 21.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.28 -4.7 56.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.31 104.99 12.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.598 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 124.44 37.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.543 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -96.11 118.41 32.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.309 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.07 74.96 2.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.24 113.99 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.013 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.99 -20.64 23.82 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.63 -61.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.152 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.94 -139.17 5.66 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.77 153.05 47.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.703 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.8 p -140.1 132.13 32.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.84 143.36 26.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.397 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.01 139.85 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.498 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.849 0.357 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 10.2 mtm180 -124.56 121.0 33.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 61.8 mt -91.76 153.01 19.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.472 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 160.76 39.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 154' ' ' ALA . 77.0 t80 -165.93 140.23 4.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.78 -105.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -123.85 53.07 1.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.28 157.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.651 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 6.5 tt0 -143.38 142.95 31.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.655 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.77 134.66 35.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.0 m-20 -110.95 105.85 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.602 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.99 -13.72 60.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.307 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -48.09 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.9 p -94.88 6.38 49.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.594 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 159' ' ' ASP . 64.8 m80 38.39 51.27 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.15 157.04 29.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.01 151.5 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 110.334 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 124.72 12.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -124.27 117.11 23.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.289 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.83 60.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.574 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.95 24.4 71.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 mt-30 -129.89 96.0 27.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.1 135.97 15.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.928 1.752 . . . . 0.0 112.497 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.71 140.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.727 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.11 96.07 9.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.12 156.04 16.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.04 169.43 15.53 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.594 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.25 -53.87 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 112.263 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -54.44 45.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -56.58 -37.97 71.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.419 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -63.17 -49.92 72.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.9 m -58.13 -43.79 87.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.6 -50.44 73.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.56 -43.61 98.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.725 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -56.98 -45.84 82.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.5 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 21.1 t80 -62.9 -41.72 99.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.2 -41.33 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.39 -48.09 74.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.126 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.84 -37.55 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -104.67 25.08 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.96 120.93 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.94 51.51 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 131.88 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.88 118.18 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.48 HD23 ' CG1' ' A' ' 198' ' ' ILE . 3.9 mp -96.55 154.48 17.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 148.82 28.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.346 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 3.3 mtpm? -56.02 -55.02 46.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.106 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -64.66 -32.63 57.33 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.919 1.746 . . . . 0.0 111.86 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -68.46 -54.02 19.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.48 ' CG1' HD23 ' A' ' 193' ' ' LEU . 6.2 mt -47.72 -41.81 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.937 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.15 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.629 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -46.41 -30.65 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.5 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 2.1 t60 -71.09 -51.19 26.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.026 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 204' ' ' ARG . 58.4 t -84.34 -57.97 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.04 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -52.89 -2.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.478 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.0 ttt-85 -63.89 -1.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 203' ' ' TRP . 34.6 m-85 . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.396 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.851 0.358 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 m -82.56 -3.19 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.75 -20.84 25.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.017 0.437 . . . . 0.0 109.855 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 210' ' ' ASP . 3.8 p -67.39 -40.45 84.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.478 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 95.6 t -56.21 -50.46 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.61 -48.02 80.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.544 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -46.36 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.461 ' CE1' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -62.86 -40.99 99.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.691 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 t -62.8 -42.13 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.82 94.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.301 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.69 -13.97 61.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.81 -47.28 9.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 226' ' ' ASP . 50.2 mtt180 -56.64 -46.31 81.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -10.68 50.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.187 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -94.65 -41.16 9.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.404 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.09 -27.86 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.143 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -97.79 143.66 28.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t -177.07 39.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.289 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -137.49 160.21 25.06 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.97 -7.26 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.355 . . . . 0.0 110.436 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -93.63 105.7 17.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -89.73 114.03 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.414 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.56 -3.37 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -121.2 110.17 15.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.316 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.98 136.12 33.24 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.7 m -101.29 112.55 25.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 237' ' ' ARG . 2.8 mt -95.27 68.19 3.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.053 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' LEU . 23.4 ttt180 -34.8 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.699 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 103.22 -17.24 52.1 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.37 -42.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.92 0.39 . . . . 0.0 110.364 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 141.86 -137.56 8.04 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 164.46 23.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.7 p -143.22 133.79 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.2 tp -91.22 122.93 34.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.355 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -161.65 130.8 4.52 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 111.047 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 -179.934 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.857 0.36 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -126.28 119.2 26.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -90.76 155.47 18.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.638 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -142.38 161.53 37.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.99 0.424 . . . . 0.0 111.148 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -165.23 132.48 2.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.645 179.749 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.57 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 36.65 -98.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.2 m-20 -125.55 53.69 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.13 153.52 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.492 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -146.03 140.82 27.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.766 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.27 134.39 37.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.136 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -110.3 107.97 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.932 0.396 . . . . 0.0 110.459 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.02 -9.26 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.057 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.98 -52.04 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.61 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 7.3 p -93.28 7.02 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 22.1 t60 36.92 62.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -136.31 154.1 50.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.372 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.85 151.23 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.76 126.74 13.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.1 ttpm? -126.68 114.62 18.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.764 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.48 54.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.445 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.49 24.09 77.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 167' ' ' LYS . 54.2 mm-40 -129.39 95.68 29.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.34 136.4 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.109 1.873 . . . . 0.0 112.224 -179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.88 140.53 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.948 -179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.7 t -93.86 94.11 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.546 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.518 ' CD2' HD22 ' A' ' 182' ' ' LEU . 9.9 mp -95.06 150.06 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.667 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.1 172.38 8.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.55 -57.02 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.544 2.163 . . . . 0.0 112.522 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -54.24 -50.14 67.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.4 -40.34 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.483 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.5 -47.4 85.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -57.41 -48.02 80.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.336 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.0 -51.22 70.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 174' ' ' LEU . 1.2 tp -57.95 -47.18 83.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.055 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.407 ' CD2' ' ND2' ' A' ' 188' ' ' ASN . 18.5 t80 -61.33 -45.39 94.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.355 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.6 m-85 -57.45 -44.46 84.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.47 -50.11 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.35 -38.67 56.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.816 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 24.2 p30 -108.58 24.45 13.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -51.87 118.01 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.16 -23.68 13.71 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 m -89.43 133.66 34.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.21 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.26 120.88 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.612 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.25 156.27 16.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.413 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.08 148.6 28.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.533 ' HZ3' ' CD ' ' A' ' 215' ' ' GLU . 1.0 OUTLIER -56.16 -56.09 34.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.982 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -66.32 -28.8 46.82 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.998 1.799 . . . . 0.0 111.927 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -49.33 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.948 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.31 -38.97 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.3 -68.51 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -49.89 -30.86 10.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.84 -49.57 44.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.282 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 204' ' ' ARG . 62.7 t -82.91 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.908 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.611 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 1.1 m-90 -53.85 -2.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 202' ' ' VAL . 30.4 ttt180 -50.91 -5.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 203' ' ' TRP . 35.9 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.249 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.9 m -83.68 -10.04 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 215' ' ' GLU . 13.0 m120 -73.0 -70.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.227 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 4.5 p -34.61 -36.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.3 t -65.52 -44.87 93.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.56 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 212' ' ' ASN . 2.2 tp10 -57.58 -44.15 85.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -47.98 83.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.699 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.594 ' O ' HD13 ' A' ' 221' ' ' LEU . 1.5 m-85 -61.48 -39.95 92.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 214' ' ' VAL . 89.6 t -63.0 -43.82 99.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.5 t -63.06 -44.73 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -36.87 85.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 110.189 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.594 HD13 ' O ' ' A' ' 217' ' ' TYR . 5.1 mp -65.11 -45.6 84.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.671 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 52.1 mtm180 -56.2 -45.76 79.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.229 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.03 -22.44 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -92.94 -26.69 17.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.47 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.47 -40.37 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.823 -179.644 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.75 156.13 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.956 -179.677 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 226' ' ' ASP . 0.8 OUTLIER 167.78 -36.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.704 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.89 -175.22 10.52 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -78.81 -13.46 59.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.653 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -92.75 105.32 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.16 103.99 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.765 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.31 -3.03 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.645 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.88 113.51 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.666 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.24 118.35 36.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.128 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.451 HG23 ' HD1' ' A' ' 241' ' ' TYR . 61.1 m -93.01 114.06 26.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.641 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 237' ' ' ARG . 1.6 mp -96.23 68.68 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 236' ' ' LEU . 30.8 mtm-85 -33.94 129.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.836 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.93 65.99 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 69.9 t -133.01 -61.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 0.0 110.675 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.96 -140.27 6.32 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.451 ' HD1' HG23 ' A' ' 235' ' ' THR . 0.1 OUTLIER -132.61 153.4 51.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.597 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.13 138.9 49.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.583 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 153' ' ' PHE . 5.3 tp -91.57 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.877 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -161.75 133.18 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 179.951 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.859 0.362 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.55 HH11 ' CG ' ' A' ' 159' ' ' ASP . 15.3 mtt-85 -140.91 121.89 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.33 149.43 22.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -139.74 156.66 46.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.124 0.488 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CE2' HD21 ' A' ' 243' ' ' LEU . 25.8 t80 -165.04 138.06 4.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.18 -104.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 52.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -137.85 148.18 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.305 -179.588 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -143.1 144.01 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.56 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.11 133.12 34.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.55 ' CG ' HH11 ' A' ' 150' ' ' ARG . 55.9 t0 -113.79 107.68 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -66.98 -14.77 63.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.49 -48.66 7.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 163' ' ' HIS . 76.9 p -97.64 8.59 44.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.522 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 162' ' ' THR . 20.8 m80 37.67 54.57 1.5 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -128.61 156.0 44.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.13 152.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 127.2 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.919 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 170' ' ' GLN . 6.2 tmtt? -130.38 117.58 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.281 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.61 64.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.28 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.56 28.54 65.28 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.4 tt0 -129.92 92.26 37.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.47 140.61 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.261 1.974 . . . . 0.0 112.392 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.3 135.75 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.1 OUTLIER -88.22 95.73 10.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.723 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.04 150.61 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.57 170.51 14.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.483 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -47.82 -54.22 5.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.658 2.238 . . . . 0.0 112.569 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -52.25 -61.0 2.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -56.76 -39.68 74.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.43 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -62.65 -46.37 88.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.31 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 m -59.4 -40.28 86.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -44.82 95.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.646 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.46 -46.7 87.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.29 -45.83 80.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.381 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.686 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.765 -179.826 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.77 -45.6 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.745 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.67 -46.81 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.34 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mt -65.71 -23.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.208 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.54 27.37 9.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.41 109.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.619 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.86 61.68 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -98.66 122.45 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 242' ' ' VAL . 95.2 t -68.04 118.15 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.89 166.08 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.638 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.66 147.25 34.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 2.6 mtpm? -58.01 -55.12 48.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.252 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.3 Cg_endo -67.89 -29.67 34.34 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.835 1.69 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -66.57 -50.75 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.843 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 mt -55.24 -42.18 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.66 -69.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.599 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -27.64 12.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.961 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.686 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -71.54 -51.49 23.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.129 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.3 t -84.28 -61.79 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.48 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -48.27 -3.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.723 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.7 OUTLIER -55.16 -7.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.321 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.48 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 213' ' ' VAL . 23.0 m-20 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.13 -12.97 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -81.01 -17.84 48.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.364 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -66.68 -39.45 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.585 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 94.2 t -58.07 -50.02 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.44 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -56.12 -46.87 79.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.572 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 6.3 t -61.25 -45.94 92.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.53 -41.51 98.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.056 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.73 -40.82 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -66.11 -44.05 85.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.443 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -15.12 62.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.02 -45.64 13.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 226' ' ' ASP . 5.8 mtp-105 -59.22 -46.75 87.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.788 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -67.72 -10.46 52.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.525 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -93.04 -35.78 13.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.317 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.5 -26.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -95.2 137.3 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.793 -179.914 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.12 26.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.006 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.76 166.62 13.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.66 -9.86 58.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -92.86 130.5 38.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.725 ' C ' HD12 ' A' ' 232' ' ' LEU . 11.2 mtp180 -83.47 156.02 23.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.711 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.6 mp -147.55 -41.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 109.93 22.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.415 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -94.0 123.83 37.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.334 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.1 m -92.01 109.41 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.939 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.6 69.26 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.313 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -39.25 120.49 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.008 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.97 -23.26 28.0 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.35 -41.66 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.697 0.284 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.24 -137.71 7.78 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 154.62 48.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.723 0.297 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 192' ' ' VAL . 7.3 p -138.45 131.38 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.8 tp -91.2 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.478 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.14 135.93 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.191 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.984 0.421 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -120.54 123.42 42.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.955 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -89.56 153.1 21.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.67 156.19 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.0 t80 -165.43 128.56 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.596 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.01 -99.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 56.7 m-20 -125.44 53.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.184 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.65 150.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.193 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -140.33 143.32 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.138 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.67 137.47 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 150' ' ' ARG . 2.1 m-20 -112.68 104.59 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 110.351 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.08 -10.65 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.72 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.6 -43.35 6.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.717 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 163' ' ' HIS . 82.3 p -98.58 9.47 43.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 162' ' ' THR . 16.8 m-70 37.18 47.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -124.1 161.39 25.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.832 0.348 . . . . 0.0 110.744 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.03 156.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.987 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.58 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.7 tmtt? -123.76 110.75 15.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.08 62.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.5 28.31 72.98 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 167' ' ' LYS . 25.4 tt0 -139.63 105.78 6.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 144.46 29.67 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.718 1.612 . . . . 0.0 112.466 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.88 138.91 50.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.9 t -86.14 138.86 31.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.281 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mt -142.85 99.6 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.656 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 171.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -46.88 -60.4 0.89 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.487 2.124 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -53.33 -56.68 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.315 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 2.6 mm-40 -59.25 -36.76 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.761 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -60.92 -47.24 87.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.9 m -58.8 -41.54 86.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.417 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 202' ' ' VAL . 4.4 tp -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.659 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -61.33 -43.03 99.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -46.73 83.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.594 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.479 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 4.5 t80 -67.41 -39.14 85.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.676 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -43.84 79.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.03 -47.41 68.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.51 -36.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -108.97 28.8 8.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.001 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.65 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.15 -22.49 22.89 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 m -95.29 135.26 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.055 0.455 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 242' ' ' VAL . 84.9 t -69.19 123.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.4 mp -96.15 154.4 17.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.093 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.65 147.87 30.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.953 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.5 mtmt -57.83 -55.03 49.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.792 179.287 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.8 Cg_endo -67.63 -29.97 35.61 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.023 1.816 . . . . 0.0 111.949 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -68.33 -49.34 60.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 109.973 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 mt -55.98 -42.23 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.805 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 199' ' ' LEU . 29.7 tp -59.2 -63.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -52.87 -28.83 24.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 19.3 t-80 -71.92 -48.34 46.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 47.7 t -84.37 -61.52 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -53.23 -3.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.315 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp180 -61.59 0.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 110.636 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.3 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.501 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.64 -8.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.64 -17.64 50.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.345 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.28 -40.01 85.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.072 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 218' ' ' VAL . 87.8 t -56.76 -50.51 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.12 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.52 -48.49 71.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.579 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.2 m -60.74 -47.77 84.82 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.6 -40.52 95.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.618 HG21 ' CE2' ' A' ' 241' ' ' TYR . 73.0 t -62.69 -43.27 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -43.92 97.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.14 -37.52 85.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 221' ' ' LEU . 1.0 OUTLIER -60.91 -48.14 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 226' ' ' ASP . 4.6 mtp85 -56.19 -43.18 78.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.494 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -67.06 -17.22 64.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -96.19 -32.29 12.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.57 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -109.53 -33.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.268 -178.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -104.49 137.83 41.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.73 27.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.404 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.59 -176.5 14.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.54 -8.7 57.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 110.481 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.67 104.81 17.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -96.15 104.46 16.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.7 -7.23 50.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.215 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.52 112.23 21.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.2 126.85 40.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.401 -179.936 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.42 70.58 3.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -43.61 112.31 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.36 -13.24 16.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.94 -54.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 110.724 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.3 -139.25 6.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.6 OUTLIER -128.43 155.35 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 0.0 110.467 179.89 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 192' ' ' VAL . 4.1 p -137.05 135.57 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.62 126.32 36.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -162.53 135.7 5.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.178 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.489 179.832 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.651 0.263 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -174.63 153.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.713 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 186' ' ' VAL . 1.7 mm? -92.37 153.86 18.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.317 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 152.37 41.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CE2' HD21 ' A' ' 243' ' ' LEU . 1.6 t80 -163.7 128.08 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.812 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.75 -99.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.6 m-20 -124.82 53.82 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 0.0 109.836 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 142.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.49 140.16 42.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.887 0.375 . . . . 0.0 110.738 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.446 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.32 124.2 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -102.59 104.87 15.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.534 -179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.588 ' OE2' ' N ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -65.97 -12.72 57.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.588 ' N ' ' OE2' ' A' ' 160' ' ' GLU . 3.1 tt0 -81.63 -52.38 7.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 163' ' ' HIS . 80.5 p -97.32 14.88 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 162' ' ' THR . 24.4 m80 35.78 63.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.601 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -140.45 162.4 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 174' ' ' LEU . 16.5 t -116.18 161.61 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.498 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.14 128.54 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.63 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -128.08 110.72 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.08 67.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.01 32.06 62.19 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -142.37 87.52 9.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.957 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.37 136.42 50.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.197 1.931 . . . . 0.0 112.133 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.4 152.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.129 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.3 m -90.11 126.62 35.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.145 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 165' ' ' VAL . 14.2 mt -141.03 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.62 171.87 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.81 -53.81 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.556 2.171 . . . . 0.0 112.096 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -57.47 -52.73 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.29 -39.6 93.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.78 -46.61 88.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.362 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.7 m -59.21 -40.44 85.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -45.89 91.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.16 -43.16 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.928 0.394 . . . . 0.0 110.163 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -55.64 -45.18 77.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.334 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.685 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -64.8 -44.05 91.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.43 -44.81 65.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 151' ' ' LEU . 10.7 t -68.69 -49.09 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.819 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 mm -54.13 -34.57 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER -109.53 27.53 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.561 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.38 116.55 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.36 -17.99 42.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.1 m -90.14 125.09 35.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.765 0.317 . . . . 0.0 110.93 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.76 115.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.962 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.91 160.44 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.677 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.45 148.43 29.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.697 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 12.9 mtpt -55.24 -53.37 62.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.8 Cg_endo -68.43 -29.77 30.71 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -46.22 74.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.16 -39.51 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.89 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.65 ' O ' HD23 ' A' ' 199' ' ' LEU . 3.7 tt -59.17 -51.4 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.724 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -72.49 -19.74 61.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.685 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 30.6 t-80 -71.39 -41.79 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.674 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.3 t -82.72 -53.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.587 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 205' ' ' TYR . 2.2 m-90 -67.29 -5.34 13.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.735 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.436 ' O ' ' NE ' ' A' ' 204' ' ' ARG . 0.4 OUTLIER -44.07 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.895 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.19 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 212' ' ' ASN . 2.3 m-20 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.3 m -58.59 1.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.556 ' H ' ' C ' ' A' ' 210' ' ' ASP . 70.2 m-20 -96.2 -24.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.65 -31.41 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.33 -53.04 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -55.34 -43.83 75.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -60.59 -49.5 77.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.81 -38.44 91.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.434 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.81 -42.75 97.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.298 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -45.29 92.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.47 -31.33 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.33 -44.43 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.17 -41.79 72.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.3 mtm-85 -67.8 -22.0 65.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -25.11 19.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -116.31 -38.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.978 -179.526 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 222' ' ' ARG . 3.7 t70 -98.48 146.27 25.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.483 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t 175.45 -30.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.281 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -72.35 163.65 54.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -64.5 -4.24 3.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 110.713 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -92.71 131.26 37.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -86.99 158.12 19.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.16 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 232' ' ' LEU . 82.4 mt -147.55 -48.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.291 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.54 119.31 38.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 124.49 41.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.264 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -91.68 109.93 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 30.0 mt -93.22 71.79 4.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 89.9 mtt180 -37.02 123.93 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 -39.82 2.74 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.1 -60.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.391 . . . . 0.0 110.659 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.08 -137.02 4.52 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -127.29 155.66 43.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 110.645 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.39 140.2 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 153' ' ' PHE . 27.8 tp -93.39 111.39 23.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.262 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.26 131.97 5.21 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.255 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.049 179.553 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -174.74 153.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.225 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -91.15 148.07 22.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.089 0.471 . . . . 0.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -140.19 155.43 46.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.201 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 155' ' ' ASP . 70.3 t80 -156.86 124.93 5.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.005 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.77 -93.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.8 m-20 -124.86 52.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.75 138.43 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.984 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -134.99 133.02 39.03 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.715 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 165' ' ' VAL . 4.5 mt -131.43 120.85 23.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -109.18 113.82 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.546 -179.521 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.95 -42.33 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.5 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.5 -47.18 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.1 p -103.62 8.99 37.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 162' ' ' THR . 0.7 OUTLIER 36.91 46.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.573 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.32 165.65 14.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 174' ' ' LEU . 11.1 t -121.26 159.33 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.433 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -146.41 120.67 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.485 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -118.25 105.12 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.237 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.84 63.42 0.31 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.52 27.5 73.39 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 tt0 -134.05 94.63 18.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.612 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.59 134.12 10.87 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.291 1.994 . . . . 0.0 111.989 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.89 134.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.374 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.2 p -81.76 100.04 9.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 165' ' ' VAL . 15.1 mt -96.62 154.31 17.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.99 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.95 160.91 65.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.964 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.55 -43.07 52.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.537 2.158 . . . . 0.0 111.624 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -55.37 30.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.644 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.58 ' HB3' HD22 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -59.64 -36.26 76.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.299 179.84 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.11 -52.78 64.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.37 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.1 m -57.47 -43.43 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.777 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -53.44 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.05 -41.5 95.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -55.54 -46.5 77.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.781 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.444 ' CZ ' ' CD2' ' A' ' 201' ' ' HIS . 29.7 t80 -64.35 -42.53 96.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.18 -43.86 83.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.47 -43.68 94.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.988 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.02 -29.59 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -113.99 23.25 13.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.109 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.23 121.36 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.776 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.59 -20.86 24.51 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -95.81 131.18 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 111.042 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.7 p -69.44 115.61 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 198' ' ' ILE . 3.7 mp -96.9 160.24 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.487 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.76 148.1 31.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.0 -50.14 89.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.751 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.4 Cg_endo -65.78 -34.59 39.68 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.56 1.507 . . . . 0.0 112.219 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.95 -47.6 65.28 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.108 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 193' ' ' LEU . 19.3 mt -53.82 -40.91 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.991 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.652 ' HG ' HG21 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -62.29 -64.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.475 179.768 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -27.65 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.294 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.14 -51.58 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.762 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.8 t -83.71 -61.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.239 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.451 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -50.6 -4.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -179.384 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttm180 -61.98 -1.44 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.53 -7.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.94 -49.31 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 214' ' ' VAL . 8.1 p -54.75 -42.96 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.044 0.45 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.836 ' O ' HG23 ' A' ' 218' ' ' VAL . 41.1 t -58.95 -44.85 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -61.13 -47.1 87.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.339 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -60.28 -41.03 92.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.984 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -64.09 -42.05 97.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.25 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.4 -40.32 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -45.15 74.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.313 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -13.07 62.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.432 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -57.09 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 24.2 ptt180 -57.54 -37.85 73.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.705 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.424 ' NH2' HH21 ' A' ' 222' ' ' ARG . 1.4 mtt-85 -69.0 -20.76 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -94.87 -27.56 15.66 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.805 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.445 HG21 ' HZ1' ' A' ' 167' ' ' LYS . 1.8 pp -114.85 -27.62 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.839 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -102.84 139.04 38.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.997 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 -33.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -46.01 163.64 0.12 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -94.45 106.43 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -74.06 107.21 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.458 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.81 1.12 56.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.587 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.2 mt -126.58 96.23 4.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' HIS . . . . . 0.439 ' HB2' ' HE ' ' A' ' 244' ' ' ARG . 0.1 OUTLIER -87.93 122.06 31.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 179.808 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.409 HG23 ' CD2' ' A' ' 241' ' ' TYR . 23.7 m -93.26 113.68 25.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.1 mt -95.27 72.14 3.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -39.06 120.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.754 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.51 -17.58 30.79 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.584 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 63.6 t -128.33 -55.11 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.12 -137.25 4.76 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.8 OUTLIER -131.24 155.16 47.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 110.265 179.82 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 242' ' ' VAL . 8.2 p -138.17 131.29 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.159 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.41 104.64 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.374 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -162.24 153.48 17.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.756 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -136.41 127.26 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.368 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.6 mt -90.57 152.72 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.95 148.97 39.5 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 84.2 t80 -158.74 127.47 5.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.89 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.38 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.111 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 25.8 m-20 -123.94 53.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 145.06 29.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.256 -179.553 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.42 149.06 50.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.434 179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.35 121.87 8.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.137 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.79 27.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 -179.3 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.476 ' OE1' ' NH2' ' A' ' 183' ' ' ARG . 8.0 mt-10 -66.57 -22.42 66.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.625 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.0 -52.11 52.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.4 p -108.18 14.79 24.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 160' ' ' GLU . 9.6 m80 37.22 54.74 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -120.86 156.79 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 174' ' ' LEU . 2.0 t -119.85 157.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.65 137.76 25.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -130.6 110.08 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 179.748 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.06 60.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.263 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.83 76.12 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.0 mt-30 -134.98 104.89 10.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.823 -0.222 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.39 144.72 26.14 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.889 1.726 . . . . 0.0 112.618 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.24 136.43 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.712 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.5 t -97.97 127.17 43.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.889 ' H ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -140.65 124.68 17.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.376 . . . . 0.0 110.539 179.707 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -45.67 174.57 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -179.617 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.7 -47.6 26.37 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.544 2.163 . . . . 0.0 111.853 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -52.34 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.07 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.52 -38.75 88.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.878 0.371 . . . . 0.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -48.39 81.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.711 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -59.38 -42.64 92.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.206 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 202' ' ' VAL . 0.8 OUTLIER -56.85 -50.8 71.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.015 -179.704 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.95 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.746 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.476 ' NH2' ' OE1' ' A' ' 160' ' ' GLU . 2.3 ttt180 -60.21 -48.89 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.43 -39.41 93.79 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.555 -179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.446 ' HD1' HD12 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -59.03 -43.14 91.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.19 -47.11 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.27 -27.65 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.062 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.54 18.54 20.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.462 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.53 120.23 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.44 -24.37 13.95 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 46.7 m -94.72 126.73 40.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.8 p -68.11 118.4 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 198' ' ' ILE . 8.0 mp -96.35 161.4 13.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.47 148.0 30.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.287 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.41 -55.75 36.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.034 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.3 Cg_endo -66.58 -33.6 35.72 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.962 1.774 . . . . 0.0 112.142 -179.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -46.33 85.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.413 HG12 HD23 ' A' ' 193' ' ' LEU . 36.8 mt -60.99 -39.09 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.579 HD22 HG22 ' A' ' 211' ' ' VAL . 8.6 tp -61.94 -51.5 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.144 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.32 -28.87 69.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.019 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -72.85 -58.5 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.505 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.677 HG21 HD12 ' A' ' 181' ' ' LEU . 39.6 t -84.34 -60.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.013 -178.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.438 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -51.04 -5.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.834 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.9 ttp85 -61.4 -1.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.985 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 212' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.245 0.545 . . . . 0.0 110.434 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.579 HG22 HD22 ' A' ' 199' ' ' LEU . 24.5 t -55.3 0.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 210' ' ' ASP . 37.3 m-20 -83.66 -12.41 55.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.57 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.11 -35.27 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.399 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.9 t -55.92 -55.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.052 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.29 -48.56 68.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.3 t -58.07 -50.53 73.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.026 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.51 -37.26 83.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.0 110.533 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 214' ' ' VAL . 35.1 t -62.04 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -60.56 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.52 -39.89 94.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.73 -45.68 88.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.42 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.0 mmm-85 -56.68 -42.29 78.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.392 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -66.15 -22.5 66.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.634 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -93.22 -30.44 15.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.671 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -110.45 -37.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 0.0 110.766 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.5 t70 -95.02 145.18 25.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.458 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.91 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.461 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.53 -178.57 4.92 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -79.34 -11.21 59.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -94.4 104.89 16.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.026 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -92.08 109.37 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.265 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 243' ' ' LEU . 2.5 mp -91.81 -9.07 44.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.445 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.72 127.25 56.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.132 179.444 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.96 124.57 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.381 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.3 m -97.61 113.74 25.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.327 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 240' ' ' GLY . 7.2 mt -96.11 72.66 2.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.632 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -39.78 115.19 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.51 -20.42 20.71 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.795 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.3 -50.02 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.915 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 158.59 -145.64 11.94 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -131.48 152.71 50.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.538 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.13 137.45 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.8 OUTLIER -91.21 127.09 36.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.652 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 244' ' ' ARG . 3.9 ptm85 -163.61 131.1 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 111.126 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.736 -179.9 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -121.65 124.67 44.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.296 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.864 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -142.33 160.78 39.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.613 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 156' ' ' ILE . 69.6 t80 -165.53 128.72 2.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.53 -99.82 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.241 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 153' ' ' PHE . 22.8 p30 -122.76 53.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.55 155.04 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.707 -179.64 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -146.84 140.58 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.407 ' CD2' HG22 ' A' ' 165' ' ' VAL . 2.4 mt -137.16 136.32 38.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -110.88 104.09 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.133 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.42 -11.08 39.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.902 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -96.92 -51.02 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.83 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.539 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 30.8 p -93.89 9.99 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.503 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 162' ' ' THR . 8.5 p-80 37.11 58.49 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -127.81 157.37 40.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.54 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 158' ' ' LEU . 6.0 t -121.64 151.46 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.325 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.23 125.19 12.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 170' ' ' GLN . 23.8 tttp -124.49 115.24 20.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.611 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 59.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.66 75.26 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.288 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 167' ' ' LYS . 48.2 mt-30 -130.5 95.28 27.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.7 138.99 12.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.121 1.881 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.61 145.26 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.381 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -94.28 100.09 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 174' ' ' LEU . 11.1 mp -96.07 150.38 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.578 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.36 168.44 22.48 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.293 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.68 -52.17 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.367 2.045 . . . . 0.0 112.322 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -47.65 85.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.71 -37.5 84.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.615 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 1.8 t80 -64.71 -49.24 71.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.5 m -57.31 -46.04 83.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.55 -49.6 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.791 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.84 -44.77 96.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.75 -46.36 89.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 2.3 t80 -62.27 -42.25 99.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.819 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 243' ' ' LEU . 0.1 OUTLIER -59.63 -43.99 93.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.337 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.19 -45.35 86.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.556 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 mm -57.35 -35.58 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -110.18 23.16 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.274 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.02 119.08 4.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.52 -26.83 9.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 127.62 35.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.326 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 192' ' ' VAL . 8.2 p -67.88 114.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.96 157.5 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 149.83 28.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.8 mttt -57.12 -49.44 93.95 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -65.36 -35.43 40.02 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.56 1.507 . . . . 0.0 111.933 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -66.33 -55.48 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.029 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 mt -49.93 -38.1 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 48.7 tp -65.06 -68.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -46.05 -27.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.572 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 24.8 t-80 -71.53 -52.29 19.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.062 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.1 t -83.42 -56.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.434 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -51.68 -4.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.458 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.541 ' H ' ' C ' ' A' ' 202' ' ' VAL . 48.1 ttm-85 -58.69 -6.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 211' ' ' VAL . 4.4 p -80.33 -9.6 12.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.644 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.83 -17.97 34.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.18 -35.04 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.298 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.1 t -58.27 -49.51 81.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.322 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -58.4 -47.07 85.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.278 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 m -59.78 -45.35 92.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.38 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -45.34 94.79 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 214' ' ' VAL . 59.6 t -62.2 -40.2 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -44.79 90.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.592 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.49 -28.5 66.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.572 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.61 -47.3 63.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 226' ' ' ASP . 3.1 mtp85 -57.02 -45.56 83.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.319 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -67.41 -10.14 48.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -90.58 -44.27 9.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.9 pp -110.14 -32.78 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -95.23 143.47 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.9 t -175.33 38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.06 -163.25 10.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -90.54 -20.54 22.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.518 ' CD ' ' H ' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -92.23 104.0 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.208 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -88.75 125.86 35.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.4 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.754 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mt -91.25 -8.8 47.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.63 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.6 mp -121.6 116.32 24.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.183 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 127.57 37.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.46 105.88 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.6 mt -94.59 73.1 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.14 136.36 5.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.708 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.18 -12.74 65.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.15 -46.06 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 147.13 -141.77 9.68 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -131.12 153.59 49.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 0.0 110.476 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.48 136.61 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.41 119.92 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -163.03 127.12 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.148 179.589 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.824 0.345 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -141.38 134.6 29.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.76 161.09 16.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 157.79 44.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' OE2' ' A' ' 245' ' ' GLU . 91.9 t80 -162.55 122.96 2.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.668 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 32.8 m-20 -124.66 54.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 152.41 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.553 -179.329 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.1 tt0 -140.23 147.7 40.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.216 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD21 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -146.33 117.46 7.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.257 -179.645 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -112.43 115.42 28.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.673 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.8 -45.07 79.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -49.49 -50.72 40.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.714 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 56.4 p -97.18 6.95 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.624 ' CE1' ' CE1' ' A' ' 179' ' ' PHE . 16.9 t60 36.1 57.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -134.18 159.18 41.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.54 154.45 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -146.42 129.14 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.123 -179.795 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 170' ' ' GLN . 25.5 tttp -127.51 114.55 17.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.414 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 65.06 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 60.4 29.57 69.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 167' ' ' LYS . 14.7 tp60 -132.95 92.18 26.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.29 136.81 16.32 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.134 1.89 . . . . 0.0 112.379 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.29 136.08 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.957 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 57.9 m -91.06 91.14 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.88 142.58 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.931 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 170.74 13.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.95 -53.96 6.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.408 2.072 . . . . 0.0 112.43 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -52.3 -63.44 1.14 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -58.33 -37.45 75.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.775 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.624 ' CE1' ' CE1' ' A' ' 163' ' ' HIS . 27.7 t80 -54.98 -51.71 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -62.77 -35.69 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.549 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.6 -51.17 69.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.152 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.18 -41.25 98.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.792 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -62.45 -41.79 99.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.23 -37.28 86.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.207 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.97 -46.05 92.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.43 -47.28 90.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.484 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -50.88 -42.08 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -108.98 25.36 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.75 117.34 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.62 -21.42 16.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 193' ' ' LEU . 21.5 m -96.5 131.47 43.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 242' ' ' VAL . 75.3 t -68.86 119.02 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 191' ' ' THR . 4.5 mp -96.78 166.27 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 110.77 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.97 148.26 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.67 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.36 -51.08 84.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.574 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.6 Cg_endo -64.27 -44.6 11.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.675 1.583 . . . . 0.0 112.149 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.04 -51.54 68.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.244 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -55.52 -39.0 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 110.393 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 199' ' ' LEU . 2.6 tt -59.43 -67.39 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.071 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -58.13 -15.9 11.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -53.38 12.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.711 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 204' ' ' ARG . 23.8 t -84.06 -30.66 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.269 -179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.452 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -60.36 -3.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.92 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 202' ' ' VAL . 13.2 mmm-85 -61.01 -1.93 0.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.568 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.9 m-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.597 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.121 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -6.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.642 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -90.8 -26.07 19.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -67.68 -32.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.7 t -57.85 -56.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.072 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.51 -46.92 76.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.229 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.0 t -60.6 -45.66 93.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.13 -39.03 89.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.15 -46.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.428 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -62.48 -43.32 99.09 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -72.69 -13.32 61.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 221' ' ' LEU . 0.3 OUTLIER -83.26 -48.33 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.131 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 12.5 mtm-85 -56.07 -45.05 79.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.135 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -68.17 -11.14 58.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.766 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.4 tttp -92.7 -33.34 14.38 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.625 -179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -21.6 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.872 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.85 -39.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -53.25 168.98 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.16 -8.55 56.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.916 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 130.1 39.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -85.79 128.43 34.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -90.09 -74.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -91.95 145.45 24.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.646 -179.652 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -105.23 132.44 51.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.38 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -91.69 108.94 20.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.737 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 10.2 mt -94.87 72.96 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.469 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -36.84 142.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.19 179.641 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.1 36.04 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.59 -57.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.567 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 154.37 -138.95 6.44 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -130.51 160.74 33.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.697 179.996 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 242' ' ' VAL . 10.8 p -142.64 126.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 36.8 tp -90.64 116.67 28.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.537 ' O ' ' NE ' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -161.9 147.18 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.437 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.545 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.4 mp0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.267 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.792 0.329 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -174.5 143.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.13 154.71 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -142.34 156.97 45.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.67 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 154' ' ' ALA . 26.2 t80 -169.66 133.84 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.833 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.95 -129.6 0.25 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.63 53.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.349 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.92 151.24 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -146.79 141.49 26.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.161 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.06 117.95 14.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.383 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -104.11 108.71 20.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.97 0.414 . . . . 0.0 110.354 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.95 -31.05 72.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.167 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 1.4 mp0 -58.77 -48.32 81.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.735 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 163' ' ' HIS . 65.9 p -109.17 13.93 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER 38.18 50.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.702 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -119.41 158.44 26.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.13 151.97 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.31 124.72 13.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.1 ttpt -128.64 121.13 27.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.57 58.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.6 27.76 70.28 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.6 mt-30 -132.18 97.83 17.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.56 138.52 17.37 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.977 1.784 . . . . 0.0 112.492 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.97 143.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.61 -179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -93.73 97.29 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -95.97 152.16 18.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.778 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.2 161.49 59.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.338 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.46 -45.05 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.628 2.219 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -42.75 88.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.773 0.32 . . . . 0.0 110.813 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -65.43 -34.46 78.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -62.41 -45.52 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.119 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -43.58 96.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.124 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -47.66 84.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.774 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.61 -44.04 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.499 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -56.11 -47.15 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.824 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.509 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 2.6 t80 -66.08 -38.6 88.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.603 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.594 ' CZ ' ' CE2' ' A' ' 241' ' ' TYR . 3.0 m-85 -55.88 -44.54 78.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.96 -47.62 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.94 -31.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -106.53 23.77 13.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.798 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.08 119.68 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.74 -23.0 27.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.1 m -94.86 127.8 41.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.535 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 192' ' ' VAL . 14.7 p -68.62 112.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.157 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.32 151.18 19.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.0 p -100.33 148.38 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.371 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -58.39 -48.78 96.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 36.4 Cg_exo -55.03 -46.26 34.6 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.417 2.078 . . . . 0.0 111.666 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -61.97 -52.36 64.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.5 mt -49.95 -38.78 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.916 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.35 -67.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.419 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.93 -21.6 1.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.509 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 63.1 t60 -72.57 -59.19 2.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 204' ' ' ARG . 64.6 t -83.69 -60.65 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -51.11 -4.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.1 OUTLIER -60.65 -0.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.678 0.275 . . . . 0.0 110.597 -179.927 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.2 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.37 . . . . 0.0 110.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -78.48 -0.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.627 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.23 -22.16 19.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.689 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 t -64.18 -43.99 97.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.481 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 218' ' ' VAL . 48.3 t -61.35 -43.05 95.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.239 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -58.88 -45.87 89.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.444 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.4 t -61.12 -40.74 94.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.106 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -64.04 -43.47 95.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.812 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 214' ' ' VAL . 70.2 t -62.47 -41.02 90.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.284 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.83 -44.21 90.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -67.41 -31.29 71.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.5 mp -67.55 -45.71 74.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.87 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 226' ' ' ASP . 30.6 mtp85 -56.74 -46.16 81.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.35 -24.41 65.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -92.73 -23.37 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -111.12 -41.15 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.695 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 222' ' ' ARG . 24.3 t70 -100.81 141.1 34.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -37.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.422 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -59.37 165.89 9.34 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -69.26 -10.53 58.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.628 0.252 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -93.67 115.75 28.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.422 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -83.9 130.73 34.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 244' ' ' ARG . 27.9 mt -89.55 -74.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.64 145.72 26.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.577 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -105.17 140.26 38.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.662 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 m -95.85 114.75 26.51 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.036 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 240' ' ' GLY . 57.3 mt -96.14 72.12 2.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 236' ' ' LEU . 2.4 ptp180 -37.93 138.15 0.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.07 -18.64 43.39 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.15 -60.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.441 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 165.19 -142.07 7.47 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.594 ' CE2' ' CZ ' ' A' ' 185' ' ' PHE . 2.0 p90 -130.35 160.27 34.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.52 133.99 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.531 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 232' ' ' LEU . 7.8 ptm180 -162.73 127.9 3.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.541 179.839 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -149.2 138.09 21.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -90.72 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.575 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.0 158.03 44.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.0 111.218 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 243' ' ' LEU . 3.8 t80 -164.79 139.76 5.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.347 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.544 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 37.28 -105.32 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.244 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.69 53.11 1.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -137.43 150.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.556 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -140.45 137.02 33.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.38 143.34 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.216 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.26 109.47 15.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.06 -17.38 64.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.41 -52.03 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 42.3 p -96.79 12.04 33.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 162' ' ' THR . 14.7 m-70 37.36 41.15 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.1 169.36 9.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.868 -179.399 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 166' ' ' TRP . 62.1 t -122.28 161.04 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.477 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.121 179.647 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.6 tmtm? -124.67 113.51 18.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.687 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 64.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.052 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.41 31.69 63.26 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.5 tt0 -142.3 89.39 8.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.82 150.07 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.23 1.953 . . . . 0.0 112.544 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.2 126.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.905 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 p -95.13 115.39 27.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.871 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -141.69 154.28 45.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.489 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.64 161.53 1.57 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.0 -33.99 95.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.889 2.393 . . . . 0.0 111.96 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -60.81 -53.61 55.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.13 -37.81 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.229 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.48 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 4.7 t80 -58.48 -48.08 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.9 m -58.8 -39.33 80.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 181' ' ' LEU . 44.7 tp -60.87 -46.87 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.348 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.18 -40.65 86.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -59.89 -43.62 94.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.64 -179.74 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.45 -43.07 91.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.564 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.43 -43.11 83.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.91 -48.75 86.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.52 -35.67 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.136 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.4 23.25 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.48 117.23 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.914 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.66 -14.15 24.79 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.3 m -98.48 130.9 45.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.18 115.07 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.457 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.89 152.65 18.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.445 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.75 147.96 27.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.201 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -56.58 -51.34 81.94 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 22.0 Cg_endo -65.23 -36.35 36.72 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.65 1.567 . . . . 0.0 111.987 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -66.49 -46.83 75.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.92 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 32.7 mt -53.81 -42.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.139 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.1 mt -63.7 -64.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.524 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -32.39 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -53.59 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.9 t -83.5 -61.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.048 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -52.0 -3.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.189 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 204' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -61.14 -4.89 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.0 110.51 179.879 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.9 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.103 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.9 -4.79 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.67 -21.09 22.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.79 -33.83 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.951 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 218' ' ' VAL . 11.7 t -60.94 -50.74 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.263 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -45.97 83.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 p -61.04 -44.04 97.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -40.48 94.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 214' ' ' VAL . 49.5 t -62.45 -40.06 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.688 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -43.31 80.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -12.99 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.66 -50.18 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.984 179.451 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.3 ttp180 -56.28 -51.14 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.295 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -8.31 29.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.547 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -92.36 -37.09 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.57 -179.085 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.76 -25.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 0.0 110.72 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.3 OUTLIER -105.49 139.43 40.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.598 179.914 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 227' ' ' THR . 13.2 t -165.93 38.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.16 -173.52 13.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.2 -13.19 57.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.69 -0.255 . . . . 0.0 111.038 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -93.89 115.49 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.954 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.2 mmt180 -97.52 113.17 24.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -90.32 -1.68 57.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 107.48 15.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.93 125.01 41.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.7 m -91.8 111.48 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.539 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.7 mt -95.23 72.8 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 19.0 ttt-85 -36.75 127.04 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.98 -10.7 70.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.91 -39.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 135.96 -137.84 9.45 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.7 154.67 46.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 0.0 110.838 -179.846 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.09 138.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -91.75 113.61 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.416 179.79 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -161.7 130.95 4.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.493 ' HG2' HD22 ' A' ' 232' ' ' LEU . 16.3 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.16 -176.53 35.28 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -112.75 -15.16 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.9 t -51.63 -85.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.206 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 46.43 -108.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -40.53 102.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -59.85 146.73 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -87.55 9.02 22.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -119.71 78.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.609 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -109.89 55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.8 m -74.14 -3.72 31.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.45 117.67 29.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.98 -167.48 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 tp -176.07 50.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.741 0.305 . . . . 0.0 110.833 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.09 56.89 2.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.01 -6.55 19.46 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.538 2.159 . . . . 0.0 111.919 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -55.33 -18.57 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -147.05 -70.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t 53.77 -114.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.697 0.284 . . . . 0.0 110.467 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -161.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.41 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.33 -12.01 0.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.41 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -142.91 -57.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.45 135.49 2.57 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -141.58 23.87 2.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.666 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -54.27 -36.73 63.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.391 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.61 145.51 16.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.251 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.34 -65.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.294 1.996 . . . . 0.0 111.926 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 148' ' ' ASN . 38.5 ttm-85 -152.68 178.81 9.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.082 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -42.48 171.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.75 111.83 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.559 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -128.63 123.59 33.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.7 146.76 23.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.624 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.2 m -142.35 155.44 45.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 155' ' ' ASP . 42.7 t80 -163.02 128.01 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.92 -96.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 43.2 p-10 -124.56 53.79 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 143.27 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.155 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -140.13 136.1 33.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.324 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.448 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.67 131.74 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -113.74 109.52 18.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.65 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 160' ' ' GLU . 1.5 mp0 -66.68 -12.21 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.838 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.8 -51.98 6.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.589 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 40.6 p -99.21 11.22 39.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 40.6 p-80 35.82 58.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.357 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.33 156.26 42.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 174' ' ' LEU . 21.9 t -122.7 148.77 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.52 125.29 12.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 170' ' ' GLN . 31.8 tttm -128.83 117.24 20.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 62.74 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.1 26.26 70.21 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 167' ' ' LYS . 5.9 mt-30 -130.49 92.93 33.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 O-C-N 122.705 -0.291 . . . . 0.0 110.522 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.74 142.21 17.78 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.154 1.902 . . . . 0.0 111.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 131.01 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -88.46 88.35 7.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 165' ' ' VAL . 1.2 mt -93.92 154.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.42 165.2 32.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.3 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -42.12 -54.62 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.258 . . . . 0.0 112.362 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 53.7 m -57.68 -56.6 19.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.282 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -58.38 -34.69 70.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.933 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.82 -45.31 78.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.1 m -58.87 -39.92 82.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -54.27 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.72 -41.78 87.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -60.48 -46.67 89.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.081 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.684 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 19.5 t80 -62.3 -41.1 98.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.414 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.13 -43.67 82.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.93 -45.45 87.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' TYR . 55.5 mt -57.09 -37.24 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.84 25.6 11.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.07 124.33 16.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.44 -24.51 15.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.8 m -95.46 131.32 41.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.583 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 t -66.96 119.39 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.285 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 158.47 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.28 148.43 34.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mtpp -56.02 -55.01 46.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.486 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.0 Cg_endo -65.07 -39.96 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.851 1.701 . . . . 0.0 112.055 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.88 -51.55 68.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 37.5 mt -53.24 -42.96 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.179 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.68 -63.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.505 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.18 -29.59 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.259 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.684 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 6.1 t60 -71.2 -46.48 61.18 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.005 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 90.4 t -83.77 -60.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -50.55 -6.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.049 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.5 OUTLIER -59.33 -6.81 1.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 13.1 m-85 -109.22 -1.03 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.511 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -175.29 92.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -69.18 149.34 48.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.203 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 121.6 59.13 0.22 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.61 103.57 0.23 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -51.63 -173.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 211' ' ' VAL . 10.1 p -86.26 -10.36 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.92 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.71 -24.5 31.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.356 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 216' ' ' SER . 21.9 t -64.31 -34.76 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.04 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 218' ' ' VAL . 39.5 t -65.93 -45.37 91.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.333 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.71 -45.72 77.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.311 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 33.0 p -60.1 -46.75 88.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.05 -38.81 92.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 214' ' ' VAL . 79.7 t -63.54 -43.11 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.607 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.72 -45.56 93.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.55 -39.87 92.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.316 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -61.33 -45.81 92.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.269 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' ASP . 47.0 ttt180 -56.18 -43.12 78.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.345 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -67.47 -30.25 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.403 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -91.1 -11.26 39.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -120.16 -25.1 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.915 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -96.2 137.03 35.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.191 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -70.83 170.74 46.19 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.1 -12.51 59.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -93.32 111.03 22.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.8 ttp85 -92.39 103.81 16.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mp -91.02 -5.72 54.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.43 HD12 ' HG ' ' A' ' 243' ' ' LEU . 1.4 tp -114.3 106.79 14.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 130.85 39.63 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.46 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.9 m -100.91 112.78 25.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.202 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.4 mt -98.07 69.61 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.066 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' LEU . 71.3 mtt180 -38.26 131.79 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.07 -20.85 49.2 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.2 t -120.08 -58.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 110.422 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.17 -139.22 5.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.89 153.85 49.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.8 p -137.0 135.15 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -90.78 125.87 35.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.995 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -162.29 134.13 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -69.68 154.08 95.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.199 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.84 130.31 20.24 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.535 2.157 . . . . 0.0 112.081 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.633 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.748 0.308 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.91 -45.2 0.02 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -46.17 156.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.919 0.39 . . . . 0.0 110.534 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.69 10.65 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.857 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -89.52 -32.83 16.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.466 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -134.81 88.6 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -163.62 -12.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.892 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -151.6 -32.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -56.07 160.85 2.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.72 93.68 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.856 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -69.02 -77.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.547 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.7 p 49.9 54.5 10.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . -169.4 -34.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 132' ' ' GLY . 1.4 tp 58.63 138.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 133' ' ' LEU . 2.8 t 41.14 60.1 8.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.103 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.29 -28.16 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.804 2.336 . . . . 0.0 113.109 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 138' ' ' SER . 4.6 tpp180 -166.79 88.34 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.63 33.9 1.39 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 136' ' ' ARG . 92.8 p -126.62 55.06 1.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 110.209 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -60.37 128.84 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.646 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.7 mtt -68.04 121.16 15.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.237 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -64.38 -65.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.43 2.59 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.4 m120 53.18 16.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -90.51 -33.51 15.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.395 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 147' ' ' ARG . 7.2 mt-10 51.2 72.75 1.13 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.98 -6.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.024 2.483 . . . . 0.0 112.55 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 145' ' ' GLU . 35.9 mtt85 63.94 76.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.841 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -86.36 122.98 31.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 149' ' ' VAL . 0.2 OUTLIER -85.36 139.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.862 0.363 . . . . 0.0 110.582 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -148.46 141.83 25.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.189 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 151' ' ' LEU . 5.2 mt -90.47 151.15 21.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 158.59 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.056 0.455 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 154' ' ' ALA . 82.7 t80 -163.84 139.5 6.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.631 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.51 -104.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -124.63 53.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -138.4 154.26 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.18 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.41 144.84 32.21 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.59 131.73 34.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -114.82 98.95 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.5 mp0 -66.83 -19.06 65.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.637 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.59 -31.51 70.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.909 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 33.8 p -129.29 -18.24 3.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.61 ' CE1' ' CD2' ' A' ' 179' ' ' PHE . 2.4 t60 83.81 54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.1 151.34 42.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 174' ' ' LEU . 2.6 t -122.51 151.62 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.586 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.55 130.65 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.3 OUTLIER -127.78 111.36 13.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.68 71.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.83 43.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 167' ' ' LYS . 18.7 tp60 -132.19 93.45 26.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.18 139.1 21.01 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.968 1.779 . . . . 0.0 112.558 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.18 140.28 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.633 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 m -91.2 87.26 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.429 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -96.65 136.01 37.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.671 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 173.01 6.24 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.7 -52.25 9.43 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.26 1.973 . . . . 0.0 112.176 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -56.42 19.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.227 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -58.45 -38.68 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.61 ' CD2' ' CE1' ' A' ' 163' ' ' HIS . 13.1 t80 -61.75 -46.69 88.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.384 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -58.66 -41.57 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.42 -46.88 83.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.835 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.98 -39.79 87.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.486 ' NH1' HD11 ' A' ' 187' ' ' ILE . 59.1 ttt-85 -58.24 -45.22 88.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.849 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.415 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 4.5 t80 -69.65 -39.29 77.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.2 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -40.97 83.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.627 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.17 -45.33 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.814 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.486 HD11 ' NH1' ' A' ' 183' ' ' ARG . 70.5 mt -58.17 -34.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.415 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 63.1 m-20 -109.26 25.21 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.486 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.57 117.52 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.5 27.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.26 128.74 42.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.897 0.379 . . . . 0.0 110.792 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.69 114.25 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.529 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.62 156.78 16.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.747 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.24 147.91 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 3.7 mttp -58.94 -43.99 98.33 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.316 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 39.5 Cg_exo -54.64 -50.0 14.87 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.367 2.045 . . . . 0.0 111.875 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -62.22 -55.97 23.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 202' ' ' VAL . 2.9 mt -47.88 -43.98 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.934 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.556 HD21 ' CA ' ' A' ' 209' ' ' GLY . 8.3 tp -59.93 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.638 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.89 -30.48 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.336 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -72.5 -48.15 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -83.39 -60.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.454 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -53.41 -4.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.1 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttt180 -62.13 -4.22 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -132.02 28.09 4.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.594 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 207' ' ' PHE . 6.0 t70 -160.91 -144.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.903 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.485 ' O ' ' O ' ' A' ' 206' ' ' ASP . 1.5 m-85 -42.01 170.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.617 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.67 -86.6 0.04 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.556 ' CA ' HD21 ' A' ' 199' ' ' LEU . . . -158.83 98.92 0.18 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -97.25 99.74 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.02 -4.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -98.73 -27.23 14.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.255 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.454 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 13.1 t -66.13 -41.33 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.77 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -53.24 -49.76 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.47 -47.07 87.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.242 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 73.7 m -61.07 -43.87 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.09 -40.62 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.656 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 214' ' ' VAL . 71.1 t -62.41 -42.43 95.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.593 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -43.45 96.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -69.3 -30.43 68.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.35 -45.98 68.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.117 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 2.1 mtp180 -56.89 -44.93 82.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.59 -16.75 63.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -94.98 -29.45 14.63 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.683 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.28 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 110.713 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -110.19 137.49 47.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.593 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.52 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.01 -178.63 17.53 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.0 -15.42 63.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 110.649 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -91.58 111.78 23.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -86.01 136.07 33.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.393 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -88.21 -75.4 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.01 146.27 24.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -102.29 138.49 39.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.943 0.402 . . . . 0.0 110.856 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 45.1 m -95.4 110.54 22.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.979 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.61 70.81 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -40.57 120.68 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.39 -16.83 29.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.49 -53.14 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.281 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.09 -138.21 5.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.74 156.32 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.634 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.1 p -134.33 132.13 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.72 117.01 29.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 232' ' ' LEU . 4.9 ptm180 -162.8 132.04 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.74 152.65 86.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.994 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 111.46 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.369 2.046 . . . . 0.0 111.835 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.84 -179.603 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 143.13 120.51 1.52 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.73 148.52 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.04 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.403 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.45 -109.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.789 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -46.14 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -68.1 165.42 18.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.183 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 42.61 -162.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -153.3 -30.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 58.03 86.64 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -79.41 92.91 5.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -107.62 107.73 18.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.05 151.96 8.41 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -26.11 15.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.995 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 4.5 t -133.42 54.56 13.33 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.776 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 37.0 Cg_endo -66.4 -67.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.671 2.247 . . . . 0.0 112.341 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.7 mmt-85 -47.48 -48.42 26.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.804 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.99 -64.78 0.54 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.5 p -173.68 171.87 3.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.94 0.4 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -126.62 -158.6 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -154.34 21.9 0.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.809 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.7 168.97 15.68 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.267 0.556 . . . . 0.0 111.874 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.84 82.09 0.14 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -83.63 -174.52 5.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.692 0.282 . . . . 0.0 110.609 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 145' ' ' GLU . 26.8 tttt -168.87 151.6 5.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.375 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 144' ' ' LYS . 57.0 mt-10 -39.64 105.57 0.37 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.018 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.39 28.39 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.281 1.987 . . . . 0.0 112.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -95.32 -108.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.76 133.18 33.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.691 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.72 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.446 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -125.41 124.25 41.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.92 154.81 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 153.65 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.512 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 154' ' ' ALA . 68.7 t80 -166.75 135.84 2.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.515 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.98 -105.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -124.47 53.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.52 145.86 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.221 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 19.7 tt0 -141.1 143.12 34.13 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.458 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 165' ' ' VAL . 4.2 mp -140.35 128.86 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.91 105.3 13.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.108 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -65.86 -20.6 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.14 -39.04 84.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 110.665 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 70.3 p -115.9 -24.64 8.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.41 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.591 ' NE2' ' CE2' ' A' ' 179' ' ' PHE . 2.2 t-80 82.77 48.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.281 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -121.77 158.6 28.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.475 HG21 HD12 ' A' ' 174' ' ' LEU . 2.9 t -120.61 150.42 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.679 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.401 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.46 125.19 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.468 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 170' ' ' GLN . 8.7 tttt -125.61 117.39 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.33 64.13 0.2 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.272 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.25 30.67 67.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 167' ' ' LYS . 12.9 tt0 -133.99 92.92 21.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -76.96 136.41 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.927 1.751 . . . . 0.0 112.448 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.34 143.58 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.937 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.2 p -99.47 87.47 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -95.45 154.18 17.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.364 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.0 168.31 23.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -48.8 -53.18 7.33 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.701 2.267 . . . . 0.0 112.572 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -47.59 85.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.91 -39.21 93.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.245 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.591 ' CE2' ' NE2' ' A' ' 163' ' ' HIS . 9.0 t80 -63.66 -48.61 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.682 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -55.49 -43.28 75.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -47.07 85.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.36 -42.37 99.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.639 ' HE ' HD11 ' A' ' 187' ' ' ILE . 7.4 ttp180 -59.96 -45.7 91.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.04 -42.68 89.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.825 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -45.38 71.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.81 -49.29 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.639 HD11 ' HE ' ' A' ' 183' ' ' ARG . 56.6 mt -56.53 -31.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -107.17 15.23 25.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -49.69 120.35 4.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.87 -28.89 8.94 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -93.9 131.62 39.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 192' ' ' VAL . 9.0 p -69.13 122.24 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 193' ' ' LEU . 11.1 mp -95.39 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.501 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 149.23 31.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.584 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 13.3 mttp -55.68 -54.35 52.56 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.242 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.0 Cg_endo -66.99 -32.9 33.97 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.047 1.831 . . . . 0.0 111.768 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -47.49 71.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.772 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.02 -44.96 76.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.361 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.4 mt -61.77 -61.52 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.482 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.2 -38.91 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.995 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -72.01 -51.01 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.212 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 204' ' ' ARG . 37.7 t -83.6 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.234 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.618 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.6 OUTLIER -51.29 -3.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.032 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp85 -62.46 -1.33 0.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.671 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 205' ' ' TYR . 42.7 t80 -117.69 14.76 14.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.781 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER 167.1 105.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.59 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' A' ' 207' ' ' PHE . 25.7 p90 -80.78 123.74 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.619 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.531 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 156.45 55.11 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.618 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -160.28 100.72 0.19 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.667 ' OD1' HG23 ' A' ' 213' ' ' VAL . 23.3 p30 -53.33 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.603 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.55 -6.5 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -88.47 -23.17 23.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.755 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.667 HG23 ' OD1' ' A' ' 210' ' ' ASP . 48.0 t -65.43 -39.29 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.027 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 218' ' ' VAL . 74.9 t -56.86 -50.75 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.251 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -55.56 -48.5 74.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.39 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -43.25 97.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -43.97 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.625 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.2 t -62.1 -41.45 91.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.609 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.92 89.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.527 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.31 -27.15 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 218' ' ' VAL . 16.3 mt -76.0 -45.31 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.054 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.44 -46.19 80.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.664 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -66.9 -23.14 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.414 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -92.46 -24.33 18.85 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.565 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.67 -41.18 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.83 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.9 137.61 39.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.544 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 227' ' ' THR . 0.8 OUTLIER -174.37 37.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.89 179.91 18.86 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -73.45 -8.65 56.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.759 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -92.19 112.08 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.568 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.97 155.85 20.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.59 -38.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.523 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.34 120.15 40.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -101.68 128.87 47.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.417 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 109.04 20.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.36 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' ARG . 38.1 mt -94.35 69.11 3.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LEU . 40.8 mtm105 -41.07 110.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 124.01 -20.44 7.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.83 -46.66 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.62 -137.07 5.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 1.7 m-85 -125.21 157.12 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.643 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.5 p -143.0 128.94 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 244' ' ' ARG . 0.7 OUTLIER -90.51 142.47 27.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.406 ' H ' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.9 136.29 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.667 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.45 158.44 81.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 247' ' ' ARG . 87.4 Cg_exo -39.25 135.48 1.03 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.585 2.19 . . . . 0.0 111.731 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 246' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.753 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.42 -133.39 1.47 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.475 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -125.8 118.46 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.227 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.58 102.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.898 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -150.29 22.95 0.83 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -11.98 58.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.935 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -57.65 -34.95 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 110.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -101.2 61.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.571 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 15.1 t60 -154.56 17.56 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -88.58 -37.3 15.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 p -68.21 128.86 38.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -169.41 56.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 158.58 157.47 8.5 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 134' ' ' VAL . 0.7 OUTLIER 64.58 97.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.715 0.293 . . . . 0.0 110.981 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 133' ' ' LEU . 17.1 m -34.01 150.76 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.64 123.53 9.89 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.567 2.178 . . . . 0.0 112.67 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -91.42 90.53 7.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.39 62.12 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -80.51 -23.71 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.085 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.6 t60 62.84 153.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.974 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.3 mtp -142.25 156.15 45.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -96.8 -17.4 20.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.01 153.72 0.02 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -134.27 -35.27 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -113.16 -12.17 13.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.67 62.39 41.63 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.911 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.55 -91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.598 2.199 . . . . 0.0 112.292 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.51 109.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.849 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.93 147.51 36.91 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.288 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.84 112.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.4 mtm-85 -136.89 123.66 21.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.77 152.27 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.507 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -141.88 157.18 45.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.732 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.2 t80 -162.95 127.73 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.87 -98.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 10.2 p30 -125.07 54.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.35 147.23 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.201 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.75 137.23 31.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.534 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.05 137.37 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.551 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.78 108.48 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.455 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.586 ' OE2' ' NH1' ' A' ' 183' ' ' ARG . 25.4 mm-40 -66.52 -10.61 46.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.07 -42.86 8.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.067 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 163' ' ' HIS . 32.7 p -100.89 10.13 41.49 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 162' ' ' THR . 39.0 t-80 36.24 50.94 0.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -124.22 155.36 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 166' ' ' TRP . 13.3 t -117.14 159.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.449 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -146.07 129.24 16.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.3 tptp -127.81 110.25 12.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.42 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.57 67.95 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.74 31.45 64.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 167' ' ' LYS . 34.2 tp60 -142.01 87.92 9.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.35 146.42 80.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.115 1.876 . . . . 0.0 112.008 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -128.94 136.8 58.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.734 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.8 m -92.89 86.95 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.37 152.19 18.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.44 169.23 18.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.95 -54.15 4.94 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 112.185 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 p -54.98 -57.35 12.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.021 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -57.48 -39.14 75.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.655 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -63.95 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.753 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 m -59.07 -39.66 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.19 -45.24 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.685 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 tp -63.85 -39.44 94.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.518 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.586 ' NH1' ' OE2' ' A' ' 160' ' ' GLU . 12.5 ttt180 -64.11 -44.8 91.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -62.84 -40.71 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.959 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.56 -45.15 99.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.777 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.8 mt -58.97 -37.05 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -108.9 28.59 8.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 118.91 5.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.504 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.56 -21.04 22.07 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -96.01 131.68 42.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.674 0.273 . . . . 0.0 110.724 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.6 p -68.62 117.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.308 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.46 150.66 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.08 148.0 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.963 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 1.7 mttp -58.67 -46.43 99.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.1 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 45.5 Cg_exo -50.15 -51.65 10.51 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.024 1.816 . . . . 0.0 111.989 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.98 -55.23 27.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.321 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -49.17 -41.18 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.943 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' A' ' 214' ' ' VAL . 30.2 tp -61.43 -67.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.8 -16.78 7.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.133 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -71.11 -52.05 21.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.66 -44.3 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.4 m-90 -65.18 -5.72 7.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -2.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 206' ' ' ASP . 0.4 OUTLIER -124.29 13.33 8.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 1.0 OUTLIER 177.35 94.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.334 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -72.88 133.49 44.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.52 61.28 0.02 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.59 106.3 0.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -59.99 178.44 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.193 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.4 p -79.71 -6.0 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.8 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.92 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 199' ' ' LEU . 17.9 t -61.66 -48.62 87.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.415 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -52.63 -48.61 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.699 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.3 t -61.8 -48.32 81.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.38 -42.08 81.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.64 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 t -62.88 -46.32 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -43.92 92.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -33.31 74.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -46.19 75.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.081 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 18.2 mtp85 -56.17 -45.11 79.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -67.77 -24.82 65.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.542 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -93.19 -24.41 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.38 -36.4 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 5.4 t0 -98.59 138.49 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 -36.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.542 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.09 165.29 16.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -70.42 -8.33 50.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.855 0.36 . . . . 0.0 110.418 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.88 122.27 34.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -82.28 157.58 23.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.33 -41.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.073 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.1 112.92 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.451 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.561 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.2 m -96.27 108.55 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.194 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 237' ' ' ARG . 7.9 mt -95.41 69.75 3.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -35.57 127.0 0.64 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.104 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.57 39.97 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.16 -49.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.939 0.399 . . . . 0.0 110.204 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.85 -139.51 7.15 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.51 154.02 48.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.54 133.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.68 126.74 36.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.641 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -161.78 135.73 6.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.85 156.42 89.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.53 129.81 3.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.443 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -41.52 150.92 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.2 23.08 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.542 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.1 t -102.98 176.47 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.477 ' C ' ' H ' ' A' ' 126' ' ' HIS . 22.7 t60 58.44 74.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 109.91 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.471 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 24.3 t-80 -77.13 30.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.048 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 49.95 -165.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.011 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 47.69 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -169.82 153.86 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.716 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 59.58 114.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.979 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.9 p -165.06 137.44 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.27 147.79 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.83 121.91 5.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.44 -12.6 15.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.679 0.276 . . . . 0.0 110.593 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.5 t 41.76 61.69 7.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.505 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 20.1 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.713 2.275 . . . . 0.0 111.997 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.624 ' NH2' ' SD ' ' A' ' 140' ' ' MET . 0.6 OUTLIER 41.42 91.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.145 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.31 -13.95 0.06 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.2 p -136.64 150.95 48.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 140' ' ' MET . 29.7 m170 50.35 -162.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.624 ' SD ' ' NH2' ' A' ' 136' ' ' ARG . 3.9 mtt 36.91 94.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.774 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -123.47 -78.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.951 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 126.19 100.14 1.17 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.619 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -87.52 2.09 51.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 110.3 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -76.38 136.17 39.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 48.05 67.43 4.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 148' ' ' ASN . 94.7 Cg_endo -84.0 15.15 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.149 2.566 . . . . 0.0 113.005 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -41.88 95.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.403 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.491 ' CB ' HH21 ' A' ' 150' ' ' ARG . 14.7 m120 43.88 101.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.637 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.69 134.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.581 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.491 HH21 ' CB ' ' A' ' 148' ' ' ASN . 4.7 ptt180 -175.17 154.93 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.954 0.407 . . . . 0.0 110.883 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -91.98 147.69 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.1 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -141.96 158.1 44.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.46 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CE2' HD21 ' A' ' 243' ' ' LEU . 74.8 t80 -168.65 142.9 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.05 -105.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -124.83 52.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.73 152.38 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.581 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -145.79 144.39 30.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.634 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.65 124.73 21.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.845 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.4 m-20 -104.39 105.24 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.775 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.4 -11.6 52.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -95.03 -39.58 10.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.633 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.9 p -103.84 8.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 74.9 m-70 37.52 47.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.21 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -121.82 157.05 31.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.749 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.05 152.04 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.81 125.65 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -126.18 115.41 19.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.547 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.48 56.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.5 75.5 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 167' ' ' LYS . 44.1 mt-30 -131.07 96.27 22.78 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.27 137.79 15.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.087 1.858 . . . . 0.0 112.469 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.27 137.39 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.9 t -89.96 89.2 7.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.02 155.64 16.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.82 171.64 10.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -51.5 -52.16 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.302 2.002 . . . . 0.0 111.675 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.0 m -56.3 -52.08 65.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.956 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.92 -41.7 87.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.459 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 27.0 t80 -60.98 -44.58 97.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.101 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -58.0 -44.84 87.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.636 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.63 HD12 HG21 ' A' ' 202' ' ' VAL . 0.7 OUTLIER -61.45 -44.37 97.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.804 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -43.67 93.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -59.07 -45.16 91.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.55 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 14.1 t80 -65.34 -42.02 93.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.82 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.6 -39.72 68.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.66 -49.31 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.099 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 187' ' ' ILE . 43.6 mm -57.3 -32.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.745 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.91 18.17 21.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.56 114.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.709 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.07 -19.26 18.04 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 193' ' ' LEU . 94.4 m -95.78 132.45 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.87 115.47 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 191' ' ' THR . 4.6 mp -96.58 159.97 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.023 0.44 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 147.72 28.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.58 -54.8 51.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.062 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.9 Cg_endo -66.84 -33.64 33.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.96 1.773 . . . . 0.0 111.693 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -64.28 -51.64 62.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.09 -41.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.87 -66.9 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -49.91 -28.24 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.101 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 69.9 t60 -72.19 -57.54 4.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.63 HG21 HD12 ' A' ' 181' ' ' LEU . 57.3 t -83.42 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.378 . . . . 0.0 111.613 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.7 OUTLIER -49.12 -4.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.4 ttm180 -59.31 -0.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.072 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 t80 -111.67 6.03 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.754 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -176.95 107.66 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.529 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 29.1 m-85 -87.77 110.12 20.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.59 52.26 0.02 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.39 103.37 0.22 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 209' ' ' GLY . 37.2 m-20 -45.16 177.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.6 m -79.05 -8.26 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.894 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -82.97 -14.82 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 80.9 t -68.75 -36.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.2 t -57.93 -49.81 79.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.83 -44.62 90.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.066 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 m -60.84 -46.97 88.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.71 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.42 -41.45 98.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.615 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 214' ' ' VAL . 99.1 t -62.52 -43.33 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -45.53 91.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -28.96 68.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.05 -46.06 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 226' ' ' ASP . 32.9 ttm180 -56.03 -47.21 78.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.382 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -67.29 -15.56 63.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.504 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -93.45 -34.24 13.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.477 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.424 ' O ' ' CE ' ' A' ' 167' ' ' LYS . 2.1 pp -109.89 -36.14 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -98.42 141.79 30.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.337 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -161.4 25.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -117.93 169.03 13.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -65.89 -7.89 19.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.599 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 129.34 39.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.745 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.8 113.77 25.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.71 -4.82 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.102 0.477 . . . . 0.0 110.746 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.48 104.92 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.385 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 122.74 33.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.37 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.25 115.39 28.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 9.1 mt -96.1 69.17 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 31.5 mtp180 -35.84 128.19 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.738 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.68 -12.47 66.06 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.0 t -128.4 -60.26 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.88 -139.29 5.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -130.61 154.06 48.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.351 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 7.2 p -135.5 137.44 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.484 HD21 ' CE2' ' A' ' 153' ' ' PHE . 3.0 tp -91.92 116.9 29.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -162.27 144.47 11.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -77.02 153.77 82.73 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -36.75 128.03 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.679 2.253 . . . . 0.0 112.148 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.67 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 123' ' ' SER . . . -104.8 -170.7 24.41 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -46.03 90.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 121' ' ' GLY . 47.6 p -93.81 27.3 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -131.05 24.2 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.115 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.11 109.25 16.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.647 ' ND1' ' N ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER 42.66 -152.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -169.56 50.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -148.87 160.22 43.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 43.24 58.46 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.624 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -162.56 176.24 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.72 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.6 m 50.14 54.35 11.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.187 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.7 173.41 5.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.79 152.07 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 110.454 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 134' ' ' VAL . 13.6 p -160.31 56.63 0.83 Allowed Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.121 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.21 17.32 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.736 2.29 . . . . 0.0 111.952 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 134' ' ' VAL . 5.2 mtp85 56.34 164.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.13 -174.16 52.1 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.4 p -138.17 -99.7 0.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.911 0.386 . . . . 0.0 110.414 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.48 107.32 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.105 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.96 69.68 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -44.64 143.01 1.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.05 -160.23 9.64 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -140.83 -59.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.589 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -79.6 47.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.553 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 1.0 OUTLIER -64.23 -42.23 66.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 23.9 Cg_exo -61.42 -153.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.706 2.271 . . . . 0.0 112.064 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -151.18 38.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.75 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.17 139.72 22.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.36 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.89 114.35 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -123.43 121.51 35.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.87 159.5 16.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.36 153.94 47.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.981 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.9 t80 -160.26 125.16 3.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.472 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.62 -98.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' PHE . 13.5 m-20 -125.61 54.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.62 148.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.416 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.729 ' C ' HD12 ' A' ' 158' ' ' LEU . 1.8 mt-10 -138.98 133.23 31.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.556 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 157' ' ' GLU . 10.6 mp -128.6 140.17 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -113.07 102.39 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 0.0 110.376 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.0 -13.11 59.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -96.59 -50.08 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.824 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 50.3 p -94.08 11.86 28.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.504 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 96.5 m-70 36.27 53.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.87 157.37 29.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.428 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.18 156.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.39 128.2 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.456 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.5 ttpt -126.88 106.44 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.22 71.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.03 30.42 37.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.8 tt0 -140.95 85.9 12.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -63.42 154.07 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.411 2.074 . . . . 0.0 112.554 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.15 121.47 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.638 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 t -92.38 87.01 5.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.36 155.37 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -62.37 178.95 0.3 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.736 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 175' ' ' SER . 5.6 Cg_exo -67.6 -48.4 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.441 2.094 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.7 m -46.13 -54.18 9.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.298 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -43.68 84.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -55.8 -44.84 78.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -59.67 -46.99 87.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.575 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.77 -42.32 99.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.11 -46.12 90.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.743 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.55 -41.57 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.034 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.58 -43.78 88.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.72 -42.03 82.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.36 -53.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.92 -31.78 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.64 19.89 19.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.47 119.94 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.66 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.41 -25.83 10.14 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -94.16 126.38 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.7 p -68.56 120.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.29 157.62 15.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 148.62 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -56.41 -52.31 74.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.634 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.5 Cg_endo -63.83 -41.24 24.72 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.721 1.614 . . . . 0.0 112.155 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -60.91 -48.79 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.272 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.86 -40.47 71.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.917 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.531 ' O ' HD23 ' A' ' 199' ' ' LEU . 1.9 tt -56.68 -61.83 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.979 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -17.03 64.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.439 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.18 -45.6 63.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.581 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -84.53 -53.7 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.793 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 206' ' ' ASP . 4.8 m-90 -64.01 -3.07 2.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.528 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -40.97 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 203' ' ' TRP . 6.4 m-85 -100.12 27.42 5.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 166.05 103.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.948 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -43.38 149.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.499 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.45 178.67 27.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.66 64.36 0.29 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.26 94.53 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.869 0.366 . . . . 0.0 110.296 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.49 -10.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.665 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -91.53 -23.11 20.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.34 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.397 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 218' ' ' VAL . 97.3 t -53.79 -48.0 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.35 -45.54 87.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.49 98.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -40.68 89.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.24 -41.29 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -44.3 88.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.0 -27.43 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.27 -48.76 32.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.105 0.479 . . . . 0.0 110.188 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 14.6 ttp180 -56.6 -51.32 69.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -67.05 -8.04 27.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -91.64 -37.46 13.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -117.54 -34.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.085 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -98.24 151.26 20.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.808 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.9 t -177.46 -30.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.209 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -65.38 174.02 18.66 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -67.08 -5.7 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.821 0.344 . . . . 0.0 110.795 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -92.96 104.77 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.477 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.6 107.31 18.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.56 -2.55 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.504 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.11 103.62 8.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.336 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 122.92 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 0.0 110.603 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.1 m -91.26 112.14 23.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.744 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.8 mt -96.29 70.12 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 236' ' ' LEU . 5.9 tpp180 -35.69 116.87 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.797 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.76 -9.97 40.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.9 -36.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.48 -137.39 8.89 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.8 150.75 51.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.24 141.08 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.08 116.57 28.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.135 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -162.2 127.5 3.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.646 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.5 mp0 -65.91 155.81 85.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.464 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.42 119.23 6.19 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.657 2.238 . . . . 0.0 112.186 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.619 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.93 20.5 2.33 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 123' ' ' SER . 0.2 OUTLIER -122.65 -59.42 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 122' ' ' SER . 0.6 OUTLIER -52.0 -32.15 32.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.769 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -154.27 139.17 17.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.389 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -104.09 -167.09 1.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.293 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -122.33 122.7 39.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.11 -43.52 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.858 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -7.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.243 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 57.46 179.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 131' ' ' SER . 44.4 m 48.43 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' SER . 14.7 m 53.0 107.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.4 -141.78 1.91 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 tp -124.61 76.66 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.778 0.323 . . . . 0.0 110.311 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.521 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 29.8 m -131.89 49.44 4.62 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 19.5 Cg_endo -63.69 179.02 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.921 2.414 . . . . 0.0 112.208 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -132.02 98.76 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.95 -44.77 94.05 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.6 t -82.48 147.95 28.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 140' ' ' MET . 14.2 t-160 -160.9 74.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.455 ' CB ' ' O ' ' A' ' 139' ' ' HIS . 4.9 ttm 77.98 -63.13 0.34 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.8 tttm 53.5 -151.77 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.392 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.95 -93.86 0.46 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -130.88 -57.95 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.08 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -61.35 144.1 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -95.03 152.16 39.34 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.376 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -38.66 121.99 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.618 2.212 . . . . 0.0 112.061 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -85.75 102.53 13.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -91.13 110.71 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.515 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.04 137.01 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.433 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -135.85 128.94 31.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.19 149.12 21.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 156' ' ' ILE . 1.7 m -141.6 155.83 45.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.5 t80 -158.15 124.48 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.989 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -94.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 153' ' ' PHE . 4.1 m-20 -124.41 53.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.3 151.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.37 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -147.76 140.7 24.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.576 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.89 138.92 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.424 ' CB ' ' OG1' ' A' ' 162' ' ' THR . 12.8 m-20 -111.36 106.37 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.382 . . . . 0.0 110.489 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -9.95 38.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.064 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.96 -47.37 4.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.015 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.0 p -94.73 8.48 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.768 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 162' ' ' THR . 12.7 m80 36.53 55.35 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -128.64 154.13 46.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.486 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.57 152.84 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.95 126.71 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.799 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 170' ' ' GLN . 10.0 tmtt? -130.13 115.69 17.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.341 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.04 67.88 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 56.7 29.47 58.19 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.1 tt0 -132.09 89.4 38.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.98 132.0 12.5 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.08 1.853 . . . . 0.0 112.475 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 135.56 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.741 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 96.51 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.7 148.19 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.562 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.31 169.85 18.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -54.18 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -49.44 77.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -60.71 -38.76 86.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.1 -46.39 87.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -63.13 -41.19 99.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 202' ' ' VAL . 1.1 tp -57.8 -48.87 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.1 -44.99 87.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.553 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -55.39 -42.69 74.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.49 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 8.1 t80 -68.53 -43.92 75.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.488 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.77 -41.39 73.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.5 -48.68 79.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.94 -32.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.791 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.49 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 51.8 m-20 -106.45 23.12 14.7 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.093 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.51 116.6 3.2 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.31 10.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.9 m -91.76 129.4 37.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 110.291 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 242' ' ' VAL . 68.8 t -67.57 121.28 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.1 162.69 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.96 147.96 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.1 mtmt -58.21 -54.75 52.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.252 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.6 Cg_endo -68.85 -30.64 26.49 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.923 1.749 . . . . 0.0 111.819 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -67.41 -50.73 58.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.933 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.9 mt -57.16 -39.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 210' ' ' ASP . 5.7 tt -59.47 -67.88 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.342 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -25.55 3.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -50.67 27.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.841 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 204' ' ' ARG . 98.9 t -83.28 -59.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.657 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.534 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -52.73 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.5 tpp180 -53.54 -4.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 203' ' ' TRP . 14.2 m-85 -104.19 7.36 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -177.15 125.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.83 133.54 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 210' ' ' ASP . . . -176.18 93.32 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.74 60.98 0.49 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 m-20 -108.64 95.86 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.2 p -84.15 -9.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.771 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -90.41 -23.94 20.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.771 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.18 -41.17 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.516 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.87 -50.58 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.327 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -56.64 -46.55 80.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -44.85 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.794 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.88 -38.84 89.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.62 -39.96 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.32 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -44.68 78.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.184 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -69.72 -14.15 62.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.4 -46.82 9.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.939 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.1 mtt-85 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -66.08 -14.5 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -93.13 -27.06 17.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.897 ' O ' HD12 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -118.25 -45.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.592 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.3 t70 -93.67 137.1 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.005 0.431 . . . . 0.0 110.642 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.6 t -179.23 36.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.161 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -143.21 165.39 27.03 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.48 -3.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 228' ' ' GLY . 24.6 mttt -93.46 133.01 37.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.633 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -92.81 158.9 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.365 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.8 mt -147.21 -55.43 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.308 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.42 126.79 48.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.503 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.494 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.81 125.08 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.51 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 112.4 24.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.447 HD12 HG13 ' A' ' 192' ' ' VAL . 68.9 mt -96.22 67.82 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.67 115.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 -12.34 24.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.03 -55.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.512 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.83 5.69 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.5 152.45 49.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.718 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 192' ' ' VAL . 5.9 p -136.03 131.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.184 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -91.88 128.7 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -162.89 138.2 6.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -79.71 156.08 75.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.296 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.0 107.47 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.291 179.72 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 34.1 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.01 -5.56 1.61 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 124' ' ' HIS . 2.1 p -168.16 14.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.356 . . . . 0.0 110.48 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t 42.95 -88.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.552 ' N ' ' O ' ' A' ' 122' ' ' SER . 1.2 t60 69.88 168.73 0.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -92.93 -57.07 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -97.33 154.23 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.46 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -134.27 -70.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.501 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.614 ' CG ' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -144.12 -149.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.333 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.614 ' N ' ' CG ' ' A' ' 128' ' ' HIS . 13.2 m170 -44.07 -96.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.7 m -158.99 -58.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.629 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 m -149.39 -92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.021 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.43 -25.17 24.0 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 134' ' ' VAL . 12.7 tp -112.6 115.14 28.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.835 0.35 . . . . 0.0 110.465 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 133' ' ' LEU . 1.6 m -30.59 97.31 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.547 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.4 -55.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.193 1.929 . . . . 0.0 112.391 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -107.78 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.722 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.77 155.16 38.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -86.62 59.75 5.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.862 0.363 . . . . 0.0 110.308 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 t60 -84.24 -14.38 50.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -149.29 172.04 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.997 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 tttm 53.3 77.62 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 110.213 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -135.32 28.87 2.97 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -80.72 -8.58 59.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 0.0 110.649 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -113.11 130.98 56.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -85.27 159.4 56.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.094 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 145' ' ' GLU . 80.6 Cg_exo -37.87 162.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.837 2.358 . . . . 0.0 112.222 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.47 5.85 9.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.067 0.461 . . . . 0.0 109.896 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.94 121.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.541 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.11 129.8 36.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.558 HH12 ' CG ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -172.07 -178.32 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.532 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.49 154.07 41.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.6 m -139.29 156.7 46.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 156' ' ' ILE . 37.1 t80 -161.59 132.58 5.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.98 -102.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -121.38 52.48 1.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.85 141.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.213 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.558 ' CG ' HH12 ' A' ' 150' ' ' ARG . 15.8 tt0 -140.05 134.03 30.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 110.401 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.663 HD23 HG22 ' A' ' 165' ' ' VAL . 1.3 mt -130.28 136.61 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 163' ' ' HIS . 83.3 m-20 -113.89 104.81 12.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.89 -27.76 68.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.789 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.64 -44.21 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 59.4 p -102.59 9.5 39.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.497 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CG ' ' C ' ' A' ' 162' ' ' THR . 12.6 p-80 37.13 55.2 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -126.85 158.92 35.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.794 HG21 HD12 ' A' ' 174' ' ' LEU . 18.4 t -121.75 155.01 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.648 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.41 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.33 125.19 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.5 tttm -124.81 109.06 12.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.26 57.34 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.121 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.76 29.15 71.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 167' ' ' LYS . 27.6 mt-30 -141.74 89.96 8.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.788 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -64.71 147.19 89.73 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 112.129 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.96 136.45 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -88.55 87.72 7.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 165' ' ' VAL . 5.9 mt -94.29 144.67 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.29 162.96 54.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.514 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.7 -53.83 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.51 2.14 . . . . 0.0 112.427 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 p -59.93 -50.04 75.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.78 -34.53 77.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.71 -46.32 79.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -58.12 -43.92 87.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 mt -58.19 -48.35 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.64 89.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -57.74 -44.79 86.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.558 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -66.23 -43.36 86.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.62 -46.55 77.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.604 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.76 -46.01 95.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.85 -38.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -104.3 23.92 12.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.98 123.58 11.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.4 -27.59 13.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.61 129.87 38.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 123.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.352 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 198' ' ' ILE . 9.3 mp -94.68 157.32 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 148.98 29.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.361 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.7 mtpt -56.57 -53.97 58.59 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 37.1 Cg_endo -71.4 -32.49 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.963 1.775 . . . . 0.0 111.828 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -64.2 -50.49 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 193' ' ' LEU . 54.9 mt -56.91 -42.43 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.46 -63.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.21 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.34 -28.6 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -72.4 -52.01 17.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.303 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.0 t -82.94 -62.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.211 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -4.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.5 ttt180 -63.19 -3.89 2.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.892 0.377 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.82 6.79 11.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.448 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.89 101.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.646 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -84.07 120.2 25.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.54 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 160.14 48.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.29 106.87 0.3 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 209' ' ' GLY . 1.5 m-20 -49.22 -173.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.971 0.415 . . . . 0.0 110.55 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.5 -8.4 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -85.24 -15.83 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.888 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.55 -33.34 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.43 -50.31 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.216 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.11 -49.24 72.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -63.78 -39.97 95.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 241' ' ' TYR . 18.2 t -62.46 -42.58 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' NH1' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -62.79 -43.65 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.39 -37.66 85.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.255 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.22 -46.78 85.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.069 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.42 -42.66 78.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.97 -10.12 50.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -39.14 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.69 -30.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.208 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 222' ' ' ARG . 19.9 t0 -91.57 -160.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER 72.14 6.11 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.73 -139.59 5.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -36.91 11.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -92.5 120.45 32.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.018 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 19.4 mtp85 -90.5 92.75 9.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.971 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.9 OUTLIER -90.73 -0.91 57.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.82 110.18 12.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.48 42.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.639 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 74.9 m -97.63 113.45 25.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 237' ' ' ARG . 4.9 mt -98.95 67.76 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.646 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.6 mtm180 -37.49 125.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.838 0.351 . . . . 0.0 110.79 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.72 -32.86 6.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.55 -56.77 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.457 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.24 -137.46 4.94 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -128.39 157.07 42.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.37 142.4 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 111.074 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.86 118.02 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.053 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -161.76 129.78 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.023 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.3 155.01 94.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -38.48 156.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.783 2.322 . . . . 0.0 112.435 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.612 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.3 ptm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.1 106.93 2.87 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.016 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.28 140.16 48.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 110.411 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 124' ' ' HIS . 1.6 m -159.55 36.43 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' A' ' 123' ' ' SER . 0.8 OUTLIER 66.86 33.26 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.475 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 16.2 t-80 -52.94 174.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.475 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER 55.51 154.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.495 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -69.75 154.6 41.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.566 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -164.03 30.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -94.61 118.37 31.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.6 107.73 3.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 t -97.51 87.89 4.23 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.749 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.73 68.47 0.31 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.82 -23.43 13.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.601 0.239 . . . . 0.0 110.91 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 134' ' ' VAL . 12.8 p -161.74 69.87 2.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.23 163.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.986 2.458 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.57 -173.18 2.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.527 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.08 84.49 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.95 -36.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.59 0.233 . . . . 0.0 110.434 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.18 136.3 34.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 59.1 mtt -45.99 154.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.347 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.76 8.71 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -39.48 129.57 2.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -146.53 63.64 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.313 . . . . 0.0 110.344 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -94.96 167.51 11.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.567 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 48.25 58.0 17.81 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.563 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.47 119.08 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.857 2.371 . . . . 0.0 112.205 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -90.38 -108.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 148' ' ' ASN . 0.3 OUTLIER 48.76 79.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 149' ' ' VAL . 0.3 OUTLIER -84.19 141.4 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.558 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -138.59 130.05 27.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.64 140.61 29.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 m -142.09 152.37 43.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.1 t80 -166.25 139.11 3.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.03 -104.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.37 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.13 147.17 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.991 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -144.62 141.67 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.712 0.292 . . . . 0.0 110.428 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -135.52 136.74 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.388 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -112.02 108.49 17.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.288 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -66.27 -9.95 37.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.661 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -100.2 -43.75 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.916 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 25.6 p -95.74 9.04 41.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 162' ' ' THR . 10.9 m170 35.65 41.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.621 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -122.44 159.02 28.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.773 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.944 HG21 HD12 ' A' ' 174' ' ' LEU . 25.1 t -118.94 158.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.465 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -146.44 123.42 11.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.51 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.9 tmtm? -127.47 115.03 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.255 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.16 67.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.43 31.46 63.05 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -133.55 90.87 27.62 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.53 138.72 15.64 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.203 1.935 . . . . 0.0 112.36 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.18 138.74 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m -85.63 93.09 8.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.944 HD12 HG21 ' A' ' 165' ' ' VAL . 89.3 mt -95.91 140.86 30.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.454 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.13 174.03 6.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.95 -53.49 7.07 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.382 2.055 . . . . 0.0 112.097 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.0 m -54.96 -56.65 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.773 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.506 ' CD ' HD11 ' A' ' 221' ' ' LEU . 2.5 mt-10 -60.98 -37.24 81.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.49 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.74 -46.36 88.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.63 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -58.65 -41.0 85.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.795 HD12 HG21 ' A' ' 202' ' ' VAL . 1.0 OUTLIER -61.39 -52.53 64.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.658 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.8 -41.86 87.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.503 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -62.41 -44.53 96.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.417 ' OH ' ' CE1' ' A' ' 201' ' ' HIS . 1.3 t80 -59.25 -39.73 83.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.77 -41.15 99.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.185 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.65 -43.24 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.962 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.8 -42.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.12 26.91 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . . . -56.13 125.21 20.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.709 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.09 -23.5 30.5 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 126.8 41.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.821 0.343 . . . . 0.0 110.294 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 192' ' ' VAL . 13.6 p -68.25 116.66 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 mp -96.56 153.12 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.15 149.23 24.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.313 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.69 -46.69 99.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.506 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 37.2 Cg_exo -55.11 -47.14 28.02 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.867 1.712 . . . . 0.0 111.897 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -61.91 -57.32 12.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.5 mt -50.63 -36.24 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.19 -58.33 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.146 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.43 -27.53 68.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.814 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' CE1' ' OH ' ' A' ' 184' ' ' TYR . 0.2 OUTLIER -73.2 -59.83 2.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.623 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.795 HG21 HD12 ' A' ' 181' ' ' LEU . 13.9 t -84.54 -58.22 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.704 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' A' ' 206' ' ' ASP . 1.1 t-105 -51.76 -4.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.055 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.8 ttt-85 -64.24 0.33 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.591 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 m-85 -106.86 5.77 28.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.608 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -174.41 102.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.771 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.9 107.51 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.91 48.85 0.02 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -158.94 101.94 0.21 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.7 OUTLIER -48.78 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.151 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.8 m -80.82 -1.0 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.7 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -95.14 -23.72 17.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.15 -38.47 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -60.81 -44.6 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.85 -48.9 74.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -60.94 -44.18 97.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -40.44 97.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' VAL . 53.5 t -62.54 -41.56 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.485 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -44.87 94.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 110.211 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -65.15 -37.85 88.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' A' ' 178' ' ' GLU . 1.8 mp -65.56 -44.74 85.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.379 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 226' ' ' ASP . 21.7 mtp180 -55.28 -42.63 73.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -16.13 64.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -93.07 -26.63 17.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.509 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -117.87 -38.47 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.769 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.5 OUTLIER -98.3 136.67 38.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.503 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -173.27 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.872 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.25 179.87 0.73 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -79.39 -12.62 59.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.7 0.286 . . . . 0.0 110.716 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -93.66 122.19 35.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.563 ' C ' HD12 ' A' ' 232' ' ' LEU . 18.1 mmm-85 -82.67 158.35 23.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -146.78 -42.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.008 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.63 112.05 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.16 122.79 40.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.6 m -92.6 107.09 18.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.4 mt -93.21 71.8 4.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 57.5 mtp180 -36.78 133.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.644 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.23 74.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.12 -58.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.952 0.406 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 156.07 -139.61 6.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -129.17 154.6 46.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.551 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 242' ' ' VAL . 15.0 p -136.67 132.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.197 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.91 126.28 35.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -162.22 130.43 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.44 157.0 87.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -37.23 113.87 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.738 2.292 . . . . 0.0 112.33 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.317 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.6 mmm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.52 -25.49 2.39 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -89.8 -86.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.809 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.5 p 47.6 -165.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -81.6 90.06 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.999 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -54.9 -56.49 18.97 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.465 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' A' ' 127' ' ' HIS . 13.1 t-80 -134.27 -128.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.765 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 126' ' ' HIS . 13.6 m-70 -121.52 117.12 26.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.248 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 12.1 m-70 -145.74 -72.48 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.191 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' SER . 12.4 m-70 -96.23 -45.54 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.528 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.1 OUTLIER 55.22 109.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.9 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 t -61.23 -28.16 68.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 110.076 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.51 148.86 17.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.507 ' C ' HD23 ' A' ' 133' ' ' LEU . 1.4 tt -115.1 -62.97 1.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 134' ' ' VAL . 9.4 p -154.38 59.66 2.54 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.546 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.84 177.14 8.5 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.271 2.647 . . . . 0.0 112.322 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -116.59 172.81 6.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.88 55.82 1.12 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -56.55 -95.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 141' ' ' LYS . 9.7 t-80 -82.53 -23.27 34.65 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.267 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.481 ' SD ' ' C ' ' A' ' 140' ' ' MET . 0.0 OUTLIER -60.13 78.15 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -75.93 -19.19 58.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.531 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.93 40.17 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -165.72 151.04 8.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -115.75 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.86 152.85 54.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.05 176.73 5.05 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.764 2.309 . . . . 0.0 112.593 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -146.37 111.18 5.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 56.68 101.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.573 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.5 109.94 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.5 mtm-85 -106.33 -177.17 3.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.59 HD22 HG11 ' A' ' 186' ' ' VAL . 3.0 mt -145.94 133.3 20.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.205 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -139.23 156.86 46.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 8.8 t80 -164.92 130.85 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.89 -99.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 74.4 m-20 -124.45 53.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.43 144.39 30.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.349 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -140.29 131.0 25.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.946 0.403 . . . . 0.0 110.557 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.506 HD23 HG22 ' A' ' 165' ' ' VAL . 1.4 mp -127.49 152.2 47.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.34 107.63 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.3 -12.23 55.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -96.11 -49.71 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.3 p -92.57 11.18 27.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.479 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 15.0 m80 35.27 48.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -117.58 159.92 22.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 158' ' ' LEU . 14.5 t -125.43 150.09 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.428 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.3 127.09 14.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.512 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.8 tmtm? -129.45 114.13 15.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.88 71.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.55 24.82 32.93 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.9 tt0 -129.02 94.73 33.26 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.488 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.94 137.28 12.34 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.158 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.63 135.83 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.068 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 m -92.63 88.96 6.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.5 153.94 17.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.67 171.48 10.52 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.455 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.8 -54.07 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.492 2.128 . . . . 0.0 112.319 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.3 m -54.76 -54.25 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.75 -38.01 83.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 110.756 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 22.5 t80 -63.57 -43.21 97.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.6 m -62.42 -43.46 98.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -59.35 -43.91 92.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 182' ' ' LEU . 38.4 tp -71.36 -38.47 71.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.659 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.474 ' HE ' HD11 ' A' ' 187' ' ' ILE . 8.7 ttp180 -58.19 -41.24 83.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.691 ' CZ ' ' NE2' ' A' ' 201' ' ' HIS . 15.4 t80 -69.83 -39.85 76.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.804 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.61 -41.95 82.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 151' ' ' LEU . 56.4 t -67.9 -48.16 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.474 HD11 ' HE ' ' A' ' 183' ' ' ARG . 88.3 mt -58.64 -31.41 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -106.08 21.25 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.0 118.35 3.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.81 -19.62 35.38 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 m -98.27 126.97 43.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 192' ' ' VAL . 3.5 p -68.53 122.08 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 198' ' ' ILE . 5.2 mp -96.59 159.82 14.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 147.85 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.796 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.4 mtmm -56.84 -56.69 30.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -63.64 -32.67 68.84 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.013 1.808 . . . . 0.0 111.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -68.61 -51.72 39.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.951 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 193' ' ' LEU . 18.2 mt -53.0 -36.94 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.893 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 199' ' ' LEU . 0.9 OUTLIER -61.21 -70.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.422 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -52.18 -17.33 1.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.155 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.691 ' NE2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.57 -53.38 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.099 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.2 t -83.26 -40.42 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -60.67 -3.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 202' ' ' VAL . 25.9 ttt180 -61.41 -0.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.6 m-85 -118.24 -0.28 11.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.085 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -171.47 85.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.303 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -42.79 160.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.393 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.89 -158.1 20.7 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 210' ' ' ASP . . . -160.97 78.27 0.17 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 209' ' ' GLY . 15.3 m-20 -147.56 95.07 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 0.0 110.655 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.2 m -83.4 -8.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -23.03 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 210' ' ' ASP . 2.4 p -63.56 -35.5 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 218' ' ' VAL . 98.8 t -57.16 -52.46 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.494 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.64 -45.5 91.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -44.84 96.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 110.735 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -61.52 -44.96 96.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 214' ' ' VAL . 87.4 t -62.24 -37.93 79.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.523 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -46.26 76.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.2 -17.41 63.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.389 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -49.19 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.069 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -55.75 -47.7 76.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.169 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -67.3 -13.04 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.553 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -95.05 -32.73 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.471 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.64 -34.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.222 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -100.08 140.04 34.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 110.69 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.23 -37.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -55.68 174.3 1.09 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.93 -9.4 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.799 0.333 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 104.64 16.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.655 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -83.69 112.59 20.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.486 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.83 1.05 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.09 107.11 12.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.25 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.548 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -92.63 123.37 35.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.618 HG23 ' CE2' ' A' ' 241' ' ' TYR . 67.9 m -90.96 111.2 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 237' ' ' ARG . 47.0 mt -95.85 68.27 2.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.467 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.4 tpp180 -38.52 124.26 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.25 -14.09 47.93 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.79 -56.79 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.632 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.19 -137.3 4.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG23 ' A' ' 235' ' ' THR . 29.4 m-85 -128.37 156.96 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 234' ' ' HIS . 5.2 p -140.55 133.55 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 2.6 tp -90.84 128.63 36.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -163.35 135.25 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.629 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 246' ' ' PRO . 7.4 mt-10 -76.09 155.86 84.28 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 245' ' ' GLU . 69.3 Cg_exo -39.89 169.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.675 2.25 . . . . 0.0 112.2 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.577 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' GLY . 17.5 mtp . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 122' ' ' SER . . . -35.3 -88.25 0.01 OUTLIER Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -34.98 111.32 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -148.56 124.14 10.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -151.39 120.29 6.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.862 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 126' ' ' HIS . 3.7 m80 -161.74 -45.22 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 125' ' ' HIS . 93.8 m-70 36.82 -109.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.553 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -119.71 -78.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.35 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 50.49 66.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.148 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.42 165.88 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 m 58.11 58.72 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.79 120.38 29.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.814 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.5 54.23 0.49 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -62.63 1.31 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.683 0.277 . . . . 0.0 110.665 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.1 t -139.77 68.87 37.03 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.792 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.5 -10.87 17.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.742 2.295 . . . . 0.0 112.025 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -133.43 86.67 2.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.541 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.14 -109.64 3.37 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' MET . 47.4 m -155.02 -58.38 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.819 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -47.57 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.2 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -74.45 103.28 4.75 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.334 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.46 175.32 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.923 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.56 -171.3 37.67 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m120 42.6 74.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.432 . . . . 0.0 110.53 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 145' ' ' GLU . 1.7 pttt -91.83 16.41 10.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.927 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 144' ' ' LYS . 2.4 pt-20 33.77 76.52 0.4 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.53 -97.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.866 2.377 . . . . 0.0 112.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -165.61 18.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.32 113.93 25.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 117.21 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.2 mtm105 -142.46 129.44 20.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.66 158.16 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.19 155.94 45.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.619 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 28.0 t80 -165.47 129.81 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.912 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.5 -99.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.1 m-20 -124.67 54.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.43 152.16 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.604 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.78 145.65 35.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.408 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -143.67 116.95 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.63 108.22 18.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.57 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -66.71 -24.95 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -50.59 -40.35 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 69.7 p -119.53 -23.9 6.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.5 t-80 84.02 53.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.384 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -127.39 156.82 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.654 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 t -117.0 153.76 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.44 126.95 15.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 170' ' ' GLN . 16.0 ttpp -126.04 113.07 16.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.13 67.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.016 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.46 32.81 64.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -137.56 92.14 13.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.89 139.96 20.04 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.095 1.864 . . . . 0.0 112.326 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.82 140.8 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.911 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -96.29 90.19 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.386 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.68 150.18 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.672 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 169.43 17.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.77 -54.53 4.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.533 2.155 . . . . 0.0 112.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.327 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -57.07 -37.2 71.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -59.3 -46.08 89.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.4 m -63.82 -41.1 97.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.284 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -46.7 84.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -45.33 86.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.712 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -60.24 -42.98 96.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.658 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 11.6 t80 -65.25 -40.35 93.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -43.01 89.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.684 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.31 -45.35 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.8 -34.65 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.753 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -106.64 22.33 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.682 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.95 110.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.9 -27.52 7.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.3 132.39 33.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.27 113.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.85 148.02 30.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.64 -51.34 82.42 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.544 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 24.4 Cg_endo -64.13 -37.84 39.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.601 1.534 . . . . 0.0 111.682 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -65.76 -44.84 84.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.052 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.85 -41.99 68.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' TRP . 5.0 mt -61.93 -65.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -41.4 -34.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.658 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 53.7 t-80 -71.76 -53.78 12.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.9 t -83.54 -57.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -53.16 -2.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.217 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -60.76 -3.1 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.567 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 39.0 t80 -117.41 10.0 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.64 97.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 132.89 41.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.274 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 149.47 55.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.12 103.04 0.22 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.605 ' O ' HG12 ' A' ' 213' ' ' VAL . 89.6 m-20 -52.81 -176.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.355 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.7 m -81.75 -6.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.562 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.22 -18.98 23.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.789 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 210' ' ' ASP . 7.0 p -65.93 -33.5 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 218' ' ' VAL . 58.7 t -65.28 -51.14 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.072 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.71 -46.01 70.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.982 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -48.55 81.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.47 -39.21 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.497 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.6 t -62.5 -42.23 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -25.48 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.24 -42.48 45.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 226' ' ' ASP . 44.5 ttt180 -55.79 -50.4 70.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.5 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -7.43 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.115 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -42.05 10.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.47 -25.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.398 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.555 ' C ' HG22 ' A' ' 227' ' ' THR . 0.2 OUTLIER -101.99 146.35 28.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.935 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 226' ' ' ASP . 0.1 OUTLIER -176.7 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.62 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -49.23 162.86 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.0 -8.12 34.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.01 126.6 38.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.56 ' C ' HD12 ' A' ' 232' ' ' LEU . 10.9 mtp180 -81.12 159.62 24.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -147.08 -41.17 0.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.969 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.9 114.67 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.476 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -97.9 124.32 42.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.534 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.56 114.61 27.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 238' ' ' GLY . 11.2 mt -95.88 68.72 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.161 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -41.87 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.162 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 236' ' ' LEU . . . 129.68 -13.28 5.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.55 -50.32 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.659 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.76 -137.71 5.46 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 151.65 50.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.2 p -140.04 127.65 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 16.4 tp -90.49 138.03 31.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.08 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 139.89 7.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -69.99 157.57 89.44 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.463 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.99 109.61 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.486 2.124 . . . . 0.0 112.091 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.631 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.445 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 5.3 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.8 35.86 4.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.2 128.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.92 27.99 4.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.59 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER -53.0 -78.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.034 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -60.74 -174.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 -166.45 1.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.048 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -150.22 115.82 5.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.915 0.388 . . . . 0.0 110.063 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -97.92 142.58 29.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.937 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.83 118.66 2.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.933 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.27 -36.68 22.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.6 p -54.17 120.91 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.465 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.72 79.11 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 mt -104.19 141.07 36.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.411 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 3.0 m -145.42 56.52 3.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.309 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 39.6 Cg_endo -68.84 50.07 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.827 2.351 . . . . 0.0 111.886 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.8 54.29 0.88 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.303 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -50.76 -62.25 5.41 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.5 m -167.92 -53.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.279 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -150.16 99.74 2.84 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.378 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.13 -57.76 1.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.808 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -86.65 -54.25 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.275 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -45.64 103.56 0.06 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -168.72 -65.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.116 0.484 . . . . 0.0 110.224 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 51.0 mttm -40.66 124.5 2.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.357 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.648 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 2.2 tt0 -81.18 -39.66 1.03 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.971 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 23.6 Cg_exo -61.09 156.94 41.89 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.547 2.165 . . . . 0.0 111.815 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -113.97 -29.48 7.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.754 0.311 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.59 123.05 28.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.777 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.96 114.35 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.461 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -122.26 121.04 35.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mt -90.54 147.78 23.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.2 154.32 46.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.095 0.474 . . . . 0.0 111.094 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 155' ' ' ASP . 62.4 t80 -159.29 126.98 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.599 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.29 -96.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 1.2 p30 -124.34 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.56 145.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -144.21 138.68 28.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.787 0.327 . . . . 0.0 110.424 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.43 139.45 42.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.07 102.91 11.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 0.0 110.588 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.12 -8.94 26.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -99.0 -45.28 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.729 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.7 p -98.88 13.04 33.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.338 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 1.0 OUTLIER 35.12 54.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.635 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.26 152.49 48.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.25 157.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.35 125.85 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.479 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 19.2 tptt -122.9 110.53 15.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.397 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.58 59.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.483 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 23.65 77.72 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 24.5 mt-30 -131.86 95.99 21.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.402 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.49 134.92 14.3 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.082 1.855 . . . . 0.0 112.439 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.5 143.79 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.772 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.43 95.39 9.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.631 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 182' ' ' LEU . 10.9 mp -94.71 154.17 17.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.48 172.46 7.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.262 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.37 -51.27 11.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.459 2.106 . . . . 0.0 112.149 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.2 m -58.1 -54.61 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' A' ' 221' ' ' LEU . 24.8 mt-10 -55.77 -43.96 77.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.483 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.92 -48.56 81.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.526 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 m -56.77 -46.32 81.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.586 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.46 -47.05 87.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.69 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 174' ' ' LEU . 0.9 OUTLIER -63.51 -41.53 98.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -59.57 -45.2 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.388 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -61.62 -43.98 97.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.615 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -55.51 -47.86 75.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -47.06 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.019 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mm -54.9 -34.32 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.786 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -112.53 20.4 16.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.0 119.59 4.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.28 -26.28 10.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.6 m -97.82 129.59 44.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.803 0.335 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.672 HG22 ' HB ' ' A' ' 242' ' ' VAL . 43.7 t -67.89 117.01 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.651 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.64 160.03 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.667 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.97 148.84 26.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.63 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.503 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.06 -49.48 93.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 35.9 Cg_exo -54.08 -44.17 51.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.373 2.048 . . . . 0.0 111.778 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -59.93 3.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.4 mt -48.25 -42.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.49 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.502 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 17.0 t0 -53.7 -24.03 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.594 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 51.7 t-80 -71.84 -50.36 30.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.715 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.1 t -84.75 -62.17 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.489 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -49.35 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.337 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.7 ttp85 -60.9 -0.57 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.437 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 203' ' ' TRP . 12.2 m-85 -117.47 10.91 13.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.294 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.78 105.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 7.0 p90 -86.94 114.62 23.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.69 47.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.27 103.22 0.22 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 209' ' ' GLY . 16.2 m-20 -48.98 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.811 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.66 -6.43 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.081 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -82.64 -18.21 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.392 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.99 -37.45 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.06 -49.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.868 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.35 -47.52 72.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.55 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.1 p -60.96 -47.52 86.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -38.56 91.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.0 -47.57 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.415 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -44.66 92.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.303 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.25 -23.3 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 178' ' ' GLU . 1.2 mp -76.73 -44.99 31.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.015 0.436 . . . . 0.0 110.151 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 226' ' ' ASP . 33.7 ttt-85 -55.44 -49.65 71.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.957 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -68.25 -7.52 31.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -94.38 -32.61 13.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.541 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.9 -7.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.124 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -116.09 138.25 51.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.006 0.431 . . . . 0.0 110.857 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 t -170.52 39.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.5 163.45 26.82 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.4 -5.61 11.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.733 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.98 104.48 16.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -86.81 101.26 13.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -89.44 1.87 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.588 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.92 96.46 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.57 125.83 34.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.718 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 44.3 m -95.83 112.32 24.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.65 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.6 mt -95.57 73.45 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.366 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 43.3 ttm-85 -35.92 128.03 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.55 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.46 61.21 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.2 -58.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 110.828 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.14 -138.1 5.6 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.485 ' OH ' ' NZ ' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -127.11 156.28 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 0.0 110.711 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.672 ' HB ' HG22 ' A' ' 192' ' ' VAL . 2.3 p -139.7 136.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.22 112.41 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.355 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -162.2 131.49 4.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.13 152.52 82.08 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.33 112.61 3.38 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.397 2.065 . . . . 0.0 111.993 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.521 179.857 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.8 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 121.0 142.26 6.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER 54.95 39.16 31.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.45 149.13 49.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.634 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -157.98 130.57 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.252 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.13 136.96 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -88.61 149.16 23.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.092 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.54 -67.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.054 0.454 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.86 -15.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.339 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -88.2 133.07 34.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 143.19 50.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 p 41.35 51.64 3.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.03 -158.01 34.13 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.7 mp 58.66 98.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 134' ' ' VAL . 71.3 t -132.16 78.44 68.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.068 0.461 . . . . 0.0 110.798 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.24 3.27 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.151 2.567 . . . . 0.0 111.874 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -95.95 64.14 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -172.93 -178.51 43.0 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -131.38 -177.14 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -112.89 -24.48 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.845 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.94 -78.18 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.336 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 142' ' ' GLY . 9.9 tttm 55.18 -168.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.809 0.338 . . . . 0.0 111.042 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.405 ' H ' ' HG2' ' A' ' 141' ' ' LYS . . . -166.53 -147.32 5.17 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -119.83 154.38 34.37 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 122.706 -0.29 . . . . 0.0 110.477 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -147.8 -17.72 0.36 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.732 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.46 65.88 27.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -41.99 136.74 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.833 2.355 . . . . 0.0 112.243 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -102.12 78.27 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.967 0.413 . . . . 0.0 111.374 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.13 133.92 33.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.69 110.71 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -126.53 121.06 31.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.37 148.78 22.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -143.71 156.68 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.8 t80 -163.85 130.27 3.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.56 -97.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 153' ' ' PHE . 5.1 m-20 -124.85 53.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.12 146.26 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -143.37 137.38 28.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 165' ' ' VAL . 22.1 mt -132.53 134.59 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 162' ' ' THR . 1.1 m-20 -107.66 104.39 13.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.141 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.92 -11.6 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.722 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.47 -38.92 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 2.7 p -99.81 6.59 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.227 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.446 ' ND1' ' C ' ' A' ' 162' ' ' THR . 52.0 p-80 36.77 51.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -122.06 158.28 29.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 174' ' ' LEU . 32.5 t -128.4 147.69 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.39 127.51 15.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.5 tmtt? -130.78 112.46 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.268 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.47 68.98 0.11 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.055 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.15 57.34 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 167' ' ' LYS . 7.1 tt0 -130.64 90.83 39.35 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.25 142.58 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.92 1.747 . . . . 0.0 112.113 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.81 132.27 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.259 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 174' ' ' LEU . 28.0 t -95.33 119.91 34.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -142.61 135.06 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.711 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.21 175.2 0.42 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.824 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.46 -41.83 73.39 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.481 2.12 . . . . 0.0 112.601 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.37 -65.83 0.49 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 111.104 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 221' ' ' LEU . 8.6 mt-10 -60.09 -33.34 71.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.29 -50.39 73.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -41.33 85.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 202' ' ' VAL . 1.9 tp -58.81 -48.62 80.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.579 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -40.61 96.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.12 -45.13 91.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.498 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.585 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 26.5 t80 -65.65 -40.83 92.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -40.99 69.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.3 t -72.87 -42.99 60.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.43 -27.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.72 18.33 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.02 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.88 119.0 3.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.792 0.33 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.6 -26.6 10.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.9 m -94.72 130.15 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 242' ' ' VAL . 48.6 t -68.43 114.77 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 184' ' ' TYR . 2.6 mp -95.12 153.63 17.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.89 148.42 26.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 16.2 mtpt -56.12 -54.92 47.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.991 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.0 Cg_endo -64.81 -32.15 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.782 1.655 . . . . 0.0 111.922 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -66.87 -48.81 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.288 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.5 mt -55.7 -39.82 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.771 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.38 -66.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -49.26 -29.34 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.585 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.7 t60 -72.01 -48.48 44.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.078 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 204' ' ' ARG . 42.4 t -84.04 -59.86 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.554 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.718 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -49.55 -4.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.604 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.7 ttp180 -61.92 -2.55 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.637 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 58.5 m-85 -118.19 11.95 13.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER 172.33 104.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.417 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -83.73 108.13 16.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.434 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.564 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 174.09 55.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.718 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -159.0 102.52 0.21 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -50.46 -173.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.945 0.402 . . . . 0.0 110.56 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -87.9 -9.74 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.072 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -91.04 -22.75 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.3 p -65.68 -40.04 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.305 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.458 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 12.7 t -60.4 -46.19 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.131 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.91 -48.04 79.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -45.18 95.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.62 -40.88 98.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.755 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.6 t -62.42 -39.73 85.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -45.38 81.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -68.49 -17.17 64.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.489 HD11 ' HG2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -82.77 -47.98 11.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.676 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.9 OUTLIER -55.99 -38.55 70.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.471 179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -66.1 -29.15 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.504 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -28.56 15.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.659 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.17 -38.79 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.136 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 222' ' ' ARG . 9.2 t0 -100.27 -151.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 226' ' ' ASP . 68.6 p 54.07 10.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.499 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 226' ' ' ASP . . . -85.09 -136.07 3.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.18 -44.74 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.796 0.332 . . . . 0.0 110.269 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.537 ' HB3' HD21 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -96.14 107.26 19.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.581 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.481 ' CD ' ' H ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -82.87 91.15 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.72 ' O ' HD23 ' A' ' 243' ' ' LEU . 0.8 OUTLIER -91.9 -5.6 52.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.294 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.68 122.47 47.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.78 130.24 56.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.644 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.0 m -95.65 115.95 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.2 mt -95.92 77.16 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.29 119.97 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.78 -2.88 57.21 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.35 -58.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.77 -136.03 4.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 40.4 m-85 -127.59 153.96 45.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.749 0.309 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 192' ' ' VAL . 12.8 p -140.8 133.1 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.49 121.38 33.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.928 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -161.46 133.81 5.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.174 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.34 153.3 85.99 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.22 124.66 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.406 2.071 . . . . 0.0 112.276 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 24.4 ptt-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.65 179.732 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.3 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.2 58.84 0.5 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.4 m -76.29 -109.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -98.54 -170.88 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.545 ' N ' ' OG ' ' A' ' 123' ' ' SER . 8.3 m80 -157.62 157.18 33.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -67.28 85.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.661 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -146.59 91.76 2.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.71 151.44 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.436 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -95.66 -59.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.83 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -71.89 127.06 31.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 p -171.46 91.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.768 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.86 39.86 1.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.47 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.22 -52.57 1.34 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.99 150.03 49.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.707 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.78 63.02 45.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.138 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -39.15 122.04 0.73 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.965 2.444 . . . . 0.0 112.791 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.57 -36.5 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.18 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.56 -145.28 2.79 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.1 m -83.61 175.56 9.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.987 0.423 . . . . 0.0 110.908 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 139' ' ' HIS . 28.1 p-80 -132.73 111.95 11.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.192 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 39.3 ttp -124.37 102.49 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.659 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -116.93 90.94 3.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.896 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.14 170.67 39.78 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -103.6 39.5 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -118.92 121.14 39.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.35 73.52 4.37 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -52.27 114.99 1.9 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.659 2.24 . . . . 0.0 112.01 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -70.5 -92.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -63.12 145.18 56.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.421 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.88 109.92 23.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.795 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -125.68 121.17 32.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.182 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.64 150.77 21.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 m -141.15 158.34 44.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 1.4 t80 -165.46 131.51 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.519 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 38.23 -99.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 19.3 m-20 -124.96 53.36 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.94 150.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.278 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -142.41 140.88 32.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.74 131.59 33.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.437 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -113.65 108.17 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.5 -9.65 36.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.19 -52.58 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.651 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 51.3 p -98.14 9.76 42.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.266 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 47.3 m80 37.12 59.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.777 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -132.63 153.81 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.56 HG21 HD11 ' A' ' 174' ' ' LEU . 46.8 t -115.71 151.81 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.232 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.19 125.49 13.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.5 tttp -124.99 115.12 20.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.36 56.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.378 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.39 23.76 75.04 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.2 mt-30 -132.29 101.6 14.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -76.77 136.78 17.26 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.82 1.68 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.16 139.25 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.91 121.68 40.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.416 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -141.06 140.68 34.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.765 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.87 173.46 4.77 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.98 -40.82 79.52 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.47 2.113 . . . . 0.0 112.576 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.7 m -51.11 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.62 -33.55 72.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.238 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -58.51 -52.79 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.9 m -57.6 -40.62 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 -47.16 85.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.58 -42.18 95.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.704 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -44.87 87.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.542 ' CE1' ' CE1' ' A' ' 201' ' ' HIS . 2.5 t80 -66.35 -42.13 88.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.587 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.44 -41.78 77.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.73 -49.12 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.67 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.9 mt -55.82 -36.15 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.012 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -109.96 23.76 13.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.3 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.77 118.78 4.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.81 10.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.587 ' O ' HD12 ' A' ' 193' ' ' LEU . 11.5 m -90.01 129.6 36.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.05 120.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.552 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 191' ' ' THR . 4.9 mp -96.94 163.93 12.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.09 148.39 29.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.962 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 4.1 mttt -56.67 -54.02 58.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.078 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 28.4 Cg_endo -70.57 -31.99 15.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.913 1.742 . . . . 0.0 112.043 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.61 -46.43 85.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.216 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.65 -39.81 86.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.62 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 203' ' ' TRP . 8.5 tp -64.25 -50.31 68.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.643 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 13.4 t70 -64.73 -30.2 71.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.444 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.542 ' CE1' ' CE1' ' A' ' 184' ' ' TYR . 18.4 t-80 -72.0 -57.23 4.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.43 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.2 t -84.42 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.683 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.494 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.8 OUTLIER -50.12 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.681 -179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -67.08 -3.21 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.441 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.28 14.52 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 207' ' ' PHE . 29.0 m-20 -137.77 -151.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.619 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 206' ' ' ASP . 0.2 OUTLIER -43.44 171.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -45.08 -93.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.67 89.6 0.11 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 212' ' ' ASN . 1.3 m-20 -97.65 94.64 7.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.867 0.365 . . . . 0.0 110.174 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 211' ' ' VAL . 90.4 t -64.02 1.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 210' ' ' ASP . 57.9 m-20 -100.17 -30.69 11.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.494 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 20.2 t -62.08 -39.43 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.87 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.002 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -53.45 -49.56 67.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -46.19 90.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.23 -38.88 90.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.29 -43.15 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.734 0.302 . . . . 0.0 110.585 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -42.93 85.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -71.6 -13.24 61.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.15 -48.74 9.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.807 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 70.1 mtt180 -56.67 -44.04 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.367 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -19.36 65.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.982 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -93.96 -28.55 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.364 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -109.37 -39.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.228 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.29 145.38 25.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.9 t -176.79 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -145.34 167.29 27.47 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.26 -6.45 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.721 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -92.72 104.59 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.858 ' O ' HD23 ' A' ' 232' ' ' LEU . 45.6 mtt85 -78.93 160.16 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 231' ' ' ARG . 4.7 mt -146.16 -36.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.24 111.88 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.607 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.16 129.88 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.329 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.497 HG23 HH22 ' A' ' 222' ' ' ARG . 0.2 OUTLIER -94.42 111.75 23.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' ARG . 3.8 mt -95.25 69.54 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.159 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' LEU . 3.7 ptt85 -35.09 128.28 0.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.95 -13.82 60.39 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.2 t -128.85 -58.17 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.416 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 159.42 -137.28 5.05 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.47 157.91 40.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.08 136.23 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.404 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 26.4 tp -93.05 118.91 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.505 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.67 131.01 3.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 0.0 111.04 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -80.35 156.42 73.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -67.26 141.35 56.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.51 2.14 . . . . 0.0 112.174 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.495 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -172.49 7.55 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.288 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 m -74.56 179.92 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.113 0.456 . . . . 0.0 111.033 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.4 m -147.54 142.8 27.27 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.41 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.41 -6.41 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.678 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.8 m80 49.1 -159.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.857 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.46 168.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.23 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.35 -166.97 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -152.05 2.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 109.98 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.57 153.68 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.626 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -106.8 60.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.556 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.5 p -108.49 161.14 15.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.134 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.35 -2.21 0.03 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.344 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.19 27.48 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.337 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 136' ' ' ARG . 14.9 m -131.35 63.53 70.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.4 28.37 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -106.19 1.81 26.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.04 170.13 39.19 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 t -101.1 140.52 35.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.67 0.271 . . . . 0.0 110.82 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 140' ' ' MET . 10.5 p-80 -162.84 -177.67 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 0.0 110.998 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' HIS . 8.7 mmt -34.22 131.29 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -88.37 5.53 41.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 56.53 -85.28 0.01 OUTLIER Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' LYS . 44.3 p30 -157.98 0.96 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.975 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.4 tttt 65.29 94.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -166.59 68.15 1.02 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.466 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -47.21 151.06 2.81 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.636 2.224 . . . . 0.0 111.73 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -127.37 141.46 51.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.38 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 149.24 45.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.383 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -140.78 132.93 27.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.77 151.56 21.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.82 156.84 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.0 t80 -166.06 125.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.86 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.3 p-10 -124.97 54.34 1.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.55 151.58 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.466 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.7 mt-10 -146.25 143.71 29.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.48 127.67 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.355 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.4 OUTLIER -113.33 103.15 11.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.839 0.352 . . . . 0.0 110.452 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.93 -12.48 55.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -71.63 -30.64 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 7.0 p -121.82 -25.39 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 162' ' ' THR . 4.9 t-80 83.13 47.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.871 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -124.26 160.09 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 166' ' ' TRP . 31.8 t -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.405 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -146.23 125.42 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.854 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.7 tmtt? -130.05 117.65 20.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.374 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.98 70.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.04 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.02 34.69 52.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -136.68 91.31 15.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.554 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.81 137.82 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.316 2.011 . . . . 0.0 112.12 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.72 131.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 91.74 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.68 150.97 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.777 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 168.67 25.26 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.189 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.44 -53.9 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.408 2.072 . . . . 0.0 112.309 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -55.84 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -61.96 -38.48 88.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -48.34 82.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.2 m -58.97 -39.05 80.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.85 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.708 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.31 -42.58 91.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CE2' HD21 ' A' ' 193' ' ' LEU . 24.8 t80 -68.69 -41.13 79.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.43 ' CD1' HD13 ' A' ' 243' ' ' LEU . 1.2 m-85 -54.6 -43.81 72.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.8 -46.07 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.91 -38.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -107.87 26.57 10.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.86 117.64 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.664 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.37 -27.18 12.92 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.61 130.36 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.64 114.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.538 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 184' ' ' TYR . 3.9 mp -97.25 158.2 15.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.33 147.39 31.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.292 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -58.06 -52.99 70.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.208 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -62.84 -31.97 77.68 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.746 1.631 . . . . 0.0 112.2 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -68.9 -49.99 53.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.054 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 193' ' ' LEU . 7.4 mt -55.91 -36.93 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.196 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.431 HD21 ' CA ' ' A' ' 209' ' ' GLY . 6.9 tp -61.22 -70.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.787 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.534 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 0.0 OUTLIER -54.2 -23.87 16.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.512 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.596 ' ND1' HG23 ' A' ' 202' ' ' VAL . 10.0 t-80 -73.9 -60.09 2.42 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.612 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.596 HG23 ' ND1' ' A' ' 201' ' ' HIS . 99.4 t -85.82 -61.52 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -53.45 -3.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 200' ' ' ASP . 0.6 OUTLIER -63.16 -3.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.92 21.71 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -143.02 -144.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 110.817 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.494 ' O ' ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -42.72 164.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.549 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 207' ' ' PHE . . . -47.47 -105.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.431 ' CA ' HD21 ' A' ' 199' ' ' LEU . . . -160.23 89.7 0.11 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.2 124.15 46.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.287 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 211' ' ' VAL . 9.0 p -82.28 -8.01 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -99.99 -29.22 12.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 2.5 p -66.28 -39.74 85.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.638 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.455 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 25.0 t -56.41 -50.5 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.106 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.03 -48.52 78.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.278 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -45.15 93.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.434 ' O ' HD13 ' A' ' 221' ' ' LEU . 2.4 m-85 -63.63 -41.83 98.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.28 -41.39 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.2 t -62.59 -47.93 81.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -33.45 75.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.369 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 217' ' ' TYR . 2.9 mp -67.32 -46.67 72.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.341 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.46 -44.18 76.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.316 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -66.53 -24.67 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -91.88 -28.41 17.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.677 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.99 -40.56 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.341 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -102.82 141.05 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -40.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.783 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.11 173.21 6.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.32 -7.04 16.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -92.55 104.95 17.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -86.83 106.98 18.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.1 mt -88.5 -0.36 57.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.546 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.93 113.22 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 123.17 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.488 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.0 m -88.28 114.33 24.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.774 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 237' ' ' ARG . 6.9 mt -96.75 72.99 2.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.23 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 236' ' ' LEU . 22.7 mtp180 -39.25 110.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.79 -16.24 13.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.71 -47.46 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.45 -137.28 6.17 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.18 152.39 48.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.383 . . . . 0.0 110.608 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.16 141.14 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' A' ' 185' ' ' PHE . 1.3 tp -91.43 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -162.02 134.03 5.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -76.64 149.4 80.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -36.61 101.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.529 2.153 . . . . 0.0 112.006 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.62 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 123' ' ' SER . . . -96.7 59.9 1.23 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 p -72.92 14.54 0.27 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 121' ' ' GLY . 75.2 m -87.43 28.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 124' ' ' HIS . 0.7 OUTLIER 63.69 178.26 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.28 -22.06 25.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -56.85 154.95 8.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.26 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.43 126.49 0.19 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.781 0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 7.0 p-80 -169.34 -14.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.402 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -152.51 92.28 1.66 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.485 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 32.2 t -126.31 89.15 2.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 131' ' ' SER . 38.8 p 44.2 75.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.932 0.396 . . . . 0.0 110.202 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.68 160.29 10.51 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mp -94.6 21.86 6.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.057 0.456 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.1 t 44.08 68.65 2.93 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.314 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' GLY . 52.3 Cg_exo -46.83 -41.75 25.04 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 123.131 2.554 . . . . 0.0 112.519 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 66.97 -61.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PRO . . . 163.33 177.36 36.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 140' ' ' MET . 22.2 t -129.87 127.31 39.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 140' ' ' MET . 2.8 t60 -74.96 36.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.452 ' H ' ' C ' ' A' ' 138' ' ' SER . 0.0 OUTLIER 34.35 -121.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -96.81 92.04 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.377 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -142.69 23.57 2.32 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -154.0 143.78 21.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.673 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -149.76 20.9 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 51.81 61.32 12.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.96 161.09 33.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.868 2.378 . . . . 0.0 111.73 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -168.22 -37.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.821 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.76 102.4 14.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.36 113.78 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.381 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -104.81 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.434 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mt -146.09 134.85 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.571 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -137.51 155.78 48.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 111.069 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.552 ' HB2' HG13 ' A' ' 186' ' ' VAL . 87.3 t80 -165.39 139.0 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.519 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.46 -104.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.924 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.5 OUTLIER -124.66 53.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 155' ' ' ASP . 2.4 mm -137.52 146.56 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.921 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.43 131.28 29.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 147.27 48.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.433 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.8 m-20 -131.15 107.89 9.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.35 -38.32 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.772 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -51.45 59.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.533 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 4.6 p -106.58 13.15 28.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.119 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 162' ' ' THR . 9.3 p80 38.52 56.09 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.683 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -119.68 161.24 21.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.536 HG21 HD12 ' A' ' 174' ' ' LEU . 4.3 t -124.5 157.86 31.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.99 125.24 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -122.71 108.76 13.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.31 67.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.057 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.86 83.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 167' ' ' LYS . 14.2 tt0 -137.04 87.35 18.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.92 132.87 13.28 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.298 1.998 . . . . 0.0 112.669 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.7 147.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.27 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m -92.63 88.35 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.287 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.536 HD12 HG21 ' A' ' 165' ' ' VAL . 35.8 mt -96.0 155.81 16.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.32 170.69 8.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.26 -53.72 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 112.135 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -57.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.073 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.678 ' OE2' HD11 ' A' ' 221' ' ' LEU . 1.4 mm-40 -62.88 -39.71 95.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.16 -42.82 95.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.8 m -61.25 -45.61 93.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.49 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.635 ' O ' HD23 ' A' ' 181' ' ' LEU . 1.5 tt -57.2 -43.95 83.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 186' ' ' VAL . 2.1 mp -66.02 -46.18 78.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.267 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -58.13 -42.98 87.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.405 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.19 -44.97 94.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.516 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -62.83 -41.93 99.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 110.771 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 182' ' ' LEU . 65.8 t -57.68 -52.66 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.394 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.42 -29.53 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.356 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -106.1 19.6 20.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.712 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -53.17 119.57 4.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.92 -23.76 20.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.1 m -92.18 125.29 36.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.3 p -69.1 118.08 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.95 149.14 22.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.7 p -99.88 149.44 23.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.53 -44.84 99.8 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.501 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 31.8 Cg_exo -52.94 -52.41 8.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.912 1.742 . . . . 0.0 111.996 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.67 -51.96 67.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.45 -42.98 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.179 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 209' ' ' GLY . 12.1 tp -60.41 -65.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.883 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.3 -16.04 30.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -49.87 31.7 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.11 -43.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.075 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' A' ' 208' ' ' GLY . 1.2 m-90 -62.82 -3.97 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -57.66 -4.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.491 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.4 m-85 -121.29 15.77 11.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.523 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 0.4 OUTLIER 171.84 116.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.484 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -84.32 129.81 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.586 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 144.58 66.4 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.405 ' O ' HD21 ' A' ' 199' ' ' LEU . . . -159.64 102.69 0.22 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 213' ' ' VAL . 43.9 m-20 -57.38 -173.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 110.103 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.0 -14.68 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -85.39 -17.47 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 210' ' ' ASP . 5.2 p -67.33 -38.1 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 218' ' ' VAL . 85.6 t -59.7 -50.69 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -54.93 -47.06 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.536 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 9.7 p -60.21 -49.47 77.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.655 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -61.63 -41.01 96.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 214' ' ' VAL . 66.3 t -62.46 -45.26 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.3 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -43.8 98.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.194 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -32.83 73.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.678 HD11 ' OE2' ' A' ' 178' ' ' GLU . 2.1 mp -66.26 -47.47 73.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 109.999 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.0 OUTLIER -54.89 -46.21 74.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.147 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -15.22 63.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.417 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.422 ' CE ' HD21 ' A' ' 174' ' ' LEU . 33.9 mtpt -95.07 -27.11 15.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.38 -13.53 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.32 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -111.92 138.21 48.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.372 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -175.37 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -48.74 168.94 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.59 -13.08 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.978 0.418 . . . . 0.0 109.962 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -93.21 151.86 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.897 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -93.08 158.96 15.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 245' ' ' GLU . 90.6 mt -147.03 -50.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 242' ' ' VAL . 1.1 mt -94.98 119.86 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 130.29 45.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.64 108.82 20.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.2 mt -98.72 69.4 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.753 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -37.28 126.55 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.567 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.86 -7.58 62.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.41 -46.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.48 -137.33 7.48 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -127.89 152.81 47.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.31 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.459 ' O ' HD23 ' A' ' 233' ' ' LEU . 11.1 p -136.62 135.95 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.964 0.411 . . . . 0.0 110.785 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.98 118.9 31.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.569 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -162.28 115.75 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 232' ' ' LEU . 0.4 OUTLIER -87.92 149.53 45.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.44 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 124.79 10.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.301 2.0 . . . . 0.0 112.131 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.475 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.79 -118.92 3.17 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.438 ' C ' ' OG ' ' A' ' 123' ' ' SER . 0.4 OUTLIER -163.87 110.46 1.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 122' ' ' SER . 0.0 OUTLIER 61.21 110.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.949 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -55.15 175.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -72.4 -63.74 1.09 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -90.32 -107.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.91 -56.51 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.237 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.6 OUTLIER 44.08 28.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.426 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 130' ' ' SER . 11.5 t-160 -71.15 -107.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.404 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -72.0 -52.09 18.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 73.78 -11.65 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.239 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.19 -169.13 33.24 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 mt -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 134' ' ' VAL . 9.4 p -155.85 65.99 4.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.064 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.31 154.51 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.275 1.983 . . . . 0.0 111.849 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -85.7 39.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.773 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 138' ' ' SER . . . 85.5 -5.56 83.03 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 137' ' ' GLY . 19.3 p 25.74 52.86 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.964 0.411 . . . . 0.0 111.088 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -67.01 -82.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.833 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.2 ttt -75.58 107.8 7.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -120.29 -49.11 2.29 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.23 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.29 -150.52 25.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -165.43 -25.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' O ' ' CD ' ' A' ' 145' ' ' GLU . 1.3 pttm -101.4 71.13 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.627 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.457 ' CD ' ' O ' ' A' ' 144' ' ' LYS . 1.4 mp0 -133.98 77.67 61.67 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.28 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.37 120.86 8.91 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.217 2.611 . . . . 0.0 112.422 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -100.21 102.43 13.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.462 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -83.64 124.45 30.83 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.76 111.3 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -175.27 145.57 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.369 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.909 HD23 HH12 ' A' ' 183' ' ' ARG . 2.6 mm? -92.43 151.6 20.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -142.05 156.95 45.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 243' ' ' LEU . 70.7 t80 -167.03 140.14 3.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 34.41 -102.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 23.8 p-10 -124.3 52.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -138.08 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.467 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 13.9 tt0 -145.71 144.05 30.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 110.631 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.527 HD21 HD23 ' A' ' 182' ' ' LEU . 1.0 OUTLIER -137.37 116.88 12.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.955 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.15 101.87 11.61 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.849 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -24.14 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.29 -32.3 56.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 34.1 p -127.5 -20.7 3.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.1 t60 82.14 52.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -122.51 156.45 34.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 174' ' ' LEU . 2.7 t -121.12 151.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.143 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.73 125.24 13.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.419 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -127.13 113.11 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.259 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.77 70.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.234 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.67 26.72 47.19 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 167' ' ' LYS . 3.1 tp60 -130.8 92.36 34.43 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.42 133.43 11.86 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.948 1.766 . . . . 0.0 112.195 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.93 138.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.576 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 75.2 m -89.58 88.32 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 165' ' ' VAL . 71.9 mt -95.38 149.31 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.563 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.8 172.86 8.06 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -52.1 -55.3 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.394 2.063 . . . . 0.0 112.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.4 m -51.06 -52.5 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.55 -44.05 97.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.0 m -61.37 -45.51 94.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.86 -43.69 92.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.004 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.527 HD23 HD21 ' A' ' 158' ' ' LEU . 29.6 tp -63.25 -39.13 93.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.909 HH12 HD23 ' A' ' 151' ' ' LEU . 3.3 ttt85 -65.09 -42.56 93.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.719 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.674 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 10.6 t80 -62.29 -44.57 96.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.6 -44.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.0 -47.68 87.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.88 -28.79 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -108.83 20.42 18.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.46 120.92 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.75 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.21 -23.28 23.38 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.544 ' O ' HD12 ' A' ' 193' ' ' LEU . 32.3 m -98.17 124.64 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.3 p -69.42 122.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 191' ' ' THR . 5.5 mp -96.8 165.86 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.422 ' OG ' ' CG ' ' A' ' 197' ' ' LYS . 1.1 p -109.77 151.11 27.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.03 -54.45 50.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.915 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 21.1 Cg_endo -66.4 -32.12 41.37 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.365 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.422 ' CG ' ' OG ' ' A' ' 194' ' ' SER . 18.9 mmtt -64.06 -58.44 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.2 -40.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.41 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.75 -64.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.67 -29.23 25.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.674 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 79.6 t60 -71.14 -48.59 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.159 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 204' ' ' ARG . 77.6 t -83.96 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.41 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.81 -2.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.294 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.7 ttp180 -61.17 -3.39 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.715 0.293 . . . . 0.0 110.68 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.419 ' O ' ' OD2' ' A' ' 206' ' ' ASP . 2.4 m-85 -117.73 16.35 14.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 0.5 OUTLIER 171.11 103.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -82.17 125.56 31.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.474 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 153.35 50.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -158.89 103.79 0.24 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.4 OUTLIER -50.46 -174.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.084 0.469 . . . . 0.0 110.671 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.83 -8.75 11.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.26 -16.42 40.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.2 p -68.9 -38.53 78.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.826 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 40.9 t -58.86 -47.85 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.527 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.14 -47.29 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.229 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 m -59.8 -43.72 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -43.39 98.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.1 -41.43 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.49 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -46.9 85.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.762 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.67 -21.9 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.642 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.82 -46.38 18.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.217 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.6 mtp180 -56.05 -47.09 78.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.974 0.416 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -66.16 -11.27 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.537 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -92.09 -46.06 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.36 -27.42 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.31 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 4.6 t70 -94.78 143.31 26.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.742 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER 173.81 -27.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.513 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -50.43 162.63 0.97 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.51 -7.65 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 0.0 110.199 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -93.13 149.58 21.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -92.24 154.15 18.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.235 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 243' ' ' LEU . 74.8 mt -147.35 -51.27 0.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.41 110.65 23.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.143 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.441 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -93.21 122.45 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.899 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.4 m -90.5 109.47 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.481 HD12 ' CG2' ' A' ' 192' ' ' VAL . 16.1 mt -95.62 70.54 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -39.45 125.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 -13.75 40.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.5 -59.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.569 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.43 -138.06 5.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -127.79 160.98 30.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.424 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.7 p -143.88 128.8 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.4 tp -91.73 137.5 32.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 128.09 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 246' ' ' PRO . 9.0 mt-10 -71.25 156.35 91.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.506 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 245' ' ' GLU . 71.2 Cg_exo -39.15 163.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.708 2.272 . . . . 0.0 112.024 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.9 ptt-85 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.716 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.49 178.18 21.83 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -146.22 0.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.29 -176.69 6.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -103.38 13.47 33.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.877 0.37 . . . . 0.0 110.688 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 144.58 46.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.172 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.66 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.558 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -78.0 -78.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -163.49 164.25 24.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 110.824 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -131.09 107.73 9.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.313 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.49 -39.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -152.82 161.15 42.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.674 ' C ' HD23 ' A' ' 133' ' ' LEU . . . -114.18 -27.31 3.46 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -105.72 116.82 32.58 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 134' ' ' VAL . 7.3 p -176.77 60.02 0.17 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.73 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.49 126.99 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.765 2.31 . . . . 0.0 112.586 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.26 146.34 45.47 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.33 31.64 0.18 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.9 m -47.72 -33.48 7.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -93.1 164.87 13.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.691 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.2 mtt 42.09 80.8 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.855 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -106.82 110.57 22.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.435 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.46 46.48 0.17 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -113.0 -155.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -59.86 179.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.9 153.32 88.99 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -38.86 150.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.258 1.972 . . . . 0.0 111.62 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -101.28 -166.03 1.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.55 ' OD1' ' NH1' ' A' ' 150' ' ' ARG . 11.1 t-20 56.71 96.79 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.469 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -83.08 146.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.481 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.55 ' NH1' ' OD1' ' A' ' 148' ' ' ASN . 24.1 mtt-85 -147.08 139.35 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.2 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 158' ' ' LEU . 1.6 mm? -89.46 157.35 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.68 157.7 45.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 110.86 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' A' ' 243' ' ' LEU . 3.5 t80 -164.18 127.16 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.476 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.47 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 13.7 p-10 -124.87 54.41 1.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.47 153.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.873 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -145.33 140.12 27.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.252 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.879 ' N ' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.43 138.83 36.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.714 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 162' ' ' THR . 62.8 t0 -111.54 105.67 14.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -8.22 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.176 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.41 -46.09 5.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.956 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.545 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 69.2 p -98.66 13.65 31.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.812 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 162' ' ' THR . 44.4 m-70 35.76 53.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.541 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -121.9 150.9 41.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.8 152.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.317 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.77 121.4 9.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.4 tmmt? -124.97 112.83 17.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.365 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.39 71.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.517 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.44 25.58 34.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.5 tt0 -131.08 94.68 27.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.13 132.6 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 112.276 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.12 144.21 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.709 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 t -95.21 94.66 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.66 154.0 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.172 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.22 172.14 8.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -50.3 -54.24 5.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.37 2.047 . . . . 0.0 111.931 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -57.46 -46.41 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.694 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -45.0 96.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -61.68 -45.33 94.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.8 m -58.16 -47.03 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 -43.94 92.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.7 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.46 -43.5 90.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.504 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -55.89 -45.25 78.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.579 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -65.06 -43.64 91.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.58 -42.84 88.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.649 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 151' ' ' LEU . 54.1 t -63.15 -47.68 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.625 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.72 -37.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -106.96 25.19 11.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.17 114.23 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.94 10.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.5 m -91.73 129.31 37.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 110.456 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.55 126.29 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.0 110.541 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -94.5 168.84 10.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.098 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.84 147.72 36.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 0.0 110.785 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 211' ' ' VAL . 6.7 mttm -56.85 -54.98 48.36 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.21 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.0 Cg_endo -65.7 -29.91 51.04 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.038 1.825 . . . . 0.0 112.426 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -70.18 -47.16 62.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.319 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.28 -38.01 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 109.978 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 199' ' ' LEU . 2.7 tt -60.96 -56.17 24.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.89 -16.6 63.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.071 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 46.4 t60 -71.76 -44.96 63.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.309 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 204' ' ' ARG . 24.5 t -84.24 -54.6 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 205' ' ' TYR . 3.0 m-90 -61.92 -3.22 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.703 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 34.4 ttp85 -44.95 -11.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 203' ' ' TRP . 17.4 t80 -105.88 26.94 9.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.35 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.8 OUTLIER 165.86 -174.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -92.71 125.46 37.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.63 103.43 0.54 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.15 59.96 0.35 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.81 101.11 3.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.595 ' O ' ' NZ ' ' A' ' 195' ' ' LYS . 2.9 m -86.42 1.5 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.841 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -96.49 -29.49 13.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.618 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.3 p -64.36 -38.89 83.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.303 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 17.6 t -60.56 -48.96 86.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.579 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.7 -44.58 85.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.166 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -60.46 -46.0 91.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.63 -38.76 87.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.899 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 214' ' ' VAL . 42.0 t -61.03 -41.06 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.51 75.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.51 ' OH ' ' NZ ' ' A' ' 224' ' ' LYS . 32.0 t80 -71.19 -10.17 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.057 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.44 -56.02 4.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.087 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.4 ptm180 -57.41 -40.48 78.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.313 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -11.21 57.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.51 ' NZ ' ' OH ' ' A' ' 220' ' ' TYR . 1.3 mmtp -93.2 -36.08 12.8 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.639 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.55 -24.04 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.834 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -97.93 153.01 18.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.647 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -174.32 -30.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.654 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -61.26 147.96 46.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.73 -5.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.404 . . . . 0.0 110.286 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 228' ' ' GLY . 29.7 mttp -94.07 116.94 29.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.313 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.2 mtm-85 -81.02 131.15 35.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 244' ' ' ARG . 5.5 mp -89.08 -76.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 233' ' ' LEU . 0.3 OUTLIER -85.41 148.38 26.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.945 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -111.08 143.71 41.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 55.0 m -101.67 116.04 31.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.931 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.8 OUTLIER -96.47 73.18 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -39.75 117.81 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.64 -25.48 9.04 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.45 -56.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.1 -136.79 4.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -129.35 160.67 32.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.889 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.568 HG12 HD21 ' A' ' 236' ' ' LEU . 14.4 p -138.84 134.64 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.522 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 53.0 tp -91.88 116.28 28.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 232' ' ' LEU . 10.1 ptm180 -163.37 117.19 1.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.64 154.87 6.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.343 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -38.73 132.55 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.72 2.28 . . . . 0.0 112.101 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.47 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -48.63 -58.13 7.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' SER . 3.0 t 58.21 44.78 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.84 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' SER . 14.8 p -36.3 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 110.552 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -113.0 139.88 48.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.679 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.92 -170.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.476 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.08 157.47 15.8 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.41 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.7 170.68 8.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -105.57 -172.42 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.029 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 128' ' ' HIS . 0.2 OUTLIER 55.19 155.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.844 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 131' ' ' SER . 0.6 OUTLIER -173.28 -17.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.704 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 130' ' ' SER . 0.7 OUTLIER 36.11 37.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.687 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.15 141.99 6.68 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.76 67.74 1.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.544 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.07 149.57 68.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -41.61 156.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.268 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 54.5 97.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.29 116.2 5.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -88.25 166.44 14.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.292 . . . . 0.0 110.645 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 141' ' ' LYS . 6.9 t60 -170.42 74.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.498 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.59 19.02 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 139' ' ' HIS . 5.2 tttt 69.29 138.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.84 106.93 0.22 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 17.8 7.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG3' ' H ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER 49.0 -153.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -142.53 72.36 20.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.945 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.07 28.83 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.784 2.322 . . . . 0.0 111.954 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -110.72 86.11 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.78 81.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.0 117.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -120.18 123.87 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.83 156.11 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.59 163.04 33.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 156' ' ' ILE . 58.5 t80 -167.58 134.5 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.41 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 11.5 p-10 -125.18 53.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.1 mt -137.05 154.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -145.83 146.88 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.07 134.32 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.5 m-20 -112.77 109.24 18.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.8 OUTLIER -65.58 -16.28 63.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.97 -52.21 8.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.4 p -101.3 11.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.588 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 11.0 m-70 36.53 53.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.666 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.22 160.02 23.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD11 ' A' ' 174' ' ' LEU . 95.2 t -124.5 149.6 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.4 127.76 15.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 39.5 tttm -128.06 114.04 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.496 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.99 62.94 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.97 29.7 75.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 15.4 tt0 -132.9 93.28 23.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.74 140.23 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.282 1.988 . . . . 0.0 112.316 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.8 130.17 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.742 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 p -93.64 87.15 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.942 ' H ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.14 154.87 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.606 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.04 168.86 23.62 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.325 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -45.93 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.54 2.16 . . . . 0.0 111.961 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -53.37 -63.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.131 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.18 -36.11 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.429 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -59.87 -48.15 82.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.5 m -60.09 -40.86 91.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.788 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 202' ' ' VAL . 1.3 tp -59.59 -47.55 85.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.84 -41.09 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -58.21 -46.88 85.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.821 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -68.17 -38.82 82.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -57.2 -44.0 83.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.483 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.35 -46.05 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 mm -53.93 -34.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -108.28 22.21 16.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.037 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.55 125.87 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.487 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.31 -33.2 6.77 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 m -87.07 132.81 33.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.04 124.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.22 161.27 13.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.24 147.88 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 5.5 mtmt -58.43 -56.36 36.2 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.35 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -63.31 -34.53 66.76 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.834 1.689 . . . . 0.0 111.967 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -64.82 -54.09 36.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.355 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 mt -52.05 -39.36 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 0.0 110.12 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.7 tp -60.52 -68.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -50.49 -25.83 4.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.464 ' ND1' ' NH2' ' A' ' 204' ' ' ARG . 56.7 t60 -71.35 -55.12 8.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 204' ' ' ARG . 55.2 t -83.87 -58.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.337 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.481 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.1 -4.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.278 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.8 ttm180 -61.76 0.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.5 m-85 -119.44 10.27 11.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.574 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.444 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.4 OUTLIER 178.04 111.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.467 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -86.93 110.71 20.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 167.44 51.72 0.03 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -154.79 100.55 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 209' ' ' GLY . 6.5 t70 -51.88 -173.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.019 0.438 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.455 ' O ' HG22 ' A' ' 211' ' ' VAL . 11.5 p -85.4 -12.2 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.846 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -91.08 -18.53 24.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 1.2 p -65.25 -37.99 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.995 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -59.2 -45.79 92.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.605 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -61.45 -45.76 92.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.5 t -60.91 -41.69 96.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.433 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -39.03 76.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.854 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 214' ' ' VAL . 60.9 t -62.27 -43.88 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -46.76 88.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.67 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -31.53 72.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.934 0.397 . . . . 0.0 110.172 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.87 -42.34 70.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.946 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 226' ' ' ASP . 35.5 ttp180 -55.11 -44.4 74.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -68.17 -26.36 65.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.468 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -93.41 -21.88 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.2 -31.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.305 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.7 t70 -107.23 135.71 48.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.462 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.64 21.35 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.31 167.84 17.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -12.49 61.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.371 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -92.42 106.2 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.815 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -89.46 110.15 21.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.28 -4.7 56.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.31 104.99 12.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.598 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 124.44 37.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.543 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -96.11 118.41 32.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.309 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.07 74.96 2.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.24 113.99 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.013 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.99 -20.64 23.82 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.63 -61.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.152 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.94 -139.17 5.66 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.77 153.05 47.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.703 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.8 p -140.1 132.13 32.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.84 143.36 26.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.397 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.01 139.85 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.53 151.59 44.31 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.498 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 247' ' ' ARG . 50.1 Cg_exo -41.32 126.65 2.89 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.599 2.2 . . . . 0.0 112.059 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 246' ' ' PRO . 26.3 mtm180 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.662 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.49 174.94 19.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.6 p -163.55 166.61 22.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.458 0.647 . . . . 0.0 111.44 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -108.01 127.62 53.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.708 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' A' ' 124' ' ' HIS . 12.5 p80 -51.56 79.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.808 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 123' ' ' SER . 75.4 m80 -56.31 144.67 29.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.172 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -113.53 160.52 18.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.257 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -105.36 -55.98 2.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.672 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -54.58 -28.93 49.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.926 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.67 -177.72 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 t 54.82 -175.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.572 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.17 170.61 0.52 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 134' ' ' VAL . 3.2 mt -80.88 98.79 8.01 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.837 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . 13.4 t -32.73 97.46 0.11 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.611 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 133' ' ' LEU . 90.9 Cg_endo -84.01 -37.98 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.715 2.277 . . . . 0.0 111.801 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -99.16 104.81 16.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.99 101.65 0.15 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.92 98.58 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.2 m80 43.2 89.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.419 . . . . 0.0 110.025 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.3 ttt -59.83 144.16 49.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -43.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.59 105.39 0.42 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.07 -21.89 65.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 0.0 110.78 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -167.76 54.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 110.185 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 146' ' ' PRO . 76.2 tt0 -153.67 65.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.743 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 145' ' ' GLU . 54.1 Cg_exo -45.89 -176.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.982 2.454 . . . . 0.0 112.417 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 148' ' ' ASN . 24.5 ptt-85 -165.6 119.16 1.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 147' ' ' ARG . 4.8 t-20 37.37 95.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 119.87 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.317 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 10.2 mtm180 -124.56 121.0 33.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 61.8 mt -91.76 153.01 19.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.472 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 160.76 39.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 154' ' ' ALA . 77.0 t80 -165.93 140.23 4.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.78 -105.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -123.85 53.07 1.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.28 157.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.651 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 6.5 tt0 -143.38 142.95 31.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.655 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.77 134.66 35.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.0 m-20 -110.95 105.85 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.602 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.99 -13.72 60.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.307 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -48.09 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.9 p -94.88 6.38 49.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.594 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 159' ' ' ASP . 64.8 m80 38.39 51.27 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.15 157.04 29.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.01 151.5 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 110.334 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 124.72 12.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -124.27 117.11 23.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.289 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.83 60.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.574 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.95 24.4 71.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 mt-30 -129.89 96.0 27.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.1 135.97 15.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.928 1.752 . . . . 0.0 112.497 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.71 140.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.727 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.11 96.07 9.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.12 156.04 16.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.04 169.43 15.53 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.594 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.25 -53.87 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 112.263 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -54.44 45.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -56.58 -37.97 71.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.419 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -63.17 -49.92 72.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.9 m -58.13 -43.79 87.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.6 -50.44 73.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.56 -43.61 98.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.725 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -56.98 -45.84 82.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.5 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 21.1 t80 -62.9 -41.72 99.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.2 -41.33 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.39 -48.09 74.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.126 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.84 -37.55 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -104.67 25.08 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.96 120.93 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.94 51.51 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 131.88 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.88 118.18 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.48 HD23 ' CG1' ' A' ' 198' ' ' ILE . 3.9 mp -96.55 154.48 17.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 148.82 28.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.346 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 3.3 mtpm? -56.02 -55.02 46.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.106 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -64.66 -32.63 57.33 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.919 1.746 . . . . 0.0 111.86 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -68.46 -54.02 19.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.48 ' CG1' HD23 ' A' ' 193' ' ' LEU . 6.2 mt -47.72 -41.81 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.937 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.15 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.629 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -46.41 -30.65 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.5 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 2.1 t60 -71.09 -51.19 26.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.026 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 204' ' ' ARG . 58.4 t -84.34 -57.97 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.04 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -52.89 -2.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.478 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.0 ttt-85 -63.89 -1.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 203' ' ' TRP . 34.6 m-85 -116.72 8.8 13.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 172.87 105.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.449 ' O ' ' CG ' ' A' ' 207' ' ' PHE . 17.2 p90 -80.6 130.39 35.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.181 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.46 60.45 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.63 101.45 0.2 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -53.18 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 0.0 110.432 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 m -82.56 -3.19 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.75 -20.84 25.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.017 0.437 . . . . 0.0 109.855 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 210' ' ' ASP . 3.8 p -67.39 -40.45 84.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.478 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 95.6 t -56.21 -50.46 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.61 -48.02 80.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.544 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -46.36 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.461 ' CE1' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -62.86 -40.99 99.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.691 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 t -62.8 -42.13 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.82 94.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.301 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.69 -13.97 61.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.81 -47.28 9.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 226' ' ' ASP . 50.2 mtt180 -56.64 -46.31 81.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -10.68 50.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.187 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -94.65 -41.16 9.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.404 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.09 -27.86 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.143 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -97.79 143.66 28.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t -177.07 39.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.289 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -137.49 160.21 25.06 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.97 -7.26 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.355 . . . . 0.0 110.436 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -93.63 105.7 17.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -89.73 114.03 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.414 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.56 -3.37 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -121.2 110.17 15.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.316 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.98 136.12 33.24 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.7 m -101.29 112.55 25.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 237' ' ' ARG . 2.8 mt -95.27 68.19 3.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.053 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' LEU . 23.4 ttt180 -34.8 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.699 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 103.22 -17.24 52.1 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.37 -42.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.92 0.39 . . . . 0.0 110.364 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 141.86 -137.56 8.04 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 164.46 23.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.7 p -143.22 133.79 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.2 tp -91.22 122.93 34.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.355 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -161.65 130.8 4.52 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 111.047 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -63.29 157.64 62.3 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -38.41 114.99 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.794 2.33 . . . . 0.0 111.907 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.91 -179.289 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 122' ' ' SER . 12.0 mmt . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -47.12 92.12 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 120' ' ' MET . 82.7 p -89.65 150.06 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -162.39 152.0 15.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.44 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 126' ' ' HIS . 1.3 t-80 -110.71 29.37 7.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 0.0 110.542 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m170 40.26 -90.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.816 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -56.65 142.09 41.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.264 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' A' ' 126' ' ' HIS . 2.1 p80 -133.22 147.99 52.0 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.247 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.43 135.77 45.86 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.4 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -94.75 91.02 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.959 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.49 162.12 39.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.657 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.1 p 51.13 -172.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.208 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.84 155.75 28.06 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.43 150.05 48.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 134' ' ' VAL . 7.0 p -167.19 70.5 0.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.906 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -66.0 106.16 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.237 2.625 . . . . 0.0 112.239 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 68.72 92.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 0.64 2.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.411 -178.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 50.57 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.406 0.603 . . . . 0.0 110.58 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' A' ' 141' ' ' LYS . 23.2 t-80 -145.63 85.36 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 61.76 2.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.986 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 139' ' ' HIS . 18.4 mmtt -98.95 -83.64 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.889 0.376 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.88 112.77 5.29 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -106.79 -175.54 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.308 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -134.45 -22.51 1.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 54.67 61.02 9.75 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.924 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.54 -166.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.615 2.21 . . . . 0.0 112.127 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -174.17 -33.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -89.03 113.7 24.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.09 120.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.845 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -126.28 119.2 26.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -90.76 155.47 18.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.638 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -142.38 161.53 37.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.99 0.424 . . . . 0.0 111.148 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -165.23 132.48 2.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.645 179.749 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.57 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 36.65 -98.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.2 m-20 -125.55 53.69 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.13 153.52 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.492 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -146.03 140.82 27.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.766 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.27 134.39 37.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.136 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -110.3 107.97 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.932 0.396 . . . . 0.0 110.459 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.02 -9.26 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.057 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.98 -52.04 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.61 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 7.3 p -93.28 7.02 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 22.1 t60 36.92 62.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -136.31 154.1 50.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.372 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.85 151.23 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.76 126.74 13.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.1 ttpm? -126.68 114.62 18.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.764 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.48 54.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.445 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.49 24.09 77.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 167' ' ' LYS . 54.2 mm-40 -129.39 95.68 29.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.34 136.4 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.109 1.873 . . . . 0.0 112.224 -179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.88 140.53 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.948 -179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.7 t -93.86 94.11 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.546 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.518 ' CD2' HD22 ' A' ' 182' ' ' LEU . 9.9 mp -95.06 150.06 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.667 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.1 172.38 8.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.55 -57.02 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.544 2.163 . . . . 0.0 112.522 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -54.24 -50.14 67.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.4 -40.34 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.483 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.5 -47.4 85.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -57.41 -48.02 80.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.336 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.0 -51.22 70.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 174' ' ' LEU . 1.2 tp -57.95 -47.18 83.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.055 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.407 ' CD2' ' ND2' ' A' ' 188' ' ' ASN . 18.5 t80 -61.33 -45.39 94.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.355 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.6 m-85 -57.45 -44.46 84.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.47 -50.11 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.35 -38.67 56.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.816 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 24.2 p30 -108.58 24.45 13.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -51.87 118.01 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.16 -23.68 13.71 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 m -89.43 133.66 34.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.21 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.26 120.88 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.612 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.25 156.27 16.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.413 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.08 148.6 28.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.533 ' HZ3' ' CD ' ' A' ' 215' ' ' GLU . 1.0 OUTLIER -56.16 -56.09 34.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.982 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -66.32 -28.8 46.82 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.998 1.799 . . . . 0.0 111.927 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -49.33 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.948 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.31 -38.97 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.3 -68.51 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -49.89 -30.86 10.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.84 -49.57 44.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.282 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 204' ' ' ARG . 62.7 t -82.91 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.908 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.611 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 1.1 m-90 -53.85 -2.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 202' ' ' VAL . 30.4 ttt180 -50.91 -5.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 203' ' ' TRP . 35.9 m-85 -103.4 19.91 18.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.249 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 205' ' ' TYR . 1.3 m-20 166.53 126.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -68.49 140.96 55.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 -179.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.21 104.89 0.18 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.64 59.71 2.5 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.81 96.6 6.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.776 0.322 . . . . 0.0 110.666 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.9 m -83.68 -10.04 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 215' ' ' GLU . 13.0 m120 -73.0 -70.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.227 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 4.5 p -34.61 -36.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.3 t -65.52 -44.87 93.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.56 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 212' ' ' ASN . 2.2 tp10 -57.58 -44.15 85.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -47.98 83.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.699 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.594 ' O ' HD13 ' A' ' 221' ' ' LEU . 1.5 m-85 -61.48 -39.95 92.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 214' ' ' VAL . 89.6 t -63.0 -43.82 99.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.5 t -63.06 -44.73 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -36.87 85.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 110.189 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.594 HD13 ' O ' ' A' ' 217' ' ' TYR . 5.1 mp -65.11 -45.6 84.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.671 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 52.1 mtm180 -56.2 -45.76 79.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.229 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.03 -22.44 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -92.94 -26.69 17.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.47 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.47 -40.37 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.823 -179.644 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.75 156.13 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.956 -179.677 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 226' ' ' ASP . 0.8 OUTLIER 167.78 -36.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.704 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.89 -175.22 10.52 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -78.81 -13.46 59.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.653 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -92.75 105.32 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.16 103.99 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.765 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.31 -3.03 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.645 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.88 113.51 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.666 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.24 118.35 36.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.128 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.451 HG23 ' HD1' ' A' ' 241' ' ' TYR . 61.1 m -93.01 114.06 26.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.641 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 237' ' ' ARG . 1.6 mp -96.23 68.68 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 236' ' ' LEU . 30.8 mtm-85 -33.94 129.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.836 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.93 65.99 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 69.9 t -133.01 -61.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 0.0 110.675 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.96 -140.27 6.32 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.451 ' HD1' HG23 ' A' ' 235' ' ' THR . 0.1 OUTLIER -132.61 153.4 51.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.597 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.13 138.9 49.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.583 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 153' ' ' PHE . 5.3 tp -91.57 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.877 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -161.75 133.18 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -60.95 158.13 36.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.68 109.25 2.05 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.513 2.142 . . . . 0.0 111.975 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.671 -179.932 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.53 -29.06 5.02 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.033 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.26 135.89 55.05 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.6 t 47.54 73.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.3 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -176.14 59.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.292 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -122.33 12.46 10.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.301 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -56.17 -45.49 79.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.149 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -142.25 157.08 45.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -144.15 -23.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.606 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -166.58 26.64 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.0 p -69.11 -84.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 p -52.89 124.11 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.831 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 133' ' ' LEU . . . -138.89 -177.34 15.3 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 132' ' ' GLY . 5.1 mt -39.03 124.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.932 0.396 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 134' ' ' VAL . 9.2 m -68.93 151.34 97.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.563 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.5 134.69 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.549 2.166 . . . . 0.0 112.222 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -66.53 -30.74 71.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.41 45.11 0.52 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.0 p 42.97 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.745 0.307 . . . . 0.0 110.256 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -114.73 -90.75 0.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.054 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.0 ttm -156.78 47.02 0.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.828 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -75.8 -50.94 13.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.452 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -42.99 142.42 1.76 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.66 -25.64 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 110.485 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.76 167.27 27.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.59 152.85 43.04 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.71 101.13 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 112.163 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -120.03 67.82 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.566 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.66 152.68 45.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.615 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.86 112.89 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.55 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.55 HH11 ' CG ' ' A' ' 159' ' ' ASP . 15.3 mtt-85 -140.91 121.89 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.33 149.43 22.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -139.74 156.66 46.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.124 0.488 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CE2' HD21 ' A' ' 243' ' ' LEU . 25.8 t80 -165.04 138.06 4.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.18 -104.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 52.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -137.85 148.18 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.305 -179.588 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -143.1 144.01 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.56 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.11 133.12 34.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.55 ' CG ' HH11 ' A' ' 150' ' ' ARG . 55.9 t0 -113.79 107.68 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -66.98 -14.77 63.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.49 -48.66 7.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 163' ' ' HIS . 76.9 p -97.64 8.59 44.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.522 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 162' ' ' THR . 20.8 m80 37.67 54.57 1.5 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -128.61 156.0 44.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.13 152.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 127.2 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.919 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 170' ' ' GLN . 6.2 tmtt? -130.38 117.58 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.281 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.61 64.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.28 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.56 28.54 65.28 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.4 tt0 -129.92 92.26 37.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.47 140.61 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.261 1.974 . . . . 0.0 112.392 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.3 135.75 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.1 OUTLIER -88.22 95.73 10.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.723 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.04 150.61 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.57 170.51 14.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.483 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -47.82 -54.22 5.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.658 2.238 . . . . 0.0 112.569 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -52.25 -61.0 2.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -56.76 -39.68 74.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.43 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -62.65 -46.37 88.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.31 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 m -59.4 -40.28 86.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -44.82 95.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.646 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.46 -46.7 87.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.29 -45.83 80.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.381 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.686 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.765 -179.826 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.77 -45.6 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.745 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.67 -46.81 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.34 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mt -65.71 -23.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.208 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.54 27.37 9.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.41 109.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.619 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.86 61.68 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -98.66 122.45 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 242' ' ' VAL . 95.2 t -68.04 118.15 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.89 166.08 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.638 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.66 147.25 34.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 2.6 mtpm? -58.01 -55.12 48.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.252 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.3 Cg_endo -67.89 -29.67 34.34 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.835 1.69 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -66.57 -50.75 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.843 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 mt -55.24 -42.18 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.66 -69.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.599 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -27.64 12.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.961 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.686 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -71.54 -51.49 23.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.129 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.3 t -84.28 -61.79 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.48 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -48.27 -3.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.723 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.7 OUTLIER -55.16 -7.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.321 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.48 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER -112.27 26.23 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER 164.83 100.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.557 -179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -81.23 104.89 12.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.42 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.09 54.97 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -155.51 100.42 0.19 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 213' ' ' VAL . 23.0 m-20 -51.89 -173.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.811 0.339 . . . . 0.0 110.249 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.13 -12.97 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -81.01 -17.84 48.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.364 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -66.68 -39.45 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.585 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 94.2 t -58.07 -50.02 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.44 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -56.12 -46.87 79.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.572 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 6.3 t -61.25 -45.94 92.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.53 -41.51 98.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.056 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.73 -40.82 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -66.11 -44.05 85.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.443 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -15.12 62.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.02 -45.64 13.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 226' ' ' ASP . 5.8 mtp-105 -59.22 -46.75 87.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.788 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -67.72 -10.46 52.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.525 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -93.04 -35.78 13.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.317 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.5 -26.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -95.2 137.3 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.793 -179.914 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.12 26.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.006 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.76 166.62 13.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.66 -9.86 58.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -92.86 130.5 38.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.725 ' C ' HD12 ' A' ' 232' ' ' LEU . 11.2 mtp180 -83.47 156.02 23.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.711 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.6 mp -147.55 -41.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 109.93 22.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.415 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -94.0 123.83 37.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.334 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.1 m -92.01 109.41 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.939 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.6 69.26 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.313 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -39.25 120.49 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.008 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.97 -23.26 28.0 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.35 -41.66 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.697 0.284 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.24 -137.71 7.78 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 154.62 48.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.723 0.297 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 192' ' ' VAL . 7.3 p -138.45 131.38 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.8 tp -91.2 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.478 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.14 135.93 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -78.15 151.3 78.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.191 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.67 144.73 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.406 2.071 . . . . 0.0 112.216 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.687 -179.963 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.46 159.05 8.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.19 126.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.561 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.31 -72.04 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -50.75 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.454 ' O ' ' CB ' ' A' ' 126' ' ' HIS . 8.0 p-80 -137.76 21.43 2.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.454 ' CB ' ' O ' ' A' ' 125' ' ' HIS . 1.1 t-80 78.01 148.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -100.16 172.11 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.437 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -107.14 147.87 29.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -25.79 14.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -16.66 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.239 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 44.78 90.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -106.63 65.51 0.26 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 mp -121.44 -22.12 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.851 0.358 . . . . 0.0 110.636 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t 53.99 67.37 3.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -47.49 -25.4 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.724 2.283 . . . . 0.0 111.642 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 57.43 -94.29 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.093 179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 158.83 140.3 2.88 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.06 -9.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.031 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 139' ' ' HIS . 9.9 m80 -90.92 -45.38 8.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.1 mtp -99.43 75.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.355 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.569 ' C ' ' H ' ' A' ' 143' ' ' ASN . 0.7 OUTLIER -152.22 -37.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.376 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 144' ' ' LYS . . . 69.3 -20.86 0.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.569 ' H ' ' C ' ' A' ' 141' ' ' LYS . 7.4 m120 -49.72 84.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -112.35 -71.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.387 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.15 156.04 71.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.539 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.93 140.49 55.16 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.699 2.266 . . . . 0.0 112.239 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 148' ' ' ASN . 72.5 mtt-85 -116.54 17.23 15.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER 58.59 141.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.734 -179.848 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.48 112.62 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -120.54 123.42 42.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.955 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -89.56 153.1 21.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.67 156.19 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.0 t80 -165.43 128.56 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.596 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.01 -99.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 56.7 m-20 -125.44 53.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.65 150.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.193 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -140.33 143.32 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.138 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.67 137.47 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 150' ' ' ARG . 2.1 m-20 -112.68 104.59 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 110.351 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.08 -10.65 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.72 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.6 -43.35 6.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.717 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 163' ' ' HIS . 82.3 p -98.58 9.47 43.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 162' ' ' THR . 16.8 m-70 37.18 47.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -124.1 161.39 25.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.832 0.348 . . . . 0.0 110.744 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.03 156.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.987 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.58 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.7 tmtt? -123.76 110.75 15.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.08 62.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.5 28.31 72.98 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 167' ' ' LYS . 25.4 tt0 -139.63 105.78 6.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 144.46 29.67 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.718 1.612 . . . . 0.0 112.466 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.88 138.91 50.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.9 t -86.14 138.86 31.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.281 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mt -142.85 99.6 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.656 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 171.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -46.88 -60.4 0.89 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.487 2.124 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -53.33 -56.68 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.315 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' GLU . 2.6 mm-40 -59.25 -36.76 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.761 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -60.92 -47.24 87.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.9 m -58.8 -41.54 86.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.417 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 202' ' ' VAL . 4.4 tp -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.659 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -61.33 -43.03 99.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -46.73 83.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.594 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.479 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 4.5 t80 -67.41 -39.14 85.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.676 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -43.84 79.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.03 -47.41 68.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.51 -36.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -108.97 28.8 8.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.001 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.65 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.15 -22.49 22.89 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 m -95.29 135.26 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.055 0.455 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 242' ' ' VAL . 84.9 t -69.19 123.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.4 mp -96.15 154.4 17.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.093 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.65 147.87 30.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.953 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.5 mtmt -57.83 -55.03 49.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.792 179.287 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.8 Cg_endo -67.63 -29.97 35.61 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.023 1.816 . . . . 0.0 111.949 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -68.33 -49.34 60.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 109.973 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 mt -55.98 -42.23 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.805 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 199' ' ' LEU . 29.7 tp -59.2 -63.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -52.87 -28.83 24.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 19.3 t-80 -71.92 -48.34 46.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 47.7 t -84.37 -61.52 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -53.23 -3.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.315 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp180 -61.59 0.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 110.636 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.3 m-85 -121.52 13.18 10.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.423 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.2 OUTLIER 175.07 100.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.633 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.11 110.16 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.39 48.86 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.06 104.23 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 209' ' ' GLY . 10.7 m-20 -49.21 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.877 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.64 -8.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.64 -17.64 50.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.345 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.28 -40.01 85.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.072 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 218' ' ' VAL . 87.8 t -56.76 -50.51 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.12 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.52 -48.49 71.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.579 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.2 m -60.74 -47.77 84.82 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.6 -40.52 95.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.618 HG21 ' CE2' ' A' ' 241' ' ' TYR . 73.0 t -62.69 -43.27 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -43.92 97.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.14 -37.52 85.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 221' ' ' LEU . 1.0 OUTLIER -60.91 -48.14 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 226' ' ' ASP . 4.6 mtp85 -56.19 -43.18 78.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.494 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -67.06 -17.22 64.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -96.19 -32.29 12.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.57 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -109.53 -33.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.268 -178.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -104.49 137.83 41.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.73 27.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.404 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.59 -176.5 14.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.54 -8.7 57.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 110.481 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.67 104.81 17.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -96.15 104.46 16.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.7 -7.23 50.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.215 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.52 112.23 21.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.2 126.85 40.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.401 -179.936 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.42 70.58 3.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -43.61 112.31 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.36 -13.24 16.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.94 -54.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 110.724 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.3 -139.25 6.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.6 OUTLIER -128.43 155.35 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 0.0 110.467 179.89 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 192' ' ' VAL . 4.1 p -137.05 135.57 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.62 126.32 36.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -162.53 135.7 5.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.178 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.97 154.94 94.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.489 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 161.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.804 2.336 . . . . 0.0 112.169 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.525 179.973 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.1 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -47.19 95.4 0.01 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.2 p -59.51 -30.46 68.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.374 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t -88.0 147.48 24.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.58 -74.05 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.1 -162.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -101.68 -168.99 1.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -105.41 -13.75 15.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -80.53 108.14 13.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 130' ' ' SER . 21.4 t-80 -50.48 -103.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.439 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.56 ' N ' ' CG ' ' A' ' 129' ' ' HIS . 2.6 p 54.32 -164.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.219 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.8 t -112.01 154.02 25.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.372 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.2 50.08 0.45 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.6 168.84 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.636 0.255 . . . . 0.0 110.626 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.07 78.71 11.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.211 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.5 91.59 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.454 2.103 . . . . 0.0 111.563 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -47.92 148.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.321 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -105.22 101.25 1.85 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 t -52.68 -61.19 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.57 137.34 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.766 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.6 mmt -122.99 123.17 40.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -90.24 107.57 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.074 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.06 61.48 1.34 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -83.55 92.88 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.34 . . . . 0.0 110.622 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -118.6 114.94 23.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.06 158.34 75.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.302 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.11 177.34 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.5 2.134 . . . . 0.0 112.012 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 148' ' ' ASN . 38.2 mtm180 -61.16 161.34 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.536 ' CG ' HH21 ' A' ' 150' ' ' ARG . 71.2 m-80 -38.88 142.28 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.664 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.65 118.98 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.536 HH21 ' CG ' ' A' ' 148' ' ' ASN . 4.5 ptt180 -174.63 153.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 186' ' ' VAL . 1.7 mm? -92.37 153.86 18.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.317 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 152.37 41.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CE2' HD21 ' A' ' 243' ' ' LEU . 1.6 t80 -163.7 128.08 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.812 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.75 -99.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.6 m-20 -124.82 53.82 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 0.0 109.836 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 142.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.49 140.16 42.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.887 0.375 . . . . 0.0 110.738 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.446 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.32 124.2 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -102.59 104.87 15.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.534 -179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.588 ' OE2' ' N ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -65.97 -12.72 57.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.588 ' N ' ' OE2' ' A' ' 160' ' ' GLU . 3.1 tt0 -81.63 -52.38 7.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 163' ' ' HIS . 80.5 p -97.32 14.88 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 162' ' ' THR . 24.4 m80 35.78 63.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.601 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -140.45 162.4 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 174' ' ' LEU . 16.5 t -116.18 161.61 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.498 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.14 128.54 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.63 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -128.08 110.72 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.08 67.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.01 32.06 62.19 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -142.37 87.52 9.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.957 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.37 136.42 50.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.197 1.931 . . . . 0.0 112.133 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.4 152.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.129 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.3 m -90.11 126.62 35.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.145 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 165' ' ' VAL . 14.2 mt -141.03 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.62 171.87 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.81 -53.81 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.556 2.171 . . . . 0.0 112.096 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -57.47 -52.73 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.29 -39.6 93.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.78 -46.61 88.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.362 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.7 m -59.21 -40.44 85.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -45.89 91.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.16 -43.16 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.928 0.394 . . . . 0.0 110.163 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -55.64 -45.18 77.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.334 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.685 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -64.8 -44.05 91.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.43 -44.81 65.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 151' ' ' LEU . 10.7 t -68.69 -49.09 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.819 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 mm -54.13 -34.57 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER -109.53 27.53 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.561 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.38 116.55 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.36 -17.99 42.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.1 m -90.14 125.09 35.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.765 0.317 . . . . 0.0 110.93 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.76 115.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.962 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.91 160.44 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.677 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.45 148.43 29.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.697 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 12.9 mtpt -55.24 -53.37 62.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.8 Cg_endo -68.43 -29.77 30.71 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -46.22 74.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.16 -39.51 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.89 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.65 ' O ' HD23 ' A' ' 199' ' ' LEU . 3.7 tt -59.17 -51.4 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.724 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -72.49 -19.74 61.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.685 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 30.6 t-80 -71.39 -41.79 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.674 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.3 t -82.72 -53.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.587 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 205' ' ' TYR . 2.2 m-90 -67.29 -5.34 13.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.735 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.436 ' O ' ' NE ' ' A' ' 204' ' ' ARG . 0.4 OUTLIER -44.07 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.895 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -98.5 25.61 6.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.19 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER 174.19 -167.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.22 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -68.91 159.99 31.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -71.82 -176.96 27.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -141.82 -157.01 7.0 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 212' ' ' ASN . 2.3 m-20 -86.17 128.01 34.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.098 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.3 m -58.59 1.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.556 ' H ' ' C ' ' A' ' 210' ' ' ASP . 70.2 m-20 -96.2 -24.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.65 -31.41 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.33 -53.04 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -55.34 -43.83 75.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -60.59 -49.5 77.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.81 -38.44 91.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.434 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.81 -42.75 97.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.298 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -45.29 92.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.47 -31.33 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.33 -44.43 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.17 -41.79 72.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.3 mtm-85 -67.8 -22.0 65.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -25.11 19.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -116.31 -38.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.978 -179.526 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 222' ' ' ARG . 3.7 t70 -98.48 146.27 25.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.483 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t 175.45 -30.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.281 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -72.35 163.65 54.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -64.5 -4.24 3.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 110.713 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -92.71 131.26 37.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -86.99 158.12 19.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.16 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 232' ' ' LEU . 82.4 mt -147.55 -48.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.291 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.54 119.31 38.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 124.49 41.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.264 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -91.68 109.93 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 30.0 mt -93.22 71.79 4.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 89.9 mtt180 -37.02 123.93 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 -39.82 2.74 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.1 -60.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.391 . . . . 0.0 110.659 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.08 -137.02 4.52 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -127.29 155.66 43.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 110.645 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.39 140.2 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 153' ' ' PHE . 27.8 tp -93.39 111.39 23.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.262 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.26 131.97 5.21 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.255 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -69.95 155.33 93.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.049 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.51 108.23 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.477 2.118 . . . . 0.0 112.034 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.64 -179.913 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 148.58 121.09 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.74 -50.03 27.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.263 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.4 t 57.88 44.83 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.664 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -68.79 -61.73 1.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.431 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -87.03 177.14 7.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.046 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -110.27 167.74 9.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -120.63 86.53 2.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.426 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -179.45 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.409 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.66 ' CG ' ' H ' ' A' ' 130' ' ' SER . 8.1 t60 -82.33 -148.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.18 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.66 ' H ' ' CG ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -107.97 161.69 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.815 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.8 t -156.74 56.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.61 -79.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.89 -166.13 1.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 110.427 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.91 71.86 77.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.701 179.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' ARG . 50.8 Cg_exo -45.49 116.79 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.887 2.392 . . . . 0.0 112.186 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' PRO . 2.6 mtt-85 38.07 62.75 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.245 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.39 90.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.42 114.27 8.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -58.2 -106.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 140' ' ' MET . 12.6 mtt -54.89 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -131.9 81.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.94 -14.76 73.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -81.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 tttt 55.08 94.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -158.06 148.5 15.86 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.94 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.48 167.71 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.237 1.958 . . . . 0.0 111.846 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 99.05 8.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.507 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -88.51 103.22 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.454 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 149' ' ' VAL . 0.3 OUTLIER -80.27 139.56 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.438 HH21 ' CG ' ' A' ' 148' ' ' ASN . 2.4 ptt180 -174.74 153.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.225 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -91.15 148.07 22.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.089 0.471 . . . . 0.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -140.19 155.43 46.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.201 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 155' ' ' ASP . 70.3 t80 -156.86 124.93 5.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.005 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.77 -93.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.8 m-20 -124.86 52.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.75 138.43 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.984 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -134.99 133.02 39.03 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.715 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 165' ' ' VAL . 4.5 mt -131.43 120.85 23.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -109.18 113.82 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.546 -179.521 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.95 -42.33 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.5 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.5 -47.18 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.1 p -103.62 8.99 37.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 162' ' ' THR . 0.7 OUTLIER 36.91 46.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.573 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.32 165.65 14.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 174' ' ' LEU . 11.1 t -121.26 159.33 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.433 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -146.41 120.67 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.485 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -118.25 105.12 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.237 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.84 63.42 0.31 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.52 27.5 73.39 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 tt0 -134.05 94.63 18.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.612 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.59 134.12 10.87 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.291 1.994 . . . . 0.0 111.989 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.89 134.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.374 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.2 p -81.76 100.04 9.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 165' ' ' VAL . 15.1 mt -96.62 154.31 17.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.99 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.95 160.91 65.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.964 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.55 -43.07 52.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.537 2.158 . . . . 0.0 111.624 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -55.37 30.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.644 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.58 ' HB3' HD22 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -59.64 -36.26 76.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.299 179.84 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.11 -52.78 64.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.37 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.1 m -57.47 -43.43 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.777 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -53.44 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.05 -41.5 95.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -55.54 -46.5 77.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.781 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.444 ' CZ ' ' CD2' ' A' ' 201' ' ' HIS . 29.7 t80 -64.35 -42.53 96.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.18 -43.86 83.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.47 -43.68 94.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.988 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.02 -29.59 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -113.99 23.25 13.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.109 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.23 121.36 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.776 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.59 -20.86 24.51 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -95.81 131.18 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 111.042 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.7 p -69.44 115.61 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 198' ' ' ILE . 3.7 mp -96.9 160.24 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.487 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.76 148.1 31.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.0 -50.14 89.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.751 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.4 Cg_endo -65.78 -34.59 39.68 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.56 1.507 . . . . 0.0 112.219 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.95 -47.6 65.28 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.108 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 193' ' ' LEU . 19.3 mt -53.82 -40.91 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.991 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.652 ' HG ' HG21 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -62.29 -64.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.475 179.768 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -27.65 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.294 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.14 -51.58 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.762 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.8 t -83.71 -61.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.239 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.498 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.6 OUTLIER -50.6 -4.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -179.384 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttm180 -61.98 -1.44 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER -117.13 11.43 14.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.782 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.65 108.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.632 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -85.3 120.24 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.448 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.67 52.19 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.498 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -156.35 102.1 0.21 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -174.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.53 -7.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.94 -49.31 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 214' ' ' VAL . 8.1 p -54.75 -42.96 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.044 0.45 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.836 ' O ' HG23 ' A' ' 218' ' ' VAL . 41.1 t -58.95 -44.85 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -61.13 -47.1 87.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.339 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -60.28 -41.03 92.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.984 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -64.09 -42.05 97.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.25 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.4 -40.32 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -45.15 74.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.313 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -13.07 62.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.432 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -57.09 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 24.2 ptt180 -57.54 -37.85 73.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.705 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.424 ' NH2' HH21 ' A' ' 222' ' ' ARG . 1.4 mtt-85 -69.0 -20.76 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -94.87 -27.56 15.66 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.805 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.445 HG21 ' HZ1' ' A' ' 167' ' ' LYS . 1.8 pp -114.85 -27.62 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.839 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -102.84 139.04 38.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.997 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 -33.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -46.01 163.64 0.12 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -94.45 106.43 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -74.06 107.21 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.458 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.81 1.12 56.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.587 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.2 mt -126.58 96.23 4.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' HIS . . . . . 0.439 ' HB2' ' HE ' ' A' ' 244' ' ' ARG . 0.1 OUTLIER -87.93 122.06 31.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 179.808 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.409 HG23 ' CD2' ' A' ' 241' ' ' TYR . 23.7 m -93.26 113.68 25.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.1 mt -95.27 72.14 3.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -39.06 120.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.754 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.51 -17.58 30.79 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.584 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 63.6 t -128.33 -55.11 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.12 -137.25 4.76 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.8 OUTLIER -131.24 155.16 47.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 110.265 179.82 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 242' ' ' VAL . 8.2 p -138.17 131.29 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.159 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.41 104.64 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.374 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -162.24 153.48 17.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.03 155.62 79.94 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.53 117.66 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.407 2.071 . . . . 0.0 112.129 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.551 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 142.34 -65.03 0.49 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -69.93 150.83 46.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.79 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.013 0.435 . . . . 0.0 111.186 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.62 -25.04 0.37 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.011 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -79.48 -25.5 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -61.99 -25.51 67.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.801 -179.723 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.66 86.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.332 179.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.633 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.2 OUTLIER 57.26 -149.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.682 179.725 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -139.35 -85.55 0.24 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.944 0.402 . . . . 0.0 110.551 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 132' ' ' GLY . 10.4 t -115.97 -141.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.865 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.59 -13.57 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.653 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 130' ' ' SER . . . 46.05 -108.22 0.23 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.699 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 134' ' ' VAL . 29.4 m -141.09 69.16 28.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' GLY . 46.6 Cg_exo -49.32 159.05 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.724 2.283 . . . . 0.0 112.041 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -63.04 -1.53 0.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.272 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' PRO . . . 85.36 -55.77 4.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 t -145.08 144.65 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 110.509 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.11 -7.77 3.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.465 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.6 mtm -66.33 -12.65 57.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -74.07 112.26 10.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.665 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -146.87 -92.63 0.11 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.14 -68.6 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.362 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 mttt 61.47 41.76 12.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.467 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 50.09 69.48 2.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.749 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 147' ' ' ARG . 40.9 Cg_exo -53.41 92.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.806 2.337 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 146' ' ' PRO . 57.1 mtm180 59.35 122.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -170.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 116.19 37.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -136.41 127.26 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.368 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.6 mt -90.57 152.72 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.95 148.97 39.5 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 84.2 t80 -158.74 127.47 5.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.89 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.38 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.111 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 25.8 m-20 -123.94 53.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 145.06 29.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.256 -179.553 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.42 149.06 50.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.434 179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.35 121.87 8.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.137 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.79 27.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 -179.3 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.476 ' OE1' ' NH2' ' A' ' 183' ' ' ARG . 8.0 mt-10 -66.57 -22.42 66.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.625 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.0 -52.11 52.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.4 p -108.18 14.79 24.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 160' ' ' GLU . 9.6 m80 37.22 54.74 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -120.86 156.79 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 174' ' ' LEU . 2.0 t -119.85 157.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.65 137.76 25.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -130.6 110.08 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 179.748 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.06 60.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.263 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.83 76.12 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.0 mt-30 -134.98 104.89 10.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.823 -0.222 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.39 144.72 26.14 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.889 1.726 . . . . 0.0 112.618 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.24 136.43 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.712 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.5 t -97.97 127.17 43.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.889 ' H ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -140.65 124.68 17.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.376 . . . . 0.0 110.539 179.707 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -45.67 174.57 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -179.617 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.7 -47.6 26.37 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.544 2.163 . . . . 0.0 111.853 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -52.34 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.07 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.52 -38.75 88.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.878 0.371 . . . . 0.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -48.39 81.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.711 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -59.38 -42.64 92.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.206 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 202' ' ' VAL . 0.8 OUTLIER -56.85 -50.8 71.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.015 -179.704 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.95 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.746 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.476 ' NH2' ' OE1' ' A' ' 160' ' ' GLU . 2.3 ttt180 -60.21 -48.89 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.43 -39.41 93.79 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.555 -179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.446 ' HD1' HD12 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -59.03 -43.14 91.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.19 -47.11 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.27 -27.65 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.062 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.54 18.54 20.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.462 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.53 120.23 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.44 -24.37 13.95 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 46.7 m -94.72 126.73 40.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.8 p -68.11 118.4 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 198' ' ' ILE . 8.0 mp -96.35 161.4 13.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.47 148.0 30.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.287 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.41 -55.75 36.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.034 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.3 Cg_endo -66.58 -33.6 35.72 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.962 1.774 . . . . 0.0 112.142 -179.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -46.33 85.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.413 HG12 HD23 ' A' ' 193' ' ' LEU . 36.8 mt -60.99 -39.09 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.579 HD22 HG22 ' A' ' 211' ' ' VAL . 8.6 tp -61.94 -51.5 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.144 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.32 -28.87 69.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.019 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -72.85 -58.5 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.505 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.677 HG21 HD12 ' A' ' 181' ' ' LEU . 39.6 t -84.34 -60.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.013 -178.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.438 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -51.04 -5.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.834 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.9 ttp85 -61.4 -1.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -111.96 9.86 20.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.985 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -171.04 67.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 0.0 110.629 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.86 171.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.404 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.17 61.18 1.76 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.11 102.44 0.21 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -43.09 139.09 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.245 0.545 . . . . 0.0 110.434 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.579 HG22 HD22 ' A' ' 199' ' ' LEU . 24.5 t -55.3 0.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 210' ' ' ASP . 37.3 m-20 -83.66 -12.41 55.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.57 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.11 -35.27 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.399 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.9 t -55.92 -55.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.052 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.29 -48.56 68.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.3 t -58.07 -50.53 73.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.026 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.51 -37.26 83.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.0 110.533 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 214' ' ' VAL . 35.1 t -62.04 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -60.56 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.52 -39.89 94.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.73 -45.68 88.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.42 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.0 mmm-85 -56.68 -42.29 78.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.392 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -66.15 -22.5 66.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.634 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -93.22 -30.44 15.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.671 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -110.45 -37.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 0.0 110.766 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.5 t70 -95.02 145.18 25.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.458 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.91 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.461 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.53 -178.57 4.92 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -79.34 -11.21 59.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -94.4 104.89 16.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.026 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -92.08 109.37 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.265 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 243' ' ' LEU . 2.5 mp -91.81 -9.07 44.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.445 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.72 127.25 56.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.132 179.444 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.96 124.57 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.381 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.3 m -97.61 113.74 25.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.327 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 240' ' ' GLY . 7.2 mt -96.11 72.66 2.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.632 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -39.78 115.19 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.51 -20.42 20.71 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.795 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.3 -50.02 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.915 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 158.59 -145.64 11.94 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -131.48 152.71 50.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.538 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.13 137.45 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.8 OUTLIER -91.21 127.09 36.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.652 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 244' ' ' ARG . 3.9 ptm85 -163.61 131.1 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 111.126 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.76 158.27 86.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.736 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.14 113.4 3.26 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.671 2.247 . . . . 0.0 112.152 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.945 -179.671 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.96 -131.56 3.08 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.79 130.05 45.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.924 0.393 . . . . 0.0 110.832 179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 125' ' ' HIS . 5.3 p -102.58 25.51 9.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' ND1' ' N ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -47.4 94.41 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.493 0.663 . . . . 0.0 110.274 -179.585 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 123' ' ' SER . 2.2 t-80 -78.36 123.74 27.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.286 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -135.56 -71.01 0.47 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 67.92 170.75 0.27 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.426 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 15.9 m80 -74.26 -76.17 0.14 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.745 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 128' ' ' HIS . 7.2 t60 74.69 139.63 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.159 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' HIS . 1.5 m 37.6 64.29 0.67 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.416 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 t -81.97 -42.84 18.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.889 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.99 -54.97 0.02 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mt -100.83 144.07 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.713 0.292 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -111.88 156.8 41.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.807 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.07 2.39 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.265 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 134' ' ' VAL . 3.7 tpp180 71.71 29.67 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.64 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ARG . . . 33.39 -106.84 0.03 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' HIS . 20.5 m 49.91 -117.96 1.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' SER . 2.0 m-70 -45.18 169.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.481 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.6 mtt 55.44 -158.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.135 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.2 158.11 16.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.36 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.93 152.32 22.94 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 112.79 2.47 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.659 -0.318 . . . . 0.0 110.767 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -106.25 123.26 47.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' ARG . 20.5 mt-10 -93.07 150.61 39.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.569 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -41.64 89.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.083 1.855 . . . . 0.0 111.804 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' GLU . 32.8 mtt180 -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.205 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 147' ' ' ARG . 99.1 m-20 57.4 135.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.05 111.58 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.726 179.228 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -121.65 124.67 44.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.296 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.864 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -142.33 160.78 39.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.613 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 156' ' ' ILE . 69.6 t80 -165.53 128.72 2.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.53 -99.82 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.241 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 153' ' ' PHE . 22.8 p30 -122.76 53.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.55 155.04 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.707 -179.64 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -146.84 140.58 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.407 ' CD2' HG22 ' A' ' 165' ' ' VAL . 2.4 mt -137.16 136.32 38.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -110.88 104.09 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.133 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.42 -11.08 39.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.902 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -96.92 -51.02 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.83 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.539 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 30.8 p -93.89 9.99 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.503 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 162' ' ' THR . 8.5 p-80 37.11 58.49 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -127.81 157.37 40.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.54 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 158' ' ' LEU . 6.0 t -121.64 151.46 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.325 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.23 125.19 12.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 170' ' ' GLN . 23.8 tttp -124.49 115.24 20.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.611 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 59.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.66 75.26 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 167' ' ' LYS . 48.2 mt-30 -130.5 95.28 27.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.7 138.99 12.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.121 1.881 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.61 145.26 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.381 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -94.28 100.09 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 174' ' ' LEU . 11.1 mp -96.07 150.38 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.578 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.36 168.44 22.48 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.293 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.68 -52.17 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.367 2.045 . . . . 0.0 112.322 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -47.65 85.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.71 -37.5 84.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.615 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 1.8 t80 -64.71 -49.24 71.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.5 m -57.31 -46.04 83.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.55 -49.6 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.791 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.84 -44.77 96.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.75 -46.36 89.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 2.3 t80 -62.27 -42.25 99.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.819 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 243' ' ' LEU . 0.1 OUTLIER -59.63 -43.99 93.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.337 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.19 -45.35 86.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.556 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 mm -57.35 -35.58 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -110.18 23.16 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.274 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.02 119.08 4.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.52 -26.83 9.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 127.62 35.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.326 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 192' ' ' VAL . 8.2 p -67.88 114.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.96 157.5 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 149.83 28.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.8 mttt -57.12 -49.44 93.95 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -65.36 -35.43 40.02 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.56 1.507 . . . . 0.0 111.933 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -66.33 -55.48 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.029 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 mt -49.93 -38.1 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 209' ' ' GLY . 48.7 tp -65.06 -68.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -46.05 -27.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.572 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 24.8 t-80 -71.53 -52.29 19.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.062 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.1 t -83.42 -56.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.434 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -51.68 -4.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.458 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.541 ' H ' ' C ' ' A' ' 202' ' ' VAL . 48.1 ttm-85 -58.69 -6.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.3 OUTLIER -114.87 14.25 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.66 116.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.074 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -91.16 119.28 31.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.429 179.561 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 160.82 53.42 0.02 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.535 ' O ' HD21 ' A' ' 199' ' ' LEU . . . -159.74 98.21 0.17 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 209' ' ' GLY . 44.1 m-20 -47.87 -177.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 211' ' ' VAL . 4.4 p -80.33 -9.6 12.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.644 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.83 -17.97 34.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.18 -35.04 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.298 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.1 t -58.27 -49.51 81.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.322 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -58.4 -47.07 85.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.278 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 m -59.78 -45.35 92.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.38 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -45.34 94.79 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 214' ' ' VAL . 59.6 t -62.2 -40.2 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -44.79 90.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.592 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.49 -28.5 66.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.572 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.61 -47.3 63.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 226' ' ' ASP . 3.1 mtp85 -57.02 -45.56 83.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.319 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -67.41 -10.14 48.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -90.58 -44.27 9.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.9 pp -110.14 -32.78 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -95.23 143.47 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.9 t -175.33 38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.06 -163.25 10.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -90.54 -20.54 22.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.518 ' CD ' ' H ' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -92.23 104.0 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.208 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -88.75 125.86 35.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.4 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.754 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mt -91.25 -8.8 47.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.63 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.6 mp -121.6 116.32 24.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.183 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 127.57 37.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.46 105.88 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.6 mt -94.59 73.1 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.14 136.36 5.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.708 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.18 -12.74 65.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.15 -46.06 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 147.13 -141.77 9.68 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -131.12 153.59 49.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 0.0 110.476 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.48 136.61 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.41 119.92 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -163.03 127.12 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -56.97 154.97 16.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.148 179.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -36.57 140.13 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.852 2.368 . . . . 0.0 112.075 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.48 -179.886 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.0 tmm? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.62 170.65 12.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.4 t -124.77 -38.34 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.364 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 93.0 p -149.42 169.44 20.86 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.833 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.86 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -42.77 136.7 2.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.483 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.86 156.55 44.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 129' ' ' HIS . 10.5 m170 55.48 62.12 2.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.697 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -73.07 11.54 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.423 ' H ' ' C ' ' A' ' 127' ' ' HIS . 33.2 t-80 46.29 88.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.09 115.61 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.832 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.1 p -77.83 64.83 3.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.58 93.8 1.49 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.14 123.78 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.84 154.07 37.44 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.463 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.79 -164.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.967 2.445 . . . . 0.0 112.618 -179.471 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -153.56 15.1 0.5 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.525 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.54 -165.77 26.01 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 139' ' ' HIS . 9.5 t -90.82 -3.81 57.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.171 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' SER . 1.7 t-80 60.84 127.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.254 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 36.5 mtt -119.26 -108.51 0.36 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.02 -8.46 3.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.312 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.32 142.57 3.49 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.45 -15.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.939 0.399 . . . . 0.0 110.419 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -65.31 167.93 7.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.555 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER 177.88 -49.62 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.4 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 49.6 Cg_exo -51.0 161.03 1.62 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.362 2.041 . . . . 0.0 111.957 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.01 -84.8 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -66.15 174.66 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.152 -179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.93 115.04 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.299 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -141.38 134.6 29.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.76 161.09 16.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 157.79 44.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' OE2' ' A' ' 245' ' ' GLU . 91.9 t80 -162.55 122.96 2.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.668 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 32.8 m-20 -124.66 54.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 152.41 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.553 -179.329 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.1 tt0 -140.23 147.7 40.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.216 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD21 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -146.33 117.46 7.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.257 -179.645 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -112.43 115.42 28.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.673 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.8 -45.07 79.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -49.49 -50.72 40.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.714 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 56.4 p -97.18 6.95 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.624 ' CE1' ' CE1' ' A' ' 179' ' ' PHE . 16.9 t60 36.1 57.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -134.18 159.18 41.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.54 154.45 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -146.42 129.14 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.123 -179.795 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 170' ' ' GLN . 25.5 tttp -127.51 114.55 17.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.414 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 65.06 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 60.4 29.57 69.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 167' ' ' LYS . 14.7 tp60 -132.95 92.18 26.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.29 136.81 16.32 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.134 1.89 . . . . 0.0 112.379 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.29 136.08 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.957 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 57.9 m -91.06 91.14 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.88 142.58 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.931 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 170.74 13.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.95 -53.96 6.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.408 2.072 . . . . 0.0 112.43 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -52.3 -63.44 1.14 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -58.33 -37.45 75.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.775 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.624 ' CE1' ' CE1' ' A' ' 163' ' ' HIS . 27.7 t80 -54.98 -51.71 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -62.77 -35.69 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.549 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.6 -51.17 69.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.152 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.18 -41.25 98.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.792 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -62.45 -41.79 99.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.23 -37.28 86.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.207 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.97 -46.05 92.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.43 -47.28 90.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.484 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -50.88 -42.08 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -108.98 25.36 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.75 117.34 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.62 -21.42 16.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 193' ' ' LEU . 21.5 m -96.5 131.47 43.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 242' ' ' VAL . 75.3 t -68.86 119.02 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 191' ' ' THR . 4.5 mp -96.78 166.27 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 110.77 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.97 148.26 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.67 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.36 -51.08 84.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.574 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.6 Cg_endo -64.27 -44.6 11.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.675 1.583 . . . . 0.0 112.149 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.04 -51.54 68.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.244 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -55.52 -39.0 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 110.393 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 199' ' ' LEU . 2.6 tt -59.43 -67.39 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.071 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -58.13 -15.9 11.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -53.38 12.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.711 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 204' ' ' ARG . 23.8 t -84.06 -30.66 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.269 -179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.575 ' NE1' ' O ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER -60.36 -3.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.92 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 202' ' ' VAL . 13.2 mmm-85 -61.01 -1.93 0.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.568 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.9 m-85 -121.83 4.47 9.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.597 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.68 110.06 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.84 172.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.575 ' O ' ' NE1' ' A' ' 203' ' ' TRP . . . 139.65 80.89 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.88 59.04 0.99 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -100.54 98.2 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.451 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -6.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.642 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -90.8 -26.07 19.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -67.68 -32.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.7 t -57.85 -56.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.072 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.51 -46.92 76.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.229 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.0 t -60.6 -45.66 93.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.13 -39.03 89.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.15 -46.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.428 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -62.48 -43.32 99.09 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -72.69 -13.32 61.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 221' ' ' LEU . 0.3 OUTLIER -83.26 -48.33 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.131 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 12.5 mtm-85 -56.07 -45.05 79.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.135 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -68.17 -11.14 58.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.766 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.4 tttp -92.7 -33.34 14.38 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.625 -179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -21.6 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.872 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.85 -39.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -53.25 168.98 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.16 -8.55 56.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.916 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 130.1 39.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -85.79 128.43 34.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -90.09 -74.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -91.95 145.45 24.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.646 -179.652 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -105.23 132.44 51.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.38 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -91.69 108.94 20.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.737 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 10.2 mt -94.87 72.96 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.469 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -36.84 142.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.19 179.641 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.1 36.04 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.59 -57.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.567 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 154.37 -138.95 6.44 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -130.51 160.74 33.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.697 179.996 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 242' ' ' VAL . 10.8 p -142.64 126.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 36.8 tp -90.64 116.67 28.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.537 ' O ' ' NE ' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -161.9 147.18 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.437 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.545 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.4 mp0 -74.52 154.63 87.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.92 150.45 73.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.505 2.137 . . . . 0.0 111.967 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.645 -179.754 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.85 -112.86 0.36 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 123' ' ' SER . 12.7 t -80.38 81.31 6.67 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.055 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 122' ' ' SER . 59.4 p 39.25 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.277 0.561 . . . . 0.0 111.491 178.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -77.06 -73.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.738 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -173.3 -176.65 1.37 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 -179.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -127.4 34.47 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 135.68 33.54 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -93.85 44.89 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.653 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -116.67 -0.01 12.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.281 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -29.69 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.534 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 122.19 32.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 0.0 110.8 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.32 -121.08 1.11 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mt -102.28 -165.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.69 0.281 . . . . 0.0 110.344 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.74 71.96 74.04 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.996 0.427 . . . . 0.0 110.959 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.84 170.68 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.855 2.37 . . . . 0.0 111.966 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 59.26 60.53 2.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.57 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.09 165.78 31.32 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.7 m -103.95 -5.01 22.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -151.34 149.6 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.8 ttt -60.43 -90.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.431 179.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 143' ' ' ASN . 4.3 mtpt -147.53 20.6 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.531 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.06 -24.11 1.69 Allowed Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 144' ' ' LYS . 10.7 t30 -141.99 170.12 16.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 27.8 mttm -100.45 170.55 8.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.006 0.432 . . . . 0.0 111.331 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -128.38 151.1 75.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.79 126.7 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.907 2.405 . . . . 0.0 112.4 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.44 -8.95 8.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.75 115.06 19.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -93.29 129.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.832 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -174.5 143.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.13 154.71 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -142.34 156.97 45.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.67 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 154' ' ' ALA . 26.2 t80 -169.66 133.84 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.833 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.95 -129.6 0.25 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.63 53.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.349 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.92 151.24 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -146.79 141.49 26.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.161 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.06 117.95 14.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.383 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -104.11 108.71 20.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.97 0.414 . . . . 0.0 110.354 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.95 -31.05 72.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.167 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 1.4 mp0 -58.77 -48.32 81.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.735 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 163' ' ' HIS . 65.9 p -109.17 13.93 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER 38.18 50.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.702 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -119.41 158.44 26.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.13 151.97 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.31 124.72 13.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.1 ttpt -128.64 121.13 27.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.57 58.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.6 27.76 70.28 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.6 mt-30 -132.18 97.83 17.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.56 138.52 17.37 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.977 1.784 . . . . 0.0 112.492 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.97 143.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.61 -179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -93.73 97.29 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -95.97 152.16 18.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.778 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.2 161.49 59.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.338 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.46 -45.05 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.628 2.219 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -42.75 88.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.773 0.32 . . . . 0.0 110.813 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -65.43 -34.46 78.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -62.41 -45.52 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.119 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -43.58 96.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.124 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -47.66 84.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.774 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.61 -44.04 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.499 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -56.11 -47.15 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.824 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.509 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 2.6 t80 -66.08 -38.6 88.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.603 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.594 ' CZ ' ' CE2' ' A' ' 241' ' ' TYR . 3.0 m-85 -55.88 -44.54 78.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.96 -47.62 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.94 -31.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -106.53 23.77 13.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.798 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.08 119.68 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.74 -23.0 27.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.1 m -94.86 127.8 41.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.535 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 192' ' ' VAL . 14.7 p -68.62 112.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.157 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.32 151.18 19.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.0 p -100.33 148.38 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.371 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -58.39 -48.78 96.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 36.4 Cg_exo -55.03 -46.26 34.6 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.417 2.078 . . . . 0.0 111.666 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -61.97 -52.36 64.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.5 mt -49.95 -38.78 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.916 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.35 -67.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.419 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.93 -21.6 1.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.509 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 63.1 t60 -72.57 -59.19 2.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 204' ' ' ARG . 64.6 t -83.69 -60.65 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -51.11 -4.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.1 OUTLIER -60.65 -0.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.678 0.275 . . . . 0.0 110.597 -179.927 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.2 m-85 -120.2 14.39 12.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.37 . . . . 0.0 110.452 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.28 98.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.7 111.2 16.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.738 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.61 52.19 0.04 OUTLIER Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.24 101.36 0.2 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 209' ' ' GLY . 7.4 t70 -47.57 -177.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -78.48 -0.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.627 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.23 -22.16 19.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.689 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 t -64.18 -43.99 97.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.481 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 218' ' ' VAL . 48.3 t -61.35 -43.05 95.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.239 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -58.88 -45.87 89.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.444 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.4 t -61.12 -40.74 94.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.106 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -64.04 -43.47 95.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.812 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 214' ' ' VAL . 70.2 t -62.47 -41.02 90.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.284 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.83 -44.21 90.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -67.41 -31.29 71.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.5 mp -67.55 -45.71 74.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.87 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 226' ' ' ASP . 30.6 mtp85 -56.74 -46.16 81.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.35 -24.41 65.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -92.73 -23.37 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -111.12 -41.15 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.695 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 222' ' ' ARG . 24.3 t70 -100.81 141.1 34.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -37.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.422 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -59.37 165.89 9.34 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -69.26 -10.53 58.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.628 0.252 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -93.67 115.75 28.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.422 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -83.9 130.73 34.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 244' ' ' ARG . 27.9 mt -89.55 -74.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.64 145.72 26.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.577 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -105.17 140.26 38.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.662 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 m -95.85 114.75 26.51 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.036 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 240' ' ' GLY . 57.3 mt -96.14 72.12 2.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 236' ' ' LEU . 2.4 ptp180 -37.93 138.15 0.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.07 -18.64 43.39 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.15 -60.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.441 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 165.19 -142.07 7.47 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.594 ' CE2' ' CZ ' ' A' ' 185' ' ' PHE . 2.0 p90 -130.35 160.27 34.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.52 133.99 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.531 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 232' ' ' LEU . 7.8 ptm180 -162.73 127.9 3.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.9 154.18 84.95 Favored Pre-proline 0 C--O 1.232 0.165 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.77 110.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.043 2.495 . . . . 0.0 112.846 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.408 179.327 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.68 ' N ' ' NE2' ' A' ' 124' ' ' HIS . 5.4 ptm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.84 22.13 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -135.12 147.74 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 110.489 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.94 20.68 6.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.859 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.68 ' NE2' ' N ' ' A' ' 120' ' ' MET . 1.6 m-70 -109.24 125.03 51.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.178 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.707 ' CE1' ' H ' ' A' ' 127' ' ' HIS . 6.1 p80 -152.66 -135.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.908 0.385 . . . . 0.0 111.127 -179.402 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.678 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 1.3 m-70 -73.64 -21.41 60.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.707 ' H ' ' CE1' ' A' ' 125' ' ' HIS . 4.6 m170 67.26 125.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 176.81 142.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.351 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -149.65 -89.2 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.699 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.61 137.11 41.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.573 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.9 -75.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 114.47 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 133' ' ' LEU . 1.1 tp 69.71 111.74 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 134' ' ' VAL . 9.1 p -163.85 54.62 0.42 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 33.0 Cg_endo -66.12 156.59 63.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.872 2.382 . . . . 0.0 111.83 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -92.47 145.31 24.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.659 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.15 125.83 0.81 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 140' ' ' MET . 0.0 OUTLIER -103.76 -13.16 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.633 0.254 . . . . 0.0 110.52 -179.801 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.4 m80 63.72 -30.85 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.589 ' H ' ' C ' ' A' ' 138' ' ' SER . 4.7 ttm -172.47 117.97 0.36 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.108 0.48 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -70.23 -23.61 62.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.435 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.52 -110.77 0.45 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -56.09 133.68 52.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -109.13 10.22 26.0 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.25 77.11 2.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.667 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.48 -15.14 46.89 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.623 2.215 . . . . 0.0 111.112 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -107.54 167.29 10.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.737 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.07 129.0 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 149' ' ' VAL . 1.0 OUTLIER -71.11 140.46 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 -179.678 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -149.2 138.09 21.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -90.72 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.575 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.0 158.03 44.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.0 111.218 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 243' ' ' LEU . 3.8 t80 -164.79 139.76 5.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.347 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.544 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 37.28 -105.32 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.244 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.69 53.11 1.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -137.43 150.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.556 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -140.45 137.02 33.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.38 143.34 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.216 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.26 109.47 15.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.06 -17.38 64.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.41 -52.03 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 42.3 p -96.79 12.04 33.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 162' ' ' THR . 14.7 m-70 37.36 41.15 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.1 169.36 9.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.868 -179.399 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 166' ' ' TRP . 62.1 t -122.28 161.04 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.477 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.121 179.647 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.6 tmtm? -124.67 113.51 18.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.687 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 64.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.052 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.41 31.69 63.26 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.5 tt0 -142.3 89.39 8.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.82 150.07 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.23 1.953 . . . . 0.0 112.544 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.2 126.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.905 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 p -95.13 115.39 27.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.871 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -141.69 154.28 45.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.489 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.64 161.53 1.57 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.0 -33.99 95.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.889 2.393 . . . . 0.0 111.96 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -60.81 -53.61 55.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.13 -37.81 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.229 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.48 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 4.7 t80 -58.48 -48.08 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.9 m -58.8 -39.33 80.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 181' ' ' LEU . 44.7 tp -60.87 -46.87 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.348 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.18 -40.65 86.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -59.89 -43.62 94.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.64 -179.74 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.45 -43.07 91.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.564 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.43 -43.11 83.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.91 -48.75 86.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.52 -35.67 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.136 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.4 23.25 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.48 117.23 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.914 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.66 -14.15 24.79 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.3 m -98.48 130.9 45.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.18 115.07 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.457 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.89 152.65 18.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.445 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.75 147.96 27.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.201 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -56.58 -51.34 81.94 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 22.0 Cg_endo -65.23 -36.35 36.72 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.65 1.567 . . . . 0.0 111.987 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -66.49 -46.83 75.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.92 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 32.7 mt -53.81 -42.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.139 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.1 mt -63.7 -64.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.524 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -32.39 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -53.59 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.9 t -83.5 -61.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.048 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -52.0 -3.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.189 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -61.14 -4.89 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.0 110.51 179.879 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.9 t80 -113.95 -0.22 14.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.103 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -175.22 91.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.57 110.56 15.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 176.14 48.86 0.06 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -155.19 101.56 0.21 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 209' ' ' GLY . 1.3 m-20 -49.55 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.776 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.9 -4.79 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.67 -21.09 22.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.79 -33.83 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.951 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 218' ' ' VAL . 11.7 t -60.94 -50.74 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.263 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -45.97 83.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 p -61.04 -44.04 97.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -40.48 94.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 214' ' ' VAL . 49.5 t -62.45 -40.06 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.688 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -43.31 80.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -12.99 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.66 -50.18 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.984 179.451 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.3 ttp180 -56.28 -51.14 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.295 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -8.31 29.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.547 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -92.36 -37.09 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.57 -179.085 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.76 -25.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 0.0 110.72 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.3 OUTLIER -105.49 139.43 40.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.598 179.914 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 227' ' ' THR . 13.2 t -165.93 38.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.16 -173.52 13.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.2 -13.19 57.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.69 -0.255 . . . . 0.0 111.038 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -93.89 115.49 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.954 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.2 mmt180 -97.52 113.17 24.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -90.32 -1.68 57.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 107.48 15.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.93 125.01 41.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.7 m -91.8 111.48 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.539 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.7 mt -95.23 72.8 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 19.0 ttt-85 -36.75 127.04 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.98 -10.7 70.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.91 -39.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 135.96 -137.84 9.45 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.7 154.67 46.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 0.0 110.838 -179.846 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.09 138.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -91.75 113.61 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.416 179.79 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -161.7 130.95 4.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.493 ' HG2' HD22 ' A' ' 232' ' ' LEU . 16.3 mt-10 -77.25 154.08 82.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.57 126.24 12.57 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.74 2.293 . . . . 0.0 112.086 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.552 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.35 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -128.63 123.59 33.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.7 146.76 23.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.624 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.2 m -142.35 155.44 45.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 155' ' ' ASP . 42.7 t80 -163.02 128.01 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.92 -96.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 43.2 p-10 -124.56 53.79 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 143.27 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.155 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -140.13 136.1 33.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.324 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.448 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.67 131.74 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -113.74 109.52 18.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.65 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 160' ' ' GLU . 1.5 mp0 -66.68 -12.21 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.838 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.8 -51.98 6.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.589 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 40.6 p -99.21 11.22 39.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 40.6 p-80 35.82 58.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.357 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.33 156.26 42.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 174' ' ' LEU . 21.9 t -122.7 148.77 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.52 125.29 12.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 170' ' ' GLN . 31.8 tttm -128.83 117.24 20.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 62.74 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.1 26.26 70.21 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 167' ' ' LYS . 5.9 mt-30 -130.49 92.93 33.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 O-C-N 122.705 -0.291 . . . . 0.0 110.522 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.74 142.21 17.78 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.154 1.902 . . . . 0.0 111.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 131.01 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -88.46 88.35 7.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 165' ' ' VAL . 1.2 mt -93.92 154.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.42 165.2 32.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.3 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -42.12 -54.62 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.258 . . . . 0.0 112.362 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 53.7 m -57.68 -56.6 19.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.282 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -58.38 -34.69 70.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.933 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.82 -45.31 78.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.1 m -58.87 -39.92 82.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -54.27 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.72 -41.78 87.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -60.48 -46.67 89.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.081 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.684 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 19.5 t80 -62.3 -41.1 98.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.414 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.13 -43.67 82.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.93 -45.45 87.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' TYR . 55.5 mt -57.09 -37.24 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.84 25.6 11.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.07 124.33 16.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.44 -24.51 15.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.8 m -95.46 131.32 41.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.583 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 t -66.96 119.39 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.285 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 158.47 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.28 148.43 34.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mtpp -56.02 -55.01 46.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.486 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.0 Cg_endo -65.07 -39.96 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.851 1.701 . . . . 0.0 112.055 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.88 -51.55 68.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 37.5 mt -53.24 -42.96 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.179 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.68 -63.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.505 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.18 -29.59 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.259 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.684 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 6.1 t60 -71.2 -46.48 61.18 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.005 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 90.4 t -83.77 -60.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -50.55 -6.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.049 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.5 OUTLIER -59.33 -6.81 1.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 13.1 m-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 211' ' ' VAL . 10.1 p -86.26 -10.36 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.92 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.71 -24.5 31.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.356 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 216' ' ' SER . 21.9 t -64.31 -34.76 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.04 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 218' ' ' VAL . 39.5 t -65.93 -45.37 91.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.333 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.71 -45.72 77.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.311 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 33.0 p -60.1 -46.75 88.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.05 -38.81 92.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 214' ' ' VAL . 79.7 t -63.54 -43.11 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.607 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.72 -45.56 93.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.55 -39.87 92.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.316 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -61.33 -45.81 92.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.269 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' ASP . 47.0 ttt180 -56.18 -43.12 78.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.345 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -67.47 -30.25 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.403 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -91.1 -11.26 39.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -120.16 -25.1 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.915 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -96.2 137.03 35.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.191 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -70.83 170.74 46.19 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.1 -12.51 59.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -93.32 111.03 22.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.8 ttp85 -92.39 103.81 16.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mp -91.02 -5.72 54.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.43 HD12 ' HG ' ' A' ' 243' ' ' LEU . 1.4 tp -114.3 106.79 14.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 130.85 39.63 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.46 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.9 m -100.91 112.78 25.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.202 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.4 mt -98.07 69.61 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.066 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' LEU . 71.3 mtt180 -38.26 131.79 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.07 -20.85 49.2 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.2 t -120.08 -58.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 110.422 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.17 -139.22 5.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.89 153.85 49.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.8 p -137.0 135.15 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -90.78 125.87 35.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.995 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -162.29 134.13 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.199 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -148.46 141.83 25.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.189 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 151' ' ' LEU . 5.2 mt -90.47 151.15 21.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 158.59 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.056 0.455 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 154' ' ' ALA . 82.7 t80 -163.84 139.5 6.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.631 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.51 -104.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -124.63 53.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -138.4 154.26 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.18 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.41 144.84 32.21 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.59 131.73 34.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -114.82 98.95 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.5 mp0 -66.83 -19.06 65.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.637 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.59 -31.51 70.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.909 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 33.8 p -129.29 -18.24 3.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.61 ' CE1' ' CD2' ' A' ' 179' ' ' PHE . 2.4 t60 83.81 54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.1 151.34 42.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 174' ' ' LEU . 2.6 t -122.51 151.62 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.586 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.55 130.65 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.3 OUTLIER -127.78 111.36 13.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.68 71.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.83 43.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 167' ' ' LYS . 18.7 tp60 -132.19 93.45 26.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.18 139.1 21.01 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.968 1.779 . . . . 0.0 112.558 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.18 140.28 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.633 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 m -91.2 87.26 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.429 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -96.65 136.01 37.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.671 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 173.01 6.24 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.7 -52.25 9.43 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.26 1.973 . . . . 0.0 112.176 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -56.42 19.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.227 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -58.45 -38.68 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.61 ' CD2' ' CE1' ' A' ' 163' ' ' HIS . 13.1 t80 -61.75 -46.69 88.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.384 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -58.66 -41.57 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.42 -46.88 83.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.835 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.98 -39.79 87.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.486 ' NH1' HD11 ' A' ' 187' ' ' ILE . 59.1 ttt-85 -58.24 -45.22 88.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.849 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.415 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 4.5 t80 -69.65 -39.29 77.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.2 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -40.97 83.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.627 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.17 -45.33 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.814 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.486 HD11 ' NH1' ' A' ' 183' ' ' ARG . 70.5 mt -58.17 -34.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.415 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 63.1 m-20 -109.26 25.21 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.486 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.57 117.52 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.5 27.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.26 128.74 42.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.897 0.379 . . . . 0.0 110.792 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.69 114.25 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.529 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.62 156.78 16.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.747 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.24 147.91 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 3.7 mttp -58.94 -43.99 98.33 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.316 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 39.5 Cg_exo -54.64 -50.0 14.87 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.367 2.045 . . . . 0.0 111.875 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -62.22 -55.97 23.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 202' ' ' VAL . 2.9 mt -47.88 -43.98 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.934 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.93 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.89 -30.48 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.336 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -72.5 -48.15 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -83.39 -60.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.454 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -53.41 -4.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.1 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttt180 -62.13 -4.22 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.594 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.02 -4.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -98.73 -27.23 14.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.255 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.454 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 13.1 t -66.13 -41.33 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.77 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -53.24 -49.76 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.47 -47.07 87.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.242 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 73.7 m -61.07 -43.87 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.09 -40.62 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.656 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 214' ' ' VAL . 71.1 t -62.41 -42.43 95.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.593 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -43.45 96.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -69.3 -30.43 68.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.35 -45.98 68.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.117 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 2.1 mtp180 -56.89 -44.93 82.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.59 -16.75 63.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -94.98 -29.45 14.63 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.683 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.28 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 110.713 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -110.19 137.49 47.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.593 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.52 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.01 -178.63 17.53 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.0 -15.42 63.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 110.649 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -91.58 111.78 23.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -86.01 136.07 33.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.393 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -88.21 -75.4 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.01 146.27 24.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -102.29 138.49 39.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.943 0.402 . . . . 0.0 110.856 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 45.1 m -95.4 110.54 22.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.979 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.61 70.81 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -40.57 120.68 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.39 -16.83 29.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.49 -53.14 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.281 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.09 -138.21 5.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.74 156.32 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.634 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.1 p -134.33 132.13 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.72 117.01 29.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 232' ' ' LEU . 4.9 ptm180 -162.8 132.04 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.994 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -125.41 124.25 41.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.92 154.81 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 153.65 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.512 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 154' ' ' ALA . 68.7 t80 -166.75 135.84 2.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.515 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.98 -105.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -124.47 53.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.52 145.86 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.221 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 19.7 tt0 -141.1 143.12 34.13 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.458 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 165' ' ' VAL . 4.2 mp -140.35 128.86 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.91 105.3 13.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.108 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -65.86 -20.6 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.14 -39.04 84.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 110.665 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 70.3 p -115.9 -24.64 8.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.41 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.591 ' NE2' ' CE2' ' A' ' 179' ' ' PHE . 2.2 t-80 82.77 48.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.281 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -121.77 158.6 28.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.475 HG21 HD12 ' A' ' 174' ' ' LEU . 2.9 t -120.61 150.42 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.679 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.401 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.46 125.19 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.468 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 170' ' ' GLN . 8.7 tttt -125.61 117.39 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.33 64.13 0.2 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.272 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.25 30.67 67.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 167' ' ' LYS . 12.9 tt0 -133.99 92.92 21.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -76.96 136.41 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.927 1.751 . . . . 0.0 112.448 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.34 143.58 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.937 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.2 p -99.47 87.47 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -95.45 154.18 17.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.364 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.0 168.31 23.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -48.8 -53.18 7.33 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.701 2.267 . . . . 0.0 112.572 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -47.59 85.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.91 -39.21 93.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.245 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.591 ' CE2' ' NE2' ' A' ' 163' ' ' HIS . 9.0 t80 -63.66 -48.61 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.682 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -55.49 -43.28 75.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -47.07 85.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.36 -42.37 99.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.639 ' HE ' HD11 ' A' ' 187' ' ' ILE . 7.4 ttp180 -59.96 -45.7 91.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.405 ' O ' ' ND2' ' A' ' 188' ' ' ASN . 19.4 t80 -66.04 -42.68 89.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.825 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -45.38 71.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.81 -49.29 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.639 HD11 ' HE ' ' A' ' 183' ' ' ARG . 56.6 mt -56.53 -31.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.616 ' N ' HD22 ' A' ' 188' ' ' ASN . 0.5 OUTLIER -107.17 15.23 25.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -49.69 120.35 4.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.87 -28.89 8.94 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -93.9 131.62 39.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 192' ' ' VAL . 9.0 p -69.13 122.24 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 193' ' ' LEU . 11.1 mp -95.39 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.501 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 149.23 31.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.584 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 13.3 mttp -55.68 -54.35 52.56 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.242 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.0 Cg_endo -66.99 -32.9 33.97 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.047 1.831 . . . . 0.0 111.768 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -47.49 71.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.772 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.02 -44.96 76.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.361 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.4 mt -61.77 -61.52 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.482 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.2 -38.91 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.995 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -72.01 -51.01 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.212 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 204' ' ' ARG . 37.7 t -83.6 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.234 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -51.29 -3.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.032 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp85 -62.46 -1.33 0.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.671 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 205' ' ' TYR . 42.7 t80 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.781 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.667 ' OD1' HG23 ' A' ' 213' ' ' VAL . 23.3 p30 . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.55 -6.5 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -88.47 -23.17 23.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.755 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.667 HG23 ' OD1' ' A' ' 210' ' ' ASP . 48.0 t -65.43 -39.29 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.027 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 218' ' ' VAL . 74.9 t -56.86 -50.75 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.251 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -55.56 -48.5 74.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.39 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -43.25 97.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -43.97 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.625 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.2 t -62.1 -41.45 91.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.609 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.92 89.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.527 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.31 -27.15 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 218' ' ' VAL . 16.3 mt -76.0 -45.31 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.054 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.44 -46.19 80.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.664 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -66.9 -23.14 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.414 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -92.46 -24.33 18.85 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.565 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.67 -41.18 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.83 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.9 137.61 39.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.544 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 227' ' ' THR . 0.8 OUTLIER -174.37 37.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.89 179.91 18.86 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -73.45 -8.65 56.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.759 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -92.19 112.08 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.568 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.97 155.85 20.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.59 -38.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.523 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.34 120.15 40.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -101.68 128.87 47.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.417 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 109.04 20.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.36 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' ARG . 38.1 mt -94.35 69.11 3.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LEU . 40.8 mtm105 -41.07 110.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 124.01 -20.44 7.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.83 -46.66 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.62 -137.07 5.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 1.7 m-85 -125.21 157.12 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.643 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.5 p -143.0 128.94 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 244' ' ' ARG . 0.7 OUTLIER -90.51 142.47 27.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.406 ' H ' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.9 136.29 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.667 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.761 0.315 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.4 mtm-85 -136.89 123.66 21.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.77 152.27 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.507 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -141.88 157.18 45.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.732 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.2 t80 -162.95 127.73 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.87 -98.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 10.2 p30 -125.07 54.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.35 147.23 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.201 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.75 137.23 31.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.534 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.05 137.37 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.551 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.78 108.48 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.455 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.586 ' OE2' ' NH1' ' A' ' 183' ' ' ARG . 25.4 mm-40 -66.52 -10.61 46.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.07 -42.86 8.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.067 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 163' ' ' HIS . 32.7 p -100.89 10.13 41.49 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 162' ' ' THR . 39.0 t-80 36.24 50.94 0.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -124.22 155.36 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 166' ' ' TRP . 13.3 t -117.14 159.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.449 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -146.07 129.24 16.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.3 tptp -127.81 110.25 12.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.42 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.57 67.95 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.74 31.45 64.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 167' ' ' LYS . 34.2 tp60 -142.01 87.92 9.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.35 146.42 80.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.115 1.876 . . . . 0.0 112.008 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -128.94 136.8 58.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.734 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.8 m -92.89 86.95 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.37 152.19 18.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.44 169.23 18.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.95 -54.15 4.94 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 112.185 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 p -54.98 -57.35 12.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.021 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -57.48 -39.14 75.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.655 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -63.95 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.753 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 m -59.07 -39.66 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.19 -45.24 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.685 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 tp -63.85 -39.44 94.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.518 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.586 ' NH1' ' OE2' ' A' ' 160' ' ' GLU . 12.5 ttt180 -64.11 -44.8 91.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -62.84 -40.71 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.959 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.56 -45.15 99.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.777 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.8 mt -58.97 -37.05 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.9 28.59 8.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 118.91 5.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.504 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.56 -21.04 22.07 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -96.01 131.68 42.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.674 0.273 . . . . 0.0 110.724 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.6 p -68.62 117.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.308 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.46 150.66 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.08 148.0 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.963 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 1.7 mttp -58.67 -46.43 99.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.1 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 45.5 Cg_exo -50.15 -51.65 10.51 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.024 1.816 . . . . 0.0 111.989 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.98 -55.23 27.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.321 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -49.17 -41.18 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.943 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' A' ' 214' ' ' VAL . 30.2 tp -61.43 -67.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.8 -16.78 7.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.133 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -71.11 -52.05 21.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.66 -44.3 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.4 m-90 -65.18 -5.72 7.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -2.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.82 0.343 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.4 p -79.71 -6.0 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.8 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.92 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 199' ' ' LEU . 17.9 t -61.66 -48.62 87.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.415 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -52.63 -48.61 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.699 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.3 t -61.8 -48.32 81.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.38 -42.08 81.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.64 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 t -62.88 -46.32 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -43.92 92.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -33.31 74.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -46.19 75.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.081 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 18.2 mtp85 -56.17 -45.11 79.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -67.77 -24.82 65.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.542 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -93.19 -24.41 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.38 -36.4 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 5.4 t0 -98.59 138.49 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 -36.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.542 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.09 165.29 16.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -70.42 -8.33 50.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.855 0.36 . . . . 0.0 110.418 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.88 122.27 34.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -82.28 157.58 23.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.33 -41.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.073 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.1 112.92 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.451 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.561 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.2 m -96.27 108.55 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.194 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 237' ' ' ARG . 7.9 mt -95.41 69.75 3.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -35.57 127.0 0.64 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.104 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.57 39.97 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.16 -49.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.939 0.399 . . . . 0.0 110.204 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.85 -139.51 7.15 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.51 154.02 48.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.54 133.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.68 126.74 36.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.641 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -161.78 135.73 6.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.764 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.728 0.299 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -175.17 154.93 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.954 0.407 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -91.98 147.69 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.1 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -141.96 158.1 44.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.46 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CE2' HD21 ' A' ' 243' ' ' LEU . 74.8 t80 -168.65 142.9 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.05 -105.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -124.83 52.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.73 152.38 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.581 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -145.79 144.39 30.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.634 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.65 124.73 21.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.845 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.4 m-20 -104.39 105.24 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.775 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.4 -11.6 52.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -95.03 -39.58 10.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.633 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.9 p -103.84 8.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 74.9 m-70 37.52 47.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.21 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -121.82 157.05 31.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.749 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.05 152.04 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.81 125.65 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -126.18 115.41 19.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.547 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.48 56.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.5 75.5 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.0 mt-30 -131.07 96.27 22.78 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.27 137.79 15.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.087 1.858 . . . . 0.0 112.469 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.27 137.39 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.9 t -89.96 89.2 7.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.02 155.64 16.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.82 171.64 10.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -51.5 -52.16 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.302 2.002 . . . . 0.0 111.675 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.0 m -56.3 -52.08 65.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.956 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.92 -41.7 87.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.459 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 27.0 t80 -60.98 -44.58 97.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.101 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -58.0 -44.84 87.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.636 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.63 HD12 HG21 ' A' ' 202' ' ' VAL . 0.7 OUTLIER -61.45 -44.37 97.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.804 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -43.67 93.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -59.07 -45.16 91.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.55 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 14.1 t80 -65.34 -42.02 93.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.82 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.6 -39.72 68.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.66 -49.31 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.099 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 187' ' ' ILE . 43.6 mm -57.3 -32.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.745 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.538 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 59.8 m-80 -107.91 18.17 21.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.56 114.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.709 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.07 -19.26 18.04 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 193' ' ' LEU . 94.4 m -95.78 132.45 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.87 115.47 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 191' ' ' THR . 4.6 mp -96.58 159.97 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.023 0.44 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 147.72 28.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.58 -54.8 51.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.062 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.9 Cg_endo -66.84 -33.64 33.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.96 1.773 . . . . 0.0 111.693 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -64.28 -51.64 62.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.09 -41.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.87 -66.9 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -49.91 -28.24 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.101 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 69.9 t60 -72.19 -57.54 4.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.63 HG21 HD12 ' A' ' 181' ' ' LEU . 57.3 t -83.42 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.378 . . . . 0.0 111.613 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.7 OUTLIER -49.12 -4.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.4 ttm180 -59.31 -0.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.072 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.6 m -79.05 -8.26 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.894 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -82.97 -14.82 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 80.9 t -68.75 -36.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.2 t -57.93 -49.81 79.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.83 -44.62 90.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.066 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 m -60.84 -46.97 88.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.71 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.42 -41.45 98.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.615 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 214' ' ' VAL . 99.1 t -62.52 -43.33 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -45.53 91.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -28.96 68.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.05 -46.06 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 226' ' ' ASP . 32.9 ttm180 -56.03 -47.21 78.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.382 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -67.29 -15.56 63.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.504 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -93.45 -34.24 13.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.477 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.424 ' O ' ' CE ' ' A' ' 167' ' ' LYS . 2.1 pp -109.89 -36.14 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -98.42 141.79 30.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.337 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -161.4 25.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -117.93 169.03 13.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -65.89 -7.89 19.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.599 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 129.34 39.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.745 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.8 113.77 25.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.71 -4.82 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.102 0.477 . . . . 0.0 110.746 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.48 104.92 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.385 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 122.74 33.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.37 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.25 115.39 28.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 9.1 mt -96.1 69.17 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 31.5 mtp180 -35.84 128.19 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.738 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.68 -12.47 66.06 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.0 t -128.4 -60.26 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.88 -139.29 5.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -130.61 154.06 48.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.351 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 7.2 p -135.5 137.44 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.484 HD21 ' CE2' ' A' ' 153' ' ' PHE . 3.0 tp -91.92 116.9 29.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -162.27 144.47 11.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.837 0.351 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -123.43 121.51 35.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.87 159.5 16.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.36 153.94 47.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.981 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.9 t80 -160.26 125.16 3.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.472 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.62 -98.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' PHE . 13.5 m-20 -125.61 54.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.62 148.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.416 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.729 ' C ' HD12 ' A' ' 158' ' ' LEU . 1.8 mt-10 -138.98 133.23 31.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.556 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 157' ' ' GLU . 10.6 mp -128.6 140.17 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -113.07 102.39 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 0.0 110.376 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.0 -13.11 59.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -96.59 -50.08 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.824 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 50.3 p -94.08 11.86 28.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.504 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 96.5 m-70 36.27 53.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.87 157.37 29.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.428 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.18 156.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.39 128.2 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.456 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.5 ttpt -126.88 106.44 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.22 71.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.03 30.42 37.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.8 tt0 -140.95 85.9 12.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -63.42 154.07 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.411 2.074 . . . . 0.0 112.554 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.15 121.47 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.638 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 t -92.38 87.01 5.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.36 155.37 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -62.37 178.95 0.3 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.736 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 175' ' ' SER . 5.6 Cg_exo -67.6 -48.4 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.441 2.094 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.7 m -46.13 -54.18 9.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.298 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -43.68 84.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -55.8 -44.84 78.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -59.67 -46.99 87.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.575 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.77 -42.32 99.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.11 -46.12 90.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.743 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.55 -41.57 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.034 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.58 -43.78 88.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.72 -42.03 82.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.36 -53.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.92 -31.78 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.64 19.89 19.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.47 119.94 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.66 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.41 -25.83 10.14 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -94.16 126.38 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.7 p -68.56 120.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.29 157.62 15.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 148.62 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -56.41 -52.31 74.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.634 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.5 Cg_endo -63.83 -41.24 24.72 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.721 1.614 . . . . 0.0 112.155 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -60.91 -48.79 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.272 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.86 -40.47 71.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.917 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 199' ' ' LEU . 1.9 tt -56.68 -61.83 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.979 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -17.03 64.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.439 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.18 -45.6 63.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.581 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -84.53 -53.7 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.793 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' A' ' 205' ' ' TYR . 4.8 m-90 -64.01 -3.07 2.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.528 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -40.97 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 203' ' ' TRP . 6.4 m-85 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.869 0.366 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.49 -10.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.665 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -91.53 -23.11 20.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.34 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.397 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 218' ' ' VAL . 97.3 t -53.79 -48.0 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.35 -45.54 87.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.49 98.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -40.68 89.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.24 -41.29 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -44.3 88.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.0 -27.43 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.27 -48.76 32.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.105 0.479 . . . . 0.0 110.188 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 14.6 ttp180 -56.6 -51.32 69.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -67.05 -8.04 27.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -91.64 -37.46 13.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -117.54 -34.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.085 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -98.24 151.26 20.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.808 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.9 t -177.46 -30.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.209 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -65.38 174.02 18.66 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -67.08 -5.7 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.821 0.344 . . . . 0.0 110.795 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -92.96 104.77 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.477 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.6 107.31 18.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.56 -2.55 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.504 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.11 103.62 8.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.336 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 122.92 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 0.0 110.603 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.1 m -91.26 112.14 23.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.744 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.8 mt -96.29 70.12 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 236' ' ' LEU . 5.9 tpp180 -35.69 116.87 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.797 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.76 -9.97 40.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.9 -36.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.48 -137.39 8.89 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.8 150.75 51.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.24 141.08 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.08 116.57 28.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.135 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -162.2 127.5 3.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.646 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.5 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.99 0.424 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -135.85 128.94 31.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.19 149.12 21.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 156' ' ' ILE . 1.7 m -141.6 155.83 45.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.5 t80 -158.15 124.48 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.989 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -94.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 153' ' ' PHE . 4.1 m-20 -124.41 53.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.3 151.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.37 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -147.76 140.7 24.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.576 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.89 138.92 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.424 ' CB ' ' OG1' ' A' ' 162' ' ' THR . 12.8 m-20 -111.36 106.37 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.382 . . . . 0.0 110.489 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -9.95 38.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.064 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.96 -47.37 4.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.015 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.0 p -94.73 8.48 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.768 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 162' ' ' THR . 12.7 m80 36.53 55.35 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -128.64 154.13 46.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.486 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.57 152.84 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.95 126.71 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.799 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 170' ' ' GLN . 10.0 tmtt? -130.13 115.69 17.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.341 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.04 67.88 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 56.7 29.47 58.19 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.1 tt0 -132.09 89.4 38.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.98 132.0 12.5 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.08 1.853 . . . . 0.0 112.475 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 135.56 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.741 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 96.51 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.7 148.19 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.562 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.31 169.85 18.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -54.18 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -49.44 77.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -60.71 -38.76 86.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.1 -46.39 87.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -63.13 -41.19 99.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 202' ' ' VAL . 1.1 tp -57.8 -48.87 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.1 -44.99 87.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.553 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -55.39 -42.69 74.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.53 -43.92 75.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.77 -41.39 73.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.5 -48.68 79.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.94 -32.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.791 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -106.45 23.12 14.7 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.093 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.51 116.6 3.2 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.31 10.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.9 m -91.76 129.4 37.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 110.291 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 242' ' ' VAL . 68.8 t -67.57 121.28 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.1 162.69 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.96 147.96 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.1 mtmt -58.21 -54.75 52.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.252 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.6 Cg_endo -68.85 -30.64 26.49 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.923 1.749 . . . . 0.0 111.819 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -67.41 -50.73 58.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.933 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.9 mt -57.16 -39.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 210' ' ' ASP . 5.7 tt -59.47 -67.88 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.342 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -25.55 3.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -50.67 27.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.841 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 204' ' ' ARG . 98.9 t -83.28 -59.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.657 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.534 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -52.73 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.5 tpp180 -53.54 -4.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 203' ' ' TRP . 14.2 m-85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 m-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.2 p -84.15 -9.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.771 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -90.41 -23.94 20.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.771 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.18 -41.17 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.516 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.87 -50.58 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.327 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -56.64 -46.55 80.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -44.85 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.794 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.88 -38.84 89.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.62 -39.96 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.32 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -44.68 78.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.184 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -69.72 -14.15 62.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.4 -46.82 9.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.939 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.1 mtt-85 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -66.08 -14.5 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -93.13 -27.06 17.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.897 ' O ' HD12 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -118.25 -45.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.592 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.3 t70 -93.67 137.1 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.005 0.431 . . . . 0.0 110.642 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.6 t -179.23 36.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.161 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -143.21 165.39 27.03 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.48 -3.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 228' ' ' GLY . 24.6 mttt -93.46 133.01 37.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.633 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -92.81 158.9 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.365 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.8 mt -147.21 -55.43 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.308 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.42 126.79 48.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.503 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.494 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.81 125.08 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.51 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 112.4 24.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.447 HD12 HG13 ' A' ' 192' ' ' VAL . 68.9 mt -96.22 67.82 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.67 115.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 -12.34 24.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.03 -55.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.512 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.83 5.69 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.64 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.5 152.45 49.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.718 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 192' ' ' VAL . 5.9 p -136.03 131.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.184 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -91.88 128.7 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -162.89 138.2 6.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.296 179.813 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.713 0.292 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.558 HH12 ' CG ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -172.07 -178.32 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.532 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.49 154.07 41.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.6 m -139.29 156.7 46.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 156' ' ' ILE . 37.1 t80 -161.59 132.58 5.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.98 -102.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -121.38 52.48 1.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.85 141.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.213 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.558 ' CG ' HH12 ' A' ' 150' ' ' ARG . 15.8 tt0 -140.05 134.03 30.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 110.401 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.663 HD23 HG22 ' A' ' 165' ' ' VAL . 1.3 mt -130.28 136.61 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 163' ' ' HIS . 83.3 m-20 -113.89 104.81 12.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.89 -27.76 68.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.789 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.64 -44.21 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 59.4 p -102.59 9.5 39.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.497 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CG ' ' C ' ' A' ' 162' ' ' THR . 12.6 p-80 37.13 55.2 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -126.85 158.92 35.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.794 HG21 HD12 ' A' ' 174' ' ' LEU . 18.4 t -121.75 155.01 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.648 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.41 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.33 125.19 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.5 tttm -124.81 109.06 12.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.26 57.34 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.121 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.76 29.15 71.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 167' ' ' LYS . 27.6 mt-30 -141.74 89.96 8.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.788 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -64.71 147.19 89.73 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 112.129 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.96 136.45 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -88.55 87.72 7.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 165' ' ' VAL . 5.9 mt -94.29 144.67 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.29 162.96 54.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.514 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.7 -53.83 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.51 2.14 . . . . 0.0 112.427 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 p -59.93 -50.04 75.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.78 -34.53 77.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.71 -46.32 79.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -58.12 -43.92 87.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 mt -58.19 -48.35 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.64 89.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -57.74 -44.79 86.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.558 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -66.23 -43.36 86.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.62 -46.55 77.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.604 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.76 -46.01 95.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.85 -38.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -104.3 23.92 12.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.98 123.58 11.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.4 -27.59 13.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.61 129.87 38.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 123.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.352 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 198' ' ' ILE . 9.3 mp -94.68 157.32 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 148.98 29.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.361 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.7 mtpt -56.57 -53.97 58.59 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 37.1 Cg_endo -71.4 -32.49 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.963 1.775 . . . . 0.0 111.828 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -64.2 -50.49 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 193' ' ' LEU . 54.9 mt -56.91 -42.43 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.46 -63.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.21 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.34 -28.6 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -72.4 -52.01 17.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.303 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.0 t -82.94 -62.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.211 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -4.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.5 ttt180 -63.19 -3.89 2.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.892 0.377 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.448 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.971 0.415 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.5 -8.4 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -85.24 -15.83 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.888 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.55 -33.34 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.43 -50.31 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.216 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.11 -49.24 72.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -63.78 -39.97 95.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 241' ' ' TYR . 18.2 t -62.46 -42.58 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' NH1' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -62.79 -43.65 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.39 -37.66 85.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.255 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.22 -46.78 85.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.069 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.42 -42.66 78.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.97 -10.12 50.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -39.14 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.69 -30.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.208 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 222' ' ' ARG . 19.9 t0 -91.57 -160.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER 72.14 6.11 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.73 -139.59 5.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -36.91 11.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -92.5 120.45 32.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.018 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 19.4 mtp85 -90.5 92.75 9.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.971 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.9 OUTLIER -90.73 -0.91 57.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.82 110.18 12.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.48 42.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.639 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 74.9 m -97.63 113.45 25.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 237' ' ' ARG . 4.9 mt -98.95 67.76 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.646 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.6 mtm180 -37.49 125.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.838 0.351 . . . . 0.0 110.79 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.72 -32.86 6.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.55 -56.77 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.457 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.24 -137.46 4.94 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -128.39 157.07 42.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.37 142.4 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 111.074 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.86 118.02 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.053 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -161.76 129.78 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.023 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.861 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -138.59 130.05 27.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.64 140.61 29.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 m -142.09 152.37 43.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.1 t80 -166.25 139.11 3.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.03 -104.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.37 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.13 147.17 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.991 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -144.62 141.67 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.712 0.292 . . . . 0.0 110.428 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -135.52 136.74 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.388 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -112.02 108.49 17.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.288 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -66.27 -9.95 37.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.661 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -100.2 -43.75 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.916 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 25.6 p -95.74 9.04 41.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 162' ' ' THR . 10.9 m170 35.65 41.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.621 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -122.44 159.02 28.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.773 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.944 HG21 HD12 ' A' ' 174' ' ' LEU . 25.1 t -118.94 158.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.465 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -146.44 123.42 11.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.51 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.9 tmtm? -127.47 115.03 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.255 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.16 67.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.43 31.46 63.05 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -133.55 90.87 27.62 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.53 138.72 15.64 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.203 1.935 . . . . 0.0 112.36 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.18 138.74 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m -85.63 93.09 8.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.944 HD12 HG21 ' A' ' 165' ' ' VAL . 89.3 mt -95.91 140.86 30.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.454 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.13 174.03 6.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.95 -53.49 7.07 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.382 2.055 . . . . 0.0 112.097 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.0 m -54.96 -56.65 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.773 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.506 ' CD ' HD11 ' A' ' 221' ' ' LEU . 2.5 mt-10 -60.98 -37.24 81.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.49 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.74 -46.36 88.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.63 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -58.65 -41.0 85.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.795 HD12 HG21 ' A' ' 202' ' ' VAL . 1.0 OUTLIER -61.39 -52.53 64.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.658 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.8 -41.86 87.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.503 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -62.41 -44.53 96.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.417 ' OH ' ' CE1' ' A' ' 201' ' ' HIS . 1.3 t80 -59.25 -39.73 83.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.77 -41.15 99.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.185 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.65 -43.24 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.962 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.8 -42.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.12 26.91 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . . . -56.13 125.21 20.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.709 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.09 -23.5 30.5 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 126.8 41.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.821 0.343 . . . . 0.0 110.294 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 192' ' ' VAL . 13.6 p -68.25 116.66 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 mp -96.56 153.12 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.15 149.23 24.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.313 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.69 -46.69 99.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.506 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 37.2 Cg_exo -55.11 -47.14 28.02 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.867 1.712 . . . . 0.0 111.897 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -61.91 -57.32 12.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.5 mt -50.63 -36.24 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.19 -58.33 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.146 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.43 -27.53 68.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.814 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' CE1' ' OH ' ' A' ' 184' ' ' TYR . 0.2 OUTLIER -73.2 -59.83 2.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.623 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.795 HG21 HD12 ' A' ' 181' ' ' LEU . 13.9 t -84.54 -58.22 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.704 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.436 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 t-105 -51.76 -4.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.055 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.8 ttt-85 -64.24 0.33 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.591 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 m-85 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.608 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.8 m -80.82 -1.0 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.7 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -95.14 -23.72 17.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.15 -38.47 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -60.81 -44.6 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.85 -48.9 74.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -60.94 -44.18 97.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -40.44 97.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' VAL . 53.5 t -62.54 -41.56 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.485 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -44.87 94.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 110.211 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -65.15 -37.85 88.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' A' ' 178' ' ' GLU . 1.8 mp -65.56 -44.74 85.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.379 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 226' ' ' ASP . 21.7 mtp180 -55.28 -42.63 73.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -16.13 64.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -93.07 -26.63 17.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.509 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -117.87 -38.47 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.769 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.5 OUTLIER -98.3 136.67 38.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.503 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -173.27 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.872 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.25 179.87 0.73 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -79.39 -12.62 59.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.7 0.286 . . . . 0.0 110.716 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -93.66 122.19 35.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.563 ' C ' HD12 ' A' ' 232' ' ' LEU . 18.1 mmm-85 -82.67 158.35 23.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -146.78 -42.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.008 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.63 112.05 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.16 122.79 40.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.6 m -92.6 107.09 18.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.4 mt -93.21 71.8 4.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 57.5 mtp180 -36.78 133.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.644 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.23 74.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.12 -58.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.952 0.406 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 156.07 -139.61 6.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -129.17 154.6 46.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.551 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 242' ' ' VAL . 15.0 p -136.67 132.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.197 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.91 126.28 35.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -162.22 130.43 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.5 mtm-85 -106.33 -177.17 3.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.59 HD22 HG11 ' A' ' 186' ' ' VAL . 3.0 mt -145.94 133.3 20.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.205 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -139.23 156.86 46.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 8.8 t80 -164.92 130.85 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.89 -99.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 74.4 m-20 -124.45 53.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.43 144.39 30.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.349 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -140.29 131.0 25.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.946 0.403 . . . . 0.0 110.557 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.506 HD23 HG22 ' A' ' 165' ' ' VAL . 1.4 mp -127.49 152.2 47.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.34 107.63 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.3 -12.23 55.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -96.11 -49.71 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.3 p -92.57 11.18 27.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.479 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 15.0 m80 35.27 48.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -117.58 159.92 22.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 158' ' ' LEU . 14.5 t -125.43 150.09 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.428 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.3 127.09 14.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.512 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.8 tmtm? -129.45 114.13 15.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.88 71.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.55 24.82 32.93 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.9 tt0 -129.02 94.73 33.26 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.488 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.94 137.28 12.34 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.158 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.63 135.83 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.068 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 m -92.63 88.96 6.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.5 153.94 17.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.67 171.48 10.52 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.455 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.8 -54.07 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.492 2.128 . . . . 0.0 112.319 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.3 m -54.76 -54.25 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.75 -38.01 83.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 110.756 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 22.5 t80 -63.57 -43.21 97.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.6 m -62.42 -43.46 98.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -59.35 -43.91 92.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 182' ' ' LEU . 38.4 tp -71.36 -38.47 71.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.659 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.474 ' HE ' HD11 ' A' ' 187' ' ' ILE . 8.7 ttp180 -58.19 -41.24 83.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.691 ' CZ ' ' NE2' ' A' ' 201' ' ' HIS . 15.4 t80 -69.83 -39.85 76.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.804 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.61 -41.95 82.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 151' ' ' LEU . 56.4 t -67.9 -48.16 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.474 HD11 ' HE ' ' A' ' 183' ' ' ARG . 88.3 mt -58.64 -31.41 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.08 21.25 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.0 118.35 3.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.81 -19.62 35.38 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 m -98.27 126.97 43.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 192' ' ' VAL . 3.5 p -68.53 122.08 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 198' ' ' ILE . 5.2 mp -96.59 159.82 14.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 147.85 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.796 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.4 mtmm -56.84 -56.69 30.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -63.64 -32.67 68.84 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.013 1.808 . . . . 0.0 111.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -68.61 -51.72 39.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.951 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 193' ' ' LEU . 18.2 mt -53.0 -36.94 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.893 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 199' ' ' LEU . 0.9 OUTLIER -61.21 -70.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.422 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -52.18 -17.33 1.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.155 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.691 ' NE2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.57 -53.38 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.099 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.2 t -83.26 -40.42 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -60.67 -3.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 202' ' ' VAL . 25.9 ttt180 -61.41 -0.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.6 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.085 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.436 ' O ' HG12 ' A' ' 213' ' ' VAL . 15.3 m-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.901 0.381 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.2 m -83.4 -8.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -23.03 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 210' ' ' ASP . 2.4 p -63.56 -35.5 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 218' ' ' VAL . 98.8 t -57.16 -52.46 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.494 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.64 -45.5 91.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -44.84 96.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 110.735 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -61.52 -44.96 96.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 214' ' ' VAL . 87.4 t -62.24 -37.93 79.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.523 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -46.26 76.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.2 -17.41 63.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.389 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -49.19 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.069 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -55.75 -47.7 76.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.169 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -67.3 -13.04 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.553 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -95.05 -32.73 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.471 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.64 -34.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.222 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -100.08 140.04 34.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 110.69 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.23 -37.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -55.68 174.3 1.09 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.93 -9.4 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.799 0.333 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 104.64 16.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.655 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -83.69 112.59 20.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.486 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.83 1.05 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.09 107.11 12.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.25 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.548 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -92.63 123.37 35.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.618 HG23 ' CE2' ' A' ' 241' ' ' TYR . 67.9 m -90.96 111.2 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 237' ' ' ARG . 47.0 mt -95.85 68.27 2.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.467 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.4 tpp180 -38.52 124.26 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.25 -14.09 47.93 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.79 -56.79 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.632 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.19 -137.3 4.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG23 ' A' ' 235' ' ' THR . 29.4 m-85 -128.37 156.96 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 234' ' ' HIS . 5.2 p -140.55 133.55 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 2.6 tp -90.84 128.63 36.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -163.35 135.25 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.629 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.944 0.402 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.2 mtm105 -142.46 129.44 20.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.66 158.16 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.19 155.94 45.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.619 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 28.0 t80 -165.47 129.81 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.912 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.5 -99.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.1 m-20 -124.67 54.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.43 152.16 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.604 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.78 145.65 35.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.408 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -143.67 116.95 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.63 108.22 18.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.57 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -66.71 -24.95 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -50.59 -40.35 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 69.7 p -119.53 -23.9 6.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.5 t-80 84.02 53.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.384 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -127.39 156.82 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.654 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 t -117.0 153.76 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.44 126.95 15.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 170' ' ' GLN . 16.0 ttpp -126.04 113.07 16.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.13 67.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.016 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.46 32.81 64.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -137.56 92.14 13.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.89 139.96 20.04 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.095 1.864 . . . . 0.0 112.326 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.82 140.8 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.911 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -96.29 90.19 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.386 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.68 150.18 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.672 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 169.43 17.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.77 -54.53 4.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.533 2.155 . . . . 0.0 112.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.327 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -57.07 -37.2 71.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -59.3 -46.08 89.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.4 m -63.82 -41.1 97.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.284 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -46.7 84.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -45.33 86.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.712 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -60.24 -42.98 96.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.658 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 11.6 t80 -65.25 -40.35 93.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -43.01 89.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.684 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.31 -45.35 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.8 -34.65 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.753 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -106.64 22.33 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.682 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.95 110.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.9 -27.52 7.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.3 132.39 33.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.27 113.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.85 148.02 30.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.64 -51.34 82.42 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.544 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 24.4 Cg_endo -64.13 -37.84 39.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.601 1.534 . . . . 0.0 111.682 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -65.76 -44.84 84.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.052 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.85 -41.99 68.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' TRP . 5.0 mt -61.93 -65.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -41.4 -34.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.658 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 53.7 t-80 -71.76 -53.78 12.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.9 t -83.54 -57.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -53.16 -2.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.217 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -60.76 -3.1 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.567 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 39.0 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.605 ' O ' HG12 ' A' ' 213' ' ' VAL . 89.6 m-20 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.978 0.418 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.7 m -81.75 -6.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.562 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.22 -18.98 23.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.789 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 210' ' ' ASP . 7.0 p -65.93 -33.5 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 218' ' ' VAL . 58.7 t -65.28 -51.14 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.072 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.71 -46.01 70.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.982 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -48.55 81.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.47 -39.21 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.497 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.6 t -62.5 -42.23 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -25.48 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.24 -42.48 45.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 226' ' ' ASP . 44.5 ttt180 -55.79 -50.4 70.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.5 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -7.43 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.115 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -42.05 10.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.47 -25.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.398 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.555 ' C ' HG22 ' A' ' 227' ' ' THR . 0.2 OUTLIER -101.99 146.35 28.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.935 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 226' ' ' ASP . 0.1 OUTLIER -176.7 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.62 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -49.23 162.86 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.0 -8.12 34.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.01 126.6 38.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.56 ' C ' HD12 ' A' ' 232' ' ' LEU . 10.9 mtp180 -81.12 159.62 24.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -147.08 -41.17 0.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.969 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.9 114.67 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.476 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -97.9 124.32 42.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.534 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.56 114.61 27.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 238' ' ' GLY . 11.2 mt -95.88 68.72 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.161 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -41.87 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.162 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 236' ' ' LEU . . . 129.68 -13.28 5.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.55 -50.32 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.659 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.76 -137.71 5.46 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 151.65 50.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.2 p -140.04 127.65 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 16.4 tp -90.49 138.03 31.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.08 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 139.89 7.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.463 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.714 0.292 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -122.26 121.04 35.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mt -90.54 147.78 23.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.2 154.32 46.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.095 0.474 . . . . 0.0 111.094 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 155' ' ' ASP . 62.4 t80 -159.29 126.98 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.599 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.29 -96.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 1.2 p30 -124.34 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.56 145.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -144.21 138.68 28.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.787 0.327 . . . . 0.0 110.424 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.43 139.45 42.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.07 102.91 11.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 0.0 110.588 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.12 -8.94 26.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -99.0 -45.28 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.729 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.7 p -98.88 13.04 33.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.338 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 1.0 OUTLIER 35.12 54.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.635 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.26 152.49 48.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.25 157.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.35 125.85 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.479 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 19.2 tptt -122.9 110.53 15.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.397 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.58 59.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.483 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 23.65 77.72 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 24.5 mt-30 -131.86 95.99 21.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.402 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.49 134.92 14.3 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.082 1.855 . . . . 0.0 112.439 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.5 143.79 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.772 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.43 95.39 9.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.631 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 182' ' ' LEU . 10.9 mp -94.71 154.17 17.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.48 172.46 7.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.262 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.37 -51.27 11.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.459 2.106 . . . . 0.0 112.149 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.2 m -58.1 -54.61 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' A' ' 221' ' ' LEU . 24.8 mt-10 -55.77 -43.96 77.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.483 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.92 -48.56 81.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.526 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 m -56.77 -46.32 81.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.586 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.46 -47.05 87.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.69 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 174' ' ' LEU . 0.9 OUTLIER -63.51 -41.53 98.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -59.57 -45.2 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.388 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -61.62 -43.98 97.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.615 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -55.51 -47.86 75.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -47.06 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.019 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mm -54.9 -34.32 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.786 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -112.53 20.4 16.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.0 119.59 4.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.28 -26.28 10.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.6 m -97.82 129.59 44.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.803 0.335 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.672 HG22 ' HB ' ' A' ' 242' ' ' VAL . 43.7 t -67.89 117.01 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.651 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.64 160.03 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.667 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.97 148.84 26.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.63 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.503 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.06 -49.48 93.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 35.9 Cg_exo -54.08 -44.17 51.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.373 2.048 . . . . 0.0 111.778 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -59.93 3.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.4 mt -48.25 -42.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.49 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.502 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 200' ' ' ASP . 17.0 t0 -53.7 -24.03 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.594 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 51.7 t-80 -71.84 -50.36 30.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.715 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.1 t -84.75 -62.17 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.489 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -49.35 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.337 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.7 ttp85 -60.9 -0.57 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.437 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 203' ' ' TRP . 12.2 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.294 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.916 0.389 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.66 -6.43 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.081 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -82.64 -18.21 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.392 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.99 -37.45 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.06 -49.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.868 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.35 -47.52 72.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.55 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.1 p -60.96 -47.52 86.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -38.56 91.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.0 -47.57 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.415 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -44.66 92.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.303 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.25 -23.3 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 178' ' ' GLU . 1.2 mp -76.73 -44.99 31.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.015 0.436 . . . . 0.0 110.151 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 226' ' ' ASP . 33.7 ttt-85 -55.44 -49.65 71.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.957 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -68.25 -7.52 31.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -94.38 -32.61 13.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.541 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.9 -7.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.124 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -116.09 138.25 51.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.006 0.431 . . . . 0.0 110.857 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 t -170.52 39.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.5 163.45 26.82 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.4 -5.61 11.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.733 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.98 104.48 16.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -86.81 101.26 13.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -89.44 1.87 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.588 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.92 96.46 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.57 125.83 34.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.718 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 44.3 m -95.83 112.32 24.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.65 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.6 mt -95.57 73.45 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.366 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 43.3 ttm-85 -35.92 128.03 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.55 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.46 61.21 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.2 -58.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 110.828 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.14 -138.1 5.6 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.485 ' OH ' ' NZ ' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -127.11 156.28 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 0.0 110.711 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.672 ' HB ' HG22 ' A' ' 192' ' ' VAL . 2.3 p -139.7 136.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.22 112.41 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.355 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -162.2 131.49 4.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.474 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -126.53 121.06 31.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.37 148.78 22.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -143.71 156.68 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.8 t80 -163.85 130.27 3.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.56 -97.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 153' ' ' PHE . 5.1 m-20 -124.85 53.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.12 146.26 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -143.37 137.38 28.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 165' ' ' VAL . 22.1 mt -132.53 134.59 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 162' ' ' THR . 1.1 m-20 -107.66 104.39 13.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.141 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.92 -11.6 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.722 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.47 -38.92 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 2.7 p -99.81 6.59 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.227 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.446 ' ND1' ' C ' ' A' ' 162' ' ' THR . 52.0 p-80 36.77 51.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -122.06 158.28 29.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 174' ' ' LEU . 32.5 t -128.4 147.69 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.39 127.51 15.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.5 tmtt? -130.78 112.46 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.268 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.47 68.98 0.11 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.055 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.15 57.34 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 167' ' ' LYS . 7.1 tt0 -130.64 90.83 39.35 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.25 142.58 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.92 1.747 . . . . 0.0 112.113 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.81 132.27 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.259 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 174' ' ' LEU . 28.0 t -95.33 119.91 34.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -142.61 135.06 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.711 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.21 175.2 0.42 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.824 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.46 -41.83 73.39 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.481 2.12 . . . . 0.0 112.601 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.37 -65.83 0.49 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 111.104 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 221' ' ' LEU . 8.6 mt-10 -60.09 -33.34 71.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.29 -50.39 73.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -41.33 85.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 202' ' ' VAL . 1.9 tp -58.81 -48.62 80.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.579 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -40.61 96.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.12 -45.13 91.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.498 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.585 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 26.5 t80 -65.65 -40.83 92.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -40.99 69.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.3 t -72.87 -42.99 60.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.43 -27.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.72 18.33 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.02 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.88 119.0 3.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.792 0.33 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.6 -26.6 10.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.9 m -94.72 130.15 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 242' ' ' VAL . 48.6 t -68.43 114.77 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 184' ' ' TYR . 2.6 mp -95.12 153.63 17.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.89 148.42 26.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 16.2 mtpt -56.12 -54.92 47.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.991 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.0 Cg_endo -64.81 -32.15 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.782 1.655 . . . . 0.0 111.922 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -66.87 -48.81 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.288 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.5 mt -55.7 -39.82 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.771 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.38 -66.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -49.26 -29.34 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.585 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.7 t60 -72.01 -48.48 44.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.078 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 204' ' ' ARG . 42.4 t -84.04 -59.86 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.554 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.5 OUTLIER -49.55 -4.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.604 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.7 ttp180 -61.92 -2.55 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.637 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 58.5 m-85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.56 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -87.9 -9.74 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.072 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.04 -22.75 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.3 p -65.68 -40.04 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.305 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.458 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 12.7 t -60.4 -46.19 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.131 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.91 -48.04 79.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -45.18 95.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.62 -40.88 98.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.755 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.6 t -62.42 -39.73 85.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -45.38 81.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -68.49 -17.17 64.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.489 HD11 ' HG2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -82.77 -47.98 11.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.676 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.9 OUTLIER -55.99 -38.55 70.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.471 179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -66.1 -29.15 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.504 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -28.56 15.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.659 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.17 -38.79 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.136 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 222' ' ' ARG . 9.2 t0 -100.27 -151.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 226' ' ' ASP . 68.6 p 54.07 10.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.499 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 226' ' ' ASP . . . -85.09 -136.07 3.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.18 -44.74 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.796 0.332 . . . . 0.0 110.269 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.537 ' HB3' HD21 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -96.14 107.26 19.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.581 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.481 ' H ' ' CD ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -82.87 91.15 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.72 ' O ' HD23 ' A' ' 243' ' ' LEU . 0.8 OUTLIER -91.9 -5.6 52.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.294 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.68 122.47 47.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.78 130.24 56.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.644 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.0 m -95.65 115.95 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.2 mt -95.92 77.16 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.29 119.97 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.78 -2.88 57.21 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.35 -58.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.77 -136.03 4.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 40.4 m-85 -127.59 153.96 45.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.749 0.309 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 192' ' ' VAL . 12.8 p -140.8 133.1 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.49 121.38 33.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.928 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -161.46 133.81 5.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.174 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.088 179.536 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -125.68 121.17 32.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.182 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.64 150.77 21.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 m -141.15 158.34 44.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 1.4 t80 -165.46 131.51 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.519 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 38.23 -99.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 19.3 m-20 -124.96 53.36 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.94 150.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.278 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -142.41 140.88 32.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.74 131.59 33.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.437 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -113.65 108.17 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.5 -9.65 36.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.19 -52.58 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.651 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 51.3 p -98.14 9.76 42.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.266 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 47.3 m80 37.12 59.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.777 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -132.63 153.81 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.56 HG21 HD11 ' A' ' 174' ' ' LEU . 46.8 t -115.71 151.81 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.232 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.19 125.49 13.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.5 tttp -124.99 115.12 20.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.36 56.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.378 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.39 23.76 75.04 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.2 mt-30 -132.29 101.6 14.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -76.77 136.78 17.26 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.82 1.68 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.16 139.25 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.91 121.68 40.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.416 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -141.06 140.68 34.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.765 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.87 173.46 4.77 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.98 -40.82 79.52 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.47 2.113 . . . . 0.0 112.576 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.7 m -51.11 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.62 -33.55 72.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.238 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -58.51 -52.79 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.9 m -57.6 -40.62 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 -47.16 85.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.58 -42.18 95.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.704 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -44.87 87.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.35 -42.13 88.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.44 -41.78 77.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.73 -49.12 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.67 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.9 mt -55.82 -36.15 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.012 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -109.96 23.76 13.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.3 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.77 118.78 4.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.81 10.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.587 ' O ' HD12 ' A' ' 193' ' ' LEU . 11.5 m -90.01 129.6 36.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.05 120.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.552 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 191' ' ' THR . 4.9 mp -96.94 163.93 12.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.09 148.39 29.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.962 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 4.1 mttt -56.67 -54.02 58.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.078 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 28.4 Cg_endo -70.57 -31.99 15.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.913 1.742 . . . . 0.0 112.043 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.61 -46.43 85.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.216 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.65 -39.81 86.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.62 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 203' ' ' TRP . 8.5 tp -64.25 -50.31 68.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.643 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 13.4 t70 -64.73 -30.2 71.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.444 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -72.0 -57.23 4.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.43 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.2 t -84.42 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.683 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.494 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.8 OUTLIER -50.12 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.681 -179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -67.08 -3.21 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.441 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.656 -179.907 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 212' ' ' ASN . 1.3 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.867 0.365 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 211' ' ' VAL . 90.4 t -64.02 1.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 210' ' ' ASP . 57.9 m-20 -100.17 -30.69 11.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.494 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 20.2 t -62.08 -39.43 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.87 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.002 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -53.45 -49.56 67.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -46.19 90.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.23 -38.88 90.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.29 -43.15 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.734 0.302 . . . . 0.0 110.585 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -42.93 85.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -71.6 -13.24 61.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.15 -48.74 9.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.807 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 70.1 mtt180 -56.67 -44.04 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.367 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -19.36 65.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.982 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -93.96 -28.55 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.364 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -109.37 -39.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.228 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.29 145.38 25.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.9 t -176.79 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -145.34 167.29 27.47 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.26 -6.45 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.721 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -92.72 104.59 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.858 ' O ' HD23 ' A' ' 232' ' ' LEU . 45.6 mtt85 -78.93 160.16 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 231' ' ' ARG . 4.7 mt -146.16 -36.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.24 111.88 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.607 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.16 129.88 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.329 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.497 HG23 HH22 ' A' ' 222' ' ' ARG . 0.2 OUTLIER -94.42 111.75 23.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' ARG . 3.8 mt -95.25 69.54 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.159 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' LEU . 3.7 ptt85 -35.09 128.28 0.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.95 -13.82 60.39 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.2 t -128.85 -58.17 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.416 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 159.42 -137.28 5.05 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.47 157.91 40.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.08 136.23 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.404 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 26.4 tp -93.05 118.91 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.505 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.67 131.01 3.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 0.0 111.04 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 179.701 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.757 0.313 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -140.78 132.93 27.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.77 151.56 21.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.82 156.84 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.0 t80 -166.06 125.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.86 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.3 p-10 -124.97 54.34 1.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.55 151.58 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.466 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.7 mt-10 -146.25 143.71 29.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.48 127.67 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.355 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.4 OUTLIER -113.33 103.15 11.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.839 0.352 . . . . 0.0 110.452 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.93 -12.48 55.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -71.63 -30.64 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 7.0 p -121.82 -25.39 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 162' ' ' THR . 4.9 t-80 83.13 47.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.871 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -124.26 160.09 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 166' ' ' TRP . 31.8 t -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.405 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -146.23 125.42 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.854 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.7 tmtt? -130.05 117.65 20.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.374 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.98 70.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.04 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.02 34.69 52.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -136.68 91.31 15.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.554 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.81 137.82 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.316 2.011 . . . . 0.0 112.12 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.72 131.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 91.74 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.68 150.97 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.777 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 168.67 25.26 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.189 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.44 -53.9 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.408 2.072 . . . . 0.0 112.309 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -55.84 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -61.96 -38.48 88.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -48.34 82.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.2 m -58.97 -39.05 80.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.85 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.708 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.31 -42.58 91.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CE2' HD21 ' A' ' 193' ' ' LEU . 24.8 t80 -68.69 -41.13 79.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.43 ' CD1' HD13 ' A' ' 243' ' ' LEU . 1.2 m-85 -54.6 -43.81 72.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.8 -46.07 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.91 -38.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -107.87 26.57 10.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.86 117.64 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.664 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.37 -27.18 12.92 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.61 130.36 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.64 114.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.538 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 184' ' ' TYR . 3.9 mp -97.25 158.2 15.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.33 147.39 31.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.292 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -58.06 -52.99 70.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.208 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -62.84 -31.97 77.68 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.746 1.631 . . . . 0.0 112.2 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -68.9 -49.99 53.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.054 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 193' ' ' LEU . 7.4 mt -55.91 -36.93 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.196 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.9 tp -61.22 -70.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.787 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.534 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 0.0 OUTLIER -54.2 -23.87 16.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.512 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.596 ' ND1' HG23 ' A' ' 202' ' ' VAL . 10.0 t-80 -73.9 -60.09 2.42 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.612 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.596 HG23 ' ND1' ' A' ' 201' ' ' HIS . 99.4 t -85.82 -61.52 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -53.45 -3.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 200' ' ' ASP . 0.6 OUTLIER -63.16 -3.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 C--N 1.33 -0.279 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.703 -179.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.74 0.305 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 211' ' ' VAL . 9.0 p -82.28 -8.01 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -99.99 -29.22 12.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 2.5 p -66.28 -39.74 85.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.638 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.455 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 25.0 t -56.41 -50.5 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.106 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.03 -48.52 78.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.278 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -45.15 93.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.434 ' O ' HD13 ' A' ' 221' ' ' LEU . 2.4 m-85 -63.63 -41.83 98.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.28 -41.39 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.2 t -62.59 -47.93 81.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -33.45 75.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.369 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 217' ' ' TYR . 2.9 mp -67.32 -46.67 72.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.341 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.46 -44.18 76.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.316 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -66.53 -24.67 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -91.88 -28.41 17.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.677 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.99 -40.56 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.341 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -102.82 141.05 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -40.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.783 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.11 173.21 6.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.32 -7.04 16.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -92.55 104.95 17.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -86.83 106.98 18.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.1 mt -88.5 -0.36 57.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.546 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.93 113.22 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 123.17 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.488 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.0 m -88.28 114.33 24.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.774 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 237' ' ' ARG . 6.9 mt -96.75 72.99 2.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.23 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 236' ' ' LEU . 22.7 mtp180 -39.25 110.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.79 -16.24 13.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.71 -47.46 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.45 -137.28 6.17 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.18 152.39 48.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.383 . . . . 0.0 110.608 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.16 141.14 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' A' ' 185' ' ' PHE . 1.3 tp -91.43 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -162.02 134.03 5.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.868 0.366 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -104.81 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.434 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mt -146.09 134.85 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.571 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -137.51 155.78 48.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 111.069 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.552 ' HB2' HG13 ' A' ' 186' ' ' VAL . 87.3 t80 -165.39 139.0 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.519 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.46 -104.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.924 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.5 OUTLIER -124.66 53.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 155' ' ' ASP . 2.4 mm -137.52 146.56 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.921 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.43 131.28 29.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 147.27 48.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.433 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.8 m-20 -131.15 107.89 9.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.35 -38.32 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.772 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -51.45 59.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.533 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 4.6 p -106.58 13.15 28.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.119 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 162' ' ' THR . 9.3 p80 38.52 56.09 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.683 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -119.68 161.24 21.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.536 HG21 HD12 ' A' ' 174' ' ' LEU . 4.3 t -124.5 157.86 31.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.99 125.24 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -122.71 108.76 13.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.31 67.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.057 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.86 83.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 167' ' ' LYS . 14.2 tt0 -137.04 87.35 18.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.92 132.87 13.28 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.298 1.998 . . . . 0.0 112.669 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.7 147.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.27 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m -92.63 88.35 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.287 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.536 HD12 HG21 ' A' ' 165' ' ' VAL . 35.8 mt -96.0 155.81 16.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.32 170.69 8.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.26 -53.72 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 112.135 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -57.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.073 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.678 ' OE2' HD11 ' A' ' 221' ' ' LEU . 1.4 mm-40 -62.88 -39.71 95.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.16 -42.82 95.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.8 m -61.25 -45.61 93.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.49 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 181' ' ' LEU . 1.5 tt -57.2 -43.95 83.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 186' ' ' VAL . 2.1 mp -66.02 -46.18 78.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.267 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -58.13 -42.98 87.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.405 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.19 -44.97 94.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.516 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -62.83 -41.93 99.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 110.771 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 182' ' ' LEU . 65.8 t -57.68 -52.66 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.394 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.42 -29.53 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.356 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.1 19.6 20.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.712 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -53.17 119.57 4.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.92 -23.76 20.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.1 m -92.18 125.29 36.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.3 p -69.1 118.08 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.95 149.14 22.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.7 p -99.88 149.44 23.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.53 -44.84 99.8 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.501 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 31.8 Cg_exo -52.94 -52.41 8.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.912 1.742 . . . . 0.0 111.996 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.67 -51.96 67.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.45 -42.98 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.179 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.41 -65.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.3 -16.04 30.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -49.87 31.7 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.11 -43.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.075 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.461 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -62.82 -3.97 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -57.66 -4.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.491 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.4 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.523 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 213' ' ' VAL . 43.9 m-20 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.828 0.347 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.0 -14.68 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -85.39 -17.47 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 210' ' ' ASP . 5.2 p -67.33 -38.1 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 218' ' ' VAL . 85.6 t -59.7 -50.69 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -54.93 -47.06 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.536 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 9.7 p -60.21 -49.47 77.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.655 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -61.63 -41.01 96.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 214' ' ' VAL . 66.3 t -62.46 -45.26 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.3 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -43.8 98.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.194 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -32.83 73.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.678 HD11 ' OE2' ' A' ' 178' ' ' GLU . 2.1 mp -66.26 -47.47 73.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 109.999 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.0 OUTLIER -54.89 -46.21 74.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.147 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -15.22 63.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.417 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.422 ' CE ' HD21 ' A' ' 174' ' ' LEU . 33.9 mtpt -95.07 -27.11 15.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.38 -13.53 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.32 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -111.92 138.21 48.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.372 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -175.37 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -48.74 168.94 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.59 -13.08 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.978 0.418 . . . . 0.0 109.962 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -93.21 151.86 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.897 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -93.08 158.96 15.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 245' ' ' GLU . 90.6 mt -147.03 -50.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 242' ' ' VAL . 1.1 mt -94.98 119.86 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 130.29 45.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.64 108.82 20.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.2 mt -98.72 69.4 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.753 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -37.28 126.55 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.567 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.86 -7.58 62.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.41 -46.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.48 -137.33 7.48 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -127.89 152.81 47.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.31 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.459 ' O ' HD23 ' A' ' 233' ' ' LEU . 11.1 p -136.62 135.95 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.964 0.411 . . . . 0.0 110.785 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.98 118.9 31.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.569 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -162.28 115.75 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 232' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.862 0.363 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.467 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -175.27 145.57 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.369 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.909 HD23 HH12 ' A' ' 183' ' ' ARG . 2.6 mm? -92.43 151.6 20.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -142.05 156.95 45.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 243' ' ' LEU . 70.7 t80 -167.03 140.14 3.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 34.41 -102.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 23.8 p-10 -124.3 52.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -138.08 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.467 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 13.9 tt0 -145.71 144.05 30.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 110.631 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.527 HD21 HD23 ' A' ' 182' ' ' LEU . 1.0 OUTLIER -137.37 116.88 12.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.955 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.15 101.87 11.61 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.849 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -24.14 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.29 -32.3 56.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 34.1 p -127.5 -20.7 3.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.1 t60 82.14 52.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -122.51 156.45 34.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 174' ' ' LEU . 2.7 t -121.12 151.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.143 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.73 125.24 13.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.419 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -127.13 113.11 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.259 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.77 70.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.234 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.67 26.72 47.19 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 167' ' ' LYS . 3.1 tp60 -130.8 92.36 34.43 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.42 133.43 11.86 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.948 1.766 . . . . 0.0 112.195 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.93 138.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.576 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 75.2 m -89.58 88.32 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 165' ' ' VAL . 71.9 mt -95.38 149.31 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.563 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.8 172.86 8.06 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -52.1 -55.3 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.394 2.063 . . . . 0.0 112.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.4 m -51.06 -52.5 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.55 -44.05 97.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.0 m -61.37 -45.51 94.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.86 -43.69 92.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.004 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.527 HD23 HD21 ' A' ' 158' ' ' LEU . 29.6 tp -63.25 -39.13 93.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.909 HH12 HD23 ' A' ' 151' ' ' LEU . 3.3 ttt85 -65.09 -42.56 93.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.719 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.674 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 10.6 t80 -62.29 -44.57 96.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.6 -44.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.0 -47.68 87.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.88 -28.79 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -108.83 20.42 18.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.46 120.92 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.75 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.21 -23.28 23.38 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.544 ' O ' HD12 ' A' ' 193' ' ' LEU . 32.3 m -98.17 124.64 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.3 p -69.42 122.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 191' ' ' THR . 5.5 mp -96.8 165.86 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . 0.422 ' OG ' ' CG ' ' A' ' 197' ' ' LYS . 1.1 p -109.77 151.11 27.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.03 -54.45 50.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.915 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 21.1 Cg_endo -66.4 -32.12 41.37 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.365 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.422 ' CG ' ' OG ' ' A' ' 194' ' ' SER . 18.9 mmtt -64.06 -58.44 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.2 -40.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.41 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.75 -64.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.67 -29.23 25.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.674 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 79.6 t60 -71.14 -48.59 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.159 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 204' ' ' ARG . 77.6 t -83.96 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.41 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.81 -2.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.294 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.7 ttp180 -61.17 -3.39 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.715 0.293 . . . . 0.0 110.68 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.4 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.544 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 210' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.83 -8.75 11.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.26 -16.42 40.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.2 p -68.9 -38.53 78.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.826 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 40.9 t -58.86 -47.85 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.527 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.14 -47.29 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.229 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 m -59.8 -43.72 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -43.39 98.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.1 -41.43 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.49 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -46.9 85.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.762 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.67 -21.9 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.642 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.82 -46.38 18.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.217 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.6 mtp180 -56.05 -47.09 78.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.974 0.416 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -66.16 -11.27 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.537 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -92.09 -46.06 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.36 -27.42 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.31 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 4.6 t70 -94.78 143.31 26.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.742 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER 173.81 -27.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.513 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -50.43 162.63 0.97 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.51 -7.65 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 0.0 110.199 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -93.13 149.58 21.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -92.24 154.15 18.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.235 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 243' ' ' LEU . 74.8 mt -147.35 -51.27 0.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.41 110.65 23.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.143 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.441 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -93.21 122.45 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.899 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.4 m -90.5 109.47 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.481 HD12 ' CG2' ' A' ' 192' ' ' VAL . 16.1 mt -95.62 70.54 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -39.45 125.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 -13.75 40.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.5 -59.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.569 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.43 -138.06 5.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -127.79 160.98 30.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.424 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.7 p -143.88 128.8 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.4 tp -91.73 137.5 32.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 128.09 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.506 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.373 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.47 ' NH1' ' OD2' ' A' ' 159' ' ' ASP . 24.1 mtt-85 -147.08 139.35 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.2 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 158' ' ' LEU . 1.6 mm? -89.46 157.35 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.68 157.7 45.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 110.86 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' A' ' 243' ' ' LEU . 3.5 t80 -164.18 127.16 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.476 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.47 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 13.7 p-10 -124.87 54.41 1.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.47 153.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.873 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -145.33 140.12 27.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.252 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.879 ' N ' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.43 138.83 36.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.714 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 162' ' ' THR . 62.8 t0 -111.54 105.67 14.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -8.22 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.176 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.41 -46.09 5.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.956 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.545 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 69.2 p -98.66 13.65 31.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.812 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 162' ' ' THR . 44.4 m-70 35.76 53.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.541 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -121.9 150.9 41.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.8 152.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.317 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.77 121.4 9.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.4 tmmt? -124.97 112.83 17.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.365 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.39 71.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.517 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.44 25.58 34.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.5 tt0 -131.08 94.68 27.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.13 132.6 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 112.276 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.12 144.21 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.709 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 t -95.21 94.66 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.66 154.0 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.172 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.22 172.14 8.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -50.3 -54.24 5.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.37 2.047 . . . . 0.0 111.931 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -57.46 -46.41 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.694 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -45.0 96.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -61.68 -45.33 94.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.8 m -58.16 -47.03 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 -43.94 92.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.7 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.46 -43.5 90.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.504 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -55.89 -45.25 78.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.579 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -65.06 -43.64 91.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.58 -42.84 88.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.649 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 151' ' ' LEU . 54.1 t -63.15 -47.68 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.625 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.72 -37.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -106.96 25.19 11.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.17 114.23 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.94 10.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.5 m -91.73 129.31 37.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 110.456 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.55 126.29 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.0 110.541 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -94.5 168.84 10.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.098 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.84 147.72 36.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 0.0 110.785 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 211' ' ' VAL . 6.7 mttm -56.85 -54.98 48.36 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.21 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.0 Cg_endo -65.7 -29.91 51.04 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.038 1.825 . . . . 0.0 112.426 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -70.18 -47.16 62.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.319 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.28 -38.01 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 109.978 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 199' ' ' LEU . 2.7 tt -60.96 -56.17 24.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.89 -16.6 63.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.071 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 46.4 t60 -71.76 -44.96 63.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.309 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 204' ' ' ARG . 24.5 t -84.24 -54.6 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 205' ' ' TYR . 3.0 m-90 -61.92 -3.22 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.703 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 34.4 ttp85 -44.95 -11.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 203' ' ' TRP . 17.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.35 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.595 ' O ' ' NZ ' ' A' ' 195' ' ' LYS . 2.9 m -86.42 1.5 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.841 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -96.49 -29.49 13.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.618 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.3 p -64.36 -38.89 83.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.303 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 17.6 t -60.56 -48.96 86.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.579 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.7 -44.58 85.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.166 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -60.46 -46.0 91.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.63 -38.76 87.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.899 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 214' ' ' VAL . 42.0 t -61.03 -41.06 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.51 75.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.51 ' OH ' ' NZ ' ' A' ' 224' ' ' LYS . 32.0 t80 -71.19 -10.17 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.057 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.44 -56.02 4.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.087 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.4 ptm180 -57.41 -40.48 78.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.313 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -11.21 57.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.51 ' NZ ' ' OH ' ' A' ' 220' ' ' TYR . 1.3 mmtp -93.2 -36.08 12.8 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.639 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.55 -24.04 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.834 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -97.93 153.01 18.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.647 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -174.32 -30.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.654 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -61.26 147.96 46.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.73 -5.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.404 . . . . 0.0 110.286 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 228' ' ' GLY . 29.7 mttp -94.07 116.94 29.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.313 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.2 mtm-85 -81.02 131.15 35.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 244' ' ' ARG . 5.5 mp -89.08 -76.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 233' ' ' LEU . 0.3 OUTLIER -85.41 148.38 26.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.945 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -111.08 143.71 41.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 55.0 m -101.67 116.04 31.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.931 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 236' ' ' LEU . 0.8 OUTLIER -96.47 73.18 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -39.75 117.81 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.64 -25.48 9.04 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.45 -56.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.1 -136.79 4.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -129.35 160.67 32.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.889 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.568 HG12 HD21 ' A' ' 236' ' ' LEU . 14.4 p -138.84 134.64 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.522 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 53.0 tp -91.88 116.28 28.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 232' ' ' LEU . 10.1 ptm180 -163.37 117.19 1.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.343 179.623 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.802 0.334 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -120.18 123.87 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.83 156.11 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.59 163.04 33.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 156' ' ' ILE . 58.5 t80 -167.58 134.5 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.41 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 11.5 p-10 -125.18 53.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.1 mt -137.05 154.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -145.83 146.88 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.07 134.32 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.5 m-20 -112.77 109.24 18.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.8 OUTLIER -65.58 -16.28 63.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.97 -52.21 8.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.4 p -101.3 11.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.588 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 11.0 m-70 36.53 53.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.666 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.22 160.02 23.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD11 ' A' ' 174' ' ' LEU . 95.2 t -124.5 149.6 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.4 127.76 15.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 39.5 tttm -128.06 114.04 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.496 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.99 62.94 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.97 29.7 75.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 15.4 tt0 -132.9 93.28 23.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.74 140.23 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.282 1.988 . . . . 0.0 112.316 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.8 130.17 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.742 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 p -93.64 87.15 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.942 HD12 ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.14 154.87 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.606 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.04 168.86 23.62 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.325 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -45.93 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.54 2.16 . . . . 0.0 111.961 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -53.37 -63.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.131 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.18 -36.11 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.429 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -59.87 -48.15 82.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.5 m -60.09 -40.86 91.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.788 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 202' ' ' VAL . 1.3 tp -59.59 -47.55 85.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.84 -41.09 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -58.21 -46.88 85.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.821 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -68.17 -38.82 82.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -57.2 -44.0 83.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.483 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.35 -46.05 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 mm -53.93 -34.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -108.28 22.21 16.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.037 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.55 125.87 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.487 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.31 -33.2 6.77 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 m -87.07 132.81 33.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.04 124.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.22 161.27 13.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.24 147.88 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 5.5 mtmt -58.43 -56.36 36.2 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.35 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -63.31 -34.53 66.76 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.834 1.689 . . . . 0.0 111.967 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -64.82 -54.09 36.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.355 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 mt -52.05 -39.36 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 0.0 110.12 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.7 tp -60.52 -68.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -50.49 -25.83 4.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.464 ' ND1' ' NH2' ' A' ' 204' ' ' ARG . 56.7 t60 -71.35 -55.12 8.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 204' ' ' ARG . 55.2 t -83.87 -58.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.337 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.481 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.1 -4.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.278 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.8 ttm180 -61.76 0.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.5 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.574 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 121.019 0.438 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.455 ' O ' HG22 ' A' ' 211' ' ' VAL . 11.5 p -85.4 -12.2 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.846 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -91.08 -18.53 24.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 1.2 p -65.25 -37.99 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.995 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -59.2 -45.79 92.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.605 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -61.45 -45.76 92.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.5 t -60.91 -41.69 96.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.433 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -39.03 76.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.854 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 214' ' ' VAL . 60.9 t -62.27 -43.88 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -46.76 88.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.67 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -31.53 72.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.934 0.397 . . . . 0.0 110.172 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.87 -42.34 70.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.946 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 226' ' ' ASP . 35.5 ttp180 -55.11 -44.4 74.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -68.17 -26.36 65.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.468 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -93.41 -21.88 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.2 -31.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.305 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.7 t70 -107.23 135.71 48.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.462 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.64 21.35 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.31 167.84 17.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -12.49 61.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.371 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -92.42 106.2 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.815 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -89.46 110.15 21.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.28 -4.7 56.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.31 104.99 12.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.598 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 124.44 37.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.543 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -96.11 118.41 32.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.309 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.07 74.96 2.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.24 113.99 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.013 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.99 -20.64 23.82 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.63 -61.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.152 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.94 -139.17 5.66 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.77 153.05 47.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.703 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.8 p -140.1 132.13 32.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.84 143.36 26.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.397 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.01 139.85 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.498 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.849 0.357 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 10.2 mtm180 -124.56 121.0 33.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 61.8 mt -91.76 153.01 19.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.472 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 160.76 39.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 154' ' ' ALA . 77.0 t80 -165.93 140.23 4.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.78 -105.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -123.85 53.07 1.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.28 157.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.651 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 6.5 tt0 -143.38 142.95 31.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.655 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.77 134.66 35.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.0 m-20 -110.95 105.85 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.602 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.99 -13.72 60.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.307 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -48.09 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.9 p -94.88 6.38 49.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.594 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 159' ' ' ASP . 64.8 m80 38.39 51.27 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.15 157.04 29.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.01 151.5 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 110.334 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 124.72 12.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -124.27 117.11 23.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.289 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.83 60.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.574 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.95 24.4 71.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 mt-30 -129.89 96.0 27.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.1 135.97 15.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.928 1.752 . . . . 0.0 112.497 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.71 140.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.727 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.11 96.07 9.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.12 156.04 16.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.04 169.43 15.53 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.594 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.25 -53.87 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 112.263 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -54.44 45.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -56.58 -37.97 71.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.419 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -63.17 -49.92 72.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.9 m -58.13 -43.79 87.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.6 -50.44 73.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.56 -43.61 98.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.725 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -56.98 -45.84 82.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.5 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 21.1 t80 -62.9 -41.72 99.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.2 -41.33 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.39 -48.09 74.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.126 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.84 -37.55 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -104.67 25.08 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.96 120.93 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.94 51.51 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 131.88 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.88 118.18 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.48 HD23 ' CG1' ' A' ' 198' ' ' ILE . 3.9 mp -96.55 154.48 17.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 148.82 28.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.346 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 3.3 mtpm? -56.02 -55.02 46.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.106 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -64.66 -32.63 57.33 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.919 1.746 . . . . 0.0 111.86 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -68.46 -54.02 19.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.48 ' CG1' HD23 ' A' ' 193' ' ' LEU . 6.2 mt -47.72 -41.81 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.937 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.15 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.629 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -46.41 -30.65 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.5 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 2.1 t60 -71.09 -51.19 26.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.026 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 204' ' ' ARG . 58.4 t -84.34 -57.97 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.04 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -52.89 -2.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.478 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.0 ttt-85 -63.89 -1.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 203' ' ' TRP . 34.6 m-85 . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.396 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.851 0.358 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 m -82.56 -3.19 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.75 -20.84 25.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.017 0.437 . . . . 0.0 109.855 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 210' ' ' ASP . 3.8 p -67.39 -40.45 84.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.478 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 95.6 t -56.21 -50.46 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.61 -48.02 80.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.544 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -46.36 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.461 ' CE1' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -62.86 -40.99 99.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.691 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 t -62.8 -42.13 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.82 94.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.301 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.69 -13.97 61.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.81 -47.28 9.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 226' ' ' ASP . 50.2 mtt180 -56.64 -46.31 81.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -10.68 50.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.187 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -94.65 -41.16 9.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.404 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.09 -27.86 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.143 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -97.79 143.66 28.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t -177.07 39.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.289 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -137.49 160.21 25.06 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.97 -7.26 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.355 . . . . 0.0 110.436 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -93.63 105.7 17.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -89.73 114.03 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.414 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.56 -3.37 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -121.2 110.17 15.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.316 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.98 136.12 33.24 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.7 m -101.29 112.55 25.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 237' ' ' ARG . 2.8 mt -95.27 68.19 3.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.053 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' LEU . 23.4 ttt180 -34.8 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.699 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 103.22 -17.24 52.1 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.37 -42.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.92 0.39 . . . . 0.0 110.364 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 141.86 -137.56 8.04 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 164.46 23.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.7 p -143.22 133.79 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.2 tp -91.22 122.93 34.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.355 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -161.65 130.8 4.52 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 111.047 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 -179.934 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.857 0.36 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -126.28 119.2 26.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -90.76 155.47 18.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.638 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -142.38 161.53 37.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.99 0.424 . . . . 0.0 111.148 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -165.23 132.48 2.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.645 179.749 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.57 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 36.65 -98.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.2 m-20 -125.55 53.69 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.13 153.52 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.492 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -146.03 140.82 27.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.766 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.27 134.39 37.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.136 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -110.3 107.97 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.932 0.396 . . . . 0.0 110.459 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.02 -9.26 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.057 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.98 -52.04 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.61 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 7.3 p -93.28 7.02 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 22.1 t60 36.92 62.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -136.31 154.1 50.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.372 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.85 151.23 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.76 126.74 13.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.1 ttpm? -126.68 114.62 18.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.764 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.48 54.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.445 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.49 24.09 77.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 167' ' ' LYS . 54.2 mm-40 -129.39 95.68 29.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.34 136.4 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.109 1.873 . . . . 0.0 112.224 -179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.88 140.53 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.948 -179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.7 t -93.86 94.11 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.546 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.518 ' CD2' HD22 ' A' ' 182' ' ' LEU . 9.9 mp -95.06 150.06 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.667 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.1 172.38 8.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.55 -57.02 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.544 2.163 . . . . 0.0 112.522 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -54.24 -50.14 67.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.4 -40.34 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.483 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.5 -47.4 85.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -57.41 -48.02 80.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.336 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.0 -51.22 70.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 174' ' ' LEU . 1.2 tp -57.95 -47.18 83.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.055 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.407 ' CD2' ' ND2' ' A' ' 188' ' ' ASN . 18.5 t80 -61.33 -45.39 94.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.355 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.6 m-85 -57.45 -44.46 84.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.47 -50.11 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.35 -38.67 56.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.816 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 24.2 p30 -108.58 24.45 13.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -51.87 118.01 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.16 -23.68 13.71 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 m -89.43 133.66 34.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.21 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.26 120.88 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.612 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.25 156.27 16.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.413 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.08 148.6 28.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.533 ' HZ3' ' CD ' ' A' ' 215' ' ' GLU . 1.0 OUTLIER -56.16 -56.09 34.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.982 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -66.32 -28.8 46.82 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.998 1.799 . . . . 0.0 111.927 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -49.33 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.948 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.31 -38.97 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.3 -68.51 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -49.89 -30.86 10.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.84 -49.57 44.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.282 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 204' ' ' ARG . 62.7 t -82.91 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.908 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.611 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 1.1 m-90 -53.85 -2.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 202' ' ' VAL . 30.4 ttt180 -50.91 -5.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 203' ' ' TRP . 35.9 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.249 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.9 m -83.68 -10.04 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 215' ' ' GLU . 13.0 m120 -73.0 -70.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.227 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 4.5 p -34.61 -36.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.3 t -65.52 -44.87 93.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.56 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 212' ' ' ASN . 2.2 tp10 -57.58 -44.15 85.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -47.98 83.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.699 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.594 ' O ' HD13 ' A' ' 221' ' ' LEU . 1.5 m-85 -61.48 -39.95 92.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 214' ' ' VAL . 89.6 t -63.0 -43.82 99.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.5 t -63.06 -44.73 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -36.87 85.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 110.189 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.594 HD13 ' O ' ' A' ' 217' ' ' TYR . 5.1 mp -65.11 -45.6 84.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.671 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 52.1 mtm180 -56.2 -45.76 79.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.229 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.03 -22.44 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -92.94 -26.69 17.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.47 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.47 -40.37 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.823 -179.644 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.75 156.13 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.956 -179.677 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 226' ' ' ASP . 0.8 OUTLIER 167.78 -36.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.704 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.89 -175.22 10.52 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -78.81 -13.46 59.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.653 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -92.75 105.32 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.16 103.99 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.765 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.31 -3.03 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.645 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.88 113.51 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.666 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.24 118.35 36.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.128 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.451 HG23 ' HD1' ' A' ' 241' ' ' TYR . 61.1 m -93.01 114.06 26.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.641 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 237' ' ' ARG . 1.6 mp -96.23 68.68 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 236' ' ' LEU . 30.8 mtm-85 -33.94 129.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.836 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.93 65.99 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 69.9 t -133.01 -61.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 0.0 110.675 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.96 -140.27 6.32 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.451 ' HD1' HG23 ' A' ' 235' ' ' THR . 0.1 OUTLIER -132.61 153.4 51.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.597 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.13 138.9 49.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.583 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 153' ' ' PHE . 5.3 tp -91.57 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.877 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -161.75 133.18 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 179.951 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.859 0.362 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.55 HH11 ' CG ' ' A' ' 159' ' ' ASP . 15.3 mtt-85 -140.91 121.89 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.33 149.43 22.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -139.74 156.66 46.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.124 0.488 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CE2' HD21 ' A' ' 243' ' ' LEU . 25.8 t80 -165.04 138.06 4.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.18 -104.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 52.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -137.85 148.18 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.305 -179.588 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -143.1 144.01 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.56 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.11 133.12 34.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.55 ' CG ' HH11 ' A' ' 150' ' ' ARG . 55.9 t0 -113.79 107.68 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -66.98 -14.77 63.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.49 -48.66 7.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 163' ' ' HIS . 76.9 p -97.64 8.59 44.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.522 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 162' ' ' THR . 20.8 m80 37.67 54.57 1.5 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -128.61 156.0 44.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.13 152.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 127.2 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.919 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 170' ' ' GLN . 6.2 tmtt? -130.38 117.58 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.281 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.61 64.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.28 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.56 28.54 65.28 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.4 tt0 -129.92 92.26 37.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.47 140.61 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.261 1.974 . . . . 0.0 112.392 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.3 135.75 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.1 OUTLIER -88.22 95.73 10.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.723 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.04 150.61 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.57 170.51 14.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.483 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -47.82 -54.22 5.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.658 2.238 . . . . 0.0 112.569 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -52.25 -61.0 2.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -56.76 -39.68 74.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.43 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -62.65 -46.37 88.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.31 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 m -59.4 -40.28 86.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -44.82 95.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.646 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.46 -46.7 87.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.29 -45.83 80.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.381 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.686 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.765 -179.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.77 -45.6 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.745 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.67 -46.81 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.34 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mt -65.71 -23.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.208 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.475 HD22 HD11 ' A' ' 193' ' ' LEU . 7.6 m-20 -107.54 27.37 9.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.41 109.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.619 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.86 61.68 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -98.66 122.45 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 242' ' ' VAL . 95.2 t -68.04 118.15 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 188' ' ' ASN . 1.5 mt -97.89 166.08 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.638 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.66 147.25 34.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 2.6 mtpm? -58.01 -55.12 48.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.252 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.3 Cg_endo -67.89 -29.67 34.34 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.835 1.69 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -66.57 -50.75 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.843 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 mt -55.24 -42.18 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.66 -69.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.599 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -27.64 12.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.961 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.686 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -71.54 -51.49 23.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.129 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.3 t -84.28 -61.79 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.48 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -48.27 -3.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.723 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.7 OUTLIER -55.16 -7.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.321 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.48 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 213' ' ' VAL . 23.0 m-20 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.13 -12.97 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -81.01 -17.84 48.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.364 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -66.68 -39.45 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.585 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 94.2 t -58.07 -50.02 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.44 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -56.12 -46.87 79.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.572 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 6.3 t -61.25 -45.94 92.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.53 -41.51 98.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.056 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.73 -40.82 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -66.11 -44.05 85.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.443 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -15.12 62.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.02 -45.64 13.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 226' ' ' ASP . 5.8 mtp-105 -59.22 -46.75 87.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.788 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -67.72 -10.46 52.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.525 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -93.04 -35.78 13.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.317 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.5 -26.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -95.2 137.3 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.793 -179.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.12 26.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.006 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.76 166.62 13.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.66 -9.86 58.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -92.86 130.5 38.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.725 ' C ' HD12 ' A' ' 232' ' ' LEU . 11.2 mtp180 -83.47 156.02 23.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.711 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.6 mp -147.55 -41.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 109.93 22.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.415 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -94.0 123.83 37.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.334 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.1 m -92.01 109.41 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.939 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.6 69.26 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.313 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -39.25 120.49 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.008 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.97 -23.26 28.0 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.35 -41.66 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.697 0.284 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.24 -137.71 7.78 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 154.62 48.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.723 0.297 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 192' ' ' VAL . 7.3 p -138.45 131.38 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.8 tp -91.2 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.478 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.14 135.93 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.191 179.95 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.984 0.421 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -120.54 123.42 42.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.955 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -89.56 153.1 21.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.67 156.19 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.0 t80 -165.43 128.56 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.596 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.01 -99.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 56.7 m-20 -125.44 53.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.65 150.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.193 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -140.33 143.32 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.138 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.67 137.47 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 150' ' ' ARG . 2.1 m-20 -112.68 104.59 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 110.351 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.08 -10.65 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.72 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.6 -43.35 6.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.717 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 163' ' ' HIS . 82.3 p -98.58 9.47 43.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 162' ' ' THR . 16.8 m-70 37.18 47.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -124.1 161.39 25.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.832 0.348 . . . . 0.0 110.744 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.03 156.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.987 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.58 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.7 tmtt? -123.76 110.75 15.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.08 62.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.5 28.31 72.98 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 167' ' ' LYS . 25.4 tt0 -139.63 105.78 6.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 144.46 29.67 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.718 1.612 . . . . 0.0 112.466 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.88 138.91 50.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.9 t -86.14 138.86 31.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.281 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mt -142.85 99.6 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.656 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 171.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -46.88 -60.4 0.89 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.487 2.124 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -53.33 -56.68 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.315 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 2.6 mm-40 -59.25 -36.76 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.761 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -60.92 -47.24 87.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.9 m -58.8 -41.54 86.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.417 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 202' ' ' VAL . 4.4 tp -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.659 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -61.33 -43.03 99.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -46.73 83.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.594 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.479 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 4.5 t80 -67.41 -39.14 85.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.676 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -43.84 79.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.03 -47.41 68.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.51 -36.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 20.5 m-80 -108.97 28.8 8.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.65 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.15 -22.49 22.89 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 m -95.29 135.26 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.055 0.455 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 242' ' ' VAL . 84.9 t -69.19 123.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.4 mp -96.15 154.4 17.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.093 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.65 147.87 30.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.953 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.5 mtmt -57.83 -55.03 49.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.792 179.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.8 Cg_endo -67.63 -29.97 35.61 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.023 1.816 . . . . 0.0 111.949 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -68.33 -49.34 60.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 109.973 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 mt -55.98 -42.23 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.805 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 199' ' ' LEU . 29.7 tp -59.2 -63.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -52.87 -28.83 24.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 19.3 t-80 -71.92 -48.34 46.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 47.7 t -84.37 -61.52 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -53.23 -3.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.315 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp180 -61.59 0.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 110.636 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.3 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.501 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.64 -8.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.64 -17.64 50.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.345 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.28 -40.01 85.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.072 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 218' ' ' VAL . 87.8 t -56.76 -50.51 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.12 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.52 -48.49 71.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.579 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.2 m -60.74 -47.77 84.82 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.6 -40.52 95.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.618 HG21 ' CE2' ' A' ' 241' ' ' TYR . 73.0 t -62.69 -43.27 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -43.92 97.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.14 -37.52 85.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 221' ' ' LEU . 1.0 OUTLIER -60.91 -48.14 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 226' ' ' ASP . 4.6 mtp85 -56.19 -43.18 78.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.494 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -67.06 -17.22 64.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -96.19 -32.29 12.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.57 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -109.53 -33.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.268 -178.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -104.49 137.83 41.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.73 27.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.404 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.59 -176.5 14.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.54 -8.7 57.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 110.481 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.67 104.81 17.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -96.15 104.46 16.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.7 -7.23 50.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.215 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.52 112.23 21.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.2 126.85 40.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.401 -179.936 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.42 70.58 3.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -43.61 112.31 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.36 -13.24 16.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.94 -54.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 110.724 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.3 -139.25 6.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.6 OUTLIER -128.43 155.35 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 0.0 110.467 179.89 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 192' ' ' VAL . 4.1 p -137.05 135.57 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.62 126.32 36.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -162.53 135.7 5.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.178 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.489 179.832 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.651 0.263 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -174.63 153.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.713 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 186' ' ' VAL . 1.7 mm? -92.37 153.86 18.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.317 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 152.37 41.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CE2' HD21 ' A' ' 243' ' ' LEU . 1.6 t80 -163.7 128.08 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.812 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.75 -99.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.6 m-20 -124.82 53.82 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 0.0 109.836 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 142.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.49 140.16 42.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.887 0.375 . . . . 0.0 110.738 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.446 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.32 124.2 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -102.59 104.87 15.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.534 -179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.588 ' OE2' ' N ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -65.97 -12.72 57.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.588 ' N ' ' OE2' ' A' ' 160' ' ' GLU . 3.1 tt0 -81.63 -52.38 7.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 163' ' ' HIS . 80.5 p -97.32 14.88 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 162' ' ' THR . 24.4 m80 35.78 63.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.601 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -140.45 162.4 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 174' ' ' LEU . 16.5 t -116.18 161.61 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.498 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.14 128.54 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.63 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -128.08 110.72 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.08 67.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.01 32.06 62.19 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -142.37 87.52 9.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.37 136.42 50.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.197 1.931 . . . . 0.0 112.133 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.4 152.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.129 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.3 m -90.11 126.62 35.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.145 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 165' ' ' VAL . 14.2 mt -141.03 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.62 171.87 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.81 -53.81 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.556 2.171 . . . . 0.0 112.096 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -57.47 -52.73 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.29 -39.6 93.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.78 -46.61 88.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.362 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.7 m -59.21 -40.44 85.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -45.89 91.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.16 -43.16 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.928 0.394 . . . . 0.0 110.163 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -55.64 -45.18 77.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.334 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.685 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -64.8 -44.05 91.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.43 -44.81 65.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 151' ' ' LEU . 10.7 t -68.69 -49.09 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.819 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 mm -54.13 -34.57 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER -109.53 27.53 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.561 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.38 116.55 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.36 -17.99 42.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.1 m -90.14 125.09 35.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.765 0.317 . . . . 0.0 110.93 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.76 115.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.962 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.91 160.44 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.677 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.45 148.43 29.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.697 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 12.9 mtpt -55.24 -53.37 62.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.8 Cg_endo -68.43 -29.77 30.71 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -46.22 74.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.16 -39.51 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.89 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 199' ' ' LEU . 3.7 tt -59.17 -51.4 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.724 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -72.49 -19.74 61.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.685 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 30.6 t-80 -71.39 -41.79 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.674 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.3 t -82.72 -53.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.587 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 205' ' ' TYR . 2.2 m-90 -67.29 -5.34 13.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.735 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.436 ' O ' ' NE ' ' A' ' 204' ' ' ARG . 0.4 OUTLIER -44.07 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.895 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.19 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 212' ' ' ASN . 2.3 m-20 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.3 m -58.59 1.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.556 ' H ' ' C ' ' A' ' 210' ' ' ASP . 70.2 m-20 -96.2 -24.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.65 -31.41 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.33 -53.04 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -55.34 -43.83 75.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -60.59 -49.5 77.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.81 -38.44 91.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.434 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.81 -42.75 97.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.298 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -45.29 92.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.47 -31.33 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.33 -44.43 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.17 -41.79 72.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.3 mtm-85 -67.8 -22.0 65.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -25.11 19.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -116.31 -38.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.978 -179.526 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 222' ' ' ARG . 3.7 t70 -98.48 146.27 25.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.483 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t 175.45 -30.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.281 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -72.35 163.65 54.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -64.5 -4.24 3.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 110.713 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -92.71 131.26 37.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -86.99 158.12 19.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.16 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 232' ' ' LEU . 82.4 mt -147.55 -48.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.291 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.54 119.31 38.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 124.49 41.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.264 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -91.68 109.93 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 30.0 mt -93.22 71.79 4.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 89.9 mtt180 -37.02 123.93 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 -39.82 2.74 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.1 -60.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.391 . . . . 0.0 110.659 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.08 -137.02 4.52 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -127.29 155.66 43.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 110.645 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.39 140.2 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 153' ' ' PHE . 27.8 tp -93.39 111.39 23.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.262 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.26 131.97 5.21 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.255 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.049 179.553 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -174.74 153.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.225 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -91.15 148.07 22.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.089 0.471 . . . . 0.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -140.19 155.43 46.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.201 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 155' ' ' ASP . 70.3 t80 -156.86 124.93 5.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.005 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.77 -93.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.8 m-20 -124.86 52.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.75 138.43 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.984 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -134.99 133.02 39.03 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.715 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 165' ' ' VAL . 4.5 mt -131.43 120.85 23.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -109.18 113.82 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.546 -179.521 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.95 -42.33 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.5 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.5 -47.18 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.1 p -103.62 8.99 37.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 162' ' ' THR . 0.7 OUTLIER 36.91 46.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.573 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.32 165.65 14.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 174' ' ' LEU . 11.1 t -121.26 159.33 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.433 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -146.41 120.67 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.485 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -118.25 105.12 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.237 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.84 63.42 0.31 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.52 27.5 73.39 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 tt0 -134.05 94.63 18.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.612 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.59 134.12 10.87 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.291 1.994 . . . . 0.0 111.989 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.89 134.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.374 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.2 p -81.76 100.04 9.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 165' ' ' VAL . 15.1 mt -96.62 154.31 17.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.99 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.95 160.91 65.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.964 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.55 -43.07 52.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.537 2.158 . . . . 0.0 111.624 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -55.37 30.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.644 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.58 ' HB3' HD22 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -59.64 -36.26 76.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.299 179.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.11 -52.78 64.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.37 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.1 m -57.47 -43.43 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.777 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -53.44 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.05 -41.5 95.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -55.54 -46.5 77.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.781 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 29.7 t80 -64.35 -42.53 96.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.18 -43.86 83.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.47 -43.68 94.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.988 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.02 -29.59 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 29.2 m-80 -113.99 23.25 13.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.109 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.23 121.36 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.776 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.59 -20.86 24.51 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -95.81 131.18 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 111.042 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.7 p -69.44 115.61 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 198' ' ' ILE . 3.7 mp -96.9 160.24 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.487 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.76 148.1 31.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.0 -50.14 89.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.751 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.4 Cg_endo -65.78 -34.59 39.68 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.56 1.507 . . . . 0.0 112.219 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.95 -47.6 65.28 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.108 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 193' ' ' LEU . 19.3 mt -53.82 -40.91 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.991 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.652 ' HG ' HG21 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -62.29 -64.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.475 179.768 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -27.65 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.294 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.14 -51.58 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.762 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.8 t -83.71 -61.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.239 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.451 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -50.6 -4.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -179.384 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttm180 -61.98 -1.44 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.53 -7.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.94 -49.31 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 214' ' ' VAL . 8.1 p -54.75 -42.96 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.044 0.45 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.836 ' O ' HG23 ' A' ' 218' ' ' VAL . 41.1 t -58.95 -44.85 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -61.13 -47.1 87.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.339 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -60.28 -41.03 92.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.984 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -64.09 -42.05 97.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.25 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.4 -40.32 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -45.15 74.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.313 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -13.07 62.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.432 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -57.09 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 24.2 ptt180 -57.54 -37.85 73.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.705 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.424 ' NH2' HH21 ' A' ' 222' ' ' ARG . 1.4 mtt-85 -69.0 -20.76 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -94.87 -27.56 15.66 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.805 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.445 HG21 ' HZ1' ' A' ' 167' ' ' LYS . 1.8 pp -114.85 -27.62 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.839 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -102.84 139.04 38.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.997 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 -33.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -46.01 163.64 0.12 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -94.45 106.43 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -74.06 107.21 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.458 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.81 1.12 56.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.587 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.2 mt -126.58 96.23 4.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . 0.439 ' HB2' ' HE ' ' A' ' 244' ' ' ARG . 0.1 OUTLIER -87.93 122.06 31.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 179.808 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.409 HG23 ' CD2' ' A' ' 241' ' ' TYR . 23.7 m -93.26 113.68 25.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.1 mt -95.27 72.14 3.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -39.06 120.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.754 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.51 -17.58 30.79 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.584 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 63.6 t -128.33 -55.11 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.12 -137.25 4.76 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.8 OUTLIER -131.24 155.16 47.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 110.265 179.82 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 242' ' ' VAL . 8.2 p -138.17 131.29 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.159 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.41 104.64 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.374 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -162.24 153.48 17.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.756 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -136.41 127.26 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.368 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.6 mt -90.57 152.72 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.95 148.97 39.5 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 84.2 t80 -158.74 127.47 5.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.89 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.38 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 25.8 m-20 -123.94 53.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 145.06 29.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.256 -179.553 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.42 149.06 50.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.434 179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.35 121.87 8.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.137 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.79 27.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 -179.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.476 ' OE1' ' NH2' ' A' ' 183' ' ' ARG . 8.0 mt-10 -66.57 -22.42 66.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.625 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.0 -52.11 52.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.4 p -108.18 14.79 24.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 160' ' ' GLU . 9.6 m80 37.22 54.74 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -120.86 156.79 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 174' ' ' LEU . 2.0 t -119.85 157.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.65 137.76 25.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -130.6 110.08 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 179.748 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.06 60.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.263 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.83 76.12 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.0 mt-30 -134.98 104.89 10.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.823 -0.222 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.39 144.72 26.14 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.889 1.726 . . . . 0.0 112.618 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.24 136.43 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.712 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.5 t -97.97 127.17 43.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.889 HD12 ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -140.65 124.68 17.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.376 . . . . 0.0 110.539 179.707 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -45.67 174.57 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -179.617 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.7 -47.6 26.37 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.544 2.163 . . . . 0.0 111.853 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -52.34 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.07 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.52 -38.75 88.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.878 0.371 . . . . 0.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -48.39 81.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.711 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -59.38 -42.64 92.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.206 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 202' ' ' VAL . 0.8 OUTLIER -56.85 -50.8 71.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.015 -179.704 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.95 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.746 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.476 ' NH2' ' OE1' ' A' ' 160' ' ' GLU . 2.3 ttt180 -60.21 -48.89 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.43 -39.41 93.79 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.555 -179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.446 ' HD1' HD12 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -59.03 -43.14 91.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.19 -47.11 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.27 -27.65 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.062 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.54 18.54 20.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.462 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.53 120.23 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.44 -24.37 13.95 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 46.7 m -94.72 126.73 40.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.8 p -68.11 118.4 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 198' ' ' ILE . 8.0 mp -96.35 161.4 13.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.47 148.0 30.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.287 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.41 -55.75 36.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.034 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.3 Cg_endo -66.58 -33.6 35.72 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.962 1.774 . . . . 0.0 112.142 -179.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -46.33 85.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.413 HG12 HD23 ' A' ' 193' ' ' LEU . 36.8 mt -60.99 -39.09 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.579 HD22 HG22 ' A' ' 211' ' ' VAL . 8.6 tp -61.94 -51.5 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.144 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.32 -28.87 69.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.019 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.85 -58.5 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.505 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.677 HG21 HD12 ' A' ' 181' ' ' LEU . 39.6 t -84.34 -60.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.013 -178.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.438 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -51.04 -5.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.834 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.9 ttp85 -61.4 -1.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.985 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 212' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.245 0.545 . . . . 0.0 110.434 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.579 HG22 HD22 ' A' ' 199' ' ' LEU . 24.5 t -55.3 0.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 210' ' ' ASP . 37.3 m-20 -83.66 -12.41 55.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.57 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.11 -35.27 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.399 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.9 t -55.92 -55.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.052 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.29 -48.56 68.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.3 t -58.07 -50.53 73.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.026 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.51 -37.26 83.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.0 110.533 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 214' ' ' VAL . 35.1 t -62.04 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -60.56 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.52 -39.89 94.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.73 -45.68 88.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.42 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.0 mmm-85 -56.68 -42.29 78.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.392 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -66.15 -22.5 66.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.634 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -93.22 -30.44 15.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.671 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -110.45 -37.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 0.0 110.766 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.5 t70 -95.02 145.18 25.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.458 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.91 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.461 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.53 -178.57 4.92 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -79.34 -11.21 59.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -94.4 104.89 16.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.026 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -92.08 109.37 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.265 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 243' ' ' LEU . 2.5 mp -91.81 -9.07 44.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.445 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.72 127.25 56.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.132 179.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.96 124.57 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.381 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.3 m -97.61 113.74 25.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.327 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 240' ' ' GLY . 7.2 mt -96.11 72.66 2.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.632 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -39.78 115.19 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.51 -20.42 20.71 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.795 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.3 -50.02 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.915 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 158.59 -145.64 11.94 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -131.48 152.71 50.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.538 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.13 137.45 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.8 OUTLIER -91.21 127.09 36.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.652 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.435 ' HB3' HH11 ' A' ' 244' ' ' ARG . 3.9 ptm85 -163.61 131.1 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 111.126 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.736 -179.9 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -121.65 124.67 44.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.296 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.864 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -142.33 160.78 39.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.613 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 156' ' ' ILE . 69.6 t80 -165.53 128.72 2.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.53 -99.82 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.241 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 153' ' ' PHE . 22.8 p30 -122.76 53.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.55 155.04 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.707 -179.64 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -146.84 140.58 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.407 ' CD2' HG22 ' A' ' 165' ' ' VAL . 2.4 mt -137.16 136.32 38.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -110.88 104.09 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.133 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.42 -11.08 39.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.902 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -96.92 -51.02 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.83 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.539 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 30.8 p -93.89 9.99 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.503 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 162' ' ' THR . 8.5 p-80 37.11 58.49 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -127.81 157.37 40.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.54 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 158' ' ' LEU . 6.0 t -121.64 151.46 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.325 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.23 125.19 12.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 170' ' ' GLN . 23.8 tttp -124.49 115.24 20.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.611 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 59.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.66 75.26 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 167' ' ' LYS . 48.2 mt-30 -130.5 95.28 27.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.7 138.99 12.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.121 1.881 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.61 145.26 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.381 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -94.28 100.09 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 174' ' ' LEU . 11.1 mp -96.07 150.38 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.578 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.36 168.44 22.48 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.293 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.68 -52.17 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.367 2.045 . . . . 0.0 112.322 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -47.65 85.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.71 -37.5 84.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.615 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 1.8 t80 -64.71 -49.24 71.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.5 m -57.31 -46.04 83.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.55 -49.6 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.791 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.84 -44.77 96.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.75 -46.36 89.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 2.3 t80 -62.27 -42.25 99.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.819 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 243' ' ' LEU . 0.1 OUTLIER -59.63 -43.99 93.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.337 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.19 -45.35 86.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.556 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 mm -57.35 -35.58 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -110.18 23.16 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.274 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.02 119.08 4.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.52 -26.83 9.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 127.62 35.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.326 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 192' ' ' VAL . 8.2 p -67.88 114.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.96 157.5 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 149.83 28.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.8 mttt -57.12 -49.44 93.95 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -65.36 -35.43 40.02 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.56 1.507 . . . . 0.0 111.933 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -66.33 -55.48 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.029 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 mt -49.93 -38.1 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 48.7 tp -65.06 -68.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -46.05 -27.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.572 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 24.8 t-80 -71.53 -52.29 19.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.062 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.1 t -83.42 -56.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.434 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -51.68 -4.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.458 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.541 ' H ' ' C ' ' A' ' 202' ' ' VAL . 48.1 ttm-85 -58.69 -6.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 211' ' ' VAL . 4.4 p -80.33 -9.6 12.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.644 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.83 -17.97 34.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.18 -35.04 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.298 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.1 t -58.27 -49.51 81.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.322 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -58.4 -47.07 85.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.278 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 m -59.78 -45.35 92.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.38 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -45.34 94.79 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 214' ' ' VAL . 59.6 t -62.2 -40.2 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -44.79 90.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.592 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.49 -28.5 66.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.572 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.61 -47.3 63.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 226' ' ' ASP . 3.1 mtp85 -57.02 -45.56 83.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.319 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -67.41 -10.14 48.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -90.58 -44.27 9.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.9 pp -110.14 -32.78 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -95.23 143.47 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.9 t -175.33 38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.06 -163.25 10.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -90.54 -20.54 22.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.518 ' H ' ' CD ' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -92.23 104.0 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.208 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -88.75 125.86 35.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.4 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.754 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mt -91.25 -8.8 47.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.63 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.6 mp -121.6 116.32 24.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.183 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 127.57 37.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.46 105.88 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.6 mt -94.59 73.1 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.14 136.36 5.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.708 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.18 -12.74 65.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.15 -46.06 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 147.13 -141.77 9.68 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -131.12 153.59 49.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 0.0 110.476 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.48 136.61 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.41 119.92 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -163.03 127.12 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.148 179.589 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.824 0.345 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -141.38 134.6 29.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.76 161.09 16.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 157.79 44.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' OE2' ' A' ' 245' ' ' GLU . 91.9 t80 -162.55 122.96 2.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.668 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 32.8 m-20 -124.66 54.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 152.41 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.553 -179.329 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.1 tt0 -140.23 147.7 40.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.216 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD21 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -146.33 117.46 7.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.257 -179.645 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -112.43 115.42 28.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.673 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.8 -45.07 79.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -49.49 -50.72 40.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.714 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 56.4 p -97.18 6.95 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.624 ' CE1' ' CE1' ' A' ' 179' ' ' PHE . 16.9 t60 36.1 57.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -134.18 159.18 41.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.54 154.45 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -146.42 129.14 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.123 -179.795 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 170' ' ' GLN . 25.5 tttp -127.51 114.55 17.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.414 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 65.06 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 60.4 29.57 69.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 167' ' ' LYS . 14.7 tp60 -132.95 92.18 26.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.29 136.81 16.32 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.134 1.89 . . . . 0.0 112.379 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.29 136.08 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.957 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 57.9 m -91.06 91.14 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.88 142.58 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.931 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 170.74 13.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.95 -53.96 6.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.408 2.072 . . . . 0.0 112.43 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -52.3 -63.44 1.14 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -58.33 -37.45 75.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.775 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.624 ' CE1' ' CE1' ' A' ' 163' ' ' HIS . 27.7 t80 -54.98 -51.71 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -62.77 -35.69 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.549 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.6 -51.17 69.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.152 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.18 -41.25 98.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.792 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -62.45 -41.79 99.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.23 -37.28 86.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.207 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.97 -46.05 92.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.43 -47.28 90.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.484 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -50.88 -42.08 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -108.98 25.36 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.75 117.34 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.62 -21.42 16.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 193' ' ' LEU . 21.5 m -96.5 131.47 43.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 242' ' ' VAL . 75.3 t -68.86 119.02 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 191' ' ' THR . 4.5 mp -96.78 166.27 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 110.77 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.97 148.26 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.67 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.36 -51.08 84.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.574 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.6 Cg_endo -64.27 -44.6 11.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.675 1.583 . . . . 0.0 112.149 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.04 -51.54 68.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.244 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -55.52 -39.0 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 110.393 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 199' ' ' LEU . 2.6 tt -59.43 -67.39 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.071 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -58.13 -15.9 11.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -53.38 12.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.711 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 204' ' ' ARG . 23.8 t -84.06 -30.66 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.269 -179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.452 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -60.36 -3.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.92 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 202' ' ' VAL . 13.2 mmm-85 -61.01 -1.93 0.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.568 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.9 m-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.597 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.121 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -6.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.642 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -26.07 19.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.789 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -67.68 -32.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.7 t -57.85 -56.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.072 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.51 -46.92 76.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.229 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.0 t -60.6 -45.66 93.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.13 -39.03 89.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.15 -46.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.428 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -62.48 -43.32 99.09 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -72.69 -13.32 61.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 221' ' ' LEU . 0.3 OUTLIER -83.26 -48.33 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.131 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 12.5 mtm-85 -56.07 -45.05 79.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -68.17 -11.14 58.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.766 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.4 tttp -92.7 -33.34 14.38 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.625 -179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -21.6 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.872 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.85 -39.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -53.25 168.98 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.16 -8.55 56.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.916 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 130.1 39.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -85.79 128.43 34.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -90.09 -74.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -91.95 145.45 24.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.646 -179.652 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -105.23 132.44 51.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.38 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -91.69 108.94 20.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.737 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 10.2 mt -94.87 72.96 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.469 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -36.84 142.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.19 179.641 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.1 36.04 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.59 -57.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.567 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 154.37 -138.95 6.44 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -130.51 160.74 33.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.697 179.996 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 242' ' ' VAL . 10.8 p -142.64 126.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 36.8 tp -90.64 116.67 28.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -161.9 147.18 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.437 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.545 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.4 mp0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.267 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.792 0.329 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -174.5 143.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.13 154.71 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -142.34 156.97 45.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.67 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 154' ' ' ALA . 26.2 t80 -169.66 133.84 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.833 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.95 -129.6 0.25 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.63 53.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.349 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.92 151.24 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -146.79 141.49 26.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.161 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.06 117.95 14.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.383 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -104.11 108.71 20.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.97 0.414 . . . . 0.0 110.354 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.95 -31.05 72.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.167 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 1.4 mp0 -58.77 -48.32 81.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.735 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 163' ' ' HIS . 65.9 p -109.17 13.93 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER 38.18 50.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.702 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -119.41 158.44 26.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.13 151.97 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.31 124.72 13.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.1 ttpt -128.64 121.13 27.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.57 58.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.6 27.76 70.28 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.6 mt-30 -132.18 97.83 17.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.56 138.52 17.37 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.977 1.784 . . . . 0.0 112.492 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.97 143.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.61 -179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -93.73 97.29 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -95.97 152.16 18.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.778 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.2 161.49 59.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.338 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.46 -45.05 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.628 2.219 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -42.75 88.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.773 0.32 . . . . 0.0 110.813 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -65.43 -34.46 78.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -62.41 -45.52 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.119 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -43.58 96.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.124 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -47.66 84.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.774 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.61 -44.04 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.499 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -56.11 -47.15 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.824 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.509 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 2.6 t80 -66.08 -38.6 88.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.603 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.594 ' CZ ' ' CE2' ' A' ' 241' ' ' TYR . 3.0 m-85 -55.88 -44.54 78.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.96 -47.62 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.94 -31.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -106.53 23.77 13.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.798 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.08 119.68 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.74 -23.0 27.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.1 m -94.86 127.8 41.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.535 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 192' ' ' VAL . 14.7 p -68.62 112.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.157 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.32 151.18 19.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.0 p -100.33 148.38 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.371 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -58.39 -48.78 96.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 36.4 Cg_exo -55.03 -46.26 34.6 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.417 2.078 . . . . 0.0 111.666 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -61.97 -52.36 64.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.5 mt -49.95 -38.78 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.916 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.35 -67.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.419 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.93 -21.6 1.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.509 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 63.1 t60 -72.57 -59.19 2.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 204' ' ' ARG . 64.6 t -83.69 -60.65 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -51.11 -4.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.1 OUTLIER -60.65 -0.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.678 0.275 . . . . 0.0 110.597 -179.927 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.2 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.37 . . . . 0.0 110.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -78.48 -0.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.627 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.23 -22.16 19.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.689 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 t -64.18 -43.99 97.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.481 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 218' ' ' VAL . 48.3 t -61.35 -43.05 95.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.239 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -58.88 -45.87 89.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.444 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.4 t -61.12 -40.74 94.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.106 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -64.04 -43.47 95.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.812 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 214' ' ' VAL . 70.2 t -62.47 -41.02 90.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.284 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.83 -44.21 90.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -67.41 -31.29 71.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.5 mp -67.55 -45.71 74.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.87 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 226' ' ' ASP . 30.6 mtp85 -56.74 -46.16 81.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.35 -24.41 65.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -92.73 -23.37 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -111.12 -41.15 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.695 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 222' ' ' ARG . 24.3 t70 -100.81 141.1 34.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -37.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.422 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -59.37 165.89 9.34 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -69.26 -10.53 58.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.628 0.252 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -93.67 115.75 28.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.422 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -83.9 130.73 34.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 244' ' ' ARG . 27.9 mt -89.55 -74.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.64 145.72 26.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.577 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -105.17 140.26 38.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.662 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 m -95.85 114.75 26.51 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.036 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 240' ' ' GLY . 57.3 mt -96.14 72.12 2.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 236' ' ' LEU . 2.4 ptp180 -37.93 138.15 0.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.07 -18.64 43.39 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.15 -60.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.441 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 165.19 -142.07 7.47 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.594 ' CE2' ' CZ ' ' A' ' 185' ' ' PHE . 2.0 p90 -130.35 160.27 34.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.52 133.99 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.531 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 232' ' ' LEU . 7.8 ptm180 -162.73 127.9 3.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.541 179.839 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -149.2 138.09 21.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -90.72 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.575 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.0 158.03 44.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.0 111.218 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 243' ' ' LEU . 3.8 t80 -164.79 139.76 5.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.347 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.544 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 37.28 -105.32 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.69 53.11 1.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -137.43 150.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.556 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -140.45 137.02 33.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.38 143.34 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.216 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.26 109.47 15.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.06 -17.38 64.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.41 -52.03 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 42.3 p -96.79 12.04 33.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 162' ' ' THR . 8.6 m80 37.36 41.15 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.1 169.36 9.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.868 -179.399 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 166' ' ' TRP . 62.1 t -122.28 161.04 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.477 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.121 179.647 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.6 tmtm? -124.67 113.51 18.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.687 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 64.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.052 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.41 31.69 63.26 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.5 tt0 -142.3 89.39 8.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.82 150.07 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.23 1.953 . . . . 0.0 112.544 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.2 126.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.905 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 p -95.13 115.39 27.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.871 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -141.69 154.28 45.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.489 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.64 161.53 1.57 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.0 -33.99 95.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.889 2.393 . . . . 0.0 111.96 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -60.81 -53.61 55.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.13 -37.81 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.229 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.48 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 4.7 t80 -58.48 -48.08 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.9 m -58.8 -39.33 80.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 181' ' ' LEU . 44.7 tp -60.87 -46.87 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.348 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.18 -40.65 86.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -59.89 -43.62 94.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.64 -179.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.45 -43.07 91.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.564 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.43 -43.11 83.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.91 -48.75 86.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.52 -35.67 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.136 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.4 23.25 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.48 117.23 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.914 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.66 -14.15 24.79 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.3 m -98.48 130.9 45.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.18 115.07 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.457 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.89 152.65 18.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.445 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.75 147.96 27.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.201 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -56.58 -51.34 81.94 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 22.0 Cg_endo -65.23 -36.35 36.72 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.65 1.567 . . . . 0.0 111.987 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -66.49 -46.83 75.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.92 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 32.7 mt -53.81 -42.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.139 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.1 mt -63.7 -64.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.524 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -32.39 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -53.59 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.9 t -83.5 -61.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.048 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -52.0 -3.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.189 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -61.14 -4.89 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.0 110.51 179.879 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.9 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.103 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.9 -4.79 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.67 -21.09 22.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.79 -33.83 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.951 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 218' ' ' VAL . 11.7 t -60.94 -50.74 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.263 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -45.97 83.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 p -61.04 -44.04 97.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -40.48 94.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 214' ' ' VAL . 49.5 t -62.45 -40.06 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.688 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -43.31 80.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -12.99 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.66 -50.18 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.984 179.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.3 ttp180 -56.28 -51.14 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.295 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -8.31 29.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.547 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -92.36 -37.09 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.57 -179.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.76 -25.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 0.0 110.72 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.3 OUTLIER -105.49 139.43 40.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.598 179.914 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 227' ' ' THR . 13.2 t -165.93 38.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.16 -173.52 13.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.2 -13.19 57.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.69 -0.255 . . . . 0.0 111.038 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -93.89 115.49 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.954 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.2 mmt180 -97.52 113.17 24.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -90.32 -1.68 57.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 107.48 15.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.93 125.01 41.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.7 m -91.8 111.48 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.539 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.7 mt -95.23 72.8 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 19.0 ttt-85 -36.75 127.04 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.98 -10.7 70.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.91 -39.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 135.96 -137.84 9.45 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.7 154.67 46.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 0.0 110.838 -179.846 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.09 138.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -91.75 113.61 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.416 179.79 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -161.7 130.95 4.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.493 ' HG2' HD22 ' A' ' 232' ' ' LEU . 16.3 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.16 -176.53 35.28 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -112.75 -15.16 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.9 t -51.63 -85.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.206 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 46.43 -108.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -40.53 102.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -59.85 146.73 40.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.707 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -87.55 9.02 22.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.15 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -119.71 78.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.609 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -109.89 55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.8 m -74.14 -3.72 31.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.45 117.67 29.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.353 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 48.98 -167.48 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 tp -176.07 50.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.741 0.305 . . . . 0.0 110.833 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.09 56.89 2.4 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.01 -6.55 19.46 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.538 2.159 . . . . 0.0 111.919 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -55.33 -18.57 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -147.05 -70.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t 53.77 -114.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.697 0.284 . . . . 0.0 110.467 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -161.87 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.41 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.33 -12.01 0.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.41 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -142.91 -57.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.554 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.45 135.49 2.57 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -141.58 23.87 2.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.666 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -54.27 -36.73 63.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.391 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.61 145.51 16.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.251 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.34 -65.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.294 1.996 . . . . 0.0 111.926 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 148' ' ' ASN . 38.5 ttm-85 -152.68 178.81 9.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.082 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -42.48 171.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.75 111.83 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.559 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -128.63 123.59 33.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.7 146.76 23.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.624 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.2 m -142.35 155.44 45.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.782 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 155' ' ' ASP . 42.7 t80 -163.02 128.01 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.92 -96.03 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 43.2 p-10 -124.56 53.79 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 143.27 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.155 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -140.13 136.1 33.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.324 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.448 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.67 131.74 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -113.74 109.52 18.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.955 0.407 . . . . 0.0 110.65 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.491 ' CD ' ' N ' ' A' ' 160' ' ' GLU . 1.5 mp0 -66.68 -12.21 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.838 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.487 ' OE1' ' ND2' ' A' ' 148' ' ' ASN . 2.2 mt-10 -85.8 -51.98 6.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.589 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 40.6 p -99.21 11.22 39.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.526 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 40.6 p-80 35.82 58.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.357 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -127.33 156.26 42.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.65 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 174' ' ' LEU . 21.9 t -122.7 148.77 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.52 125.29 12.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 170' ' ' GLN . 31.8 tttm -128.83 117.24 20.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 62.74 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.1 26.26 70.21 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 167' ' ' LYS . 5.9 mt-30 -130.49 92.93 33.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 O-C-N 122.705 -0.291 . . . . 0.0 110.522 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.74 142.21 17.78 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.154 1.902 . . . . 0.0 111.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.1 131.01 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 m -88.46 88.35 7.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 165' ' ' VAL . 1.2 mt -93.92 154.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.42 165.2 32.01 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.3 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -42.12 -54.62 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.688 2.258 . . . . 0.0 112.362 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 53.7 m -57.68 -56.6 19.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.282 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -58.38 -34.69 70.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.933 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.82 -45.31 78.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.463 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.1 m -58.87 -39.92 82.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.202 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -54.27 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.72 -41.78 87.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -60.48 -46.67 89.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.081 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.684 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 19.5 t80 -62.3 -41.1 98.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.414 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.13 -43.67 82.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.93 -45.45 87.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 184' ' ' TYR . 55.5 mt -57.09 -37.24 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.687 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -107.84 25.6 11.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.07 124.33 16.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.44 -24.51 15.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.8 m -95.46 131.32 41.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.583 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 t -66.96 119.39 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.285 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 158.47 15.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.058 0.456 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.28 148.43 34.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.522 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.5 mtpp -56.02 -55.01 46.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.486 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.0 Cg_endo -65.07 -39.96 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.851 1.701 . . . . 0.0 112.055 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.88 -51.55 68.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 37.5 mt -53.24 -42.96 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.179 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.68 -63.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.505 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -52.18 -29.59 23.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.259 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.684 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 6.1 t60 -71.2 -46.48 61.18 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.005 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 90.4 t -83.77 -60.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.065 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -50.55 -6.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.049 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.5 OUTLIER -59.33 -6.81 1.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 13.1 m-85 -109.22 -1.03 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.511 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -175.29 92.14 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -69.18 149.34 48.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.203 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 121.6 59.13 0.22 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.61 103.57 0.23 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -51.63 -173.44 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 110.652 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 211' ' ' VAL . 10.1 p -86.26 -10.36 11.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.92 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -83.71 -24.5 31.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.356 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 216' ' ' SER . 21.9 t -64.31 -34.76 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.04 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 218' ' ' VAL . 39.5 t -65.93 -45.37 91.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.333 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.71 -45.72 77.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.311 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 33.0 p -60.1 -46.75 88.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.484 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.05 -38.81 92.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 214' ' ' VAL . 79.7 t -63.54 -43.11 98.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.607 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.72 -45.56 93.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.55 -39.87 92.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.316 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -61.33 -45.81 92.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.269 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' ASP . 47.0 ttt180 -56.18 -43.12 78.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.345 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -67.47 -30.25 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.403 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -91.1 -11.26 39.14 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -120.16 -25.1 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.915 -179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -96.2 137.03 35.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.191 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.79 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -70.83 170.74 46.19 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -77.1 -12.51 59.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -93.32 111.03 22.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.8 ttp85 -92.39 103.81 16.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mp -91.02 -5.72 54.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.43 HD12 ' HG ' ' A' ' 243' ' ' LEU . 1.4 tp -114.3 106.79 14.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 130.85 39.63 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.46 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 19.9 m -100.91 112.78 25.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.202 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.4 mt -98.07 69.61 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.066 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' LEU . 71.3 mtt180 -38.26 131.79 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.07 -20.85 49.2 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.2 t -120.08 -58.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 110.422 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.17 -139.22 5.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.89 153.85 49.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.332 . . . . 0.0 110.721 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.8 p -137.0 135.15 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -90.78 125.87 35.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.995 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -162.29 134.13 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.839 0.352 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -69.68 154.08 95.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.199 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.84 130.31 20.24 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.535 2.157 . . . . 0.0 112.081 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.633 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.748 0.308 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.91 -45.2 0.02 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -46.17 156.48 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.919 0.39 . . . . 0.0 110.534 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.69 10.65 11.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.857 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -89.52 -32.83 16.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.466 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -134.81 88.6 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.627 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -163.62 -12.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.892 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -151.6 -32.63 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -56.07 160.85 2.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.72 93.68 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.856 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -69.02 -77.68 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.547 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.7 p 49.9 54.5 10.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 133' ' ' LEU . . . -169.4 -34.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 132' ' ' GLY . 1.4 tp 58.63 138.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 133' ' ' LEU . 2.8 t 41.14 60.1 8.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.103 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.29 -28.16 15.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.804 2.336 . . . . 0.0 113.109 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 138' ' ' SER . 4.6 tpp180 -166.79 88.34 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.63 33.9 1.39 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 136' ' ' ARG . 92.8 p -126.62 55.06 1.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 110.209 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -60.37 128.84 38.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.646 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.7 mtt -68.04 121.16 15.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.237 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -64.38 -65.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.28 -123.43 2.59 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.4 m120 53.18 16.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -90.51 -33.51 15.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.395 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 147' ' ' ARG . 7.2 mt-10 51.2 72.75 1.13 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.98 -6.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.024 2.483 . . . . 0.0 112.55 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 145' ' ' GLU . 35.9 mtt85 63.94 76.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.841 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -86.36 122.98 31.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 149' ' ' VAL . 0.2 OUTLIER -85.36 139.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.862 0.363 . . . . 0.0 110.582 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -148.46 141.83 25.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.189 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 151' ' ' LEU . 5.2 mt -90.47 151.15 21.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.308 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -140.32 158.59 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.056 0.455 . . . . 0.0 111.026 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 154' ' ' ALA . 82.7 t80 -163.84 139.5 6.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.631 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.51 -104.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -124.63 53.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -138.4 154.26 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.18 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.41 144.84 32.21 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.662 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.59 131.73 34.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.374 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -114.82 98.95 7.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.5 mp0 -66.83 -19.06 65.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.637 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.59 -31.51 70.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.909 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 33.8 p -129.29 -18.24 3.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.681 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.61 ' CE1' ' CD2' ' A' ' 179' ' ' PHE . 2.4 t60 83.81 54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.1 151.34 42.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.495 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 174' ' ' LEU . 2.6 t -122.51 151.62 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.586 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.55 130.65 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.3 OUTLIER -127.78 111.36 13.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.577 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.68 71.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.83 43.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 167' ' ' LYS . 18.7 tp60 -132.19 93.45 26.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -76.18 139.1 21.01 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.968 1.779 . . . . 0.0 112.558 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.18 140.28 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.633 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 m -91.2 87.26 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.429 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.747 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -96.65 136.01 37.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.671 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 173.01 6.24 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.7 -52.25 9.43 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.26 1.973 . . . . 0.0 112.176 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -56.42 19.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.227 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -58.45 -38.68 78.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.61 ' CD2' ' CE1' ' A' ' 163' ' ' HIS . 13.1 t80 -61.75 -46.69 88.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.384 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -58.66 -41.57 86.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.42 -46.88 83.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.835 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.98 -39.79 87.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.486 ' NH1' HD11 ' A' ' 187' ' ' ILE . 59.1 ttt-85 -58.24 -45.22 88.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.849 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.415 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 4.5 t80 -69.65 -39.29 77.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.2 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -40.97 83.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.627 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.17 -45.33 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.814 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.486 HD11 ' NH1' ' A' ' 183' ' ' ARG . 70.5 mt -58.17 -34.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.507 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.415 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 63.1 m-20 -109.26 25.21 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.486 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.57 117.52 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.5 27.71 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.26 128.74 42.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.897 0.379 . . . . 0.0 110.792 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.69 114.25 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.529 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.62 156.78 16.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.747 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.24 147.91 32.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.129 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 3.7 mttp -58.94 -43.99 98.33 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.316 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 39.5 Cg_exo -54.64 -50.0 14.87 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.367 2.045 . . . . 0.0 111.875 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -62.22 -55.97 23.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.791 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 202' ' ' VAL . 2.9 mt -47.88 -43.98 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.934 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.556 HD21 ' CA ' ' A' ' 209' ' ' GLY . 8.3 tp -59.93 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.638 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.89 -30.48 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.336 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -72.5 -48.15 42.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.497 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 204' ' ' ARG . 13.9 t -83.39 -60.94 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.309 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.454 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -53.41 -4.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.1 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttt180 -62.13 -4.22 1.61 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.789 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -132.02 28.09 4.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.594 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 207' ' ' PHE . 6.0 t70 -160.91 -144.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.903 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.485 ' O ' ' O ' ' A' ' 206' ' ' ASP . 1.5 m-85 -42.01 170.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.617 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.67 -86.6 0.04 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.556 ' CA ' HD21 ' A' ' 199' ' ' LEU . . . -158.83 98.92 0.18 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -97.25 99.74 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.02 -4.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -98.73 -27.23 14.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.255 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.454 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 13.1 t -66.13 -41.33 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.77 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.668 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -53.24 -49.76 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.47 -47.07 87.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.242 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 73.7 m -61.07 -43.87 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.09 -40.62 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.656 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 214' ' ' VAL . 71.1 t -62.41 -42.43 95.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.593 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -43.45 96.68 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 110.508 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -69.3 -30.43 68.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.35 -45.98 68.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.117 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 2.1 mtp180 -56.89 -44.93 82.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -68.59 -16.75 63.96 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.492 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -94.98 -29.45 14.63 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.683 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.28 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 110.713 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 2.3 t70 -110.19 137.49 47.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.593 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.52 28.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.581 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.01 -178.63 17.53 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -70.0 -15.42 63.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 110.649 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -91.58 111.78 23.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -86.01 136.07 33.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.393 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -88.21 -75.4 0.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.01 146.27 24.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.548 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -102.29 138.49 39.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.943 0.402 . . . . 0.0 110.856 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 45.1 m -95.4 110.54 22.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.979 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 mt -95.61 70.81 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -40.57 120.68 1.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.39 -16.83 29.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.49 -53.14 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 110.281 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.09 -138.21 5.66 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.74 156.32 45.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.696 0.284 . . . . 0.0 110.634 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.1 p -134.33 132.13 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.72 117.01 29.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 232' ' ' LEU . 4.9 ptm180 -162.8 132.04 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -63.74 152.65 86.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.994 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 111.46 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.369 2.046 . . . . 0.0 111.835 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.84 -179.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 143.13 120.51 1.52 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.73 148.52 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.867 0.365 . . . . 0.0 110.927 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.04 -26.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.403 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 38.3 m80 -72.45 -109.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.789 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -46.14 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.6 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 124' ' ' HIS . 33.9 m-70 -68.1 165.42 18.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.183 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 42.61 -162.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -153.3 -30.38 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 58.03 86.64 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.442 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 m -79.41 92.91 5.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.299 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -107.62 107.73 18.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 111.034 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.05 151.96 8.41 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -26.11 15.04 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.995 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 4.5 t -133.42 54.56 13.33 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.776 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 37.0 Cg_endo -66.4 -67.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.671 2.247 . . . . 0.0 112.341 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.7 mmt-85 -47.48 -48.42 26.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.804 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 123.99 -64.78 0.54 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.5 p -173.68 171.87 3.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.94 0.4 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -126.62 -158.6 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -154.34 21.9 0.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.809 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.7 168.97 15.68 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.267 0.556 . . . . 0.0 111.874 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.84 82.09 0.14 Allowed Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -83.63 -174.52 5.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.692 0.282 . . . . 0.0 110.609 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 145' ' ' GLU . 26.8 tttt -168.87 151.6 5.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.375 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 144' ' ' LYS . 57.0 mt-10 -39.64 105.57 0.37 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.018 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.39 28.39 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.281 1.987 . . . . 0.0 112.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -95.32 -108.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.548 HD22 HH21 ' A' ' 150' ' ' ARG . 0.1 OUTLIER -87.76 133.18 33.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.691 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.82 108.72 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.446 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.548 HH21 HD22 ' A' ' 148' ' ' ASN . 1.8 mtt180 -125.41 124.25 41.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.92 154.81 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 153.65 48.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.512 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 154' ' ' ALA . 68.7 t80 -166.75 135.84 2.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.515 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.98 -105.17 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -124.47 53.65 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.1 mt -137.52 145.86 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.221 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 19.7 tt0 -141.1 143.12 34.13 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.458 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 165' ' ' VAL . 4.2 mp -140.35 128.86 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.91 105.3 13.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.108 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -65.86 -20.6 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.14 -39.04 84.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 110.665 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 70.3 p -115.9 -24.64 8.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.41 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.591 ' NE2' ' CE2' ' A' ' 179' ' ' PHE . 2.2 t-80 82.77 48.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.281 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -121.77 158.6 28.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.66 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.475 HG21 HD12 ' A' ' 174' ' ' LEU . 2.9 t -120.61 150.42 23.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.679 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.401 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.46 125.19 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.468 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 170' ' ' GLN . 8.7 tttt -125.61 117.39 23.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.33 64.13 0.2 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.272 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.25 30.67 67.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 167' ' ' LYS . 12.9 tt0 -133.99 92.92 21.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -76.96 136.41 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.927 1.751 . . . . 0.0 112.448 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.34 143.58 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.937 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.2 p -99.47 87.47 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.657 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.475 HD12 HG21 ' A' ' 165' ' ' VAL . 6.3 mt -95.45 154.18 17.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.364 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.0 168.31 23.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.925 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -48.8 -53.18 7.33 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.701 2.267 . . . . 0.0 112.572 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -47.59 85.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.91 -39.21 93.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.245 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.591 ' CE2' ' NE2' ' A' ' 163' ' ' HIS . 9.0 t80 -63.66 -48.61 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.682 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -55.49 -43.28 75.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -47.07 85.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.36 -42.37 99.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.478 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.639 ' HE ' HD11 ' A' ' 187' ' ' ILE . 7.4 ttp180 -59.96 -45.7 91.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.405 ' O ' ' ND2' ' A' ' 188' ' ' ASN . 19.4 t80 -66.04 -42.68 89.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.381 . . . . 0.0 110.825 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -45.38 71.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.7 t -65.81 -49.29 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.984 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.639 HD11 ' HE ' ' A' ' 183' ' ' ARG . 56.6 mt -56.53 -31.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.616 ' N ' HD22 ' A' ' 188' ' ' ASN . 0.5 OUTLIER -107.17 15.23 25.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -49.69 120.35 4.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.377 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.87 -28.89 8.94 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -93.9 131.62 39.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 192' ' ' VAL . 9.0 p -69.13 122.24 20.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.783 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 193' ' ' LEU . 11.1 mp -95.39 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.501 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 149.23 31.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.698 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.584 ' NZ ' ' OH ' ' A' ' 241' ' ' TYR . 13.3 mttp -55.68 -54.35 52.56 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.242 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.0 Cg_endo -66.99 -32.9 33.97 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.047 1.831 . . . . 0.0 111.768 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -47.49 71.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.772 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.02 -44.96 76.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.361 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.4 mt -61.77 -61.52 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.482 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.2 -38.91 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.995 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -72.01 -51.01 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.212 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 204' ' ' ARG . 37.7 t -83.6 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.234 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.618 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.6 OUTLIER -51.29 -3.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.032 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp85 -62.46 -1.33 0.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.671 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 205' ' ' TYR . 42.7 t80 -117.69 14.76 14.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.781 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER 167.1 105.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.59 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' A' ' 207' ' ' PHE . 25.7 p90 -80.78 123.74 28.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.619 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.531 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 156.45 55.11 0.01 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.618 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -160.28 100.72 0.19 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.667 ' OD1' HG23 ' A' ' 213' ' ' VAL . 23.3 p30 -53.33 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.603 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.55 -6.5 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -88.47 -23.17 23.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.755 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.667 HG23 ' OD1' ' A' ' 210' ' ' ASP . 48.0 t -65.43 -39.29 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.027 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.78 ' O ' HG23 ' A' ' 218' ' ' VAL . 74.9 t -56.86 -50.75 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.251 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -55.56 -48.5 74.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.39 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -43.25 97.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -43.97 94.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.625 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.2 t -62.1 -41.45 91.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.609 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.92 89.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.527 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.31 -27.15 62.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 218' ' ' VAL . 16.3 mt -76.0 -45.31 35.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.054 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.44 -46.19 80.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.664 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -66.9 -23.14 65.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.414 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -92.46 -24.33 18.85 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.565 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.67 -41.18 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.83 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -101.9 137.61 39.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 110.544 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 227' ' ' THR . 0.8 OUTLIER -174.37 37.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -140.89 179.91 18.86 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -73.45 -8.65 56.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 110.759 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -92.19 112.08 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.568 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.97 155.85 20.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.264 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.59 -38.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.523 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.0 mp -102.34 120.15 40.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -101.68 128.87 47.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.417 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 109.04 20.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.36 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' ARG . 38.1 mt -94.35 69.11 3.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LEU . 40.8 mtm105 -41.07 110.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 124.01 -20.44 7.16 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.83 -46.66 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.62 -137.07 5.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 1.7 m-85 -125.21 157.12 37.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.643 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.5 p -143.0 128.94 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 244' ' ' ARG . 0.7 OUTLIER -90.51 142.47 27.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.406 ' H ' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.9 136.29 5.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.667 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -76.45 158.44 81.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 247' ' ' ARG . 87.4 Cg_exo -39.25 135.48 1.03 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.585 2.19 . . . . 0.0 111.731 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 246' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.753 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.42 -133.39 1.47 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.475 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -125.8 118.46 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.227 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.58 102.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.898 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -150.29 22.95 0.83 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -11.98 58.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.935 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -57.65 -34.95 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 110.483 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -101.2 61.3 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.571 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 15.1 t60 -154.56 17.56 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -88.58 -37.3 15.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.9 p -68.21 128.86 38.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -169.41 56.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 158.58 157.47 8.5 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 134' ' ' VAL . 0.7 OUTLIER 64.58 97.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.715 0.293 . . . . 0.0 110.981 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 133' ' ' LEU . 17.1 m -34.01 150.76 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -70.64 123.53 9.89 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.567 2.178 . . . . 0.0 112.67 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -91.42 90.53 7.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.206 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.39 62.12 0.01 OUTLIER Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 m -80.51 -23.71 39.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.085 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.6 t60 62.84 153.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.974 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.3 mtp -142.25 156.15 45.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.61 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -96.8 -17.4 20.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.01 153.72 0.02 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -134.27 -35.27 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.503 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -113.16 -12.17 13.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.67 62.39 41.63 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.911 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.55 -91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.598 2.199 . . . . 0.0 112.292 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.51 109.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.849 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.655 ' H ' HD22 ' A' ' 148' ' ' ASN . 0.1 OUTLIER -76.93 147.51 36.91 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.288 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.84 112.48 26.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.4 mtm-85 -136.89 123.66 21.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.665 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.77 152.27 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.507 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.9 m -141.88 157.18 45.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.732 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.2 t80 -162.95 127.73 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.645 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.87 -98.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 10.2 p30 -125.07 54.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.35 147.23 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.201 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.75 137.23 31.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.77 0.319 . . . . 0.0 110.534 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.05 137.37 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.551 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.78 108.48 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.455 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.586 ' OE2' ' NH1' ' A' ' 183' ' ' ARG . 25.4 mm-40 -66.52 -10.61 46.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.07 -42.86 8.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.067 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 163' ' ' HIS . 32.7 p -100.89 10.13 41.49 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 162' ' ' THR . 39.0 t-80 36.24 50.94 0.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -124.22 155.36 38.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 166' ' ' TRP . 13.3 t -117.14 159.7 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.449 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -146.07 129.24 16.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.3 tptp -127.81 110.25 12.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.42 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.57 67.95 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.74 31.45 64.11 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 167' ' ' LYS . 34.2 tp60 -142.01 87.92 9.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.543 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.35 146.42 80.62 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.115 1.876 . . . . 0.0 112.008 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.1 t -128.94 136.8 58.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.734 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.8 m -92.89 86.95 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.37 152.19 18.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.44 169.23 18.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.95 -54.15 4.94 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.545 2.163 . . . . 0.0 112.185 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.2 p -54.98 -57.35 12.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.021 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -57.48 -39.14 75.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.655 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -63.95 -47.15 81.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.753 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 m -59.07 -39.66 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.796 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.19 -45.24 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.685 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 tp -63.85 -39.44 94.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.518 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.586 ' NH1' ' OE2' ' A' ' 160' ' ' GLU . 12.5 ttt180 -64.11 -44.8 91.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -62.84 -40.71 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.785 0.326 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.959 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.56 -45.15 99.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.777 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.8 mt -58.97 -37.05 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -108.9 28.59 8.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 118.91 5.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.504 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.56 -21.04 22.07 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -96.01 131.68 42.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.674 0.273 . . . . 0.0 110.724 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.6 p -68.62 117.26 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.308 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.46 150.66 20.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.08 148.0 27.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.963 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 1.7 mttp -58.67 -46.43 99.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.1 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 45.5 Cg_exo -50.15 -51.65 10.51 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.024 1.816 . . . . 0.0 111.989 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -62.98 -55.23 27.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.321 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.9 mt -49.17 -41.18 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.943 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' A' ' 214' ' ' VAL . 30.2 tp -61.43 -67.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.8 -16.78 7.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.133 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -71.11 -52.05 21.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.572 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 19.0 t -83.66 -44.3 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.424 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.4 m-90 -65.18 -5.72 7.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -2.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.478 ' O ' ' OD2' ' A' ' 206' ' ' ASP . 0.4 OUTLIER -124.29 13.33 8.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 1.0 OUTLIER 177.35 94.78 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.334 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -72.88 133.49 44.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.52 61.28 0.02 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.59 106.3 0.28 Allowed Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -59.99 178.44 0.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.193 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.4 p -79.71 -6.0 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.968 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.8 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.92 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 199' ' ' LEU . 17.9 t -61.66 -48.62 87.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.415 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -52.63 -48.61 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.699 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.3 t -61.8 -48.32 81.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.38 -42.08 81.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.64 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 t -62.88 -46.32 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -43.92 92.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -33.31 74.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -46.19 75.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.081 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 18.2 mtp85 -56.17 -45.11 79.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.169 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -67.77 -24.82 65.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.542 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -93.19 -24.41 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.38 -36.4 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.761 0.315 . . . . 0.0 110.898 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 5.4 t0 -98.59 138.49 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 -36.82 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.542 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.09 165.29 16.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -70.42 -8.33 50.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.855 0.36 . . . . 0.0 110.418 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.88 122.27 34.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -82.28 157.58 23.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.33 -41.76 0.23 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.073 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.1 112.92 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.451 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.561 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.2 m -96.27 108.55 21.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.194 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 237' ' ' ARG . 7.9 mt -95.41 69.75 3.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.951 0.405 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -35.57 127.0 0.64 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.104 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.57 39.97 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.16 -49.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.939 0.399 . . . . 0.0 110.204 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.85 -139.51 7.15 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.51 154.02 48.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.54 133.98 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.68 126.74 36.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.641 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -161.78 135.73 6.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.366 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.85 156.42 89.38 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.53 129.81 3.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.393 2.062 . . . . 0.0 111.748 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.443 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -41.52 150.92 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.2 23.08 3.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 0.0 110.542 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.1 t -102.98 176.47 5.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.477 ' C ' ' H ' ' A' ' 126' ' ' HIS . 22.7 t60 58.44 74.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.173 0.511 . . . . 0.0 109.91 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.3 t-80 -77.13 30.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.048 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 49.95 -165.83 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.011 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 47.69 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 110.666 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -169.82 153.86 5.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.716 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 59.58 114.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.979 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.9 p -165.06 137.44 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.27 147.79 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.628 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.83 121.91 5.39 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.44 -12.6 15.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.679 0.276 . . . . 0.0 110.593 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 136' ' ' ARG . 4.5 t 41.76 61.69 7.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.505 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 20.1 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.713 2.275 . . . . 0.0 111.997 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.624 ' NH2' ' SD ' ' A' ' 140' ' ' MET . 0.6 OUTLIER 41.42 91.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.145 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.31 -13.95 0.06 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.2 p -136.64 150.95 48.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 140' ' ' MET . 29.7 m170 50.35 -162.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.624 ' SD ' ' NH2' ' A' ' 136' ' ' ARG . 3.9 mtt 36.91 94.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.774 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -123.47 -78.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.951 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 126.19 100.14 1.17 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.619 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.555 ' H ' HD22 ' A' ' 143' ' ' ASN . 0.4 OUTLIER -87.52 2.09 51.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 110.3 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -76.38 136.17 39.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 48.05 67.43 4.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 148' ' ' ASN . 94.7 Cg_endo -84.0 15.15 2.22 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.149 2.566 . . . . 0.0 113.005 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -41.88 95.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.403 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.491 ' CB ' HH21 ' A' ' 150' ' ' ARG . 14.7 m120 43.88 101.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.637 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.69 134.41 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.581 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.491 HH21 ' CB ' ' A' ' 148' ' ' ASN . 4.7 ptt180 -175.17 154.93 1.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.954 0.407 . . . . 0.0 110.883 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -91.98 147.69 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.1 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -141.96 158.1 44.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.46 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CE2' HD21 ' A' ' 243' ' ' LEU . 74.8 t80 -168.65 142.9 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.05 -105.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -124.83 52.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.73 152.38 24.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.581 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -145.79 144.39 30.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.861 -0.335 . . . . 0.0 110.634 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.65 124.73 21.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.845 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.4 m-20 -104.39 105.24 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 110.775 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.4 -11.6 52.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -95.03 -39.58 10.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.633 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.9 p -103.84 8.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 74.9 m-70 37.52 47.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.21 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -121.82 157.05 31.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.749 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.5 t -119.05 152.04 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.81 125.65 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.782 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -126.18 115.41 19.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.547 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.48 56.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.95 25.5 75.5 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.0 mt-30 -131.07 96.27 22.78 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.27 137.79 15.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.087 1.858 . . . . 0.0 112.469 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.27 137.39 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.798 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.9 t -89.96 89.2 7.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.02 155.64 16.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.82 171.64 10.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -51.5 -52.16 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.302 2.002 . . . . 0.0 111.675 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.0 m -56.3 -52.08 65.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.956 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.92 -41.7 87.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.459 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 27.0 t80 -60.98 -44.58 97.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.101 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -58.0 -44.84 87.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.636 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.63 HD12 HG21 ' A' ' 202' ' ' VAL . 0.7 OUTLIER -61.45 -44.37 97.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.804 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -43.67 93.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -59.07 -45.16 91.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.55 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 14.1 t80 -65.34 -42.02 93.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.82 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -54.6 -39.72 68.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.66 -49.31 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.099 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 187' ' ' ILE . 43.6 mm -57.3 -32.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.745 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.538 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 59.8 m-80 -107.91 18.17 21.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.56 114.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.709 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.07 -19.26 18.04 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 193' ' ' LEU . 94.4 m -95.78 132.45 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.493 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.87 115.47 6.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 191' ' ' THR . 4.6 mp -96.58 159.97 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.023 0.44 . . . . 0.0 110.532 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 147.72 28.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.659 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.58 -54.8 51.28 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.062 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.9 Cg_endo -66.84 -33.64 33.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.96 1.773 . . . . 0.0 111.693 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -64.28 -51.64 62.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.861 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.09 -41.35 50.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.87 -66.9 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -49.91 -28.24 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.101 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 69.9 t60 -72.19 -57.54 4.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.686 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.63 HG21 HD12 ' A' ' 181' ' ' LEU . 57.3 t -83.42 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.895 0.378 . . . . 0.0 111.613 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.7 OUTLIER -49.12 -4.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.4 ttm180 -59.31 -0.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.072 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 t80 -111.67 6.03 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.754 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -176.95 107.66 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.529 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 29.1 m-85 -87.77 110.12 20.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.59 52.26 0.02 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.39 103.37 0.22 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 209' ' ' GLY . 37.2 m-20 -45.16 177.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 0.0 110.785 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.6 m -79.05 -8.26 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.894 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -82.97 -14.82 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 80.9 t -68.75 -36.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.2 t -57.93 -49.81 79.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -58.83 -44.62 90.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.066 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.8 m -60.84 -46.97 88.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.71 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.42 -41.45 98.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.615 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 214' ' ' VAL . 99.1 t -62.52 -43.33 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.01 -45.53 91.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.814 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -28.96 68.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.05 -46.06 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.074 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 226' ' ' ASP . 32.9 ttm180 -56.03 -47.21 78.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.382 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -67.29 -15.56 63.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.504 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -93.45 -34.24 13.5 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.477 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.424 ' O ' ' CE ' ' A' ' 167' ' ' LYS . 2.1 pp -109.89 -36.14 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -98.42 141.79 30.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.337 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 15.2 t -161.4 25.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -117.93 169.03 13.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -65.89 -7.89 19.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.599 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 129.34 39.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.745 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.8 113.77 25.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.71 -4.82 57.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.102 0.477 . . . . 0.0 110.746 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.48 104.92 8.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.385 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.15 122.74 33.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.37 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.25 115.39 28.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 9.1 mt -96.1 69.17 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 31.5 mtp180 -35.84 128.19 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.738 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.68 -12.47 66.06 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.0 t -128.4 -60.26 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.88 -139.29 5.82 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -130.61 154.06 48.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.351 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.599 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 7.2 p -135.5 137.44 49.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.484 HD21 ' CE2' ' A' ' 153' ' ' PHE . 3.0 tp -91.92 116.9 29.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -162.27 144.47 11.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -77.02 153.77 82.73 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -36.75 128.03 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.679 2.253 . . . . 0.0 112.148 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.67 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 123' ' ' SER . . . -104.8 -170.7 24.41 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -46.03 90.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.43 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 121' ' ' GLY . 47.6 p -93.81 27.3 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.71 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -131.05 24.2 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.115 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.11 109.25 16.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.647 ' N ' ' ND1' ' A' ' 126' ' ' HIS . 0.5 OUTLIER 42.66 -152.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -169.56 50.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -148.87 160.22 43.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 43.24 58.46 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.624 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -162.56 176.24 10.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.72 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.6 m 50.14 54.35 11.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.187 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.7 173.41 5.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mp -79.79 152.07 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 110.454 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 134' ' ' VAL . 13.6 p -160.31 56.63 0.83 Allowed Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.121 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.21 17.32 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.736 2.29 . . . . 0.0 111.952 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 134' ' ' VAL . 5.2 mtp85 56.34 164.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.13 -174.16 52.1 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.4 p -138.17 -99.7 0.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.911 0.386 . . . . 0.0 110.414 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.48 107.32 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.105 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.96 69.68 2.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.671 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -44.64 143.01 1.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.338 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -132.05 -160.23 9.64 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -140.83 -59.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.589 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -79.6 47.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.553 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 1.0 OUTLIER -64.23 -42.23 66.42 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 23.9 Cg_exo -61.42 -153.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.706 2.271 . . . . 0.0 112.064 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -151.18 38.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.75 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.17 139.72 22.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.36 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.89 114.35 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -123.43 121.51 35.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.253 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.87 159.5 16.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.36 153.94 47.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.981 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.9 t80 -160.26 125.16 3.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.472 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.62 -98.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 153' ' ' PHE . 13.5 m-20 -125.61 54.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.62 148.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.416 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.729 ' C ' HD12 ' A' ' 158' ' ' LEU . 1.8 mt-10 -138.98 133.23 31.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.556 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 157' ' ' GLU . 10.6 mp -128.6 140.17 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -113.07 102.39 10.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 0.0 110.376 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.0 -13.11 59.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -96.59 -50.08 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.824 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 50.3 p -94.08 11.86 28.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.504 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 96.5 m-70 36.27 53.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -120.87 157.37 29.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.428 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.18 156.48 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.604 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.39 128.2 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.456 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.5 ttpt -126.88 106.44 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.22 71.61 0.08 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.025 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.03 30.42 37.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.8 tt0 -140.95 85.9 12.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -63.42 154.07 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.411 2.074 . . . . 0.0 112.554 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.15 121.47 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.638 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 t -92.38 87.01 5.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.549 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.36 155.37 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.456 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 0.3 OUTLIER -62.37 178.95 0.3 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.736 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 175' ' ' SER . 5.6 Cg_exo -67.6 -48.4 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.441 2.094 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.7 m -46.13 -54.18 9.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.298 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.43 -43.68 84.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.879 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -55.8 -44.84 78.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -59.67 -46.99 87.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.575 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.77 -42.32 99.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.11 -46.12 90.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.743 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -60.55 -41.57 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.034 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.58 -43.78 88.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.72 -42.03 82.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.53 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.36 -53.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.692 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 94.2 mt -55.92 -31.78 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.64 19.89 19.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.47 119.94 5.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.66 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.41 -25.83 10.14 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -94.16 126.38 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.7 p -68.56 120.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.29 157.62 15.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.47 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 148.62 26.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -56.41 -52.31 74.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.634 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.5 Cg_endo -63.83 -41.24 24.72 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.721 1.614 . . . . 0.0 112.155 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -60.91 -48.79 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.272 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.86 -40.47 71.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.917 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 199' ' ' LEU . 1.9 tt -56.68 -61.83 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.979 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -17.03 64.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.439 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.18 -45.6 63.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.581 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -84.53 -53.7 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.793 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.6 ' O ' ' N ' ' A' ' 206' ' ' ASP . 4.8 m-90 -64.01 -3.07 2.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.528 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -40.97 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 203' ' ' TRP . 6.4 m-85 -100.12 27.42 5.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.9 OUTLIER 166.05 103.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.948 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -43.38 149.21 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.499 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.45 178.67 27.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -159.66 64.36 0.29 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.26 94.53 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.869 0.366 . . . . 0.0 110.296 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.49 -10.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.665 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -91.53 -23.11 20.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.34 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.397 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 218' ' ' VAL . 97.3 t -53.79 -48.0 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.181 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.35 -45.54 87.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.49 98.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.666 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -40.68 89.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.24 -41.29 90.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -44.3 88.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.0 -27.43 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.45 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.27 -48.76 32.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.105 0.479 . . . . 0.0 110.188 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 226' ' ' ASP . 14.6 ttp180 -56.6 -51.32 69.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.417 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -67.05 -8.04 27.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -91.64 -37.46 13.05 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -117.54 -34.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.085 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -98.24 151.26 20.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.808 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.9 t -177.46 -30.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.209 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -65.38 174.02 18.66 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -67.08 -5.7 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.821 0.344 . . . . 0.0 110.795 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -92.96 104.77 16.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.477 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.6 107.31 18.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.56 -2.55 57.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.504 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.11 103.62 8.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.336 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.83 122.92 33.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 0.0 110.603 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.1 m -91.26 112.14 23.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.744 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.8 mt -96.29 70.12 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 236' ' ' LEU . 5.9 tpp180 -35.69 116.87 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.797 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.76 -9.97 40.96 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.9 -36.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.48 -137.39 8.89 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -130.8 150.75 51.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.24 141.08 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.849 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.4 tp -91.08 116.57 28.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.135 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -162.2 127.5 3.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.646 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.426 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.5 mp0 -65.91 155.81 85.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.464 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.42 119.23 6.19 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.657 2.238 . . . . 0.0 112.186 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.619 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.93 20.5 2.33 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 123' ' ' SER . 0.2 OUTLIER -122.65 -59.42 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.699 0.285 . . . . 0.0 110.727 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 122' ' ' SER . 0.6 OUTLIER -52.0 -32.15 32.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.769 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -154.27 139.17 17.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 110.389 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -104.09 -167.09 1.32 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.293 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.467 ' CD2' ' H ' ' A' ' 126' ' ' HIS . 2.9 p80 -122.33 122.7 39.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.11 -43.52 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.858 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -7.76 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.243 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 57.46 179.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.572 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 131' ' ' SER . 44.4 m 48.43 -175.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.324 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 130' ' ' SER . 14.7 m 53.0 107.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.4 -141.78 1.91 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 tp -124.61 76.66 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.778 0.323 . . . . 0.0 110.311 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.521 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 29.8 m -131.89 49.44 4.62 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 19.5 Cg_endo -63.69 179.02 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.921 2.414 . . . . 0.0 112.208 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -132.02 98.76 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.95 -44.77 94.05 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.6 t -82.48 147.95 28.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.455 ' O ' ' CB ' ' A' ' 140' ' ' MET . 14.2 t-160 -160.9 74.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.455 ' CB ' ' O ' ' A' ' 139' ' ' HIS . 4.9 ttm 77.98 -63.13 0.34 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.967 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.8 tttm 53.5 -151.77 0.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.392 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -80.95 -93.86 0.46 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -130.88 -57.95 1.03 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.08 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -61.35 144.1 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.892 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -95.03 152.16 39.34 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.376 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -38.66 121.99 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.618 2.212 . . . . 0.0 112.061 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -85.75 102.53 13.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -91.13 110.71 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.515 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.04 137.01 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.433 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 -135.85 128.94 31.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.35 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.19 149.12 21.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 156' ' ' ILE . 1.7 m -141.6 155.83 45.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.067 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.5 t80 -158.15 124.48 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.989 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -94.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 153' ' ' PHE . 4.1 m-20 -124.41 53.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.3 151.57 26.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.37 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -147.76 140.7 24.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.576 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -136.89 138.92 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.424 ' CB ' ' OG1' ' A' ' 162' ' ' THR . 12.8 m-20 -111.36 106.37 15.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.901 0.382 . . . . 0.0 110.489 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -9.95 38.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.064 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.96 -47.37 4.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.015 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.0 p -94.73 8.48 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.768 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 162' ' ' THR . 12.7 m80 36.53 55.35 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.739 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -128.64 154.13 46.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.486 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.57 152.84 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.95 126.71 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.799 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 170' ' ' GLN . 10.0 tmtt? -130.13 115.69 17.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.341 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.04 67.88 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 56.7 29.47 58.19 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 167' ' ' LYS . 11.1 tt0 -132.09 89.4 38.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.98 132.0 12.5 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.08 1.853 . . . . 0.0 112.475 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 135.56 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.741 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.5 p -88.81 96.51 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.7 148.19 22.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.562 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.31 169.85 18.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -47.84 -54.18 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 112.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -49.44 77.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -60.71 -38.76 86.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.1 -46.39 87.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -63.13 -41.19 99.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.479 HD12 HG21 ' A' ' 202' ' ' VAL . 1.1 tp -57.8 -48.87 78.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.1 -44.99 87.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.553 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -55.39 -42.69 74.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -68.53 -43.92 75.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.488 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.77 -41.39 73.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.5 -48.68 79.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.94 -32.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.791 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -106.45 23.12 14.7 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.093 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.51 116.6 3.2 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.31 10.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.9 m -91.76 129.4 37.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.677 0.275 . . . . 0.0 110.291 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 242' ' ' VAL . 68.8 t -67.57 121.28 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.1 162.69 13.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.96 147.96 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.1 mtmt -58.21 -54.75 52.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.252 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.6 Cg_endo -68.85 -30.64 26.49 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.923 1.749 . . . . 0.0 111.819 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -67.41 -50.73 58.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.933 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.9 mt -57.16 -39.22 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 210' ' ' ASP . 5.7 tt -59.47 -67.88 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.342 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -25.55 3.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -50.67 27.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.841 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 204' ' ' ARG . 98.9 t -83.28 -59.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.657 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.534 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -52.73 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.5 tpp180 -53.54 -4.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 203' ' ' TRP . 14.2 m-85 -104.19 7.36 36.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -177.15 125.61 0.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.83 133.54 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.564 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 210' ' ' ASP . . . -176.18 93.32 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.74 60.98 0.49 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 199' ' ' LEU . 1.4 m-20 -108.64 95.86 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.886 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 211' ' ' VAL . 13.2 p -84.15 -9.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.771 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -90.41 -23.94 20.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.771 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 t -66.18 -41.17 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.516 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.87 -50.58 67.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.327 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -56.64 -46.55 80.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.69 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.84 -44.85 96.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.794 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.88 -38.84 89.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.7 t -61.62 -39.96 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.32 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.37 -44.68 78.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.184 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -69.72 -14.15 62.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.4 -46.82 9.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.939 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.1 mtt-85 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -66.08 -14.5 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -93.13 -27.06 17.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.744 0.307 . . . . 0.0 111.144 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.897 ' O ' HD12 ' A' ' 225' ' ' ILE . 0.1 OUTLIER -118.25 -45.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.592 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.3 t70 -93.67 137.1 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.005 0.431 . . . . 0.0 110.642 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.6 t -179.23 36.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.161 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -143.21 165.39 27.03 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.48 -3.17 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 228' ' ' GLY . 24.6 mttt -93.46 133.01 37.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.633 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -92.81 158.9 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.365 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 83.8 mt -147.21 -55.43 0.24 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.308 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.42 126.79 48.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.503 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.494 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.81 125.08 40.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.51 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 112.4 24.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.447 HD12 HG13 ' A' ' 192' ' ' VAL . 68.9 mt -96.22 67.82 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.448 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.67 115.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 -12.34 24.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.03 -55.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.512 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.88 -138.83 5.69 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.64 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.5 152.45 49.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.718 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 192' ' ' VAL . 5.9 p -136.03 131.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.184 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.423 HD22 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -91.88 128.7 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -162.89 138.2 6.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -79.71 156.08 75.44 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.296 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.0 107.47 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.291 179.72 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 34.1 ttm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.01 -5.56 1.61 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 124' ' ' HIS . 2.1 p -168.16 14.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.356 . . . . 0.0 110.48 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t 42.95 -88.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.831 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.552 ' N ' ' O ' ' A' ' 122' ' ' SER . 1.2 t60 69.88 168.73 0.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -92.93 -57.07 2.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -97.33 154.23 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.46 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -134.27 -70.21 0.51 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.501 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.614 ' CG ' ' N ' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -144.12 -149.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.333 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.614 ' N ' ' CG ' ' A' ' 128' ' ' HIS . 13.2 m170 -44.07 -96.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.7 m -158.99 -58.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.629 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.6 m -149.39 -92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.021 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.43 -25.17 24.0 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 134' ' ' VAL . 12.7 tp -112.6 115.14 28.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.835 0.35 . . . . 0.0 110.465 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 133' ' ' LEU . 1.6 m -30.59 97.31 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.547 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.4 -55.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.193 1.929 . . . . 0.0 112.391 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -107.78 90.61 3.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.722 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.77 155.16 38.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.5 m -86.62 59.75 5.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.862 0.363 . . . . 0.0 110.308 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 t60 -84.24 -14.38 50.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.405 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -149.29 172.04 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.997 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 tttm 53.3 77.62 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.009 0.433 . . . . 0.0 110.213 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -135.32 28.87 2.97 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -80.72 -8.58 59.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 0.0 110.649 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -113.11 130.98 56.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.482 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -85.27 159.4 56.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.094 179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 145' ' ' GLU . 80.6 Cg_exo -37.87 162.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.837 2.358 . . . . 0.0 112.222 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.47 5.85 9.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.067 0.461 . . . . 0.0 109.896 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.94 121.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.541 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.11 129.8 36.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.558 HH12 ' CG ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -172.07 -178.32 2.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.532 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.49 154.07 41.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.6 m -139.29 156.7 46.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 156' ' ' ILE . 37.1 t80 -161.59 132.58 5.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 36.98 -102.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -121.38 52.48 1.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.85 141.49 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.213 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.558 ' CG ' HH12 ' A' ' 150' ' ' ARG . 15.8 tt0 -140.05 134.03 30.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 110.401 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.663 HD23 HG22 ' A' ' 165' ' ' VAL . 1.3 mt -130.28 136.61 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 163' ' ' HIS . 83.3 m-20 -113.89 104.81 12.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.248 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.89 -27.76 68.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.789 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.64 -44.21 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.483 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 59.4 p -102.59 9.5 39.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.497 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.483 ' CG ' ' C ' ' A' ' 162' ' ' THR . 12.6 p-80 37.13 55.2 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -126.85 158.92 35.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.794 HG21 HD12 ' A' ' 174' ' ' LEU . 18.4 t -121.75 155.01 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.648 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.41 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.33 125.19 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.342 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.5 tttm -124.81 109.06 12.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.26 57.34 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.121 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.76 29.15 71.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 167' ' ' LYS . 27.6 mt-30 -141.74 89.96 8.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.788 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -64.71 147.19 89.73 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.188 1.925 . . . . 0.0 112.129 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.96 136.45 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 t -88.55 87.72 7.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.955 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.794 HD12 HG21 ' A' ' 165' ' ' VAL . 5.9 mt -94.29 144.67 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.29 162.96 54.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.514 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -42.7 -53.83 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.51 2.14 . . . . 0.0 112.427 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 p -59.93 -50.04 75.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.78 -34.53 77.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.71 -46.32 79.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 18.6 m -58.12 -43.92 87.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 mt -58.19 -48.35 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.56 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.64 89.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.588 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -57.74 -44.79 86.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.558 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -66.23 -43.36 86.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.754 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.62 -46.55 77.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.604 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 56.9 t -63.76 -46.01 95.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.01 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.85 -38.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.061 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -104.3 23.92 12.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.719 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.98 123.58 11.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 108.4 -27.59 13.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.61 129.87 38.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 3.2 p -67.72 123.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.352 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 198' ' ' ILE . 9.3 mp -94.68 157.32 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.1 148.98 29.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.361 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.7 mtpt -56.57 -53.97 58.59 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.872 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 37.1 Cg_endo -71.4 -32.49 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.963 1.775 . . . . 0.0 111.828 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -64.2 -50.49 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 193' ' ' LEU . 54.9 mt -56.91 -42.43 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 29.6 tp -58.46 -63.68 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.21 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -51.34 -28.6 12.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.084 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -72.4 -52.01 17.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.303 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.0 t -82.94 -62.11 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.211 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -4.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 3.5 ttt180 -63.19 -3.89 2.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.892 0.377 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.82 6.79 11.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.448 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -174.89 101.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.646 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -84.07 120.2 25.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.54 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 160.14 48.0 0.01 OUTLIER Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.29 106.87 0.3 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 209' ' ' GLY . 1.5 m-20 -49.22 -173.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.971 0.415 . . . . 0.0 110.55 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.0 m -83.5 -8.4 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -85.24 -15.83 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.888 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.55 -33.34 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.43 -50.31 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.216 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -55.11 -49.24 72.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.438 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -63.78 -39.97 95.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.703 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.465 HG21 ' CE1' ' A' ' 241' ' ' TYR . 18.2 t -62.46 -42.58 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' NH1' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -62.79 -43.65 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.39 -37.66 85.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.255 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.22 -46.78 85.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.069 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -56.42 -42.66 78.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -67.97 -10.12 50.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -39.14 11.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.69 -30.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.208 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 222' ' ' ARG . 19.9 t0 -91.57 -160.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER 72.14 6.11 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.551 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.73 -139.59 5.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -36.91 11.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.47 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -92.5 120.45 32.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.018 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 19.4 mtp85 -90.5 92.75 9.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.971 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.9 OUTLIER -90.73 -0.91 57.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.82 110.18 12.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.515 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.48 42.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.639 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 74.9 m -97.63 113.45 25.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 237' ' ' ARG . 4.9 mt -98.95 67.76 1.67 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.646 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.6 mtm180 -37.49 125.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.838 0.351 . . . . 0.0 110.79 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 107.72 -32.86 6.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.55 -56.77 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.457 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 161.24 -137.46 4.94 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.465 ' CE1' HG21 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -128.39 157.07 42.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.37 142.4 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 111.074 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.86 118.02 30.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.053 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -161.76 129.78 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 111.023 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -69.3 155.01 94.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -38.48 156.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.783 2.322 . . . . 0.0 112.435 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.612 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.3 ptm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.1 106.93 2.87 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.016 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.28 140.16 48.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 110.411 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.466 ' C ' ' CG ' ' A' ' 124' ' ' HIS . 1.6 m -159.55 36.43 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.659 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' A' ' 123' ' ' SER . 0.8 OUTLIER 66.86 33.26 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.475 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 16.2 t-80 -52.94 174.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.475 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER 55.51 154.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.495 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -69.75 154.6 41.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.566 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -164.03 30.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -94.61 118.37 31.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.6 107.73 3.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 t -97.51 87.89 4.23 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.749 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -152.73 68.47 0.31 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.82 -23.43 13.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.601 0.239 . . . . 0.0 110.91 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 134' ' ' VAL . 12.8 p -161.74 69.87 2.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 110.435 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.23 163.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.986 2.458 . . . . 0.0 112.595 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.57 -173.18 2.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.527 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.08 84.49 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.95 -36.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.59 0.233 . . . . 0.0 110.434 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.18 136.3 34.02 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 59.1 mtt -45.99 154.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.347 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.76 8.71 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -39.48 129.57 2.33 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -146.53 63.64 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.313 . . . . 0.0 110.344 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -94.96 167.51 11.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.567 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 48.25 58.0 17.81 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.563 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.47 119.08 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.857 2.371 . . . . 0.0 112.205 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -90.38 -108.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 148' ' ' ASN . 0.3 OUTLIER 48.76 79.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 149' ' ' VAL . 0.3 OUTLIER -84.19 141.4 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.558 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -138.59 130.05 27.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.64 140.61 29.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.587 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 m -142.09 152.37 43.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.597 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' A' ' 154' ' ' ALA . 1.1 t80 -166.25 139.11 3.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.052 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.03 -104.64 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.37 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.13 147.17 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.991 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -144.62 141.67 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.712 0.292 . . . . 0.0 110.428 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -135.52 136.74 41.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.388 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -112.02 108.49 17.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.288 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -66.27 -9.95 37.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.661 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -100.2 -43.75 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.916 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.441 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 25.6 p -95.74 9.04 41.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 162' ' ' THR . 10.9 m170 35.65 41.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.621 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -122.44 159.02 28.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.773 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.944 HG21 HD12 ' A' ' 174' ' ' LEU . 25.1 t -118.94 158.2 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.465 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -146.44 123.42 11.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.51 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.9 tmtm? -127.47 115.03 18.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.255 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.16 67.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.43 31.46 63.05 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -133.55 90.87 27.62 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.53 138.72 15.64 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.203 1.935 . . . . 0.0 112.36 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.18 138.74 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 m -85.63 93.09 8.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.944 HD12 HG21 ' A' ' 165' ' ' VAL . 89.3 mt -95.91 140.86 30.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.454 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.13 174.03 6.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.95 -53.49 7.07 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.382 2.055 . . . . 0.0 112.097 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.0 m -54.96 -56.65 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.773 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.506 ' CD ' HD11 ' A' ' 221' ' ' LEU . 2.5 mt-10 -60.98 -37.24 81.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.49 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.74 -46.36 88.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.63 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -58.65 -41.0 85.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.025 0.441 . . . . 0.0 110.257 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.795 HD12 HG21 ' A' ' 202' ' ' VAL . 1.0 OUTLIER -61.39 -52.53 64.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.658 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.8 -41.86 87.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.503 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -62.41 -44.53 96.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.417 ' OH ' ' CE1' ' A' ' 201' ' ' HIS . 1.3 t80 -59.25 -39.73 83.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.77 -41.15 99.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.185 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.65 -43.24 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.962 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.8 -42.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.12 26.91 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . . . -56.13 125.21 20.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.82 0.343 . . . . 0.0 110.709 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.09 -23.5 30.5 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.66 126.8 41.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.821 0.343 . . . . 0.0 110.294 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 192' ' ' VAL . 13.6 p -68.25 116.66 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.728 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 mp -96.56 153.12 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.463 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.15 149.23 24.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.313 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.69 -46.69 99.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.506 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 37.2 Cg_exo -55.11 -47.14 28.02 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.867 1.712 . . . . 0.0 111.897 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -61.91 -57.32 12.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.5 mt -50.63 -36.24 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.19 -58.33 5.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.146 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.43 -27.53 68.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.814 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' CE1' ' OH ' ' A' ' 184' ' ' TYR . 0.2 OUTLIER -73.2 -59.83 2.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.623 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.795 HG21 HD12 ' A' ' 181' ' ' LEU . 13.9 t -84.54 -58.22 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.704 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' A' ' 206' ' ' ASP . 1.1 t-105 -51.76 -4.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.055 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.8 ttt-85 -64.24 0.33 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.591 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.2 m-85 -106.86 5.77 28.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.608 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -174.41 102.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.771 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.9 107.51 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.555 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.91 48.85 0.02 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -158.94 101.94 0.21 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.7 OUTLIER -48.78 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.936 0.398 . . . . 0.0 110.151 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.8 m -80.82 -1.0 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.7 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -95.14 -23.72 17.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.15 -38.47 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.238 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -60.81 -44.6 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -55.85 -48.9 74.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.393 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -60.94 -44.18 97.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -40.44 97.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' VAL . 53.5 t -62.54 -41.56 92.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.485 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -44.87 94.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.962 0.41 . . . . 0.0 110.211 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -65.15 -37.85 88.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.401 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' A' ' 178' ' ' GLU . 1.8 mp -65.56 -44.74 85.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.379 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 226' ' ' ASP . 21.7 mtp180 -55.28 -42.63 73.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 0.0 110.239 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -16.13 64.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -93.07 -26.63 17.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.509 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -117.87 -38.47 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.769 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.5 OUTLIER -98.3 136.67 38.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.503 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -173.27 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.872 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.25 179.87 0.73 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -79.39 -12.62 59.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.7 0.286 . . . . 0.0 110.716 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -93.66 122.19 35.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.563 ' C ' HD12 ' A' ' 232' ' ' LEU . 18.1 mmm-85 -82.67 158.35 23.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -146.78 -42.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.008 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.63 112.05 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.16 122.79 40.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.48 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 29.6 m -92.6 107.09 18.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.4 mt -93.21 71.8 4.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 0.0 110.09 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 57.5 mtp180 -36.78 133.17 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.644 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.23 74.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.12 -58.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.952 0.406 . . . . 0.0 110.078 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 156.07 -139.61 6.69 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -129.17 154.6 46.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.551 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 242' ' ' VAL . 15.0 p -136.67 132.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.197 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.91 126.28 35.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.292 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -162.22 130.43 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.44 157.0 87.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -37.23 113.87 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.738 2.292 . . . . 0.0 112.33 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.317 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.6 mmm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.52 -25.49 2.39 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.9 t -89.8 -86.62 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.919 0.39 . . . . 0.0 110.809 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.5 p 47.6 -165.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.055 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -81.6 90.06 6.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 109.999 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -54.9 -56.49 18.97 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.465 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' A' ' 127' ' ' HIS . 58.3 t60 -134.27 -128.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.765 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 126' ' ' HIS . 13.6 m-70 -121.52 117.12 26.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.695 0.283 . . . . 0.0 110.248 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' ND1' ' O ' ' A' ' 127' ' ' HIS . 12.1 m-70 -145.74 -72.48 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.191 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 130' ' ' SER . 12.4 m-70 -96.23 -45.54 6.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.528 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.1 OUTLIER 55.22 109.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.9 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 t -61.23 -28.16 68.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 110.076 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.51 148.86 17.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 133' ' ' LEU . 1.4 tt -115.1 -62.97 1.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 134' ' ' VAL . 9.4 p -154.38 59.66 2.54 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.546 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.84 177.14 8.5 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.271 2.647 . . . . 0.0 112.322 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -116.59 172.81 6.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.88 55.82 1.12 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -56.55 -95.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 141' ' ' LYS . 9.7 t-80 -82.53 -23.27 34.65 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.267 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.481 ' C ' ' SD ' ' A' ' 140' ' ' MET . 0.0 OUTLIER -60.13 78.15 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -75.93 -19.19 58.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.531 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 63.68 10.93 40.17 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -165.72 151.04 8.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -115.75 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.86 152.85 54.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.05 176.73 5.05 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.764 2.309 . . . . 0.0 112.593 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.6 OUTLIER -146.37 111.18 5.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' A' ' 148' ' ' ASN . 0.9 OUTLIER 56.68 101.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.573 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.5 109.94 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.5 mtm-85 -106.33 -177.17 3.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.59 HD22 HG11 ' A' ' 186' ' ' VAL . 3.0 mt -145.94 133.3 20.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.205 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 m -139.23 156.86 46.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 8.8 t80 -164.92 130.85 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.89 -99.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 74.4 m-20 -124.45 53.14 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.43 144.39 30.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.349 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -140.29 131.0 25.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.946 0.403 . . . . 0.0 110.557 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.506 HD23 HG22 ' A' ' 165' ' ' VAL . 1.4 mp -127.49 152.2 47.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.34 107.63 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 110.35 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.3 -12.23 55.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -96.11 -49.71 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.747 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.3 p -92.57 11.18 27.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.479 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' THR . 15.0 m80 35.27 48.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.78 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -117.58 159.92 22.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 158' ' ' LEU . 14.5 t -125.43 150.09 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.428 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.3 127.09 14.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.512 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 170' ' ' GLN . 4.8 tmtm? -129.45 114.13 15.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.88 71.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.55 24.82 32.93 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.9 tt0 -129.02 94.73 33.26 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.488 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.94 137.28 12.34 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.136 1.891 . . . . 0.0 112.158 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.63 135.83 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.068 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 m -92.63 88.96 6.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 54.6 mt -95.5 153.94 17.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.583 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.67 171.48 10.52 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.455 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.8 -54.07 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.492 2.128 . . . . 0.0 112.319 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.3 m -54.76 -54.25 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.75 -38.01 83.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 110.756 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 22.5 t80 -63.57 -43.21 97.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.6 m -62.42 -43.46 98.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -59.35 -43.91 92.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 182' ' ' LEU . 38.4 tp -71.36 -38.47 71.59 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.659 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.474 ' HE ' HD11 ' A' ' 187' ' ' ILE . 8.7 ttp180 -58.19 -41.24 83.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.691 ' CZ ' ' NE2' ' A' ' 201' ' ' HIS . 15.4 t80 -69.83 -39.85 76.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.804 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.61 -41.95 82.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.59 HG11 HD22 ' A' ' 151' ' ' LEU . 56.4 t -67.9 -48.16 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.474 HD11 ' HE ' ' A' ' 183' ' ' ARG . 88.3 mt -58.64 -31.41 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.08 21.25 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.0 118.35 3.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 106.81 -19.62 35.38 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 m -98.27 126.97 43.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.358 . . . . 0.0 110.724 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 192' ' ' VAL . 3.5 p -68.53 122.08 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.962 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 198' ' ' ILE . 5.2 mp -96.59 159.82 14.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 147.85 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.796 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.4 mtmm -56.84 -56.69 30.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.972 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -63.64 -32.67 68.84 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.013 1.808 . . . . 0.0 111.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -68.61 -51.72 39.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.951 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 193' ' ' LEU . 18.2 mt -53.0 -36.94 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 109.893 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.423 ' C ' HD23 ' A' ' 199' ' ' LEU . 0.9 OUTLIER -61.21 -70.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.422 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -52.18 -17.33 1.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.155 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.691 ' NE2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.57 -53.38 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.099 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.2 t -83.26 -40.42 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.1 m-90 -60.67 -3.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.7 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 202' ' ' VAL . 25.9 ttt180 -61.41 -0.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.328 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.6 m-85 -118.24 -0.28 11.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.085 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -171.47 85.65 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.303 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -42.79 160.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.393 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -178.89 -158.1 20.7 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 210' ' ' ASP . . . -160.97 78.27 0.17 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 209' ' ' GLY . 15.3 m-20 -147.56 95.07 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 0.0 110.655 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.2 m -83.4 -8.68 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -23.03 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 210' ' ' ASP . 2.4 p -63.56 -35.5 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 218' ' ' VAL . 98.8 t -57.16 -52.46 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.494 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.64 -45.5 91.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.753 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -44.84 96.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.912 0.387 . . . . 0.0 110.735 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -61.52 -44.96 96.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.672 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 214' ' ' VAL . 87.4 t -62.24 -37.93 79.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.523 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -46.26 76.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.748 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.2 -17.41 63.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.389 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.73 -49.19 11.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.069 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -55.75 -47.7 76.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.169 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -67.3 -13.04 61.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.553 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -95.05 -32.73 12.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.471 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.64 -34.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.222 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -100.08 140.04 34.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.9 0.381 . . . . 0.0 110.69 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.23 -37.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -55.68 174.3 1.09 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -73.93 -9.4 58.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.799 0.333 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.24 104.64 16.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.655 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 ttp-105 -83.69 112.59 20.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.486 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.83 1.05 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.09 107.11 12.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.25 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.548 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -92.63 123.37 35.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.618 HG23 ' CE2' ' A' ' 241' ' ' TYR . 67.9 m -90.96 111.2 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 237' ' ' ARG . 47.0 mt -95.85 68.27 2.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.467 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 236' ' ' LEU . 11.4 tpp180 -38.52 124.26 1.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 105.25 -14.09 47.93 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.79 -56.79 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.632 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 160.19 -137.3 4.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG23 ' A' ' 235' ' ' THR . 29.4 m-85 -128.37 156.96 42.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.469 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 234' ' ' HIS . 5.2 p -140.55 133.55 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 2.6 tp -90.84 128.63 36.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -163.35 135.25 5.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.629 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 246' ' ' PRO . 7.4 mt-10 -76.09 155.86 84.28 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 245' ' ' GLU . 69.3 Cg_exo -39.89 169.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.675 2.25 . . . . 0.0 112.2 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.577 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' GLY . 17.5 mtp . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 122' ' ' SER . . . -35.3 -88.25 0.01 OUTLIER Glycine 0 C--N 1.333 0.365 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -34.98 111.32 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -148.56 124.14 10.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -151.39 120.29 6.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.862 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 126' ' ' HIS . 8.0 m-70 -161.74 -45.22 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.465 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 125' ' ' HIS . 93.8 m-70 36.82 -109.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.553 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -119.71 -78.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.35 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 50.49 66.18 1.23 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.148 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.42 165.88 30.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 m 58.11 58.72 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.79 120.38 29.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.814 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.5 54.23 0.49 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -62.63 1.31 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.683 0.277 . . . . 0.0 110.665 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.1 t -139.77 68.87 37.03 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.792 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.5 -10.87 17.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.742 2.295 . . . . 0.0 112.025 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -133.43 86.67 2.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.541 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.14 -109.64 3.37 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' MET . 47.4 m -155.02 -58.38 0.1 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.819 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -47.57 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.2 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -74.45 103.28 4.75 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.334 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 68.46 175.32 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.832 0.349 . . . . 0.0 110.923 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.56 -171.3 37.67 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m120 42.6 74.34 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.432 . . . . 0.0 110.53 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 145' ' ' GLU . 1.7 pttt -91.83 16.41 10.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.927 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 144' ' ' LYS . 2.4 pt-20 33.77 76.52 0.4 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.53 -97.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.866 2.377 . . . . 0.0 112.129 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -165.61 18.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -95.32 113.93 25.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 110.147 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.93 117.21 44.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.2 mtm105 -142.46 129.44 20.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.66 158.16 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.19 155.94 45.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.619 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 243' ' ' LEU . 28.0 t80 -165.47 129.81 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.912 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.5 -99.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.1 m-20 -124.67 54.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.43 152.16 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.604 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -141.78 145.65 35.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.408 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 mt -143.67 116.95 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.003 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.63 108.22 18.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.57 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -66.71 -24.95 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.828 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -50.59 -40.35 52.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 69.7 p -119.53 -23.9 6.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.5 t-80 84.02 53.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.384 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -127.39 156.82 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.654 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 t -117.0 153.76 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.44 126.95 15.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 170' ' ' GLN . 16.0 ttpp -126.04 113.07 16.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.243 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.13 67.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.016 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.46 32.81 64.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -137.56 92.14 13.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.89 139.96 20.04 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.095 1.864 . . . . 0.0 112.326 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.82 140.8 46.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.911 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -96.29 90.19 5.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.386 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.68 150.18 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.672 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 169.43 17.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.267 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.77 -54.53 4.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.533 2.155 . . . . 0.0 112.398 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.327 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -57.07 -37.2 71.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -59.3 -46.08 89.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.42 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 37.4 m -63.82 -41.1 97.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.284 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -46.7 84.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -45.33 86.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.712 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -60.24 -42.98 96.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.658 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 11.6 t80 -65.25 -40.35 93.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -43.01 89.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.684 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 38.7 t -66.31 -45.35 89.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.8 -34.65 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.753 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -106.64 22.33 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.682 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.95 110.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.793 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.9 -27.52 7.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.3 132.39 33.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 110.755 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.27 113.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.298 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.109 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.85 148.02 30.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.64 -51.34 82.42 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.544 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 24.4 Cg_endo -64.13 -37.84 39.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.601 1.534 . . . . 0.0 111.682 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -65.76 -44.84 84.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.052 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.85 -41.99 68.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 203' ' ' TRP . 5.0 mt -61.93 -65.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.71 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -41.4 -34.72 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.658 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 53.7 t-80 -71.76 -53.78 12.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.737 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.9 t -83.54 -57.45 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.157 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -53.16 -2.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.217 -179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -60.76 -3.1 0.65 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.716 0.293 . . . . 0.0 110.567 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 203' ' ' TRP . 39.0 t80 -117.41 10.0 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.64 97.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.16 132.89 41.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.274 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 149.47 55.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.12 103.04 0.22 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.605 ' O ' HG12 ' A' ' 213' ' ' VAL . 89.6 m-20 -52.81 -176.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.355 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.7 m -81.75 -6.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.562 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.22 -18.98 23.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.789 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 210' ' ' ASP . 7.0 p -65.93 -33.5 64.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 218' ' ' VAL . 58.7 t -65.28 -51.14 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.072 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.71 -46.01 70.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.982 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -48.55 81.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.47 -39.21 93.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.497 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 214' ' ' VAL . 45.6 t -62.5 -42.23 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.256 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.824 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -25.48 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.24 -42.48 45.68 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 226' ' ' ASP . 44.5 ttt180 -55.79 -50.4 70.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.5 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.47 -7.43 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.115 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -42.05 10.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 111.115 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.47 -25.16 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.398 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.555 ' C ' HG22 ' A' ' 227' ' ' THR . 0.2 OUTLIER -101.99 146.35 28.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.935 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 226' ' ' ASP . 0.1 OUTLIER -176.7 -34.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.62 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -49.23 162.86 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.0 -8.12 34.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.768 0.318 . . . . 0.0 110.468 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.01 126.6 38.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.56 ' C ' HD12 ' A' ' 232' ' ' LEU . 10.9 mtp180 -81.12 159.62 24.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.3 mp -147.08 -41.17 0.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.969 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.9 114.67 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.476 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -97.9 124.32 42.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.534 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.56 114.61 27.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.951 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 238' ' ' GLY . 11.2 mt -95.88 68.72 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.161 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -41.87 96.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.162 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 236' ' ' LEU . . . 129.68 -13.28 5.87 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.55 -50.32 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.659 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.76 -137.71 5.46 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 151.65 50.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.2 p -140.04 127.65 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 16.4 tp -90.49 138.03 31.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.08 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.23 139.89 7.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.77 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -69.99 157.57 89.44 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.463 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.99 109.61 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.486 2.124 . . . . 0.0 112.091 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.631 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.445 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 5.3 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.8 35.86 4.05 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.2 128.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.92 27.99 4.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.59 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER -53.0 -78.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.034 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -60.74 -174.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.047 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 -166.45 1.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.048 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -150.22 115.82 5.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.915 0.388 . . . . 0.0 110.063 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -97.92 142.58 29.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.937 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.83 118.66 2.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.933 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.27 -36.68 22.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.6 p -54.17 120.91 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.465 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.72 79.11 0.03 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 mt -104.19 141.07 36.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.411 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 3.0 m -145.42 56.52 3.59 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.309 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 39.6 Cg_endo -68.84 50.07 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.827 2.351 . . . . 0.0 111.886 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.8 54.29 0.88 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.303 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -50.76 -62.25 5.41 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.5 m -167.92 -53.85 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.279 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -150.16 99.74 2.84 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.378 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.5 ttt -130.13 -57.76 1.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.808 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -86.65 -54.25 4.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.275 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -45.64 103.56 0.06 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -168.72 -65.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.116 0.484 . . . . 0.0 110.224 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 51.0 mttm -40.66 124.5 2.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.357 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.648 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 2.2 tt0 -81.18 -39.66 1.03 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.971 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 23.6 Cg_exo -61.09 156.94 41.89 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.547 2.165 . . . . 0.0 111.815 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -113.97 -29.48 7.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.754 0.311 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.59 123.05 28.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.777 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.96 114.35 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.461 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.5 mtt180 -122.26 121.04 35.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mt -90.54 147.78 23.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.2 154.32 46.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.095 0.474 . . . . 0.0 111.094 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 155' ' ' ASP . 62.4 t80 -159.29 126.98 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.599 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.29 -96.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 1.2 p30 -124.34 53.43 1.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.56 145.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -144.21 138.68 28.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.787 0.327 . . . . 0.0 110.424 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mp -136.43 139.45 42.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -112.07 102.91 11.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.096 0.474 . . . . 0.0 110.588 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.12 -8.94 26.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -99.0 -45.28 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.729 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 163' ' ' HIS . 17.7 p -98.88 13.04 33.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.338 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 1.0 OUTLIER 35.12 54.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.635 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.26 152.49 48.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.25 157.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.477 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.35 125.85 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.479 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 170' ' ' GLN . 19.2 tptt -122.9 110.53 15.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.397 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.58 59.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.483 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 23.65 77.72 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 24.5 mt-30 -131.86 95.99 21.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.402 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.49 134.92 14.3 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.082 1.855 . . . . 0.0 112.439 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.5 143.79 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.772 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.43 95.39 9.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.631 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 182' ' ' LEU . 10.9 mp -94.71 154.17 17.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.48 172.46 7.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.262 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.37 -51.27 11.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.459 2.106 . . . . 0.0 112.149 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.2 m -58.1 -54.61 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.402 ' HG2' HD11 ' A' ' 221' ' ' LEU . 24.8 mt-10 -55.77 -43.96 77.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.483 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -58.92 -48.56 81.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.526 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 m -56.77 -46.32 81.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.586 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.46 -47.05 87.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.69 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 174' ' ' LEU . 0.9 OUTLIER -63.51 -41.53 98.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.958 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -59.57 -45.2 92.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.388 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 0.6 OUTLIER -61.62 -43.98 97.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.615 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -55.51 -47.86 75.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.8 t -65.96 -47.06 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.019 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.5 mm -54.9 -34.32 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.786 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -112.53 20.4 16.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.0 119.59 4.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.738 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.28 -26.28 10.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.6 m -97.82 129.59 44.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.803 0.335 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.672 HG22 ' HB ' ' A' ' 242' ' ' VAL . 43.7 t -67.89 117.01 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.651 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.1 mp -97.64 160.03 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.667 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.97 148.84 26.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.63 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.503 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.4 OUTLIER -58.06 -49.48 93.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 35.9 Cg_exo -54.08 -44.17 51.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.373 2.048 . . . . 0.0 111.778 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -59.93 3.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.233 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.4 mt -48.25 -42.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.49 -62.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.502 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 200' ' ' ASP . 17.0 t0 -53.7 -24.03 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.594 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 51.7 t-80 -71.84 -50.36 30.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.715 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 204' ' ' ARG . 39.1 t -84.75 -62.17 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.489 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -49.35 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.337 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.7 ttp85 -60.9 -0.57 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.437 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 203' ' ' TRP . 12.2 m-85 -117.47 10.91 13.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.294 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.78 105.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 7.0 p90 -86.94 114.62 23.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.536 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.69 47.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.27 103.22 0.22 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 209' ' ' GLY . 16.2 m-20 -48.98 -174.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.916 0.389 . . . . 0.0 110.811 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.66 -6.43 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.081 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -82.64 -18.21 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.392 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.99 -37.45 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.063 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.06 -49.21 84.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.868 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -54.35 -47.52 72.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.55 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 47.1 p -60.96 -47.52 86.05 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.569 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -38.56 91.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.0 -47.57 92.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.415 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -44.66 92.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.303 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.25 -23.3 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 178' ' ' GLU . 1.2 mp -76.73 -44.99 31.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.015 0.436 . . . . 0.0 110.151 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 226' ' ' ASP . 33.7 ttt-85 -55.44 -49.65 71.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.957 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -68.25 -7.52 31.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -94.38 -32.61 13.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.541 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.9 -7.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.124 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -116.09 138.25 51.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.006 0.431 . . . . 0.0 110.857 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.8 t -170.52 39.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -141.5 163.45 26.82 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.4 -5.61 11.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.733 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.98 104.48 16.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -86.81 101.26 13.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -89.44 1.87 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.588 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.92 96.46 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.204 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.57 125.83 34.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.718 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 44.3 m -95.83 112.32 24.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.65 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 11.6 mt -95.57 73.45 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.366 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 43.3 ttm-85 -35.92 128.03 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.55 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.46 61.21 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.2 -58.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 110.828 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.14 -138.1 5.6 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.485 ' OH ' ' NZ ' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -127.11 156.28 41.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.78 0.324 . . . . 0.0 110.711 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.672 ' HB ' HG22 ' A' ' 192' ' ' VAL . 2.3 p -139.7 136.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.22 112.41 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.355 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -162.2 131.49 4.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.13 152.52 82.08 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.33 112.61 3.38 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.397 2.065 . . . . 0.0 111.993 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.521 179.857 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.8 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 121.0 142.26 6.4 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER 54.95 39.16 31.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.45 149.13 49.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.634 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -157.98 130.57 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.252 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.13 136.96 32.73 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -88.61 149.16 23.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.092 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.54 -67.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.054 0.454 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.86 -15.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.339 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.488 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 1.4 m170 -88.2 133.07 34.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.103 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 143.19 50.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.526 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.0 p 41.35 51.64 3.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.03 -158.01 34.13 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.7 mp 58.66 98.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 0.0 110.735 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 134' ' ' VAL . 71.3 t -132.16 78.44 68.85 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.068 0.461 . . . . 0.0 110.798 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.24 3.27 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.151 2.567 . . . . 0.0 111.874 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -95.95 64.14 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -172.93 -178.51 43.0 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -131.38 -177.14 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 110.596 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -112.89 -24.48 9.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.845 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.94 -78.18 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.336 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 142' ' ' GLY . 9.9 tttm 55.18 -168.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.809 0.338 . . . . 0.0 111.042 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.405 ' H ' ' HG2' ' A' ' 141' ' ' LYS . . . -166.53 -147.32 5.17 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -119.83 154.38 34.37 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 122.706 -0.29 . . . . 0.0 110.477 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -147.8 -17.72 0.36 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.732 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.46 65.88 27.75 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -41.99 136.74 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.833 2.355 . . . . 0.0 112.243 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -102.12 78.27 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.967 0.413 . . . . 0.0 111.374 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.13 133.92 33.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.69 110.71 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -126.53 121.06 31.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.37 148.78 22.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -143.71 156.68 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.951 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' ASP . 52.8 t80 -163.85 130.27 3.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.56 -97.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 153' ' ' PHE . 5.1 m-20 -124.85 53.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.12 146.26 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -143.37 137.38 28.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.494 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 165' ' ' VAL . 22.1 mt -132.53 134.59 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 162' ' ' THR . 1.1 m-20 -107.66 104.39 13.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.141 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.92 -11.6 48.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.722 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.47 -38.92 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 159' ' ' ASP . 2.7 p -99.81 6.59 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.227 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.446 ' ND1' ' C ' ' A' ' 162' ' ' THR . 52.0 p-80 36.77 51.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -122.06 158.28 29.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 174' ' ' LEU . 32.5 t -128.4 147.69 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.39 127.51 15.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.5 tmtt? -130.78 112.46 13.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.268 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.47 68.98 0.11 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.055 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.22 27.15 57.34 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 167' ' ' LYS . 7.1 tt0 -130.64 90.83 39.35 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.25 142.58 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.92 1.747 . . . . 0.0 112.113 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.81 132.27 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.259 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.427 ' C ' HD23 ' A' ' 174' ' ' LEU . 28.0 t -95.33 119.91 34.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -142.61 135.06 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.711 -179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.21 175.2 0.42 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.824 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.46 -41.83 73.39 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.481 2.12 . . . . 0.0 112.601 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.37 -65.83 0.49 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 111.104 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 221' ' ' LEU . 8.6 mt-10 -60.09 -33.34 71.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.29 -50.39 73.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -41.33 85.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 202' ' ' VAL . 1.9 tp -58.81 -48.62 80.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.579 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -40.61 96.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -59.12 -45.13 91.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.498 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.585 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 26.5 t80 -65.65 -40.83 92.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.69 -40.99 69.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.3 t -72.87 -42.99 60.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.43 -27.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -111.72 18.33 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.02 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.88 119.0 3.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.792 0.33 . . . . 0.0 110.541 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.6 -26.6 10.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.9 m -94.72 130.15 41.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 110.545 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 242' ' ' VAL . 48.6 t -68.43 114.77 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 184' ' ' TYR . 2.6 mp -95.12 153.63 17.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.89 148.42 26.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 16.2 mtpt -56.12 -54.92 47.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.991 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.0 Cg_endo -64.81 -32.15 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.782 1.655 . . . . 0.0 111.922 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -66.87 -48.81 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.288 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.5 mt -55.7 -39.82 57.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.771 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.38 -66.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.645 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -49.26 -29.34 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.585 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.7 t60 -72.01 -48.48 44.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.078 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 204' ' ' ARG . 42.4 t -84.04 -59.86 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.554 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.718 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -49.55 -4.33 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.604 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 202' ' ' VAL . 10.7 ttp180 -61.92 -2.55 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.637 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 203' ' ' TRP . 58.5 m-85 -118.19 11.95 13.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER 172.33 104.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.417 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -83.73 108.13 16.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.434 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.564 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 174.09 55.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.718 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -159.0 102.52 0.21 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -50.46 -173.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.945 0.402 . . . . 0.0 110.56 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -87.9 -9.74 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.072 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -91.04 -22.75 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.3 p -65.68 -40.04 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.305 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.458 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 12.7 t -60.4 -46.19 95.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.131 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.91 -48.04 79.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -45.18 95.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.62 -40.88 98.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.755 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 34.6 t -62.42 -39.73 85.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -45.38 81.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.253 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -68.49 -17.17 64.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.489 HD11 ' HG2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -82.77 -47.98 11.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.676 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.9 OUTLIER -55.99 -38.55 70.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.471 179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -66.1 -29.15 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.504 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -28.56 15.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.659 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -112.17 -38.79 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.136 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 222' ' ' ARG . 9.2 t0 -100.27 -151.93 0.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 226' ' ' ASP . 68.6 p 54.07 10.05 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.499 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 226' ' ' ASP . . . -85.09 -136.07 3.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -97.18 -44.74 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.796 0.332 . . . . 0.0 110.269 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.537 ' HB3' HD21 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -96.14 107.26 19.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.581 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.481 ' H ' ' CD ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -82.87 91.15 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.72 ' O ' HD23 ' A' ' 243' ' ' LEU . 0.8 OUTLIER -91.9 -5.6 52.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.294 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.68 122.47 47.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.27 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.78 130.24 56.48 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.644 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.0 m -95.65 115.95 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.008 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.2 mt -95.92 77.16 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.509 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.29 119.97 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.763 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.78 -2.88 57.21 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.35 -58.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 157.77 -136.03 4.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 40.4 m-85 -127.59 153.96 45.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.749 0.309 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 192' ' ' VAL . 12.8 p -140.8 133.1 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.49 121.38 33.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.928 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -161.46 133.81 5.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.174 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.34 153.3 85.99 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.22 124.66 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.406 2.071 . . . . 0.0 112.276 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 24.4 ptt-85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.65 179.732 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.3 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.2 58.84 0.5 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.4 m -76.29 -109.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -98.54 -170.88 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.545 ' N ' ' OG ' ' A' ' 123' ' ' SER . 8.3 m80 -157.62 157.18 33.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -67.28 85.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.661 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -146.59 91.76 2.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.553 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -140.71 151.44 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.436 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -95.66 -59.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.83 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -71.89 127.06 31.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.57 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 p -171.46 91.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.768 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.86 39.86 1.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.47 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.22 -52.57 1.34 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.99 150.03 49.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 110.707 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.78 63.02 45.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.138 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -39.15 122.04 0.73 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.965 2.444 . . . . 0.0 112.791 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -103.57 -36.5 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.18 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.56 -145.28 2.79 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.1 m -83.61 175.56 9.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.987 0.423 . . . . 0.0 110.908 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 139' ' ' HIS . 6.7 p80 -132.73 111.95 11.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.192 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 39.3 ttp -124.37 102.49 7.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.659 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -116.93 90.94 3.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.896 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.14 170.67 39.78 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -103.6 39.5 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -118.92 121.14 39.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -157.35 73.52 4.37 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -52.27 114.99 1.9 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.659 2.24 . . . . 0.0 112.01 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -70.5 -92.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -63.12 145.18 56.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.421 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.88 109.92 23.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.795 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -125.68 121.17 32.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.182 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.64 150.77 21.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 m -141.15 158.34 44.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.404 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 1.4 t80 -165.46 131.51 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.999 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.519 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 38.23 -99.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 153' ' ' PHE . 19.3 m-20 -124.96 53.36 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.94 150.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.278 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -142.41 140.88 32.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.74 131.59 33.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.437 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -113.65 108.17 16.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.5 -9.65 36.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.873 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.19 -52.58 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.651 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 51.3 p -98.14 9.76 42.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.266 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 47.3 m80 37.12 59.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.777 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -132.63 153.81 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.56 HG21 HD11 ' A' ' 174' ' ' LEU . 46.8 t -115.71 151.81 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.232 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.19 125.49 13.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.5 tttp -124.99 115.12 20.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.36 56.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.378 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.39 23.76 75.04 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.2 mt-30 -132.29 101.6 14.7 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -76.77 136.78 17.26 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.82 1.68 . . . . 0.0 112.199 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.16 139.25 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.965 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.91 121.68 40.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.416 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -141.06 140.68 34.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.765 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.87 173.46 4.77 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.98 -40.82 79.52 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.47 2.113 . . . . 0.0 112.576 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.7 m -51.11 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.811 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.62 -33.55 72.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.238 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -58.51 -52.79 64.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.606 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 20.9 m -57.6 -40.62 79.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 -47.16 85.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.58 -42.18 95.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.704 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -44.87 87.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -66.35 -42.13 88.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.587 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.44 -41.78 77.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.73 -49.12 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.67 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 64.9 mt -55.82 -36.15 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.012 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -109.96 23.76 13.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.3 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.77 118.78 4.52 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.739 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.81 10.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.587 ' O ' HD12 ' A' ' 193' ' ' LEU . 11.5 m -90.01 129.6 36.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.05 120.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.552 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 191' ' ' THR . 4.9 mp -96.94 163.93 12.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.09 148.39 29.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.962 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 4.1 mttt -56.67 -54.02 58.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.078 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 28.4 Cg_endo -70.57 -31.99 15.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.913 1.742 . . . . 0.0 112.043 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -63.61 -46.43 85.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.216 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 27.7 mt -64.65 -39.81 86.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.62 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 203' ' ' TRP . 8.5 tp -64.25 -50.31 68.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.643 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 13.4 t70 -64.73 -30.2 71.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.444 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -72.0 -57.23 4.47 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.43 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 204' ' ' ARG . 60.2 t -84.42 -61.63 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.683 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.494 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 0.8 OUTLIER -50.12 -4.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.681 -179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -67.08 -3.21 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.441 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.28 14.52 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.656 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 207' ' ' PHE . 29.0 m-20 -137.77 -151.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.619 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 206' ' ' ASP . 0.2 OUTLIER -43.44 171.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -45.08 -93.93 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.67 89.6 0.11 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 212' ' ' ASN . 1.3 m-20 -97.65 94.64 7.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.867 0.365 . . . . 0.0 110.174 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 211' ' ' VAL . 90.4 t -64.02 1.36 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 210' ' ' ASP . 57.9 m-20 -100.17 -30.69 11.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.831 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.494 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 20.2 t -62.08 -39.43 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.284 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.87 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.002 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -53.45 -49.56 67.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -46.19 90.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.23 -38.88 90.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.29 -43.15 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.734 0.302 . . . . 0.0 110.585 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.75 -42.93 85.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -71.6 -13.24 61.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.15 -48.74 9.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.807 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 70.1 mtt180 -56.67 -44.04 81.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.367 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -19.36 65.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.982 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -93.96 -28.55 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.364 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.4 OUTLIER -109.37 -39.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.228 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -96.29 145.38 25.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 8.9 t -176.79 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -145.34 167.29 27.47 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.26 -6.45 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.721 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -92.72 104.59 16.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.858 ' O ' HD23 ' A' ' 232' ' ' LEU . 45.6 mtt85 -78.93 160.16 27.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 231' ' ' ARG . 4.7 mt -146.16 -36.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.24 111.88 24.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.607 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.16 129.88 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.329 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.497 HG23 HH22 ' A' ' 222' ' ' ARG . 0.2 OUTLIER -94.42 111.75 23.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 237' ' ' ARG . 3.8 mt -95.25 69.54 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.159 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 236' ' ' LEU . 3.7 ptt85 -35.09 128.28 0.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.95 -13.82 60.39 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.2 t -128.85 -58.17 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.416 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 159.42 -137.28 5.05 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -129.47 157.91 40.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.08 136.23 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.404 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 26.4 tp -93.05 118.91 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.505 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.67 131.01 3.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.359 . . . . 0.0 111.04 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -80.35 156.42 73.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.302 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -67.26 141.35 56.5 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.51 2.14 . . . . 0.0 112.174 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.495 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -172.49 7.55 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.288 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 m -74.56 179.92 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.113 0.456 . . . . 0.0 111.033 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.4 m -147.54 142.8 27.27 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.41 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.41 -6.41 6.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.678 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.8 m80 49.1 -159.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.857 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.46 168.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.23 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.35 -166.97 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -152.05 2.11 0.36 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 109.98 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.57 153.68 23.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.626 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.5 m -106.8 60.63 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.556 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.5 p -108.49 161.14 15.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.134 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.35 -2.21 0.03 OUTLIER Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.344 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.19 27.48 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.337 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 136' ' ' ARG . 14.9 m -131.35 63.53 70.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.603 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.4 28.37 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -106.19 1.81 26.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.04 170.13 39.19 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 t -101.1 140.52 35.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.67 0.271 . . . . 0.0 110.82 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 140' ' ' MET . 10.5 p-80 -162.84 -177.67 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 0.0 110.998 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' HIS . 8.7 mmt -34.22 131.29 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -88.37 5.53 41.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 56.53 -85.28 0.01 OUTLIER Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 141' ' ' LYS . 44.3 p30 -157.98 0.96 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.975 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.4 tttt 65.29 94.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.437 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -166.59 68.15 1.02 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.466 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -47.21 151.06 2.81 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.636 2.224 . . . . 0.0 111.73 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -127.37 141.46 51.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.38 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.73 149.24 45.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.383 . . . . 0.0 110.539 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.705 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -140.78 132.93 27.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.77 151.56 21.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.82 156.84 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 155' ' ' ASP . 87.0 t80 -166.06 125.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.941 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.86 -95.78 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.3 p-10 -124.97 54.34 1.43 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.55 151.58 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.466 -179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.7 mt-10 -146.25 143.71 29.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.48 127.67 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.355 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.4 OUTLIER -113.33 103.15 11.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.839 0.352 . . . . 0.0 110.452 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.93 -12.48 55.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -71.63 -30.64 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 7.0 p -121.82 -25.39 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.062 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 162' ' ' THR . 4.9 t-80 83.13 47.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.871 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -124.26 160.09 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 166' ' ' TRP . 31.8 t -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.405 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -146.23 125.42 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.854 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 170' ' ' GLN . 12.7 tmtt? -130.05 117.65 20.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.374 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.98 70.58 0.07 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.04 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.02 34.69 52.66 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -136.68 91.31 15.83 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.554 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.81 137.82 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.316 2.011 . . . . 0.0 112.12 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.72 131.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 91.74 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.68 150.97 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.777 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 168.67 25.26 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.189 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -47.44 -53.9 5.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.408 2.072 . . . . 0.0 112.309 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -55.84 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -61.96 -38.48 88.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.666 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -48.34 82.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.368 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.2 m -58.97 -39.05 80.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.193 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.85 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.708 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.673 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -59.31 -42.58 91.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.318 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CE2' HD21 ' A' ' 193' ' ' LEU . 24.8 t80 -68.69 -41.13 79.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.551 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.43 ' CD1' HD13 ' A' ' 243' ' ' LEU . 1.2 m-85 -54.6 -43.81 72.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.8 -46.07 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 92.2 mt -56.91 -38.02 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -107.87 26.57 10.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.86 117.64 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.664 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.37 -27.18 12.92 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.61 130.36 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.927 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.64 114.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.538 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 184' ' ' TYR . 3.9 mp -97.25 158.2 15.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.84 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.33 147.39 31.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.292 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -58.06 -52.99 70.44 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.208 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -62.84 -31.97 77.68 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.746 1.631 . . . . 0.0 112.2 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -68.9 -49.99 53.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.054 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 193' ' ' LEU . 7.4 mt -55.91 -36.93 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.196 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.431 HD21 ' CA ' ' A' ' 209' ' ' GLY . 6.9 tp -61.22 -70.61 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.787 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.534 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 0.0 OUTLIER -54.2 -23.87 16.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.512 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.596 ' ND1' HG23 ' A' ' 202' ' ' VAL . 10.0 t-80 -73.9 -60.09 2.42 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.612 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.596 HG23 ' ND1' ' A' ' 201' ' ' HIS . 99.4 t -85.82 -61.52 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -53.45 -3.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.534 ' CG ' ' O ' ' A' ' 200' ' ' ASP . 0.6 OUTLIER -63.16 -3.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.92 21.71 4.56 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.703 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -143.02 -144.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.906 0.384 . . . . 0.0 110.817 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.494 ' O ' ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -42.72 164.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.549 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 207' ' ' PHE . . . -47.47 -105.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.431 ' CA ' HD21 ' A' ' 199' ' ' LEU . . . -160.23 89.7 0.11 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.2 124.15 46.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.287 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 211' ' ' VAL . 9.0 p -82.28 -8.01 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.648 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -99.99 -29.22 12.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 2.5 p -66.28 -39.74 85.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.638 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.455 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 25.0 t -56.41 -50.5 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.106 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.03 -48.52 78.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.278 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -45.15 93.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.434 ' O ' HD13 ' A' ' 221' ' ' LEU . 2.4 m-85 -63.63 -41.83 98.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.28 -41.39 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.2 t -62.59 -47.93 81.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -33.45 75.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.369 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 217' ' ' TYR . 2.9 mp -67.32 -46.67 72.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.341 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.46 -44.18 76.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.316 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -66.53 -24.67 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -91.88 -28.41 17.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.677 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.99 -40.56 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.341 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -102.82 141.05 36.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 110.815 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -40.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.783 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.11 173.21 6.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -66.32 -7.04 16.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -92.55 104.95 17.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -86.83 106.98 18.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.1 mt -88.5 -0.36 57.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.546 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.93 113.22 14.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.322 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 123.17 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.488 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.0 m -88.28 114.33 24.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.774 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 237' ' ' ARG . 6.9 mt -96.75 72.99 2.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.23 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 236' ' ' LEU . 22.7 mtp180 -39.25 110.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.676 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.79 -16.24 13.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.71 -47.46 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.45 -137.28 6.17 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.18 152.39 48.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.383 . . . . 0.0 110.608 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.16 141.14 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.43 HD13 ' CD1' ' A' ' 185' ' ' PHE . 1.3 tp -91.43 111.51 23.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -162.02 134.03 5.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -76.64 149.4 80.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -36.61 101.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.529 2.153 . . . . 0.0 112.006 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.62 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 123' ' ' SER . . . -96.7 59.9 1.23 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.1 p -72.92 14.54 0.27 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 121' ' ' GLY . 75.2 m -87.43 28.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.7 OUTLIER 63.69 178.26 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.28 -22.06 25.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.663 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -56.85 154.95 8.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.26 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.43 126.49 0.19 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.781 0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 7.0 p-80 -169.34 -14.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.402 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -152.51 92.28 1.66 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.485 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 32.2 t -126.31 89.15 2.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.735 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 131' ' ' SER . 38.8 p 44.2 75.65 0.1 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.932 0.396 . . . . 0.0 110.202 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.68 160.29 10.51 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mp -94.6 21.86 6.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.057 0.456 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.1 t 44.08 68.65 2.93 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.314 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' GLY . 52.3 Cg_exo -46.83 -41.75 25.04 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 123.131 2.554 . . . . 0.0 112.519 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 66.97 -61.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PRO . . . 163.33 177.36 36.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 140' ' ' MET . 22.2 t -129.87 127.31 39.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 140' ' ' MET . 2.8 t60 -74.96 36.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.452 ' H ' ' C ' ' A' ' 138' ' ' SER . 0.0 OUTLIER 34.35 -121.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.817 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -96.81 92.04 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.377 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . . . -142.69 23.57 2.32 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 142' ' ' GLY . 7.2 m120 -154.0 143.78 21.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.673 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -149.76 20.9 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 51.81 61.32 12.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.607 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.96 161.09 33.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.868 2.378 . . . . 0.0 111.73 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -168.22 -37.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.821 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.72 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -86.76 102.4 14.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.36 113.78 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.381 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -104.81 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.434 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mt -146.09 134.85 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.571 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -137.51 155.78 48.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 111.069 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.552 ' HB2' HG13 ' A' ' 186' ' ' VAL . 87.3 t80 -165.39 139.0 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.519 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.46 -104.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.924 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.5 OUTLIER -124.66 53.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 155' ' ' ASP . 2.4 mm -137.52 146.56 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.921 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.43 131.28 29.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 147.27 48.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.433 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 163' ' ' HIS . 1.8 m-20 -131.15 107.89 9.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.439 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.35 -38.32 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.772 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -51.45 59.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.533 ' C ' ' CD2' ' A' ' 163' ' ' HIS . 4.6 p -106.58 13.15 28.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.119 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 162' ' ' THR . 9.3 p80 38.52 56.09 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.683 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -119.68 161.24 21.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.536 HG21 HD12 ' A' ' 174' ' ' LEU . 4.3 t -124.5 157.86 31.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.99 125.24 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -122.71 108.76 13.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HB3' ' NZ ' ' A' ' 167' ' ' LYS . . . 31.31 67.01 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.057 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.84 32.86 83.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 167' ' ' LYS . 14.2 tt0 -137.04 87.35 18.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.92 132.87 13.28 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.298 1.998 . . . . 0.0 112.669 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.7 147.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.27 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.3 m -92.63 88.35 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.287 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.536 HD12 HG21 ' A' ' 165' ' ' VAL . 35.8 mt -96.0 155.81 16.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.32 170.69 8.26 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.06 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.26 -53.72 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 112.135 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -57.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.073 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.678 ' OE2' HD11 ' A' ' 221' ' ' LEU . 1.4 mm-40 -62.88 -39.71 95.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.16 -42.82 95.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.8 m -61.25 -45.61 93.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.49 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 181' ' ' LEU . 1.5 tt -57.2 -43.95 83.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 186' ' ' VAL . 2.1 mp -66.02 -46.18 78.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.267 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -58.13 -42.98 87.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.405 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.19 -44.97 94.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.516 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' N ' ' A' ' 189' ' ' ALA . 0.4 OUTLIER -62.83 -41.93 99.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 110.771 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 182' ' ' LEU . 65.8 t -57.68 -52.66 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.394 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.6 pt -62.42 -29.53 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.356 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.1 19.6 20.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.712 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -53.17 119.57 4.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.92 -23.76 20.7 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.1 m -92.18 125.29 36.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.735 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.3 p -69.1 118.08 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.036 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.95 149.14 22.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.744 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.7 p -99.88 149.44 23.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.53 -44.84 99.8 Favored Pre-proline 0 CA--C 1.53 0.177 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.501 -178.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 31.8 Cg_exo -52.94 -52.41 8.89 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.912 1.742 . . . . 0.0 111.996 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.67 -51.96 67.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.45 -42.98 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.179 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 209' ' ' GLY . 12.1 tp -60.41 -65.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.883 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.3 -16.04 30.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -49.87 31.7 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.11 -43.82 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.075 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' A' ' 208' ' ' GLY . 1.2 m-90 -62.82 -3.97 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.814 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.3 ttt-85 -57.66 -4.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.491 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.4 m-85 -121.29 15.77 11.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.523 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 0.4 OUTLIER 171.84 116.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.484 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -84.32 129.81 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.586 ' C ' ' HE1' ' A' ' 203' ' ' TRP . . . 144.58 66.4 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.405 ' O ' HD21 ' A' ' 199' ' ' LEU . . . -159.64 102.69 0.22 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 213' ' ' VAL . 43.9 m-20 -57.38 -173.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 110.103 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.0 -14.68 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -85.39 -17.47 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.77 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 210' ' ' ASP . 5.2 p -67.33 -38.1 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.456 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.813 ' O ' HG23 ' A' ' 218' ' ' VAL . 85.6 t -59.7 -50.69 79.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -54.93 -47.06 74.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.536 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 213' ' ' VAL . 9.7 p -60.21 -49.47 77.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.655 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -61.63 -41.01 96.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 214' ' ' VAL . 66.3 t -62.46 -45.26 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.3 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -43.8 98.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.194 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -32.83 73.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.678 HD11 ' OE2' ' A' ' 178' ' ' GLU . 2.1 mp -66.26 -47.47 73.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 109.999 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.0 OUTLIER -54.89 -46.21 74.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.147 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -15.22 63.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.417 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.422 ' CE ' HD21 ' A' ' 174' ' ' LEU . 33.9 mtpt -95.07 -27.11 15.76 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.3 pp -122.38 -13.53 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 111.32 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -111.92 138.21 48.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.372 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.0 t -175.37 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -48.74 168.94 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.59 -13.08 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.978 0.418 . . . . 0.0 109.962 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -93.21 151.86 19.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.897 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -93.08 158.96 15.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.217 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 245' ' ' GLU . 90.6 mt -147.03 -50.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 242' ' ' VAL . 1.1 mt -94.98 119.86 34.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.683 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 130.29 45.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.64 108.82 20.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.2 mt -98.72 69.4 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.753 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -37.28 126.55 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.567 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.86 -7.58 62.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.41 -46.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 0.0 110.507 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.48 -137.33 7.48 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.567 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -127.89 152.81 47.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.31 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.459 ' O ' HD23 ' A' ' 233' ' ' LEU . 11.1 p -136.62 135.95 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.964 0.411 . . . . 0.0 110.785 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.98 118.9 31.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.569 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -162.28 115.75 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 232' ' ' LEU . 0.4 OUTLIER -87.92 149.53 45.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.44 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.88 124.79 10.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.301 2.0 . . . . 0.0 112.131 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.475 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.79 -118.92 3.17 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.438 ' C ' ' OG ' ' A' ' 123' ' ' SER . 0.4 OUTLIER -163.87 110.46 1.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 110.336 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.438 ' OG ' ' C ' ' A' ' 122' ' ' SER . 0.0 OUTLIER 61.21 110.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.949 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -55.15 175.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.771 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -72.4 -63.74 1.09 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -90.32 -107.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.177 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.91 -56.51 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.237 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.6 OUTLIER 44.08 28.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.426 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' CG ' ' N ' ' A' ' 130' ' ' SER . 11.5 t-160 -71.15 -107.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.404 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.477 ' N ' ' CG ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -72.0 -52.09 18.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.515 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 73.78 -11.65 0.93 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.239 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -97.19 -169.13 33.24 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.2 mt -78.58 142.9 36.94 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 134' ' ' VAL . 9.4 p -155.85 65.99 4.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.064 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.31 154.51 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.275 1.983 . . . . 0.0 111.849 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -85.7 39.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.773 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 138' ' ' SER . . . 85.5 -5.56 83.03 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 137' ' ' GLY . 19.3 p 25.74 52.86 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.964 0.411 . . . . 0.0 111.088 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -67.01 -82.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.833 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.2 ttt -75.58 107.8 7.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.789 0.328 . . . . 0.0 110.798 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -120.29 -49.11 2.29 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.23 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.29 -150.52 25.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -165.43 -25.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' O ' ' CD ' ' A' ' 145' ' ' GLU . 1.3 pttm -101.4 71.13 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.627 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.457 ' CD ' ' O ' ' A' ' 144' ' ' LYS . 1.4 mp0 -133.98 77.67 61.67 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.28 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.37 120.86 8.91 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.217 2.611 . . . . 0.0 112.422 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -100.21 102.43 13.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.462 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -83.64 124.45 30.83 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.76 111.3 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -175.27 145.57 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.369 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.909 HD23 HH12 ' A' ' 183' ' ' ARG . 2.6 mm? -92.43 151.6 20.15 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -142.05 156.95 45.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 243' ' ' LEU . 70.7 t80 -167.03 140.14 3.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 34.41 -102.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 155' ' ' ASP . 23.8 p-10 -124.3 52.36 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -138.08 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.467 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 13.9 tt0 -145.71 144.05 30.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 0.0 110.631 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.527 HD21 HD23 ' A' ' 182' ' ' LEU . 1.0 OUTLIER -137.37 116.88 12.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.955 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.15 101.87 11.61 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.849 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -24.14 66.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.597 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -54.29 -32.3 56.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.616 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.517 ' O ' ' CB ' ' A' ' 163' ' ' HIS . 34.1 p -127.5 -20.7 3.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 162' ' ' THR . 2.1 t60 82.14 52.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -122.51 156.45 34.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.457 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 174' ' ' LEU . 2.7 t -121.12 151.34 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.143 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.73 125.24 13.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.981 0.419 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -127.13 113.11 15.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.259 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.77 70.3 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.234 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.67 26.72 47.19 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 167' ' ' LYS . 3.1 tp60 -130.8 92.36 34.43 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -78.42 133.43 11.86 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.948 1.766 . . . . 0.0 112.195 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.93 138.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.576 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 75.2 m -89.58 88.32 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 165' ' ' VAL . 71.9 mt -95.38 149.31 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.563 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.8 172.86 8.06 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.214 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -52.1 -55.3 4.0 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.394 2.063 . . . . 0.0 112.19 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.4 m -51.06 -52.5 42.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.55 -44.05 97.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.0 m -61.37 -45.51 94.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.605 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.86 -43.69 92.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.004 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.527 HD23 HD21 ' A' ' 158' ' ' LEU . 29.6 tp -63.25 -39.13 93.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.909 HH12 HD23 ' A' ' 151' ' ' LEU . 3.3 ttt85 -65.09 -42.56 93.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.719 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.674 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 10.6 t80 -62.29 -44.57 96.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.6 -44.91 77.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.0 -47.68 87.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.88 -28.79 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -108.83 20.42 18.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.801 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.46 120.92 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.75 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 109.21 -23.28 23.38 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.544 ' O ' HD12 ' A' ' 193' ' ' LEU . 32.3 m -98.17 124.64 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 192' ' ' VAL . 7.3 p -69.42 122.27 20.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 191' ' ' THR . 5.5 mp -96.8 165.86 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.422 ' OG ' ' CG ' ' A' ' 197' ' ' LYS . 1.1 p -109.77 151.11 27.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.03 -54.45 50.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.915 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 21.1 Cg_endo -66.4 -32.12 41.37 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.988 1.792 . . . . 0.0 112.365 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.422 ' CG ' ' OG ' ' A' ' 194' ' ' SER . 18.9 mmtt -64.06 -58.44 6.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 0.0 110.461 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.2 -40.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.41 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.75 -64.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.67 -29.23 25.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.674 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 79.6 t60 -71.14 -48.59 51.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.159 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 204' ' ' ARG . 77.6 t -83.96 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.41 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.81 -2.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.294 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.7 ttp180 -61.17 -3.39 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.715 0.293 . . . . 0.0 110.68 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.419 ' O ' ' OD2' ' A' ' 206' ' ' ASP . 2.4 m-85 -117.73 16.35 14.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 205' ' ' TYR . 0.5 OUTLIER 171.11 103.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -82.17 125.56 31.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.474 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 153.35 50.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -158.89 103.79 0.24 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 210' ' ' ASP . 0.4 OUTLIER -50.46 -174.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.084 0.469 . . . . 0.0 110.671 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.83 -8.75 11.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.26 -16.42 40.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 3.2 p -68.9 -38.53 78.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.826 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 40.9 t -58.86 -47.85 88.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.527 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -58.14 -47.29 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.229 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 m -59.8 -43.72 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -43.39 98.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 16.5 t -62.1 -41.43 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.49 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -46.9 85.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.762 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.67 -21.9 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.642 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.82 -46.38 18.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.217 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.6 mtp180 -56.05 -47.09 78.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.974 0.416 . . . . 0.0 110.464 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -66.16 -11.27 48.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.537 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -92.09 -46.06 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.36 -27.42 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.31 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 222' ' ' ARG . 4.6 t70 -94.78 143.31 26.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.742 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.444 ' OG1' ' C ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER 173.81 -27.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.513 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -50.43 162.63 0.97 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -68.51 -7.65 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.804 0.335 . . . . 0.0 110.199 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -93.13 149.58 21.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -92.24 154.15 18.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.235 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 243' ' ' LEU . 74.8 mt -147.35 -51.27 0.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.41 110.65 23.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.143 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.441 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -93.21 122.45 35.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.899 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.4 m -90.5 109.47 20.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.127 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.481 HD12 ' CG2' ' A' ' 192' ' ' VAL . 16.1 mt -95.62 70.54 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -39.45 125.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.99 -13.75 40.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.5 -59.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 110.569 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.43 -138.06 5.07 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -127.79 160.98 30.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.424 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 234' ' ' HIS . 7.7 p -143.88 128.8 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.4 tp -91.73 137.5 32.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.58 128.09 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 246' ' ' PRO . 9.0 mt-10 -71.25 156.35 91.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.506 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 245' ' ' GLU . 71.2 Cg_exo -39.15 163.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.708 2.272 . . . . 0.0 112.024 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.9 ptt-85 . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.716 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.49 178.18 21.83 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -146.22 0.24 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.519 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.29 -176.69 6.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -103.38 13.47 33.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.877 0.37 . . . . 0.0 110.688 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 144.58 46.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.172 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -175.66 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.558 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -78.0 -78.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -163.49 164.25 24.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 110.824 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -131.09 107.73 9.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.313 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.49 -39.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -152.82 161.15 42.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.674 ' C ' HD23 ' A' ' 133' ' ' LEU . . . -114.18 -27.31 3.46 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -105.72 116.82 32.58 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.651 ' O ' HG22 ' A' ' 134' ' ' VAL . 7.3 p -176.77 60.02 0.17 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.73 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.49 126.99 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.765 2.31 . . . . 0.0 112.586 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.26 146.34 45.47 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.33 31.64 0.18 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.9 m -47.72 -33.48 7.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -93.1 164.87 13.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.691 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 52.2 mtt 42.09 80.8 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.855 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -106.82 110.57 22.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.435 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.46 46.48 0.17 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -113.0 -155.85 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -59.86 179.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.9 153.32 88.99 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -38.86 150.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.258 1.972 . . . . 0.0 111.62 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 mtt85 -101.28 -166.03 1.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.716 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.55 ' OD1' ' NH1' ' A' ' 150' ' ' ARG . 11.1 t-20 56.71 96.79 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.469 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 149' ' ' VAL . 0.6 OUTLIER -83.08 146.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.481 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.55 ' NH1' ' OD1' ' A' ' 148' ' ' ASN . 24.1 mtt-85 -147.08 139.35 24.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.2 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 158' ' ' LEU . 1.6 mm? -89.46 157.35 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.68 157.7 45.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.0 0.429 . . . . 0.0 110.86 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' A' ' 243' ' ' LEU . 3.5 t80 -164.18 127.16 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.476 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 39.47 -99.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 13.7 p-10 -124.87 54.41 1.42 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.47 153.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.873 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -145.33 140.12 27.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.252 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.879 ' N ' HD12 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -139.43 138.83 36.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.714 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 162' ' ' THR . 62.8 t0 -111.54 105.67 14.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -8.22 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.176 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.41 -46.09 5.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 110.956 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.545 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 69.2 p -98.66 13.65 31.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.812 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.439 ' C ' ' O ' ' A' ' 162' ' ' THR . 44.4 m-70 35.76 53.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.541 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -121.9 150.9 41.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.8 152.89 22.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.317 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.77 121.4 9.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.4 tmmt? -124.97 112.83 17.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.365 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.39 71.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.517 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.44 25.58 34.78 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 167' ' ' LYS . 6.5 tt0 -131.08 94.68 27.15 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.13 132.6 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.195 1.93 . . . . 0.0 112.276 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.12 144.21 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.709 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.9 t -95.21 94.66 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.66 154.0 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.172 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.22 172.14 8.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -50.3 -54.24 5.78 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.37 2.047 . . . . 0.0 111.931 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -57.46 -46.41 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.694 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -45.0 96.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -61.68 -45.33 94.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.8 m -58.16 -47.03 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 -43.94 92.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.7 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.46 -43.5 90.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.504 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -55.89 -45.25 78.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.579 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -65.06 -43.64 91.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -58.58 -42.84 88.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.649 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 151' ' ' LEU . 54.1 t -63.15 -47.68 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.625 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.72 -37.55 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -106.96 25.19 11.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.17 114.23 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.79 -25.94 10.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.5 m -91.73 129.31 37.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.61 0.243 . . . . 0.0 110.456 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 p -67.55 126.29 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.0 110.541 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.4 mp -94.5 168.84 10.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.098 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.84 147.72 36.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 0.0 110.785 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 211' ' ' VAL . 6.7 mttm -56.85 -54.98 48.36 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.21 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.0 Cg_endo -65.7 -29.91 51.04 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.038 1.825 . . . . 0.0 112.426 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -70.18 -47.16 62.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.319 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.28 -38.01 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 109.978 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 199' ' ' LEU . 2.7 tt -60.96 -56.17 24.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -69.89 -16.6 63.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.071 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.579 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 46.4 t60 -71.76 -44.96 63.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.309 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 204' ' ' ARG . 24.5 t -84.24 -54.6 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 205' ' ' TYR . 3.0 m-90 -61.92 -3.22 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.703 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 204' ' ' ARG . 34.4 ttp85 -44.95 -11.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 203' ' ' TRP . 17.4 t80 -105.88 26.94 9.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.35 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.8 OUTLIER 165.86 -174.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -92.71 125.46 37.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.63 103.43 0.54 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.15 59.96 0.35 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.81 101.11 3.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.44 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.595 ' O ' ' NZ ' ' A' ' 195' ' ' LYS . 2.9 m -86.42 1.5 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.841 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -96.49 -29.49 13.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.618 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 4.3 p -64.36 -38.89 83.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.303 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.429 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 17.6 t -60.56 -48.96 86.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.579 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.7 -44.58 85.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.166 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -60.46 -46.0 91.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.63 -38.76 87.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.899 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 214' ' ' VAL . 42.0 t -61.03 -41.06 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.51 75.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.197 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.51 ' OH ' ' NZ ' ' A' ' 224' ' ' LYS . 32.0 t80 -71.19 -10.17 59.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.057 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.44 -56.02 4.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.087 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.4 ptm180 -57.41 -40.48 78.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.313 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -11.21 57.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.51 ' NZ ' ' OH ' ' A' ' 220' ' ' TYR . 1.3 mmtp -93.2 -36.08 12.8 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.639 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.55 -24.04 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.363 . . . . 0.0 110.834 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -97.93 153.01 18.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.647 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -174.32 -30.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.654 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 230' ' ' LYS . . . -61.26 147.96 46.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.73 -5.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.404 . . . . 0.0 110.286 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 228' ' ' GLY . 29.7 mttp -94.07 116.94 29.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.313 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.2 mtm-85 -81.02 131.15 35.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 244' ' ' ARG . 5.5 mp -89.08 -76.59 0.4 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 233' ' ' LEU . 0.3 OUTLIER -85.41 148.38 26.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.945 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -111.08 143.71 41.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 55.0 m -101.67 116.04 31.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.931 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 236' ' ' LEU . 0.8 OUTLIER -96.47 73.18 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.0 mtt-85 -39.75 117.81 0.78 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.469 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.64 -25.48 9.04 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.1 t -122.45 -56.5 2.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.1 -136.79 4.53 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -129.35 160.67 32.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 0.0 110.889 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.568 HG12 HD21 ' A' ' 236' ' ' LEU . 14.4 p -138.84 134.64 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.215 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.522 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 53.0 tp -91.88 116.28 28.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 232' ' ' LEU . 10.1 ptm180 -163.37 117.19 1.58 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.64 154.87 6.17 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.343 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -38.73 132.55 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.72 2.28 . . . . 0.0 112.101 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.47 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -48.63 -58.13 7.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' SER . 3.0 t 58.21 44.78 18.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.84 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' SER . 14.8 p -36.3 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 110.552 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -113.0 139.88 48.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.679 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.92 -170.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.476 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.08 157.47 15.8 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.41 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.7 170.68 8.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.218 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.681 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -105.57 -172.42 2.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.029 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 128' ' ' HIS . 0.2 OUTLIER 55.19 155.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.844 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 131' ' ' SER . 0.6 OUTLIER -173.28 -17.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.704 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 130' ' ' SER . 0.7 OUTLIER 36.11 37.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.687 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.15 141.99 6.68 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.76 67.74 1.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.544 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.07 149.57 68.68 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.524 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -41.61 156.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.433 2.089 . . . . 0.0 112.268 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 54.5 97.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.77 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.29 116.2 5.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -88.25 166.44 14.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.712 0.292 . . . . 0.0 110.645 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 141' ' ' LYS . 6.9 t60 -170.42 74.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.498 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.59 19.02 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 139' ' ' HIS . 5.2 tttt 69.29 138.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.641 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.84 106.93 0.22 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 17.8 7.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.719 0.295 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG3' ' H ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER 49.0 -153.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.506 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -142.53 72.36 20.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.945 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.07 28.83 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.784 2.322 . . . . 0.0 111.954 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -110.72 86.11 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -176.78 81.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.0 117.1 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.422 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -120.18 123.87 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.0 mt -90.83 156.11 18.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.59 163.04 33.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.892 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 156' ' ' ILE . 58.5 t80 -167.58 134.5 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.41 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 153' ' ' PHE . 11.5 p-10 -125.18 53.38 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.1 mt -137.05 154.34 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -145.83 146.88 31.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.1 mp -141.07 134.32 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.413 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.5 m-20 -112.77 109.24 18.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.203 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 0.8 OUTLIER -65.58 -16.28 63.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.458 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.97 -52.21 8.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.774 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' HIS . 41.4 p -101.3 11.45 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.588 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 162' ' ' THR . 11.0 m-70 36.53 53.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.666 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -120.22 160.02 23.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD11 ' A' ' 174' ' ' LEU . 95.2 t -124.5 149.6 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.4 127.76 15.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.493 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 39.5 tttm -128.06 114.04 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.496 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.99 62.94 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 63.97 29.7 75.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 15.4 tt0 -132.9 93.28 23.83 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.74 140.23 12.89 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.282 1.988 . . . . 0.0 112.316 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.8 130.17 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.742 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.5 p -93.64 87.15 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.604 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.942 HD12 ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -95.14 154.87 16.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.606 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.04 168.86 23.62 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.325 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -48.26 -45.93 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.54 2.16 . . . . 0.0 111.961 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -53.37 -63.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.131 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.18 -36.11 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.429 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -59.87 -48.15 82.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.5 m -60.09 -40.86 91.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.788 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 202' ' ' VAL . 1.3 tp -59.59 -47.55 85.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.69 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.84 -41.09 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -58.21 -46.88 85.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.821 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -68.17 -38.82 82.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -57.2 -44.0 83.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.483 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.35 -46.05 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 mm -53.93 -34.67 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -108.28 22.21 16.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.037 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.55 125.87 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.487 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.31 -33.2 6.77 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 m -87.07 132.81 33.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.04 124.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.916 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.22 161.27 13.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.24 147.88 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 5.5 mtmt -58.43 -56.36 36.2 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.35 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 18.3 Cg_endo -63.31 -34.53 66.76 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.834 1.689 . . . . 0.0 111.967 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -64.82 -54.09 36.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.355 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 18.2 mt -52.05 -39.36 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.035 0.445 . . . . 0.0 110.12 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 25.7 tp -60.52 -68.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -50.49 -25.83 4.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.464 ' ND1' ' NH2' ' A' ' 204' ' ' ARG . 56.7 t60 -71.35 -55.12 8.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 204' ' ' ARG . 55.2 t -83.87 -58.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.337 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.481 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -52.1 -4.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.278 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 202' ' ' VAL . 1.8 ttm180 -61.76 0.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.5 m-85 -119.44 10.27 11.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.574 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.444 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.4 OUTLIER 178.04 111.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.467 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -86.93 110.71 20.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 167.44 51.72 0.03 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -154.79 100.55 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 209' ' ' GLY . 6.5 t70 -51.88 -173.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.019 0.438 . . . . 0.0 110.648 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.455 ' O ' HG22 ' A' ' 211' ' ' VAL . 11.5 p -85.4 -12.2 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.846 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -91.08 -18.53 24.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.374 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 214' ' ' VAL . 1.2 p -65.25 -37.99 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.995 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -59.2 -45.79 92.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.605 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -61.45 -45.76 92.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.5 t -60.91 -41.69 96.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.433 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.01 -39.03 76.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.854 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 214' ' ' VAL . 60.9 t -62.27 -43.88 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -46.76 88.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.67 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -31.53 72.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.934 0.397 . . . . 0.0 110.172 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.0 mp -70.87 -42.34 70.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.946 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 226' ' ' ASP . 35.5 ttp180 -55.11 -44.4 74.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.152 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -68.17 -26.36 65.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.468 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -93.41 -21.88 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -113.2 -31.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.305 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.7 t70 -107.23 135.71 48.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.462 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.64 21.35 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.31 167.84 17.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -12.49 61.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.371 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -92.42 106.2 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.815 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 24.3 mtt-85 -89.46 110.15 21.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.28 -4.7 56.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.202 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.31 104.99 12.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.598 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.89 124.44 37.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.543 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 62.4 m -96.11 118.41 32.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.309 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.07 74.96 2.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.24 113.99 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.013 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 110.99 -20.64 23.82 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 32.6 t -119.63 -61.27 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.152 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.94 -139.17 5.66 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.77 153.05 47.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.918 0.389 . . . . 0.0 110.703 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.8 p -140.1 132.13 32.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.951 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.84 143.36 26.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.397 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.01 139.85 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.53 151.59 44.31 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.498 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 247' ' ' ARG . 50.1 Cg_exo -41.32 126.65 2.89 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.599 2.2 . . . . 0.0 112.059 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 246' ' ' PRO . 26.3 mtm180 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.662 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.49 174.94 19.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.6 p -163.55 166.61 22.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.458 0.647 . . . . 0.0 111.44 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -108.01 127.62 53.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.708 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.427 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 12.5 p80 -51.56 79.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.808 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 123' ' ' SER . 75.4 m80 -56.31 144.67 29.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.172 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -113.53 160.52 18.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 -16.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.257 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -105.36 -55.98 2.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.672 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -54.58 -28.93 49.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.926 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.67 -177.72 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.3 t 54.82 -175.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.572 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.17 170.61 0.52 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 134' ' ' VAL . 3.2 mt -80.88 98.79 8.01 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.061 -0.255 . . . . 0.0 110.837 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 133' ' ' LEU . 13.4 t -32.73 97.46 0.11 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.611 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' N ' ' O ' ' A' ' 133' ' ' LEU . 90.9 Cg_endo -84.01 -37.98 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.715 2.277 . . . . 0.0 111.801 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -99.16 104.81 16.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.967 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.99 101.65 0.15 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.92 98.58 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 43.2 89.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.419 . . . . 0.0 110.025 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.3 ttt -59.83 144.16 49.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -43.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.59 105.39 0.42 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -21.89 65.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 0.0 110.78 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -167.76 54.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 110.185 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 146' ' ' PRO . 76.2 tt0 -153.67 65.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.743 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 145' ' ' GLU . 54.1 Cg_exo -45.89 -176.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.982 2.454 . . . . 0.0 112.417 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 148' ' ' ASN . 24.5 ptt-85 -165.6 119.16 1.18 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 147' ' ' ARG . 4.8 t-20 37.37 95.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 119.87 38.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.317 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 157' ' ' GLU . 10.2 mtm180 -124.56 121.0 33.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 61.8 mt -91.76 153.01 19.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.472 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 160.76 39.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 154' ' ' ALA . 77.0 t80 -165.93 140.23 4.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.728 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 35.78 -105.85 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -123.85 53.07 1.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.28 157.58 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.651 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 150' ' ' ARG . 6.5 tt0 -143.38 142.95 31.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.655 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.77 134.66 35.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 163' ' ' HIS . 6.0 m-20 -110.95 105.85 14.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.602 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.99 -13.72 60.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.307 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -48.09 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 0.0 110.609 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 163' ' ' HIS . 5.9 p -94.88 6.38 49.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.594 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 159' ' ' ASP . 64.8 m80 38.39 51.27 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.15 157.04 29.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.01 151.5 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 110.334 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.02 124.72 12.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.355 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -124.27 117.11 23.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.289 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.83 60.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.574 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.95 24.4 71.57 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.587 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 mt-30 -129.89 96.0 27.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.1 135.97 15.86 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.928 1.752 . . . . 0.0 112.497 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.71 140.81 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.727 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.11 96.07 9.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.63 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.12 156.04 16.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.04 169.43 15.53 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.594 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.25 -53.87 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 112.263 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -54.44 45.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -56.58 -37.97 71.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.419 -179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -63.17 -49.92 72.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.9 m -58.13 -43.79 87.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.6 -50.44 73.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.56 -43.61 98.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.725 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -56.98 -45.84 82.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.5 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 21.1 t80 -62.9 -41.72 99.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.534 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.2 -41.33 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.39 -48.09 74.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.126 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.84 -37.55 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -104.67 25.08 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.96 120.93 7.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 104.28 -13.94 51.51 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.07 131.88 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.358 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.88 118.18 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.48 HD23 ' CG1' ' A' ' 198' ' ' ILE . 3.9 mp -96.55 154.48 17.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.191 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 148.82 28.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.346 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 3.3 mtpm? -56.02 -55.02 46.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.106 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 17.7 Cg_endo -64.66 -32.63 57.33 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.919 1.746 . . . . 0.0 111.86 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -68.46 -54.02 19.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.48 ' CG1' HD23 ' A' ' 193' ' ' LEU . 6.2 mt -47.72 -41.81 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.937 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.15 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.629 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -46.41 -30.65 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.5 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 2.1 t60 -71.09 -51.19 26.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.026 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 204' ' ' ARG . 58.4 t -84.34 -57.97 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.04 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -52.89 -2.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.478 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.0 ttt-85 -63.89 -1.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 203' ' ' TRP . 34.6 m-85 -116.72 8.8 13.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.045 0.45 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 172.87 105.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.207 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.449 ' O ' ' CG ' ' A' ' 207' ' ' PHE . 17.2 p90 -80.6 130.39 35.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.181 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.46 60.45 0.01 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -160.63 101.45 0.2 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.481 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -53.18 -175.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 0.0 110.432 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 20.8 m -82.56 -3.19 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.75 -20.84 25.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.017 0.437 . . . . 0.0 109.855 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 210' ' ' ASP . 3.8 p -67.39 -40.45 84.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.478 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 95.6 t -56.21 -50.46 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.61 -48.02 80.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.544 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -46.36 90.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.461 ' CE1' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -62.86 -40.99 99.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.691 -179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 t -62.8 -42.13 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.495 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -41.82 94.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.301 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.69 -13.97 61.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.81 -47.28 9.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 226' ' ' ASP . 50.2 mtt180 -56.64 -46.31 81.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.427 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -10.68 50.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.187 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -94.65 -41.16 9.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.404 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.09 -27.86 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.143 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.8 OUTLIER -97.79 143.66 28.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t -177.07 39.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.289 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -137.49 160.21 25.06 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.97 -7.26 10.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.355 . . . . 0.0 110.436 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -93.63 105.7 17.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -89.73 114.03 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.414 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.56 -3.37 55.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.3 mp -121.2 110.17 15.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.316 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.98 136.12 33.24 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.7 m -101.29 112.55 25.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 110.803 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 237' ' ' ARG . 2.8 mt -95.27 68.19 3.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.053 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 236' ' ' LEU . 23.4 ttt180 -34.8 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.699 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 103.22 -17.24 52.1 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.37 -42.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.92 0.39 . . . . 0.0 110.364 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 141.86 -137.56 8.04 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.21 164.46 23.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 242' ' ' VAL . 14.7 p -143.22 133.79 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.269 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.2 tp -91.22 122.93 34.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.355 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -161.65 130.8 4.52 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 111.047 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -63.29 157.64 62.3 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -38.41 114.99 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.794 2.33 . . . . 0.0 111.907 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.91 -179.289 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 122' ' ' SER . 12.0 mmt . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -47.12 92.12 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 120' ' ' MET . 82.7 p -89.65 150.06 22.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -162.39 152.0 15.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.44 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 126' ' ' HIS . 1.3 t-80 -110.71 29.37 7.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.879 0.371 . . . . 0.0 110.542 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m170 40.26 -90.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.816 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -56.65 142.09 41.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.264 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' A' ' 126' ' ' HIS . 2.1 p80 -133.22 147.99 52.0 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.247 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.43 135.77 45.86 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.4 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -94.75 91.02 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.959 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.49 162.12 39.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.657 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.1 p 51.13 -172.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.208 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.84 155.75 28.06 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.43 150.05 48.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 134' ' ' VAL . 7.0 p -167.19 70.5 0.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.906 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -66.0 106.16 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.237 2.625 . . . . 0.0 112.239 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 68.72 92.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 0.64 2.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.411 -178.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 50.57 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.406 0.603 . . . . 0.0 110.58 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' A' ' 141' ' ' LYS . 23.2 t-80 -145.63 85.36 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 61.76 2.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.986 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 139' ' ' HIS . 18.4 mmtt -98.95 -83.64 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.889 0.376 . . . . 0.0 110.332 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.88 112.77 5.29 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -106.79 -175.54 2.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.308 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -134.45 -22.51 1.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.226 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 54.67 61.02 9.75 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.924 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.54 -166.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.615 2.21 . . . . 0.0 112.127 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -174.17 -33.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -89.03 113.7 24.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.09 120.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.845 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -126.28 119.2 26.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.6 mt -90.76 155.47 18.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.638 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 m -142.38 161.53 37.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.99 0.424 . . . . 0.0 111.148 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -165.23 132.48 2.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.645 179.749 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.57 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 36.65 -98.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 18.2 m-20 -125.55 53.69 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.13 153.52 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.492 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -146.03 140.82 27.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.766 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.27 134.39 37.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.136 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -110.3 107.97 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.932 0.396 . . . . 0.0 110.459 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.02 -9.26 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.057 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.98 -52.04 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.61 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 163' ' ' HIS . 7.3 p -93.28 7.02 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.425 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 162' ' ' THR . 22.1 t60 36.92 62.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -136.31 154.1 50.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.372 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.85 151.23 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.592 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.76 126.74 13.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 170' ' ' GLN . 2.1 ttpm? -126.68 114.62 18.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.764 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.48 54.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.445 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.49 24.09 77.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.601 ' N ' ' O ' ' A' ' 167' ' ' LYS . 54.2 mm-40 -129.39 95.68 29.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.34 136.4 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.109 1.873 . . . . 0.0 112.224 -179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.88 140.53 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.948 -179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.7 t -93.86 94.11 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.546 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.518 ' CD2' HD22 ' A' ' 182' ' ' LEU . 9.9 mp -95.06 150.06 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.667 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.1 172.38 8.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.55 -57.02 2.52 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.544 2.163 . . . . 0.0 112.522 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -54.24 -50.14 67.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.4 -40.34 96.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.483 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.5 -47.4 85.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.521 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -57.41 -48.02 80.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.336 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.0 -51.22 70.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 174' ' ' LEU . 1.2 tp -57.95 -47.18 83.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.055 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -59.62 -44.19 93.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.407 ' CD2' ' ND2' ' A' ' 188' ' ' ASN . 18.5 t80 -61.33 -45.39 94.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.355 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.6 m-85 -57.45 -44.46 84.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 45.6 t -59.47 -50.11 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.641 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.35 -38.67 56.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.816 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.407 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 24.2 p30 -108.58 24.45 13.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . -51.87 118.01 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.16 -23.68 13.71 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.5 m -89.43 133.66 34.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.21 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.26 120.88 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.612 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.25 156.27 16.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.413 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.08 148.6 28.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.794 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.533 ' HZ3' ' CD ' ' A' ' 215' ' ' GLU . 1.0 OUTLIER -56.16 -56.09 34.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.982 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -66.32 -28.8 46.82 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.998 1.799 . . . . 0.0 111.927 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -49.33 54.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.948 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.31 -38.97 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.3 -68.51 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -49.89 -30.86 10.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -70.84 -49.57 44.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.282 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 204' ' ' ARG . 62.7 t -82.91 -60.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.908 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.611 ' CZ2' HG11 ' A' ' 213' ' ' VAL . 1.1 m-90 -53.85 -2.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.56 ' H ' ' C ' ' A' ' 202' ' ' VAL . 30.4 ttt180 -50.91 -5.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 203' ' ' TRP . 35.9 m-85 -103.4 19.91 18.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.249 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 205' ' ' TYR . 1.3 m-20 166.53 126.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -68.49 140.96 55.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.813 -179.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.21 104.89 0.18 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.64 59.71 2.5 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.81 96.6 6.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.776 0.322 . . . . 0.0 110.666 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.9 m -83.68 -10.04 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 215' ' ' GLU . 13.0 m120 -73.0 -70.56 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.227 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' CZ2' ' A' ' 203' ' ' TRP . 4.5 p -34.61 -36.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.3 t -65.52 -44.87 93.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.56 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 212' ' ' ASN . 2.2 tp10 -57.58 -44.15 85.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -47.98 83.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.699 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.594 ' O ' HD13 ' A' ' 221' ' ' LEU . 1.5 m-85 -61.48 -39.95 92.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 214' ' ' VAL . 89.6 t -63.0 -43.82 99.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.57 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.5 t -63.06 -44.73 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -36.87 85.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 110.189 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.594 HD13 ' O ' ' A' ' 217' ' ' TYR . 5.1 mp -65.11 -45.6 84.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.671 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 226' ' ' ASP . 52.1 mtm180 -56.2 -45.76 79.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.229 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.03 -22.44 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.357 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -92.94 -26.69 17.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.47 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -108.47 -40.37 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.823 -179.644 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -95.75 156.13 16.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 0.0 110.956 -179.677 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 226' ' ' ASP . 0.8 OUTLIER 167.78 -36.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.704 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.89 -175.22 10.52 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -78.81 -13.46 59.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.653 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -92.75 105.32 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.41 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.16 103.99 15.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.765 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mp -90.31 -3.03 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.645 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.88 113.51 21.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.666 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.24 118.35 36.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.128 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.451 HG23 ' HD1' ' A' ' 241' ' ' TYR . 61.1 m -93.01 114.06 26.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.641 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 237' ' ' ARG . 1.6 mp -96.23 68.68 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.76 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 236' ' ' LEU . 30.8 mtm-85 -33.94 129.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.836 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.93 65.99 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 69.9 t -133.01 -61.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 0.0 110.675 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.96 -140.27 6.32 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.451 ' HD1' HG23 ' A' ' 235' ' ' THR . 0.1 OUTLIER -132.61 153.4 51.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.597 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.13 138.9 49.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.583 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 153' ' ' PHE . 5.3 tp -91.57 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.877 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -161.75 133.18 5.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.623 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -60.95 158.13 36.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.68 109.25 2.05 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.513 2.142 . . . . 0.0 111.975 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.671 -179.932 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.53 -29.06 5.02 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.033 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.26 135.89 55.05 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.49 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.6 t 47.54 73.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.3 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -176.14 59.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.292 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -122.33 12.46 10.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.301 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -56.17 -45.49 79.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.149 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -142.25 157.08 45.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.622 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.632 ' N ' ' ND1' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -144.15 -23.44 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -166.58 26.64 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.0 p -69.11 -84.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 p -52.89 124.11 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.831 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 133' ' ' LEU . . . -138.89 -177.34 15.3 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 132' ' ' GLY . 5.1 mt -39.03 124.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.932 0.396 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 134' ' ' VAL . 9.2 m -68.93 151.34 97.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.563 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.5 134.69 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.549 2.166 . . . . 0.0 112.222 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -66.53 -30.74 71.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.02 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.41 45.11 0.52 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.0 p 42.97 -163.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.745 0.307 . . . . 0.0 110.256 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -114.73 -90.75 0.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.054 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.0 ttm -156.78 47.02 0.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.828 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -75.8 -50.94 13.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.452 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -42.99 142.42 1.76 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.66 -25.64 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 110.485 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.76 167.27 27.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.59 152.85 43.04 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.71 101.13 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 112.163 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -120.03 67.82 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.048 0.451 . . . . 0.0 110.566 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -68.66 152.68 45.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.615 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.86 112.89 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.55 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.55 HH11 ' CG ' ' A' ' 159' ' ' ASP . 15.3 mtt-85 -140.91 121.89 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.33 149.43 22.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 m -139.74 156.66 46.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.124 0.488 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CE2' HD21 ' A' ' 243' ' ' LEU . 25.8 t80 -165.04 138.06 4.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.714 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.18 -104.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.65 52.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -137.85 148.18 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.305 -179.588 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -143.1 144.01 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.56 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.11 133.12 34.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.31 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.55 ' CG ' HH11 ' A' ' 150' ' ' ARG . 55.9 t0 -113.79 107.68 16.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.854 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -66.98 -14.77 63.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.011 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.49 -48.66 7.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 163' ' ' HIS . 76.9 p -97.64 8.59 44.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.522 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 162' ' ' THR . 20.8 m80 37.67 54.57 1.5 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -128.61 156.0 44.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.13 152.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.83 127.2 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.919 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 170' ' ' GLN . 6.2 tmtt? -130.38 117.58 19.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.281 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.61 64.51 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.28 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.56 28.54 65.28 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 167' ' ' LYS . 8.4 tt0 -129.92 92.26 37.39 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.47 140.61 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.261 1.974 . . . . 0.0 112.392 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.3 135.75 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.1 OUTLIER -88.22 95.73 10.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.723 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.04 150.61 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.782 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.57 170.51 14.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.483 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -47.82 -54.22 5.49 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.658 2.238 . . . . 0.0 112.569 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -52.25 -61.0 2.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.996 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -56.76 -39.68 74.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.43 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -62.65 -46.37 88.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.31 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 m -59.4 -40.28 86.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.266 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -44.82 95.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.646 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.46 -46.7 87.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.29 -45.83 80.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.381 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.686 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.765 -179.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.77 -45.6 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.745 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.67 -46.81 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.34 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mt -65.71 -23.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.208 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.475 HD22 HD11 ' A' ' 193' ' ' LEU . 7.6 m-20 -107.54 27.37 9.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.846 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.41 109.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.619 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.83 -8.86 61.68 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 49.5 m -98.66 122.45 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 242' ' ' VAL . 95.2 t -68.04 118.15 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 188' ' ' ASN . 1.5 mt -97.89 166.08 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.638 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.66 147.25 34.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 2.6 mtpm? -58.01 -55.12 48.54 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.252 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 29.3 Cg_endo -67.89 -29.67 34.34 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.835 1.69 . . . . 0.0 111.72 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -66.57 -50.75 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.843 179.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 mt -55.24 -42.18 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.66 -69.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.599 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.71 -27.64 12.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.961 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.686 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 1.0 OUTLIER -71.54 -51.49 23.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.129 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.3 t -84.28 -61.79 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.211 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.48 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -48.27 -3.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.723 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.7 OUTLIER -55.16 -7.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.321 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.48 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER -112.27 26.23 10.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.746 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER 164.83 100.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.557 -179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 207' ' ' PHE . 0.2 OUTLIER -81.23 104.89 12.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.42 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.09 54.97 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -155.51 100.42 0.19 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.516 ' O ' HG12 ' A' ' 213' ' ' VAL . 23.0 m-20 -51.89 -173.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.811 0.339 . . . . 0.0 110.249 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.13 -12.97 12.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -81.01 -17.84 48.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.364 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -66.68 -39.45 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.585 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.449 ' N ' ' CG1' ' A' ' 213' ' ' VAL . 94.2 t -58.07 -50.02 79.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.44 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -56.12 -46.87 79.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.572 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 6.3 t -61.25 -45.94 92.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -63.53 -41.51 98.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.056 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.73 -40.82 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -66.11 -44.05 85.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.443 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -15.12 62.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.02 -45.64 13.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 226' ' ' ASP . 5.8 mtp-105 -59.22 -46.75 87.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.788 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -67.72 -10.46 52.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.525 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -93.04 -35.78 13.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.317 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.5 -26.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -95.2 137.3 34.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.793 -179.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -174.12 26.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.006 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.76 166.62 13.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -74.66 -9.86 58.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 2.7 pttp -92.86 130.5 38.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.725 ' C ' HD12 ' A' ' 232' ' ' LEU . 11.2 mtp180 -83.47 156.02 23.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.711 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.725 HD12 ' C ' ' A' ' 231' ' ' ARG . 5.6 mp -147.55 -41.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 109.93 22.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.415 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -94.0 123.83 37.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.334 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 27.1 m -92.01 109.41 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.939 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.6 69.26 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.313 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -39.25 120.49 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.008 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.97 -23.26 28.0 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.35 -41.66 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.697 0.284 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.24 -137.71 7.78 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.31 154.62 48.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.723 0.297 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 192' ' ' VAL . 7.3 p -138.45 131.38 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.933 0.397 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 153' ' ' PHE . 57.8 tp -91.2 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.478 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.14 135.93 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -78.15 151.3 78.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.191 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.67 144.73 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.406 2.071 . . . . 0.0 112.216 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.687 -179.963 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.46 159.05 8.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.19 126.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.561 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.31 -72.04 0.72 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -50.75 -177.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 -179.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.454 ' O ' ' CB ' ' A' ' 126' ' ' HIS . 1.6 p80 -137.76 21.43 2.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.454 ' CB ' ' O ' ' A' ' 125' ' ' HIS . 1.1 t-80 78.01 148.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.215 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -100.16 172.11 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.437 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 128' ' ' HIS . 0.0 OUTLIER -107.14 147.87 29.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.657 -179.338 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -25.79 14.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -16.66 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.239 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 44.78 90.49 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -106.63 65.51 0.26 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 mp -121.44 -22.12 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.851 0.358 . . . . 0.0 110.636 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t 53.99 67.37 3.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -47.49 -25.4 5.13 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.724 2.283 . . . . 0.0 111.642 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 57.43 -94.29 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.093 179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 158.83 140.3 2.88 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.06 -9.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.031 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.416 ' ND1' ' N ' ' A' ' 139' ' ' HIS . 9.9 m80 -90.92 -45.38 8.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.1 mtp -99.43 75.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.355 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.569 ' C ' ' H ' ' A' ' 143' ' ' ASN . 0.7 OUTLIER -152.22 -37.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.376 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 144' ' ' LYS . . . 69.3 -20.86 0.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.569 ' H ' ' C ' ' A' ' 141' ' ' LYS . 7.4 m120 -49.72 84.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -112.35 -71.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.387 179.497 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.15 156.04 71.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.539 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.93 140.49 55.16 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.699 2.266 . . . . 0.0 112.239 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 148' ' ' ASN . 72.5 mtt-85 -116.54 17.23 15.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.494 HD22 ' CD ' ' A' ' 161' ' ' GLU . 1.2 m120 58.59 141.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.734 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.48 112.62 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.753 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -120.54 123.42 42.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.955 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 mt -89.56 153.1 21.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.67 156.19 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.001 0.429 . . . . 0.0 110.829 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.0 t80 -165.43 128.56 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.596 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.01 -99.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 153' ' ' PHE . 56.7 m-20 -125.44 53.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.65 150.05 25.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.193 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -140.33 143.32 35.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.138 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.67 137.47 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 150' ' ' ARG . 2.1 m-20 -112.68 104.59 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 110.351 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.08 -10.65 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.72 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.494 ' CD ' HD22 ' A' ' 148' ' ' ASN . 2.8 mt-10 -98.6 -43.35 6.87 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 163' ' ' HIS . 82.3 p -98.58 9.47 43.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 162' ' ' THR . 16.8 m-70 37.18 47.3 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.775 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -124.1 161.39 25.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.832 0.348 . . . . 0.0 110.744 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.03 156.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.987 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.73 125.58 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' A' ' 170' ' ' GLN . 13.7 tmtt? -123.76 110.75 15.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.08 62.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.71 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 64.5 28.31 72.98 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 167' ' ' LYS . 25.4 tt0 -139.63 105.78 6.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.19 144.46 29.67 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.718 1.612 . . . . 0.0 112.466 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.88 138.91 50.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.9 t -86.14 138.86 31.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.281 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.1 mt -142.85 99.6 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.656 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 171.02 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -46.88 -60.4 0.89 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.487 2.124 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.423 ' OG1' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -53.33 -56.68 14.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.315 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 178' ' ' GLU . 2.6 mm-40 -59.25 -36.76 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.761 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -60.92 -47.24 87.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.582 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.9 m -58.8 -41.54 86.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.417 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 202' ' ' VAL . 4.4 tp -58.39 -51.61 69.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.659 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.7 tp -61.33 -43.03 99.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.582 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -46.73 83.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.594 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.479 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 4.5 t80 -67.41 -39.14 85.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.676 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -43.84 79.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -70.03 -47.41 68.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -53.51 -36.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.434 ' ND2' ' CD2' ' A' ' 184' ' ' TYR . 20.5 m-80 -108.97 28.8 8.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.001 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.65 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.16 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.15 -22.49 22.89 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 m -95.29 135.26 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.055 0.455 . . . . 0.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 242' ' ' VAL . 84.9 t -69.19 123.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.058 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.4 mp -96.15 154.4 17.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.093 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.65 147.87 30.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.953 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 7.5 mtmt -57.83 -55.03 49.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.792 179.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 26.8 Cg_endo -67.63 -29.97 35.61 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.023 1.816 . . . . 0.0 111.949 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -68.33 -49.34 60.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 109.973 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 mt -55.98 -42.23 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.805 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 199' ' ' LEU . 29.7 tp -59.2 -63.71 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -52.87 -28.83 24.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 19.3 t-80 -71.92 -48.34 46.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 204' ' ' ARG . 47.7 t -84.37 -61.52 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 205' ' ' TYR . 1.2 m-90 -53.23 -3.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.315 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 202' ' ' VAL . 5.3 ttp180 -61.59 0.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 110.636 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.3 m-85 -121.52 13.18 10.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.423 ' O ' ' CD1' ' A' ' 203' ' ' TRP . 0.2 OUTLIER 175.07 100.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.633 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.11 110.16 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.234 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.39 48.86 0.03 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -159.06 104.23 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 209' ' ' GLY . 10.7 m-20 -49.21 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 110.877 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.64 -8.96 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.64 -17.64 50.6 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.345 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.28 -40.01 85.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.072 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 218' ' ' VAL . 87.8 t -56.76 -50.51 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.12 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.52 -48.49 71.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.579 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.2 m -60.74 -47.77 84.82 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -61.6 -40.52 95.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.618 HG21 ' CE2' ' A' ' 241' ' ' TYR . 73.0 t -62.69 -43.27 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -43.92 97.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -66.14 -37.52 85.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 221' ' ' LEU . 1.0 OUTLIER -60.91 -48.14 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.311 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 226' ' ' ASP . 4.6 mtp85 -56.19 -43.18 78.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.494 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -67.06 -17.22 64.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.205 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -96.19 -32.29 12.54 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.57 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -109.53 -33.72 2.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.268 -178.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -104.49 137.83 41.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.771 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.73 27.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.404 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.59 -176.5 14.62 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.54 -8.7 57.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 110.481 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -91.67 104.81 17.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.692 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -96.15 104.46 16.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.7 -7.23 50.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.215 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.0 mt -116.52 112.23 21.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.296 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.418 ' HB2' HG13 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -95.2 126.85 40.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.401 -179.936 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 111.9 23.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.42 70.58 3.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -43.61 112.31 0.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.541 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 116.36 -13.24 16.04 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.94 -54.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 110.724 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 158.3 -139.25 6.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 218' ' ' VAL . 0.6 OUTLIER -128.43 155.35 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 0.0 110.467 179.89 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 192' ' ' VAL . 4.1 p -137.05 135.57 47.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.83 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.9 tp -91.62 126.32 36.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -162.53 135.7 5.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.178 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -68.97 154.94 94.49 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.489 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 161.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.804 2.336 . . . . 0.0 112.169 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.525 179.973 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 11.1 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -47.19 95.4 0.01 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.2 p -59.51 -30.46 68.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.733 0.301 . . . . 0.0 110.374 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t -88.0 147.48 24.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.58 -74.05 0.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.1 -162.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.554 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -101.68 -168.99 1.62 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -105.41 -13.75 15.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -80.53 108.14 13.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 130' ' ' SER . 21.4 t-80 -50.48 -103.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.439 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.56 ' N ' ' CG ' ' A' ' 129' ' ' HIS . 2.6 p 54.32 -164.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.219 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 46.8 t -112.01 154.02 25.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.372 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -156.2 50.08 0.45 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.6 168.84 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.636 0.255 . . . . 0.0 110.626 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.07 78.71 11.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.211 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.5 91.59 0.98 Allowed 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.454 2.103 . . . . 0.0 111.563 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -47.92 148.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.321 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -105.22 101.25 1.85 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 t -52.68 -61.19 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.57 137.34 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.766 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.6 mmt -122.99 123.17 40.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -90.24 107.57 19.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.074 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.06 61.48 1.34 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -83.55 92.88 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.34 . . . . 0.0 110.622 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -118.6 114.94 23.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.06 158.34 75.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.302 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.11 177.34 6.62 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.5 2.134 . . . . 0.0 112.012 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 148' ' ' ASN . 38.2 mtm180 -61.16 161.34 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.536 ' CG ' HH21 ' A' ' 150' ' ' ARG . 71.2 m-80 -38.88 142.28 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.664 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.65 118.98 45.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.421 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.536 HH21 ' CG ' ' A' ' 148' ' ' ASN . 4.5 ptt180 -174.63 153.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.713 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 186' ' ' VAL . 1.7 mm? -92.37 153.86 18.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.317 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 152.37 41.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.67 ' CE2' HD21 ' A' ' 243' ' ' LEU . 1.6 t80 -163.7 128.08 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.812 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.75 -99.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 1.6 m-20 -124.82 53.82 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 0.0 109.836 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -137.63 142.38 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -136.49 140.16 42.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.887 0.375 . . . . 0.0 110.738 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.446 HD23 HG22 ' A' ' 165' ' ' VAL . 1.1 mp -136.32 124.2 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -102.59 104.87 15.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.534 -179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.588 ' OE2' ' N ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -65.97 -12.72 57.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.588 ' N ' ' OE2' ' A' ' 160' ' ' GLU . 3.1 tt0 -81.63 -52.38 7.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 163' ' ' HIS . 80.5 p -97.32 14.88 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 162' ' ' THR . 24.4 m80 35.78 63.79 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.601 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -140.45 162.4 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 174' ' ' LEU . 16.5 t -116.18 161.61 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.498 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -147.14 128.54 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.63 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.0 OUTLIER -128.08 110.72 12.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.559 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.08 67.46 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.01 32.06 62.19 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -142.37 87.52 9.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.37 136.42 50.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.197 1.931 . . . . 0.0 112.133 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.4 152.41 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.129 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.3 m -90.11 126.62 35.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.145 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 165' ' ' VAL . 14.2 mt -141.03 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.758 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.62 171.87 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.81 -53.81 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.556 2.171 . . . . 0.0 112.096 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -57.47 -52.73 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.783 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.29 -39.6 93.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -59.78 -46.61 88.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.362 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.7 m -59.21 -40.44 85.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.362 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -45.89 91.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.16 -43.16 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.928 0.394 . . . . 0.0 110.163 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -55.64 -45.18 77.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.334 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.685 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 3.0 t80 -64.8 -44.05 91.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.43 -44.81 65.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 151' ' ' LEU . 10.7 t -68.69 -49.09 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.819 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 mm -54.13 -34.57 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 188' ' ' ASN . 0.0 OUTLIER -109.53 27.53 9.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.561 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.38 116.55 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.36 -17.99 42.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.1 m -90.14 125.09 35.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.765 0.317 . . . . 0.0 110.93 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.76 115.46 5.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.962 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.91 160.44 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.677 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.45 148.43 29.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.697 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 12.9 mtpt -55.24 -53.37 62.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.8 Cg_endo -68.43 -29.77 30.71 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -46.22 74.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.0 mt -63.16 -39.51 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.89 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 199' ' ' LEU . 3.7 tt -59.17 -51.4 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.724 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -72.49 -19.74 61.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.685 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 30.6 t-80 -71.39 -41.79 69.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.674 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.3 t -82.72 -53.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.587 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 205' ' ' TYR . 2.2 m-90 -67.29 -5.34 13.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.735 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.436 ' O ' ' NE ' ' A' ' 204' ' ' ARG . 0.4 OUTLIER -44.07 -13.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.895 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -98.5 25.61 6.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.19 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER 174.19 -167.49 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.22 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -68.91 159.99 31.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.928 0.394 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -71.82 -176.96 27.36 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -141.82 -157.01 7.0 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 212' ' ' ASN . 2.3 m-20 -86.17 128.01 34.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.098 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.3 m -58.59 1.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.622 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.556 ' H ' ' C ' ' A' ' 210' ' ' ASP . 70.2 m-20 -96.2 -24.03 16.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 p -61.65 -31.41 50.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.33 -53.04 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.854 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -55.34 -43.83 75.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.562 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -60.59 -49.5 77.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.962 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.81 -38.44 91.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.434 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.81 -42.75 97.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.298 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -45.29 92.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.47 -31.33 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 mp -73.33 -44.43 58.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 226' ' ' ASP . 0.0 OUTLIER -55.17 -41.79 72.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 31.3 mtm-85 -67.8 -22.0 65.2 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -25.11 19.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -116.31 -38.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.978 -179.526 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 222' ' ' ARG . 3.7 t70 -98.48 146.27 25.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.483 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.4 t 175.45 -30.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.281 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -72.35 163.65 54.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -64.5 -4.24 3.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 110.713 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -92.71 131.26 37.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -86.99 158.12 19.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.16 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 232' ' ' LEU . 82.4 mt -147.55 -48.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.291 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.54 119.31 38.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 124.49 41.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.264 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -91.68 109.93 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 237' ' ' ARG . 30.0 mt -93.22 71.79 4.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 236' ' ' LEU . 89.9 mtt180 -37.02 123.93 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.601 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.3 -39.82 2.74 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.1 -60.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.92 0.391 . . . . 0.0 110.659 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.08 -137.02 4.52 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -127.29 155.66 43.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.978 0.418 . . . . 0.0 110.645 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.39 140.2 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.753 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 153' ' ' PHE . 27.8 tp -93.39 111.39 23.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.262 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.26 131.97 5.21 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.255 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -69.95 155.33 93.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.049 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.51 108.23 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.477 2.118 . . . . 0.0 112.034 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.64 -179.913 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.521 ' O ' ' SD ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 148.58 121.09 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.74 -50.03 27.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.263 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.4 t 57.88 44.83 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.664 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -68.79 -61.73 1.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.431 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -87.03 177.14 7.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.046 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -110.27 167.74 9.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 110.53 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -120.63 86.53 2.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.426 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -179.45 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.409 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.66 ' CG ' ' H ' ' A' ' 130' ' ' SER . 8.1 t60 -82.33 -148.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.18 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.66 ' H ' ' CG ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -107.97 161.69 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.815 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.8 t -156.74 56.46 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.748 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.61 -79.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.89 -166.13 1.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 110.427 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.91 71.86 77.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.701 179.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' ARG . 50.8 Cg_exo -45.49 116.79 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.887 2.392 . . . . 0.0 112.186 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' PRO . 2.6 mtt-85 38.07 62.75 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.245 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.39 90.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.42 114.27 8.47 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -58.2 -106.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 140' ' ' MET . 12.6 mtt -54.89 -175.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -131.9 81.34 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.94 -14.76 73.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -81.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.9 tttt 55.08 94.4 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -158.06 148.5 15.86 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.94 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.48 167.71 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.237 1.958 . . . . 0.0 111.846 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.13 99.05 8.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.507 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -88.51 103.22 15.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.454 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 149' ' ' VAL . 0.3 OUTLIER -80.27 139.56 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.286 179.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.438 HH21 ' CG ' ' A' ' 148' ' ' ASN . 2.4 ptt180 -174.74 153.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.225 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -91.15 148.07 22.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.089 0.471 . . . . 0.0 111.039 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.5 m -140.19 155.43 46.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.201 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 155' ' ' ASP . 70.3 t80 -156.86 124.93 5.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.005 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 37.77 -93.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 153' ' ' PHE . 7.8 m-20 -124.86 52.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.75 138.43 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.984 179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -134.99 133.02 39.03 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.715 179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 165' ' ' VAL . 4.5 mt -131.43 120.85 23.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 163' ' ' HIS . 0.7 OUTLIER -109.18 113.82 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.546 -179.521 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.95 -42.33 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.5 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.5 -47.18 57.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.1 p -103.62 8.99 37.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 162' ' ' THR . 0.7 OUTLIER 36.91 46.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.573 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.32 165.65 14.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.951 0.405 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 174' ' ' LEU . 11.1 t -121.26 159.33 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.639 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.433 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -146.41 120.67 9.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.485 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.7 OUTLIER -118.25 105.12 11.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.237 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.84 63.42 0.31 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.52 27.5 73.39 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.8 tt0 -134.05 94.63 18.01 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.612 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.59 134.12 10.87 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.291 1.994 . . . . 0.0 111.989 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.89 134.99 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.374 -178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.2 p -81.76 100.04 9.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.352 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 165' ' ' VAL . 15.1 mt -96.62 154.31 17.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.99 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.95 160.91 65.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.964 179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -51.55 -43.07 52.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.537 2.158 . . . . 0.0 111.624 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -55.37 30.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.644 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.58 ' HB3' HD22 ' A' ' 174' ' ' LEU . 0.8 OUTLIER -59.64 -36.26 76.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.299 179.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -58.11 -52.78 64.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.37 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 23.1 m -57.47 -43.43 84.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.777 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -53.44 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.05 -41.5 95.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.928 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -55.54 -46.5 77.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.781 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 188' ' ' ASN . 29.7 t80 -64.35 -42.53 96.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.18 -43.86 83.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.47 -43.68 94.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.988 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.02 -29.59 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' A' ' 184' ' ' TYR . 29.2 m-80 -113.99 23.25 13.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.109 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.23 121.36 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.776 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 110.59 -20.86 24.51 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 m -95.81 131.18 42.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 111.042 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 192' ' ' VAL . 10.7 p -69.44 115.61 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 198' ' ' ILE . 3.7 mp -96.9 160.24 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.487 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.76 148.1 31.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.413 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -57.0 -50.14 89.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.751 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.4 Cg_endo -65.78 -34.59 39.68 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.56 1.507 . . . . 0.0 112.219 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.95 -47.6 65.28 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.108 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 193' ' ' LEU . 19.3 mt -53.82 -40.91 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.991 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.652 ' HG ' HG21 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -62.29 -64.44 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.475 179.768 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.55 -27.65 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.294 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 184' ' ' TYR . 0.1 OUTLIER -71.14 -51.58 24.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.762 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 204' ' ' ARG . 19.8 t -83.71 -61.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.239 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.498 ' HE1' ' N ' ' A' ' 209' ' ' GLY . 0.6 OUTLIER -50.6 -4.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -179.384 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 202' ' ' VAL . 7.1 ttm180 -61.98 -1.44 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.852 0.358 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.2 OUTLIER -117.13 11.43 14.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.65 108.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.632 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -85.3 120.24 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.448 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.67 52.19 0.02 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.498 ' N ' ' HE1' ' A' ' 203' ' ' TRP . . . -156.35 102.1 0.21 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -174.28 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 1.4 p -85.53 -7.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.94 -49.31 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 214' ' ' VAL . 8.1 p -54.75 -42.96 64.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.044 0.45 . . . . 0.0 110.009 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.836 ' O ' HG23 ' A' ' 218' ' ' VAL . 41.1 t -58.95 -44.85 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -61.13 -47.1 87.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.339 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.8 m -60.28 -41.03 92.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.984 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -64.09 -42.05 97.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.25 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 214' ' ' VAL . 52.4 t -62.4 -40.32 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -45.15 74.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.313 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -13.07 62.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.432 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -57.09 3.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.239 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 24.2 ptt180 -57.54 -37.85 73.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.705 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.424 ' NH2' HH21 ' A' ' 222' ' ' ARG . 1.4 mtt-85 -69.0 -20.76 64.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.675 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -94.87 -27.56 15.66 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.805 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.445 HG21 ' HZ1' ' A' ' 167' ' ' LYS . 1.8 pp -114.85 -27.62 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.839 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.6 OUTLIER -102.84 139.04 38.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.997 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.83 -33.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.514 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -46.01 163.64 0.12 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.95 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -94.45 106.43 18.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -74.06 107.21 6.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.458 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.81 1.12 56.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.587 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 3.2 mt -126.58 96.23 4.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.709 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . 0.439 ' HB2' ' HE ' ' A' ' 244' ' ' ARG . 0.1 OUTLIER -87.93 122.06 31.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 179.808 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.409 HG23 ' CD2' ' A' ' 241' ' ' TYR . 23.7 m -93.26 113.68 25.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.1 mt -95.27 72.14 3.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.499 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -39.06 120.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.754 179.821 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.51 -17.58 30.79 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.584 179.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 63.6 t -128.33 -55.11 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 162.12 -137.25 4.76 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.8 OUTLIER -131.24 155.16 47.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 110.265 179.82 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 242' ' ' VAL . 8.2 p -138.17 131.29 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.159 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.41 104.64 16.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.374 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.458 ' HG3' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -162.24 153.48 17.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.63 179.424 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -78.03 155.62 79.94 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.53 117.66 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.407 2.071 . . . . 0.0 112.129 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.551 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 142.34 -65.03 0.49 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.5 p -69.93 150.83 46.31 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.79 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.013 0.435 . . . . 0.0 111.186 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.62 -25.04 0.37 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.011 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -79.48 -25.5 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.418 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -61.99 -25.51 67.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.801 -179.723 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -53.66 86.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.332 179.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.633 ' N ' ' ND1' ' A' ' 128' ' ' HIS . 0.2 OUTLIER 57.26 -149.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.682 179.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -139.35 -85.55 0.24 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.944 0.402 . . . . 0.0 110.551 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 132' ' ' GLY . 10.4 t -115.97 -141.08 0.37 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.865 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.59 -13.57 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.653 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 130' ' ' SER . . . 46.05 -108.22 0.23 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.699 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 134' ' ' VAL . 29.4 m -141.09 69.16 28.26 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' GLY . 46.6 Cg_exo -49.32 159.05 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.724 2.283 . . . . 0.0 112.041 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -63.04 -1.53 0.97 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.272 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' PRO . . . 85.36 -55.77 4.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 t -145.08 144.65 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 110.509 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.421 ' CD2' ' H ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -131.11 -7.77 3.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.465 -179.943 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.6 mtm -66.33 -12.65 57.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -74.07 112.26 10.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.665 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -146.87 -92.63 0.11 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.14 -68.6 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.362 . . . . 0.0 110.257 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.9 mttt 61.47 41.76 12.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.467 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 50.09 69.48 2.61 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.749 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 147' ' ' ARG . 40.9 Cg_exo -53.41 92.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.806 2.337 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 146' ' ' PRO . 57.1 mtm180 59.35 122.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.501 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -170.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.35 116.19 37.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.722 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -136.41 127.26 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.368 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.6 mt -90.57 152.72 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.194 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.95 148.97 39.5 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.15 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 243' ' ' LEU . 84.2 t80 -158.74 127.47 5.39 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.89 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.38 -99.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 153' ' ' PHE . 25.8 m-20 -123.94 53.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 145.06 29.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.256 -179.553 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.42 149.06 50.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.434 179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.35 121.87 8.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.137 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.79 27.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 -179.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.476 ' OE1' ' NH2' ' A' ' 183' ' ' ARG . 8.0 mt-10 -66.57 -22.42 66.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.625 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.0 -52.11 52.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' HIS . 70.4 p -108.18 14.79 24.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 160' ' ' GLU . 9.6 m80 37.22 54.74 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -120.86 156.79 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 174' ' ' LEU . 2.0 t -119.85 157.9 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.65 137.76 25.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.472 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 0.1 OUTLIER -130.6 110.08 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 179.748 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 31.06 60.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.263 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.38 21.83 76.12 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.0 mt-30 -134.98 104.89 10.51 Favored Pre-proline 0 C--N 1.327 -0.411 0 O-C-N 122.823 -0.222 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.39 144.72 26.14 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.889 1.726 . . . . 0.0 112.618 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.3 t -125.24 136.43 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.712 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.5 t -97.97 127.17 43.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.679 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.889 HD12 ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -140.65 124.68 17.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.891 0.376 . . . . 0.0 110.539 179.707 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -45.67 174.57 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -179.617 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.7 -47.6 26.37 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.544 2.163 . . . . 0.0 111.853 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -52.34 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.07 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.52 -38.75 88.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.878 0.371 . . . . 0.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -48.39 81.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.711 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 89.2 m -59.38 -42.64 92.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.206 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 202' ' ' VAL . 0.8 OUTLIER -56.85 -50.8 71.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.015 -179.704 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.95 -43.5 98.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.746 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.476 ' NH2' ' OE1' ' A' ' 160' ' ' GLU . 2.3 ttt180 -60.21 -48.89 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.43 -39.41 93.79 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.555 -179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.446 ' HD1' HD12 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -59.03 -43.14 91.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.19 -47.11 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.644 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.27 -27.65 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.062 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.54 18.54 20.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.462 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.53 120.23 6.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.44 -24.37 13.95 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 46.7 m -94.72 126.73 40.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.747 0.308 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 192' ' ' VAL . 11.8 p -68.11 118.4 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.16 179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 198' ' ' ILE . 8.0 mp -96.35 161.4 13.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.314 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.47 148.0 30.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.287 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.469 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -55.41 -55.75 36.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.034 179.907 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 25.3 Cg_endo -66.58 -33.6 35.72 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.962 1.774 . . . . 0.0 112.142 -179.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -46.33 85.63 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.413 HG12 HD23 ' A' ' 193' ' ' LEU . 36.8 mt -60.99 -39.09 81.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.579 HD22 HG22 ' A' ' 211' ' ' VAL . 8.6 tp -61.94 -51.5 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.144 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.32 -28.87 69.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.019 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.85 -58.5 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.505 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.677 HG21 HD12 ' A' ' 181' ' ' LEU . 39.6 t -84.34 -60.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.013 -178.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.438 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -51.04 -5.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.776 0.322 . . . . 0.0 110.834 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 202' ' ' VAL . 4.9 ttp85 -61.4 -1.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.795 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -111.96 9.86 20.52 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.985 -179.775 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -171.04 67.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 0.0 110.629 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.86 171.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.404 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.17 61.18 1.76 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -161.11 102.44 0.21 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 212' ' ' ASN . 0.0 OUTLIER -43.09 139.09 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.245 0.545 . . . . 0.0 110.434 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.579 HG22 HD22 ' A' ' 199' ' ' LEU . 24.5 t -55.3 0.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 210' ' ' ASP . 37.3 m-20 -83.66 -12.41 55.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.57 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.11 -35.27 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.399 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.473 ' O ' HG23 ' A' ' 218' ' ' VAL . 21.9 t -55.92 -55.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.052 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.29 -48.56 68.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.126 0.489 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.3 t -58.07 -50.53 73.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.026 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.51 -37.26 83.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.135 0.493 . . . . 0.0 110.533 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 214' ' ' VAL . 35.1 t -62.04 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.3 t -60.56 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.52 -39.89 94.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.463 179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.73 -45.68 88.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.42 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 226' ' ' ASP . 6.0 mmm-85 -56.68 -42.29 78.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.392 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -66.15 -22.5 66.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.634 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -93.22 -30.44 15.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.671 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -110.45 -37.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.885 0.374 . . . . 0.0 110.766 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 222' ' ' ARG . 1.5 t70 -95.02 145.18 25.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.156 -179.458 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 179.91 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.461 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -63.53 -178.57 4.92 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -79.34 -11.21 59.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -94.4 104.89 16.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.026 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -92.08 109.37 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.265 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 243' ' ' LEU . 2.5 mp -91.81 -9.07 44.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.445 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.72 127.25 56.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.132 179.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.96 124.57 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.381 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.3 m -97.61 113.74 25.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.327 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 240' ' ' GLY . 7.2 mt -96.11 72.66 2.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.632 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -39.78 115.19 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.51 -20.42 20.71 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.795 179.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.3 -50.02 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.915 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 158.59 -145.64 11.94 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.0 OUTLIER -131.48 152.71 50.47 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.538 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.13 137.45 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.8 OUTLIER -91.21 127.09 36.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.652 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.435 ' HB3' HH11 ' A' ' 244' ' ' ARG . 3.9 ptm85 -163.61 131.1 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 111.126 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.76 158.27 86.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.736 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.14 113.4 3.26 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.671 2.247 . . . . 0.0 112.152 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.945 -179.671 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.435 ' CG ' ' O ' ' A' ' 120' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.388 0.613 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.96 -131.56 3.08 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.79 130.05 45.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.924 0.393 . . . . 0.0 110.832 179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 125' ' ' HIS . 5.3 p -102.58 25.51 9.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -47.4 94.41 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.493 0.663 . . . . 0.0 110.274 -179.585 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 123' ' ' SER . 2.2 t-80 -78.36 123.74 27.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.286 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -135.56 -71.01 0.47 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 67.92 170.75 0.27 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.498 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.426 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 15.9 m80 -74.26 -76.17 0.14 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.745 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 128' ' ' HIS . 7.2 t60 74.69 139.63 0.06 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.159 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' HIS . 1.5 m 37.6 64.29 0.67 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.416 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 t -81.97 -42.84 18.85 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.889 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -146.99 -54.97 0.02 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.3 mt -100.83 144.07 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.713 0.292 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -111.88 156.8 41.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.993 -179.807 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.07 2.39 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.265 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 134' ' ' VAL . 3.7 tpp180 71.71 29.67 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.64 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 136' ' ' ARG . . . 33.39 -106.84 0.03 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' HIS . 20.5 m 49.91 -117.96 1.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 138' ' ' SER . 2.0 m-70 -45.18 169.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.481 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 2.6 mtt 55.44 -158.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.135 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.2 158.11 16.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.36 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.93 152.32 22.94 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 112.79 2.47 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.659 -0.318 . . . . 0.0 110.767 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -106.25 123.26 47.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.228 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 147' ' ' ARG . 20.5 mt-10 -93.07 150.61 39.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.569 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -41.64 89.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.083 1.855 . . . . 0.0 111.804 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 145' ' ' GLU . 32.8 mtt180 -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.205 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 147' ' ' ARG . 99.1 m-20 57.4 135.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.991 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.05 111.58 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.726 179.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -121.65 124.67 44.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.296 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.864 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.5 m -142.33 160.78 39.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.613 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' O ' ' N ' ' A' ' 156' ' ' ILE . 69.6 t80 -165.53 128.72 2.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.53 -99.82 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.241 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 153' ' ' PHE . 22.8 p30 -122.76 53.7 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -138.55 155.04 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.707 -179.64 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -146.84 140.58 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.604 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.407 ' CD2' HG22 ' A' ' 165' ' ' VAL . 2.4 mt -137.16 136.32 38.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -110.88 104.09 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.133 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.42 -11.08 39.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.902 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -96.92 -51.02 4.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.83 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.539 ' C ' ' CG ' ' A' ' 163' ' ' HIS . 30.8 p -93.89 9.99 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.503 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 162' ' ' THR . 8.5 p-80 37.11 58.49 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -127.81 157.37 40.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.54 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 158' ' ' LEU . 6.0 t -121.64 151.46 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.325 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.23 125.19 12.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 170' ' ' GLN . 23.8 tttp -124.49 115.24 20.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.611 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 29.87 59.55 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.66 75.26 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 179.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 167' ' ' LYS . 48.2 mt-30 -130.5 95.28 27.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.7 138.99 12.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.121 1.881 . . . . 0.0 112.375 -179.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.61 145.26 34.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.381 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 173' ' ' SER . 0.0 OUTLIER -94.28 100.09 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 174' ' ' LEU . 11.1 mp -96.07 150.38 20.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.578 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.36 168.44 22.48 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.293 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.68 -52.17 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.367 2.045 . . . . 0.0 112.322 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -47.65 85.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.71 -37.5 84.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.615 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 1.8 t80 -64.71 -49.24 71.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.5 m -57.31 -46.04 83.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.411 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.55 -49.6 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.791 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.84 -44.77 96.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.548 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -59.75 -46.36 89.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 201' ' ' HIS . 2.3 t80 -62.27 -42.25 99.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.819 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 243' ' ' LEU . 0.1 OUTLIER -59.63 -43.99 93.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.337 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.19 -45.35 86.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.556 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.3 mm -57.35 -35.58 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -110.18 23.16 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.274 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.02 119.08 4.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 0.0 110.999 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.52 -26.83 9.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 127.62 35.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.326 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 192' ' ' VAL . 8.2 p -67.88 114.48 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.96 157.5 15.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.538 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 149.83 28.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.718 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 1.8 mttt -57.12 -49.44 93.95 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.459 179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 20.0 Cg_endo -65.36 -35.43 40.02 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.56 1.507 . . . . 0.0 111.933 -179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -66.33 -55.48 15.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.029 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.9 mt -49.93 -38.1 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.231 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 209' ' ' GLY . 48.7 tp -65.06 -68.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.534 179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -46.05 -27.42 0.94 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.572 ' NE2' ' CE1' ' A' ' 184' ' ' TYR . 24.8 t-80 -71.53 -52.29 19.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.062 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 204' ' ' ARG . 46.1 t -83.42 -56.04 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.434 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.6 OUTLIER -51.68 -4.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.458 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.541 ' H ' ' C ' ' A' ' 202' ' ' VAL . 48.1 ttm-85 -58.69 -6.44 0.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 203' ' ' TRP . 0.3 OUTLIER -114.87 14.25 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.519 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.66 116.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.074 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 207' ' ' PHE . 0.0 OUTLIER -91.16 119.28 31.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.429 179.561 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 160.82 53.42 0.02 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.535 ' O ' HD21 ' A' ' 199' ' ' LEU . . . -159.74 98.21 0.17 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 209' ' ' GLY . 44.1 m-20 -47.87 -177.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 211' ' ' VAL . 4.4 p -80.33 -9.6 12.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.644 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -85.83 -17.97 34.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.18 -35.04 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.298 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 218' ' ' VAL . 61.1 t -58.27 -49.51 81.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.322 179.453 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -58.4 -47.07 85.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.278 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 m -59.78 -45.35 92.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.38 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -45.34 94.79 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 214' ' ' VAL . 59.6 t -62.2 -40.2 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.358 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -44.79 90.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.592 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.49 -28.5 66.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.572 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.61 -47.3 63.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 226' ' ' ASP . 3.1 mtp85 -57.02 -45.56 83.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.319 179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -67.41 -10.14 48.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -90.58 -44.27 9.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 110.881 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.9 pp -110.14 -32.78 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.1 OUTLIER -95.23 143.47 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 110.411 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.9 t -175.33 38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.06 -163.25 10.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -90.54 -20.54 22.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.518 ' H ' ' CD ' ' A' ' 230' ' ' LYS . 0.0 OUTLIER -92.23 104.0 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.208 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -88.75 125.86 35.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.4 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.754 ' O ' HD23 ' A' ' 243' ' ' LEU . 3.0 mt -91.25 -8.8 47.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.63 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 2.6 mp -121.6 116.32 24.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.183 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 127.57 37.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.46 105.88 18.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.995 -179.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.6 mt -94.59 73.1 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.14 136.36 5.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.708 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.18 -12.74 65.41 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.15 -46.06 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.242 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 241' ' ' TYR . . . 147.13 -141.77 9.68 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 240' ' ' GLY . 0.1 OUTLIER -131.12 153.59 49.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 0.0 110.476 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.48 136.61 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.94 0.4 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.754 HD23 ' O ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -91.41 119.92 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.414 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -163.03 127.12 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -56.97 154.97 16.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.148 179.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -36.57 140.13 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.852 2.368 . . . . 0.0 112.075 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.48 -179.886 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.0 tmm? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.62 170.65 12.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.4 t -124.77 -38.34 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.364 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 93.0 p -149.42 169.44 20.86 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.833 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -79.85 93.86 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.349 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -42.77 136.7 2.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.483 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.86 156.55 44.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 129' ' ' HIS . 10.5 m170 55.48 62.12 2.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.697 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -73.07 11.54 0.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.752 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.423 ' H ' ' C ' ' A' ' 127' ' ' HIS . 33.2 t-80 46.29 88.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.09 115.61 22.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.832 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.1 p -77.83 64.83 3.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -80.58 93.8 1.49 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.14 123.78 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.84 154.07 37.44 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.463 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.79 -164.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.967 2.445 . . . . 0.0 112.618 -179.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -153.56 15.1 0.5 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.525 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.54 -165.77 26.01 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 139' ' ' HIS . 9.5 t -90.82 -3.81 57.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.171 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' SER . 1.7 t-80 60.84 127.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.254 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 36.5 mtt -119.26 -108.51 0.36 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.02 -8.46 3.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.312 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.32 142.57 3.49 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.45 -15.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.939 0.399 . . . . 0.0 110.419 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -65.31 167.93 7.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.555 -179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER 177.88 -49.62 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.4 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 145' ' ' GLU . 49.6 Cg_exo -51.0 161.03 1.62 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.362 2.041 . . . . 0.0 111.957 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.01 -84.8 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.0 110.641 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -66.15 174.66 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.152 -179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.93 115.04 31.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.299 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -141.38 134.6 29.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.76 161.09 16.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.629 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.62 157.79 44.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.848 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' OE2' ' A' ' 245' ' ' GLU . 91.9 t80 -162.55 122.96 2.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.668 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.8 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 153' ' ' PHE . 32.8 m-20 -124.66 54.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -137.73 152.41 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.553 -179.329 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 166' ' ' TRP . 1.1 tt0 -140.23 147.7 40.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.216 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD21 ' CZ ' ' A' ' 179' ' ' PHE . 0.4 OUTLIER -146.33 117.46 7.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.257 -179.645 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -112.43 115.42 28.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 110.673 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.8 -45.07 79.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -49.49 -50.72 40.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.714 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 56.4 p -97.18 6.95 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.624 ' CE1' ' CE1' ' A' ' 179' ' ' PHE . 16.9 t60 36.1 57.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.608 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -134.18 159.18 41.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.54 154.45 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.418 ' O ' ' N ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -146.42 129.14 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.731 0.301 . . . . 0.0 111.123 -179.795 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 170' ' ' GLN . 25.5 tttp -127.51 114.55 17.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.414 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 65.06 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.098 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 60.4 29.57 69.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.594 ' N ' ' O ' ' A' ' 167' ' ' LYS . 14.7 tp60 -132.95 92.18 26.72 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.29 136.81 16.32 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.134 1.89 . . . . 0.0 112.379 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.29 136.08 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.957 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 57.9 m -91.06 91.14 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.88 142.58 28.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.931 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 170.74 13.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.95 -53.96 6.18 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.408 2.072 . . . . 0.0 112.43 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 19.2 m -52.3 -63.44 1.14 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -58.33 -37.45 75.16 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.775 -179.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.624 ' CE1' ' CE1' ' A' ' 163' ' ' HIS . 27.7 t80 -54.98 -51.71 65.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -62.77 -35.69 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.549 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tp -61.6 -51.17 69.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.152 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.18 -41.25 98.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.792 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -62.45 -41.79 99.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.23 -37.28 86.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.207 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.97 -46.05 92.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.43 -47.28 90.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.484 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 mm -50.88 -42.08 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -108.98 25.36 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -52.75 117.34 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 113.62 -21.42 16.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 193' ' ' LEU . 21.5 m -96.5 131.47 43.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 242' ' ' VAL . 75.3 t -68.86 119.02 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.697 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 191' ' ' THR . 4.5 mp -96.78 166.27 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 110.77 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.97 148.26 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.67 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -57.36 -51.08 84.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.574 179.782 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 19.6 Cg_endo -64.27 -44.6 11.59 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.675 1.583 . . . . 0.0 112.149 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -57.04 -51.54 68.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 110.244 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 8.5 mt -55.52 -39.0 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 110.393 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 199' ' ' LEU . 2.6 tt -59.43 -67.39 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.071 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -58.13 -15.9 11.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -53.38 12.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.711 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 204' ' ' ARG . 23.8 t -84.06 -30.66 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.269 -179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.575 ' NE1' ' O ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER -60.36 -3.37 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.92 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 202' ' ' VAL . 13.2 mmm-85 -61.01 -1.93 0.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.568 -179.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' TRP . 3.9 m-85 -121.83 4.47 9.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.597 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.68 110.06 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.84 172.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.014 0.435 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.575 ' O ' ' NE1' ' A' ' 203' ' ' TRP . . . 139.65 80.89 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.88 59.04 0.99 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -100.54 98.2 8.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.451 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -6.17 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.642 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -26.07 19.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.789 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 210' ' ' ASP . 4.2 p -67.68 -32.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 92.7 t -57.85 -56.2 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.072 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.51 -46.92 76.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.229 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.0 t -60.6 -45.66 93.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.13 -39.03 89.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.816 0.341 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.15 -46.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.428 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -62.48 -43.32 99.09 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -72.69 -13.32 61.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 221' ' ' LEU . 0.3 OUTLIER -83.26 -48.33 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.131 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 226' ' ' ASP . 12.5 mtm-85 -56.07 -45.05 79.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -68.17 -11.14 58.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.766 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 12.4 tttp -92.7 -33.34 14.38 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.625 -179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -21.6 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -102.74 138.43 39.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.872 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.85 -39.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -53.25 168.98 0.98 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.16 -8.55 56.3 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.916 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 130.1 39.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -85.79 128.43 34.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' ARG . 4.3 mm? -90.09 -74.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.755 179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -91.95 145.45 24.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.646 -179.652 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -105.23 132.44 51.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.38 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -91.69 108.94 20.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.737 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 237' ' ' ARG . 10.2 mt -94.87 72.96 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.469 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -36.84 142.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.19 179.641 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 81.44 -13.1 36.04 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.59 -57.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.567 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 154.37 -138.95 6.44 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.2 OUTLIER -130.51 160.74 33.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.759 0.314 . . . . 0.0 110.697 179.996 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 242' ' ' VAL . 10.8 p -142.64 126.87 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.74 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 36.8 tp -90.64 116.67 28.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -161.9 147.18 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.437 -179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.545 ' OE2' ' CZ ' ' A' ' 153' ' ' PHE . 3.4 mp0 -74.52 154.63 87.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.92 150.45 73.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.505 2.137 . . . . 0.0 111.967 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.645 -179.754 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.85 -112.86 0.36 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 123' ' ' SER . 12.7 t -80.38 81.31 6.67 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.055 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.558 ' O ' ' O ' ' A' ' 122' ' ' SER . 59.4 p 39.25 106.33 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.277 0.561 . . . . 0.0 111.491 178.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -77.06 -73.62 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.738 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -173.3 -176.65 1.37 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 -179.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -127.4 34.47 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 135.68 33.54 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.457 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -93.85 44.89 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.653 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -116.67 -0.01 12.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.281 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -29.69 1.33 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.117 -179.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.03 122.19 32.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.889 0.376 . . . . 0.0 110.8 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.32 -121.08 1.11 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mt -102.28 -165.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.69 0.281 . . . . 0.0 110.344 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.74 71.96 74.04 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-O 120.996 0.427 . . . . 0.0 110.959 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.84 170.68 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.855 2.37 . . . . 0.0 111.966 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 59.26 60.53 2.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.57 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.09 165.78 31.32 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.7 m -103.95 -5.01 22.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -151.34 149.6 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.8 ttt -60.43 -90.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.431 179.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 143' ' ' ASN . 4.3 mtpt -147.53 20.6 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.531 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.06 -24.11 1.69 Allowed Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 144' ' ' LYS . 10.7 t30 -141.99 170.12 16.31 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 27.8 mttm -100.45 170.55 8.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.006 0.432 . . . . 0.0 111.331 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -128.38 151.1 75.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.79 126.7 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.907 2.405 . . . . 0.0 112.4 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.44 -8.95 8.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.75 115.06 19.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -93.29 129.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.832 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -174.5 143.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.13 154.71 18.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 m -142.34 156.97 45.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.67 179.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 154' ' ' ALA . 26.2 t80 -169.66 133.84 1.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.833 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 153' ' ' PHE . . . 38.95 -129.6 0.25 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.63 53.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.349 178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.92 151.24 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -146.79 141.49 26.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.161 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.06 117.95 14.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.383 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -104.11 108.71 20.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.97 0.414 . . . . 0.0 110.354 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.95 -31.05 72.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.167 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 1.4 mp0 -58.77 -48.32 81.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.735 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 163' ' ' HIS . 65.9 p -109.17 13.93 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 0.4 OUTLIER 38.18 50.5 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.733 179.702 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -119.41 158.44 26.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.13 151.97 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.585 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.31 124.72 13.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 170' ' ' GLN . 3.1 ttpt -128.64 121.13 27.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.515 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 32.57 58.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.6 27.76 70.28 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' N ' ' O ' ' A' ' 167' ' ' LYS . 4.6 mt-30 -132.18 97.83 17.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.56 138.52 17.37 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.977 1.784 . . . . 0.0 112.492 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.97 143.24 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.61 -179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.0 t -93.73 97.29 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.737 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -95.97 152.16 18.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.778 -179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.2 161.49 59.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.338 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.46 -45.05 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.628 2.219 . . . . 0.0 112.33 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -42.75 88.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.773 0.32 . . . . 0.0 110.813 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -65.43 -34.46 78.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.162 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -62.41 -45.52 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.119 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -60.3 -43.58 96.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.124 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -47.66 84.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.774 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -60.61 -44.04 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.499 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -56.11 -47.15 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.824 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.509 ' CD1' ' NE2' ' A' ' 201' ' ' HIS . 2.6 t80 -66.08 -38.6 88.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.603 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.594 ' CZ ' ' CE2' ' A' ' 241' ' ' TYR . 3.0 m-85 -55.88 -44.54 78.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.96 -47.62 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.052 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.94 -31.37 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -106.53 23.77 13.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.798 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.08 119.68 9.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 107.74 -23.0 27.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.1 m -94.86 127.8 41.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.916 0.389 . . . . 0.0 110.535 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 192' ' ' VAL . 14.7 p -68.62 112.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.157 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.32 151.18 19.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.792 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.0 p -100.33 148.38 24.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.371 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 196' ' ' PRO . 0.8 OUTLIER -58.39 -48.78 96.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.974 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 195' ' ' LYS . 36.4 Cg_exo -55.03 -46.26 34.6 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.417 2.078 . . . . 0.0 111.666 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -61.97 -52.36 64.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.5 mt -49.95 -38.78 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.916 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.35 -67.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.419 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.93 -21.6 1.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.509 ' NE2' ' CD1' ' A' ' 184' ' ' TYR . 63.1 t60 -72.57 -59.19 2.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 204' ' ' ARG . 64.6 t -83.69 -60.65 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 205' ' ' TYR . 0.9 OUTLIER -51.11 -4.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.507 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.1 OUTLIER -60.65 -0.65 0.29 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.678 0.275 . . . . 0.0 110.597 -179.927 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 203' ' ' TRP . 2.2 m-85 -120.2 14.39 12.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.37 . . . . 0.0 110.452 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.28 98.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.7 111.2 16.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.738 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.61 52.19 0.04 OUTLIER Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -160.24 101.36 0.2 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 209' ' ' GLY . 7.4 t70 -47.57 -177.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 211' ' ' VAL . 7.1 p -78.48 -0.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.627 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.23 -22.16 19.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.689 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 t -64.18 -43.99 97.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.481 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 218' ' ' VAL . 48.3 t -61.35 -43.05 95.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.239 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -58.88 -45.87 89.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.444 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 35.4 t -61.12 -40.74 94.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.106 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -64.04 -43.47 95.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.812 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 214' ' ' VAL . 70.2 t -62.47 -41.02 90.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.284 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.83 -44.21 90.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.357 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -67.41 -31.29 71.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.5 mp -67.55 -45.71 74.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.87 179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 226' ' ' ASP . 30.6 mtp85 -56.74 -46.16 81.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.44 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.35 -24.41 65.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -92.73 -23.37 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.3 OUTLIER -111.12 -41.15 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.695 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 222' ' ' ARG . 24.3 t70 -100.81 141.1 34.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -37.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.422 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -59.37 165.89 9.34 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -69.26 -10.53 58.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.628 0.252 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -93.67 115.75 28.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.422 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -83.9 130.73 34.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 244' ' ' ARG . 27.9 mt -89.55 -74.17 0.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.681 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.64 145.72 26.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.577 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -105.17 140.26 38.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.662 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.6 m -95.85 114.75 26.51 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.036 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 240' ' ' GLY . 57.3 mt -96.14 72.12 2.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 236' ' ' LEU . 2.4 ptp180 -37.93 138.15 0.43 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.07 -18.64 43.39 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.15 -60.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.441 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 236' ' ' LEU . . . 165.19 -142.07 7.47 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.594 ' CE2' ' CZ ' ' A' ' 185' ' ' PHE . 2.0 p90 -130.35 160.27 34.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.52 133.99 52.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.531 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 232' ' ' LEU . 7.8 ptm180 -162.73 127.9 3.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.036 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -75.9 154.18 84.95 Favored Pre-proline 0 C--O 1.232 0.165 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -37.77 110.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.043 2.495 . . . . 0.0 112.846 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.408 179.327 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.68 ' N ' ' NE2' ' A' ' 124' ' ' HIS . 5.4 ptm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.84 22.13 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -135.12 147.74 49.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 110.489 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.94 20.68 6.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.859 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.68 ' NE2' ' N ' ' A' ' 120' ' ' MET . 1.6 m-70 -109.24 125.03 51.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.178 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.707 ' CE1' ' H ' ' A' ' 127' ' ' HIS . 6.1 p80 -152.66 -135.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.908 0.385 . . . . 0.0 111.127 -179.402 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.678 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 1.3 m-70 -73.64 -21.41 60.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.705 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.707 ' H ' ' CE1' ' A' ' 125' ' ' HIS . 4.6 m170 67.26 125.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 176.81 142.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.351 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -149.65 -89.2 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.699 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.61 137.11 41.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.573 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.9 -75.96 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.311 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.47 114.47 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 133' ' ' LEU . 1.1 tp 69.71 111.74 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.765 ' O ' HG13 ' A' ' 134' ' ' VAL . 9.1 p -163.85 54.62 0.42 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 134' ' ' VAL . 33.0 Cg_endo -66.12 156.59 63.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.872 2.382 . . . . 0.0 111.83 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -92.47 145.31 24.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.659 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.15 125.83 0.81 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 140' ' ' MET . 0.0 OUTLIER -103.76 -13.16 16.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.633 0.254 . . . . 0.0 110.52 -179.801 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 33.4 m80 63.72 -30.85 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.589 ' H ' ' C ' ' A' ' 138' ' ' SER . 4.7 ttm -172.47 117.97 0.36 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.108 0.48 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -70.23 -23.61 62.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.435 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.52 -110.77 0.45 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.634 HD22 ' H ' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -56.09 133.68 52.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.86 0.362 . . . . 0.0 111.117 -179.687 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.548 ' N ' HD22 ' A' ' 143' ' ' ASN . 10.4 mtpt -109.13 10.22 26.0 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.634 ' H ' HD22 ' A' ' 143' ' ' ASN . 0.6 OUTLIER -162.25 77.11 2.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.667 179.567 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.48 -15.14 46.89 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.623 2.215 . . . . 0.0 111.112 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -107.54 167.29 10.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.737 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.07 129.0 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.199 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 149' ' ' VAL . 1.0 OUTLIER -71.11 140.46 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 -179.678 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -149.2 138.09 21.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mt -90.72 151.27 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.575 -179.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.0 158.03 44.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.141 0.496 . . . . 0.0 111.218 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 243' ' ' LEU . 3.8 t80 -164.79 139.76 5.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.347 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.544 ' N ' ' CD1' ' A' ' 153' ' ' PHE . . . 37.28 -105.32 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.69 53.11 1.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -137.43 150.71 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.556 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -140.45 137.02 33.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.779 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.38 143.34 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.216 179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.26 109.47 15.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.06 -17.38 64.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.41 -52.03 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 163' ' ' HIS . 42.3 p -96.79 12.04 33.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.646 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 162' ' ' THR . 8.6 m80 37.36 41.15 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.1 169.36 9.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.868 -179.399 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 166' ' ' TRP . 62.1 t -122.28 161.04 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.477 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -145.62 127.09 15.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.121 179.647 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 170' ' ' GLN . 1.6 tmtm? -124.67 113.51 18.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.687 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 167' ' ' LYS . . . 30.93 64.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.052 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 57.41 31.69 63.26 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.5 tt0 -142.3 89.39 8.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -61.82 150.07 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.23 1.953 . . . . 0.0 112.544 -179.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.2 126.5 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.905 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.0 p -95.13 115.39 27.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.302 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.871 ' N ' HD23 ' A' ' 174' ' ' LEU . 0.6 OUTLIER -141.69 154.28 45.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.489 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.64 161.53 1.57 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.0 -33.99 95.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.889 2.393 . . . . 0.0 111.96 179.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -60.81 -53.61 55.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.954 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -62.13 -37.81 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.229 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.48 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 4.7 t80 -58.48 -48.08 81.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.9 m -58.8 -39.33 80.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.611 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 181' ' ' LEU . 44.7 tp -60.87 -46.87 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.348 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.18 -40.65 86.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -59.89 -43.62 94.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.64 -179.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.45 -43.07 91.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.564 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.43 -43.11 83.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.91 -48.75 86.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.52 -35.67 64.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.136 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.4 23.25 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.789 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.48 117.23 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.914 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.66 -14.15 24.79 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.3 m -98.48 130.9 45.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.723 0.297 . . . . 0.0 110.695 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.18 115.07 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.457 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.89 152.65 18.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.445 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.75 147.96 27.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.201 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -56.58 -51.34 81.94 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.291 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 195' ' ' LYS . 22.0 Cg_endo -65.23 -36.35 36.72 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.65 1.567 . . . . 0.0 111.987 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -66.49 -46.83 75.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.92 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 32.7 mt -53.81 -42.22 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.139 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 203' ' ' TRP . 4.1 mt -63.7 -64.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.524 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.49 -32.39 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.37 -53.59 10.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.064 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 204' ' ' ARG . 25.9 t -83.5 -61.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.048 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -52.0 -3.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.189 -179.359 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 202' ' ' VAL . 0.0 OUTLIER -61.14 -4.89 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.0 110.51 179.879 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 203' ' ' TRP . 1.9 t80 -113.95 -0.22 14.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.103 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -175.22 91.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.57 110.56 15.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 176.14 48.86 0.06 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 210' ' ' ASP . . . -155.19 101.56 0.21 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 209' ' ' GLY . 1.3 m-20 -49.55 -173.78 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 0.0 110.776 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.9 -4.79 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.67 -21.09 22.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.387 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.79 -33.83 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.951 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 218' ' ' VAL . 11.7 t -60.94 -50.74 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.263 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -45.97 83.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.3 p -61.04 -44.04 97.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -40.48 94.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 214' ' ' VAL . 49.5 t -62.45 -40.06 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.688 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -43.31 80.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.285 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -12.99 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.66 -50.18 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.984 179.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 226' ' ' ASP . 1.3 ttp180 -56.28 -51.14 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.295 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -8.31 29.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.547 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -92.36 -37.09 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.57 -179.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.76 -25.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.946 0.403 . . . . 0.0 110.72 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' ARG . 0.3 OUTLIER -105.49 139.43 40.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.598 179.914 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 227' ' ' THR . 13.2 t -165.93 38.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -129.16 -173.52 13.44 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.2 -13.19 57.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.69 -0.255 . . . . 0.0 111.038 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -93.89 115.49 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.954 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.2 mmt180 -97.52 113.17 24.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -90.32 -1.68 57.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.483 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.4 107.48 15.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.93 125.01 41.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 36.7 m -91.8 111.48 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.539 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 237' ' ' ARG . 5.7 mt -95.23 72.8 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.462 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 236' ' ' LEU . 19.0 ttt-85 -36.75 127.04 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.98 -10.7 70.07 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.91 -39.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.274 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 135.96 -137.84 9.45 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 241' ' ' TYR . 0.1 OUTLIER -128.7 154.67 46.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 0.0 110.838 -179.846 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.09 138.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -91.75 113.61 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.416 179.79 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -161.7 130.95 4.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.634 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.493 ' HG2' HD22 ' A' ' 232' ' ' LEU . 16.3 mt-10 -77.25 154.08 82.15 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.57 126.24 12.57 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.74 2.293 . . . . 0.0 112.086 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.552 179.912 . . . . . . . . 0 0 . 1 stop_ save_